data_1uvf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1uvf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.4 m -80.25 -6.76 58.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.499 -0.751 . . . . 0.0 109.112 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -57.69 -25.65 60.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.844 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -149.82 66.87 0.99 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 110.051 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.503 ' OH ' ' CD1' ' A' ' 44' ' ' LEU . 6.2 p90 -127.27 171.03 11.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 109.153 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.422 ' C ' HG21 ' A' ' 10' ' ' VAL . 49.1 ttp180 -145.39 155.64 43.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.739 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.422 HG21 ' C ' ' A' ' 9' ' ' ARG . 92.7 t -148.57 122.75 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 109.291 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 mp -114.6 175.67 1.79 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.334 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.9 Cg_endo -67.64 -28.13 37.88 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.579 2.186 . . . . 0.0 111.578 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -101.48 -26.33 13.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.21 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 91.6 mt -88.49 -41.19 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.365 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.02 -144.67 46.82 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.498 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 2.0 t80 -104.7 157.66 17.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -1.19 . . . . 0.0 109.476 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.2 tp -119.36 119.55 34.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.897 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 85.9 m -135.52 157.04 77.23 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.153 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.9 Cg_endo -70.93 167.38 26.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.468 2.112 . . . . 0.0 111.585 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.64 -13.89 36.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.431 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.32 121.27 19.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.122 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.6 tp -84.03 114.92 22.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 0.0 109.781 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mmtm -128.45 107.37 19.15 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 108.94 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.52 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.6 Cg_endo -65.96 121.06 8.31 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 123.141 2.561 . . . . 0.0 112.41 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.8 m -118.2 156.11 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.786 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.5 t -97.1 142.15 29.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 108.855 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -96.48 138.38 13.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.5 p30 -66.48 -15.06 63.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -1.105 . . . . 0.0 109.569 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 85.9 m-20 -84.64 8.83 15.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.68 25.81 37.38 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.446 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 82.2 mt-30 -125.65 177.21 6.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -1.094 . . . . 0.0 109.328 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.527 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 16.4 m -137.97 138.4 38.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 109.298 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.606 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 41.8 m-85 -118.17 121.08 39.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.316 -0.865 . . . . 0.0 109.265 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.7 m-20 -46.71 -78.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.836 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.7 t-20 -81.54 146.9 58.17 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 120.88 -1.137 . . . . 0.0 109.669 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.26 -53.08 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.839 2.359 . . . . 0.0 111.705 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -62.92 -27.58 69.48 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.988 -1.07 . . . . 0.0 108.13 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.427 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 24.6 mtp -64.52 -17.5 63.96 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.606 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 24.5 tp -66.43 -54.75 20.59 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.459 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 7.7 t -60.07 -27.35 66.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 36.8 t60 -63.1 -57.4 10.71 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -61.35 -21.26 63.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 47' ' ' GLN . 89.6 m-20 -79.91 -26.9 40.02 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.503 ' CD1' ' OH ' ' A' ' 8' ' ' TYR . 38.3 tp -65.71 -36.81 84.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.393 -0.817 . . . . 0.0 108.982 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.451 HD11 HG22 ' A' ' 45' ' ' ILE . 5.6 mt -80.08 -48.57 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.03 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 75.7 mtt-85 -70.77 -39.41 73.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 109.535 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.9 mt-30 64.01 40.66 7.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.83 . . . . 0.0 109.416 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.8 p -108.93 5.41 24.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.595 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.458 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 39.8 t-20 52.73 59.25 4.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.602 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 m -79.41 141.75 36.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.895 . . . . 0.0 109.467 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.458 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 33.5 m80 -114.09 167.68 10.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.85 . . . . 0.0 108.967 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 52' ' ' ILE . 35.1 mt -80.22 127.26 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.026 . . . . 0.0 109.433 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.7 ttt180 -80.03 -42.24 24.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.373 -0.829 . . . . 0.0 109.146 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 t -160.35 156.22 25.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.6 p -70.91 144.3 50.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 109.475 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.27 166.85 40.68 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.527 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 54.1 mttp -67.02 149.68 50.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -1.075 . . . . 0.0 109.404 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 56.7 m -59.46 152.69 21.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.526 -179.883 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 8' ' ' TYR . 31.6 m -81.18 -19.67 42.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -0.847 . . . . 0.0 109.136 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 5' ' ' CYS . 23.5 mttm -45.21 -28.81 0.84 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 109.024 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 55.4 p30 -111.13 31.21 6.23 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 5' ' ' CYS . 2.1 t80 -80.0 144.07 33.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.57 -0.706 . . . . 0.0 109.675 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -142.78 115.24 8.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.352 -0.842 . . . . 0.0 109.299 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.461 ' CG2' ' C ' ' A' ' 15' ' ' GLY . 9.3 p -129.82 145.78 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.601 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.517 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -103.63 174.47 2.76 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.6 Cg_endo -67.89 -25.1 39.24 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.622 2.215 . . . . 0.0 111.803 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -91.88 -29.72 16.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 0.0 109.255 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.6 mt -81.47 -39.57 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.575 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.461 ' C ' ' CG2' ' A' ' 10' ' ' VAL . . . 64.41 140.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.443 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 1.2 t80 -43.85 153.58 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -1.195 . . . . 0.0 109.456 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 32.5 tp -119.26 126.19 50.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.844 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 66.3 m -139.37 156.63 71.64 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.989 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.68 166.34 30.18 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.562 2.175 . . . . 0.0 111.66 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -86.79 -19.89 28.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -66.08 122.58 17.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.274 -0.891 . . . . 0.0 109.502 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.5 tp -82.51 126.5 32.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.512 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -139.86 100.44 7.32 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.32 118.6 5.55 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.904 2.403 . . . . 0.0 112.27 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.466 HG13 HD12 ' A' ' 52' ' ' ILE . 13.7 m -116.51 155.53 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.664 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 47.2 t -95.57 133.86 39.1 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 108.804 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -88.88 136.47 13.65 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.5 p30 -66.99 -8.31 28.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -1.152 . . . . 0.0 109.643 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -88.02 10.47 18.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.352 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.01 21.87 54.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 72.8 mt-30 -126.33 175.52 7.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -1.081 . . . . 0.0 109.578 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 21.1 m -135.2 138.9 44.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.393 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.644 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 61.1 m-85 -118.06 125.42 50.28 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.279 -0.888 . . . . 0.0 109.299 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.504 ' O ' ' O ' ' A' ' 23' ' ' LYS . 5.0 m-20 -49.79 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.646 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.1 t-20 -82.06 146.06 54.41 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.015 -1.053 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.89 -51.64 2.82 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.774 2.316 . . . . 0.0 111.538 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.5 t -60.9 -29.96 69.89 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.459 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 16.4 mtp -65.2 -13.45 58.26 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.644 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 43.5 tp -68.87 -52.09 33.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 109.095 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.443 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.8 m -66.68 -22.2 66.08 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -67.27 -55.55 13.48 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.1 mm-40 -61.99 -20.01 63.42 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' GLN . 61.2 m-20 -80.43 -36.82 33.14 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.0 tp -54.79 -34.64 62.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 45' ' ' ILE . 11.1 mm -80.13 -50.95 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.457 -0.777 . . . . 0.0 108.966 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 7.2 mtp85 -64.36 -24.89 67.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.251 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.4 mt-30 62.96 41.62 8.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.836 . . . . 0.0 109.477 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 p -128.32 167.93 16.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.435 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 48.1 p-10 -98.28 62.27 1.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.536 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.6 m -76.5 129.19 36.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.431 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.435 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 59.3 m80 -111.22 172.52 6.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.37 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.466 HD12 HG13 ' A' ' 25' ' ' VAL . 27.5 mt -79.72 124.55 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.234 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 58.7 ttt85 -79.99 -44.38 20.33 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.397 -0.814 . . . . 0.0 109.362 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 p -157.08 158.62 36.77 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.465 -0.772 . . . . 0.0 109.114 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -76.88 133.0 39.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.533 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 100.47 163.48 28.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 14.2 tttp -53.34 154.41 3.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.496 -1.002 . . . . 0.0 109.457 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 89.5 m -64.88 147.39 53.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.385 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.429 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 67.8 mtm . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.566 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 2.8 m -80.64 -9.47 59.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.497 -0.752 . . . . 0.0 109.173 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -80.53 8.77 7.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 109.662 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 4' ' ' MET . 43.7 p30 -120.1 -0.31 10.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.08 -1.013 . . . . 0.0 110.065 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 4.2 p90 -103.37 -179.61 4.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.974 -1.078 . . . . 0.0 109.632 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.606 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 56.2 mtt180 -162.39 140.93 8.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.522 -0.736 . . . . 0.0 109.201 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 16' ' ' TYR . 61.4 t -117.69 140.17 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 109.747 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.535 ' CD2' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -128.09 175.65 3.29 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.401 -0.812 . . . . 0.0 109.143 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 11' ' ' LEU . 44.9 Cg_endo -67.31 -22.4 46.18 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.557 2.172 . . . . 0.0 111.674 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -121.47 -12.15 8.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.425 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 14' ' ' ILE . 31.4 mm -86.91 -50.68 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.89 -169.43 46.48 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.461 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 1.5 t80 -83.16 148.89 27.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.171 -1.193 . . . . 0.0 109.544 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.443 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 20.8 tp -119.57 130.05 54.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.742 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 73.2 m -145.19 157.53 53.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.0 109.023 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.5 Cg_endo -70.38 166.42 28.43 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.541 2.161 . . . . 0.0 111.554 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -84.2 -31.75 24.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.215 -0.928 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -54.87 134.42 48.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.346 -0.846 . . . . 0.0 109.054 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.477 ' CD1' ' OD1' ' A' ' 34' ' ' ASN . 61.2 tp -101.74 123.45 45.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.932 . . . . 0.0 109.504 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 10.9 mttt -140.32 111.58 7.13 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -65.59 120.25 7.41 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 122.989 2.459 . . . . 0.0 112.024 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.469 HG22 HD11 ' A' ' 39' ' ' LEU . 35.0 m -117.65 153.86 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.233 -0.917 . . . . 0.0 109.772 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 35.6 t -95.48 132.59 40.41 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.23 137.89 13.94 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 43.0 p30 -67.19 -8.28 30.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -1.062 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.45 16.17 5.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.34 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.25 20.61 72.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 27' ' ' GLY . 76.2 mt-30 -131.13 153.66 49.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -1.209 . . . . 0.0 109.586 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.503 HG23 ' CG ' ' A' ' 57' ' ' LYS . 11.1 m -115.74 141.01 48.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 50.0 m-85 -115.26 130.85 57.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.296 -0.877 . . . . 0.0 109.327 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 50.8 t-20 -53.07 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.315 -0.865 . . . . 0.0 109.563 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -81.39 150.02 66.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.998 -1.064 . . . . 0.0 109.416 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -62.47 -54.08 1.51 Allowed 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.7 2.267 . . . . 0.0 112.051 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.1 t -59.84 -30.61 69.07 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.97 -1.081 . . . . 0.0 108.159 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.471 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 16.4 mtp -59.29 -25.41 64.09 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.529 HD13 ' CD2' ' A' ' 33' ' ' TYR . 7.6 tt -63.93 -46.37 85.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 35.0 m -55.86 -27.99 54.34 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -59.33 -49.73 76.7 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 18.0 tp10 -57.71 -19.22 25.73 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 50' ' ' THR . 4.0 m-80 -80.36 -35.13 35.89 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.38 -37.99 74.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.456 -0.777 . . . . 0.0 109.308 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 45' ' ' ILE . 12.5 mm -79.94 -51.17 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.259 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.519 ' CD ' ' HG3' ' A' ' 42' ' ' GLU . 67.9 mtp85 -73.13 -33.12 65.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 109.636 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.2 mt-30 58.15 27.45 15.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 82.4 p -105.04 5.17 32.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.18 -0.95 . . . . 0.0 109.544 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.519 ' O ' ' NE2' ' A' ' 51' ' ' HIS . 33.4 m120 64.53 52.37 1.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.873 . . . . 0.0 109.675 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 67.8 m -72.3 135.94 46.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.519 ' NE2' ' O ' ' A' ' 49' ' ' ASN . 5.3 m-70 -115.34 -177.23 3.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.295 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 52' ' ' ILE . 23.6 mt -87.09 124.25 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.904 . . . . 0.0 109.473 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 44.7 ttt-85 -80.44 -40.59 26.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.41 -0.806 . . . . 0.0 109.341 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -159.04 151.23 21.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.481 -0.762 . . . . 0.0 109.204 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.6 p -71.21 146.56 48.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.132 -0.98 . . . . 0.0 109.382 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.19 166.69 42.61 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.503 ' CG ' HG23 ' A' ' 32' ' ' THR . 62.4 tttt -65.25 146.32 55.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -1.101 . . . . 0.0 109.252 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.1 150.71 30.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.699 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.45 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 m -79.64 -17.03 54.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 109.133 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -47.74 -23.73 0.78 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.254 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -116.66 41.85 2.59 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.476 ' OH ' ' N ' ' A' ' 17' ' ' LEU . 4.8 t80 -92.63 160.93 14.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.604 0.716 . . . . 0.0 110.748 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.432 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 10.1 ttp180 -146.39 135.47 22.6 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.512 HG11 ' CA ' ' A' ' 15' ' ' GLY . 55.2 t -126.87 117.6 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.968 . . . . 0.0 109.669 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.539 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -100.24 175.71 2.26 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 109.506 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.4 Cg_endo -67.45 -24.01 43.16 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.741 2.294 . . . . 0.0 112.118 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -108.66 -21.63 12.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.383 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.1 -45.53 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.868 . . . . 0.0 109.603 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.512 ' CA ' HG11 ' A' ' 10' ' ' VAL . . . 65.98 -148.3 50.86 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.519 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 1.2 t80 -99.48 154.55 18.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -1.213 . . . . 0.0 109.372 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.476 ' N ' ' OH ' ' A' ' 8' ' ' TYR . 18.3 tp -125.76 125.8 43.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.943 . . . . 0.0 109.717 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 86.0 m -138.44 156.88 73.19 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.324 -0.86 . . . . 0.0 109.244 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -69.96 166.01 29.29 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.629 2.219 . . . . 0.0 111.666 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -85.0 -20.43 30.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.306 -0.872 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -65.08 123.07 18.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.335 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.4 tm? -87.74 121.78 30.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.526 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.474 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 22.1 mtpt -141.08 114.88 7.04 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 0.0 109.616 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 45.7 Cg_endo -67.31 120.68 7.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.839 2.36 . . . . 0.0 111.627 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.465 HG22 HD11 ' A' ' 39' ' ' LEU . 34.1 m -119.44 153.81 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.303 -0.873 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.0 t -97.91 144.83 27.06 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -99.61 139.92 14.69 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -67.48 -7.37 25.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -1.158 . . . . 0.0 109.578 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 27.5 m-20 -91.04 8.58 34.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.51 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.07 29.43 28.34 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 27' ' ' GLY . 80.7 mt-30 -133.12 165.81 23.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -1.155 . . . . 0.0 109.45 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.48 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 32.4 m -125.25 147.57 49.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.427 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.587 ' CE2' HD13 ' A' ' 39' ' ' LEU . 76.5 m-85 -127.28 119.49 26.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.221 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' LYS . 50.4 t30 -41.74 -77.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.782 . . . . 0.0 109.673 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -81.28 148.73 64.04 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.985 -1.072 . . . . 0.0 108.863 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.3 Cg_endo -62.62 -51.91 2.83 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.506 2.137 . . . . 0.0 112.101 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.0 t -63.52 -25.7 68.37 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.949 -1.094 . . . . 0.0 108.47 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 15.8 mtt -64.72 -18.4 64.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.292 -0.88 . . . . 0.0 108.848 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.587 HD13 ' CE2' ' A' ' 33' ' ' TYR . 4.7 tt -70.13 -53.9 15.31 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.375 -0.828 . . . . 0.0 108.87 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.519 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . 63.8 m -50.9 -24.31 3.5 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -60.04 -49.84 76.06 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.322 -0.861 . . . . 0.0 108.685 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 12.2 tp10 -55.93 -19.74 13.35 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 50' ' ' THR . 4.0 m-80 -80.07 -32.52 39.32 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.3 tp -66.45 -42.19 87.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.833 . . . . 0.0 109.38 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.97 -45.24 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.306 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HB3' HG22 ' A' ' 48' ' ' THR . 46.9 mtp85 -77.33 -17.3 58.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.178 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 57.68 28.8 16.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.667 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.45 HG22 ' HB3' ' A' ' 46' ' ' ARG . 8.4 p -110.2 -173.11 2.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.235 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -112.03 51.81 0.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.525 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 51.6 m -71.68 122.28 20.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -109.3 -175.69 2.83 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.324 -0.86 . . . . 0.0 108.999 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.45 HG22 ' HB ' ' A' ' 25' ' ' VAL . 21.2 mt -80.08 125.82 39.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 109.398 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 26.9 ttt85 -79.87 -45.68 18.21 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.331 -0.856 . . . . 0.0 109.584 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 p -160.42 131.69 5.74 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.57 -0.706 . . . . 0.0 109.465 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 p -48.25 142.83 5.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.439 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 93.65 166.71 37.71 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.48 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 68.2 mttt -67.36 148.69 51.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.451 -1.029 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.421 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 86.5 m -57.03 146.39 27.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.449 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.491 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.3 mtm . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.3 m -79.83 -0.52 34.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.772 . . . . 0.0 109.046 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -60.61 -28.86 68.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 109.377 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -149.14 67.09 1.03 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.877 . . . . 0.0 109.681 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 11.4 p90 -118.27 -170.71 1.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 109.414 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -153.91 145.58 23.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.893 . . . . 0.0 109.628 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.46 HG22 ' CD2' ' A' ' 16' ' ' TYR . 42.5 t -139.73 135.53 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.409 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.53 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -115.03 174.79 2.16 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.668 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.7 Cg_endo -68.1 -22.76 40.7 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.787 2.325 . . . . 0.0 111.678 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -97.35 -29.45 13.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.239 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.11 -44.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.652 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.86 -164.2 39.64 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -100.59 151.37 21.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -1.217 . . . . 0.0 109.569 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.5 tp -116.38 110.47 18.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.337 -0.852 . . . . 0.0 109.828 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 63.4 m -126.62 156.35 73.43 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.245 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.13 171.39 16.88 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.645 2.23 . . . . 0.0 111.619 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 tttm -88.6 -29.86 19.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.473 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -57.14 133.57 55.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.385 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.7 tp -92.88 115.42 28.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.506 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -125.07 104.4 29.57 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.475 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.4 118.65 5.65 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 C-N-CA 122.911 2.407 . . . . 0.0 111.997 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' HG21 ' A' ' 32' ' ' THR . 14.8 m -117.03 155.68 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 109.737 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.5 t -97.02 123.33 40.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.827 . . . . 0.0 109.006 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -77.57 136.08 17.69 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.4 p30 -67.39 -8.6 34.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -1.12 . . . . 0.0 109.562 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.4 p30 -87.05 11.96 12.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 17.76 62.3 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.0 mt-30 -123.51 176.92 5.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -1.098 . . . . 0.0 109.53 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 57' ' ' LYS . 41.1 m -135.91 141.82 44.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.063 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.61 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 42.0 m-85 -121.13 128.2 52.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -0.922 . . . . 0.0 109.505 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' A' ' 23' ' ' LYS . 6.7 m-20 -48.66 -79.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.813 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.8 t-20 -81.67 147.13 58.29 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.006 -1.059 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.51 -52.49 1.89 Allowed 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.877 2.385 . . . . 0.0 111.936 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.8 t -64.16 -25.08 67.92 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.941 -1.099 . . . . 0.0 108.208 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.462 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 44.3 mmm -68.93 -14.72 63.21 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.61 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 20.6 tp -65.69 -51.0 62.86 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.468 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.0 m -68.72 -18.16 64.19 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 25.7 t60 -69.88 -55.29 10.12 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.517 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 88.7 tt0 -64.26 -18.64 64.75 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 47' ' ' GLN . 73.8 m-20 -79.74 -36.11 37.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.9 -32.94 66.43 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mt -80.35 -46.14 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.515 ' NE ' HG22 ' A' ' 48' ' ' THR . 69.7 ttt180 -70.53 -21.6 62.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.118 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . 81.4 mt-30 63.54 43.36 5.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.506 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.515 HG22 ' NE ' ' A' ' 46' ' ' ARG . 75.4 p -126.72 167.68 15.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -103.16 56.52 0.75 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.487 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.41 HG21 ' OD1' ' A' ' 28' ' ' ASP . 85.6 m -77.63 138.77 39.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 109.321 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -118.91 176.46 5.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.26 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 52' ' ' ILE . 34.4 mt -80.12 124.72 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 29.2 tpt180 -81.28 -53.27 6.49 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.599 -0.688 . . . . 0.0 109.427 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 p -146.05 146.1 30.82 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.595 -0.69 . . . . 0.0 109.447 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.8 p -66.4 147.85 52.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.396 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.71 162.61 37.53 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.455 ' HA ' HG22 ' A' ' 32' ' ' THR . 41.0 tttt -63.92 148.85 48.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.474 -1.015 . . . . 0.0 109.341 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.3 148.68 30.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.451 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 65.1 mmm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 13.4 m -84.21 -27.97 27.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.3 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -75.63 -2.48 29.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.632 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 4' ' ' MET . 15.7 p30 -122.94 1.1 9.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.849 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.581 ' OH ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -119.13 154.56 33.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.091 -1.006 . . . . 0.0 109.321 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -133.43 127.46 33.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.259 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 16' ' ' TYR . 4.6 p -124.08 142.73 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 109.588 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.507 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.8 mp -105.62 174.06 2.87 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.158 -0.964 . . . . 0.0 109.211 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.4 Cg_endo -67.79 -28.86 36.19 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.606 2.204 . . . . 0.0 111.88 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -87.4 -28.33 22.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.365 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.4 HD12 HG22 ' A' ' 14' ' ' ILE . 89.2 mt -84.0 -39.39 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 109.401 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.448 ' C ' ' CG2' ' A' ' 10' ' ' VAL . . . 67.41 155.77 0.55 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.581 ' CE2' ' OH ' ' A' ' 8' ' ' TYR . 1.3 t80 -52.63 148.39 7.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.281 -1.129 . . . . 0.0 109.604 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.3 tp -115.82 112.49 22.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.457 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 60.5 m -123.7 155.82 65.81 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.303 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.75 165.18 33.33 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.648 2.232 . . . . 0.0 111.794 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -87.31 -10.41 52.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.478 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.66 133.73 44.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.348 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.487 ' CD1' ' HD3' ' A' ' 24' ' ' PRO . 3.1 tm? -89.73 118.94 29.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' ASN . 5.9 mttp -134.38 100.67 12.53 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.319 -0.863 . . . . 0.0 109.103 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.0 Cg_endo -63.33 123.11 11.57 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 123.121 2.547 . . . . 0.0 112.411 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' HG21 ' A' ' 32' ' ' THR . 32.4 m -120.62 154.79 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.446 -0.784 . . . . 0.0 109.641 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -98.35 137.5 36.98 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -94.02 138.16 13.91 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.49 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.1 p30 -64.96 -11.31 37.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.366 -1.079 . . . . 0.0 109.535 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 57.5 p30 -87.43 11.5 14.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.28 21.19 61.03 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.437 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 89.4 mt-30 -122.16 170.37 9.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.509 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.469 HG21 ' O ' ' A' ' 25' ' ' VAL . 86.9 m -129.31 135.49 48.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.305 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.639 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 64.2 m-85 -115.12 121.22 42.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.286 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -44.61 -82.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.835 . . . . 0.0 109.802 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.9 t-20 -80.07 147.13 64.76 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.157 -0.964 . . . . 0.0 109.565 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 39.6 Cg_endo -62.7 -52.1 2.63 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.659 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.557 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 10.7 t -62.69 -26.71 68.8 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 40.2 mmm -65.32 -16.51 63.65 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.639 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 25.6 tp -67.11 -55.57 13.69 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 16' ' ' TYR . 16.1 t -57.72 -23.16 50.39 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -72.92 -59.84 2.51 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.476 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 81.7 mt-10 -58.42 -18.5 28.81 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.5 m-20 -76.72 -39.09 53.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.496 -0.752 . . . . 0.0 108.98 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.484 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.3 tm? -55.67 -37.09 67.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.281 -0.887 . . . . 0.0 108.844 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.4 mt -75.36 -46.17 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 0.0 108.939 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 43.9 ttt85 -68.26 -27.84 66.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.0 109.191 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 90.2 mt-30 63.25 42.27 7.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 109.668 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.42 ' CG2' ' HG2' ' A' ' 46' ' ' ARG . 72.5 p -131.25 175.76 8.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.227 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.575 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 78.9 m-20 -101.57 64.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.215 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.8 m -76.66 132.21 39.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 109.953 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 42.9 m80 -116.03 171.28 7.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -0.869 . . . . 0.0 108.681 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.463 HG22 ' HB ' ' A' ' 25' ' ' VAL . 11.4 mt -79.71 123.91 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.073 -1.017 . . . . 0.0 109.186 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.49 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 54.7 ttt85 -79.71 -42.09 25.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.292 -0.88 . . . . 0.0 109.317 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 t -160.3 155.07 24.18 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.6 p -70.84 143.89 50.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.094 -1.004 . . . . 0.0 109.171 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.69 168.29 40.94 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.445 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 31.6 mttm -66.47 151.69 46.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -1.1 . . . . 0.0 109.428 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.46 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 71.8 m -60.89 152.58 27.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.346 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.499 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 mtt . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.53 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.5 m -86.98 -8.66 56.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.391 -0.818 . . . . 0.0 109.517 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -60.02 -23.43 63.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 109.783 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -150.69 63.51 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.062 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.53 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 4.2 p90 -129.16 167.12 18.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 109.203 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -143.97 145.07 31.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 109.616 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.0 t -137.61 131.87 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 109.659 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.529 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -122.49 175.1 2.81 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.36 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.0 Cg_endo -67.67 -26.28 39.49 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.648 2.232 . . . . 0.0 111.772 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -100.3 -27.52 13.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.293 -0.879 . . . . 0.0 109.203 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.8 mm -91.02 -43.2 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.42 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.33 -146.41 45.8 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' A' ' 40' ' ' CYS . 2.2 t80 -104.58 157.43 17.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -1.134 . . . . 0.0 109.482 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.1 tp -115.58 115.02 25.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 109.865 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 57.7 m -135.86 155.77 77.69 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 109.231 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.55 167.62 25.91 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.549 2.166 . . . . 0.0 111.587 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -84.68 -18.71 34.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -70.4 123.34 21.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.29 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.429 HD23 ' CA ' ' A' ' 35' ' ' ASN . 3.4 tm? -86.46 109.76 19.29 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.492 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -116.05 103.61 53.14 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.399 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.2 Cg_endo -63.68 117.2 4.19 Favored 'Trans proline' 0 C--O 1.213 -0.764 0 C-N-CA 123.082 2.521 . . . . 0.0 112.414 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.462 ' O ' HG21 ' A' ' 32' ' ' THR . 11.0 m -115.29 157.18 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.403 -0.811 . . . . 0.0 109.83 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 46.0 t -98.65 141.57 31.31 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.72 141.32 15.48 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.479 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.5 t0 -69.84 -9.4 54.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -1.147 . . . . 0.0 109.414 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -90.31 0.59 57.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.404 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.79 21.76 22.77 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.2 mt-30 -121.5 172.66 7.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -1.138 . . . . 0.0 109.48 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 25' ' ' VAL . 99.4 m -133.48 140.09 47.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.624 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 40.8 m-85 -121.78 129.01 52.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.012 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 23' ' ' LYS . 1.8 m-20 -52.77 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.026 -1.046 . . . . 0.0 109.67 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 15.3 t-20 -81.85 145.73 54.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.019 -1.05 . . . . 0.0 109.587 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.29 -51.15 2.87 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.643 2.228 . . . . 0.0 111.346 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.503 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.5 t -61.64 -27.99 69.06 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 36.3 mmm -67.05 -13.93 62.41 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.624 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 29.8 tp -68.44 -53.69 21.92 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.464 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 14.0 t -58.98 -23.29 61.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -69.21 -57.93 4.71 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -61.97 -19.35 62.7 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.483 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 99.2 m-20 -77.15 -32.09 56.03 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.461 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 1.7 tm? -61.49 -38.09 86.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 108.875 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mt -75.89 -48.51 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.299 -0.876 . . . . 0.0 109.222 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -68.7 -36.86 79.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.885 . . . . 0.0 109.354 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.2 mt-30 59.81 38.04 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.425 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' ASN . 43.9 p -112.87 16.66 19.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.391 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.572 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 57.7 m-20 44.94 58.88 3.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.331 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.483 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 36.0 m -77.21 144.83 38.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.683 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 27.6 m80 -118.93 169.45 9.87 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 52' ' ' ILE . 41.7 mt -79.14 126.55 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.109 -0.995 . . . . 0.0 109.357 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 42.1 ttt85 -79.71 -46.85 16.32 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.412 -0.805 . . . . 0.0 109.251 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 m -160.29 151.92 19.8 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 p -65.29 142.75 58.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.099 -1.001 . . . . 0.0 109.591 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.31 165.02 36.27 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 65.0 mttt -67.94 148.84 50.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -1.056 . . . . 0.0 109.408 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.46 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 58.4 m -60.04 153.44 21.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.477 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 86.9 mtp . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.425 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 4.0 m -79.75 -6.88 58.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.507 -0.745 . . . . 0.0 109.069 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 15.6 mttm -56.39 -32.29 64.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 77.2 m-20 -146.36 67.18 1.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 109.866 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.576 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 4.4 p90 -126.41 169.78 12.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 109.068 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -140.95 149.4 41.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.124 -0.985 . . . . 0.0 109.846 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.409 HG22 ' CD2' ' A' ' 16' ' ' TYR . 77.8 t -145.06 131.39 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.832 . . . . 0.0 109.359 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.526 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mp -122.34 175.09 2.79 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.955 . . . . 0.0 109.551 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.2 Cg_endo -67.9 -22.89 41.76 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.69 2.26 . . . . 0.0 111.77 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -107.07 -31.32 8.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.147 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.437 HD11 HG22 ' A' ' 14' ' ' ILE . 48.9 mm -83.3 -39.95 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.518 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.83 -145.52 41.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.6 t80 -107.26 156.1 19.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 109.458 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 tp -117.29 121.15 40.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 81.9 m -132.25 157.06 79.26 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.36 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.3 Cg_endo -71.17 165.7 31.59 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.681 2.254 . . . . 0.0 111.578 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -88.68 -13.52 39.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.327 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -68.67 130.66 43.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.103 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.497 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.3 tm? -89.2 122.5 32.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.607 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.481 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -141.69 105.59 5.86 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.337 -0.852 . . . . 0.0 109.279 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.539 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -66.05 121.38 8.7 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 C-N-CA 122.951 2.434 . . . . 0.0 111.902 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.439 HG22 HD11 ' A' ' 39' ' ' LEU . 18.7 m -117.14 154.96 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 109.949 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 16.7 t -97.61 130.45 44.63 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -88.77 139.53 15.42 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.2 p30 -66.33 -9.84 37.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -1.118 . . . . 0.0 109.606 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 57.2 p30 -85.39 12.9 7.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.333 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.35 21.53 64.54 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.2 mt-30 -127.25 168.97 14.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -1.151 . . . . 0.0 109.374 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 57' ' ' LYS . 24.6 m -127.37 139.81 52.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.895 . . . . 0.0 109.513 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.595 ' CD2' ' CD1' ' A' ' 39' ' ' LEU . 42.9 m-85 -116.8 128.4 55.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.205 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 47.7 t-20 -50.96 -78.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -80.9 148.46 64.73 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 120.825 -1.172 . . . . 0.0 109.48 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.36 -53.7 1.34 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.645 2.23 . . . . 0.0 111.76 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -61.3 -28.45 69.21 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.987 -1.07 . . . . 0.0 108.144 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 17.0 mtp -63.14 -19.23 64.27 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.595 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 8.4 tt -67.11 -50.76 60.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.308 -0.87 . . . . 0.0 108.791 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 6.0 t -52.61 -47.33 67.04 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.509 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 9.5 t60 -48.51 -49.07 37.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.966 -1.084 . . . . 0.0 108.201 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.572 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 23.6 mm-40 -57.36 -19.41 22.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.1 m-80 -78.87 -32.96 46.15 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 82.9 mt -70.71 -37.19 73.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 109.549 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mt -77.22 -49.6 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.239 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.518 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 14.9 mtt-85 -76.96 -30.99 56.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 109.374 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 57.87 32.91 22.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.439 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.0 p -108.28 7.64 27.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.531 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 38.8 t-20 57.14 55.02 6.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.528 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 87.2 m -78.52 136.46 37.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.545 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.531 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 3.8 m80 -114.93 -175.92 2.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.215 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.443 HD11 HG22 ' A' ' 52' ' ' ILE . 29.9 mt -89.59 123.42 41.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.238 -0.914 . . . . 0.0 109.62 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 38.4 ttt-85 -81.39 -46.94 13.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.52 -0.738 . . . . 0.0 109.326 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -153.2 151.27 29.91 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.657 -0.652 . . . . 0.0 109.474 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -70.91 144.38 50.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.964 . . . . 0.0 109.218 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.539 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.59 165.24 40.76 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.539 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 30.3 mttm -65.86 144.03 57.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.443 -1.033 . . . . 0.0 109.464 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -77.22 153.2 34.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.245 -0.909 . . . . 0.0 109.326 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 58' ' ' CYS . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.391 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 60.9 mtm . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.478 ' CA ' ' HB2' ' A' ' 8' ' ' TYR . 18.5 p -104.44 -3.28 24.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.236 -0.915 . . . . 0.0 109.537 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -49.23 -24.33 1.72 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.205 -0.934 . . . . 0.0 108.749 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -119.13 28.46 8.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.547 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 3.6 t80 -80.29 157.98 26.27 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.608 0.718 . . . . 0.0 110.617 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.432 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 6.2 ttt85 -142.7 133.45 25.37 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.51 ' CG2' ' CD2' ' A' ' 16' ' ' TYR . 81.9 t -133.37 136.77 54.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.367 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.49 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 mp -119.66 173.16 3.78 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.538 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.8 Cg_endo -68.51 -25.73 34.84 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 122.653 2.235 . . . . 0.0 111.763 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 15.2 ttt180 -104.12 -20.71 13.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.375 -0.828 . . . . 0.0 109.285 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.1 mt -93.13 -46.39 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 17' ' ' LEU . . . 73.64 -170.72 52.46 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.547 ' CE1' ' CZ ' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -87.27 151.44 23.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.174 . . . . 0.0 109.463 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.579 ' N ' ' CD1' ' A' ' 17' ' ' LEU . 1.8 mp -122.47 132.9 54.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.7 m -139.18 157.32 71.3 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.139 -0.976 . . . . 0.0 109.317 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.2 Cg_endo -70.18 168.78 21.12 Favored 'Trans proline' 0 C--O 1.216 -0.581 0 C-N-CA 122.572 2.181 . . . . 0.0 111.668 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -90.0 -12.67 37.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.482 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -73.94 119.8 18.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.159 -0.963 . . . . 0.0 109.214 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.2 tp -81.75 112.19 18.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.774 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.527 ' CD ' ' HG3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -122.08 105.77 36.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.905 . . . . 0.0 108.741 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 45.2 Cg_endo -66.64 118.32 5.45 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.954 2.436 . . . . 0.0 112.088 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.459 ' O ' HG21 ' A' ' 32' ' ' THR . 18.8 m -115.59 154.94 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.042 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.4 t -97.3 140.27 32.02 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.53 138.13 13.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.5 p30 -65.49 -12.93 57.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -1.119 . . . . 0.0 109.436 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 84.2 m-20 -86.98 12.37 11.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.216 -0.927 . . . . 0.0 109.374 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.06 32.14 36.77 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 79.6 mt-30 -131.16 173.82 10.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.391 -1.064 . . . . 0.0 109.293 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 25' ' ' VAL . 87.5 m -135.12 133.55 39.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.149 -0.969 . . . . 0.0 109.488 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.614 ' CE2' ' CD1' ' A' ' 39' ' ' LEU . 65.6 m-85 -112.61 122.93 49.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 108.956 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' LYS . 9.7 m-20 -48.18 -79.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 110.093 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.7 t-20 -81.98 148.04 59.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.018 -1.051 . . . . 0.0 109.895 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.527 ' HG3' ' CD ' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.6 -53.33 1.41 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.718 2.279 . . . . 0.0 111.768 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.7 t -61.42 -25.78 67.43 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.413 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 29.7 mtp -70.49 -5.87 31.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.177 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.614 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 24.4 tp -74.11 -61.36 1.88 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.18 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.447 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -54.52 -28.38 44.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 108.567 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.402 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 29.4 t60 -60.35 -56.88 16.09 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -64.06 -19.43 65.22 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' GLN . 89.6 m-20 -79.44 -31.01 42.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.506 -0.746 . . . . 0.0 109.037 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.2 tm? -63.46 -37.81 88.73 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.385 -0.822 . . . . 0.0 108.844 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mm -77.09 -48.64 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.114 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 26.4 mtt-85 -68.14 -38.46 82.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.436 -0.79 . . . . 0.0 109.192 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ASN . 86.3 mt-30 62.2 38.74 13.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.478 -0.764 . . . . 0.0 109.449 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.4 p -113.37 15.38 19.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 0.0 109.384 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 46.29 60.41 3.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.472 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.476 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 76.8 m -79.96 143.01 34.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.416 ' N ' HG21 ' A' ' 50' ' ' THR . 25.7 m-70 -118.97 170.61 8.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 108.855 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 52' ' ' ILE . 30.9 mt -79.99 126.86 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.07 -1.019 . . . . 0.0 109.271 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 18.0 ttt-85 -81.82 -41.5 21.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.398 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -160.53 151.78 19.2 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -67.61 142.56 56.41 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.074 -1.016 . . . . 0.0 109.443 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.55 166.17 38.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 41.2 mttm -65.45 149.04 50.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -1.018 . . . . 0.0 109.467 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 59.0 m -59.3 153.84 17.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.444 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.41 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 76.8 mtp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.2 m -91.91 -18.4 23.81 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.419 -0.8 . . . . 0.0 109.165 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -78.41 -0.02 27.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.91 . . . . 0.0 109.478 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.412 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 34.6 p30 -106.78 -9.44 16.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.786 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.572 ' OH ' ' CZ ' ' A' ' 16' ' ' TYR . 1.1 p90 -107.61 170.49 7.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.166 -0.959 . . . . 0.0 109.47 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -133.37 161.02 35.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.202 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 16' ' ' TYR . 13.4 p -140.43 166.01 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.94 . . . . 0.0 109.81 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.519 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -121.75 174.49 3.16 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.846 . . . . 0.0 109.312 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 48.2 Cg_endo -68.19 -23.62 39.08 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.726 2.284 . . . . 0.0 111.806 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 45.8 tpt85 -89.0 -19.41 25.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.222 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 14' ' ' ILE . 59.2 mt -99.02 -34.6 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.292 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' C ' HG22 ' A' ' 10' ' ' VAL . . . 73.66 -68.65 1.53 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.572 ' CZ ' ' OH ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -155.38 159.11 39.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -1.153 . . . . 0.0 109.489 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 tp -127.74 114.42 17.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.742 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.5 m -131.56 157.63 77.63 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 108.977 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.1 Cg_endo -70.45 167.01 26.56 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.591 2.194 . . . . 0.0 111.586 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -88.38 -16.68 32.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.417 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -71.54 129.2 38.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.269 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.26 114.75 27.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 34' ' ' ASN . 2.5 mtmt -126.79 107.2 22.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.19 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.53 116.67 4.05 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 C-N-CA 122.807 2.338 . . . . 0.0 111.796 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.84 155.41 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.741 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 40.5 t -97.74 123.4 41.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.369 -0.832 . . . . 0.0 109.046 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -77.15 137.93 21.21 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.6 p-10 -67.88 -7.52 28.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -1.098 . . . . 0.0 109.425 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -88.71 7.69 32.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.485 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.45 12.91 62.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' GLY . 78.0 mt-30 -118.32 166.44 12.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -1.163 . . . . 0.0 109.323 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 36.9 m -127.3 137.27 52.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.302 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.639 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 34.1 m-85 -114.29 130.47 56.65 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.234 -0.916 . . . . 0.0 109.361 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.4 m-20 -53.57 -76.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.33 -0.857 . . . . 0.0 109.65 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -81.84 148.66 61.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.074 -1.016 . . . . 0.0 109.466 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.459 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.0 Cg_endo -63.65 -53.25 1.42 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.726 2.284 . . . . 0.0 111.9 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.7 t -63.58 -28.69 70.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.047 -1.033 . . . . 0.0 108.394 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.0 mmm -59.87 -23.57 63.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.639 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 27.9 tp -61.9 -43.83 98.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.607 -0.683 . . . . 0.0 109.288 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.489 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.2 m -71.32 -20.07 62.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.216 -0.928 . . . . 0.0 108.554 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -72.98 -53.42 11.23 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.426 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 70.0 mt-10 -64.53 -19.0 65.34 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.5 m-20 -74.69 -37.58 62.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.8 tm? -56.39 -36.16 68.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.343 -0.848 . . . . 0.0 108.735 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 45' ' ' ILE . 2.6 mt -74.43 -50.01 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.461 -0.774 . . . . 0.0 109.033 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 31.2 mtm-85 -68.59 -23.97 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.139 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' ASN . 85.6 mt-30 61.81 40.83 12.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.431 -0.793 . . . . 0.0 109.564 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.417 HG22 ' HB3' ' A' ' 46' ' ' ARG . 9.1 p -128.67 169.71 14.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.293 -0.879 . . . . 0.0 109.199 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -97.5 62.24 1.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.373 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.1 m -70.98 130.2 40.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -0.85 . . . . 0.0 109.599 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -113.82 169.43 8.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 108.979 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 52' ' ' ILE . 43.4 mt -79.81 127.06 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.009 . . . . 0.0 109.339 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 47.7 ttt85 -84.71 -49.51 8.43 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.373 -0.829 . . . . 0.0 109.533 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.1 p -149.23 141.3 23.89 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.432 -0.792 . . . . 0.0 109.254 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.4 p -61.86 143.97 55.57 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.258 -0.901 . . . . 0.0 109.182 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.53 163.29 39.18 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 53.4 tttt -50.88 152.54 2.09 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.541 -0.976 . . . . 0.0 109.601 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.41 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 31.5 m -55.65 142.12 35.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.634 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.397 179.862 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.4 mmm . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.4 m -83.93 0.59 47.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.503 -0.748 . . . . 0.0 109.191 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 10.7 mttm -61.38 -30.32 70.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.344 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 76.2 m-20 -147.84 68.02 1.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.67 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.566 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 12.6 p90 -119.78 -171.59 2.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.268 -0.895 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -153.76 139.65 18.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 109.746 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.412 HG12 ' C ' ' A' ' 15' ' ' GLY . 53.4 t -132.73 137.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 109.612 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.517 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -112.63 174.38 2.35 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.832 . . . . 0.0 109.275 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.9 Cg_endo -67.85 -24.44 40.19 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.655 2.237 . . . . 0.0 111.816 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -96.77 -26.94 14.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.468 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.1 mm -85.91 -48.17 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.546 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 71.84 -163.2 54.42 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.566 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -102.37 150.27 23.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -1.157 . . . . 0.0 109.315 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.3 tp -116.74 106.83 13.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.8 m -120.67 155.89 56.55 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.128 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.04 166.61 29.11 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.545 2.163 . . . . 0.0 111.625 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -89.81 -13.94 35.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.9 . . . . 0.0 109.662 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -72.31 123.88 23.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 0.0 109.278 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.444 HD12 ' HB3' ' A' ' 34' ' ' ASN . 48.1 tp -80.29 121.17 25.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.619 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 3.2 mttp -133.71 101.45 12.95 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.324 -0.86 . . . . 0.0 109.242 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.54 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 41.0 Cg_endo -64.15 120.66 8.07 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.848 2.365 . . . . 0.0 112.122 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.9 m -119.81 157.36 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.8 t -99.49 114.76 27.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -0.824 . . . . 0.0 109.028 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -69.94 137.76 28.83 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 58.4 p30 -68.4 -8.02 36.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.344 -1.092 . . . . 0.0 109.661 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -84.86 6.81 23.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 109.341 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.91 17.86 55.45 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -126.76 160.62 30.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -1.09 . . . . 0.0 109.429 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.498 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 38.5 m -116.79 144.86 43.98 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.931 . . . . 0.0 109.207 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.618 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 87.4 m-85 -124.51 129.37 50.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.292 -0.88 . . . . 0.0 109.331 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 23' ' ' LYS . 6.2 m-20 -50.44 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.2 t-20 -82.16 146.41 54.84 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 0.0 109.788 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.0 Cg_endo -63.53 -52.36 1.95 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.772 2.315 . . . . 0.0 111.555 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.1 t -60.97 -30.87 70.51 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 23.0 mtt -61.6 -20.68 63.61 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.618 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 58.6 tp -62.06 -46.81 87.49 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.538 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 3.3 m -70.94 -26.48 63.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.466 ' HA ' HD11 ' A' ' 44' ' ' LEU . 33.3 t60 -64.42 -55.04 23.64 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 73.8 mm-40 -65.1 -17.5 64.51 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.237 -0.914 . . . . 0.0 108.671 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 47' ' ' GLN . 92.1 m-20 -76.53 -30.91 57.32 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.469 -0.77 . . . . 0.0 109.278 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.538 ' CD1' ' O ' ' A' ' 40' ' ' CYS . 1.8 mp -59.76 -36.63 77.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.12 -0.987 . . . . 0.0 108.624 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 45' ' ' ILE . 7.0 mm -75.72 -48.67 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 15.7 mtp85 -67.28 -25.52 66.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.429 -0.794 . . . . 0.0 109.153 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.9 mt-30 63.71 41.26 7.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.54 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.424 HG21 ' C ' ' A' ' 47' ' ' GLN . 10.5 p -130.63 164.07 25.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.214 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.562 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 65.6 m-20 -95.68 59.99 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 109.504 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 m -75.0 132.05 41.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 109.417 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 6.6 m80 -112.87 -172.32 2.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.138 -0.976 . . . . 0.0 109.333 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.7 mt -89.79 126.62 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.337 -0.852 . . . . 0.0 109.776 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 16.2 tpt180 -85.4 -53.98 4.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.557 -0.714 . . . . 0.0 109.365 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 p -144.76 152.61 40.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -72.96 144.45 47.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.095 -1.003 . . . . 0.0 109.385 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.92 166.19 39.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.54 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 55.1 mttp -68.07 141.5 56.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.36 -1.083 . . . . 0.0 109.306 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.23 149.8 37.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.482 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.541 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.7 m -79.81 -17.94 52.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.928 . . . . 0.0 109.23 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -51.13 -22.93 2.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 108.994 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -118.13 36.87 4.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.453 ' OH ' ' N ' ' A' ' 17' ' ' LEU . 5.2 t80 -85.09 159.48 20.17 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.559 0.695 . . . . 0.0 110.663 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.443 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 7.7 ttm180 -140.71 136.6 32.76 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 15' ' ' GLY . 52.1 t -134.83 128.03 49.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.768 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.534 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -106.23 175.51 2.05 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.437 -0.79 . . . . 0.0 109.057 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.8 Cg_endo -67.21 -23.15 45.66 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.541 2.161 . . . . 0.0 111.632 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -110.83 -24.33 10.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.342 -0.849 . . . . 0.0 109.326 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 81.5 mt -83.25 -38.46 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.622 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.487 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 61.28 -143.8 48.66 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.471 ' CD1' HD13 ' A' ' 44' ' ' LEU . 1.6 t80 -107.3 150.65 26.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.239 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.453 ' N ' ' OH ' ' A' ' 8' ' ' TYR . 25.7 tp -114.7 121.59 43.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.813 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.0 m -135.52 157.04 77.23 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.029 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.2 Cg_endo -70.01 163.82 37.06 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.588 2.192 . . . . 0.0 111.683 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -87.77 -8.77 55.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.43 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -77.76 111.45 13.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.855 . . . . 0.0 109.182 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.4 tp -79.62 123.17 27.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.935 . . . . 0.0 109.66 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 34' ' ' ASN . 7.4 mtmt -140.63 109.22 6.64 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.812 . . . . 0.0 109.054 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.543 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.9 Cg_endo -63.56 123.85 12.74 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.86 2.373 . . . . 0.0 112.214 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.529 HG22 ' CD1' ' A' ' 52' ' ' ILE . 29.2 m -120.39 156.55 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.9 t -98.23 119.71 37.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 109.291 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -73.19 134.7 20.14 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 56.6 p30 -68.05 -7.55 30.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -1.148 . . . . 0.0 109.722 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.456 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 93.0 m-20 -86.21 7.57 24.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.75 16.97 53.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 93.6 mt-30 -126.05 171.96 10.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.513 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 89.3 m -129.37 142.75 50.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.182 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.632 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 20.3 m-85 -123.68 128.82 50.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.2 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.505 ' O ' ' O ' ' A' ' 23' ' ' LYS . 9.1 m-20 -51.14 -79.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.203 -0.936 . . . . 0.0 109.822 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.3 t-20 -81.82 147.45 58.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.917 -1.114 . . . . 0.0 109.758 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.2 Cg_endo -63.3 -52.19 2.18 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.728 2.285 . . . . 0.0 111.872 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -64.04 -27.8 69.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.033 -1.042 . . . . 0.0 108.297 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.516 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.5 mmm -62.51 -16.2 54.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.471 -0.768 . . . . 0.0 109.191 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.632 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 8.1 tp -68.55 -51.79 39.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.347 -0.845 . . . . 0.0 109.125 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 3.9 m -63.78 -18.49 64.14 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -69.16 -57.64 5.12 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -64.74 -18.61 65.19 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.2 m-20 -72.79 -31.47 64.89 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.478 HD12 HG22 ' A' ' 10' ' ' VAL . 36.8 mt -58.85 -38.9 79.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 108.745 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mt -74.31 -51.96 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.46 -0.775 . . . . 0.0 109.091 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.516 ' NH2' ' OH ' ' A' ' 33' ' ' TYR . 45.2 mtm180 -66.49 -25.27 66.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 0.0 109.415 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.3 mt-30 63.73 44.47 5.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.527 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 p -130.21 167.88 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.524 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.456 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 72.9 m-20 -103.37 65.21 0.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.258 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.466 HG23 HD12 ' A' ' 39' ' ' LEU . 51.9 m -73.43 136.5 44.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.76 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.456 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 70.4 m80 -117.13 169.7 9.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.322 -0.861 . . . . 0.0 108.88 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.529 ' CD1' HG22 ' A' ' 25' ' ' VAL . 22.2 mm -80.17 127.01 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.005 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 72.0 ttt180 -85.79 -47.93 9.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.368 -0.833 . . . . 0.0 109.446 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -148.29 142.6 26.22 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.535 -0.728 . . . . 0.0 109.367 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.2 p -62.24 151.3 36.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.911 . . . . 0.0 109.368 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.12 166.42 40.71 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.513 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 39.5 mttt -59.98 147.15 39.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.419 -1.047 . . . . 0.0 109.445 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.453 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 53.2 m -47.62 142.1 4.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 109.379 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.476 -179.934 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.0 mmm . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.562 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.6 m -82.12 4.06 24.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.362 -0.836 . . . . 0.0 109.214 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -62.95 -28.64 70.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.706 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.459 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 14.3 t70 -147.31 68.34 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 110.13 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.562 ' CE1' ' HB3' ' A' ' 5' ' ' CYS . 19.7 p90 -127.12 -177.77 4.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 109.382 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptt-85 -156.07 146.06 21.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.323 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.417 HG12 ' C ' ' A' ' 15' ' ' GLY . 74.4 t -130.56 135.96 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.714 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.531 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -109.57 175.5 1.91 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.276 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.7 Cg_endo -67.95 -24.72 39.28 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.594 2.196 . . . . 0.0 111.83 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -95.78 -31.18 13.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 109.421 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.3 mt -80.87 -49.41 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.474 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.417 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 71.4 -173.52 43.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.541 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -98.96 146.53 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.2 tp -114.44 110.0 19.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.817 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 55.7 m -125.73 154.7 73.2 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 109.077 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.32 165.68 31.68 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.454 2.103 . . . . 0.0 111.655 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -85.22 -23.07 28.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -62.72 128.91 38.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 34' ' ' ASN . 22.0 tp -83.83 126.2 32.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 109.421 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.512 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -137.71 97.69 10.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.0 109.436 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.4 Cg_endo -62.69 121.01 8.77 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.961 2.441 . . . . 0.0 111.938 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.466 ' O ' HG21 ' A' ' 32' ' ' THR . 9.8 m -121.65 155.75 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.981 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.6 t -98.3 141.22 31.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -96.65 136.73 12.95 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 58.4 p30 -62.26 -12.4 20.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -1.113 . . . . 0.0 109.58 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 48.8 m-20 -88.33 10.01 21.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 0.0 109.595 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.18 15.68 68.86 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.5 mt-30 -117.85 156.24 28.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.382 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 25' ' ' VAL . 23.7 m -118.32 148.56 42.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.453 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.583 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 78.0 m-85 -130.26 127.83 40.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.317 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 23' ' ' LYS . 5.8 m-20 -49.36 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 38' ' ' MET . 13.8 t-20 -82.06 146.19 54.71 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.978 -1.076 . . . . 0.0 109.468 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.64 -50.15 3.58 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.463 2.108 . . . . 0.0 111.459 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.473 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.0 t -62.2 -27.68 69.15 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.476 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 23.8 mtt -69.78 -23.58 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.494 HD13 ' CD2' ' A' ' 33' ' ' TYR . 4.8 tt -63.59 -47.34 81.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.344 -0.847 . . . . 0.0 108.782 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 9.5 m -56.75 -27.97 60.33 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -56.83 -47.78 79.52 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 29.1 tp10 -57.87 -22.01 45.99 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 3.3 m-80 -76.57 -31.85 57.78 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.903 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.503 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 67.0 mt -64.43 -41.19 96.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.384 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 45' ' ' ILE . 3.5 mt -73.29 -54.23 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.392 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 81.0 mtm180 -70.22 -22.02 62.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.383 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 63.01 36.0 12.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -120.0 177.35 5.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.565 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 90.7 m-20 -103.98 56.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.55 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.513 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 82.9 m -75.88 129.38 36.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 109.579 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 8.0 m80 -115.34 -170.96 1.87 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.177 -0.952 . . . . 0.0 109.33 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.518 HD11 HG22 ' A' ' 52' ' ' ILE . 41.3 mt -85.9 126.56 40.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.727 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 12.7 tpt180 -81.06 -43.14 19.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.408 -0.808 . . . . 0.0 109.24 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.8 p -154.51 137.89 15.83 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 p -58.48 149.34 25.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 109.405 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 83.43 165.89 38.96 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HA ' HG22 ' A' ' 32' ' ' THR . 39.5 tttm -65.3 149.04 50.64 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.352 -1.087 . . . . 0.0 109.356 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.8 138.7 39.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.481 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.444 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 81.5 mtp . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 24.6 m -85.23 -13.03 51.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.446 -0.784 . . . . 0.0 109.28 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -80.95 10.87 4.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.923 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 4' ' ' MET . 41.7 p30 -145.02 19.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.032 -1.042 . . . . 0.0 109.671 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.632 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -128.24 154.09 46.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.129 -0.982 . . . . 0.0 109.494 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.418 ' HA ' ' HD2' ' A' ' 9' ' ' ARG . 39.2 tpt85 -135.66 146.81 48.2 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.305 -0.872 . . . . 0.0 108.984 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.495 HG22 ' CE2' ' A' ' 8' ' ' TYR . 75.5 t -137.58 137.53 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.15 -0.969 . . . . 0.0 109.647 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.533 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -116.0 175.66 1.84 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 109.233 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.4 Cg_endo -66.53 -21.77 52.42 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.598 2.198 . . . . 0.0 111.763 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -101.96 -28.66 12.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -0.847 . . . . 0.0 109.563 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.2 mt -80.87 -51.56 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.45 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 81.29 -165.38 46.73 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.8 OUTLIER -100.78 147.45 26.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -1.112 . . . . 0.0 109.672 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -119.87 127.64 52.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.853 . . . . 0.0 109.481 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 70.4 m -133.48 156.72 79.38 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.296 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.7 Cg_endo -70.06 166.66 27.21 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.621 2.214 . . . . 0.0 111.815 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -87.53 -14.42 40.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 109.534 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -73.01 106.1 4.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.311 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.8 tp -72.93 113.66 10.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.455 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' ASN . 1.8 mttm -124.02 102.92 33.91 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 109.323 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.09 116.98 4.15 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.875 2.383 . . . . 0.0 112.138 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.407 ' HB ' HG22 ' A' ' 52' ' ' ILE . 7.6 m -116.41 156.93 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 53' ' ' ARG . 16.5 t -98.3 111.94 24.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.566 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.08 139.16 37.8 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.1 p30 -69.8 -9.74 55.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -1.109 . . . . 0.0 109.667 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.472 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 91.3 m-20 -81.42 1.99 30.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.446 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.48 15.19 44.68 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -125.03 168.66 13.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.336 -1.097 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 39.1 m -123.45 134.18 53.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 72.8 m-85 -110.99 121.09 44.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 109.215 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' LYS . 8.7 m-20 -46.89 -82.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.4 -0.812 . . . . 0.0 109.722 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.3 t-20 -81.84 146.38 55.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 109.593 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -62.95 -51.96 2.54 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.77 2.313 . . . . 0.0 111.599 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.8 t -61.92 -26.78 68.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.959 -1.088 . . . . 0.0 108.091 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.422 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 31.5 mmm -67.43 -16.66 64.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.634 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 17.3 tp -68.03 -57.35 6.29 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.459 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 9.4 t -55.45 -25.41 36.21 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -69.51 -61.7 1.68 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.571 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 88.5 mt-10 -57.57 -19.53 26.13 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.41 ' ND2' ' HG ' ' A' ' 39' ' ' LEU . 92.9 m-20 -75.39 -33.55 61.02 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.499 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.2 tm? -57.76 -38.23 75.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.412 -0.805 . . . . 0.0 108.882 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mt -77.3 -46.81 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.846 . . . . 0.0 108.972 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 62.2 mtt-85 -64.76 -26.22 68.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 109.01 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 91.5 mt-30 61.27 37.99 16.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.37 -0.831 . . . . 0.0 109.639 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 p -128.39 169.77 13.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.322 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.512 ' O ' ' NE2' ' A' ' 51' ' ' HIS . 79.9 m-20 -98.91 63.13 1.35 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.266 -0.896 . . . . 0.0 109.311 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.472 ' OG1' ' OD2' ' A' ' 29' ' ' ASP . 32.6 m -71.47 137.65 48.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.827 . . . . 0.0 109.666 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.512 ' NE2' ' O ' ' A' ' 49' ' ' ASN . 11.8 m-70 -117.95 178.54 4.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 109.022 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.407 HG22 ' HB ' ' A' ' 25' ' ' VAL . 20.4 mt -86.08 124.8 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.142 -0.974 . . . . 0.0 109.611 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 66.4 ttt180 -80.99 -56.73 3.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.142 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -147.13 156.56 43.09 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.535 -0.728 . . . . 0.0 109.037 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -75.05 142.72 43.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.0 109.632 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.04 162.46 35.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 32.5 mttt -64.77 136.75 57.25 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.588 -0.948 . . . . 0.0 109.484 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -71.11 149.15 46.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.388 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 58' ' ' CYS . 84.4 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.502 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.3 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 8' ' ' TYR . 3.9 m -82.8 -26.84 31.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.441 -0.787 . . . . 0.0 109.376 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' CYS . 69.3 mttt -44.76 -27.24 0.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.348 -0.845 . . . . 0.0 108.757 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 5' ' ' CYS . 94.5 m-20 -116.08 35.05 4.66 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 5' ' ' CYS . 2.7 t80 -80.34 163.2 24.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -150.64 114.61 5.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -0.829 . . . . 0.0 109.093 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.553 ' CG2' ' CD1' ' A' ' 16' ' ' TYR . 59.7 t -116.97 156.74 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 109.639 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.535 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -136.27 174.91 3.97 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.371 -0.83 . . . . 0.0 109.386 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.9 Cg_endo -67.44 -21.75 46.32 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.672 2.248 . . . . 0.0 111.947 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -112.1 -21.56 11.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.673 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.0 mt -88.21 -49.32 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 0.0 109.627 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.463 ' C ' ' CG1' ' A' ' 10' ' ' VAL . . . 75.2 -165.43 54.62 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.553 ' CD1' ' CG2' ' A' ' 10' ' ' VAL . 1.2 t80 -94.06 153.84 17.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -1.212 . . . . 0.0 109.514 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.8 tp -117.08 109.92 17.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.965 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.9 m -126.13 155.35 73.71 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 109.115 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.09 168.52 23.82 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.527 2.151 . . . . 0.0 111.611 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -88.19 -23.34 23.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -0.964 . . . . 0.0 109.741 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.53 126.53 28.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.329 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 34' ' ' ASN . 31.3 tp -85.0 113.13 21.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -121.45 104.35 40.26 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 0.0 109.363 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HB2' ' HG3' ' A' ' 57' ' ' LYS . 43.2 Cg_endo -65.62 117.28 4.49 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.875 2.383 . . . . 0.0 112.059 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.453 ' O ' HG21 ' A' ' 32' ' ' THR . 34.0 m -120.44 154.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.871 . . . . 0.0 109.835 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.0 t -97.3 140.79 31.24 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -90.99 142.39 16.11 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 43.9 t0 -68.58 -11.5 60.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -1.203 . . . . 0.0 109.306 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -86.4 -5.0 59.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.303 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.77 21.38 14.35 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 27' ' ' GLY . 66.8 mt-30 -127.58 145.84 50.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -1.194 . . . . 0.0 109.585 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.461 ' OG1' ' SG ' ' A' ' 58' ' ' CYS . 92.8 m -99.4 154.72 17.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.868 . . . . 0.0 109.602 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.629 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 48.8 m-85 -135.59 117.63 15.36 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.372 -0.83 . . . . 0.0 108.901 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 23' ' ' LYS . 10.8 m-20 -41.97 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.0 109.828 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.8 t-20 -82.27 146.61 54.89 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.031 . . . . 0.0 109.205 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.18 -51.16 2.93 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.618 2.212 . . . . 0.0 111.695 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.5 t -63.34 -28.27 69.89 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.094 -1.004 . . . . 0.0 108.423 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 14.0 mtp -60.89 -14.93 25.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.019 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.629 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 6.2 tp -74.65 -54.9 6.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.494 -0.754 . . . . 0.0 109.746 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.4 m -61.72 -19.92 62.93 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.197 -0.94 . . . . 0.0 108.665 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.549 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 34.9 t60 -67.79 -54.39 19.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -66.2 -18.75 65.55 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.0 m-20 -75.79 -27.47 58.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.45 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.492 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 1.8 tm? -67.52 -35.98 80.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -0.976 . . . . 0.0 108.966 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.441 HD11 HG23 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -78.25 -46.27 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.208 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.502 ' NH2' ' OE1' ' A' ' 31' ' ' GLN . 74.2 mtm180 -75.79 -35.01 60.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 109.109 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.2 mt-30 62.51 40.36 10.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.71 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.4 HG22 ' HB3' ' A' ' 46' ' ' ARG . 32.9 p -109.8 7.31 24.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 47.82 60.66 3.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.853 . . . . 0.0 109.761 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.453 HG23 HD12 ' A' ' 39' ' ' LEU . 95.3 m -79.77 133.49 36.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.451 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -105.46 -173.97 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.478 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.443 HD12 HD23 ' A' ' 39' ' ' LEU . 33.6 mm -91.33 127.15 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.616 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 73.8 ttt180 -79.44 -49.01 12.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.231 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.6 p -159.3 155.18 26.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 p -67.82 141.56 56.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.074 -1.016 . . . . 0.0 109.769 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.29 165.77 35.17 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HA ' HG22 ' A' ' 32' ' ' THR . 83.0 mttt -66.94 146.28 54.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -1.087 . . . . 0.0 109.364 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.461 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 70.1 m -55.28 150.54 11.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.59 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.458 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 48.2 ttm . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.441 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 38.9 m -80.82 -28.06 36.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.335 -0.853 . . . . 0.0 109.167 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -68.08 -12.6 61.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 109.368 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -91.0 -16.59 27.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.689 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.495 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -109.76 157.22 19.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.183 179.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -128.95 140.79 51.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.564 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.495 ' CG2' ' C ' ' A' ' 15' ' ' GLY . 14.7 p -125.71 146.77 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.545 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mp -108.77 175.6 1.9 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.3 Cg_endo -67.32 -23.3 44.81 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.641 2.227 . . . . 0.0 111.669 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -88.93 -30.6 18.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.247 -0.908 . . . . 0.0 109.146 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.6 mm -85.9 -39.79 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 0.0 109.307 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.495 ' C ' ' CG2' ' A' ' 10' ' ' VAL . . . 69.18 144.71 0.16 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.581 ' CD1' HD13 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -41.88 152.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -1.065 . . . . 0.0 109.789 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.1 tp -128.35 111.72 13.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.882 . . . . 0.0 109.511 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 81.0 m -116.85 158.08 44.72 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.327 -0.858 . . . . 0.0 109.2 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -71.79 165.62 31.99 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.575 2.183 . . . . 0.0 111.792 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -86.81 -11.61 50.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -74.11 113.42 11.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.246 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.509 ' CD1' ' OD1' ' A' ' 34' ' ' ASN . 55.9 tp -80.02 123.22 27.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.554 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 11.9 mmtm -141.03 109.63 6.44 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.394 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -66.02 120.28 7.42 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 123.04 2.493 . . . . 0.0 112.055 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.461 ' HB ' HG21 ' A' ' 52' ' ' ILE . 11.1 m -116.86 156.64 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 109.82 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 46.8 t -98.59 119.8 37.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.0 109.368 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -72.62 137.31 24.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.471 ' OD2' ' HA ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -68.33 -7.61 32.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -1.08 . . . . 0.0 109.532 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.445 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 91.5 m-20 -89.07 11.77 17.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.504 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.6 71.59 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 27' ' ' GLY . 78.4 mt-30 -116.01 173.95 6.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -1.164 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 57' ' ' LYS . 50.6 m -133.9 140.33 46.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.328 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.597 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 24.6 m-85 -118.62 123.32 44.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.467 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' OD1' ' CD1' ' A' ' 22' ' ' LEU . 54.6 t-20 -45.99 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 109.737 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.8 t-20 -80.82 147.52 62.53 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.866 -1.146 . . . . 0.0 109.343 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.8 Cg_endo -62.45 -53.15 2.0 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.699 2.266 . . . . 0.0 111.804 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.6 t -62.76 -28.15 69.78 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.479 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 50.3 mmm -63.13 -16.77 61.12 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.597 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 27.9 tp -66.77 -50.67 61.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.454 -0.779 . . . . 0.0 108.899 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.478 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.6 m -67.92 -19.36 64.98 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -73.54 -54.82 7.3 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 88.6 mt-10 -63.35 -17.05 62.17 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 47' ' ' GLN . 94.0 m-20 -77.35 -35.74 54.36 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.493 -0.754 . . . . 0.0 108.967 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.581 HD13 ' CD1' ' A' ' 16' ' ' TYR . 31.2 mt -54.14 -36.09 62.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.116 -0.99 . . . . 0.0 108.567 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mt -78.45 -50.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.075 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 91.5 mtt-85 -65.31 -26.89 68.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.23 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.97 41.95 7.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 109.587 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.422 HG21 ' C ' ' A' ' 47' ' ' GLN . 8.0 p -128.86 158.61 38.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.446 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.475 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 63.0 m-20 -87.71 58.4 4.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.332 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.445 ' OG1' ' OD2' ' A' ' 29' ' ' ASP . 57.6 m -75.15 133.6 41.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.858 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.475 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 67.9 m80 -119.88 174.86 6.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.858 . . . . 0.0 108.873 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 52' ' ' ILE . 37.9 mt -79.71 138.43 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.322 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.471 ' HA ' ' OD2' ' A' ' 28' ' ' ASP . 23.3 ttt180 -101.9 -47.52 4.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.387 -0.821 . . . . 0.0 109.578 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.5 m -146.86 137.61 23.84 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.49 -0.756 . . . . 0.0 109.33 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.7 p -60.69 145.17 50.3 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.24 164.09 39.9 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HA ' HG22 ' A' ' 32' ' ' THR . 22.4 tttp -53.88 150.22 7.91 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.348 -1.09 . . . . 0.0 109.525 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 36.3 m -52.73 144.85 13.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.444 179.888 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.2 m -85.5 8.96 17.2 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.486 ' HE2' ' NE2' ' A' ' 51' ' ' HIS . 31.1 mttt -70.13 -27.42 64.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 82.6 m-20 -144.44 64.25 1.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.52 ' OH ' ' CD2' ' A' ' 44' ' ' LEU . 11.7 p90 -125.33 -176.44 3.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.442 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -146.7 152.87 39.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 109.557 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -144.57 127.93 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.534 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -106.8 175.32 2.09 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.865 . . . . 0.0 109.501 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -67.94 -23.23 41.05 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.693 2.262 . . . . 0.0 111.844 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -96.73 -26.64 15.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.254 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.2 mt -89.3 -42.07 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.655 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.32 -165.46 31.49 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.464 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -93.42 149.83 20.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -1.197 . . . . 0.0 109.407 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.2 tp -116.24 107.19 14.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.639 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 60.3 m -125.47 156.26 70.67 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 109.557 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.12 167.84 25.69 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.733 2.288 . . . . 0.0 111.669 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -84.32 -26.0 28.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -62.34 117.01 5.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.482 HD22 ' CB ' ' A' ' 34' ' ' ASN . 3.4 tm? -84.67 104.32 14.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 34' ' ' ASN . 16.1 mtpt -116.12 111.37 42.71 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.223 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.6 Cg_endo -63.38 121.14 8.84 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 C-N-CA 122.999 2.466 . . . . 0.0 112.21 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.526 ' CG2' HD11 ' A' ' 39' ' ' LEU . 5.8 m -115.1 157.73 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.418 -0.801 . . . . 0.0 109.584 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 47.6 t -97.21 140.58 31.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.8 135.38 12.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.464 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.7 p30 -62.0 -12.23 17.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -1.065 . . . . 0.0 109.71 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 49.8 m-20 -87.47 10.84 16.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.484 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.72 64.31 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 62.0 mt-30 -117.35 178.79 4.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.519 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 57' ' ' LYS . 20.7 m -139.49 142.65 37.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.31 -0.869 . . . . 0.0 109.234 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.632 ' CD2' ' CD1' ' A' ' 39' ' ' LEU . 23.9 m-85 -122.42 134.84 54.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.505 ' O ' ' O ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -54.68 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 109.491 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.4 t-20 -82.16 146.39 54.81 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.003 -1.061 . . . . 0.0 109.504 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.64 -52.3 1.94 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.703 2.269 . . . . 0.0 111.645 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.536 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -63.5 -24.28 67.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.501 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 62.2 mtp -73.66 -16.51 61.21 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.632 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 7.5 tt -64.55 -51.8 60.95 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' ASN . 8.7 m -54.09 -38.54 65.45 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.425 ' C ' ' O ' ' A' ' 40' ' ' CYS . 7.2 t60 -47.48 -50.21 23.78 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 37.3 mm-40 -56.48 -25.98 52.78 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.2 m-80 -74.32 -33.72 63.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 0.0 108.85 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.52 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 37.2 mt -63.96 -44.26 93.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.1 mm -74.86 -52.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.125 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 37.7 mtt-85 -66.83 -22.25 66.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.198 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 61.51 35.26 17.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.359 -0.838 . . . . 0.0 109.584 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 p -123.13 170.38 10.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.419 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.57 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 77.7 m-20 -96.77 57.37 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.857 . . . . 0.0 109.609 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.513 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 43.9 m -80.03 126.12 30.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.554 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.57 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 22.3 m80 -113.18 -173.32 2.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.519 HD11 HG22 ' A' ' 52' ' ' ILE . 31.8 mt -87.09 124.69 40.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.176 -0.952 . . . . 0.0 109.366 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 79.3 ttt180 -80.44 -39.99 27.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.366 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.06 148.64 17.15 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.493 -0.754 . . . . 0.0 109.288 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -65.91 144.43 56.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.723 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.11 162.01 38.06 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.447 ' HA ' HG22 ' A' ' 32' ' ' THR . 13.5 tttm -54.8 154.27 5.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.51 -0.994 . . . . 0.0 109.372 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 84.5 m -62.55 141.13 58.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.499 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.488 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.73 -5.68 55.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.455 -0.778 . . . . 0.0 108.968 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -54.24 -31.47 53.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.795 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -146.43 67.74 1.18 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -0.948 . . . . 0.0 110.073 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.508 ' OH ' ' CD1' ' A' ' 44' ' ' LEU . 5.8 p90 -125.2 173.76 8.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.158 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -143.9 147.52 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.063 -1.023 . . . . 0.0 109.755 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.558 HG22 ' CD2' ' A' ' 16' ' ' TYR . 66.6 t -144.57 132.83 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.126 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 1.5 mp -125.42 170.94 8.34 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 109.497 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.71 -24.59 40.93 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.556 2.171 . . . . 0.0 111.449 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -102.89 -27.16 12.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.039 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.4 mt -88.88 -43.09 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.294 -0.879 . . . . 0.0 109.24 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.04 -141.72 27.52 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.558 ' CD2' HG22 ' A' ' 10' ' ' VAL . 2.9 t80 -114.17 155.3 26.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 32.5 tp -112.44 124.5 52.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.991 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 85.1 m -138.54 156.66 73.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.388 -0.82 . . . . 0.0 109.057 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.59 168.21 25.02 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.633 2.222 . . . . 0.0 111.552 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -84.82 -27.83 26.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.379 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.82 130.88 48.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.7 tp -95.06 117.71 30.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 109.5 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 7.5 mttt -128.22 104.88 19.94 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.3 Cg_endo -64.62 120.41 7.69 Favored 'Trans proline' 0 C--O 1.213 -0.755 0 C-N-CA 122.962 2.442 . . . . 0.0 112.081 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 52' ' ' ILE . 11.9 m -119.62 156.46 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.851 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.3 t -99.87 121.48 41.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.432 -0.793 . . . . 0.0 108.873 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -79.41 137.05 18.45 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 45.5 p30 -68.5 -8.82 44.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -1.152 . . . . 0.0 109.548 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 29' ' ' ASP . 58.0 p30 -82.89 8.21 13.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -0.955 . . . . 0.0 109.313 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.44 23.01 45.2 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.4 mt-30 -133.79 158.25 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -1.154 . . . . 0.0 109.499 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.518 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 42.2 m -116.19 143.63 45.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 109.225 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.572 ' CD1' HD11 ' A' ' 39' ' ' LEU . 81.0 m-85 -122.51 127.82 50.02 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.272 -0.893 . . . . 0.0 109.213 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 23' ' ' LYS . 10.7 m-20 -51.55 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.942 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 10.1 t-20 -81.97 146.56 55.85 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 120.947 -1.096 . . . . 0.0 109.731 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.9 -51.78 2.71 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.813 2.342 . . . . 0.0 111.674 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.9 t -60.14 -31.57 70.21 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.431 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 8.5 mtt -60.97 -17.53 52.24 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.572 HD11 ' CD1' ' A' ' 33' ' ' TYR . 63.5 tp -67.85 -54.45 18.86 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.458 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 8.1 t -58.19 -27.72 64.13 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -62.28 -58.93 5.89 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -59.62 -21.01 59.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.0 m-20 -80.09 -30.74 39.27 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.508 ' CD1' ' OH ' ' A' ' 8' ' ' TYR . 35.6 tp -61.14 -40.61 94.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.512 -0.742 . . . . 0.0 109.054 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.514 HD11 HG22 ' A' ' 45' ' ' ILE . 4.0 mt -80.43 -47.49 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.81 . . . . 0.0 109.322 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 46.7 ttm-85 -67.66 -43.67 79.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.5 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' ASN . 84.8 mt-30 65.88 47.18 2.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.387 -0.821 . . . . 0.0 109.58 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.462 ' OG1' ' HD2' ' A' ' 46' ' ' ARG . 21.3 p -120.83 8.07 10.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.1 t30 52.73 60.65 3.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.402 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 28.9 m -77.87 141.12 39.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.327 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -115.12 168.58 9.81 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.204 -0.935 . . . . 0.0 109.094 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.424 HG22 ' HB ' ' A' ' 25' ' ' VAL . 21.7 mt -79.71 123.55 36.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.146 -0.972 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 65.2 ttt-85 -81.06 -45.98 15.69 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.571 -0.706 . . . . 0.0 109.266 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -152.99 153.85 33.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 109.138 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 p -74.0 144.89 44.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.0 164.6 40.4 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.518 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 75.1 mttt -64.9 138.44 58.37 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.46 -1.024 . . . . 0.0 109.345 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 152.6 44.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 109.418 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.496 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 7.9 m -80.39 -20.15 44.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.393 -0.817 . . . . 0.0 109.285 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 49' ' ' ASN . 86.1 mttt -50.19 -27.13 5.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 108.822 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -108.84 26.53 10.47 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 1.9 t80 -80.97 147.71 30.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.985 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -141.17 114.61 8.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 16' ' ' TYR . 5.4 p -128.71 154.71 39.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.348 -0.845 . . . . 0.0 109.431 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -110.12 168.42 7.67 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.948 . . . . 0.0 109.327 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 44.7 Cg_endo -67.2 -24.82 43.77 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.614 2.209 . . . . 0.0 111.543 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -92.92 -25.02 18.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.218 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 14' ' ' ILE . 72.3 mt -85.69 -40.37 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.96 145.9 0.36 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.529 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 1.9 t80 -51.44 150.89 3.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -1.163 . . . . 0.0 109.331 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.559 ' N ' ' CD1' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -116.92 136.12 53.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.425 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.6 m -142.95 157.27 61.38 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.208 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -69.87 165.42 31.16 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.661 2.241 . . . . 0.0 111.755 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -87.93 -13.34 42.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -72.56 114.34 10.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.181 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.0 tp -80.04 120.74 24.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 109.629 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -136.83 107.47 9.0 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.091 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.3 121.66 9.16 Favored 'Trans proline' 0 C--O 1.212 -0.784 0 C-N-CA 123.016 2.478 . . . . 0.0 112.249 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.465 ' O ' HG21 ' A' ' 32' ' ' THR . 16.3 m -118.89 155.57 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 109.877 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 32.2 t -97.36 139.03 33.91 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.68 140.31 15.04 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -70.98 -4.77 26.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -1.134 . . . . 0.0 109.618 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -93.57 4.61 53.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.01 20.26 33.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.7 mt-30 -124.63 163.58 21.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -1.139 . . . . 0.0 109.54 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 25' ' ' VAL . 52.0 m -125.13 135.58 52.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.128 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.582 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 55.3 m-85 -115.36 130.16 56.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.228 -0.92 . . . . 0.0 109.349 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 8.3 m-20 -54.52 -78.15 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.731 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.9 t-20 -81.88 147.86 59.47 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.722 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.4 Cg_endo -62.92 -52.92 1.87 Allowed 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.751 2.3 . . . . 0.0 111.704 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.5 t -60.91 -29.81 69.81 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.984 -1.072 . . . . 0.0 108.111 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 44.9 mmm -63.65 -15.24 57.77 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.582 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 39.4 tp -68.76 -49.29 59.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.494 -0.754 . . . . 0.0 109.286 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 3.2 m -69.32 -21.35 63.85 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.529 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 40.5 t60 -70.27 -55.33 9.5 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 78.1 mt-10 -63.28 -19.49 64.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.1 m-20 -75.26 -33.42 61.27 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 40' ' ' CYS . 20.9 mt -59.3 -37.0 76.62 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 mm -72.69 -49.6 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 36.4 ttt180 -68.48 -25.86 65.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.1 mt-30 64.03 43.91 4.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.778 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.1 p -132.36 166.89 20.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.303 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.48 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 95.9 m-20 -95.71 61.13 2.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.396 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.3 m -72.32 139.3 47.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.619 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.48 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 72.1 m80 -119.15 173.57 6.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.845 . . . . 0.0 109.053 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.443 HG22 ' HB ' ' A' ' 25' ' ' VAL . 35.1 mt -80.07 124.93 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.097 -1.002 . . . . 0.0 109.269 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 21.7 ttt180 -79.93 -45.94 17.63 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.679 0.752 . . . . 0.0 109.235 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 p -156.49 146.47 21.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 p -65.37 147.4 53.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.157 -0.965 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.22 165.15 40.47 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.497 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 47.4 mttp -65.69 146.2 55.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -1.087 . . . . 0.0 109.346 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 152.86 35.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.504 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.405 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.7 mtp . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.497 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 34.4 m -80.56 -6.08 57.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.378 -0.826 . . . . 0.0 109.214 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -81.38 12.61 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 110.038 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -132.98 7.83 4.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.991 -1.068 . . . . 0.0 110.399 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 5.8 p90 -105.48 -176.56 3.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.912 -1.118 . . . . 0.0 109.604 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.621 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 10.4 ttt180 -151.48 142.81 23.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.339 -0.851 . . . . 0.0 109.142 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.433 HG12 ' C ' ' A' ' 15' ' ' GLY . 15.0 t -143.61 149.39 18.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.346 -0.846 . . . . 0.0 109.321 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.54 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -124.46 175.33 3.0 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.4 Cg_endo -66.71 -21.56 51.45 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.63 2.22 . . . . 0.0 111.739 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 66.1 ttt180 -99.6 -16.89 18.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.84 . . . . 0.0 109.641 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 mm -94.82 -49.82 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.033 -1.042 . . . . 0.0 109.611 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.433 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 86.47 -178.29 48.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.493 ' CE2' ' OH ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -90.63 146.91 23.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 109.736 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.3 tp -114.18 107.59 15.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 74.1 m -117.28 156.62 48.6 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.343 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.1 Cg_endo -72.21 167.94 25.47 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.642 2.228 . . . . 0.0 111.531 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -91.79 -12.81 32.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -66.74 129.45 39.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 109.277 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.3 tm? -89.56 120.68 31.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.518 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 27.3 mttm -143.65 108.13 5.13 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.541 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 47.1 Cg_endo -66.77 122.39 9.76 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 123.056 2.504 . . . . 0.0 112.126 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -116.21 154.66 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.6 t -97.04 138.56 34.38 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.57 139.82 14.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.9 t0 -69.2 -8.44 45.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -1.099 . . . . 0.0 109.459 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -87.54 3.61 46.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.978 . . . . 0.0 109.438 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.56 17.29 45.98 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 65.8 mt-30 -121.33 175.22 6.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -1.108 . . . . 0.0 109.625 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.513 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 10.8 m -134.29 136.78 43.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 0.0 109.54 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.583 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 30.6 m-85 -114.42 127.67 55.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 59.6 t-20 -50.6 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.433 -0.792 . . . . 0.0 110.079 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.8 t-20 -80.85 149.5 67.36 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.004 -1.06 . . . . 0.0 109.555 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.35 -54.92 0.85 Allowed 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.793 2.329 . . . . 0.0 111.917 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.2 t -62.09 -28.33 69.54 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.965 -1.084 . . . . 0.0 108.265 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.4 mmm -64.41 -12.58 44.55 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.583 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 28.4 tp -73.56 -57.67 3.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.465 -0.772 . . . . 0.0 109.067 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.43 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.8 m -62.85 -18.47 62.93 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -71.85 -58.27 3.6 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -61.92 -17.08 55.52 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 47' ' ' GLN . 95.6 m-20 -77.15 -31.91 55.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.524 -0.735 . . . . 0.0 109.076 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 40' ' ' CYS . 19.5 mt -58.55 -35.99 73.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.935 . . . . 0.0 108.678 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.2 mm -78.64 -50.25 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.056 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.9 mtt-85 -64.46 -34.71 78.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.168 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.7 mt-30 58.79 36.47 24.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.379 -0.826 . . . . 0.0 109.447 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 p -113.12 11.82 18.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.37 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 46.28 57.73 5.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.367 -0.833 . . . . 0.0 109.44 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.3 m -75.04 140.57 43.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.492 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -112.5 170.01 8.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.416 HG12 HD23 ' A' ' 39' ' ' LEU . 39.7 mt -79.85 126.52 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 41.3 ttt180 -79.77 -45.82 18.12 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.7 p -158.19 162.51 37.9 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.4 p -79.05 133.08 36.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -0.986 . . . . 0.0 109.755 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 99.95 165.35 29.06 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.513 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 30.1 tttp -54.39 158.51 2.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -1.083 . . . . 0.0 109.236 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.464 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 91.2 m -69.39 150.42 47.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.6 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.384 179.918 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtp . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.9 m -85.48 -22.93 28.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.375 -0.828 . . . . 0.0 109.247 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -74.75 -14.33 60.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -109.34 4.09 22.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.872 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -119.43 155.11 32.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.038 -1.039 . . . . 0.0 109.238 179.909 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -136.74 130.79 32.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.408 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HB ' ' CE2' ' A' ' 8' ' ' TYR . 4.9 p -129.39 142.2 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.469 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.522 ' CD2' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -103.88 173.55 3.33 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.522 ' HD2' ' CD2' ' A' ' 11' ' ' LEU . 47.6 Cg_endo -68.44 -26.72 34.37 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.595 2.197 . . . . 0.0 111.717 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -89.01 -28.41 20.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.295 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.7 mm -84.39 -40.57 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.244 -0.91 . . . . 0.0 109.304 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.478 ' C ' ' CG2' ' A' ' 10' ' ' VAL . . . 68.56 155.85 0.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CE2' ' CZ ' ' A' ' 8' ' ' TYR . 1.3 t80 -55.67 148.06 17.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.292 -1.122 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.6 tp -123.1 119.62 30.83 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.859 . . . . 0.0 109.323 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.4 m -117.67 155.82 50.2 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.525 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.3 Cg_endo -71.55 166.02 30.69 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.844 2.363 . . . . 0.0 111.791 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -86.63 -8.01 57.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.867 . . . . 0.0 109.335 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -72.99 128.77 36.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 109.304 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.513 ' CD2' ' OD1' ' A' ' 34' ' ' ASN . 3.1 tm? -92.12 124.69 36.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 34' ' ' ASN . 2.2 mmmm -145.27 103.68 4.36 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.304 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.541 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -65.36 124.29 12.7 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 123.061 2.507 . . . . 0.0 112.298 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.7 m -120.74 156.26 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 109.939 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 53' ' ' ARG . 11.6 t -101.64 115.46 30.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.172 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -71.77 139.29 28.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.0 p30 -69.41 -9.83 55.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -1.14 . . . . 0.0 109.484 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.8 m-20 -82.95 8.13 13.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.75 14.35 63.31 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.0 mt-30 -120.75 159.73 24.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.304 -1.116 . . . . 0.0 109.467 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.496 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 33.1 m -119.1 134.66 55.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.286 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.623 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 56.5 m-85 -113.26 123.83 51.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.119 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.513 ' OD1' ' CD2' ' A' ' 22' ' ' LEU . 64.2 t-20 -49.41 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.256 -0.902 . . . . 0.0 109.806 -179.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.5 t-20 -80.93 147.97 63.28 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 120.871 -1.143 . . . . 0.0 109.72 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.475 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 39.6 Cg_endo -62.16 -53.11 2.17 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.845 2.363 . . . . 0.0 111.941 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.0 t -60.92 -28.5 68.98 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 120.911 -1.118 . . . . 0.0 108.023 178.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 22.2 mtp -63.99 -20.92 66.25 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.623 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 32.7 tp -67.38 -54.57 19.31 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 38.1 t -58.34 -30.96 67.14 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -66.52 -59.04 4.0 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 73.9 mt-10 -59.2 -18.41 36.43 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.466 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 94.4 m-20 -77.28 -37.88 51.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.589 -0.695 . . . . 0.0 109.162 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 40' ' ' CYS . 5.4 mp -56.38 -34.24 66.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 108.79 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.484 HD12 HG22 ' A' ' 45' ' ' ILE . 5.0 mt -79.01 -48.49 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.396 -0.815 . . . . 0.0 109.278 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.507 ' HG3' ' CG2' ' A' ' 48' ' ' THR . 19.9 tpt85 -65.64 -39.22 91.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 88.7 mt-30 62.67 41.84 8.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.56 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.507 ' CG2' ' HG3' ' A' ' 46' ' ' ARG . 27.3 p -121.92 10.65 10.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.497 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 51.51 60.84 3.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.355 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.466 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 26.7 m -77.52 141.56 39.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.625 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -115.18 172.12 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.011 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.4 mt -82.96 124.75 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 26' ' ' CYS . 24.7 tpt180 -82.16 -53.52 6.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.422 -0.799 . . . . 0.0 109.31 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.9 p -148.02 154.58 40.46 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -73.05 147.58 44.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.116 -0.99 . . . . 0.0 109.312 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.95 165.15 40.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.518 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 35.0 mttm -66.86 145.6 55.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -1.041 . . . . 0.0 109.301 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 153.06 29.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.453 -179.964 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.581 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 34.8 m -81.13 -17.12 50.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.785 . . . . 0.0 109.475 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 63.1 mttt -80.51 8.38 7.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.733 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 95.9 m-20 -137.83 10.76 2.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.011 -1.056 . . . . 0.0 110.241 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.616 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -121.36 151.18 40.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 109.565 179.803 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -132.02 134.86 46.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.236 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.558 HG22 ' CE2' ' A' ' 8' ' ' TYR . 61.8 t -124.47 148.92 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.82 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.529 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -129.6 175.23 3.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.437 -0.789 . . . . 0.0 109.276 179.849 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.8 Cg_endo -66.9 -21.73 49.83 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.651 2.234 . . . . 0.0 111.784 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -103.65 -28.26 11.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.52 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.2 mt -81.76 -46.99 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.547 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.41 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 78.97 -166.43 51.83 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.2 t80 -97.16 150.8 20.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.174 . . . . 0.0 109.502 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.6 tp -120.07 116.29 25.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 109.681 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.6 m -127.37 157.37 72.94 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.201 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.8 Cg_endo -71.05 166.49 28.99 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.501 2.134 . . . . 0.0 111.682 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -88.12 -14.41 38.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.521 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -71.87 119.31 15.87 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.207 -0.933 . . . . 0.0 109.242 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.0 tp -83.61 116.39 22.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.75 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 34' ' ' ASN . 1.6 mmtt -129.7 105.45 17.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.885 . . . . 0.0 109.087 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.4 Cg_endo -65.27 119.82 6.91 Favored 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 122.952 2.434 . . . . 0.0 112.283 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.63 154.8 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.873 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 25.8 t -95.72 127.61 41.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.329 -0.857 . . . . 0.0 108.753 179.21 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -83.07 137.51 16.61 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.4 p30 -67.8 -8.52 36.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -85.6 7.34 23.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 109.384 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.54 16.07 57.45 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.5 mt-30 -123.2 173.46 7.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.477 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 25.9 m -133.0 135.42 45.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.387 -0.82 . . . . 0.0 109.263 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.637 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 37.0 m-85 -112.54 130.09 56.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.202 -0.936 . . . . 0.0 109.371 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 23' ' ' LYS . 8.4 m-20 -53.77 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 109.72 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.0 t-20 -81.84 147.8 59.45 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.29 -53.87 1.3 Allowed 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.789 2.326 . . . . 0.0 111.813 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -61.32 -27.49 68.52 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 42.8 mmm -64.81 -17.88 64.62 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.234 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.637 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 24.2 tp -68.54 -58.16 4.72 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.457 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 10.5 t -56.36 -26.12 51.72 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -68.59 -61.56 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -56.02 -19.86 14.38 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.2 m-20 -78.56 -40.27 35.31 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.7 tp -55.83 -33.84 64.85 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.417 -0.802 . . . . 0.0 108.845 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.489 HG23 HD11 ' A' ' 45' ' ' ILE . 3.1 mt -78.82 -50.53 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.836 . . . . 0.0 108.995 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 13.2 mtt-85 -65.48 -22.02 66.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 109.348 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 89.0 mt-30 63.83 43.67 5.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.333 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.4 t -131.57 168.99 16.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.579 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 90.7 m-20 -103.56 63.29 0.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.1 m -74.42 140.01 44.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.703 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 31.4 m80 -116.66 178.93 4.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.044 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 52' ' ' ILE . 30.0 mt -87.99 124.9 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.058 -1.026 . . . . 0.0 109.4 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 69.9 ttt-85 -80.19 -47.5 14.58 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.543 -0.723 . . . . 0.0 109.288 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 p -155.33 152.99 29.83 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -71.69 146.03 48.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.15 -0.969 . . . . 0.0 109.415 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.98 164.23 40.17 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 26.1 mttp -64.58 143.66 57.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.554 -0.968 . . . . 0.0 109.447 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 151.55 35.47 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.257 -0.902 . . . . 0.0 109.397 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.5 -179.864 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.7 mtp . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.57 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.0 m -85.58 4.14 37.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 109.083 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.564 ' HE2' ' CD2' ' A' ' 51' ' ' HIS . 24.7 mttt -73.05 -20.48 60.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 58.6 p30 -148.93 57.55 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 109.838 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.57 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 12.0 p90 -120.83 -175.44 3.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 109.242 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -152.64 145.6 24.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.391 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.571 HG22 ' CD2' ' A' ' 16' ' ' TYR . 55.5 t -132.04 129.68 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.532 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -111.94 175.37 1.9 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.355 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.4 Cg_endo -67.57 -23.66 42.85 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.61 2.207 . . . . 0.0 111.651 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.9 ttp85 -93.28 -39.72 10.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.89 . . . . 0.0 109.207 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.7 mt -79.95 -43.84 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.351 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.422 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 67.27 -155.05 52.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.571 ' CD2' HG22 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -112.71 148.13 35.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -1.104 . . . . 0.0 109.25 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.583 ' N ' ' CD1' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -122.0 128.93 52.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.0 m -136.4 157.27 75.7 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.272 -0.893 . . . . 0.0 109.317 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -70.4 165.73 30.74 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.575 2.184 . . . . 0.0 111.662 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -87.4 -10.5 51.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -78.52 108.88 12.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.443 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 35' ' ' ASN . 3.5 tm? -76.0 110.8 10.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 34' ' ' ASN . 2.6 mtpt -124.3 109.66 29.01 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 109.313 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.4 Cg_endo -62.31 121.26 9.19 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 123.035 2.49 . . . . 0.0 112.272 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.471 HG22 HD11 ' A' ' 39' ' ' LEU . 11.1 m -115.78 155.78 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -0.804 . . . . 0.0 109.904 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.7 t -97.27 112.92 24.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.365 -0.834 . . . . 0.0 108.932 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -67.18 133.5 31.04 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.4 t0 -69.62 -6.46 31.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 109.783 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 57.4 p30 -85.53 1.99 46.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.084 -1.01 . . . . 0.0 109.342 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.71 18.26 30.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.3 mt-30 -126.84 173.88 9.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.498 -1.001 . . . . 0.0 109.341 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 57' ' ' LYS . 23.5 m -132.63 138.35 47.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.266 -0.896 . . . . 0.0 109.29 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.613 ' CD2' ' CD1' ' A' ' 39' ' ' LEU . 31.4 m-85 -118.38 139.81 50.81 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.163 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.506 ' O ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -61.03 -76.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 -179.365 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.0 t-20 -82.31 146.81 55.22 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.988 -1.07 . . . . 0.0 109.64 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.9 Cg_endo -63.65 -52.23 1.98 Allowed 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.599 2.199 . . . . 0.0 111.68 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.537 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -63.42 -27.62 69.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 0.0 108.183 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.484 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 54.3 mtp -67.88 -19.8 65.06 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.315 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.613 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 7.3 tt -66.52 -52.92 40.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.331 -0.856 . . . . 0.0 108.873 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 43' ' ' ASN . 9.4 m -51.16 -41.05 59.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 40' ' ' CYS . 16.1 t60 -48.06 -48.1 33.54 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.972 -1.08 . . . . 0.0 108.209 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.562 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 49.8 mm-40 -58.37 -22.18 52.75 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 40' ' ' CYS . 2.9 m-80 -75.7 -35.83 60.18 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.997 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.517 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 31.7 mt -65.86 -48.69 70.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.301 -0.874 . . . . 0.0 109.389 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.8 mm -67.2 -52.82 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.118 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 72.8 ttt180 -68.56 -22.87 64.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.307 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ASN . 86.7 mt-30 63.06 43.17 6.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.363 -0.835 . . . . 0.0 109.571 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.432 ' OG1' ' HD3' ' A' ' 46' ' ' ARG . 60.7 p -132.96 167.42 20.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.145 -0.972 . . . . 0.0 109.576 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.577 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 89.8 m-20 -94.3 57.83 2.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.48 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 57.0 m -80.19 127.16 32.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.467 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 14.6 m80 -115.79 -169.22 1.55 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.444 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.491 HD11 HG22 ' A' ' 52' ' ' ILE . 37.8 mt -88.12 124.98 41.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.473 -0.767 . . . . 0.0 109.836 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 64.5 ttt180 -82.53 -49.64 9.67 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.746 0.784 . . . . 0.0 109.383 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 p -150.72 138.83 20.14 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -60.95 144.59 52.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.117 -0.99 . . . . 0.0 109.284 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.48 160.72 36.43 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HA ' HG22 ' A' ' 32' ' ' THR . 17.7 tttm -61.52 148.87 40.62 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.521 -0.987 . . . . 0.0 109.397 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.1 145.31 32.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.654 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.587 -179.948 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.4 m -80.0 -5.54 55.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.296 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -61.6 -23.2 65.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.674 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -151.31 64.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.928 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.496 ' OH ' ' CD1' ' A' ' 44' ' ' LEU . 6.7 p90 -123.77 174.33 7.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.109 -0.994 . . . . 0.0 109.198 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.423 ' C ' HG21 ' A' ' 10' ' ' VAL . 86.0 mtt-85 -147.35 146.49 29.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.648 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' ' 16' ' ' TYR . 69.3 t -145.29 132.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.484 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.531 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -117.8 175.08 2.2 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.269 -0.894 . . . . 0.0 109.597 -179.968 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.9 Cg_endo -67.73 -26.35 39.1 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.687 2.258 . . . . 0.0 111.951 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -107.8 -24.49 11.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.369 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.4 mm -82.59 -43.08 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.25 -159.14 53.23 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.473 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.7 t80 -98.6 153.73 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -1.177 . . . . 0.0 109.466 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 31.3 tp -107.86 123.25 48.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 109.877 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 68.3 m -140.19 156.48 70.03 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.306 -0.871 . . . . 0.0 109.21 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.56 167.6 25.96 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.558 2.172 . . . . 0.0 111.701 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -84.07 -29.47 26.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.613 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.34 125.94 25.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.418 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.44 HD13 ' C ' ' A' ' 34' ' ' ASN . 59.5 tp -88.26 113.21 23.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.154 -0.966 . . . . 0.0 109.432 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.5 mttt -121.27 105.61 39.29 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.511 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -64.69 118.67 5.63 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 123.085 2.523 . . . . 0.0 112.215 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.47 ' HB ' HG22 ' A' ' 52' ' ' ILE . 14.1 m -115.72 156.01 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 109.885 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.4 t -98.95 142.87 29.9 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.82 143.7 16.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.2 t0 -71.87 -14.33 61.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -1.124 . . . . 0.0 109.416 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -83.69 -5.38 59.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.44 22.04 10.87 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.5 mt-30 -121.46 170.95 9.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -1.13 . . . . 0.0 109.469 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.484 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 86.6 m -133.61 136.66 45.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.493 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.639 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 28.3 m-85 -115.02 146.23 41.47 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 108.754 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.531 ' N ' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -67.98 -75.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.01 -1.056 . . . . 0.0 108.626 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.9 t-20 -82.77 146.7 53.29 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 109.403 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -63.61 -51.18 2.64 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.693 2.262 . . . . 0.0 111.591 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -62.18 -28.58 69.77 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.444 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 10.3 mtt -64.4 -16.91 63.21 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.639 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 30.9 tp -65.94 -53.69 35.98 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.418 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 12.5 t -60.65 -23.48 64.82 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.447 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 25.2 t60 -67.31 -58.98 3.8 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -58.79 -22.07 57.48 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 47' ' ' GLN . 78.2 m-20 -80.38 -30.77 37.87 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.496 ' CD1' ' OH ' ' A' ' 8' ' ' TYR . 49.5 tp -62.38 -35.56 79.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 108.76 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 45' ' ' ILE . 2.1 mt -80.49 -50.33 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.4 -0.813 . . . . 0.0 109.249 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 96.1 mtt180 -68.89 -40.27 79.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.7 mt-30 65.0 39.56 5.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.543 -0.723 . . . . 0.0 109.547 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.6 p -108.15 6.97 27.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.393 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.1 t30 52.74 56.79 7.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.524 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.9 m -78.6 140.46 38.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -112.12 169.11 9.08 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.275 -0.891 . . . . 0.0 108.993 179.523 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.47 HG22 ' HB ' ' A' ' 25' ' ' VAL . 23.3 mt -79.47 127.11 39.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.218 -0.926 . . . . 0.0 109.241 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 53.7 ttt-85 -79.35 -46.14 18.23 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.389 -0.819 . . . . 0.0 109.134 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 m -160.61 148.08 15.89 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.7 p -61.18 145.3 51.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.6 166.23 40.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.484 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 89.2 mttt -67.71 150.16 49.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -1.085 . . . . 0.0 109.499 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.466 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 66.7 m -59.79 151.11 26.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.9 . . . . 0.0 109.318 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.488 179.971 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.0 ttm . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 81.3 m -81.64 -31.18 32.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.244 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -60.49 -23.71 64.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.398 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -76.41 -25.73 54.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.512 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.483 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -103.66 155.22 18.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.197 -0.939 . . . . 0.0 109.226 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -128.36 139.71 52.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 0.0 109.317 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.484 ' CG2' ' C ' ' A' ' 15' ' ' GLY . 13.0 p -123.17 146.0 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -0.924 . . . . 0.0 109.51 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.538 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -108.59 176.08 1.72 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.3 Cg_endo -67.14 -25.4 43.54 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.601 2.201 . . . . 0.0 111.675 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -85.01 -31.3 23.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.253 -0.904 . . . . 0.0 108.917 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.8 mt -87.04 -37.68 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.398 -0.814 . . . . 0.0 109.128 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.484 ' C ' ' CG2' ' A' ' 10' ' ' VAL . . . 66.52 142.24 0.05 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.5 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER -42.27 152.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.446 -1.032 . . . . 0.0 109.833 -179.921 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 tp -123.53 118.29 27.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.426 -0.796 . . . . 0.0 109.518 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.7 m -129.24 157.28 76.58 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.188 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.67 165.86 30.63 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.691 2.261 . . . . 0.0 111.755 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -89.12 -8.74 53.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.23 -0.919 . . . . 0.0 109.421 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -76.97 107.18 9.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 0.0 109.07 179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.4 tp -71.2 121.16 17.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.811 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.508 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 31.1 mtmt -139.57 110.53 7.47 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.235 -0.915 . . . . 0.0 109.102 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.8 Cg_endo -65.54 119.48 6.51 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 C-N-CA 123.175 2.584 . . . . 0.0 112.631 -179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.519 ' O ' ' CG2' ' A' ' 32' ' ' THR . 27.3 m -112.49 156.22 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 0.0 109.65 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 53' ' ' ARG . 12.3 t -98.59 111.44 23.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 109.315 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.3 138.16 36.17 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.49 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 40.1 t0 -71.26 -4.73 27.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -1.199 . . . . 0.0 109.606 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 57.6 m-20 -90.07 7.2 38.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.083 -1.01 . . . . 0.0 109.101 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.77 14.5 59.48 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 27' ' ' GLY . 77.0 mt-30 -125.69 140.23 52.88 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.414 -1.051 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 25' ' ' VAL . 17.1 m -103.59 153.21 20.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -0.902 . . . . 0.0 109.34 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.574 ' CZ ' ' HG3' ' A' ' 42' ' ' GLU . 19.9 m-85 -128.58 143.16 50.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 23' ' ' LYS . 6.1 m-20 -58.54 -75.23 0.05 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -0.888 . . . . 0.0 109.962 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.7 t-20 -82.5 147.76 56.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.069 -1.019 . . . . 0.0 109.993 -179.543 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.5 Cg_endo -64.3 -53.44 1.12 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.746 2.298 . . . . 0.0 111.485 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.5 t -60.77 -27.69 68.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 36.5 mmm -63.78 -17.46 63.09 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.54 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . 8.2 tt -68.26 -52.82 29.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.352 -0.843 . . . . 0.0 108.985 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 45.0 m -47.9 -47.41 32.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.095 -1.003 . . . . 0.0 108.392 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.445 ' HA ' HD11 ' A' ' 44' ' ' LEU . 14.7 t60 -47.97 -49.35 30.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.128 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.574 ' HG3' ' CZ ' ' A' ' 33' ' ' TYR . 71.8 mm-40 -49.41 -24.05 1.79 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 4.6 m-80 -80.02 -37.64 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.416 -0.803 . . . . 0.0 108.873 179.352 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' A' ' 41' ' ' HIS . 8.3 mp -67.5 -36.71 81.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.221 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 45' ' ' ILE . 5.3 mt -77.12 -52.53 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.077 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.472 ' O ' HG21 ' A' ' 48' ' ' THR . 47.0 mtt-85 -71.85 -20.99 61.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.373 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 43' ' ' ASN . 88.2 mt-30 62.44 35.45 14.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -0.851 . . . . 0.0 109.312 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.472 HG21 ' O ' ' A' ' 46' ' ' ARG . 30.8 p -125.48 175.11 7.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.444 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.575 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 79.8 m-20 -94.75 58.87 2.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 109.451 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.472 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 30.9 m -79.22 126.11 30.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 32.3 m80 -115.7 -172.57 2.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.172 179.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.452 HG22 ' HB ' ' A' ' 25' ' ' VAL . 13.0 mt -87.78 124.27 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 109.576 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.49 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 61.3 ttt180 -80.07 -53.49 6.66 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.647 0.737 . . . . 0.0 109.319 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 p -150.88 143.89 24.66 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.629 -0.67 . . . . 0.0 109.203 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.3 p -64.83 144.86 56.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.196 -0.94 . . . . 0.0 109.405 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.03 161.66 36.92 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.474 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 23.2 tttt -62.22 144.96 54.82 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.449 -1.03 . . . . 0.0 109.278 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.37 157.22 26.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.616 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.545 -179.986 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.4 mmm . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 33.5 m -80.31 -17.74 51.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.524 -0.735 . . . . 0.0 109.021 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -80.77 8.35 8.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.516 179.596 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -133.24 2.8 3.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.132 -0.98 . . . . 0.0 109.996 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.677 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -118.76 148.52 42.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.014 -1.054 . . . . 0.0 109.539 -179.977 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.7 mtm-85 -129.14 132.21 47.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.112 179.553 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.518 HG22 ' CE2' ' A' ' 8' ' ' TYR . 42.2 t -126.51 140.48 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 -179.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.533 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 3.8 mm? -117.95 170.26 6.53 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 41.7 Cg_endo -65.44 -21.43 60.56 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.192 1.928 . . . . 0.0 111.575 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -94.88 -25.29 16.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.418 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.2 mt -88.92 -50.44 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.298 -0.876 . . . . 0.0 109.944 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.404 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 82.24 -174.31 53.46 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.677 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -91.81 148.28 22.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -1.172 . . . . 0.0 109.552 -179.938 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.3 tp -120.96 100.67 7.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 109.728 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.6 m -111.04 157.73 37.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.235 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 53.6 Cg_endo -73.22 167.87 26.23 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.67 2.247 . . . . 0.0 111.681 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -87.62 -26.5 23.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 109.346 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 46.4 m-20 -57.89 124.54 19.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.163 -0.961 . . . . 0.0 109.171 179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.2 tp -88.73 116.3 26.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.613 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASN . 3.8 mttt -127.43 103.2 22.65 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 108.983 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.527 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.7 Cg_endo -65.63 115.85 3.61 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.937 2.425 . . . . 0.0 111.842 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.401 ' O ' HG21 ' A' ' 32' ' ' THR . 21.7 m -113.89 154.43 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 0.0 109.732 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.1 t -94.22 131.49 39.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.343 -0.848 . . . . 0.0 108.738 179.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -86.85 137.24 14.64 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.4 p30 -66.23 -12.11 54.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -1.159 . . . . 0.0 109.616 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 52.6 p30 -83.75 8.92 13.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.01 20.83 54.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 68.8 mt-30 -125.51 175.98 7.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.47 -1.017 . . . . 0.0 109.326 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 14.1 m -135.1 136.38 41.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 109.432 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.633 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 47.5 m-85 -113.87 120.43 40.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.882 . . . . 0.0 109.267 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 23' ' ' LYS . 10.4 m-20 -45.55 -78.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.985 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.3 t-20 -81.66 148.92 63.08 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.02 -1.05 . . . . 0.0 109.881 -179.583 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.79 -54.35 0.98 Allowed 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.732 2.288 . . . . 0.0 111.927 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -63.01 -25.59 68.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.026 -1.046 . . . . 0.0 108.373 179.137 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.2 mmm -66.43 -11.56 52.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.559 -0.713 . . . . 0.0 109.095 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.633 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 20.9 tp -71.38 -60.12 2.4 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.29 -0.881 . . . . 0.0 108.707 179.594 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.461 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 10.3 t -54.65 -28.35 46.53 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -67.8 -60.64 2.36 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.143 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -57.78 -18.74 23.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 47' ' ' GLN . 96.7 m-20 -77.54 -32.6 54.06 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.4 tm? -58.36 -38.99 78.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.514 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mm -75.56 -49.73 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -0.867 . . . . 0.0 108.767 179.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 47.0 mtt-85 -63.71 -28.55 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.187 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 89.5 mt-30 63.15 44.03 6.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.415 HG21 ' C ' ' A' ' 47' ' ' GLN . 30.6 p -133.51 167.05 21.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 179.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.576 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 48.7 p-10 -95.91 61.35 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.309 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.466 HG23 HD13 ' A' ' 39' ' ' LEU . 93.9 m -72.46 135.37 45.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.856 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 42.5 m80 -115.28 -178.1 3.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 108.939 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.517 HD11 HG22 ' A' ' 52' ' ' ILE . 15.2 mt -90.25 123.04 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 109.004 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 50.1 ttt85 -79.65 -44.52 20.77 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.393 -0.817 . . . . 0.0 109.432 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 p -158.56 158.09 33.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.549 -0.719 . . . . 0.0 109.121 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 p -75.5 136.97 40.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.897 . . . . 0.0 109.698 -179.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.47 162.73 34.11 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 48.0 tttm -49.59 159.4 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.486 -1.008 . . . . 0.0 109.216 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.477 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 73.1 m -68.39 145.35 54.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.38 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.549 179.965 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.447 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 45.1 ttm . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 71.2 m -80.48 -9.15 59.77 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.451 -0.781 . . . . 0.0 109.138 179.657 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -81.12 11.03 4.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.092 -1.005 . . . . 0.0 109.617 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 4' ' ' MET . 49.2 p30 -127.31 8.29 6.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.994 -1.066 . . . . 0.0 110.653 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.579 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 6.9 p90 -107.59 -177.41 3.34 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.723 -1.235 . . . . 0.0 109.686 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.579 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 46.8 mtt180 -151.91 128.46 10.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.226 179.567 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.431 HG12 ' C ' ' A' ' 15' ' ' GLY . 24.5 t -127.14 145.36 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.7 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.541 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -118.53 176.33 1.72 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.365 -0.834 . . . . 0.0 109.169 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.0 Cg_endo -66.96 -21.97 49.04 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.557 2.171 . . . . 0.0 111.773 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.8 mtt-85 -96.81 -27.75 14.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 mm -84.1 -47.47 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.707 -179.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.431 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 78.32 177.6 48.48 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.477 ' CE1' ' SG ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -83.0 147.68 28.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -1.16 . . . . 0.0 109.435 -179.917 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.0 tp -118.9 105.74 11.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.755 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.9 m -116.22 155.87 47.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 108.964 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.25 165.63 32.08 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.561 2.174 . . . . 0.0 111.543 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -84.04 -31.79 25.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 109.267 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -54.18 132.8 43.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.384 -0.823 . . . . 0.0 109.052 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.3 tp -96.93 119.45 35.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.175 -0.953 . . . . 0.0 109.628 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.496 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 3.9 mttm -130.99 106.56 15.1 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 0.0 108.899 179.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.64 123.41 11.66 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 123.009 2.472 . . . . 0.0 112.354 -179.183 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.461 ' HB ' HG22 ' A' ' 52' ' ' ILE . 17.6 m -118.18 155.15 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.728 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.7 t -96.49 138.09 34.59 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -91.44 135.64 12.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.472 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -66.83 -11.03 53.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 109.465 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.7 p30 -89.03 10.68 20.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.437 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.45 19.25 57.24 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.1 mt-30 -120.5 178.42 4.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -1.147 . . . . 0.0 109.549 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.454 ' OG1' ' SG ' ' A' ' 58' ' ' CYS . 35.3 m -139.58 136.76 34.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.887 . . . . 0.0 109.29 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.583 ' CD2' HD11 ' A' ' 39' ' ' LEU . 26.4 m-85 -117.81 128.79 55.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.161 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' LYS . 11.7 m-20 -52.66 -78.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.794 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.5 t-20 -81.69 147.25 58.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.99 -1.069 . . . . 0.0 109.719 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.5 Cg_endo -63.51 -52.12 2.12 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.782 2.321 . . . . 0.0 111.739 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.4 t -62.95 -26.47 68.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.16 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.432 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 54.0 mmm -68.71 -15.15 63.43 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.149 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.583 HD11 ' CD2' ' A' ' 33' ' ' TYR . 21.2 tp -72.21 -50.85 24.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.415 -0.803 . . . . 0.0 109.339 179.784 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.477 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.5 m -66.14 -22.38 66.38 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.017 -1.052 . . . . 0.0 108.224 179.265 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -66.81 -56.17 11.62 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.485 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 95.5 mt-10 -63.43 -17.04 62.26 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 47' ' ' GLN . 86.2 m-20 -79.95 -26.37 40.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.602 -0.686 . . . . 0.0 109.186 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.456 HD13 ' CD2' ' A' ' 16' ' ' TYR . 19.2 mt -69.02 -33.29 73.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.165 -0.959 . . . . 0.0 108.649 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.4 mt -78.73 -50.36 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 108.978 179.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.443 ' NH2' ' OG1' ' A' ' 50' ' ' THR . 47.0 mtm180 -74.35 -34.25 63.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.305 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 59.62 39.24 21.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.553 179.805 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 49' ' ' ASN . 38.1 p -103.97 16.68 25.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 48' ' ' THR . 53.2 m-20 44.22 52.13 7.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.408 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.476 HG21 ' N ' ' A' ' 51' ' ' HIS . 76.6 m -74.9 146.26 42.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.614 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.476 ' N ' HG21 ' A' ' 50' ' ' THR . 31.6 m-70 -123.72 168.76 12.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.282 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 52' ' ' ILE . 16.9 mt -79.73 124.35 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.447 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 78.3 ttt180 -79.76 -44.14 21.24 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 p -160.19 148.82 17.04 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 p -64.86 145.12 56.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.166 -0.959 . . . . 0.0 109.536 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.94 164.23 39.79 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HA ' HG22 ' A' ' 32' ' ' THR . 17.4 tttt -60.44 151.45 28.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.461 -1.023 . . . . 0.0 109.361 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 72.2 m -58.47 152.39 18.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.469 179.89 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.547 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 5.7 m -79.77 -12.35 59.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.447 -0.783 . . . . 0.0 109.05 179.496 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -55.21 -26.78 41.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.933 -179.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -151.56 65.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.692 -179.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.557 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 4.1 p90 -128.79 170.7 13.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.508 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.427 ' C ' HG21 ' A' ' 10' ' ' VAL . 31.8 ttt180 -144.85 154.99 43.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.293 -0.88 . . . . 0.0 109.386 179.579 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.427 HG21 ' C ' ' A' ' 9' ' ' ARG . 95.3 t -146.66 127.27 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.488 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -117.19 173.42 3.15 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.21 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.1 Cg_endo -65.94 -22.92 55.11 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.498 2.132 . . . . 0.0 111.568 179.736 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -105.92 -33.66 7.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.852 . . . . 0.0 109.066 179.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.6 mt -81.64 -40.95 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.118 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.09 -145.13 48.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.9 t80 -105.34 158.0 16.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.31 -1.112 . . . . 0.0 109.495 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.32 114.01 21.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 62.6 m -128.1 156.19 76.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.331 179.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.13 170.28 18.55 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.616 2.211 . . . . 0.0 111.625 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -91.3 -12.48 34.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.122 -0.986 . . . . 0.0 109.644 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -73.3 115.84 13.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.283 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.43 HD12 ' HB3' ' A' ' 34' ' ' ASN . 31.4 tp -73.17 126.36 29.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.625 -179.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -139.75 100.39 7.41 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.849 . . . . 0.0 109.007 179.818 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -64.09 117.71 4.71 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.971 2.447 . . . . 0.0 112.345 -179.272 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.463 ' O ' HG22 ' A' ' 32' ' ' THR . 11.0 m -116.1 155.15 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.402 -0.811 . . . . 0.0 109.841 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.7 t -96.81 137.31 36.09 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.27 139.56 14.6 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 46.2 p30 -65.76 -9.12 25.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -1.068 . . . . 0.0 109.612 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.431 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 66.8 m-20 -89.12 14.03 11.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.12 26.33 58.06 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.459 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 79.7 mt-30 -130.5 174.86 9.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -1.166 . . . . 0.0 109.288 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 32.9 m -131.81 152.93 50.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.586 ' CD2' ' CD1' ' A' ' 39' ' ' LEU . 40.6 m-85 -132.68 119.88 20.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.246 -0.909 . . . . 0.0 109.197 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 23' ' ' LYS . 3.7 m-20 -43.6 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 109.689 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.2 t-20 -81.69 146.26 56.21 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.299 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.518 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.94 -50.95 2.57 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.593 2.195 . . . . 0.0 111.483 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.8 t -61.96 -25.35 67.56 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.456 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 13.9 mtp -68.14 -17.95 64.49 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.368 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.586 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 8.3 tt -67.74 -50.61 56.35 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.426 -0.796 . . . . 0.0 108.858 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 4.7 t -52.54 -45.69 66.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 0.0 108.521 179.194 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -48.99 -48.94 43.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.16 -0.962 . . . . 0.0 108.481 179.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 23.0 mm-40 -57.18 -20.22 25.28 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.528 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.8 m-80 -79.69 -33.13 41.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 108.612 179.2 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.515 ' CD1' ' OH ' ' A' ' 8' ' ' TYR . 3.9 mm? -67.11 -46.71 73.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 109.388 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 45' ' ' ILE . 5.0 mm -66.47 -52.21 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.458 ' O ' HG21 ' A' ' 48' ' ' THR . 66.4 mtp85 -71.02 -19.24 62.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.204 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 60.81 34.45 19.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.458 HG21 ' O ' ' A' ' 46' ' ' ARG . 8.7 p -123.06 -177.55 3.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.519 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 36.5 t-20 -107.59 64.78 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.923 . . . . 0.0 109.527 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 25.0 m -78.91 127.71 32.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 109.66 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.519 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 3.8 m80 -113.84 -172.13 2.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.25 -0.906 . . . . 0.0 109.143 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 52' ' ' ILE . 22.9 mt -89.15 124.16 41.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.21 -0.932 . . . . 0.0 109.572 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.3 ttt-85 -80.8 -42.59 21.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.407 -0.808 . . . . 0.0 109.307 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -160.95 140.77 10.83 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.563 -0.71 . . . . 0.0 109.139 -179.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 p -57.9 140.6 51.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -0.957 . . . . 0.0 109.623 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 96.38 165.91 33.68 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.514 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 27.5 mttp -67.6 143.36 56.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.532 -0.981 . . . . 0.0 109.258 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 62.3 m -53.43 148.92 8.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.446 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.504 -179.955 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.4 mmm . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.564 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.6 m -80.06 -5.0 55.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.369 -0.832 . . . . 0.0 109.301 179.608 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 23.7 mttm -61.26 -28.73 69.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 -179.546 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 80.5 m-20 -145.1 61.66 1.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.067 -1.021 . . . . 0.0 110.339 -179.635 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.637 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 6.5 p90 -127.03 171.34 11.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.064 -1.023 . . . . 0.0 109.309 179.429 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -146.14 148.9 33.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 109.567 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.443 HG22 ' CD2' ' A' ' 16' ' ' TYR . 85.8 t -138.51 132.26 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.419 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.534 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -123.66 175.65 2.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.349 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.5 Cg_endo -67.21 -25.84 42.71 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.53 2.153 . . . . 0.0 111.514 179.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -107.37 -27.33 10.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.388 -0.82 . . . . 0.0 108.991 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 14' ' ' ILE . 28.9 mm -82.06 -39.77 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 109.437 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.98 -145.62 43.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.637 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 3.3 t80 -111.17 155.17 23.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -1.164 . . . . 0.0 109.27 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 39.7 mt -111.64 123.79 50.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.942 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.1 m -142.0 155.36 65.58 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.457 -0.777 . . . . 0.0 108.954 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.36 164.57 34.66 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.51 2.14 . . . . 0.0 111.554 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -83.46 -26.48 30.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.875 . . . . 0.0 109.544 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.51 129.31 40.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 109.299 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.7 tp -88.8 123.17 32.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 0.0 109.472 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.2 mmtm -133.91 102.74 12.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.432 -0.793 . . . . 0.0 109.179 179.815 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.1 Cg_endo -64.05 122.04 9.91 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 123.032 2.488 . . . . 0.0 112.331 -179.222 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.45 HG22 HD11 ' A' ' 39' ' ' LEU . 16.8 m -122.22 155.41 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.753 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 34.7 t -99.15 137.51 37.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.403 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.16 138.74 14.13 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.212 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 56.6 p30 -63.59 -11.14 22.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -1.064 . . . . 0.0 109.671 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 86.4 m-20 -85.76 12.93 7.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.345 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.39 20.22 69.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.0 mt-30 -124.52 159.52 30.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -1.121 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 57.3 m -119.97 142.66 48.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -0.963 . . . . 0.0 109.569 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.561 ' CD2' HD13 ' A' ' 39' ' ' LEU . 57.7 m-85 -121.36 130.88 53.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.386 -0.821 . . . . 0.0 109.16 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.1 m-20 -53.8 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.16 -0.962 . . . . 0.0 109.54 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 11.4 t-20 -82.26 147.07 56.0 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 120.99 -1.069 . . . . 0.0 109.699 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.0 Cg_endo -63.1 -51.24 2.94 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.569 2.179 . . . . 0.0 111.409 179.371 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.502 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -60.25 -29.75 68.98 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 38.3 mmm -64.4 -23.52 67.32 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.35 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.561 HD13 ' CD2' ' A' ' 33' ' ' TYR . 7.2 tt -63.4 -48.01 79.6 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.362 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 12.0 t -52.63 -34.01 49.32 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -54.43 -50.04 68.59 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 108.763 179.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.5 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 26.2 tp10 -56.78 -19.9 19.52 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.363 -0.836 . . . . 0.0 108.774 179.338 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 4.7 m-80 -80.06 -31.65 39.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.858 . . . . 0.0 109.125 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.482 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.4 tm? -68.89 -42.39 77.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.084 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.0 mt -71.17 -55.22 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 109.175 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 35.6 mtt-85 -70.33 -21.73 62.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.394 -0.816 . . . . 0.0 109.258 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 62.3 32.33 17.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.343 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.417 HG22 ' HB3' ' A' ' 46' ' ' ARG . 17.9 p -119.52 176.78 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 109.353 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.532 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 84.6 m-20 -100.13 61.37 1.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.481 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 56.0 m -71.79 131.7 43.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.882 . . . . 0.0 109.522 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 14.7 m-70 -116.58 -175.88 2.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.277 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.446 HD11 HG22 ' A' ' 52' ' ' ILE . 20.6 mt -86.19 124.26 40.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.199 -0.938 . . . . 0.0 109.542 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 70.1 ttt180 -80.53 -39.71 27.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.421 -0.799 . . . . 0.0 109.051 179.694 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -158.57 153.56 25.18 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.2 p -73.39 145.57 45.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.179 -0.951 . . . . 0.0 109.495 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.92 164.71 40.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.523 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 37.5 mttp -63.09 144.88 56.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.478 -1.013 . . . . 0.0 109.406 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.53 156.08 29.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.57 179.998 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.1 mmm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 38.2 m -81.19 -19.58 43.03 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.387 -0.821 . . . . 0.0 109.331 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -80.68 9.26 6.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -133.17 2.69 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.973 . . . . 0.0 109.958 -179.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.584 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -119.45 144.89 46.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.02 -1.05 . . . . 0.0 109.74 -179.916 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.0 mtt85 -127.5 129.83 48.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 108.894 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.464 ' O ' HD23 ' A' ' 11' ' ' LEU . 42.9 t -116.76 141.49 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.035 -1.041 . . . . 0.0 110.201 -179.289 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.547 ' CD1' ' HD2' ' A' ' 12' ' ' PRO . 4.0 mm? -124.43 171.09 7.69 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.547 ' HD2' ' CD1' ' A' ' 11' ' ' LEU . 42.7 Cg_endo -66.28 -22.25 53.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.305 2.003 . . . . 0.0 111.666 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -97.0 -29.51 13.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 109.206 179.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.6 mt -83.06 -48.57 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.402 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.407 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 86.7 -175.0 46.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.471 ' OH ' ' HB3' ' A' ' 40' ' ' CYS . 1.5 t80 -81.15 153.05 27.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -1.143 . . . . 0.0 109.544 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.447 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 38.6 mt -127.86 134.08 49.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 72.4 m -146.92 158.4 45.35 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.347 -0.845 . . . . 0.0 109.141 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.9 Cg_endo -69.52 167.5 23.94 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.636 2.224 . . . . 0.0 111.459 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -85.62 -21.72 28.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.188 -0.945 . . . . 0.0 109.693 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -68.01 115.98 8.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.307 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.9 tp -86.95 121.38 29.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.174 -0.954 . . . . 0.0 109.536 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASN . 13.0 mmtm -135.83 113.26 10.75 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.403 -0.81 . . . . 0.0 108.908 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.531 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -64.78 116.06 3.59 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.953 2.436 . . . . 0.0 112.13 -179.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 32' ' ' THR . 34.2 m -113.53 156.13 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.956 -179.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.5 t -100.49 124.02 45.47 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -80.85 137.54 18.13 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.621 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 46.8 p30 -63.9 -10.58 21.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -1.127 . . . . 0.0 109.727 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.412 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 28.5 m-20 -87.29 16.76 4.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.52 19.59 75.95 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.8 mt-30 -120.83 169.0 10.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -1.1 . . . . 0.0 109.392 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.518 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 88.6 m -129.86 142.71 50.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.403 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 41.8 m-85 -122.43 118.0 27.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.329 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 23' ' ' LYS . 7.1 m-20 -43.09 -75.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.855 . . . . 0.0 109.536 -179.656 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.1 t-20 -81.79 150.28 65.54 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.81 -54.5 1.17 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.684 2.256 . . . . 0.0 111.906 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.516 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.0 t -58.42 -30.5 66.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.947 -1.095 . . . . 0.0 108.149 179.051 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 7.5 mtt -59.71 -21.09 60.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.572 HD13 ' CD2' ' A' ' 33' ' ' TYR . 7.3 tt -66.89 -53.63 30.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 16.9 t -49.48 -28.56 5.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -57.89 -53.58 56.64 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.282 -0.886 . . . . 0.0 108.617 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 16.3 tp10 -54.03 -20.48 6.43 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.8 m-80 -80.46 -33.44 36.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 108.773 179.541 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.26 -39.35 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.83 . . . . 0.0 109.346 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.31 -46.56 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.66 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 27.0 mmt180 -80.3 -33.83 37.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.542 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 89.5 mt-30 58.97 32.05 21.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.504 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 81.2 p -104.63 6.23 34.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.151 -0.968 . . . . 0.0 109.637 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.567 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 73.3 m-20 63.11 52.86 2.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.637 179.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.523 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 91.6 m -78.7 142.35 37.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 109.357 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 35.7 m80 -120.33 -171.7 2.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.535 179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.2 mt -92.05 123.35 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 179.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.467 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.4 ttt180 -79.31 -50.73 10.44 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.327 -0.858 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -158.93 139.31 12.35 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 109.348 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 p -53.54 145.86 14.11 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.35 162.91 35.5 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.518 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 53.8 mttp -66.93 150.04 49.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.458 -1.025 . . . . 0.0 109.528 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 72.7 m -59.27 147.17 36.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.91 . . . . 0.0 109.395 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.534 -179.932 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.6 ttt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 30.7 m -82.76 -15.46 51.71 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.3 -0.875 . . . . 0.0 109.451 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 23.5 mttm -80.65 7.51 9.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.729 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 98.3 m-20 -138.23 16.02 2.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.028 -1.045 . . . . 0.0 110.29 -179.401 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.1 p90 -126.58 153.0 45.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.925 -1.11 . . . . 0.0 109.697 179.857 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -131.53 143.84 50.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.309 -0.869 . . . . 0.0 108.834 179.171 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.525 HG22 ' CE2' ' A' ' 8' ' ' TYR . 55.7 t -132.65 134.96 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 -179.766 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.531 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -115.11 174.65 2.25 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.226 179.89 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.4 Cg_endo -67.15 -22.63 46.81 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.59 2.194 . . . . 0.0 111.68 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -101.7 -22.0 14.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 179.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.8 mt -88.96 -45.42 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.671 -179.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.424 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 77.27 -165.65 53.26 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.7 t80 -96.02 150.01 20.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -1.2 . . . . 0.0 109.499 179.935 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.5 tp -116.97 118.33 32.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.3 m -130.34 157.03 78.53 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.9 Cg_endo -70.91 166.31 29.44 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.612 2.208 . . . . 0.0 111.655 -179.721 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -86.42 -20.9 27.51 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.308 -0.87 . . . . 0.0 109.352 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -65.4 125.95 26.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.95 . . . . 0.0 109.11 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.1 tp -90.77 119.22 30.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.683 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -132.82 106.84 12.73 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.031 179.689 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -65.09 120.55 7.8 Favored 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 122.88 2.387 . . . . 0.0 112.108 -179.556 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.461 ' O ' HG21 ' A' ' 32' ' ' THR . 30.3 m -118.14 154.45 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.644 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 31.1 t -97.11 136.14 38.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.251 -0.906 . . . . 0.0 108.769 179.235 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -87.29 139.98 16.47 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.464 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.7 t0 -70.95 -5.33 30.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.141 -1.211 . . . . 0.0 109.563 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -92.84 5.82 49.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.344 179.676 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.19 14.93 53.39 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.873 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.6 mt-30 -116.07 175.83 5.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -1.116 . . . . 0.0 109.561 179.948 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 25' ' ' VAL . 30.5 m -138.94 135.43 34.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.122 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.641 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 22.0 m-85 -115.6 131.08 57.04 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.307 -179.887 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 23' ' ' LYS . 7.5 m-20 -55.41 -76.95 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 -179.515 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.9 t-20 -81.94 148.54 61.04 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.014 -1.053 . . . . 0.0 109.81 -179.73 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.4 Cg_endo -62.73 -53.8 1.54 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.897 2.398 . . . . 0.0 111.916 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.9 t -62.37 -26.91 68.72 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.073 -1.017 . . . . 0.0 108.381 179.189 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 18.8 mtt -64.67 -18.1 64.67 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.343 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.641 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 26.8 tp -66.82 -54.96 17.24 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.451 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 14.2 t -61.21 -23.9 65.95 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.57 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -70.12 -60.94 1.98 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.19 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.432 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 84.2 tt0 -56.7 -20.98 24.59 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.434 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 47' ' ' GLN . 86.5 m-20 -78.64 -35.99 44.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.133 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 44' ' ' LEU . 42.9 tp -58.65 -33.82 70.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.55 -50.18 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.433 -0.792 . . . . 0.0 108.922 179.452 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 34.5 mtt-85 -69.06 -24.15 64.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.263 179.685 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 43' ' ' ASN . 88.8 mt-30 64.13 41.75 6.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.849 . . . . 0.0 109.478 -179.858 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.4 p -124.74 165.36 18.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 109.267 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -98.36 63.49 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.4 m -78.29 136.24 37.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 109.84 -179.866 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -114.26 171.44 7.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.181 179.63 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.465 HG12 HD23 ' A' ' 39' ' ' LEU . 40.7 mt -80.04 126.92 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.5 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.466 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 73.4 ttt180 -79.91 -49.81 11.36 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.652 0.739 . . . . 0.0 109.314 179.806 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.7 m -156.57 145.84 20.5 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.858 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.4 p -61.99 151.3 35.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.537 -179.939 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 81.36 163.49 31.03 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.699 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HA ' HG22 ' A' ' 32' ' ' THR . 14.6 tttt -63.81 150.58 44.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -1.068 . . . . 0.0 109.259 179.838 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.24 148.3 34.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.241 -0.912 . . . . 0.0 109.533 -179.909 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.475 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.412 ' OD1' HD13 ' A' ' 52' ' ' ILE . 76.0 m-20 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.528 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 4.2 m -45.82 -25.32 0.5 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.419 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.4 mt-10 -49.75 -25.27 2.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 0.0 108.689 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.7 mtp -79.87 -27.44 40.06 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.498 ' N ' ' O ' ' A' ' 2' ' ' SER . 4.4 m -80.25 -6.76 58.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.499 -0.751 . . . . 0.0 109.112 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 17.3 mttm -57.69 -25.65 60.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.844 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -149.82 66.87 0.99 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 110.051 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.503 ' OH ' ' CD1' ' A' ' 44' ' ' LEU . 6.2 p90 -127.27 171.03 11.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 109.153 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.422 ' C ' HG21 ' A' ' 10' ' ' VAL . 49.1 ttp180 -145.39 155.64 43.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.739 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.422 HG21 ' C ' ' A' ' 9' ' ' ARG . 92.7 t -148.57 122.75 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 109.291 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 mp -114.6 175.67 1.79 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.334 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.9 Cg_endo -67.64 -28.13 37.88 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.579 2.186 . . . . 0.0 111.578 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -101.48 -26.33 13.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.21 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 91.6 mt -88.49 -41.19 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.365 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 66.02 -144.67 46.82 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.498 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 2.0 t80 -104.7 157.66 17.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -1.19 . . . . 0.0 109.476 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.2 tp -119.36 119.55 34.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.897 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 85.9 m -135.52 157.04 77.23 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.153 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.9 Cg_endo -70.93 167.38 26.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.468 2.112 . . . . 0.0 111.585 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.64 -13.89 36.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.431 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.32 121.27 19.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.122 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.6 tp -84.03 114.92 22.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 0.0 109.781 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mmtm -128.45 107.37 19.15 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 108.94 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.52 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.6 Cg_endo -65.96 121.06 8.31 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 123.141 2.561 . . . . 0.0 112.41 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.8 m -118.2 156.11 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.786 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.5 t -97.1 142.15 29.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 108.855 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -96.48 138.38 13.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.5 p30 -66.48 -15.06 63.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -1.105 . . . . 0.0 109.569 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 85.9 m-20 -84.64 8.83 15.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.68 25.81 37.38 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.446 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 82.2 mt-30 -125.65 177.21 6.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -1.094 . . . . 0.0 109.328 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.527 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 16.4 m -137.97 138.4 38.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 109.298 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.606 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 41.8 m-85 -118.17 121.08 39.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.316 -0.865 . . . . 0.0 109.265 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.7 m-20 -46.71 -78.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.836 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.7 t-20 -81.54 146.9 58.17 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 120.88 -1.137 . . . . 0.0 109.669 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.26 -53.08 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.839 2.359 . . . . 0.0 111.705 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -62.92 -27.58 69.48 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.988 -1.07 . . . . 0.0 108.13 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.427 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 24.6 mtp -64.52 -17.5 63.96 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.606 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 24.5 tp -66.43 -54.75 20.59 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.459 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 7.7 t -60.07 -27.35 66.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 36.8 t60 -63.1 -57.4 10.71 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -61.35 -21.26 63.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 47' ' ' GLN . 89.6 m-20 -79.91 -26.9 40.02 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.503 ' CD1' ' OH ' ' A' ' 8' ' ' TYR . 38.3 tp -65.71 -36.81 84.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.393 -0.817 . . . . 0.0 108.982 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.451 HD11 HG22 ' A' ' 45' ' ' ILE . 5.6 mt -80.08 -48.57 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.03 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 75.7 mtt-85 -70.77 -39.41 73.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 109.535 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.521 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.9 mt-30 64.01 40.66 7.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.83 . . . . 0.0 109.416 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.8 p -108.93 5.41 24.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.595 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.458 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 39.8 t-20 52.73 59.25 4.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.602 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 m -79.41 141.75 36.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.895 . . . . 0.0 109.467 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.528 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 33.5 m80 -114.09 167.68 10.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.85 . . . . 0.0 108.967 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 52' ' ' ILE . 35.1 mt -80.22 127.26 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.026 . . . . 0.0 109.433 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.7 ttt180 -80.03 -42.24 24.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.373 -0.829 . . . . 0.0 109.146 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 t -160.35 156.22 25.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.6 p -70.91 144.3 50.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 109.475 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.27 166.85 40.68 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.527 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 54.1 mttp -67.02 149.68 50.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -1.075 . . . . 0.0 109.404 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 56.7 m -59.46 152.69 21.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.526 -179.883 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.467 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 4.3 m -48.21 -29.07 3.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.331 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -53.41 -25.69 16.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 108.886 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.7 mtp -79.01 -25.52 43.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.463 -0.773 . . . . 0.0 108.934 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 8' ' ' TYR . 31.6 m -81.18 -19.67 42.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -0.847 . . . . 0.0 109.136 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 5' ' ' CYS . 23.5 mttm -45.21 -28.81 0.84 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 109.024 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 55.4 p30 -111.13 31.21 6.23 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 5' ' ' CYS . 2.1 t80 -80.0 144.07 33.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.57 -0.706 . . . . 0.0 109.675 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -142.78 115.24 8.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.352 -0.842 . . . . 0.0 109.299 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.461 ' CG2' ' C ' ' A' ' 15' ' ' GLY . 9.3 p -129.82 145.78 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.601 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.517 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -103.63 174.47 2.76 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.6 Cg_endo -67.89 -25.1 39.24 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.622 2.215 . . . . 0.0 111.803 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -91.88 -29.72 16.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 0.0 109.255 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.6 mt -81.47 -39.57 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.575 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.461 ' C ' ' CG2' ' A' ' 10' ' ' VAL . . . 64.41 140.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.443 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 1.2 t80 -43.85 153.58 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -1.195 . . . . 0.0 109.456 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 32.5 tp -119.26 126.19 50.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.844 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 66.3 m -139.37 156.63 71.64 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.989 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.68 166.34 30.18 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.562 2.175 . . . . 0.0 111.66 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -86.79 -19.89 28.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -66.08 122.58 17.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.274 -0.891 . . . . 0.0 109.502 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.5 tp -82.51 126.5 32.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -139.86 100.44 7.32 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.32 118.6 5.55 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.904 2.403 . . . . 0.0 112.27 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.466 HG13 HD12 ' A' ' 52' ' ' ILE . 13.7 m -116.51 155.53 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.664 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 47.2 t -95.57 133.86 39.1 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 108.804 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -88.88 136.47 13.65 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.476 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.5 p30 -66.99 -8.31 28.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -1.152 . . . . 0.0 109.643 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -88.02 10.47 18.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.352 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.01 21.87 54.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 72.8 mt-30 -126.33 175.52 7.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -1.081 . . . . 0.0 109.578 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 21.1 m -135.2 138.9 44.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.393 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.644 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 61.1 m-85 -118.06 125.42 50.28 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.279 -0.888 . . . . 0.0 109.299 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.504 ' O ' ' O ' ' A' ' 23' ' ' LYS . 5.0 m-20 -49.79 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.646 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.1 t-20 -82.06 146.06 54.41 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.015 -1.053 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.89 -51.64 2.82 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.774 2.316 . . . . 0.0 111.538 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.5 t -60.9 -29.96 69.89 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.459 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 16.4 mtp -65.2 -13.45 58.26 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.644 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 43.5 tp -68.87 -52.09 33.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 109.095 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.443 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.8 m -66.68 -22.2 66.08 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -67.27 -55.55 13.48 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.1 mm-40 -61.99 -20.01 63.42 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' GLN . 61.2 m-20 -80.43 -36.82 33.14 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.0 tp -54.79 -34.64 62.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 45' ' ' ILE . 11.1 mm -80.13 -50.95 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.457 -0.777 . . . . 0.0 108.966 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 7.2 mtp85 -64.36 -24.89 67.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.251 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.4 mt-30 62.96 41.62 8.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.836 . . . . 0.0 109.477 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 p -128.32 167.93 16.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.435 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 48.1 p-10 -98.28 62.27 1.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.536 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.6 m -76.5 129.19 36.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.431 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.467 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 59.3 m80 -111.22 172.52 6.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.37 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.466 HD12 HG13 ' A' ' 25' ' ' VAL . 27.5 mt -79.72 124.55 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.234 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.476 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 58.7 ttt85 -79.99 -44.38 20.33 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.397 -0.814 . . . . 0.0 109.362 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 p -157.08 158.62 36.77 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.465 -0.772 . . . . 0.0 109.114 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -76.88 133.0 39.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.533 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 100.47 163.48 28.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 14.2 tttp -53.34 154.41 3.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.496 -1.002 . . . . 0.0 109.457 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 89.5 m -64.88 147.39 53.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.385 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -60.14 -26.18 66.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 109.491 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.408 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 10.1 mt-10 -52.18 -26.17 10.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.065 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.429 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 67.8 mtm -76.35 -28.09 56.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.566 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 2.8 m -80.64 -9.47 59.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.497 -0.752 . . . . 0.0 109.173 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 45.5 mttm -80.53 8.77 7.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 109.662 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 4' ' ' MET . 43.7 p30 -120.1 -0.31 10.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.08 -1.013 . . . . 0.0 110.065 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.606 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 4.2 p90 -103.37 -179.61 4.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.974 -1.078 . . . . 0.0 109.632 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.606 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 56.2 mtt180 -162.39 140.93 8.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.522 -0.736 . . . . 0.0 109.201 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 16' ' ' TYR . 61.4 t -117.69 140.17 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 109.747 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.535 ' CD2' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -128.09 175.65 3.29 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.401 -0.812 . . . . 0.0 109.143 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 11' ' ' LEU . 44.9 Cg_endo -67.31 -22.4 46.18 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.557 2.172 . . . . 0.0 111.674 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -121.47 -12.15 8.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.425 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.449 HD11 HG22 ' A' ' 14' ' ' ILE . 31.4 mm -86.91 -50.68 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 83.89 -169.43 46.48 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.461 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 1.5 t80 -83.16 148.89 27.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.171 -1.193 . . . . 0.0 109.544 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.443 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 20.8 tp -119.57 130.05 54.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.742 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 73.2 m -145.19 157.53 53.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.0 109.023 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.5 Cg_endo -70.38 166.42 28.43 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.541 2.161 . . . . 0.0 111.554 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -84.2 -31.75 24.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.215 -0.928 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -54.87 134.42 48.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.346 -0.846 . . . . 0.0 109.054 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.477 ' CD1' ' OD1' ' A' ' 34' ' ' ASN . 61.2 tp -101.74 123.45 45.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.932 . . . . 0.0 109.504 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 10.9 mttt -140.32 111.58 7.13 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -65.59 120.25 7.41 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 122.989 2.459 . . . . 0.0 112.024 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.469 HG22 HD11 ' A' ' 39' ' ' LEU . 35.0 m -117.65 153.86 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.233 -0.917 . . . . 0.0 109.772 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 35.6 t -95.48 132.59 40.41 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.23 137.89 13.94 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 43.0 p30 -67.19 -8.28 30.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -1.062 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.45 16.17 5.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.34 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.25 20.61 72.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 27' ' ' GLY . 76.2 mt-30 -131.13 153.66 49.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -1.209 . . . . 0.0 109.586 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.503 HG23 ' CG ' ' A' ' 57' ' ' LYS . 11.1 m -115.74 141.01 48.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.569 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 50.0 m-85 -115.26 130.85 57.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.296 -0.877 . . . . 0.0 109.327 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 50.8 t-20 -53.07 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.315 -0.865 . . . . 0.0 109.563 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -81.39 150.02 66.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.998 -1.064 . . . . 0.0 109.416 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -62.47 -54.08 1.51 Allowed 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.7 2.267 . . . . 0.0 112.051 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.1 t -59.84 -30.61 69.07 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.97 -1.081 . . . . 0.0 108.159 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.471 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 16.4 mtp -59.29 -25.41 64.09 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.529 HD13 ' CD2' ' A' ' 33' ' ' TYR . 7.6 tt -63.93 -46.37 85.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 35.0 m -55.86 -27.99 54.34 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -59.33 -49.73 76.7 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 18.0 tp10 -57.71 -19.22 25.73 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 50' ' ' THR . 4.0 m-80 -80.36 -35.13 35.89 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.38 -37.99 74.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.456 -0.777 . . . . 0.0 109.308 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 45' ' ' ILE . 12.5 mm -79.94 -51.17 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.259 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.519 ' CD ' ' HG3' ' A' ' 42' ' ' GLU . 67.9 mtp85 -73.13 -33.12 65.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 109.636 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.2 mt-30 58.15 27.45 15.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 82.4 p -105.04 5.17 32.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.18 -0.95 . . . . 0.0 109.544 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.519 ' O ' ' NE2' ' A' ' 51' ' ' HIS . 33.4 m120 64.53 52.37 1.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.873 . . . . 0.0 109.675 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 67.8 m -72.3 135.94 46.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.519 ' NE2' ' O ' ' A' ' 49' ' ' ASN . 5.3 m-70 -115.34 -177.23 3.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.295 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 52' ' ' ILE . 23.6 mt -87.09 124.25 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.904 . . . . 0.0 109.473 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 44.7 ttt-85 -80.44 -40.59 26.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.41 -0.806 . . . . 0.0 109.341 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -159.04 151.23 21.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.481 -0.762 . . . . 0.0 109.204 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.6 p -71.21 146.56 48.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.132 -0.98 . . . . 0.0 109.382 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.19 166.69 42.61 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.503 ' CG ' HG23 ' A' ' 32' ' ' THR . 62.4 tttt -65.25 146.32 55.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -1.101 . . . . 0.0 109.252 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.1 150.71 30.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.699 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.45 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.316 0.579 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.535 ' CB ' ' HA ' ' A' ' 51' ' ' HIS . 3.9 m -51.34 -26.42 7.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.627 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.465 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 4.0 mt-10 -53.69 -20.9 6.0 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.291 -0.881 . . . . 0.0 109.051 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.6 mtt -78.46 -28.6 46.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.312 -0.867 . . . . 0.0 109.028 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 m -79.64 -17.03 54.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 109.133 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 60.9 mttt -47.74 -23.73 0.78 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.254 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -116.66 41.85 2.59 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.476 ' OH ' ' N ' ' A' ' 17' ' ' LEU . 4.8 t80 -92.63 160.93 14.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.604 0.716 . . . . 0.0 110.748 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.432 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 10.1 ttp180 -146.39 135.47 22.6 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.512 HG11 ' CA ' ' A' ' 15' ' ' GLY . 55.2 t -126.87 117.6 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.968 . . . . 0.0 109.669 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.539 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -100.24 175.71 2.26 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 109.506 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.539 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.4 Cg_endo -67.45 -24.01 43.16 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.741 2.294 . . . . 0.0 112.118 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -108.66 -21.63 12.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.383 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.1 -45.53 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.868 . . . . 0.0 109.603 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.512 ' CA ' HG11 ' A' ' 10' ' ' VAL . . . 65.98 -148.3 50.86 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.519 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 1.2 t80 -99.48 154.55 18.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -1.213 . . . . 0.0 109.372 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.476 ' N ' ' OH ' ' A' ' 8' ' ' TYR . 18.3 tp -125.76 125.8 43.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.943 . . . . 0.0 109.717 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 86.0 m -138.44 156.88 73.19 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.324 -0.86 . . . . 0.0 109.244 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -69.96 166.01 29.29 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.629 2.219 . . . . 0.0 111.666 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -85.0 -20.43 30.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.306 -0.872 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -65.08 123.07 18.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.335 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.4 tm? -87.74 121.78 30.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.526 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.474 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 22.1 mtpt -141.08 114.88 7.04 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 0.0 109.616 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 45.7 Cg_endo -67.31 120.68 7.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.839 2.36 . . . . 0.0 111.627 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.465 HG22 HD11 ' A' ' 39' ' ' LEU . 34.1 m -119.44 153.81 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.303 -0.873 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.0 t -97.91 144.83 27.06 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -99.61 139.92 14.69 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -67.48 -7.37 25.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -1.158 . . . . 0.0 109.578 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 27.5 m-20 -91.04 8.58 34.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.51 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.07 29.43 28.34 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.489 ' O ' ' N ' ' A' ' 27' ' ' GLY . 80.7 mt-30 -133.12 165.81 23.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -1.155 . . . . 0.0 109.45 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.48 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 32.4 m -125.25 147.57 49.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.427 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.587 ' CE2' HD13 ' A' ' 39' ' ' LEU . 76.5 m-85 -127.28 119.49 26.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.221 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' LYS . 50.4 t30 -41.74 -77.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.782 . . . . 0.0 109.673 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -81.28 148.73 64.04 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.985 -1.072 . . . . 0.0 108.863 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.3 Cg_endo -62.62 -51.91 2.83 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.506 2.137 . . . . 0.0 112.101 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.0 t -63.52 -25.7 68.37 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.949 -1.094 . . . . 0.0 108.47 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.428 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 15.8 mtt -64.72 -18.4 64.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.292 -0.88 . . . . 0.0 108.848 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.587 HD13 ' CE2' ' A' ' 33' ' ' TYR . 4.7 tt -70.13 -53.9 15.31 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.375 -0.828 . . . . 0.0 108.87 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.519 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . 63.8 m -50.9 -24.31 3.5 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -60.04 -49.84 76.06 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.322 -0.861 . . . . 0.0 108.685 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 12.2 tp10 -55.93 -19.74 13.35 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 50' ' ' THR . 4.0 m-80 -80.07 -32.52 39.32 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.3 tp -66.45 -42.19 87.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.833 . . . . 0.0 109.38 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.97 -45.24 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.306 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' HB3' HG22 ' A' ' 48' ' ' THR . 46.9 mtp85 -77.33 -17.3 58.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.178 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 57.68 28.8 16.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.667 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.45 HG22 ' HB3' ' A' ' 46' ' ' ARG . 8.4 p -110.2 -173.11 2.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.235 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -112.03 51.81 0.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.525 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 51.6 m -71.68 122.28 20.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.535 ' HA ' ' CB ' ' A' ' 2' ' ' SER . 26.8 m-70 -109.3 -175.69 2.83 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.324 -0.86 . . . . 0.0 108.999 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.45 HG22 ' HB ' ' A' ' 25' ' ' VAL . 21.2 mt -80.08 125.82 39.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 109.398 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 26.9 ttt85 -79.87 -45.68 18.21 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.331 -0.856 . . . . 0.0 109.584 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 p -160.42 131.69 5.74 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.57 -0.706 . . . . 0.0 109.465 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 p -48.25 142.83 5.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.439 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 93.65 166.71 37.71 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.48 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 68.2 mttt -67.36 148.69 51.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.451 -1.029 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.421 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 86.5 m -57.03 146.39 27.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.449 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.491 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.362 0.601 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' ' 5' ' ' CYS . 24.2 m -70.98 -3.67 20.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.701 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.435 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.8 mt-10 -46.23 -25.5 0.62 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.127 -0.983 . . . . 0.0 108.51 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.404 ' N ' ' C ' ' A' ' 2' ' ' SER . 67.3 mtm -77.02 -35.27 57.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 2' ' ' SER . 2.3 m -79.83 -0.52 34.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.772 . . . . 0.0 109.046 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 12.8 mttm -60.61 -28.86 68.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 109.377 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -149.14 67.09 1.03 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.877 . . . . 0.0 109.681 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 11.4 p90 -118.27 -170.71 1.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 109.414 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -153.91 145.58 23.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.893 . . . . 0.0 109.628 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.46 HG22 ' CD2' ' A' ' 16' ' ' TYR . 42.5 t -139.73 135.53 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.409 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.53 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -115.03 174.79 2.16 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.668 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.7 Cg_endo -68.1 -22.76 40.7 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.787 2.325 . . . . 0.0 111.678 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -97.35 -29.45 13.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.239 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.11 -44.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.652 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.86 -164.2 39.64 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -100.59 151.37 21.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -1.217 . . . . 0.0 109.569 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.5 tp -116.38 110.47 18.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.337 -0.852 . . . . 0.0 109.828 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 63.4 m -126.62 156.35 73.43 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.245 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.13 171.39 16.88 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.645 2.23 . . . . 0.0 111.619 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 tttm -88.6 -29.86 19.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.473 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -57.14 133.57 55.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.385 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 47.7 tp -92.88 115.42 28.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.506 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -125.07 104.4 29.57 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.475 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.4 118.65 5.65 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 C-N-CA 122.911 2.407 . . . . 0.0 111.997 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.446 ' O ' HG21 ' A' ' 32' ' ' THR . 14.8 m -117.03 155.68 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 109.737 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.5 t -97.02 123.33 40.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.827 . . . . 0.0 109.006 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -77.57 136.08 17.69 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.4 p30 -67.39 -8.6 34.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -1.12 . . . . 0.0 109.562 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.4 p30 -87.05 11.96 12.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 17.76 62.3 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.0 mt-30 -123.51 176.92 5.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -1.098 . . . . 0.0 109.53 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 57' ' ' LYS . 41.1 m -135.91 141.82 44.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.063 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.61 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 42.0 m-85 -121.13 128.2 52.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -0.922 . . . . 0.0 109.505 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' A' ' 23' ' ' LYS . 6.7 m-20 -48.66 -79.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.813 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.8 t-20 -81.67 147.13 58.29 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.006 -1.059 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.51 -52.49 1.89 Allowed 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.877 2.385 . . . . 0.0 111.936 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.8 t -64.16 -25.08 67.92 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.941 -1.099 . . . . 0.0 108.208 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.462 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 44.3 mmm -68.93 -14.72 63.21 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.61 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 20.6 tp -65.69 -51.0 62.86 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.468 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.0 m -68.72 -18.16 64.19 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.419 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 25.7 t60 -69.88 -55.29 10.12 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.517 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 88.7 tt0 -64.26 -18.64 64.75 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 47' ' ' GLN . 73.8 m-20 -79.74 -36.11 37.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.9 -32.94 66.43 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mt -80.35 -46.14 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.515 ' NE ' HG22 ' A' ' 48' ' ' THR . 69.7 ttt180 -70.53 -21.6 62.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.118 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . 81.4 mt-30 63.54 43.36 5.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.506 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.515 HG22 ' NE ' ' A' ' 46' ' ' ARG . 75.4 p -126.72 167.68 15.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -103.16 56.52 0.75 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.487 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.41 HG21 ' OD1' ' A' ' 28' ' ' ASP . 85.6 m -77.63 138.77 39.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 109.321 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -118.91 176.46 5.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.26 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 52' ' ' ILE . 34.4 mt -80.12 124.72 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 29.2 tpt180 -81.28 -53.27 6.49 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.599 -0.688 . . . . 0.0 109.427 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 p -146.05 146.1 30.82 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.595 -0.69 . . . . 0.0 109.447 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.8 p -66.4 147.85 52.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.396 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.71 162.61 37.53 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.455 ' HA ' HG22 ' A' ' 32' ' ' THR . 41.0 tttt -63.92 148.85 48.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.474 -1.015 . . . . 0.0 109.341 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.3 148.68 30.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.451 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.33 0.585 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.582 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 3.5 m -56.25 -30.44 62.42 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.312 -0.867 . . . . 0.0 109.444 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -56.32 -24.43 43.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.869 . . . . 0.0 109.23 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 65.1 mmm -74.7 -24.22 58.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -0.793 . . . . 0.0 109.062 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.489 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 13.4 m -84.21 -27.97 27.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.3 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -75.63 -2.48 29.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.632 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 4' ' ' MET . 15.7 p30 -122.94 1.1 9.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.849 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.581 ' OH ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -119.13 154.56 33.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.091 -1.006 . . . . 0.0 109.321 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -133.43 127.46 33.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.259 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 16' ' ' TYR . 4.6 p -124.08 142.73 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 109.588 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.507 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.8 mp -105.62 174.06 2.87 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.158 -0.964 . . . . 0.0 109.211 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.4 Cg_endo -67.79 -28.86 36.19 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.606 2.204 . . . . 0.0 111.88 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -87.4 -28.33 22.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.365 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.4 HD12 HG22 ' A' ' 14' ' ' ILE . 89.2 mt -84.0 -39.39 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 109.401 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.448 ' C ' ' CG2' ' A' ' 10' ' ' VAL . . . 67.41 155.77 0.55 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.581 ' CE2' ' OH ' ' A' ' 8' ' ' TYR . 1.3 t80 -52.63 148.39 7.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.281 -1.129 . . . . 0.0 109.604 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.3 tp -115.82 112.49 22.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.457 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 60.5 m -123.7 155.82 65.81 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.303 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.75 165.18 33.33 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.648 2.232 . . . . 0.0 111.794 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -87.31 -10.41 52.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.478 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.66 133.73 44.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.348 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.487 ' CD1' ' HD3' ' A' ' 24' ' ' PRO . 3.1 tm? -89.73 118.94 29.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' ASN . 5.9 mttp -134.38 100.67 12.53 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.319 -0.863 . . . . 0.0 109.103 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.0 Cg_endo -63.33 123.11 11.57 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 123.121 2.547 . . . . 0.0 112.411 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' HG21 ' A' ' 32' ' ' THR . 32.4 m -120.62 154.79 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.446 -0.784 . . . . 0.0 109.641 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -98.35 137.5 36.98 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -94.02 138.16 13.91 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.49 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.1 p30 -64.96 -11.31 37.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.366 -1.079 . . . . 0.0 109.535 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 57.5 p30 -87.43 11.5 14.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.28 21.19 61.03 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.437 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 89.4 mt-30 -122.16 170.37 9.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.509 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.469 HG21 ' O ' ' A' ' 25' ' ' VAL . 86.9 m -129.31 135.49 48.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.305 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.639 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 64.2 m-85 -115.12 121.22 42.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.286 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -44.61 -82.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.835 . . . . 0.0 109.802 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.9 t-20 -80.07 147.13 64.76 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.157 -0.964 . . . . 0.0 109.565 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 39.6 Cg_endo -62.7 -52.1 2.63 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.659 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.557 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 10.7 t -62.69 -26.71 68.8 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 40.2 mmm -65.32 -16.51 63.65 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.639 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 25.6 tp -67.11 -55.57 13.69 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.543 ' HB3' ' CZ ' ' A' ' 16' ' ' TYR . 16.1 t -57.72 -23.16 50.39 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -72.92 -59.84 2.51 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.476 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 81.7 mt-10 -58.42 -18.5 28.81 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.5 m-20 -76.72 -39.09 53.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.496 -0.752 . . . . 0.0 108.98 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.484 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.3 tm? -55.67 -37.09 67.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.281 -0.887 . . . . 0.0 108.844 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.4 mt -75.36 -46.17 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 0.0 108.939 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 43.9 ttt85 -68.26 -27.84 66.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.0 109.191 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 90.2 mt-30 63.25 42.27 7.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 109.668 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.42 ' CG2' ' HG2' ' A' ' 46' ' ' ARG . 72.5 p -131.25 175.76 8.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.227 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.575 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 78.9 m-20 -101.57 64.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.215 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.8 m -76.66 132.21 39.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 109.953 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.582 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 42.9 m80 -116.03 171.28 7.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -0.869 . . . . 0.0 108.681 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.463 HG22 ' HB ' ' A' ' 25' ' ' VAL . 11.4 mt -79.71 123.91 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.073 -1.017 . . . . 0.0 109.186 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.49 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 54.7 ttt85 -79.71 -42.09 25.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.292 -0.88 . . . . 0.0 109.317 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 t -160.3 155.07 24.18 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.6 p -70.84 143.89 50.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.094 -1.004 . . . . 0.0 109.171 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.69 168.29 40.94 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.445 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 31.6 mttm -66.47 151.69 46.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -1.1 . . . . 0.0 109.428 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.46 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 71.8 m -60.89 152.58 27.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.346 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.499 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.402 ' OD1' ' CG1' ' A' ' 52' ' ' ILE . 91.3 m-20 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 m -59.33 -23.76 62.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.871 . . . . 0.0 109.395 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.4 tt0 -52.65 -24.38 8.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.087 -1.008 . . . . 0.0 109.028 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 mtt -79.94 -25.74 40.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.413 -0.804 . . . . 0.0 109.109 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.53 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.5 m -86.98 -8.66 56.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.391 -0.818 . . . . 0.0 109.517 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 43.6 mttm -60.02 -23.43 63.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 109.783 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -150.69 63.51 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.062 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.53 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 4.2 p90 -129.16 167.12 18.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 109.203 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -143.97 145.07 31.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 109.616 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 92.0 t -137.61 131.87 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 109.659 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.529 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -122.49 175.1 2.81 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.36 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.0 Cg_endo -67.67 -26.28 39.49 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.648 2.232 . . . . 0.0 111.772 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -100.3 -27.52 13.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.293 -0.879 . . . . 0.0 109.203 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.8 mm -91.02 -43.2 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.42 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.33 -146.41 45.8 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.464 ' OH ' ' HB3' ' A' ' 40' ' ' CYS . 2.2 t80 -104.58 157.43 17.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -1.134 . . . . 0.0 109.482 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.1 tp -115.58 115.02 25.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 109.865 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 57.7 m -135.86 155.77 77.69 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 109.231 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.55 167.62 25.91 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.549 2.166 . . . . 0.0 111.587 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -84.68 -18.71 34.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -70.4 123.34 21.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.29 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.429 HD23 ' CA ' ' A' ' 35' ' ' ASN . 3.4 tm? -86.46 109.76 19.29 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.492 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -116.05 103.61 53.14 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.399 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.2 Cg_endo -63.68 117.2 4.19 Favored 'Trans proline' 0 C--O 1.213 -0.764 0 C-N-CA 123.082 2.521 . . . . 0.0 112.414 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.462 ' O ' HG21 ' A' ' 32' ' ' THR . 11.0 m -115.29 157.18 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.403 -0.811 . . . . 0.0 109.83 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 46.0 t -98.65 141.57 31.31 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.72 141.32 15.48 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.479 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.5 t0 -69.84 -9.4 54.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -1.147 . . . . 0.0 109.414 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -90.31 0.59 57.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.404 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.79 21.76 22.77 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.2 mt-30 -121.5 172.66 7.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -1.138 . . . . 0.0 109.48 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 25' ' ' VAL . 99.4 m -133.48 140.09 47.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.624 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 40.8 m-85 -121.78 129.01 52.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.012 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 23' ' ' LYS . 1.8 m-20 -52.77 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.026 -1.046 . . . . 0.0 109.67 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 15.3 t-20 -81.85 145.73 54.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.019 -1.05 . . . . 0.0 109.587 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.29 -51.15 2.87 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.643 2.228 . . . . 0.0 111.346 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.503 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.5 t -61.64 -27.99 69.06 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 36.3 mmm -67.05 -13.93 62.41 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.624 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 29.8 tp -68.44 -53.69 21.92 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.464 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 14.0 t -58.98 -23.29 61.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -69.21 -57.93 4.71 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -61.97 -19.35 62.7 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 99.2 m-20 -77.15 -32.09 56.03 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.461 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 1.7 tm? -61.49 -38.09 86.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 108.875 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mt -75.89 -48.51 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.299 -0.876 . . . . 0.0 109.222 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -68.7 -36.86 79.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.885 . . . . 0.0 109.354 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.46 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.2 mt-30 59.81 38.04 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.425 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' ASN . 43.9 p -112.87 16.66 19.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.391 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.572 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 57.7 m-20 44.94 58.88 3.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.331 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.483 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 36.0 m -77.21 144.83 38.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.683 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 27.6 m80 -118.93 169.45 9.87 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.448 HD11 HG22 ' A' ' 52' ' ' ILE . 41.7 mt -79.14 126.55 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.109 -0.995 . . . . 0.0 109.357 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 42.1 ttt85 -79.71 -46.85 16.32 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.412 -0.805 . . . . 0.0 109.251 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 m -160.29 151.92 19.8 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 p -65.29 142.75 58.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.099 -1.001 . . . . 0.0 109.591 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.31 165.02 36.27 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 65.0 mttt -67.94 148.84 50.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -1.056 . . . . 0.0 109.408 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.46 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 58.4 m -60.04 153.44 21.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.477 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 21.3 p-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.312 0.577 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 5' ' ' CYS . 3.1 m -46.75 -30.63 2.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.382 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.427 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 13.2 mt-10 -52.0 -27.48 13.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 108.697 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 86.9 mtp -76.74 -28.61 55.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.425 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 4.0 m -79.75 -6.88 58.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.507 -0.745 . . . . 0.0 109.069 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 15.6 mttm -56.39 -32.29 64.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 77.2 m-20 -146.36 67.18 1.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 109.866 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.576 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 4.4 p90 -126.41 169.78 12.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 109.068 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -140.95 149.4 41.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.124 -0.985 . . . . 0.0 109.846 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.409 HG22 ' CD2' ' A' ' 16' ' ' TYR . 77.8 t -145.06 131.39 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.832 . . . . 0.0 109.359 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.526 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mp -122.34 175.09 2.79 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.955 . . . . 0.0 109.551 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.2 Cg_endo -67.9 -22.89 41.76 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.69 2.26 . . . . 0.0 111.77 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -107.07 -31.32 8.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.147 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.437 HD11 HG22 ' A' ' 14' ' ' ILE . 48.9 mm -83.3 -39.95 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.518 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.83 -145.52 41.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.6 t80 -107.26 156.1 19.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 109.458 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 tp -117.29 121.15 40.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 81.9 m -132.25 157.06 79.26 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.36 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.3 Cg_endo -71.17 165.7 31.59 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.681 2.254 . . . . 0.0 111.578 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -88.68 -13.52 39.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.327 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -68.67 130.66 43.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.103 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.497 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.3 tm? -89.2 122.5 32.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.607 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.481 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -141.69 105.59 5.86 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.337 -0.852 . . . . 0.0 109.279 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.539 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -66.05 121.38 8.7 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 C-N-CA 122.951 2.434 . . . . 0.0 111.902 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.439 HG22 HD11 ' A' ' 39' ' ' LEU . 18.7 m -117.14 154.96 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 109.949 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 16.7 t -97.61 130.45 44.63 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -88.77 139.53 15.42 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.2 p30 -66.33 -9.84 37.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -1.118 . . . . 0.0 109.606 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 57.2 p30 -85.39 12.9 7.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.333 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.35 21.53 64.54 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.2 mt-30 -127.25 168.97 14.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -1.151 . . . . 0.0 109.374 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.467 HG22 ' HA ' ' A' ' 57' ' ' LYS . 24.6 m -127.37 139.81 52.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.895 . . . . 0.0 109.513 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.595 ' CD2' ' CD1' ' A' ' 39' ' ' LEU . 42.9 m-85 -116.8 128.4 55.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.205 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 47.7 t-20 -50.96 -78.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -80.9 148.46 64.73 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 120.825 -1.172 . . . . 0.0 109.48 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.36 -53.7 1.34 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.645 2.23 . . . . 0.0 111.76 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -61.3 -28.45 69.21 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.987 -1.07 . . . . 0.0 108.144 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 17.0 mtp -63.14 -19.23 64.27 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.595 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 8.4 tt -67.11 -50.76 60.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.308 -0.87 . . . . 0.0 108.791 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 6.0 t -52.61 -47.33 67.04 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.509 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 9.5 t60 -48.51 -49.07 37.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.966 -1.084 . . . . 0.0 108.201 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.572 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 23.6 mm-40 -57.36 -19.41 22.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.1 m-80 -78.87 -32.96 46.15 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 82.9 mt -70.71 -37.19 73.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 109.549 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mt -77.22 -49.6 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.239 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.518 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 14.9 mtt-85 -76.96 -30.99 56.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 109.374 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 57.87 32.91 22.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.439 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.0 p -108.28 7.64 27.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.531 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 38.8 t-20 57.14 55.02 6.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.528 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 87.2 m -78.52 136.46 37.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.545 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.531 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 3.8 m80 -114.93 -175.92 2.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.215 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.443 HD11 HG22 ' A' ' 52' ' ' ILE . 29.9 mt -89.59 123.42 41.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.238 -0.914 . . . . 0.0 109.62 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 38.4 ttt-85 -81.39 -46.94 13.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.52 -0.738 . . . . 0.0 109.326 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -153.2 151.27 29.91 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.657 -0.652 . . . . 0.0 109.474 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -70.91 144.38 50.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.964 . . . . 0.0 109.218 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.539 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.59 165.24 40.76 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.539 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 30.3 mttm -65.86 144.03 57.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.443 -1.033 . . . . 0.0 109.464 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -77.22 153.2 34.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.245 -0.909 . . . . 0.0 109.326 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 58' ' ' CYS . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.391 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 1' ' ' ASP . 16.6 p-10 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 6' ' ' LYS . 1.2 m -44.75 -30.28 0.93 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.179 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.462 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 5.2 mm-40 -52.54 -25.86 11.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.414 -0.804 . . . . 0.0 108.951 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 60.9 mtm -70.6 -37.65 73.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 109.202 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.478 ' CA ' ' HB2' ' A' ' 8' ' ' TYR . 18.5 p -104.44 -3.28 24.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.236 -0.915 . . . . 0.0 109.537 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 2' ' ' SER . 5.2 mttm -49.23 -24.33 1.72 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.205 -0.934 . . . . 0.0 108.749 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -119.13 28.46 8.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.547 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 3.6 t80 -80.29 157.98 26.27 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.608 0.718 . . . . 0.0 110.617 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.432 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 6.2 ttt85 -142.7 133.45 25.37 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.51 ' CG2' ' CD2' ' A' ' 16' ' ' TYR . 81.9 t -133.37 136.77 54.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.367 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.49 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 mp -119.66 173.16 3.78 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.538 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.8 Cg_endo -68.51 -25.73 34.84 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 122.653 2.235 . . . . 0.0 111.763 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.461 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 15.2 ttt180 -104.12 -20.71 13.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.375 -0.828 . . . . 0.0 109.285 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.1 mt -93.13 -46.39 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 17' ' ' LEU . . . 73.64 -170.72 52.46 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.547 ' CE1' ' CZ ' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -87.27 151.44 23.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.174 . . . . 0.0 109.463 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.579 ' N ' ' CD1' ' A' ' 17' ' ' LEU . 1.8 mp -122.47 132.9 54.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.7 m -139.18 157.32 71.3 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.139 -0.976 . . . . 0.0 109.317 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.2 Cg_endo -70.18 168.78 21.12 Favored 'Trans proline' 0 C--O 1.216 -0.581 0 C-N-CA 122.572 2.181 . . . . 0.0 111.668 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -90.0 -12.67 37.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.482 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -73.94 119.8 18.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.159 -0.963 . . . . 0.0 109.214 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.2 tp -81.75 112.19 18.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.774 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.527 ' CD ' ' HG3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -122.08 105.77 36.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.905 . . . . 0.0 108.741 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 45.2 Cg_endo -66.64 118.32 5.45 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.954 2.436 . . . . 0.0 112.088 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.459 ' O ' HG21 ' A' ' 32' ' ' THR . 18.8 m -115.59 154.94 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.042 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.4 t -97.3 140.27 32.02 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.53 138.13 13.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.5 p30 -65.49 -12.93 57.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -1.119 . . . . 0.0 109.436 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 84.2 m-20 -86.98 12.37 11.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.216 -0.927 . . . . 0.0 109.374 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.06 32.14 36.77 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 79.6 mt-30 -131.16 173.82 10.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.391 -1.064 . . . . 0.0 109.293 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.459 HG21 ' O ' ' A' ' 25' ' ' VAL . 87.5 m -135.12 133.55 39.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.149 -0.969 . . . . 0.0 109.488 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.614 ' CE2' ' CD1' ' A' ' 39' ' ' LEU . 65.6 m-85 -112.61 122.93 49.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 108.956 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.473 ' O ' ' O ' ' A' ' 23' ' ' LYS . 9.7 m-20 -48.18 -79.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 110.093 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.7 t-20 -81.98 148.04 59.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.018 -1.051 . . . . 0.0 109.895 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.527 ' HG3' ' CD ' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.6 -53.33 1.41 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.718 2.279 . . . . 0.0 111.768 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.7 t -61.42 -25.78 67.43 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.413 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 29.7 mtp -70.49 -5.87 31.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.177 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.614 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 24.4 tp -74.11 -61.36 1.88 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.18 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.447 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -54.52 -28.38 44.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 108.567 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.402 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 29.4 t60 -60.35 -56.88 16.09 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -64.06 -19.43 65.22 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' GLN . 89.6 m-20 -79.44 -31.01 42.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.506 -0.746 . . . . 0.0 109.037 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.2 tm? -63.46 -37.81 88.73 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.385 -0.822 . . . . 0.0 108.844 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mm -77.09 -48.64 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.114 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 26.4 mtt-85 -68.14 -38.46 82.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.436 -0.79 . . . . 0.0 109.192 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ASN . 86.3 mt-30 62.2 38.74 13.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.478 -0.764 . . . . 0.0 109.449 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.4 p -113.37 15.38 19.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 0.0 109.384 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 46.29 60.41 3.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.472 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.476 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 76.8 m -79.96 143.01 34.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.416 ' N ' HG21 ' A' ' 50' ' ' THR . 25.7 m-70 -118.97 170.61 8.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 108.855 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 52' ' ' ILE . 30.9 mt -79.99 126.86 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.07 -1.019 . . . . 0.0 109.271 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 18.0 ttt-85 -81.82 -41.5 21.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.398 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -160.53 151.78 19.2 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -67.61 142.56 56.41 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.074 -1.016 . . . . 0.0 109.443 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.55 166.17 38.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.455 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 41.2 mttm -65.45 149.04 50.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -1.018 . . . . 0.0 109.467 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 59.0 m -59.3 153.84 17.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.444 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.304 0.573 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.403 ' HA ' ' SG ' ' A' ' 40' ' ' CYS . 1.0 OUTLIER -52.98 -32.99 49.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.943 . . . . 0.0 109.386 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -54.21 -23.27 13.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 108.963 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.41 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 76.8 mtp -74.29 -16.55 60.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.837 . . . . 0.0 108.818 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.2 m -91.91 -18.4 23.81 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.419 -0.8 . . . . 0.0 109.165 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -78.41 -0.02 27.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.91 . . . . 0.0 109.478 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.412 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 34.6 p30 -106.78 -9.44 16.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.786 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.572 ' OH ' ' CZ ' ' A' ' 16' ' ' TYR . 1.1 p90 -107.61 170.49 7.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.166 -0.959 . . . . 0.0 109.47 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -133.37 161.02 35.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.202 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.447 HG22 ' HA ' ' A' ' 16' ' ' TYR . 13.4 p -140.43 166.01 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.94 . . . . 0.0 109.81 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.519 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -121.75 174.49 3.16 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.846 . . . . 0.0 109.312 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 48.2 Cg_endo -68.19 -23.62 39.08 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.726 2.284 . . . . 0.0 111.806 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 13' ' ' ARG . 45.8 tpt85 -89.0 -19.41 25.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.222 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.445 HG23 HD11 ' A' ' 14' ' ' ILE . 59.2 mt -99.02 -34.6 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.292 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' C ' HG22 ' A' ' 10' ' ' VAL . . . 73.66 -68.65 1.53 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.572 ' CZ ' ' OH ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -155.38 159.11 39.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -1.153 . . . . 0.0 109.489 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 tp -127.74 114.42 17.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.742 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.5 m -131.56 157.63 77.63 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 108.977 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.1 Cg_endo -70.45 167.01 26.56 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.591 2.194 . . . . 0.0 111.586 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -88.38 -16.68 32.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.417 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -71.54 129.2 38.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.269 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -91.26 114.75 27.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 34' ' ' ASN . 2.5 mtmt -126.79 107.2 22.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.19 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.53 116.67 4.05 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 C-N-CA 122.807 2.338 . . . . 0.0 111.796 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.2 m -114.84 155.41 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.741 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 40.5 t -97.74 123.4 41.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.369 -0.832 . . . . 0.0 109.046 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -77.15 137.93 21.21 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.6 p-10 -67.88 -7.52 28.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -1.098 . . . . 0.0 109.425 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -88.71 7.69 32.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.485 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.45 12.91 62.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' GLY . 78.0 mt-30 -118.32 166.44 12.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -1.163 . . . . 0.0 109.323 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 36.9 m -127.3 137.27 52.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.302 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.639 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 34.1 m-85 -114.29 130.47 56.65 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.234 -0.916 . . . . 0.0 109.361 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.4 m-20 -53.57 -76.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.33 -0.857 . . . . 0.0 109.65 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -81.84 148.66 61.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.074 -1.016 . . . . 0.0 109.466 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.459 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.0 Cg_endo -63.65 -53.25 1.42 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.726 2.284 . . . . 0.0 111.9 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.7 t -63.58 -28.69 70.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.047 -1.033 . . . . 0.0 108.394 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.0 mmm -59.87 -23.57 63.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.639 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 27.9 tp -61.9 -43.83 98.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.607 -0.683 . . . . 0.0 109.288 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.489 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.2 m -71.32 -20.07 62.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.216 -0.928 . . . . 0.0 108.554 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -72.98 -53.42 11.23 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.426 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 70.0 mt-10 -64.53 -19.0 65.34 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.5 m-20 -74.69 -37.58 62.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.8 tm? -56.39 -36.16 68.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.343 -0.848 . . . . 0.0 108.735 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 45' ' ' ILE . 2.6 mt -74.43 -50.01 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.461 -0.774 . . . . 0.0 109.033 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 31.2 mtm-85 -68.59 -23.97 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.139 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' ASN . 85.6 mt-30 61.81 40.83 12.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.431 -0.793 . . . . 0.0 109.564 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.417 HG22 ' HB3' ' A' ' 46' ' ' ARG . 9.1 p -128.67 169.71 14.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.293 -0.879 . . . . 0.0 109.199 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -97.5 62.24 1.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.373 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.1 m -70.98 130.2 40.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -0.85 . . . . 0.0 109.599 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -113.82 169.43 8.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 108.979 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 52' ' ' ILE . 43.4 mt -79.81 127.06 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.009 . . . . 0.0 109.339 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 47.7 ttt85 -84.71 -49.51 8.43 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.373 -0.829 . . . . 0.0 109.533 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.1 p -149.23 141.3 23.89 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.432 -0.792 . . . . 0.0 109.254 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.4 p -61.86 143.97 55.57 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.258 -0.901 . . . . 0.0 109.182 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.53 163.29 39.18 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 53.4 tttt -50.88 152.54 2.09 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.541 -0.976 . . . . 0.0 109.601 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.41 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 31.5 m -55.65 142.12 35.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.634 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.397 179.862 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.308 0.575 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 51' ' ' HIS . 4.0 m -45.58 -29.17 1.12 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.34 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -51.55 -28.08 12.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.199 -0.938 . . . . 0.0 108.75 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.4 mmm -79.04 -30.37 44.07 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.4 m -83.93 0.59 47.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.503 -0.748 . . . . 0.0 109.191 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 10.7 mttm -61.38 -30.32 70.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.344 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 76.2 m-20 -147.84 68.02 1.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.67 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.566 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 12.6 p90 -119.78 -171.59 2.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.268 -0.895 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -153.76 139.65 18.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 109.746 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.412 HG12 ' C ' ' A' ' 15' ' ' GLY . 53.4 t -132.73 137.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 109.612 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.517 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -112.63 174.38 2.35 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.832 . . . . 0.0 109.275 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.9 Cg_endo -67.85 -24.44 40.19 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.655 2.237 . . . . 0.0 111.816 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -96.77 -26.94 14.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.468 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.1 mm -85.91 -48.17 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.546 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 71.84 -163.2 54.42 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.566 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -102.37 150.27 23.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -1.157 . . . . 0.0 109.315 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.3 tp -116.74 106.83 13.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.8 m -120.67 155.89 56.55 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.128 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.04 166.61 29.11 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.545 2.163 . . . . 0.0 111.625 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -89.81 -13.94 35.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.9 . . . . 0.0 109.662 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -72.31 123.88 23.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 0.0 109.278 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.444 HD12 ' HB3' ' A' ' 34' ' ' ASN . 48.1 tp -80.29 121.17 25.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.619 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 3.2 mttp -133.71 101.45 12.95 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.324 -0.86 . . . . 0.0 109.242 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.54 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 41.0 Cg_endo -64.15 120.66 8.07 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.848 2.365 . . . . 0.0 112.122 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.9 m -119.81 157.36 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 -179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.8 t -99.49 114.76 27.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -0.824 . . . . 0.0 109.028 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -69.94 137.76 28.83 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 58.4 p30 -68.4 -8.02 36.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.344 -1.092 . . . . 0.0 109.661 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -84.86 6.81 23.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 109.341 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.91 17.86 55.45 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -126.76 160.62 30.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -1.09 . . . . 0.0 109.429 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.498 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 38.5 m -116.79 144.86 43.98 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.931 . . . . 0.0 109.207 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.618 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 87.4 m-85 -124.51 129.37 50.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.292 -0.88 . . . . 0.0 109.331 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 23' ' ' LYS . 6.2 m-20 -50.44 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.2 t-20 -82.16 146.41 54.84 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 0.0 109.788 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.0 Cg_endo -63.53 -52.36 1.95 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.772 2.315 . . . . 0.0 111.555 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.1 t -60.97 -30.87 70.51 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.455 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 23.0 mtt -61.6 -20.68 63.61 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.618 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 58.6 tp -62.06 -46.81 87.49 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.538 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 3.3 m -70.94 -26.48 63.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.466 ' HA ' HD11 ' A' ' 44' ' ' LEU . 33.3 t60 -64.42 -55.04 23.64 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 73.8 mm-40 -65.1 -17.5 64.51 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.237 -0.914 . . . . 0.0 108.671 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 47' ' ' GLN . 92.1 m-20 -76.53 -30.91 57.32 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.469 -0.77 . . . . 0.0 109.278 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.538 ' CD1' ' O ' ' A' ' 40' ' ' CYS . 1.8 mp -59.76 -36.63 77.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.12 -0.987 . . . . 0.0 108.624 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 45' ' ' ILE . 7.0 mm -75.72 -48.67 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 15.7 mtp85 -67.28 -25.52 66.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.429 -0.794 . . . . 0.0 109.153 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.9 mt-30 63.71 41.26 7.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.54 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.424 HG21 ' C ' ' A' ' 47' ' ' GLN . 10.5 p -130.63 164.07 25.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.214 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.562 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 65.6 m-20 -95.68 59.99 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 109.504 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 m -75.0 132.05 41.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 109.417 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 6.6 m80 -112.87 -172.32 2.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.138 -0.976 . . . . 0.0 109.333 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.7 mt -89.79 126.62 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.337 -0.852 . . . . 0.0 109.776 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 16.2 tpt180 -85.4 -53.98 4.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.557 -0.714 . . . . 0.0 109.365 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 p -144.76 152.61 40.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -72.96 144.45 47.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.095 -1.003 . . . . 0.0 109.385 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.92 166.19 39.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.54 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 55.1 mttp -68.07 141.5 56.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.36 -1.083 . . . . 0.0 109.306 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.23 149.8 37.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.482 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.541 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.498 ' OG ' ' CD2' ' A' ' 39' ' ' LEU . 13.6 m -52.26 -26.72 12.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.458 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 16.2 mt-10 -51.56 -26.39 8.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.02 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.6 mtm -68.13 -28.79 67.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.765 . . . . 0.0 109.307 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.7 m -79.81 -17.94 52.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.928 . . . . 0.0 109.23 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 44.5 mttm -51.13 -22.93 2.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 108.994 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -118.13 36.87 4.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.453 ' OH ' ' N ' ' A' ' 17' ' ' LEU . 5.2 t80 -85.09 159.48 20.17 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.559 0.695 . . . . 0.0 110.663 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.443 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 7.7 ttm180 -140.71 136.6 32.76 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 15' ' ' GLY . 52.1 t -134.83 128.03 49.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.768 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.534 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -106.23 175.51 2.05 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.437 -0.79 . . . . 0.0 109.057 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.8 Cg_endo -67.21 -23.15 45.66 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.541 2.161 . . . . 0.0 111.632 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -110.83 -24.33 10.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.342 -0.849 . . . . 0.0 109.326 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 81.5 mt -83.25 -38.46 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.622 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.487 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 61.28 -143.8 48.66 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.471 ' CD1' HD13 ' A' ' 44' ' ' LEU . 1.6 t80 -107.3 150.65 26.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.239 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.453 ' N ' ' OH ' ' A' ' 8' ' ' TYR . 25.7 tp -114.7 121.59 43.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.813 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.0 m -135.52 157.04 77.23 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.029 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.2 Cg_endo -70.01 163.82 37.06 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.588 2.192 . . . . 0.0 111.683 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -87.77 -8.77 55.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.43 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -77.76 111.45 13.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.855 . . . . 0.0 109.182 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.4 tp -79.62 123.17 27.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.935 . . . . 0.0 109.66 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 34' ' ' ASN . 7.4 mtmt -140.63 109.22 6.64 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.812 . . . . 0.0 109.054 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.543 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.9 Cg_endo -63.56 123.85 12.74 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.86 2.373 . . . . 0.0 112.214 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.529 HG22 ' CD1' ' A' ' 52' ' ' ILE . 29.2 m -120.39 156.55 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.9 t -98.23 119.71 37.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 109.291 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -73.19 134.7 20.14 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 56.6 p30 -68.05 -7.55 30.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -1.148 . . . . 0.0 109.722 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.456 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 93.0 m-20 -86.21 7.57 24.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.75 16.97 53.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 93.6 mt-30 -126.05 171.96 10.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.513 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 89.3 m -129.37 142.75 50.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.182 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.632 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 20.3 m-85 -123.68 128.82 50.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.2 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.505 ' O ' ' O ' ' A' ' 23' ' ' LYS . 9.1 m-20 -51.14 -79.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.203 -0.936 . . . . 0.0 109.822 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.3 t-20 -81.82 147.45 58.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.917 -1.114 . . . . 0.0 109.758 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.2 Cg_endo -63.3 -52.19 2.18 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.728 2.285 . . . . 0.0 111.872 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -64.04 -27.8 69.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.033 -1.042 . . . . 0.0 108.297 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.516 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.5 mmm -62.51 -16.2 54.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.471 -0.768 . . . . 0.0 109.191 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.632 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 8.1 tp -68.55 -51.79 39.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.347 -0.845 . . . . 0.0 109.125 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 3.9 m -63.78 -18.49 64.14 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -69.16 -57.64 5.12 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -64.74 -18.61 65.19 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.2 m-20 -72.79 -31.47 64.89 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.478 HD12 HG22 ' A' ' 10' ' ' VAL . 36.8 mt -58.85 -38.9 79.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 108.745 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mt -74.31 -51.96 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.46 -0.775 . . . . 0.0 109.091 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.516 ' NH2' ' OH ' ' A' ' 33' ' ' TYR . 45.2 mtm180 -66.49 -25.27 66.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 0.0 109.415 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.3 mt-30 63.73 44.47 5.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.527 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 p -130.21 167.88 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.524 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.456 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 72.9 m-20 -103.37 65.21 0.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.258 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.466 HG23 HD12 ' A' ' 39' ' ' LEU . 51.9 m -73.43 136.5 44.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.76 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.456 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 70.4 m80 -117.13 169.7 9.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.322 -0.861 . . . . 0.0 108.88 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.529 ' CD1' HG22 ' A' ' 25' ' ' VAL . 22.2 mm -80.17 127.01 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.005 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 72.0 ttt180 -85.79 -47.93 9.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.368 -0.833 . . . . 0.0 109.446 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -148.29 142.6 26.22 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.535 -0.728 . . . . 0.0 109.367 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.2 p -62.24 151.3 36.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.911 . . . . 0.0 109.368 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.12 166.42 40.71 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.513 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 39.5 mttt -59.98 147.15 39.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.419 -1.047 . . . . 0.0 109.445 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.453 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 53.2 m -47.62 142.1 4.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 109.379 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.476 -179.934 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 2' ' ' SER . 76.3 m-20 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 5' ' ' CYS . 2.8 m -45.12 -34.24 2.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.309 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.465 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 49.9 mt-10 -47.26 -31.93 4.18 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.0 mmm -77.1 -32.26 56.47 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.562 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.6 m -82.12 4.06 24.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.362 -0.836 . . . . 0.0 109.214 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HE3' ' HG2' ' A' ' 3' ' ' GLU . 11.6 mttm -62.95 -28.64 70.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.706 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.459 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 14.3 t70 -147.31 68.34 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 110.13 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.562 ' CE1' ' HB3' ' A' ' 5' ' ' CYS . 19.7 p90 -127.12 -177.77 4.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 109.382 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptt-85 -156.07 146.06 21.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.323 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.417 HG12 ' C ' ' A' ' 15' ' ' GLY . 74.4 t -130.56 135.96 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.714 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.531 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -109.57 175.5 1.91 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.276 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.7 Cg_endo -67.95 -24.72 39.28 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.594 2.196 . . . . 0.0 111.83 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -95.78 -31.18 13.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 109.421 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.3 mt -80.87 -49.41 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.474 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.417 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 71.4 -173.52 43.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.541 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -98.96 146.53 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.2 tp -114.44 110.0 19.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.817 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 55.7 m -125.73 154.7 73.2 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 109.077 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.32 165.68 31.68 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.454 2.103 . . . . 0.0 111.655 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -85.22 -23.07 28.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -62.72 128.91 38.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 34' ' ' ASN . 22.0 tp -83.83 126.2 32.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 109.421 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -137.71 97.69 10.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.0 109.436 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.4 Cg_endo -62.69 121.01 8.77 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.961 2.441 . . . . 0.0 111.938 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.466 ' O ' HG21 ' A' ' 32' ' ' THR . 9.8 m -121.65 155.75 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.981 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.6 t -98.3 141.22 31.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -96.65 136.73 12.95 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 58.4 p30 -62.26 -12.4 20.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -1.113 . . . . 0.0 109.58 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 48.8 m-20 -88.33 10.01 21.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 0.0 109.595 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.18 15.68 68.86 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.5 mt-30 -117.85 156.24 28.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.382 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 25' ' ' VAL . 23.7 m -118.32 148.56 42.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.453 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.583 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 78.0 m-85 -130.26 127.83 40.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.317 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 23' ' ' LYS . 5.8 m-20 -49.36 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 38' ' ' MET . 13.8 t-20 -82.06 146.19 54.71 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.978 -1.076 . . . . 0.0 109.468 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.64 -50.15 3.58 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.463 2.108 . . . . 0.0 111.459 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.473 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.0 t -62.2 -27.68 69.15 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.476 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 23.8 mtt -69.78 -23.58 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.494 HD13 ' CD2' ' A' ' 33' ' ' TYR . 4.8 tt -63.59 -47.34 81.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.344 -0.847 . . . . 0.0 108.782 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 9.5 m -56.75 -27.97 60.33 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -56.83 -47.78 79.52 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.583 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 29.1 tp10 -57.87 -22.01 45.99 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 3.3 m-80 -76.57 -31.85 57.78 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.903 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.503 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 67.0 mt -64.43 -41.19 96.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.384 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.458 HG23 HD11 ' A' ' 45' ' ' ILE . 3.5 mt -73.29 -54.23 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.392 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 81.0 mtm180 -70.22 -22.02 62.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.383 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 63.01 36.0 12.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -120.0 177.35 5.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.565 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 90.7 m-20 -103.98 56.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.55 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.513 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 82.9 m -75.88 129.38 36.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 109.579 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 8.0 m80 -115.34 -170.96 1.87 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.177 -0.952 . . . . 0.0 109.33 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.518 HD11 HG22 ' A' ' 52' ' ' ILE . 41.3 mt -85.9 126.56 40.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.727 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 12.7 tpt180 -81.06 -43.14 19.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.408 -0.808 . . . . 0.0 109.24 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.8 p -154.51 137.89 15.83 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 p -58.48 149.34 25.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 109.405 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 83.43 165.89 38.96 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HA ' HG22 ' A' ' 32' ' ' THR . 39.5 tttm -65.3 149.04 50.64 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.352 -1.087 . . . . 0.0 109.356 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.8 138.7 39.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.481 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.474 ' HB2' ' ND1' ' A' ' 51' ' ' HIS . 0.6 OUTLIER -55.59 -33.03 63.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.32 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.428 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.0 OUTLIER -55.56 -23.26 25.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.323 -0.861 . . . . 0.0 109.042 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.444 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 81.5 mtp -72.23 -26.54 62.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 108.834 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 24.6 m -85.23 -13.03 51.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.446 -0.784 . . . . 0.0 109.28 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.428 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 17.0 mttm -80.95 10.87 4.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.923 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 4' ' ' MET . 41.7 p30 -145.02 19.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.032 -1.042 . . . . 0.0 109.671 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.632 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -128.24 154.09 46.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.129 -0.982 . . . . 0.0 109.494 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.418 ' HA ' ' HD2' ' A' ' 9' ' ' ARG . 39.2 tpt85 -135.66 146.81 48.2 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.305 -0.872 . . . . 0.0 108.984 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.495 HG22 ' CE2' ' A' ' 8' ' ' TYR . 75.5 t -137.58 137.53 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.15 -0.969 . . . . 0.0 109.647 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.533 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -116.0 175.66 1.84 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 109.233 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.4 Cg_endo -66.53 -21.77 52.42 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.598 2.198 . . . . 0.0 111.763 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -101.96 -28.66 12.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -0.847 . . . . 0.0 109.563 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.2 mt -80.87 -51.56 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.45 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 81.29 -165.38 46.73 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.8 OUTLIER -100.78 147.45 26.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -1.112 . . . . 0.0 109.672 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.57 ' N ' ' CD1' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -119.87 127.64 52.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.853 . . . . 0.0 109.481 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 70.4 m -133.48 156.72 79.38 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.296 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.7 Cg_endo -70.06 166.66 27.21 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.621 2.214 . . . . 0.0 111.815 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -87.53 -14.42 40.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 109.534 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -73.01 106.1 4.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.311 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.8 tp -72.93 113.66 10.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.455 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' ASN . 1.8 mttm -124.02 102.92 33.91 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 109.323 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.09 116.98 4.15 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.875 2.383 . . . . 0.0 112.138 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.407 ' HB ' HG22 ' A' ' 52' ' ' ILE . 7.6 m -116.41 156.93 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 53' ' ' ARG . 16.5 t -98.3 111.94 24.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.566 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.08 139.16 37.8 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.1 p30 -69.8 -9.74 55.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -1.109 . . . . 0.0 109.667 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.472 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 91.3 m-20 -81.42 1.99 30.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.446 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.48 15.19 44.68 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -125.03 168.66 13.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.336 -1.097 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 39.1 m -123.45 134.18 53.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.634 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 72.8 m-85 -110.99 121.09 44.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 109.215 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' LYS . 8.7 m-20 -46.89 -82.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.4 -0.812 . . . . 0.0 109.722 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.3 t-20 -81.84 146.38 55.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 109.593 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -62.95 -51.96 2.54 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.77 2.313 . . . . 0.0 111.599 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.8 t -61.92 -26.78 68.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.959 -1.088 . . . . 0.0 108.091 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.422 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 31.5 mmm -67.43 -16.66 64.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.634 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 17.3 tp -68.03 -57.35 6.29 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.459 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 9.4 t -55.45 -25.41 36.21 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -69.51 -61.7 1.68 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.571 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 88.5 mt-10 -57.57 -19.53 26.13 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.41 ' ND2' ' HG ' ' A' ' 39' ' ' LEU . 92.9 m-20 -75.39 -33.55 61.02 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.499 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.2 tm? -57.76 -38.23 75.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.412 -0.805 . . . . 0.0 108.882 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mt -77.3 -46.81 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.846 . . . . 0.0 108.972 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 62.2 mtt-85 -64.76 -26.22 68.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 109.01 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 91.5 mt-30 61.27 37.99 16.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.37 -0.831 . . . . 0.0 109.639 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 p -128.39 169.77 13.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.322 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.512 ' O ' ' NE2' ' A' ' 51' ' ' HIS . 79.9 m-20 -98.91 63.13 1.35 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.266 -0.896 . . . . 0.0 109.311 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.472 ' OG1' ' OD2' ' A' ' 29' ' ' ASP . 32.6 m -71.47 137.65 48.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.827 . . . . 0.0 109.666 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.512 ' NE2' ' O ' ' A' ' 49' ' ' ASN . 11.8 m-70 -117.95 178.54 4.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 109.022 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.407 HG22 ' HB ' ' A' ' 25' ' ' VAL . 20.4 mt -86.08 124.8 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.142 -0.974 . . . . 0.0 109.611 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 66.4 ttt180 -80.99 -56.73 3.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.142 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -147.13 156.56 43.09 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.535 -0.728 . . . . 0.0 109.037 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -75.05 142.72 43.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.0 109.632 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.04 162.46 35.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 32.5 mttt -64.77 136.75 57.25 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.588 -0.948 . . . . 0.0 109.484 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -71.11 149.15 46.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.388 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 58' ' ' CYS . 84.4 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.502 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.469 ' OG ' ' HA ' ' A' ' 51' ' ' HIS . 0.6 OUTLIER -54.43 -34.5 61.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.45 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.79 -21.54 7.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.189 -0.944 . . . . 0.0 108.78 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.3 mtp -71.54 -30.66 66.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.036 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 8' ' ' TYR . 3.9 m -82.8 -26.84 31.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.441 -0.787 . . . . 0.0 109.376 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' CYS . 69.3 mttt -44.76 -27.24 0.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.348 -0.845 . . . . 0.0 108.757 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 5' ' ' CYS . 94.5 m-20 -116.08 35.05 4.66 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 5' ' ' CYS . 2.7 t80 -80.34 163.2 24.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -150.64 114.61 5.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -0.829 . . . . 0.0 109.093 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.553 ' CG2' ' CD1' ' A' ' 16' ' ' TYR . 59.7 t -116.97 156.74 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 109.639 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.535 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -136.27 174.91 3.97 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.371 -0.83 . . . . 0.0 109.386 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.9 Cg_endo -67.44 -21.75 46.32 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.672 2.248 . . . . 0.0 111.947 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -112.1 -21.56 11.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.673 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.0 mt -88.21 -49.32 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 0.0 109.627 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.463 ' C ' ' CG1' ' A' ' 10' ' ' VAL . . . 75.2 -165.43 54.62 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.553 ' CD1' ' CG2' ' A' ' 10' ' ' VAL . 1.2 t80 -94.06 153.84 17.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -1.212 . . . . 0.0 109.514 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.8 tp -117.08 109.92 17.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.965 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.9 m -126.13 155.35 73.71 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 109.115 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.09 168.52 23.82 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.527 2.151 . . . . 0.0 111.611 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -88.19 -23.34 23.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -0.964 . . . . 0.0 109.741 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.53 126.53 28.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.329 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.45 HD12 ' HB3' ' A' ' 34' ' ' ASN . 31.3 tp -85.0 113.13 21.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -121.45 104.35 40.26 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 0.0 109.363 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HB2' ' HG3' ' A' ' 57' ' ' LYS . 43.2 Cg_endo -65.62 117.28 4.49 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.875 2.383 . . . . 0.0 112.059 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.453 ' O ' HG21 ' A' ' 32' ' ' THR . 34.0 m -120.44 154.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.871 . . . . 0.0 109.835 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.0 t -97.3 140.79 31.24 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -90.99 142.39 16.11 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 43.9 t0 -68.58 -11.5 60.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -1.203 . . . . 0.0 109.306 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -86.4 -5.0 59.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.303 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.77 21.38 14.35 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 27' ' ' GLY . 66.8 mt-30 -127.58 145.84 50.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -1.194 . . . . 0.0 109.585 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.461 ' OG1' ' SG ' ' A' ' 58' ' ' CYS . 92.8 m -99.4 154.72 17.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.868 . . . . 0.0 109.602 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.629 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 48.8 m-85 -135.59 117.63 15.36 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.372 -0.83 . . . . 0.0 108.901 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 23' ' ' LYS . 10.8 m-20 -41.97 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.0 109.828 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.8 t-20 -82.27 146.61 54.89 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.031 . . . . 0.0 109.205 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.18 -51.16 2.93 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.618 2.212 . . . . 0.0 111.695 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.5 t -63.34 -28.27 69.89 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.094 -1.004 . . . . 0.0 108.423 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 14.0 mtp -60.89 -14.93 25.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.019 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.629 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 6.2 tp -74.65 -54.9 6.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.494 -0.754 . . . . 0.0 109.746 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.4 m -61.72 -19.92 62.93 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.197 -0.94 . . . . 0.0 108.665 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.549 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 34.9 t60 -67.79 -54.39 19.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -66.2 -18.75 65.55 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.0 m-20 -75.79 -27.47 58.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.45 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.492 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 1.8 tm? -67.52 -35.98 80.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -0.976 . . . . 0.0 108.966 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.441 HD11 HG23 ' A' ' 45' ' ' ILE . 0.6 OUTLIER -78.25 -46.27 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.208 179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.502 ' NH2' ' OE1' ' A' ' 31' ' ' GLN . 74.2 mtm180 -75.79 -35.01 60.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 109.109 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.2 mt-30 62.51 40.36 10.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.71 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.4 HG22 ' HB3' ' A' ' 46' ' ' ARG . 32.9 p -109.8 7.31 24.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 47.82 60.66 3.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.853 . . . . 0.0 109.761 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.453 HG23 HD12 ' A' ' 39' ' ' LEU . 95.3 m -79.77 133.49 36.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.451 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.469 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 8.1 m-70 -105.46 -173.97 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.478 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.443 HD12 HD23 ' A' ' 39' ' ' LEU . 33.6 mm -91.33 127.15 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.616 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 73.8 ttt180 -79.44 -49.01 12.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.231 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.6 p -159.3 155.18 26.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 p -67.82 141.56 56.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.074 -1.016 . . . . 0.0 109.769 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.29 165.77 35.17 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HA ' HG22 ' A' ' 32' ' ' THR . 83.0 mttt -66.94 146.28 54.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -1.087 . . . . 0.0 109.364 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.461 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 70.1 m -55.28 150.54 11.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.59 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.458 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.294 0.569 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 3.5 m -52.93 -40.4 63.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.383 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -54.25 -26.41 28.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.441 -0.787 . . . . 0.0 109.069 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 48.2 ttm -67.68 -25.88 65.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.108 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.441 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 38.9 m -80.82 -28.06 36.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.335 -0.853 . . . . 0.0 109.167 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -68.08 -12.6 61.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 109.368 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -91.0 -16.59 27.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.689 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.495 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -109.76 157.22 19.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.183 179.852 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -128.95 140.79 51.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.564 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.495 ' CG2' ' C ' ' A' ' 15' ' ' GLY . 14.7 p -125.71 146.77 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.545 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mp -108.77 175.6 1.9 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.3 Cg_endo -67.32 -23.3 44.81 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.641 2.227 . . . . 0.0 111.669 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -88.93 -30.6 18.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.247 -0.908 . . . . 0.0 109.146 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.6 mm -85.9 -39.79 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 0.0 109.307 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.495 ' C ' ' CG2' ' A' ' 10' ' ' VAL . . . 69.18 144.71 0.16 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.581 ' CD1' HD13 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -41.88 152.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -1.065 . . . . 0.0 109.789 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.1 tp -128.35 111.72 13.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.882 . . . . 0.0 109.511 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 81.0 m -116.85 158.08 44.72 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.327 -0.858 . . . . 0.0 109.2 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -71.79 165.62 31.99 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.575 2.183 . . . . 0.0 111.792 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -86.81 -11.61 50.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -74.11 113.42 11.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.246 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.509 ' CD1' ' OD1' ' A' ' 34' ' ' ASN . 55.9 tp -80.02 123.22 27.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.554 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 11.9 mmtm -141.03 109.63 6.44 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.394 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -66.02 120.28 7.42 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 123.04 2.493 . . . . 0.0 112.055 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.461 ' HB ' HG21 ' A' ' 52' ' ' ILE . 11.1 m -116.86 156.64 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 109.82 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 46.8 t -98.59 119.8 37.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.0 109.368 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -72.62 137.31 24.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.471 ' OD2' ' HA ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -68.33 -7.61 32.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -1.08 . . . . 0.0 109.532 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.445 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 91.5 m-20 -89.07 11.77 17.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.504 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.6 71.59 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 27' ' ' GLY . 78.4 mt-30 -116.01 173.95 6.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -1.164 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 57' ' ' LYS . 50.6 m -133.9 140.33 46.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.328 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.597 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 24.6 m-85 -118.62 123.32 44.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.467 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' OD1' ' CD1' ' A' ' 22' ' ' LEU . 54.6 t-20 -45.99 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 109.737 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.8 t-20 -80.82 147.52 62.53 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.866 -1.146 . . . . 0.0 109.343 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.8 Cg_endo -62.45 -53.15 2.0 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.699 2.266 . . . . 0.0 111.804 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.6 t -62.76 -28.15 69.78 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.479 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 50.3 mmm -63.13 -16.77 61.12 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.597 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 27.9 tp -66.77 -50.67 61.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.454 -0.779 . . . . 0.0 108.899 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.478 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.6 m -67.92 -19.36 64.98 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -73.54 -54.82 7.3 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 88.6 mt-10 -63.35 -17.05 62.17 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 47' ' ' GLN . 94.0 m-20 -77.35 -35.74 54.36 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.493 -0.754 . . . . 0.0 108.967 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.581 HD13 ' CD1' ' A' ' 16' ' ' TYR . 31.2 mt -54.14 -36.09 62.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.116 -0.99 . . . . 0.0 108.567 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mt -78.45 -50.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.075 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 91.5 mtt-85 -65.31 -26.89 68.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.23 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.97 41.95 7.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 109.587 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.422 HG21 ' C ' ' A' ' 47' ' ' GLN . 8.0 p -128.86 158.61 38.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.446 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.475 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 63.0 m-20 -87.71 58.4 4.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.332 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.445 ' OG1' ' OD2' ' A' ' 29' ' ' ASP . 57.6 m -75.15 133.6 41.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.858 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.475 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 67.9 m80 -119.88 174.86 6.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.858 . . . . 0.0 108.873 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.522 HG22 HD11 ' A' ' 52' ' ' ILE . 37.9 mt -79.71 138.43 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.322 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.471 ' HA ' ' OD2' ' A' ' 28' ' ' ASP . 23.3 ttt180 -101.9 -47.52 4.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.387 -0.821 . . . . 0.0 109.578 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.5 m -146.86 137.61 23.84 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.49 -0.756 . . . . 0.0 109.33 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.7 p -60.69 145.17 50.3 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.24 164.09 39.9 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' HA ' HG22 ' A' ' 32' ' ' THR . 22.4 tttp -53.88 150.22 7.91 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.348 -1.09 . . . . 0.0 109.525 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 36.3 m -52.73 144.85 13.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.444 179.888 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.472 ' OG ' ' HA ' ' A' ' 51' ' ' HIS . 3.7 m -54.24 -23.8 16.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.2 tt0 -48.57 -27.05 2.52 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.21 -0.931 . . . . 0.0 108.561 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.6 mtm -79.99 -36.29 36.23 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.2 m -85.5 8.96 17.2 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.486 ' HE2' ' NE2' ' A' ' 51' ' ' HIS . 31.1 mttt -70.13 -27.42 64.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 82.6 m-20 -144.44 64.25 1.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.52 ' OH ' ' CD2' ' A' ' 44' ' ' LEU . 11.7 p90 -125.33 -176.44 3.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.442 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -146.7 152.87 39.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 109.557 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -144.57 127.93 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.534 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -106.8 175.32 2.09 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.865 . . . . 0.0 109.501 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -67.94 -23.23 41.05 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.693 2.262 . . . . 0.0 111.844 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -96.73 -26.64 15.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.254 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.2 mt -89.3 -42.07 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.655 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.32 -165.46 31.49 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.464 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -93.42 149.83 20.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -1.197 . . . . 0.0 109.407 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.2 tp -116.24 107.19 14.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.639 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 60.3 m -125.47 156.26 70.67 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 109.557 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -72.12 167.84 25.69 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.733 2.288 . . . . 0.0 111.669 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -84.32 -26.0 28.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -62.34 117.01 5.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.482 HD22 ' CB ' ' A' ' 34' ' ' ASN . 3.4 tm? -84.67 104.32 14.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 34' ' ' ASN . 16.1 mtpt -116.12 111.37 42.71 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.223 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.6 Cg_endo -63.38 121.14 8.84 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 C-N-CA 122.999 2.466 . . . . 0.0 112.21 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.526 ' CG2' HD11 ' A' ' 39' ' ' LEU . 5.8 m -115.1 157.73 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.418 -0.801 . . . . 0.0 109.584 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 47.6 t -97.21 140.58 31.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.8 135.38 12.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.464 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.7 p30 -62.0 -12.23 17.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -1.065 . . . . 0.0 109.71 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 49.8 m-20 -87.47 10.84 16.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.484 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.72 64.31 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 62.0 mt-30 -117.35 178.79 4.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.519 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.447 HG22 ' HA ' ' A' ' 57' ' ' LYS . 20.7 m -139.49 142.65 37.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.31 -0.869 . . . . 0.0 109.234 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.632 ' CD2' ' CD1' ' A' ' 39' ' ' LEU . 23.9 m-85 -122.42 134.84 54.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.505 ' O ' ' O ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -54.68 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 109.491 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.4 t-20 -82.16 146.39 54.81 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.003 -1.061 . . . . 0.0 109.504 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.64 -52.3 1.94 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.703 2.269 . . . . 0.0 111.645 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.536 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -63.5 -24.28 67.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.501 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 62.2 mtp -73.66 -16.51 61.21 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.632 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 7.5 tt -64.55 -51.8 60.95 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' ASN . 8.7 m -54.09 -38.54 65.45 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.425 ' C ' ' O ' ' A' ' 40' ' ' CYS . 7.2 t60 -47.48 -50.21 23.78 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 37.3 mm-40 -56.48 -25.98 52.78 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.2 m-80 -74.32 -33.72 63.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 0.0 108.85 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.52 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 37.2 mt -63.96 -44.26 93.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.1 mm -74.86 -52.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.125 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 37.7 mtt-85 -66.83 -22.25 66.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.198 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 61.51 35.26 17.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.359 -0.838 . . . . 0.0 109.584 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 p -123.13 170.38 10.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.419 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.57 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 77.7 m-20 -96.77 57.37 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.857 . . . . 0.0 109.609 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.513 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 43.9 m -80.03 126.12 30.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.554 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.57 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 22.3 m80 -113.18 -173.32 2.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.519 HD11 HG22 ' A' ' 52' ' ' ILE . 31.8 mt -87.09 124.69 40.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.176 -0.952 . . . . 0.0 109.366 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 79.3 ttt180 -80.44 -39.99 27.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.366 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.06 148.64 17.15 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.493 -0.754 . . . . 0.0 109.288 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -65.91 144.43 56.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.723 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.11 162.01 38.06 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.447 ' HA ' HG22 ' A' ' 32' ' ' THR . 13.5 tttm -54.8 154.27 5.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.51 -0.994 . . . . 0.0 109.372 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 84.5 m -62.55 141.13 58.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.499 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.488 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.464 ' OD1' ' CG1' ' A' ' 52' ' ' ILE . 61.9 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.47 -0.566 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.504 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 6.1 m -44.01 -27.56 0.38 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.252 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.482 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 20.8 mt-10 -49.39 -29.3 6.1 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.8 mtp -75.26 -27.43 59.42 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 2' ' ' SER . 4.1 m -79.73 -5.68 55.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.455 -0.778 . . . . 0.0 108.968 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 18.5 mttm -54.24 -31.47 53.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.795 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -146.43 67.74 1.18 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -0.948 . . . . 0.0 110.073 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.508 ' OH ' ' CD1' ' A' ' 44' ' ' LEU . 5.8 p90 -125.2 173.76 8.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.158 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -143.9 147.52 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.063 -1.023 . . . . 0.0 109.755 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.558 HG22 ' CD2' ' A' ' 16' ' ' TYR . 66.6 t -144.57 132.83 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.126 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 1.5 mp -125.42 170.94 8.34 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 109.497 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.71 -24.59 40.93 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.556 2.171 . . . . 0.0 111.449 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -102.89 -27.16 12.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.039 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.4 mt -88.88 -43.09 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.294 -0.879 . . . . 0.0 109.24 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.04 -141.72 27.52 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.558 ' CD2' HG22 ' A' ' 10' ' ' VAL . 2.9 t80 -114.17 155.3 26.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 32.5 tp -112.44 124.5 52.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.991 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 85.1 m -138.54 156.66 73.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.388 -0.82 . . . . 0.0 109.057 179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.59 168.21 25.02 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.633 2.222 . . . . 0.0 111.552 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -84.82 -27.83 26.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.379 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.82 130.88 48.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.7 tp -95.06 117.71 30.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 109.5 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.497 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 7.5 mttt -128.22 104.88 19.94 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.3 Cg_endo -64.62 120.41 7.69 Favored 'Trans proline' 0 C--O 1.213 -0.755 0 C-N-CA 122.962 2.442 . . . . 0.0 112.081 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.424 ' HB ' HG22 ' A' ' 52' ' ' ILE . 11.9 m -119.62 156.46 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.851 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.3 t -99.87 121.48 41.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.432 -0.793 . . . . 0.0 108.873 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -79.41 137.05 18.45 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 45.5 p30 -68.5 -8.82 44.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -1.152 . . . . 0.0 109.548 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 29' ' ' ASP . 58.0 p30 -82.89 8.21 13.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -0.955 . . . . 0.0 109.313 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.44 23.01 45.2 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.4 mt-30 -133.79 158.25 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -1.154 . . . . 0.0 109.499 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.518 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 42.2 m -116.19 143.63 45.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 109.225 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.572 ' CD1' HD11 ' A' ' 39' ' ' LEU . 81.0 m-85 -122.51 127.82 50.02 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.272 -0.893 . . . . 0.0 109.213 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 23' ' ' LYS . 10.7 m-20 -51.55 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.942 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 10.1 t-20 -81.97 146.56 55.85 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 120.947 -1.096 . . . . 0.0 109.731 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.9 -51.78 2.71 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.813 2.342 . . . . 0.0 111.674 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.9 t -60.14 -31.57 70.21 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.431 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 8.5 mtt -60.97 -17.53 52.24 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.572 HD11 ' CD1' ' A' ' 33' ' ' TYR . 63.5 tp -67.85 -54.45 18.86 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.458 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 8.1 t -58.19 -27.72 64.13 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -62.28 -58.93 5.89 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -59.62 -21.01 59.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.0 m-20 -80.09 -30.74 39.27 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.508 ' CD1' ' OH ' ' A' ' 8' ' ' TYR . 35.6 tp -61.14 -40.61 94.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.512 -0.742 . . . . 0.0 109.054 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.514 HD11 HG22 ' A' ' 45' ' ' ILE . 4.0 mt -80.43 -47.49 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.81 . . . . 0.0 109.322 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 46.7 ttm-85 -67.66 -43.67 79.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.5 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' ASN . 84.8 mt-30 65.88 47.18 2.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.387 -0.821 . . . . 0.0 109.58 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.462 ' OG1' ' HD2' ' A' ' 46' ' ' ARG . 21.3 p -120.83 8.07 10.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.449 ' OD1' ' CB ' ' A' ' 2' ' ' SER . 41.1 t30 52.73 60.65 3.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.535 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.402 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 28.9 m -77.87 141.12 39.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.327 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.504 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 59.6 m80 -115.12 168.58 9.81 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.204 -0.935 . . . . 0.0 109.094 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.464 ' CG1' ' OD1' ' A' ' 1' ' ' ASP . 21.7 mt -79.71 123.55 36.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.146 -0.972 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 65.2 ttt-85 -81.06 -45.98 15.69 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.571 -0.706 . . . . 0.0 109.266 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -152.99 153.85 33.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 109.138 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 p -74.0 144.89 44.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.0 164.6 40.4 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.518 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 75.1 mttt -64.9 138.44 58.37 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.46 -1.024 . . . . 0.0 109.345 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 152.6 44.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 109.418 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.496 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.252 0.549 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.477 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 7.6 m -53.64 -26.7 23.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.375 -0.828 . . . . 0.0 109.389 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.476 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 6.3 mt-10 -53.17 -24.41 10.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.279 -0.888 . . . . 0.0 109.055 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.9 mtm -70.62 -30.06 66.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.104 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 7.9 m -80.39 -20.15 44.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.393 -0.817 . . . . 0.0 109.285 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 86.1 mttt -50.19 -27.13 5.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 108.822 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -108.84 26.53 10.47 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 1.9 t80 -80.97 147.71 30.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.985 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -141.17 114.61 8.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.439 HG22 ' HA ' ' A' ' 16' ' ' TYR . 5.4 p -128.71 154.71 39.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.348 -0.845 . . . . 0.0 109.431 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -110.12 168.42 7.67 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.948 . . . . 0.0 109.327 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 44.7 Cg_endo -67.2 -24.82 43.77 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.614 2.209 . . . . 0.0 111.543 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -92.92 -25.02 18.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.218 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.5 HD11 HG22 ' A' ' 14' ' ' ILE . 72.3 mt -85.69 -40.37 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.96 145.9 0.36 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.529 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 1.9 t80 -51.44 150.89 3.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -1.163 . . . . 0.0 109.331 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.559 ' N ' ' CD1' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -116.92 136.12 53.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.425 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.6 m -142.95 157.27 61.38 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.208 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -69.87 165.42 31.16 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.661 2.241 . . . . 0.0 111.755 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -87.93 -13.34 42.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -72.56 114.34 10.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.181 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.0 tp -80.04 120.74 24.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 109.629 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -136.83 107.47 9.0 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.091 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.3 121.66 9.16 Favored 'Trans proline' 0 C--O 1.212 -0.784 0 C-N-CA 123.016 2.478 . . . . 0.0 112.249 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.465 ' O ' HG21 ' A' ' 32' ' ' THR . 16.3 m -118.89 155.57 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 109.877 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 32.2 t -97.36 139.03 33.91 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.68 140.31 15.04 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -70.98 -4.77 26.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -1.134 . . . . 0.0 109.618 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -93.57 4.61 53.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.01 20.26 33.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.7 mt-30 -124.63 163.58 21.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -1.139 . . . . 0.0 109.54 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.465 HG21 ' O ' ' A' ' 25' ' ' VAL . 52.0 m -125.13 135.58 52.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.128 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.582 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 55.3 m-85 -115.36 130.16 56.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.228 -0.92 . . . . 0.0 109.349 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 8.3 m-20 -54.52 -78.15 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.731 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.9 t-20 -81.88 147.86 59.47 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.722 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.4 Cg_endo -62.92 -52.92 1.87 Allowed 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.751 2.3 . . . . 0.0 111.704 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.5 t -60.91 -29.81 69.81 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.984 -1.072 . . . . 0.0 108.111 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.438 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 44.9 mmm -63.65 -15.24 57.77 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.582 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 39.4 tp -68.76 -49.29 59.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.494 -0.754 . . . . 0.0 109.286 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 3.2 m -69.32 -21.35 63.85 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.529 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 40.5 t60 -70.27 -55.33 9.5 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 78.1 mt-10 -63.28 -19.49 64.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.1 m-20 -75.26 -33.42 61.27 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 40' ' ' CYS . 20.9 mt -59.3 -37.0 76.62 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 mm -72.69 -49.6 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 36.4 ttt180 -68.48 -25.86 65.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.1 mt-30 64.03 43.91 4.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.778 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.1 p -132.36 166.89 20.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.303 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.48 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 95.9 m-20 -95.71 61.13 2.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.396 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.3 m -72.32 139.3 47.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.619 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.48 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 72.1 m80 -119.15 173.57 6.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.845 . . . . 0.0 109.053 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.443 HG22 ' HB ' ' A' ' 25' ' ' VAL . 35.1 mt -80.07 124.93 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.097 -1.002 . . . . 0.0 109.269 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 21.7 ttt180 -79.93 -45.94 17.63 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.679 0.752 . . . . 0.0 109.235 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 p -156.49 146.47 21.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 p -65.37 147.4 53.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.157 -0.965 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.22 165.15 40.47 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.497 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 47.4 mttp -65.69 146.2 55.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -1.087 . . . . 0.0 109.346 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 152.86 35.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.504 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.405 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.466 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 1.8 m -58.26 -29.63 65.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.378 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.458 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.3 tt0 -53.17 -24.25 10.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.313 -0.867 . . . . 0.0 108.895 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.7 mtp -70.17 -32.1 69.89 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.497 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 34.4 m -80.56 -6.08 57.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.378 -0.826 . . . . 0.0 109.214 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.458 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 65.6 mttt -81.38 12.61 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 110.038 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -132.98 7.83 4.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.991 -1.068 . . . . 0.0 110.399 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 5.8 p90 -105.48 -176.56 3.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.912 -1.118 . . . . 0.0 109.604 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.621 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 10.4 ttt180 -151.48 142.81 23.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.339 -0.851 . . . . 0.0 109.142 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.433 HG12 ' C ' ' A' ' 15' ' ' GLY . 15.0 t -143.61 149.39 18.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.346 -0.846 . . . . 0.0 109.321 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.54 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -124.46 175.33 3.0 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.4 Cg_endo -66.71 -21.56 51.45 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.63 2.22 . . . . 0.0 111.739 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 66.1 ttt180 -99.6 -16.89 18.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.84 . . . . 0.0 109.641 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 40.0 mm -94.82 -49.82 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.033 -1.042 . . . . 0.0 109.611 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.433 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 86.47 -178.29 48.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.493 ' CE2' ' OH ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -90.63 146.91 23.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 109.736 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.3 tp -114.18 107.59 15.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 74.1 m -117.28 156.62 48.6 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.343 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.1 Cg_endo -72.21 167.94 25.47 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.642 2.228 . . . . 0.0 111.531 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -91.79 -12.81 32.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -66.74 129.45 39.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 109.277 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.3 tm? -89.56 120.68 31.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.518 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 27.3 mttm -143.65 108.13 5.13 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.541 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 47.1 Cg_endo -66.77 122.39 9.76 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 123.056 2.504 . . . . 0.0 112.126 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -116.21 154.66 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.6 t -97.04 138.56 34.38 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.57 139.82 14.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.9 t0 -69.2 -8.44 45.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -1.099 . . . . 0.0 109.459 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -87.54 3.61 46.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.978 . . . . 0.0 109.438 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.56 17.29 45.98 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 65.8 mt-30 -121.33 175.22 6.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -1.108 . . . . 0.0 109.625 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.513 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 10.8 m -134.29 136.78 43.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 0.0 109.54 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.583 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 30.6 m-85 -114.42 127.67 55.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 59.6 t-20 -50.6 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.433 -0.792 . . . . 0.0 110.079 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.8 t-20 -80.85 149.5 67.36 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.004 -1.06 . . . . 0.0 109.555 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.35 -54.92 0.85 Allowed 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.793 2.329 . . . . 0.0 111.917 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.2 t -62.09 -28.33 69.54 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.965 -1.084 . . . . 0.0 108.265 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.4 mmm -64.41 -12.58 44.55 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.583 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 28.4 tp -73.56 -57.67 3.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.465 -0.772 . . . . 0.0 109.067 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.43 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.8 m -62.85 -18.47 62.93 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -71.85 -58.27 3.6 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -61.92 -17.08 55.52 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.459 ' O ' ' N ' ' A' ' 47' ' ' GLN . 95.6 m-20 -77.15 -31.91 55.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.524 -0.735 . . . . 0.0 109.076 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 40' ' ' CYS . 19.5 mt -58.55 -35.99 73.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.935 . . . . 0.0 108.678 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.2 mm -78.64 -50.25 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.056 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.9 mtt-85 -64.46 -34.71 78.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.168 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.7 mt-30 58.79 36.47 24.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.379 -0.826 . . . . 0.0 109.447 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 p -113.12 11.82 18.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.37 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 46.28 57.73 5.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.367 -0.833 . . . . 0.0 109.44 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.421 ' O ' ' OG ' ' A' ' 2' ' ' SER . 56.3 m -75.04 140.57 43.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.492 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.466 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 48.7 m-70 -112.5 170.01 8.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.416 HG12 HD23 ' A' ' 39' ' ' LEU . 39.7 mt -79.85 126.52 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 41.3 ttt180 -79.77 -45.82 18.12 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.7 p -158.19 162.51 37.9 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.4 p -79.05 133.08 36.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -0.986 . . . . 0.0 109.755 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 99.95 165.35 29.06 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.513 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 30.1 tttp -54.39 158.51 2.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -1.083 . . . . 0.0 109.236 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.464 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 91.2 m -69.39 150.42 47.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.6 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.384 179.918 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.445 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 3.1 m -53.97 -34.95 61.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.361 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -54.15 -27.52 34.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.3 -0.875 . . . . 0.0 109.039 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtp -71.71 -19.84 62.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.392 -0.818 . . . . 0.0 109.044 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.9 m -85.48 -22.93 28.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.375 -0.828 . . . . 0.0 109.247 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -74.75 -14.33 60.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -109.34 4.09 22.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.872 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -119.43 155.11 32.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.038 -1.039 . . . . 0.0 109.238 179.909 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -136.74 130.79 32.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.408 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.514 ' HB ' ' CE2' ' A' ' 8' ' ' TYR . 4.9 p -129.39 142.2 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.469 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.522 ' CD2' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -103.88 173.55 3.33 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.522 ' HD2' ' CD2' ' A' ' 11' ' ' LEU . 47.6 Cg_endo -68.44 -26.72 34.37 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.595 2.197 . . . . 0.0 111.717 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -89.01 -28.41 20.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.295 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.7 mm -84.39 -40.57 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.244 -0.91 . . . . 0.0 109.304 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.478 ' C ' ' CG2' ' A' ' 10' ' ' VAL . . . 68.56 155.85 0.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CE2' ' CZ ' ' A' ' 8' ' ' TYR . 1.3 t80 -55.67 148.06 17.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.292 -1.122 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.6 tp -123.1 119.62 30.83 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.859 . . . . 0.0 109.323 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.4 m -117.67 155.82 50.2 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.525 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.416 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.3 Cg_endo -71.55 166.02 30.69 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.844 2.363 . . . . 0.0 111.791 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -86.63 -8.01 57.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.867 . . . . 0.0 109.335 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -72.99 128.77 36.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 109.304 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.513 ' CD2' ' OD1' ' A' ' 34' ' ' ASN . 3.1 tm? -92.12 124.69 36.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 34' ' ' ASN . 2.2 mmmm -145.27 103.68 4.36 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.304 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.541 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -65.36 124.29 12.7 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 123.061 2.507 . . . . 0.0 112.298 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.7 m -120.74 156.26 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 109.939 179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 53' ' ' ARG . 11.6 t -101.64 115.46 30.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.172 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -71.77 139.29 28.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.0 p30 -69.41 -9.83 55.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -1.14 . . . . 0.0 109.484 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.8 m-20 -82.95 8.13 13.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.75 14.35 63.31 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.0 mt-30 -120.75 159.73 24.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.304 -1.116 . . . . 0.0 109.467 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.496 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 33.1 m -119.1 134.66 55.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.286 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.623 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 56.5 m-85 -113.26 123.83 51.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.119 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.513 ' OD1' ' CD2' ' A' ' 22' ' ' LEU . 64.2 t-20 -49.41 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.256 -0.902 . . . . 0.0 109.806 -179.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.5 t-20 -80.93 147.97 63.28 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 120.871 -1.143 . . . . 0.0 109.72 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.475 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 39.6 Cg_endo -62.16 -53.11 2.17 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.845 2.363 . . . . 0.0 111.941 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.0 t -60.92 -28.5 68.98 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 120.911 -1.118 . . . . 0.0 108.023 178.863 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 22.2 mtp -63.99 -20.92 66.25 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.623 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 32.7 tp -67.38 -54.57 19.31 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.519 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 38.1 t -58.34 -30.96 67.14 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -66.52 -59.04 4.0 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 73.9 mt-10 -59.2 -18.41 36.43 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.466 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 94.4 m-20 -77.28 -37.88 51.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.589 -0.695 . . . . 0.0 109.162 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 40' ' ' CYS . 5.4 mp -56.38 -34.24 66.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 108.79 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.484 HD12 HG22 ' A' ' 45' ' ' ILE . 5.0 mt -79.01 -48.49 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.396 -0.815 . . . . 0.0 109.278 179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.507 ' HG3' ' CG2' ' A' ' 48' ' ' THR . 19.9 tpt85 -65.64 -39.22 91.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 88.7 mt-30 62.67 41.84 8.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.56 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.507 ' CG2' ' HG3' ' A' ' 46' ' ' ARG . 27.3 p -121.92 10.65 10.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.497 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 51.51 60.84 3.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.355 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.466 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 26.7 m -77.52 141.56 39.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.625 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.445 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 22.7 m-70 -115.18 172.12 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.011 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.4 mt -82.96 124.75 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.49 ' N ' ' O ' ' A' ' 26' ' ' CYS . 24.7 tpt180 -82.16 -53.52 6.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.422 -0.799 . . . . 0.0 109.31 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.9 p -148.02 154.58 40.46 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -73.05 147.58 44.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.116 -0.99 . . . . 0.0 109.312 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.95 165.15 40.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.518 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 35.0 mttm -66.86 145.6 55.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -1.041 . . . . 0.0 109.301 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 153.06 29.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.453 -179.964 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 14.9 p30 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.34 0.59 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.56 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 4.0 m -56.17 -28.34 57.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.336 -0.852 . . . . 0.0 109.235 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -53.12 -26.1 15.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.282 -0.886 . . . . 0.0 108.863 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.1 mtm -69.32 -26.62 64.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 108.777 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.581 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 34.8 m -81.13 -17.12 50.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.785 . . . . 0.0 109.475 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 63.1 mttt -80.51 8.38 7.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.733 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 95.9 m-20 -137.83 10.76 2.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.011 -1.056 . . . . 0.0 110.241 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.616 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -121.36 151.18 40.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 109.565 179.803 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -132.02 134.86 46.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.236 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.558 HG22 ' CE2' ' A' ' 8' ' ' TYR . 61.8 t -124.47 148.92 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.82 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.529 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -129.6 175.23 3.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.437 -0.789 . . . . 0.0 109.276 179.849 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.8 Cg_endo -66.9 -21.73 49.83 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.651 2.234 . . . . 0.0 111.784 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -103.65 -28.26 11.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.52 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.2 mt -81.76 -46.99 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.547 -179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.41 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 78.97 -166.43 51.83 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.2 t80 -97.16 150.8 20.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.174 . . . . 0.0 109.502 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.6 tp -120.07 116.29 25.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 109.681 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.6 m -127.37 157.37 72.94 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.201 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.8 Cg_endo -71.05 166.49 28.99 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.501 2.134 . . . . 0.0 111.682 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -88.12 -14.41 38.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.521 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -71.87 119.31 15.87 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.207 -0.933 . . . . 0.0 109.242 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.0 tp -83.61 116.39 22.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.75 -179.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.496 ' O ' ' O ' ' A' ' 34' ' ' ASN . 1.6 mmtt -129.7 105.45 17.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.885 . . . . 0.0 109.087 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.4 Cg_endo -65.27 119.82 6.91 Favored 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 122.952 2.434 . . . . 0.0 112.283 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.3 m -117.63 154.8 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.873 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 25.8 t -95.72 127.61 41.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.329 -0.857 . . . . 0.0 108.753 179.21 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -83.07 137.51 16.61 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.4 p30 -67.8 -8.52 36.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -85.6 7.34 23.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 109.384 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.54 16.07 57.45 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.5 mt-30 -123.2 173.46 7.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.477 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 25.9 m -133.0 135.42 45.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.387 -0.82 . . . . 0.0 109.263 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.637 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 37.0 m-85 -112.54 130.09 56.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.202 -0.936 . . . . 0.0 109.371 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.496 ' O ' ' O ' ' A' ' 23' ' ' LYS . 8.4 m-20 -53.77 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 109.72 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.0 t-20 -81.84 147.8 59.45 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.29 -53.87 1.3 Allowed 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.789 2.326 . . . . 0.0 111.813 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -61.32 -27.49 68.52 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 42.8 mmm -64.81 -17.88 64.62 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.234 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.637 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 24.2 tp -68.54 -58.16 4.72 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.457 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 10.5 t -56.36 -26.12 51.72 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -68.59 -61.56 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -56.02 -19.86 14.38 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.2 m-20 -78.56 -40.27 35.31 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.7 tp -55.83 -33.84 64.85 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.417 -0.802 . . . . 0.0 108.845 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.489 HG23 HD11 ' A' ' 45' ' ' ILE . 3.1 mt -78.82 -50.53 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.836 . . . . 0.0 108.995 179.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 13.2 mtt-85 -65.48 -22.02 66.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 109.348 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 89.0 mt-30 63.83 43.67 5.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.333 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.4 t -131.57 168.99 16.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.579 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 90.7 m-20 -103.56 63.29 0.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.1 m -74.42 140.01 44.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.703 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 31.4 m80 -116.66 178.93 4.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.044 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.493 HD11 HG22 ' A' ' 52' ' ' ILE . 30.0 mt -87.99 124.9 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.058 -1.026 . . . . 0.0 109.4 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 69.9 ttt-85 -80.19 -47.5 14.58 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.543 -0.723 . . . . 0.0 109.288 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 p -155.33 152.99 29.83 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -71.69 146.03 48.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.15 -0.969 . . . . 0.0 109.415 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.98 164.23 40.17 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.531 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 26.1 mttp -64.58 143.66 57.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.554 -0.968 . . . . 0.0 109.447 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 151.55 35.47 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.257 -0.902 . . . . 0.0 109.397 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.5 -179.864 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.31 0.576 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.437 ' HB2' ' HB3' ' A' ' 51' ' ' HIS . 5.0 m -55.08 -26.55 38.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.466 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.3 tt0 -53.22 -25.88 15.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.062 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.7 mtp -73.89 -36.02 64.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.351 -0.843 . . . . 0.0 108.915 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.57 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.0 m -85.58 4.14 37.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 109.083 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.564 ' HE2' ' CD2' ' A' ' 51' ' ' HIS . 24.7 mttt -73.05 -20.48 60.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 58.6 p30 -148.93 57.55 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 109.838 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.57 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 12.0 p90 -120.83 -175.44 3.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 109.242 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -152.64 145.6 24.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.391 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.571 HG22 ' CD2' ' A' ' 16' ' ' TYR . 55.5 t -132.04 129.68 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.532 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -111.94 175.37 1.9 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.355 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.4 Cg_endo -67.57 -23.66 42.85 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.61 2.207 . . . . 0.0 111.651 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.9 ttp85 -93.28 -39.72 10.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.89 . . . . 0.0 109.207 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.7 mt -79.95 -43.84 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.351 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.422 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 67.27 -155.05 52.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.571 ' CD2' HG22 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -112.71 148.13 35.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -1.104 . . . . 0.0 109.25 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.583 ' N ' ' CD1' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -122.0 128.93 52.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.0 m -136.4 157.27 75.7 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.272 -0.893 . . . . 0.0 109.317 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -70.4 165.73 30.74 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.575 2.184 . . . . 0.0 111.662 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -87.4 -10.5 51.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -78.52 108.88 12.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.443 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 35' ' ' ASN . 3.5 tm? -76.0 110.8 10.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 34' ' ' ASN . 2.6 mtpt -124.3 109.66 29.01 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 109.313 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.4 Cg_endo -62.31 121.26 9.19 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 123.035 2.49 . . . . 0.0 112.272 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.471 HG22 HD11 ' A' ' 39' ' ' LEU . 11.1 m -115.78 155.78 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -0.804 . . . . 0.0 109.904 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.7 t -97.27 112.92 24.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.365 -0.834 . . . . 0.0 108.932 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -67.18 133.5 31.04 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.4 t0 -69.62 -6.46 31.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 109.783 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 57.4 p30 -85.53 1.99 46.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.084 -1.01 . . . . 0.0 109.342 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.71 18.26 30.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.3 mt-30 -126.84 173.88 9.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.498 -1.001 . . . . 0.0 109.341 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 57' ' ' LYS . 23.5 m -132.63 138.35 47.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.266 -0.896 . . . . 0.0 109.29 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.613 ' CD2' ' CD1' ' A' ' 39' ' ' LEU . 31.4 m-85 -118.38 139.81 50.81 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.163 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.506 ' O ' ' O ' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -61.03 -76.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 -179.365 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.0 t-20 -82.31 146.81 55.22 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.988 -1.07 . . . . 0.0 109.64 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.9 Cg_endo -63.65 -52.23 1.98 Allowed 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.599 2.199 . . . . 0.0 111.68 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -63.42 -27.62 69.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 0.0 108.183 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.484 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 54.3 mtp -67.88 -19.8 65.06 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.315 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.613 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 7.3 tt -66.52 -52.92 40.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.331 -0.856 . . . . 0.0 108.873 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 43' ' ' ASN . 9.4 m -51.16 -41.05 59.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 40' ' ' CYS . 16.1 t60 -48.06 -48.1 33.54 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.972 -1.08 . . . . 0.0 108.209 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.562 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 49.8 mm-40 -58.37 -22.18 52.75 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 40' ' ' CYS . 2.9 m-80 -75.7 -35.83 60.18 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.997 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.517 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 31.7 mt -65.86 -48.69 70.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.301 -0.874 . . . . 0.0 109.389 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.8 mm -67.2 -52.82 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.118 179.78 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 72.8 ttt180 -68.56 -22.87 64.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.307 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ASN . 86.7 mt-30 63.06 43.17 6.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.363 -0.835 . . . . 0.0 109.571 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.432 ' OG1' ' HD3' ' A' ' 46' ' ' ARG . 60.7 p -132.96 167.42 20.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.145 -0.972 . . . . 0.0 109.576 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.577 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 89.8 m-20 -94.3 57.83 2.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.48 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 57.0 m -80.19 127.16 32.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.467 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 14.6 m80 -115.79 -169.22 1.55 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.444 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.491 HD11 HG22 ' A' ' 52' ' ' ILE . 37.8 mt -88.12 124.98 41.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.473 -0.767 . . . . 0.0 109.836 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 64.5 ttt180 -82.53 -49.64 9.67 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.746 0.784 . . . . 0.0 109.383 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 p -150.72 138.83 20.14 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.629 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -60.95 144.59 52.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.117 -0.99 . . . . 0.0 109.284 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.48 160.72 36.43 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HA ' HG22 ' A' ' 32' ' ' THR . 17.7 tttm -61.52 148.87 40.62 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.521 -0.987 . . . . 0.0 109.397 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.1 145.31 32.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.654 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.587 -179.948 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.477 ' OD1' HG13 ' A' ' 52' ' ' ILE . 72.3 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.527 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 5.2 m -51.55 -26.12 8.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.87 . . . . 0.0 109.352 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 4.4 mt-10 -52.13 -25.93 10.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.22 -0.925 . . . . 0.0 108.867 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.5 mtt -80.36 -31.79 37.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.375 -0.828 . . . . 0.0 109.034 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.4 m -80.0 -5.54 55.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.296 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 32.2 mttm -61.6 -23.2 65.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.674 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -151.31 64.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.928 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.496 ' OH ' ' CD1' ' A' ' 44' ' ' LEU . 6.7 p90 -123.77 174.33 7.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.109 -0.994 . . . . 0.0 109.198 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.423 ' C ' HG21 ' A' ' 10' ' ' VAL . 86.0 mtt-85 -147.35 146.49 29.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.648 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.447 HG23 ' HA ' ' A' ' 16' ' ' TYR . 69.3 t -145.29 132.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.484 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.531 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -117.8 175.08 2.2 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.269 -0.894 . . . . 0.0 109.597 -179.968 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.9 Cg_endo -67.73 -26.35 39.1 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.687 2.258 . . . . 0.0 111.951 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -107.8 -24.49 11.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.369 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.4 mm -82.59 -43.08 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.25 -159.14 53.23 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.473 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.7 t80 -98.6 153.73 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -1.177 . . . . 0.0 109.466 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 31.3 tp -107.86 123.25 48.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 109.877 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 68.3 m -140.19 156.48 70.03 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.306 -0.871 . . . . 0.0 109.21 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -71.56 167.6 25.96 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.558 2.172 . . . . 0.0 111.701 -179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -84.07 -29.47 26.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.613 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.34 125.94 25.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.418 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.44 HD13 ' C ' ' A' ' 34' ' ' ASN . 59.5 tp -88.26 113.21 23.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.154 -0.966 . . . . 0.0 109.432 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.5 mttt -121.27 105.61 39.29 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.511 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -64.69 118.67 5.63 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 123.085 2.523 . . . . 0.0 112.215 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.47 ' HB ' HG22 ' A' ' 52' ' ' ILE . 14.1 m -115.72 156.01 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 109.885 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.4 t -98.95 142.87 29.9 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.82 143.7 16.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.2 t0 -71.87 -14.33 61.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -1.124 . . . . 0.0 109.416 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -83.69 -5.38 59.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.44 22.04 10.87 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.5 mt-30 -121.46 170.95 9.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -1.13 . . . . 0.0 109.469 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.484 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 86.6 m -133.61 136.66 45.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.493 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.639 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 28.3 m-85 -115.02 146.23 41.47 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 108.754 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.531 ' N ' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -67.98 -75.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.01 -1.056 . . . . 0.0 108.626 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.9 t-20 -82.77 146.7 53.29 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 109.403 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -63.61 -51.18 2.64 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.693 2.262 . . . . 0.0 111.591 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -62.18 -28.58 69.77 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.444 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 10.3 mtt -64.4 -16.91 63.21 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.639 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 30.9 tp -65.94 -53.69 35.98 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.418 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 12.5 t -60.65 -23.48 64.82 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.447 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 25.2 t60 -67.31 -58.98 3.8 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -58.79 -22.07 57.48 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.487 ' O ' ' N ' ' A' ' 47' ' ' GLN . 78.2 m-20 -80.38 -30.77 37.87 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.496 ' CD1' ' OH ' ' A' ' 8' ' ' TYR . 49.5 tp -62.38 -35.56 79.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 108.76 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.424 HG22 HD11 ' A' ' 45' ' ' ILE . 2.1 mt -80.49 -50.33 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.4 -0.813 . . . . 0.0 109.249 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.479 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 96.1 mtt180 -68.89 -40.27 79.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.7 mt-30 65.0 39.56 5.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.543 -0.723 . . . . 0.0 109.547 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.6 p -108.15 6.97 27.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.393 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.463 ' OD1' ' OG ' ' A' ' 2' ' ' SER . 47.1 t30 52.74 56.79 7.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.524 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.9 m -78.6 140.46 38.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.527 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 51.2 m80 -112.12 169.11 9.08 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.275 -0.891 . . . . 0.0 108.993 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.477 HG13 ' OD1' ' A' ' 1' ' ' ASP . 23.3 mt -79.47 127.11 39.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.218 -0.926 . . . . 0.0 109.241 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 53.7 ttt-85 -79.35 -46.14 18.23 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.389 -0.819 . . . . 0.0 109.134 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 m -160.61 148.08 15.89 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.7 p -61.18 145.3 51.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.6 166.23 40.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.484 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 89.2 mttt -67.71 150.16 49.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -1.085 . . . . 0.0 109.499 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.466 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 66.7 m -59.79 151.11 26.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.9 . . . . 0.0 109.318 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.488 179.971 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.516 ' OG ' ' CD2' ' A' ' 39' ' ' LEU . 1.4 m -49.91 -36.88 29.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.224 -0.923 . . . . 0.0 109.482 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -54.28 -27.19 33.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.301 -0.874 . . . . 0.0 108.93 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.0 ttm -69.17 -28.73 66.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -0.812 . . . . 0.0 109.277 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 81.3 m -81.64 -31.18 32.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.244 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -60.49 -23.71 64.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.398 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -76.41 -25.73 54.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.512 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.483 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -103.66 155.22 18.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.197 -0.939 . . . . 0.0 109.226 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -128.36 139.71 52.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 0.0 109.317 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.484 ' CG2' ' C ' ' A' ' 15' ' ' GLY . 13.0 p -123.17 146.0 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -0.924 . . . . 0.0 109.51 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.538 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -108.59 176.08 1.72 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.3 Cg_endo -67.14 -25.4 43.54 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.601 2.201 . . . . 0.0 111.675 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -85.01 -31.3 23.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.253 -0.904 . . . . 0.0 108.917 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.8 mt -87.04 -37.68 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.398 -0.814 . . . . 0.0 109.128 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.484 ' C ' ' CG2' ' A' ' 10' ' ' VAL . . . 66.52 142.24 0.05 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.5 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 0.7 OUTLIER -42.27 152.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.446 -1.032 . . . . 0.0 109.833 -179.921 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 tp -123.53 118.29 27.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.426 -0.796 . . . . 0.0 109.518 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.7 m -129.24 157.28 76.58 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.188 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.67 165.86 30.63 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.691 2.261 . . . . 0.0 111.755 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -89.12 -8.74 53.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.23 -0.919 . . . . 0.0 109.421 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -76.97 107.18 9.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 0.0 109.07 179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.4 tp -71.2 121.16 17.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.811 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.508 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 31.1 mtmt -139.57 110.53 7.47 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.235 -0.915 . . . . 0.0 109.102 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.8 Cg_endo -65.54 119.48 6.51 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 C-N-CA 123.175 2.584 . . . . 0.0 112.631 -179.288 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.519 ' O ' ' CG2' ' A' ' 32' ' ' THR . 27.3 m -112.49 156.22 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 0.0 109.65 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 53' ' ' ARG . 12.3 t -98.59 111.44 23.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 109.315 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.3 138.16 36.17 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.49 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 40.1 t0 -71.26 -4.73 27.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -1.199 . . . . 0.0 109.606 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 57.6 m-20 -90.07 7.2 38.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.083 -1.01 . . . . 0.0 109.101 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.77 14.5 59.48 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 27' ' ' GLY . 77.0 mt-30 -125.69 140.23 52.88 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.414 -1.051 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 25' ' ' VAL . 17.1 m -103.59 153.21 20.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -0.902 . . . . 0.0 109.34 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.574 ' CZ ' ' HG3' ' A' ' 42' ' ' GLU . 19.9 m-85 -128.58 143.16 50.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 23' ' ' LYS . 6.1 m-20 -58.54 -75.23 0.05 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -0.888 . . . . 0.0 109.962 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.7 t-20 -82.5 147.76 56.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.069 -1.019 . . . . 0.0 109.993 -179.543 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.5 Cg_endo -64.3 -53.44 1.12 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.746 2.298 . . . . 0.0 111.485 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.5 t -60.77 -27.69 68.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 36.5 mmm -63.78 -17.46 63.09 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.54 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . 8.2 tt -68.26 -52.82 29.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.352 -0.843 . . . . 0.0 108.985 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 45.0 m -47.9 -47.41 32.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.095 -1.003 . . . . 0.0 108.392 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.445 ' HA ' HD11 ' A' ' 44' ' ' LEU . 14.7 t60 -47.97 -49.35 30.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.128 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.574 ' HG3' ' CZ ' ' A' ' 33' ' ' TYR . 71.8 mm-40 -49.41 -24.05 1.79 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 4.6 m-80 -80.02 -37.64 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.416 -0.803 . . . . 0.0 108.873 179.352 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' A' ' 41' ' ' HIS . 8.3 mp -67.5 -36.71 81.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.221 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 45' ' ' ILE . 5.3 mt -77.12 -52.53 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.077 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.472 ' O ' HG21 ' A' ' 48' ' ' THR . 47.0 mtt-85 -71.85 -20.99 61.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.373 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 43' ' ' ASN . 88.2 mt-30 62.44 35.45 14.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -0.851 . . . . 0.0 109.312 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.472 HG21 ' O ' ' A' ' 46' ' ' ARG . 30.8 p -125.48 175.11 7.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.444 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.575 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 79.8 m-20 -94.75 58.87 2.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 109.451 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.472 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 30.9 m -79.22 126.11 30.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 32.3 m80 -115.7 -172.57 2.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.172 179.672 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.452 HG22 ' HB ' ' A' ' 25' ' ' VAL . 13.0 mt -87.78 124.27 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 109.576 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.49 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 61.3 ttt180 -80.07 -53.49 6.66 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.647 0.737 . . . . 0.0 109.319 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 p -150.88 143.89 24.66 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.629 -0.67 . . . . 0.0 109.203 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.3 p -64.83 144.86 56.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.196 -0.94 . . . . 0.0 109.405 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.03 161.66 36.92 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.474 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 23.2 tttt -62.22 144.96 54.82 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.449 -1.03 . . . . 0.0 109.278 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.37 157.22 26.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.616 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.545 -179.986 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.571 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 0.5 OUTLIER -52.62 -35.04 53.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.136 -0.977 . . . . 0.0 109.289 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -51.58 -26.47 8.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.298 -0.877 . . . . 0.0 108.74 179.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.4 mmm -72.17 -23.78 61.33 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.244 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 33.5 m -80.31 -17.74 51.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.524 -0.735 . . . . 0.0 109.021 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -80.77 8.35 8.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.516 179.596 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -133.24 2.8 3.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.132 -0.98 . . . . 0.0 109.996 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.677 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -118.76 148.52 42.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.014 -1.054 . . . . 0.0 109.539 -179.977 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.7 mtm-85 -129.14 132.21 47.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.112 179.553 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.518 HG22 ' CE2' ' A' ' 8' ' ' TYR . 42.2 t -126.51 140.48 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 -179.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.533 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 3.8 mm? -117.95 170.26 6.53 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 41.7 Cg_endo -65.44 -21.43 60.56 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.192 1.928 . . . . 0.0 111.575 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -94.88 -25.29 16.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.418 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.2 mt -88.92 -50.44 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.298 -0.876 . . . . 0.0 109.944 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.404 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 82.24 -174.31 53.46 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.801 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.677 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -91.81 148.28 22.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -1.172 . . . . 0.0 109.552 -179.938 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.3 tp -120.96 100.67 7.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 109.728 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.6 m -111.04 157.73 37.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.235 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 53.6 Cg_endo -73.22 167.87 26.23 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.67 2.247 . . . . 0.0 111.681 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -87.62 -26.5 23.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 109.346 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 46.4 m-20 -57.89 124.54 19.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.163 -0.961 . . . . 0.0 109.171 179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.2 tp -88.73 116.3 26.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.613 -179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASN . 3.8 mttt -127.43 103.2 22.65 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 108.983 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.527 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.7 Cg_endo -65.63 115.85 3.61 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.937 2.425 . . . . 0.0 111.842 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.401 ' O ' HG21 ' A' ' 32' ' ' THR . 21.7 m -113.89 154.43 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 0.0 109.732 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.1 t -94.22 131.49 39.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.343 -0.848 . . . . 0.0 108.738 179.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -86.85 137.24 14.64 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.4 p30 -66.23 -12.11 54.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -1.159 . . . . 0.0 109.616 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 52.6 p30 -83.75 8.92 13.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.01 20.83 54.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 68.8 mt-30 -125.51 175.98 7.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.47 -1.017 . . . . 0.0 109.326 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 14.1 m -135.1 136.38 41.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 109.432 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.633 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 47.5 m-85 -113.87 120.43 40.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.882 . . . . 0.0 109.267 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 23' ' ' LYS . 10.4 m-20 -45.55 -78.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.985 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.3 t-20 -81.66 148.92 63.08 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.02 -1.05 . . . . 0.0 109.881 -179.583 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.79 -54.35 0.98 Allowed 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.732 2.288 . . . . 0.0 111.927 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -63.01 -25.59 68.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.026 -1.046 . . . . 0.0 108.373 179.137 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.2 mmm -66.43 -11.56 52.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.559 -0.713 . . . . 0.0 109.095 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.633 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 20.9 tp -71.38 -60.12 2.4 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.29 -0.881 . . . . 0.0 108.707 179.594 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.461 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 10.3 t -54.65 -28.35 46.53 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.966 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -67.8 -60.64 2.36 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.143 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -57.78 -18.74 23.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.217 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 47' ' ' GLN . 96.7 m-20 -77.54 -32.6 54.06 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.4 tm? -58.36 -38.99 78.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.514 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mm -75.56 -49.73 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -0.867 . . . . 0.0 108.767 179.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 47.0 mtt-85 -63.71 -28.55 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.187 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 89.5 mt-30 63.15 44.03 6.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.415 HG21 ' C ' ' A' ' 47' ' ' GLN . 30.6 p -133.51 167.05 21.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 179.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.576 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 48.7 p-10 -95.91 61.35 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.309 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.466 HG23 HD13 ' A' ' 39' ' ' LEU . 93.9 m -72.46 135.37 45.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.856 -179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 42.5 m80 -115.28 -178.1 3.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 108.939 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.517 HD11 HG22 ' A' ' 52' ' ' ILE . 15.2 mt -90.25 123.04 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 109.004 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 50.1 ttt85 -79.65 -44.52 20.77 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.393 -0.817 . . . . 0.0 109.432 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 p -158.56 158.09 33.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.549 -0.719 . . . . 0.0 109.121 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 p -75.5 136.97 40.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.897 . . . . 0.0 109.698 -179.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.47 162.73 34.11 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 48.0 tttm -49.59 159.4 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.486 -1.008 . . . . 0.0 109.216 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.477 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 73.1 m -68.39 145.35 54.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.38 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.549 179.965 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.468 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 2.8 m -52.25 -39.49 60.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.281 -0.887 . . . . 0.0 109.531 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.469 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 35.4 mt-10 -50.61 -31.18 15.24 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.447 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 45.1 ttm -66.12 -27.23 67.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.11 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 71.2 m -80.48 -9.15 59.77 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.451 -0.781 . . . . 0.0 109.138 179.657 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 22.5 mttm -81.12 11.03 4.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.092 -1.005 . . . . 0.0 109.617 179.508 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 4' ' ' MET . 49.2 p30 -127.31 8.29 6.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.994 -1.066 . . . . 0.0 110.653 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.579 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 6.9 p90 -107.59 -177.41 3.34 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.723 -1.235 . . . . 0.0 109.686 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.579 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 46.8 mtt180 -151.91 128.46 10.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.226 179.567 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.431 HG12 ' C ' ' A' ' 15' ' ' GLY . 24.5 t -127.14 145.36 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.7 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.541 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -118.53 176.33 1.72 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.365 -0.834 . . . . 0.0 109.169 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.0 Cg_endo -66.96 -21.97 49.04 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.557 2.171 . . . . 0.0 111.773 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.8 mtt-85 -96.81 -27.75 14.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 mm -84.1 -47.47 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.707 -179.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.431 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 78.32 177.6 48.48 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.477 ' CE1' ' SG ' ' A' ' 37' ' ' CYS . 0.9 OUTLIER -83.0 147.68 28.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -1.16 . . . . 0.0 109.435 -179.917 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.0 tp -118.9 105.74 11.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.755 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.9 m -116.22 155.87 47.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 108.964 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.25 165.63 32.08 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.561 2.174 . . . . 0.0 111.543 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -84.04 -31.79 25.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 109.267 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -54.18 132.8 43.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.384 -0.823 . . . . 0.0 109.052 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.3 tp -96.93 119.45 35.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.175 -0.953 . . . . 0.0 109.628 -179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.496 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 3.9 mttm -130.99 106.56 15.1 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 0.0 108.899 179.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.64 123.41 11.66 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 123.009 2.472 . . . . 0.0 112.354 -179.183 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.461 ' HB ' HG22 ' A' ' 52' ' ' ILE . 17.6 m -118.18 155.15 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.728 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.7 t -96.49 138.09 34.59 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -91.44 135.64 12.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.521 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.472 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -66.83 -11.03 53.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 109.465 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.7 p30 -89.03 10.68 20.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.437 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.45 19.25 57.24 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.1 mt-30 -120.5 178.42 4.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -1.147 . . . . 0.0 109.549 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.454 ' OG1' ' SG ' ' A' ' 58' ' ' CYS . 35.3 m -139.58 136.76 34.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.887 . . . . 0.0 109.29 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.583 ' CD2' HD11 ' A' ' 39' ' ' LEU . 26.4 m-85 -117.81 128.79 55.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.161 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 23' ' ' LYS . 11.7 m-20 -52.66 -78.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.794 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.5 t-20 -81.69 147.25 58.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.99 -1.069 . . . . 0.0 109.719 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.5 Cg_endo -63.51 -52.12 2.12 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.782 2.321 . . . . 0.0 111.739 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.4 t -62.95 -26.47 68.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.16 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.432 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 54.0 mmm -68.71 -15.15 63.43 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.149 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.583 HD11 ' CD2' ' A' ' 33' ' ' TYR . 21.2 tp -72.21 -50.85 24.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.415 -0.803 . . . . 0.0 109.339 179.784 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.477 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.5 m -66.14 -22.38 66.38 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.017 -1.052 . . . . 0.0 108.224 179.265 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -66.81 -56.17 11.62 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 95.5 mt-10 -63.43 -17.04 62.26 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 47' ' ' GLN . 86.2 m-20 -79.95 -26.37 40.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.602 -0.686 . . . . 0.0 109.186 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.456 HD13 ' CD2' ' A' ' 16' ' ' TYR . 19.2 mt -69.02 -33.29 73.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.165 -0.959 . . . . 0.0 108.649 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.4 mt -78.73 -50.36 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 108.978 179.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.443 ' NH2' ' OG1' ' A' ' 50' ' ' THR . 47.0 mtm180 -74.35 -34.25 63.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.305 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 59.62 39.24 21.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.553 179.805 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 49' ' ' ASN . 38.1 p -103.97 16.68 25.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 48' ' ' THR . 53.2 m-20 44.22 52.13 7.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.408 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.476 HG21 ' N ' ' A' ' 51' ' ' HIS . 76.6 m -74.9 146.26 42.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.614 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.476 ' N ' HG21 ' A' ' 50' ' ' THR . 31.6 m-70 -123.72 168.76 12.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.282 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.484 HD11 HG22 ' A' ' 52' ' ' ILE . 16.9 mt -79.73 124.35 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.447 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 78.3 ttt180 -79.76 -44.14 21.24 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 p -160.19 148.82 17.04 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 p -64.86 145.12 56.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.166 -0.959 . . . . 0.0 109.536 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.94 164.23 39.79 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HA ' HG22 ' A' ' 32' ' ' THR . 17.4 tttt -60.44 151.45 28.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.461 -1.023 . . . . 0.0 109.361 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 72.2 m -58.47 152.39 18.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.469 179.89 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.423 ' OD1' HD13 ' A' ' 52' ' ' ILE . 58.0 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.476 ' O ' ' N ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -47.9 -37.88 15.14 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.185 179.739 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 6' ' ' LYS . 11.0 mt-10 -49.88 -26.42 4.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 ttm -70.41 -27.58 64.4 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.547 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 5.7 m -79.77 -12.35 59.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.447 -0.783 . . . . 0.0 109.05 179.496 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 3' ' ' GLU . 28.3 mttm -55.21 -26.78 41.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.933 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -151.56 65.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.692 -179.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.557 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 4.1 p90 -128.79 170.7 13.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.508 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.427 ' C ' HG21 ' A' ' 10' ' ' VAL . 31.8 ttt180 -144.85 154.99 43.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.293 -0.88 . . . . 0.0 109.386 179.579 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.427 HG21 ' C ' ' A' ' 9' ' ' ARG . 95.3 t -146.66 127.27 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.488 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -117.19 173.42 3.15 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.21 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.1 Cg_endo -65.94 -22.92 55.11 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.498 2.132 . . . . 0.0 111.568 179.736 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -105.92 -33.66 7.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.852 . . . . 0.0 109.066 179.565 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.6 mt -81.64 -40.95 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.118 179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 65.09 -145.13 48.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.9 t80 -105.34 158.0 16.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.31 -1.112 . . . . 0.0 109.495 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.32 114.01 21.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 62.6 m -128.1 156.19 76.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.331 179.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.13 170.28 18.55 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.616 2.211 . . . . 0.0 111.625 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -91.3 -12.48 34.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.122 -0.986 . . . . 0.0 109.644 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -73.3 115.84 13.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.283 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.43 HD12 ' HB3' ' A' ' 34' ' ' ASN . 31.4 tp -73.17 126.36 29.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.625 -179.878 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -139.75 100.39 7.41 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.849 . . . . 0.0 109.007 179.818 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -64.09 117.71 4.71 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.971 2.447 . . . . 0.0 112.345 -179.272 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.463 ' O ' HG22 ' A' ' 32' ' ' THR . 11.0 m -116.1 155.15 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.402 -0.811 . . . . 0.0 109.841 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.7 t -96.81 137.31 36.09 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.27 139.56 14.6 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.482 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 46.2 p30 -65.76 -9.12 25.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -1.068 . . . . 0.0 109.612 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.431 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 66.8 m-20 -89.12 14.03 11.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.12 26.33 58.06 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.459 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 79.7 mt-30 -130.5 174.86 9.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -1.166 . . . . 0.0 109.288 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 32.9 m -131.81 152.93 50.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.586 ' CD2' ' CD1' ' A' ' 39' ' ' LEU . 40.6 m-85 -132.68 119.88 20.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.246 -0.909 . . . . 0.0 109.197 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 23' ' ' LYS . 3.7 m-20 -43.6 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 109.689 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.2 t-20 -81.69 146.26 56.21 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.299 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.518 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.94 -50.95 2.57 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.593 2.195 . . . . 0.0 111.483 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.8 t -61.96 -25.35 67.56 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.828 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.456 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 13.9 mtp -68.14 -17.95 64.49 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.368 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.586 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 8.3 tt -67.74 -50.61 56.35 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.426 -0.796 . . . . 0.0 108.858 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 4.7 t -52.54 -45.69 66.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 0.0 108.521 179.194 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -48.99 -48.94 43.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.16 -0.962 . . . . 0.0 108.481 179.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 23.0 mm-40 -57.18 -20.22 25.28 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.528 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.8 m-80 -79.69 -33.13 41.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 108.612 179.2 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.515 ' CD1' ' OH ' ' A' ' 8' ' ' TYR . 3.9 mm? -67.11 -46.71 73.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 109.388 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.476 HD12 ' N ' ' A' ' 45' ' ' ILE . 5.0 mm -66.47 -52.21 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.458 ' O ' HG21 ' A' ' 48' ' ' THR . 66.4 mtp85 -71.02 -19.24 62.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.204 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 60.81 34.45 19.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.458 HG21 ' O ' ' A' ' 46' ' ' ARG . 8.7 p -123.06 -177.55 3.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.519 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 36.5 t-20 -107.59 64.78 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.923 . . . . 0.0 109.527 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 25.0 m -78.91 127.71 32.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 109.66 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.519 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 3.8 m80 -113.84 -172.13 2.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.25 -0.906 . . . . 0.0 109.143 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 52' ' ' ILE . 22.9 mt -89.15 124.16 41.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.21 -0.932 . . . . 0.0 109.572 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.3 ttt-85 -80.8 -42.59 21.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.407 -0.808 . . . . 0.0 109.307 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -160.95 140.77 10.83 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.563 -0.71 . . . . 0.0 109.139 -179.568 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 p -57.9 140.6 51.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -0.957 . . . . 0.0 109.623 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 96.38 165.91 33.68 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.514 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 27.5 mttp -67.6 143.36 56.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.532 -0.981 . . . . 0.0 109.258 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 62.3 m -53.43 148.92 8.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.446 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.504 -179.955 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 21.0 p-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.26 0.553 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 5' ' ' CYS . 3.6 m -48.78 -33.11 9.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -0.833 . . . . 0.0 109.385 179.858 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.465 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 31.4 mt-10 -49.74 -30.5 9.54 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.692 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.4 mmm -76.23 -29.1 57.42 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.564 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.6 m -80.06 -5.0 55.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.369 -0.832 . . . . 0.0 109.301 179.608 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 23.7 mttm -61.26 -28.73 69.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 -179.546 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 80.5 m-20 -145.1 61.66 1.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.067 -1.021 . . . . 0.0 110.339 -179.635 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.637 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 6.5 p90 -127.03 171.34 11.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.064 -1.023 . . . . 0.0 109.309 179.429 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -146.14 148.9 33.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 109.567 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.443 HG22 ' CD2' ' A' ' 16' ' ' TYR . 85.8 t -138.51 132.26 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.419 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.534 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -123.66 175.65 2.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.349 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.5 Cg_endo -67.21 -25.84 42.71 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.53 2.153 . . . . 0.0 111.514 179.813 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -107.37 -27.33 10.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.388 -0.82 . . . . 0.0 108.991 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.417 HG22 HD11 ' A' ' 14' ' ' ILE . 28.9 mm -82.06 -39.77 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 109.437 -179.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.98 -145.62 43.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.637 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 3.3 t80 -111.17 155.17 23.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -1.164 . . . . 0.0 109.27 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 39.7 mt -111.64 123.79 50.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.942 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.1 m -142.0 155.36 65.58 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.457 -0.777 . . . . 0.0 108.954 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.36 164.57 34.66 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.51 2.14 . . . . 0.0 111.554 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -83.46 -26.48 30.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.875 . . . . 0.0 109.544 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.51 129.31 40.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 109.299 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 52.7 tp -88.8 123.17 32.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 0.0 109.472 -179.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.504 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.2 mmtm -133.91 102.74 12.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.432 -0.793 . . . . 0.0 109.179 179.815 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.1 Cg_endo -64.05 122.04 9.91 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 123.032 2.488 . . . . 0.0 112.331 -179.222 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.45 HG22 HD11 ' A' ' 39' ' ' LEU . 16.8 m -122.22 155.41 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.753 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 34.7 t -99.15 137.51 37.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.403 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.16 138.74 14.13 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.212 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 56.6 p30 -63.59 -11.14 22.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -1.064 . . . . 0.0 109.671 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 86.4 m-20 -85.76 12.93 7.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.345 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.39 20.22 69.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.0 mt-30 -124.52 159.52 30.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -1.121 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 57.3 m -119.97 142.66 48.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -0.963 . . . . 0.0 109.569 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.561 ' CD2' HD13 ' A' ' 39' ' ' LEU . 57.7 m-85 -121.36 130.88 53.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.386 -0.821 . . . . 0.0 109.16 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.1 m-20 -53.8 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.16 -0.962 . . . . 0.0 109.54 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 11.4 t-20 -82.26 147.07 56.0 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 120.99 -1.069 . . . . 0.0 109.699 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.0 Cg_endo -63.1 -51.24 2.94 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.569 2.179 . . . . 0.0 111.409 179.371 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.502 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -60.25 -29.75 68.98 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.804 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.464 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 38.3 mmm -64.4 -23.52 67.32 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.35 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.561 HD13 ' CD2' ' A' ' 33' ' ' TYR . 7.2 tt -63.4 -48.01 79.6 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.362 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.497 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 12.0 t -52.63 -34.01 49.32 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -54.43 -50.04 68.59 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 108.763 179.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.5 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 26.2 tp10 -56.78 -19.9 19.52 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.363 -0.836 . . . . 0.0 108.774 179.338 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 4.7 m-80 -80.06 -31.65 39.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.858 . . . . 0.0 109.125 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.482 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.4 tm? -68.89 -42.39 77.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.084 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.0 mt -71.17 -55.22 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 109.175 179.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 35.6 mtt-85 -70.33 -21.73 62.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.394 -0.816 . . . . 0.0 109.258 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 62.3 32.33 17.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.343 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.417 HG22 ' HB3' ' A' ' 46' ' ' ARG . 17.9 p -119.52 176.78 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 109.353 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.532 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 84.6 m-20 -100.13 61.37 1.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.481 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 56.0 m -71.79 131.7 43.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.882 . . . . 0.0 109.522 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 14.7 m-70 -116.58 -175.88 2.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.277 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.446 HD11 HG22 ' A' ' 52' ' ' ILE . 20.6 mt -86.19 124.26 40.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.199 -0.938 . . . . 0.0 109.542 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 70.1 ttt180 -80.53 -39.71 27.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.421 -0.799 . . . . 0.0 109.051 179.694 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -158.57 153.56 25.18 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.2 p -73.39 145.57 45.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.179 -0.951 . . . . 0.0 109.495 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.92 164.71 40.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.523 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 37.5 mttp -63.09 144.88 56.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.478 -1.013 . . . . 0.0 109.406 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.53 156.08 29.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.57 179.998 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' A' ' 3' ' ' GLU . 24.4 p30 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -47.8 -29.92 3.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.617 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.45 ' HB2' ' OD1' ' A' ' 1' ' ' ASP . 1.2 mt-10 -54.73 -21.81 12.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 109.008 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 1' ' ' ASP . 51.1 mmm -77.56 -26.85 51.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.37 -0.831 . . . . 0.0 108.957 179.535 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 38.2 m -81.19 -19.58 43.03 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.387 -0.821 . . . . 0.0 109.331 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -80.68 9.26 6.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -133.17 2.69 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.973 . . . . 0.0 109.958 -179.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.584 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -119.45 144.89 46.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.02 -1.05 . . . . 0.0 109.74 -179.916 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.0 mtt85 -127.5 129.83 48.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 108.894 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.464 ' O ' HD23 ' A' ' 11' ' ' LEU . 42.9 t -116.76 141.49 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.035 -1.041 . . . . 0.0 110.201 -179.289 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.547 ' CD1' ' HD2' ' A' ' 12' ' ' PRO . 4.0 mm? -124.43 171.09 7.69 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.547 ' HD2' ' CD1' ' A' ' 11' ' ' LEU . 42.7 Cg_endo -66.28 -22.25 53.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.305 2.003 . . . . 0.0 111.666 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -97.0 -29.51 13.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 109.206 179.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.6 mt -83.06 -48.57 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.402 179.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.407 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 86.7 -175.0 46.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.471 ' OH ' ' HB3' ' A' ' 40' ' ' CYS . 1.5 t80 -81.15 153.05 27.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -1.143 . . . . 0.0 109.544 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.447 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 38.6 mt -127.86 134.08 49.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 72.4 m -146.92 158.4 45.35 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.347 -0.845 . . . . 0.0 109.141 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.9 Cg_endo -69.52 167.5 23.94 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.636 2.224 . . . . 0.0 111.459 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -85.62 -21.72 28.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.188 -0.945 . . . . 0.0 109.693 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -68.01 115.98 8.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.307 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 32.9 tp -86.95 121.38 29.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.174 -0.954 . . . . 0.0 109.536 179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASN . 13.0 mmtm -135.83 113.26 10.75 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.403 -0.81 . . . . 0.0 108.908 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.531 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -64.78 116.06 3.59 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.953 2.436 . . . . 0.0 112.13 -179.351 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.465 ' O ' HG22 ' A' ' 32' ' ' THR . 34.2 m -113.53 156.13 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.956 -179.822 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.5 t -100.49 124.02 45.47 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -80.85 137.54 18.13 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.621 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 46.8 p30 -63.9 -10.58 21.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -1.127 . . . . 0.0 109.727 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.412 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 28.5 m-20 -87.29 16.76 4.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.52 19.59 75.95 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.8 mt-30 -120.83 169.0 10.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -1.1 . . . . 0.0 109.392 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.518 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 88.6 m -129.86 142.71 50.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.403 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.576 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 41.8 m-85 -122.43 118.0 27.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.329 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.491 ' O ' ' O ' ' A' ' 23' ' ' LYS . 7.1 m-20 -43.09 -75.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.855 . . . . 0.0 109.536 -179.656 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.1 t-20 -81.79 150.28 65.54 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.81 -54.5 1.17 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.684 2.256 . . . . 0.0 111.906 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.0 t -58.42 -30.5 66.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.947 -1.095 . . . . 0.0 108.149 179.051 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 7.5 mtt -59.71 -21.09 60.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.572 HD13 ' CD2' ' A' ' 33' ' ' TYR . 7.3 tt -66.89 -53.63 30.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 16.9 t -49.48 -28.56 5.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 21.5 t60 -57.89 -53.58 56.64 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.282 -0.886 . . . . 0.0 108.617 179.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.576 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 16.3 tp10 -54.03 -20.48 6.43 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.8 m-80 -80.46 -33.44 36.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 108.773 179.541 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.26 -39.35 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.83 . . . . 0.0 109.346 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.31 -46.56 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.66 -179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 42' ' ' GLU . 27.0 mmt180 -80.3 -33.83 37.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.542 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 89.5 mt-30 58.97 32.05 21.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.504 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 81.2 p -104.63 6.23 34.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.151 -0.968 . . . . 0.0 109.637 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.567 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 73.3 m-20 63.11 52.86 2.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.637 179.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.523 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 91.6 m -78.7 142.35 37.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 109.357 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 35.7 m80 -120.33 -171.7 2.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.535 179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.2 mt -92.05 123.35 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 179.848 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.467 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.4 ttt180 -79.31 -50.73 10.44 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.327 -0.858 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -158.93 139.31 12.35 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 109.348 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 p -53.54 145.86 14.11 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.35 162.91 35.5 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.518 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 53.8 mttp -66.93 150.04 49.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.458 -1.025 . . . . 0.0 109.528 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 72.7 m -59.27 147.17 36.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.91 . . . . 0.0 109.395 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.534 -179.932 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.287 0.565 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.501 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 3.6 m -60.11 -33.4 72.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 0.0 109.431 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -54.75 -25.93 30.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 109.119 179.872 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.6 ttt -73.57 -26.14 60.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.421 -0.799 . . . . 0.0 109.034 179.547 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 30.7 m -82.76 -15.46 51.71 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.3 -0.875 . . . . 0.0 109.451 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 23.5 mttm -80.65 7.51 9.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.729 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 98.3 m-20 -138.23 16.02 2.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.028 -1.045 . . . . 0.0 110.29 -179.401 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.1 p90 -126.58 153.0 45.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.925 -1.11 . . . . 0.0 109.697 179.857 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -131.53 143.84 50.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.309 -0.869 . . . . 0.0 108.834 179.171 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.525 HG22 ' CE2' ' A' ' 8' ' ' TYR . 55.7 t -132.65 134.96 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 -179.766 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.531 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -115.11 174.65 2.25 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.226 179.89 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.4 Cg_endo -67.15 -22.63 46.81 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.59 2.194 . . . . 0.0 111.68 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -101.7 -22.0 14.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 179.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.8 mt -88.96 -45.42 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.671 -179.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.424 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 77.27 -165.65 53.26 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.7 t80 -96.02 150.01 20.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -1.2 . . . . 0.0 109.499 179.935 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.5 tp -116.97 118.33 32.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.3 m -130.34 157.03 78.53 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.9 Cg_endo -70.91 166.31 29.44 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.612 2.208 . . . . 0.0 111.655 -179.721 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -86.42 -20.9 27.51 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.308 -0.87 . . . . 0.0 109.352 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -65.4 125.95 26.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.95 . . . . 0.0 109.11 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.1 tp -90.77 119.22 30.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.683 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -132.82 106.84 12.73 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.031 179.689 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -65.09 120.55 7.8 Favored 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 122.88 2.387 . . . . 0.0 112.108 -179.556 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.461 ' O ' HG21 ' A' ' 32' ' ' THR . 30.3 m -118.14 154.45 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.644 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 31.1 t -97.11 136.14 38.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.251 -0.906 . . . . 0.0 108.769 179.235 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -87.29 139.98 16.47 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.982 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.464 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.7 t0 -70.95 -5.33 30.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.141 -1.211 . . . . 0.0 109.563 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -92.84 5.82 49.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.344 179.676 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.19 14.93 53.39 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.873 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.6 mt-30 -116.07 175.83 5.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -1.116 . . . . 0.0 109.561 179.948 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.461 HG21 ' O ' ' A' ' 25' ' ' VAL . 30.5 m -138.94 135.43 34.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.122 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.641 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 22.0 m-85 -115.6 131.08 57.04 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.307 -179.887 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 23' ' ' LYS . 7.5 m-20 -55.41 -76.95 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 -179.515 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.9 t-20 -81.94 148.54 61.04 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.014 -1.053 . . . . 0.0 109.81 -179.73 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.4 Cg_endo -62.73 -53.8 1.54 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.897 2.398 . . . . 0.0 111.916 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.9 t -62.37 -26.91 68.72 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.073 -1.017 . . . . 0.0 108.381 179.189 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 18.8 mtt -64.67 -18.1 64.67 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.343 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.641 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 26.8 tp -66.82 -54.96 17.24 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.451 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 14.2 t -61.21 -23.9 65.95 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.57 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -70.12 -60.94 1.98 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.19 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 84.2 tt0 -56.7 -20.98 24.59 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.434 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 47' ' ' GLN . 86.5 m-20 -78.64 -35.99 44.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.133 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 44' ' ' LEU . 42.9 tp -58.65 -33.82 70.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.55 -50.18 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.433 -0.792 . . . . 0.0 108.922 179.452 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 34.5 mtt-85 -69.06 -24.15 64.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.263 179.685 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 43' ' ' ASN . 88.8 mt-30 64.13 41.75 6.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.849 . . . . 0.0 109.478 -179.858 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.4 p -124.74 165.36 18.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 109.267 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -98.36 63.49 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.4 m -78.29 136.24 37.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 109.84 -179.866 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.501 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 51.3 m-70 -114.26 171.44 7.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.181 179.63 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.465 HG12 HD23 ' A' ' 39' ' ' LEU . 40.7 mt -80.04 126.92 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.5 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.466 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 73.4 ttt180 -79.91 -49.81 11.36 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.652 0.739 . . . . 0.0 109.314 179.806 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.7 m -156.57 145.84 20.5 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.858 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.4 p -61.99 151.3 35.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.537 -179.939 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 81.36 163.49 31.03 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.699 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.454 ' HA ' HG22 ' A' ' 32' ' ' THR . 14.6 tttt -63.81 150.58 44.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -1.068 . . . . 0.0 109.259 179.838 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.24 148.3 34.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.241 -0.912 . . . . 0.0 109.533 -179.909 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.475 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.4 m -80.25 -6.76 58.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.499 -0.751 . . . . 0.0 109.112 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -57.69 -25.65 60.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.844 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -149.82 66.87 0.99 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 110.051 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.661 ' OH ' HD13 ' A' ' 44' ' ' LEU . 6.2 p90 -127.27 171.03 11.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 109.153 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -145.39 155.64 43.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.739 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.792 HG13 ' C ' ' A' ' 15' ' ' GLY . 92.7 t -148.57 122.75 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 109.291 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.557 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 mp -114.6 175.67 1.79 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.334 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.9 Cg_endo -67.64 -28.13 37.88 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.579 2.186 . . . . 0.0 111.578 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -101.48 -26.33 13.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.21 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 11' ' ' LEU . 91.6 mt -88.49 -41.19 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.365 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.792 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 66.02 -144.67 46.82 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.52 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 2.0 t80 -104.7 157.66 17.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -1.19 . . . . 0.0 109.476 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.2 tp -119.36 119.55 34.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.897 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 85.9 m -135.52 157.04 77.23 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.153 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.9 Cg_endo -70.93 167.38 26.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.468 2.112 . . . . 0.0 111.585 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.64 -13.89 36.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.431 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.32 121.27 19.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.122 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.6 tp -84.03 114.92 22.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 0.0 109.781 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mmtm -128.45 107.37 19.15 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 108.94 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.6 Cg_endo -65.96 121.06 8.31 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 123.141 2.561 . . . . 0.0 112.41 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.515 ' HB ' HG23 ' A' ' 52' ' ' ILE . 34.8 m -118.2 156.11 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.786 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.5 t -97.1 142.15 29.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 108.855 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.48 138.38 13.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.507 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.5 p30 -66.48 -15.06 63.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -1.105 . . . . 0.0 109.569 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 85.9 m-20 -84.64 8.83 15.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.68 25.81 37.38 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.446 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 82.2 mt-30 -125.65 177.21 6.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -1.094 . . . . 0.0 109.328 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.536 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 16.4 m -137.97 138.4 38.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 109.298 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.823 ' CD1' HD13 ' A' ' 39' ' ' LEU . 41.8 m-85 -118.17 121.08 39.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.316 -0.865 . . . . 0.0 109.265 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.7 m-20 -46.71 -78.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.836 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.7 t-20 -81.54 146.9 58.17 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 120.88 -1.137 . . . . 0.0 109.669 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.26 -53.08 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.839 2.359 . . . . 0.0 111.705 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -62.92 -27.58 69.48 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.988 -1.07 . . . . 0.0 108.13 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.425 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 24.6 mtp -64.52 -17.5 63.96 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.823 HD13 ' CD1' ' A' ' 33' ' ' TYR . 24.5 tp -66.43 -54.75 20.59 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 7.7 t -60.07 -27.35 66.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.52 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 36.8 t60 -63.1 -57.4 10.71 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -61.35 -21.26 63.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 47' ' ' GLN . 89.6 m-20 -79.91 -26.9 40.02 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.661 HD13 ' OH ' ' A' ' 8' ' ' TYR . 38.3 tp -65.71 -36.81 84.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.393 -0.817 . . . . 0.0 108.982 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.6 mt -80.08 -48.57 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.03 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 75.7 mtt-85 -70.77 -39.41 73.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 109.535 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.9 mt-30 64.01 40.66 7.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.83 . . . . 0.0 109.416 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 46' ' ' ARG . 44.8 p -108.93 5.41 24.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.595 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.458 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 39.8 t-20 52.73 59.25 4.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.602 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 m -79.41 141.75 36.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.895 . . . . 0.0 109.467 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.458 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 33.5 m80 -114.09 167.68 10.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.85 . . . . 0.0 108.967 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.515 HG23 ' HB ' ' A' ' 25' ' ' VAL . 35.1 mt -80.22 127.26 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.026 . . . . 0.0 109.433 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.507 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.7 ttt180 -80.03 -42.24 24.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.373 -0.829 . . . . 0.0 109.146 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 t -160.35 156.22 25.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.6 p -70.91 144.3 50.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 109.475 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.27 166.85 40.68 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 54.1 mttp -67.02 149.68 50.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -1.075 . . . . 0.0 109.404 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 56.7 m -59.46 152.69 21.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.526 -179.883 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 8' ' ' TYR . 31.6 m -81.18 -19.67 42.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -0.847 . . . . 0.0 109.136 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 5' ' ' CYS . 23.5 mttm -45.21 -28.81 0.84 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 109.024 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 55.4 p30 -111.13 31.21 6.23 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 5' ' ' CYS . 2.1 t80 -80.0 144.07 33.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.57 -0.706 . . . . 0.0 109.675 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -142.78 115.24 8.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.352 -0.842 . . . . 0.0 109.299 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.793 HG21 ' N ' ' A' ' 16' ' ' TYR . 9.3 p -129.82 145.78 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.601 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.551 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -103.63 174.47 2.76 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.6 Cg_endo -67.89 -25.1 39.24 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.622 2.215 . . . . 0.0 111.803 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -91.88 -29.72 16.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 0.0 109.255 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.6 mt -81.47 -39.57 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.575 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.694 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 64.41 140.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.793 ' N ' HG21 ' A' ' 10' ' ' VAL . 1.2 t80 -43.85 153.58 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -1.195 . . . . 0.0 109.456 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 32.5 tp -119.26 126.19 50.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.844 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 66.3 m -139.37 156.63 71.64 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.989 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.68 166.34 30.18 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.562 2.175 . . . . 0.0 111.66 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -86.79 -19.89 28.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -66.08 122.58 17.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.274 -0.891 . . . . 0.0 109.502 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.5 tp -82.51 126.5 32.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.55 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -139.86 100.44 7.32 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.32 118.6 5.55 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.904 2.403 . . . . 0.0 112.27 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.411 ' HB ' HG23 ' A' ' 52' ' ' ILE . 13.7 m -116.51 155.53 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.664 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 47.2 t -95.57 133.86 39.1 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 108.804 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.88 136.47 13.65 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.5 p30 -66.99 -8.31 28.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -1.152 . . . . 0.0 109.643 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -88.02 10.47 18.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.352 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.01 21.87 54.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 72.8 mt-30 -126.33 175.52 7.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -1.081 . . . . 0.0 109.578 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.621 HG21 ' HG3' ' A' ' 57' ' ' LYS . 21.1 m -135.2 138.9 44.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.393 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.907 ' CD1' HD13 ' A' ' 39' ' ' LEU . 61.1 m-85 -118.06 125.42 50.28 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.279 -0.888 . . . . 0.0 109.299 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.0 m-20 -49.79 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.646 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.1 t-20 -82.06 146.06 54.41 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.015 -1.053 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.89 -51.64 2.82 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.774 2.316 . . . . 0.0 111.538 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.5 t -60.9 -29.96 69.89 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.442 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 16.4 mtp -65.2 -13.45 58.26 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.907 HD13 ' CD1' ' A' ' 33' ' ' TYR . 43.5 tp -68.87 -52.09 33.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 109.095 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.463 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.8 m -66.68 -22.2 66.08 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -67.27 -55.55 13.48 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.1 mm-40 -61.99 -20.01 63.42 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' GLN . 8.6 m120 -80.43 -36.82 33.14 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.0 tp -54.79 -34.64 62.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.1 mm -80.13 -50.95 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.457 -0.777 . . . . 0.0 108.966 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 7.2 mtp85 -64.36 -24.89 67.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.251 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.4 mt-30 62.96 41.62 8.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.836 . . . . 0.0 109.477 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 p -128.32 167.93 16.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.435 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 48.1 p-10 -98.28 62.27 1.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.536 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.6 m -76.5 129.19 36.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.431 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.435 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 59.3 m80 -111.22 172.52 6.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.37 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.514 HG12 HD22 ' A' ' 39' ' ' LEU . 27.5 mt -79.72 124.55 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.234 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 58.7 ttt85 -79.99 -44.38 20.33 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.397 -0.814 . . . . 0.0 109.362 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 p -157.08 158.62 36.77 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.465 -0.772 . . . . 0.0 109.114 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -76.88 133.0 39.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.533 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 100.47 163.48 28.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.621 ' HG3' HG21 ' A' ' 32' ' ' THR . 14.2 tttp -53.34 154.41 3.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.496 -1.002 . . . . 0.0 109.457 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 89.5 m -64.88 147.39 53.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.385 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.429 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 67.8 mtm . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.566 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 2.8 m -80.64 -9.47 59.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.497 -0.752 . . . . 0.0 109.173 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -80.53 8.77 7.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 109.662 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 4' ' ' MET . 43.7 p30 -120.1 -0.31 10.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.08 -1.013 . . . . 0.0 110.065 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.78 ' HE1' HG23 ' A' ' 10' ' ' VAL . 4.2 p90 -103.37 -179.61 4.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.974 -1.078 . . . . 0.0 109.632 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.606 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 56.2 mtt180 -162.39 140.93 8.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.522 -0.736 . . . . 0.0 109.201 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.78 HG23 ' HE1' ' A' ' 8' ' ' TYR . 61.4 t -117.69 140.17 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 109.747 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.766 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -128.09 175.65 3.29 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.401 -0.812 . . . . 0.0 109.143 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.766 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.9 Cg_endo -67.31 -22.4 46.18 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.557 2.172 . . . . 0.0 111.674 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -121.47 -12.15 8.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.425 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 11' ' ' LEU . 31.4 mm -86.91 -50.68 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.563 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 83.89 -169.43 46.48 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.567 ' HA ' HG22 ' A' ' 10' ' ' VAL . 1.5 t80 -83.16 148.89 27.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.171 -1.193 . . . . 0.0 109.544 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.443 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 20.8 tp -119.57 130.05 54.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.742 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 73.2 m -145.19 157.53 53.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.0 109.023 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.5 Cg_endo -70.38 166.42 28.43 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.541 2.161 . . . . 0.0 111.554 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -84.2 -31.75 24.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.215 -0.928 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -54.87 134.42 48.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.346 -0.846 . . . . 0.0 109.054 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.935 HD11 ' OD1' ' A' ' 34' ' ' ASN . 61.2 tp -101.74 123.45 45.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.932 . . . . 0.0 109.504 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 10.9 mttt -140.32 111.58 7.13 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -65.59 120.25 7.41 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 122.989 2.459 . . . . 0.0 112.024 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 32' ' ' THR . 35.0 m -117.65 153.86 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.233 -0.917 . . . . 0.0 109.772 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 35.6 t -95.48 132.59 40.41 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.23 137.89 13.94 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 43.0 p30 -67.19 -8.28 30.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -1.062 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.45 16.17 5.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.34 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.25 20.61 72.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 27' ' ' GLY . 76.2 mt-30 -131.13 153.66 49.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -1.209 . . . . 0.0 109.586 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.544 HG21 ' HA ' ' A' ' 57' ' ' LYS . 11.1 m -115.74 141.01 48.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.769 ' HD2' HD12 ' A' ' 39' ' ' LEU . 50.0 m-85 -115.26 130.85 57.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.296 -0.877 . . . . 0.0 109.327 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.935 ' OD1' HD11 ' A' ' 22' ' ' LEU . 50.8 t-20 -53.07 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.315 -0.865 . . . . 0.0 109.563 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -81.39 150.02 66.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.998 -1.064 . . . . 0.0 109.416 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -62.47 -54.08 1.51 Allowed 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.7 2.267 . . . . 0.0 112.051 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.545 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -59.84 -30.61 69.07 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.97 -1.081 . . . . 0.0 108.159 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 16.4 mtp -59.29 -25.41 64.09 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.844 HD13 HG12 ' A' ' 52' ' ' ILE . 7.6 tt -63.93 -46.37 85.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 35.0 m -55.86 -27.99 54.34 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -59.33 -49.73 76.7 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 18.0 tp10 -57.71 -19.22 25.73 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 50' ' ' THR . 4.0 m-80 -80.36 -35.13 35.89 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.38 -37.99 74.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.456 -0.777 . . . . 0.0 109.308 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.94 -51.17 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.259 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.539 ' CD ' ' HG3' ' A' ' 42' ' ' GLU . 67.9 mtp85 -73.13 -33.12 65.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 109.636 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.2 mt-30 58.15 27.45 15.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 82.4 p -105.04 5.17 32.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.18 -0.95 . . . . 0.0 109.544 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.719 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 33.4 m120 64.53 52.37 1.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.873 . . . . 0.0 109.675 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 67.8 m -72.3 135.94 46.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.719 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 3.8 m80 -115.34 -177.23 3.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.295 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.844 HG12 HD13 ' A' ' 39' ' ' LEU . 23.6 mt -87.09 124.25 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.904 . . . . 0.0 109.473 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 44.7 ttt-85 -80.44 -40.59 26.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.41 -0.806 . . . . 0.0 109.341 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -159.04 151.23 21.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.481 -0.762 . . . . 0.0 109.204 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.6 p -71.21 146.56 48.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.132 -0.98 . . . . 0.0 109.382 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.19 166.69 42.61 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.544 ' HA ' HG21 ' A' ' 32' ' ' THR . 62.4 tttt -65.25 146.32 55.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -1.101 . . . . 0.0 109.252 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.1 150.71 30.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.699 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.45 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 m -79.64 -17.03 54.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 109.133 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -47.74 -23.73 0.78 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.254 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -116.66 41.85 2.59 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 17' ' ' LEU . 4.8 t80 -92.63 160.93 14.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.604 0.716 . . . . 0.0 110.748 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.432 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 10.1 ttp180 -146.39 135.47 22.6 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.968 HG13 ' C ' ' A' ' 15' ' ' GLY . 55.2 t -126.87 117.6 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.968 . . . . 0.0 109.669 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.557 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -100.24 175.71 2.26 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 109.506 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.4 Cg_endo -67.45 -24.01 43.16 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.741 2.294 . . . . 0.0 112.118 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -108.66 -21.63 12.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.383 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.1 -45.53 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.868 . . . . 0.0 109.603 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.968 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 65.98 -148.3 50.86 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.519 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 1.2 t80 -99.48 154.55 18.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -1.213 . . . . 0.0 109.372 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.481 ' HB3' ' OH ' ' A' ' 8' ' ' TYR . 18.3 tp -125.76 125.8 43.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.943 . . . . 0.0 109.717 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 86.0 m -138.44 156.88 73.19 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.324 -0.86 . . . . 0.0 109.244 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -69.96 166.01 29.29 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.629 2.219 . . . . 0.0 111.666 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -85.0 -20.43 30.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.306 -0.872 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -65.08 123.07 18.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.335 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.755 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -87.74 121.78 30.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.526 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.548 ' N ' HD13 ' A' ' 22' ' ' LEU . 22.1 mtpt -141.08 114.88 7.04 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 0.0 109.616 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 45.7 Cg_endo -67.31 120.68 7.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.839 2.36 . . . . 0.0 111.627 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.47 ' HB ' HG23 ' A' ' 52' ' ' ILE . 34.1 m -119.44 153.81 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.303 -0.873 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.0 t -97.91 144.83 27.06 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.61 139.92 14.69 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -67.48 -7.37 25.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -1.158 . . . . 0.0 109.578 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 27.5 m-20 -91.04 8.58 34.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.51 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.07 29.43 28.34 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -133.12 165.81 23.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -1.155 . . . . 0.0 109.45 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.488 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 32.4 m -125.25 147.57 49.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.427 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.847 ' CD2' HD12 ' A' ' 39' ' ' LEU . 76.5 m-85 -127.28 119.49 26.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.221 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.555 ' CG ' HD21 ' A' ' 22' ' ' LEU . 50.4 t30 -41.74 -77.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.782 . . . . 0.0 109.673 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -81.28 148.73 64.04 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.985 -1.072 . . . . 0.0 108.863 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 39.3 Cg_endo -62.62 -51.91 2.83 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.506 2.137 . . . . 0.0 112.101 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.0 t -63.52 -25.7 68.37 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.949 -1.094 . . . . 0.0 108.47 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 15.8 mtt -64.72 -18.4 64.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.292 -0.88 . . . . 0.0 108.848 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.847 HD12 ' CD2' ' A' ' 33' ' ' TYR . 4.7 tt -70.13 -53.9 15.31 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.375 -0.828 . . . . 0.0 108.87 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.615 ' N ' HD23 ' A' ' 39' ' ' LEU . 63.8 m -50.9 -24.31 3.5 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -60.04 -49.84 76.06 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.322 -0.861 . . . . 0.0 108.685 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.594 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 12.2 tp10 -55.93 -19.74 13.35 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 50' ' ' THR . 4.0 m-80 -80.07 -32.52 39.32 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.583 HD22 HG21 ' A' ' 10' ' ' VAL . 34.3 tp -66.45 -42.19 87.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.833 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.97 -45.24 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.306 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.447 ' HB3' HG23 ' A' ' 48' ' ' THR . 46.9 mtp85 -77.33 -17.3 58.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.178 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 57.68 28.8 16.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.667 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 46' ' ' ARG . 8.4 p -110.2 -173.11 2.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.235 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -112.03 51.81 0.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.525 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 51.6 m -71.68 122.28 20.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -109.3 -175.69 2.83 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.324 -0.86 . . . . 0.0 108.999 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.518 HG12 HD13 ' A' ' 39' ' ' LEU . 21.2 mt -80.08 125.82 39.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 109.398 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 26.9 ttt85 -79.87 -45.68 18.21 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.331 -0.856 . . . . 0.0 109.584 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 p -160.42 131.69 5.74 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.57 -0.706 . . . . 0.0 109.465 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.479 ' H ' HG23 ' A' ' 55' ' ' THR . 7.3 p -48.25 142.83 5.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.439 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 93.65 166.71 37.71 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.488 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 68.2 mttt -67.36 148.69 51.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.451 -1.029 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.5 m -57.03 146.39 27.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.449 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.491 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.3 mtm . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.3 m -79.83 -0.52 34.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.772 . . . . 0.0 109.046 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -60.61 -28.86 68.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 109.377 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -149.14 67.09 1.03 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.877 . . . . 0.0 109.681 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 11.4 p90 -118.27 -170.71 1.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 109.414 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -153.91 145.58 23.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.893 . . . . 0.0 109.628 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 15' ' ' GLY . 42.5 t -139.73 135.53 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.409 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.753 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -115.03 174.79 2.16 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.668 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.753 ' HD2' HD23 ' A' ' 11' ' ' LEU . 46.7 Cg_endo -68.1 -22.76 40.7 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.787 2.325 . . . . 0.0 111.678 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -97.35 -29.45 13.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.239 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.11 -44.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.652 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.538 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 65.86 -164.2 39.64 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -100.59 151.37 21.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -1.217 . . . . 0.0 109.569 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.5 tp -116.38 110.47 18.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.337 -0.852 . . . . 0.0 109.828 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 63.4 m -126.62 156.35 73.43 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.245 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 51.5 Cg_endo -72.13 171.39 16.88 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.645 2.23 . . . . 0.0 111.619 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 tttm -88.6 -29.86 19.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.473 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -57.14 133.57 55.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.385 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' A' ' 34' ' ' ASN . 47.7 tp -92.88 115.42 28.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -125.07 104.4 29.57 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.475 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.4 118.65 5.65 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 C-N-CA 122.911 2.407 . . . . 0.0 111.997 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 32' ' ' THR . 14.8 m -117.03 155.68 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 109.737 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.5 t -97.02 123.33 40.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.827 . . . . 0.0 109.006 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -77.57 136.08 17.69 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.603 ' OD1' HG23 ' A' ' 50' ' ' THR . 54.4 p30 -67.39 -8.6 34.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -1.12 . . . . 0.0 109.562 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.4 p30 -87.05 11.96 12.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 17.76 62.3 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.0 mt-30 -123.51 176.92 5.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -1.098 . . . . 0.0 109.53 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.582 HG21 ' HG3' ' A' ' 57' ' ' LYS . 41.1 m -135.91 141.82 44.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.063 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.795 ' CD1' HD13 ' A' ' 39' ' ' LEU . 42.0 m-85 -121.13 128.2 52.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -0.922 . . . . 0.0 109.505 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.7 m-20 -48.66 -79.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.813 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.8 t-20 -81.67 147.13 58.29 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.006 -1.059 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.51 -52.49 1.89 Allowed 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.877 2.385 . . . . 0.0 111.936 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.8 t -64.16 -25.08 67.92 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.941 -1.099 . . . . 0.0 108.208 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 44.3 mmm -68.93 -14.72 63.21 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.795 HD13 ' CD1' ' A' ' 33' ' ' TYR . 20.6 tp -65.69 -51.0 62.86 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.486 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.0 m -68.72 -18.16 64.19 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.444 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 25.7 t60 -69.88 -55.29 10.12 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.517 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 88.7 tt0 -64.26 -18.64 64.75 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 47' ' ' GLN . 9.4 m120 -79.74 -36.11 37.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.9 -32.94 66.43 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mt -80.35 -46.14 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.6 ' HG2' HG23 ' A' ' 48' ' ' THR . 69.7 ttt180 -70.53 -21.6 62.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.118 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . 81.4 mt-30 63.54 43.36 5.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.506 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.6 HG23 ' HG2' ' A' ' 46' ' ' ARG . 75.4 p -126.72 167.68 15.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -103.16 56.52 0.75 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.487 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.603 HG23 ' OD1' ' A' ' 28' ' ' ASP . 85.6 m -77.63 138.77 39.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 109.321 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -118.91 176.46 5.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.26 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.471 HG12 HD22 ' A' ' 39' ' ' LEU . 34.4 mt -80.12 124.72 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 29.2 tpt180 -81.28 -53.27 6.49 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.599 -0.688 . . . . 0.0 109.427 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 p -146.05 146.1 30.82 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.595 -0.69 . . . . 0.0 109.447 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.8 p -66.4 147.85 52.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.396 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.71 162.61 37.53 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HG3' HG21 ' A' ' 32' ' ' THR . 41.0 tttt -63.92 148.85 48.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.474 -1.015 . . . . 0.0 109.341 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.3 148.68 30.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.451 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 65.1 mmm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.496 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 13.4 m -84.21 -27.97 27.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.3 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -75.63 -2.48 29.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.632 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 4' ' ' MET . 15.7 p30 -122.94 1.1 9.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.849 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.576 ' OH ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -119.13 154.56 33.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.091 -1.006 . . . . 0.0 109.321 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -133.43 127.46 33.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.259 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.554 HG21 ' C ' ' A' ' 15' ' ' GLY . 4.6 p -124.08 142.73 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 109.588 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.518 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.8 mp -105.62 174.06 2.87 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.158 -0.964 . . . . 0.0 109.211 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.4 Cg_endo -67.79 -28.86 36.19 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.606 2.204 . . . . 0.0 111.88 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -87.4 -28.33 22.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.365 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.2 mt -84.0 -39.39 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 109.401 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.554 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 67.41 155.77 0.55 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CE2' ' OH ' ' A' ' 8' ' ' TYR . 1.3 t80 -52.63 148.39 7.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.281 -1.129 . . . . 0.0 109.604 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.3 tp -115.82 112.49 22.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.457 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 60.5 m -123.7 155.82 65.81 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.303 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.75 165.18 33.33 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.648 2.232 . . . . 0.0 111.794 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -87.31 -10.41 52.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.478 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.66 133.73 44.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.348 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.731 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.1 tm? -89.73 118.94 29.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.644 ' N ' HD13 ' A' ' 22' ' ' LEU . 5.9 mttp -134.38 100.67 12.53 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.319 -0.863 . . . . 0.0 109.103 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.0 Cg_endo -63.33 123.11 11.57 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 123.121 2.547 . . . . 0.0 112.411 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 33' ' ' TYR . 32.4 m -120.62 154.79 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.446 -0.784 . . . . 0.0 109.641 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -98.35 137.5 36.98 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.02 138.16 13.91 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.1 p30 -64.96 -11.31 37.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.366 -1.079 . . . . 0.0 109.535 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.5 p30 -87.43 11.5 14.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.28 21.19 61.03 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.422 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 89.4 mt-30 -122.16 170.37 9.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.509 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.454 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 86.9 m -129.31 135.49 48.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.305 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.766 ' CD1' HD13 ' A' ' 39' ' ' LEU . 64.2 m-85 -115.12 121.22 42.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.286 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.563 ' HB2' HD21 ' A' ' 22' ' ' LEU . 0.6 OUTLIER -44.61 -82.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.835 . . . . 0.0 109.802 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.9 t-20 -80.07 147.13 64.76 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.157 -0.964 . . . . 0.0 109.565 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.6 Cg_endo -62.7 -52.1 2.63 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.659 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.557 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 10.7 t -62.69 -26.71 68.8 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 40.2 mmm -65.32 -16.51 63.65 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.766 HD13 ' CD1' ' A' ' 33' ' ' TYR . 25.6 tp -67.11 -55.57 13.69 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 16' ' ' TYR . 16.1 t -57.72 -23.16 50.39 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -72.92 -59.84 2.51 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.476 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 81.7 mt-10 -58.42 -18.5 28.81 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.5 m-20 -76.72 -39.09 53.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.496 -0.752 . . . . 0.0 108.98 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.936 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.3 tm? -55.67 -37.09 67.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.281 -0.887 . . . . 0.0 108.844 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.4 mt -75.36 -46.17 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 0.0 108.939 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.492 ' HG2' HG23 ' A' ' 48' ' ' THR . 43.9 ttt85 -68.26 -27.84 66.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.0 109.191 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 90.2 mt-30 63.25 42.27 7.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 109.668 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.492 HG23 ' HG2' ' A' ' 46' ' ' ARG . 72.5 p -131.25 175.76 8.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.227 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.575 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 78.9 m-20 -101.57 64.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.215 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.8 m -76.66 132.21 39.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 109.953 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 42.9 m80 -116.03 171.28 7.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -0.869 . . . . 0.0 108.681 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.431 HG12 HD22 ' A' ' 39' ' ' LEU . 11.4 mt -79.71 123.91 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.073 -1.017 . . . . 0.0 109.186 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 54.7 ttt85 -79.71 -42.09 25.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.292 -0.88 . . . . 0.0 109.317 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 t -160.3 155.07 24.18 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.6 p -70.84 143.89 50.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.094 -1.004 . . . . 0.0 109.171 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.69 168.29 40.94 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.486 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 31.6 mttm -66.47 151.69 46.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -1.1 . . . . 0.0 109.428 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.414 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 71.8 m -60.89 152.58 27.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.346 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.499 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 mtt . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.5 m -86.98 -8.66 56.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.391 -0.818 . . . . 0.0 109.517 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -60.02 -23.43 63.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 109.783 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -150.69 63.51 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.062 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.918 ' OH ' HD23 ' A' ' 44' ' ' LEU . 4.2 p90 -129.16 167.12 18.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 109.203 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -143.97 145.07 31.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 109.616 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.862 HG13 ' C ' ' A' ' 15' ' ' GLY . 92.0 t -137.61 131.87 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 109.659 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.544 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -122.49 175.1 2.81 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.36 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.0 Cg_endo -67.67 -26.28 39.49 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.648 2.232 . . . . 0.0 111.772 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -100.3 -27.52 13.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.293 -0.879 . . . . 0.0 109.203 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.8 mm -91.02 -43.2 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.42 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.862 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 68.33 -146.41 45.8 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.489 ' CD2' HG21 ' A' ' 10' ' ' VAL . 2.2 t80 -104.58 157.43 17.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -1.134 . . . . 0.0 109.482 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.1 tp -115.58 115.02 25.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 109.865 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 57.7 m -135.86 155.77 77.69 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 109.231 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.55 167.62 25.91 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.549 2.166 . . . . 0.0 111.587 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -84.68 -18.71 34.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -70.4 123.34 21.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.29 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.685 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -86.46 109.76 19.29 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.492 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -116.05 103.61 53.14 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.399 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.2 Cg_endo -63.68 117.2 4.19 Favored 'Trans proline' 0 C--O 1.213 -0.764 0 C-N-CA 123.082 2.521 . . . . 0.0 112.414 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.459 ' HB ' HG23 ' A' ' 52' ' ' ILE . 11.0 m -115.29 157.18 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.403 -0.811 . . . . 0.0 109.83 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.405 ' O ' ' N ' ' A' ' 53' ' ' ARG . 46.0 t -98.65 141.57 31.31 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.72 141.32 15.48 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.5 t0 -69.84 -9.4 54.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -1.147 . . . . 0.0 109.414 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -90.31 0.59 57.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.404 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.79 21.76 22.77 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.2 mt-30 -121.5 172.66 7.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -1.138 . . . . 0.0 109.48 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' ' 57' ' ' LYS . 99.4 m -133.48 140.09 47.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.884 ' CD1' HD13 ' A' ' 39' ' ' LEU . 40.8 m-85 -121.78 129.01 52.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.012 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.58 ' CB ' HD21 ' A' ' 22' ' ' LEU . 1.8 m-20 -52.77 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.026 -1.046 . . . . 0.0 109.67 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 15.3 t-20 -81.85 145.73 54.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.019 -1.05 . . . . 0.0 109.587 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.29 -51.15 2.87 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.643 2.228 . . . . 0.0 111.346 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.503 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.5 t -61.64 -27.99 69.06 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.444 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 36.3 mmm -67.05 -13.93 62.41 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.884 HD13 ' CD1' ' A' ' 33' ' ' TYR . 29.8 tp -68.44 -53.69 21.92 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.466 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 14.0 t -58.98 -23.29 61.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -69.21 -57.93 4.71 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -61.97 -19.35 62.7 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.491 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 99.2 m-20 -77.15 -32.09 56.03 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.933 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -61.49 -38.09 86.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 108.875 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mt -75.89 -48.51 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.299 -0.876 . . . . 0.0 109.222 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -68.7 -36.86 79.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.885 . . . . 0.0 109.354 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 59.81 38.04 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.425 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' ASN . 43.9 p -112.87 16.66 19.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.391 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.572 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 57.7 m-20 44.94 58.88 3.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.331 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.491 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 36.0 m -77.21 144.83 38.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.683 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 27.6 m80 -118.93 169.45 9.87 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.459 HG23 ' HB ' ' A' ' 25' ' ' VAL . 41.7 mt -79.14 126.55 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.109 -0.995 . . . . 0.0 109.357 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 42.1 ttt85 -79.71 -46.85 16.32 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.412 -0.805 . . . . 0.0 109.251 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 m -160.29 151.92 19.8 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 p -65.29 142.75 58.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.099 -1.001 . . . . 0.0 109.591 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.31 165.02 36.27 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 65.0 mttt -67.94 148.84 50.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -1.056 . . . . 0.0 109.408 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 58.4 m -60.04 153.44 21.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.477 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 86.9 mtp . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 4.0 m -79.75 -6.88 58.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.507 -0.745 . . . . 0.0 109.069 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 15.6 mttm -56.39 -32.29 64.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 77.2 m-20 -146.36 67.18 1.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 109.866 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 1.061 ' OH ' HD21 ' A' ' 44' ' ' LEU . 4.4 p90 -126.41 169.78 12.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 109.068 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -140.95 149.4 41.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.124 -0.985 . . . . 0.0 109.846 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 15' ' ' GLY . 77.8 t -145.06 131.39 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.832 . . . . 0.0 109.359 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mp -122.34 175.09 2.79 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.955 . . . . 0.0 109.551 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.2 Cg_endo -67.9 -22.89 41.76 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.69 2.26 . . . . 0.0 111.77 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -107.07 -31.32 8.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.147 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 14' ' ' ILE . 48.9 mm -83.3 -39.95 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.518 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.749 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 69.83 -145.52 41.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.6 t80 -107.26 156.1 19.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 109.458 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 tp -117.29 121.15 40.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 81.9 m -132.25 157.06 79.26 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.36 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.3 Cg_endo -71.17 165.7 31.59 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.681 2.254 . . . . 0.0 111.578 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -88.68 -13.52 39.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.327 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -68.67 130.66 43.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.103 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.764 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -89.2 122.5 32.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.607 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.673 ' N ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -141.69 105.59 5.86 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.337 -0.852 . . . . 0.0 109.279 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 42.6 Cg_endo -66.05 121.38 8.7 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 C-N-CA 122.951 2.434 . . . . 0.0 111.902 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.481 ' O ' HG23 ' A' ' 32' ' ' THR . 18.7 m -117.14 154.96 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 109.949 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 16.7 t -97.61 130.45 44.63 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.77 139.53 15.42 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.2 p30 -66.33 -9.84 37.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -1.118 . . . . 0.0 109.606 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 57.2 p30 -85.39 12.9 7.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.333 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.35 21.53 64.54 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.446 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 87.2 mt-30 -127.25 168.97 14.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -1.151 . . . . 0.0 109.374 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 25' ' ' VAL . 24.6 m -127.37 139.81 52.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.895 . . . . 0.0 109.513 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.872 ' CD2' HD12 ' A' ' 39' ' ' LEU . 42.9 m-85 -116.8 128.4 55.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.205 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.764 ' OD1' HD21 ' A' ' 22' ' ' LEU . 47.7 t-20 -50.96 -78.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -80.9 148.46 64.73 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 120.825 -1.172 . . . . 0.0 109.48 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HG3' ' HD2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.36 -53.7 1.34 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.645 2.23 . . . . 0.0 111.76 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -61.3 -28.45 69.21 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.987 -1.07 . . . . 0.0 108.144 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 17.0 mtp -63.14 -19.23 64.27 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.872 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.4 tt -67.11 -50.76 60.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.308 -0.87 . . . . 0.0 108.791 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 6.0 t -52.61 -47.33 67.04 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 9.5 t60 -48.51 -49.07 37.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.966 -1.084 . . . . 0.0 108.201 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.572 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 23.6 mm-40 -57.36 -19.41 22.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.1 m-80 -78.87 -32.96 46.15 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.061 HD21 ' OH ' ' A' ' 8' ' ' TYR . 82.9 mt -70.71 -37.19 73.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 109.549 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mt -77.22 -49.6 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.239 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.518 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 14.9 mtt-85 -76.96 -30.99 56.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 109.374 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 57.87 32.91 22.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.439 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.0 p -108.28 7.64 27.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.531 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 38.8 t-20 57.14 55.02 6.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.616 HG21 ' OH ' ' A' ' 33' ' ' TYR . 87.2 m -78.52 136.46 37.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.545 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.531 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 3.8 m80 -114.93 -175.92 2.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.215 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.713 HG12 HD13 ' A' ' 39' ' ' LEU . 29.9 mt -89.59 123.42 41.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.238 -0.914 . . . . 0.0 109.62 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 38.4 ttt-85 -81.39 -46.94 13.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.52 -0.738 . . . . 0.0 109.326 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -153.2 151.27 29.91 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.657 -0.652 . . . . 0.0 109.474 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -70.91 144.38 50.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.964 . . . . 0.0 109.218 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.539 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.59 165.24 40.76 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.575 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 30.3 mttm -65.86 144.03 57.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.443 -1.033 . . . . 0.0 109.464 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -77.22 153.2 34.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.245 -0.909 . . . . 0.0 109.326 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' CYS . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.391 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 60.9 mtm . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.485 ' CA ' ' HB2' ' A' ' 8' ' ' TYR . 18.5 p -104.44 -3.28 24.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.236 -0.915 . . . . 0.0 109.537 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -49.23 -24.33 1.72 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.205 -0.934 . . . . 0.0 108.749 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -119.13 28.46 8.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.547 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 3.6 t80 -80.29 157.98 26.27 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.608 0.718 . . . . 0.0 110.617 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.432 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 6.2 ttt85 -142.7 133.45 25.37 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.906 HG21 ' CD2' ' A' ' 16' ' ' TYR . 81.9 t -133.37 136.77 54.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.367 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 10' ' ' VAL . 2.9 mp -119.66 173.16 3.78 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.538 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.8 Cg_endo -68.51 -25.73 34.84 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 122.653 2.235 . . . . 0.0 111.763 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 15.2 ttt180 -104.12 -20.71 13.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.375 -0.828 . . . . 0.0 109.285 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.1 mt -93.13 -46.39 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.891 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.64 -170.72 52.46 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.906 ' CD2' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -87.27 151.44 23.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.174 . . . . 0.0 109.463 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.866 ' N ' HD12 ' A' ' 17' ' ' LEU . 1.8 mp -122.47 132.9 54.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.7 m -139.18 157.32 71.3 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.139 -0.976 . . . . 0.0 109.317 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.2 Cg_endo -70.18 168.78 21.12 Favored 'Trans proline' 0 C--O 1.216 -0.581 0 C-N-CA 122.572 2.181 . . . . 0.0 111.668 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -90.0 -12.67 37.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.482 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -73.94 119.8 18.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.159 -0.963 . . . . 0.0 109.214 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 34' ' ' ASN . 37.2 tp -81.75 112.19 18.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.774 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.539 ' CD ' ' HG3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -122.08 105.77 36.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.905 . . . . 0.0 108.741 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 45.2 Cg_endo -66.64 118.32 5.45 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.954 2.436 . . . . 0.0 112.088 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 52' ' ' ILE . 18.8 m -115.59 154.94 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.042 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.4 t -97.3 140.27 32.02 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.53 138.13 13.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.5 p30 -65.49 -12.93 57.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -1.119 . . . . 0.0 109.436 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 84.2 m-20 -86.98 12.37 11.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.216 -0.927 . . . . 0.0 109.374 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.06 32.14 36.77 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 79.6 mt-30 -131.16 173.82 10.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.391 -1.064 . . . . 0.0 109.293 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.5 m -135.12 133.55 39.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.149 -0.969 . . . . 0.0 109.488 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.94 ' CD2' HD13 ' A' ' 39' ' ' LEU . 65.6 m-85 -112.61 122.93 49.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 108.956 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.7 m-20 -48.18 -79.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 110.093 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.7 t-20 -81.98 148.04 59.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.018 -1.051 . . . . 0.0 109.895 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.539 ' HG3' ' CD ' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.6 -53.33 1.41 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.718 2.279 . . . . 0.0 111.768 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.7 t -61.42 -25.78 67.43 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 29.7 mtp -70.49 -5.87 31.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.177 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.94 HD13 ' CD2' ' A' ' 33' ' ' TYR . 24.4 tp -74.11 -61.36 1.88 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.18 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -54.52 -28.38 44.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 108.567 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 29.4 t60 -60.35 -56.88 16.09 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -64.06 -19.43 65.22 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.486 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 89.6 m-20 -79.44 -31.01 42.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.506 -0.746 . . . . 0.0 109.037 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.933 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.2 tm? -63.46 -37.81 88.73 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.385 -0.822 . . . . 0.0 108.844 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mm -77.09 -48.64 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.114 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 26.4 mtt-85 -68.14 -38.46 82.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.436 -0.79 . . . . 0.0 109.192 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 86.3 mt-30 62.2 38.74 13.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.478 -0.764 . . . . 0.0 109.449 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.4 p -113.37 15.38 19.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 0.0 109.384 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 46.29 60.41 3.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.472 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.486 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 76.8 m -79.96 143.01 34.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -118.97 170.61 8.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 108.855 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.451 HG12 HD22 ' A' ' 39' ' ' LEU . 30.9 mt -79.99 126.86 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.07 -1.019 . . . . 0.0 109.271 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 18.0 ttt-85 -81.82 -41.5 21.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.398 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -160.53 151.78 19.2 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -67.61 142.56 56.41 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.074 -1.016 . . . . 0.0 109.443 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.55 166.17 38.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.513 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 41.2 mttm -65.45 149.04 50.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -1.018 . . . . 0.0 109.467 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 59.0 m -59.3 153.84 17.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.444 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.41 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 76.8 mtp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.2 m -91.91 -18.4 23.81 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.419 -0.8 . . . . 0.0 109.165 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -78.41 -0.02 27.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.91 . . . . 0.0 109.478 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.412 ' C ' ' OD1' ' A' ' 7' ' ' ASP . 34.6 p30 -106.78 -9.44 16.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.786 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.547 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 1.1 p90 -107.61 170.49 7.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.166 -0.959 . . . . 0.0 109.47 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -133.37 161.02 35.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.202 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.721 HG21 ' C ' ' A' ' 15' ' ' GLY . 13.4 p -140.43 166.01 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.94 . . . . 0.0 109.81 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.75 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -121.75 174.49 3.16 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.846 . . . . 0.0 109.312 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.75 ' HD2' HD23 ' A' ' 11' ' ' LEU . 48.2 Cg_endo -68.19 -23.62 39.08 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.726 2.284 . . . . 0.0 111.806 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.8 tpt85 -89.0 -19.41 25.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.222 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -99.02 -34.6 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.292 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.721 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 73.66 -68.65 1.53 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.547 ' CE1' ' OH ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -155.38 159.11 39.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -1.153 . . . . 0.0 109.489 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 tp -127.74 114.42 17.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.742 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.5 m -131.56 157.63 77.63 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 108.977 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.1 Cg_endo -70.45 167.01 26.56 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.591 2.194 . . . . 0.0 111.586 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -88.38 -16.68 32.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.417 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -71.54 129.2 38.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.269 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 ' N ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -91.26 114.75 27.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 34' ' ' ASN . 2.5 mtmt -126.79 107.2 22.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.19 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.53 116.67 4.05 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 C-N-CA 122.807 2.338 . . . . 0.0 111.796 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 32' ' ' THR . 20.2 m -114.84 155.41 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.741 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 40.5 t -97.74 123.4 41.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.369 -0.832 . . . . 0.0 109.046 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -77.15 137.93 21.21 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.6 p-10 -67.88 -7.52 28.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -1.098 . . . . 0.0 109.425 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -88.71 7.69 32.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.485 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.45 12.91 62.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' GLY . 78.0 mt-30 -118.32 166.44 12.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -1.163 . . . . 0.0 109.323 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.607 HG21 ' HG3' ' A' ' 57' ' ' LYS . 36.9 m -127.3 137.27 52.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.302 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.776 ' CD1' HD13 ' A' ' 39' ' ' LEU . 34.1 m-85 -114.29 130.47 56.65 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.234 -0.916 . . . . 0.0 109.361 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.4 m-20 -53.57 -76.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.33 -0.857 . . . . 0.0 109.65 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -81.84 148.66 61.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.074 -1.016 . . . . 0.0 109.466 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.458 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.0 Cg_endo -63.65 -53.25 1.42 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.726 2.284 . . . . 0.0 111.9 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.7 t -63.58 -28.69 70.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.047 -1.033 . . . . 0.0 108.394 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.0 mmm -59.87 -23.57 63.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.776 HD13 ' CD1' ' A' ' 33' ' ' TYR . 27.9 tp -61.9 -43.83 98.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.607 -0.683 . . . . 0.0 109.288 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.511 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.2 m -71.32 -20.07 62.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.216 -0.928 . . . . 0.0 108.554 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -72.98 -53.42 11.23 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.426 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 70.0 mt-10 -64.53 -19.0 65.34 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.5 m-20 -74.69 -37.58 62.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.958 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.8 tm? -56.39 -36.16 68.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.343 -0.848 . . . . 0.0 108.735 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mt -74.43 -50.01 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.461 -0.774 . . . . 0.0 109.033 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 31.2 mtm-85 -68.59 -23.97 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.139 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' ASN . 85.6 mt-30 61.81 40.83 12.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.431 -0.793 . . . . 0.0 109.564 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.1 p -128.67 169.71 14.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.293 -0.879 . . . . 0.0 109.199 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -97.5 62.24 1.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.373 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.1 m -70.98 130.2 40.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -0.85 . . . . 0.0 109.599 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -113.82 169.43 8.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 108.979 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.456 HG23 ' HB ' ' A' ' 25' ' ' VAL . 43.4 mt -79.81 127.06 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.009 . . . . 0.0 109.339 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 47.7 ttt85 -84.71 -49.51 8.43 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.373 -0.829 . . . . 0.0 109.533 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.1 p -149.23 141.3 23.89 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.432 -0.792 . . . . 0.0 109.254 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.4 p -61.86 143.97 55.57 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.258 -0.901 . . . . 0.0 109.182 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.53 163.29 39.18 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.607 ' HG3' HG21 ' A' ' 32' ' ' THR . 53.4 tttt -50.88 152.54 2.09 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.541 -0.976 . . . . 0.0 109.601 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 31.5 m -55.65 142.12 35.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.634 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.397 179.862 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.4 mmm . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.4 m -83.93 0.59 47.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.503 -0.748 . . . . 0.0 109.191 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 10.7 mttm -61.38 -30.32 70.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.344 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 76.2 m-20 -147.84 68.02 1.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.67 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.566 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 12.6 p90 -119.78 -171.59 2.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.268 -0.895 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -153.76 139.65 18.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 109.746 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 15' ' ' GLY . 53.4 t -132.73 137.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 109.612 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.579 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -112.63 174.38 2.35 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.832 . . . . 0.0 109.275 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.579 ' HD2' HD23 ' A' ' 11' ' ' LEU . 46.9 Cg_endo -67.85 -24.44 40.19 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.655 2.237 . . . . 0.0 111.816 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -96.77 -26.94 14.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.468 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.1 mm -85.91 -48.17 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.546 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.674 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.84 -163.2 54.42 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.817 ' CE2' HD11 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -102.37 150.27 23.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -1.157 . . . . 0.0 109.315 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.3 tp -116.74 106.83 13.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.8 m -120.67 155.89 56.55 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.128 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.04 166.61 29.11 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.545 2.163 . . . . 0.0 111.625 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -89.81 -13.94 35.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.9 . . . . 0.0 109.662 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -72.31 123.88 23.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 0.0 109.278 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 34' ' ' ASN . 48.1 tp -80.29 121.17 25.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.619 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 3.2 mttp -133.71 101.45 12.95 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.324 -0.86 . . . . 0.0 109.242 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 41.0 Cg_endo -64.15 120.66 8.07 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.848 2.365 . . . . 0.0 112.122 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 32' ' ' THR . 7.9 m -119.81 157.36 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.8 t -99.49 114.76 27.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -0.824 . . . . 0.0 109.028 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -69.94 137.76 28.83 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 58.4 p30 -68.4 -8.02 36.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.344 -1.092 . . . . 0.0 109.661 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -84.86 6.81 23.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 109.341 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.91 17.86 55.45 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -126.76 160.62 30.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -1.09 . . . . 0.0 109.429 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.506 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 38.5 m -116.79 144.86 43.98 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.931 . . . . 0.0 109.207 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.777 ' CD1' HD13 ' A' ' 39' ' ' LEU . 87.4 m-85 -124.51 129.37 50.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.292 -0.88 . . . . 0.0 109.331 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.2 m-20 -50.44 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.2 t-20 -82.16 146.41 54.84 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 0.0 109.788 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.0 Cg_endo -63.53 -52.36 1.95 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.772 2.315 . . . . 0.0 111.555 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.1 t -60.97 -30.87 70.51 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.477 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 23.0 mtt -61.6 -20.68 63.61 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.777 HD13 ' CD1' ' A' ' 33' ' ' TYR . 58.6 tp -62.06 -46.81 87.49 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.973 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.3 m -70.94 -26.48 63.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.461 ' HA ' ' CD1' ' A' ' 44' ' ' LEU . 33.3 t60 -64.42 -55.04 23.64 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 73.8 mm-40 -65.1 -17.5 64.51 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.237 -0.914 . . . . 0.0 108.671 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 47' ' ' GLN . 92.1 m-20 -76.53 -30.91 57.32 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.469 -0.77 . . . . 0.0 109.278 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.973 HD12 ' O ' ' A' ' 40' ' ' CYS . 1.8 mp -59.76 -36.63 77.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.12 -0.987 . . . . 0.0 108.624 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 45' ' ' ILE . 7.0 mm -75.72 -48.67 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 15.7 mtp85 -67.28 -25.52 66.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.429 -0.794 . . . . 0.0 109.153 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.9 mt-30 63.71 41.26 7.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.54 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 p -130.63 164.07 25.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.214 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.562 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 65.6 m-20 -95.68 59.99 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 109.504 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 m -75.0 132.05 41.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 109.417 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 6.6 m80 -112.87 -172.32 2.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.138 -0.976 . . . . 0.0 109.333 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.7 mt -89.79 126.62 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.337 -0.852 . . . . 0.0 109.776 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 16.2 tpt180 -85.4 -53.98 4.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.557 -0.714 . . . . 0.0 109.365 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 p -144.76 152.61 40.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -72.96 144.45 47.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.095 -1.003 . . . . 0.0 109.385 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.92 166.19 39.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.573 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 55.1 mttp -68.07 141.5 56.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.36 -1.083 . . . . 0.0 109.306 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.23 149.8 37.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.482 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.541 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 9.7 m -79.81 -17.94 52.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.928 . . . . 0.0 109.23 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -51.13 -22.93 2.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 108.994 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -118.13 36.87 4.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 5.2 t80 -85.09 159.48 20.17 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.559 0.695 . . . . 0.0 110.663 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.443 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 7.7 ttm180 -140.71 136.6 32.76 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 1.036 HG13 ' O ' ' A' ' 15' ' ' GLY . 52.1 t -134.83 128.03 49.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.768 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.55 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -106.23 175.51 2.05 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.437 -0.79 . . . . 0.0 109.057 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.8 Cg_endo -67.21 -23.15 45.66 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.541 2.161 . . . . 0.0 111.632 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -110.83 -24.33 10.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.342 -0.849 . . . . 0.0 109.326 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 11' ' ' LEU . 81.5 mt -83.25 -38.46 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.622 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 1.036 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 61.28 -143.8 48.66 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.828 ' CE1' HD11 ' A' ' 44' ' ' LEU . 1.6 t80 -107.3 150.65 26.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.239 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.7 tp -114.7 121.59 43.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.813 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.0 m -135.52 157.04 77.23 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.029 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.2 Cg_endo -70.01 163.82 37.06 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.588 2.192 . . . . 0.0 111.683 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -87.77 -8.77 55.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.43 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -77.76 111.45 13.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.855 . . . . 0.0 109.182 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.4 tp -79.62 123.17 27.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.935 . . . . 0.0 109.66 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 34' ' ' ASN . 7.4 mtmt -140.63 109.22 6.64 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.812 . . . . 0.0 109.054 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.543 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.9 Cg_endo -63.56 123.85 12.74 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.86 2.373 . . . . 0.0 112.214 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.654 ' HB ' HG23 ' A' ' 52' ' ' ILE . 29.2 m -120.39 156.55 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.9 t -98.23 119.71 37.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 109.291 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -73.19 134.7 20.14 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 56.6 p30 -68.05 -7.55 30.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -1.148 . . . . 0.0 109.722 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -86.21 7.57 24.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.75 16.97 53.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 93.6 mt-30 -126.05 171.96 10.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 25' ' ' VAL . 89.3 m -129.37 142.75 50.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.182 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.662 ' CD2' HD12 ' A' ' 39' ' ' LEU . 20.3 m-85 -123.68 128.82 50.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.2 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.1 m-20 -51.14 -79.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.203 -0.936 . . . . 0.0 109.822 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.527 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 7.3 t-20 -81.82 147.45 58.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.917 -1.114 . . . . 0.0 109.758 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.2 Cg_endo -63.3 -52.19 2.18 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.728 2.285 . . . . 0.0 111.872 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -64.04 -27.8 69.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.033 -1.042 . . . . 0.0 108.297 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.527 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.5 mmm -62.51 -16.2 54.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.471 -0.768 . . . . 0.0 109.191 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.662 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.1 tp -68.55 -51.79 39.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.347 -0.845 . . . . 0.0 109.125 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.482 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.9 m -63.78 -18.49 64.14 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -69.16 -57.64 5.12 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -64.74 -18.61 65.19 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.2 m-20 -72.79 -31.47 64.89 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.828 HD11 ' CE1' ' A' ' 16' ' ' TYR . 36.8 mt -58.85 -38.9 79.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 108.745 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mt -74.31 -51.96 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.46 -0.775 . . . . 0.0 109.091 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.516 ' NH2' ' OH ' ' A' ' 33' ' ' TYR . 45.2 mtm180 -66.49 -25.27 66.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 0.0 109.415 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.3 mt-30 63.73 44.47 5.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.527 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 p -130.21 167.88 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.524 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.456 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 72.9 m-20 -103.37 65.21 0.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.258 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.439 ' OG1' ' NH2' ' A' ' 46' ' ' ARG . 51.9 m -73.43 136.5 44.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.76 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.456 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 70.4 m80 -117.13 169.7 9.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.322 -0.861 . . . . 0.0 108.88 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 25' ' ' VAL . 22.2 mm -80.17 127.01 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.005 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 72.0 ttt180 -85.79 -47.93 9.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.368 -0.833 . . . . 0.0 109.446 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -148.29 142.6 26.22 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.535 -0.728 . . . . 0.0 109.367 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.2 p -62.24 151.3 36.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.911 . . . . 0.0 109.368 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.12 166.42 40.71 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.52 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 39.5 mttt -59.98 147.15 39.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.419 -1.047 . . . . 0.0 109.445 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.433 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 53.2 m -47.62 142.1 4.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 109.379 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.476 -179.934 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.0 mmm . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.566 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.6 m -82.12 4.06 24.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.362 -0.836 . . . . 0.0 109.214 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -62.95 -28.64 70.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.706 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.459 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 14.3 t70 -147.31 68.34 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 110.13 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.66 ' CZ ' HD21 ' A' ' 44' ' ' LEU . 19.7 p90 -127.12 -177.77 4.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 109.382 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptt-85 -156.07 146.06 21.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.323 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 15' ' ' GLY . 74.4 t -130.56 135.96 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.714 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -109.57 175.5 1.91 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.276 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.7 Cg_endo -67.95 -24.72 39.28 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.594 2.196 . . . . 0.0 111.83 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -95.78 -31.18 13.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 109.421 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.3 mt -80.87 -49.41 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.474 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.605 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.4 -173.52 43.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.541 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -98.96 146.53 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.2 tp -114.44 110.0 19.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.817 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 55.7 m -125.73 154.7 73.2 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 109.077 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.32 165.68 31.68 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.454 2.103 . . . . 0.0 111.655 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -85.22 -23.07 28.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -62.72 128.91 38.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 34' ' ' ASN . 22.0 tp -83.83 126.2 32.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 109.421 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.522 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -137.71 97.69 10.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.0 109.436 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.4 Cg_endo -62.69 121.01 8.77 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.961 2.441 . . . . 0.0 111.938 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.506 ' HB ' HG23 ' A' ' 52' ' ' ILE . 9.8 m -121.65 155.75 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.981 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.6 t -98.3 141.22 31.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -96.65 136.73 12.95 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.593 ' OD1' HG23 ' A' ' 50' ' ' THR . 58.4 p30 -62.26 -12.4 20.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -1.113 . . . . 0.0 109.58 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 48.8 m-20 -88.33 10.01 21.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 0.0 109.595 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.18 15.68 68.86 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.5 mt-30 -117.85 156.24 28.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.382 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.963 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.7 m -118.32 148.56 42.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.453 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.826 ' HD2' HD12 ' A' ' 39' ' ' LEU . 78.0 m-85 -130.26 127.83 40.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.317 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 m-20 -49.36 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.8 t-20 -82.06 146.19 54.71 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.978 -1.076 . . . . 0.0 109.468 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.522 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.64 -50.15 3.58 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.463 2.108 . . . . 0.0 111.459 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 8.0 t -62.2 -27.68 69.15 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.464 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 23.8 mtt -69.78 -23.58 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.826 HD12 ' HD2' ' A' ' 33' ' ' TYR . 4.8 tt -63.59 -47.34 81.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.344 -0.847 . . . . 0.0 108.782 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.547 ' N ' HD23 ' A' ' 39' ' ' LEU . 9.5 m -56.75 -27.97 60.33 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -56.83 -47.78 79.52 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 29.1 tp10 -57.87 -22.01 45.99 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 3.3 m-80 -76.57 -31.85 57.78 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.903 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.66 HD21 ' CZ ' ' A' ' 8' ' ' TYR . 67.0 mt -64.43 -41.19 96.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.384 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 mt -73.29 -54.23 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.392 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.679 HH22 HG21 ' A' ' 50' ' ' THR . 81.0 mtm180 -70.22 -22.02 62.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.383 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 63.01 36.0 12.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -120.0 177.35 5.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -103.98 56.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.55 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.679 HG21 HH22 ' A' ' 46' ' ' ARG . 82.9 m -75.88 129.38 36.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 109.579 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -115.34 -170.96 1.87 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.177 -0.952 . . . . 0.0 109.33 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.534 HG12 HD13 ' A' ' 39' ' ' LEU . 41.3 mt -85.9 126.56 40.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.727 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 12.7 tpt180 -81.06 -43.14 19.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.408 -0.808 . . . . 0.0 109.24 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.8 p -154.51 137.89 15.83 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 p -58.48 149.34 25.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 109.405 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 83.43 165.89 38.96 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.963 ' HG3' HG21 ' A' ' 32' ' ' THR . 39.5 tttm -65.3 149.04 50.64 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.352 -1.087 . . . . 0.0 109.356 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.8 138.7 39.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.481 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.444 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 81.5 mtp . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.581 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 24.6 m -85.23 -13.03 51.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.446 -0.784 . . . . 0.0 109.28 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -80.95 10.87 4.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.923 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 4' ' ' MET . 41.7 p30 -145.02 19.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.032 -1.042 . . . . 0.0 109.671 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.632 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -128.24 154.09 46.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.129 -0.982 . . . . 0.0 109.494 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 9' ' ' ARG . 39.2 tpt85 -135.66 146.81 48.2 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.305 -0.872 . . . . 0.0 108.984 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 15' ' ' GLY . 75.5 t -137.58 137.53 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.15 -0.969 . . . . 0.0 109.647 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.556 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -116.0 175.66 1.84 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 109.233 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.4 Cg_endo -66.53 -21.77 52.42 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.598 2.198 . . . . 0.0 111.763 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -101.96 -28.66 12.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -0.847 . . . . 0.0 109.563 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 11' ' ' LEU . 83.2 mt -80.87 -51.56 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.856 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 81.29 -165.38 46.73 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.8 OUTLIER -100.78 147.45 26.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -1.112 . . . . 0.0 109.672 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.83 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -119.87 127.64 52.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.853 . . . . 0.0 109.481 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 70.4 m -133.48 156.72 79.38 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.296 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.7 Cg_endo -70.06 166.66 27.21 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.621 2.214 . . . . 0.0 111.815 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -87.53 -14.42 40.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 109.534 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -73.01 106.1 4.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.311 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.422 HD11 ' HB3' ' A' ' 34' ' ' ASN . 48.8 tp -72.93 113.66 10.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.455 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.8 mttm -124.02 102.92 33.91 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 109.323 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 42.9 Cg_endo -65.09 116.98 4.15 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.875 2.383 . . . . 0.0 112.138 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 32' ' ' THR . 7.6 m -116.41 156.93 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 16.5 t -98.3 111.94 24.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.566 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.08 139.16 37.8 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.516 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.1 p30 -69.8 -9.74 55.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -1.109 . . . . 0.0 109.667 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -81.42 1.99 30.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.446 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.48 15.19 44.68 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -125.03 168.66 13.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.336 -1.097 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.566 HG21 ' HA ' ' A' ' 57' ' ' LYS . 39.1 m -123.45 134.18 53.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.661 ' CD1' HD13 ' A' ' 39' ' ' LEU . 72.8 m-85 -110.99 121.09 44.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 109.215 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 8.7 m-20 -46.89 -82.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.4 -0.812 . . . . 0.0 109.722 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.3 t-20 -81.84 146.38 55.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 109.593 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -62.95 -51.96 2.54 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.77 2.313 . . . . 0.0 111.599 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.8 t -61.92 -26.78 68.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.959 -1.088 . . . . 0.0 108.091 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 31.5 mmm -67.43 -16.66 64.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.661 HD13 ' CD1' ' A' ' 33' ' ' TYR . 17.3 tp -68.03 -57.35 6.29 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 9.4 t -55.45 -25.41 36.21 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -69.51 -61.7 1.68 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.571 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 88.5 mt-10 -57.57 -19.53 26.13 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.421 ' ND2' ' HG ' ' A' ' 39' ' ' LEU . 92.9 m-20 -75.39 -33.55 61.02 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.95 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.2 tm? -57.76 -38.23 75.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.412 -0.805 . . . . 0.0 108.882 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mt -77.3 -46.81 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.846 . . . . 0.0 108.972 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.438 ' O ' HG23 ' A' ' 48' ' ' THR . 62.2 mtt-85 -64.76 -26.22 68.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 109.01 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 91.5 mt-30 61.27 37.99 16.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.37 -0.831 . . . . 0.0 109.639 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 46' ' ' ARG . 10.1 p -128.39 169.77 13.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.322 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.512 ' O ' ' NE2' ' A' ' 51' ' ' HIS . 79.9 m-20 -98.91 63.13 1.35 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.266 -0.896 . . . . 0.0 109.311 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.6 m -71.47 137.65 48.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.827 . . . . 0.0 109.666 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.512 ' NE2' ' O ' ' A' ' 49' ' ' ASN . 11.8 m-70 -117.95 178.54 4.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 109.022 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.413 HG23 ' HB ' ' A' ' 25' ' ' VAL . 20.4 mt -86.08 124.8 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.142 -0.974 . . . . 0.0 109.611 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 66.4 ttt180 -80.99 -56.73 3.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.142 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -147.13 156.56 43.09 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.535 -0.728 . . . . 0.0 109.037 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -75.05 142.72 43.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.0 109.632 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.04 162.46 35.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.566 ' HA ' HG21 ' A' ' 32' ' ' THR . 32.5 mttt -64.77 136.75 57.25 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.588 -0.948 . . . . 0.0 109.484 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -71.11 149.15 46.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.388 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 58' ' ' CYS . 84.4 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.502 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.3 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 8' ' ' TYR . 3.9 m -82.8 -26.84 31.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.441 -0.787 . . . . 0.0 109.376 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' CYS . 69.3 mttt -44.76 -27.24 0.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.348 -0.845 . . . . 0.0 108.757 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 5' ' ' CYS . 94.5 m-20 -116.08 35.05 4.66 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 5' ' ' CYS . 2.7 t80 -80.34 163.2 24.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -150.64 114.61 5.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -0.829 . . . . 0.0 109.093 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.873 HG13 ' C ' ' A' ' 15' ' ' GLY . 59.7 t -116.97 156.74 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 109.639 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.55 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -136.27 174.91 3.97 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.371 -0.83 . . . . 0.0 109.386 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.9 Cg_endo -67.44 -21.75 46.32 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.672 2.248 . . . . 0.0 111.947 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -112.1 -21.56 11.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.673 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 11' ' ' LEU . 97.0 mt -88.21 -49.32 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 0.0 109.627 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.873 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 75.2 -165.43 54.62 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.83 ' CD1' HG21 ' A' ' 10' ' ' VAL . 1.2 t80 -94.06 153.84 17.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -1.212 . . . . 0.0 109.514 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.8 tp -117.08 109.92 17.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.965 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.9 m -126.13 155.35 73.71 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 109.115 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.09 168.52 23.82 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.527 2.151 . . . . 0.0 111.611 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -88.19 -23.34 23.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -0.964 . . . . 0.0 109.741 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.53 126.53 28.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.329 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 34' ' ' ASN . 31.3 tp -85.0 113.13 21.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.528 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -121.45 104.35 40.26 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 0.0 109.363 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.499 ' HB2' ' HG3' ' A' ' 57' ' ' LYS . 43.2 Cg_endo -65.62 117.28 4.49 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.875 2.383 . . . . 0.0 112.059 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.489 ' HB ' HG23 ' A' ' 52' ' ' ILE . 34.0 m -120.44 154.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.871 . . . . 0.0 109.835 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.0 t -97.3 140.79 31.24 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -90.99 142.39 16.11 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 43.9 t0 -68.58 -11.5 60.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -1.203 . . . . 0.0 109.306 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -86.4 -5.0 59.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.303 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.77 21.38 14.35 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 27' ' ' GLY . 66.8 mt-30 -127.58 145.84 50.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -1.194 . . . . 0.0 109.585 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.48 HG23 ' HA ' ' A' ' 57' ' ' LYS . 92.8 m -99.4 154.72 17.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.868 . . . . 0.0 109.602 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.655 ' CD2' HD12 ' A' ' 39' ' ' LEU . 48.8 m-85 -135.59 117.63 15.36 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.372 -0.83 . . . . 0.0 108.901 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.552 ' HB3' HD11 ' A' ' 22' ' ' LEU . 10.8 m-20 -41.97 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.0 109.828 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.8 t-20 -82.27 146.61 54.89 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.031 . . . . 0.0 109.205 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.18 -51.16 2.93 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.618 2.212 . . . . 0.0 111.695 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.5 t -63.34 -28.27 69.89 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.094 -1.004 . . . . 0.0 108.423 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 14.0 mtp -60.89 -14.93 25.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.019 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.712 HD22 ' CD1' ' A' ' 52' ' ' ILE . 6.2 tp -74.65 -54.9 6.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.494 -0.754 . . . . 0.0 109.746 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.472 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.4 m -61.72 -19.92 62.93 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.197 -0.94 . . . . 0.0 108.665 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.57 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 34.9 t60 -67.79 -54.39 19.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -66.2 -18.75 65.55 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.0 m-20 -75.79 -27.47 58.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.45 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.974 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.8 tm? -67.52 -35.98 80.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -0.976 . . . . 0.0 108.966 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.25 -46.27 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.208 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.502 ' NH2' ' OE1' ' A' ' 31' ' ' GLN . 74.2 mtm180 -75.79 -35.01 60.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 109.109 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.2 mt-30 62.51 40.36 10.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.71 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.444 HG23 ' HB3' ' A' ' 46' ' ' ARG . 32.9 p -109.8 7.31 24.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 47.82 60.66 3.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.853 . . . . 0.0 109.761 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.3 m -79.77 133.49 36.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.451 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -105.46 -173.97 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.478 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.712 ' CD1' HD22 ' A' ' 39' ' ' LEU . 33.6 mm -91.33 127.15 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.616 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 73.8 ttt180 -79.44 -49.01 12.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.231 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.6 p -159.3 155.18 26.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 p -67.82 141.56 56.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.074 -1.016 . . . . 0.0 109.769 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.29 165.77 35.17 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.499 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 83.0 mttt -66.94 146.28 54.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -1.087 . . . . 0.0 109.364 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 70.1 m -55.28 150.54 11.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.59 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.458 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 48.2 ttm . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.457 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 38.9 m -80.82 -28.06 36.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.335 -0.853 . . . . 0.0 109.167 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -68.08 -12.6 61.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 109.368 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -91.0 -16.59 27.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.689 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.495 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -109.76 157.22 19.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.183 179.852 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -128.95 140.79 51.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.564 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.766 HG21 ' C ' ' A' ' 15' ' ' GLY . 14.7 p -125.71 146.77 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.561 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mp -108.77 175.6 1.9 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.3 Cg_endo -67.32 -23.3 44.81 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.641 2.227 . . . . 0.0 111.669 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -88.93 -30.6 18.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.247 -0.908 . . . . 0.0 109.146 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.429 ' HA ' HD13 ' A' ' 14' ' ' ILE . 28.6 mm -85.9 -39.79 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 0.0 109.307 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.766 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 69.18 144.71 0.16 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.912 ' CE1' HD11 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -41.88 152.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -1.065 . . . . 0.0 109.789 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.1 tp -128.35 111.72 13.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.882 . . . . 0.0 109.511 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 81.0 m -116.85 158.08 44.72 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.327 -0.858 . . . . 0.0 109.2 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -71.79 165.62 31.99 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.575 2.183 . . . . 0.0 111.792 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -86.81 -11.61 50.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -74.11 113.42 11.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.246 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.975 HD11 ' OD1' ' A' ' 34' ' ' ASN . 55.9 tp -80.02 123.22 27.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.554 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 11.9 mmtm -141.03 109.63 6.44 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.394 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -66.02 120.28 7.42 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 123.04 2.493 . . . . 0.0 112.055 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 32' ' ' THR . 11.1 m -116.86 156.64 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 109.82 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 46.8 t -98.59 119.8 37.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.0 109.368 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -72.62 137.31 24.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -68.33 -7.61 32.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -1.08 . . . . 0.0 109.532 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 91.5 m-20 -89.07 11.77 17.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.504 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.6 71.59 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 27' ' ' GLY . 78.4 mt-30 -116.01 173.95 6.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -1.164 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.652 HG21 ' HG3' ' A' ' 57' ' ' LYS . 50.6 m -133.9 140.33 46.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.328 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.766 ' CD1' HD13 ' A' ' 39' ' ' LEU . 24.6 m-85 -118.62 123.32 44.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.467 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.975 ' OD1' HD11 ' A' ' 22' ' ' LEU . 54.6 t-20 -45.99 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 109.737 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.8 t-20 -80.82 147.52 62.53 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.866 -1.146 . . . . 0.0 109.343 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.8 Cg_endo -62.45 -53.15 2.0 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.699 2.266 . . . . 0.0 111.804 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.6 t -62.76 -28.15 69.78 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.485 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 50.3 mmm -63.13 -16.77 61.12 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.766 HD13 ' CD1' ' A' ' 33' ' ' TYR . 27.9 tp -66.77 -50.67 61.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.454 -0.779 . . . . 0.0 108.899 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.6 m -67.92 -19.36 64.98 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -73.54 -54.82 7.3 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 88.6 mt-10 -63.35 -17.05 62.17 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 47' ' ' GLN . 94.0 m-20 -77.35 -35.74 54.36 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.493 -0.754 . . . . 0.0 108.967 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.912 HD11 ' CE1' ' A' ' 16' ' ' TYR . 31.2 mt -54.14 -36.09 62.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.116 -0.99 . . . . 0.0 108.567 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mt -78.45 -50.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.075 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 91.5 mtt-85 -65.31 -26.89 68.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.23 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.97 41.95 7.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 109.587 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 p -128.86 158.61 38.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.446 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.475 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 63.0 m-20 -87.71 58.4 4.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.332 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.435 ' OG1' ' OD2' ' A' ' 29' ' ' ASP . 57.6 m -75.15 133.6 41.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.858 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.475 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 67.9 m80 -119.88 174.86 6.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.858 . . . . 0.0 108.873 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.519 HG23 ' HB ' ' A' ' 25' ' ' VAL . 37.9 mt -79.71 138.43 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.322 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HA ' ' OD2' ' A' ' 28' ' ' ASP . 23.3 ttt180 -101.9 -47.52 4.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.387 -0.821 . . . . 0.0 109.578 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.5 m -146.86 137.61 23.84 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.49 -0.756 . . . . 0.0 109.33 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.7 p -60.69 145.17 50.3 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.24 164.09 39.9 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.652 ' HG3' HG21 ' A' ' 32' ' ' THR . 22.4 tttp -53.88 150.22 7.91 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.348 -1.09 . . . . 0.0 109.525 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 36.3 m -52.73 144.85 13.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.444 179.888 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.511 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.2 m -85.5 8.96 17.2 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.491 ' HE2' ' NE2' ' A' ' 51' ' ' HIS . 31.1 mttt -70.13 -27.42 64.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 82.6 m-20 -144.44 64.25 1.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.882 ' OH ' HD21 ' A' ' 44' ' ' LEU . 11.7 p90 -125.33 -176.44 3.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.442 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -146.7 152.87 39.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 109.557 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 15' ' ' GLY . 42.5 t -144.57 127.93 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -106.8 175.32 2.09 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.865 . . . . 0.0 109.501 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -67.94 -23.23 41.05 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.693 2.262 . . . . 0.0 111.844 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -96.73 -26.64 15.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.254 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.2 mt -89.3 -42.07 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.655 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.586 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 64.32 -165.46 31.49 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.484 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -93.42 149.83 20.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -1.197 . . . . 0.0 109.407 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.2 tp -116.24 107.19 14.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.639 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 60.3 m -125.47 156.26 70.67 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 109.557 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 51.5 Cg_endo -72.12 167.84 25.69 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.733 2.288 . . . . 0.0 111.669 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -84.32 -26.0 28.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -62.34 117.01 5.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -84.67 104.32 14.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 34' ' ' ASN . 16.1 mtpt -116.12 111.37 42.71 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.223 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.6 Cg_endo -63.38 121.14 8.84 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 C-N-CA 122.999 2.466 . . . . 0.0 112.21 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' A' ' 52' ' ' ILE . 5.8 m -115.1 157.73 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.418 -0.801 . . . . 0.0 109.584 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 53' ' ' ARG . 47.6 t -97.21 140.58 31.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.8 135.38 12.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.7 p30 -62.0 -12.23 17.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -1.065 . . . . 0.0 109.71 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 49.8 m-20 -87.47 10.84 16.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.484 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.72 64.31 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 62.0 mt-30 -117.35 178.79 4.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.519 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.611 HG21 ' HG3' ' A' ' 57' ' ' LYS . 20.7 m -139.49 142.65 37.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.31 -0.869 . . . . 0.0 109.234 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.832 ' CD2' HD12 ' A' ' 39' ' ' LEU . 23.9 m-85 -122.42 134.84 54.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.58 ' CB ' HD21 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -54.68 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 109.491 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.4 t-20 -82.16 146.39 54.81 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.003 -1.061 . . . . 0.0 109.504 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.64 -52.3 1.94 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.703 2.269 . . . . 0.0 111.645 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.536 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -63.5 -24.28 67.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.509 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 62.2 mtp -73.66 -16.51 61.21 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.832 HD12 ' CD2' ' A' ' 33' ' ' TYR . 7.5 tt -64.55 -51.8 60.95 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' ASN . 8.7 m -54.09 -38.54 65.45 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.425 ' C ' ' O ' ' A' ' 40' ' ' CYS . 7.2 t60 -47.48 -50.21 23.78 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HG3' ' CD1' ' A' ' 33' ' ' TYR . 37.3 mm-40 -56.48 -25.98 52.78 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.2 m-80 -74.32 -33.72 63.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 0.0 108.85 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.882 HD21 ' OH ' ' A' ' 8' ' ' TYR . 37.2 mt -63.96 -44.26 93.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.1 mm -74.86 -52.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.125 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 37.7 mtt-85 -66.83 -22.25 66.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.198 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 61.51 35.26 17.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.359 -0.838 . . . . 0.0 109.584 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 p -123.13 170.38 10.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.419 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.57 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 77.7 m-20 -96.77 57.37 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.857 . . . . 0.0 109.609 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.622 HG21 ' OH ' ' A' ' 33' ' ' TYR . 43.9 m -80.03 126.12 30.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.554 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.57 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 22.3 m80 -113.18 -173.32 2.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.804 HG12 HD13 ' A' ' 39' ' ' LEU . 31.8 mt -87.09 124.69 40.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.176 -0.952 . . . . 0.0 109.366 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 79.3 ttt180 -80.44 -39.99 27.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.366 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.06 148.64 17.15 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.493 -0.754 . . . . 0.0 109.288 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -65.91 144.43 56.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.723 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.11 162.01 38.06 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.611 ' HG3' HG21 ' A' ' 32' ' ' THR . 13.5 tttm -54.8 154.27 5.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.51 -0.994 . . . . 0.0 109.372 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 84.5 m -62.55 141.13 58.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.499 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.488 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.73 -5.68 55.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.455 -0.778 . . . . 0.0 108.968 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -54.24 -31.47 53.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.795 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -146.43 67.74 1.18 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -0.948 . . . . 0.0 110.073 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.612 ' OH ' HD13 ' A' ' 44' ' ' LEU . 5.8 p90 -125.2 173.76 8.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.158 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -143.9 147.52 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.063 -1.023 . . . . 0.0 109.755 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 15' ' ' GLY . 66.6 t -144.57 132.83 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.126 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 1.5 mp -125.42 170.94 8.34 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 109.497 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.71 -24.59 40.93 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.556 2.171 . . . . 0.0 111.449 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -102.89 -27.16 12.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.039 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.4 mt -88.88 -43.09 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.294 -0.879 . . . . 0.0 109.24 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.785 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 76.04 -141.72 27.52 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.62 ' CD2' HG21 ' A' ' 10' ' ' VAL . 2.9 t80 -114.17 155.3 26.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 32.5 tp -112.44 124.5 52.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.991 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -138.54 156.66 73.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.388 -0.82 . . . . 0.0 109.057 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.2 Cg_endo -72.59 168.21 25.02 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.633 2.222 . . . . 0.0 111.552 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -84.82 -27.83 26.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.379 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.82 130.88 48.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.471 HD11 ' HB3' ' A' ' 34' ' ' ASN . 63.7 tp -95.06 117.71 30.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 109.5 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.531 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 7.5 mttt -128.22 104.88 19.94 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.3 Cg_endo -64.62 120.41 7.69 Favored 'Trans proline' 0 C--O 1.213 -0.755 0 C-N-CA 122.962 2.442 . . . . 0.0 112.081 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 32' ' ' THR . 11.9 m -119.62 156.46 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.851 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.3 t -99.87 121.48 41.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.432 -0.793 . . . . 0.0 108.873 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -79.41 137.05 18.45 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 45.5 p30 -68.5 -8.82 44.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -1.152 . . . . 0.0 109.548 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 29' ' ' ASP . 58.0 p30 -82.89 8.21 13.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -0.955 . . . . 0.0 109.313 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.44 23.01 45.2 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.4 mt-30 -133.79 158.25 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -1.154 . . . . 0.0 109.499 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 42.2 m -116.19 143.63 45.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 109.225 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.778 ' CD1' HD13 ' A' ' 39' ' ' LEU . 81.0 m-85 -122.51 127.82 50.02 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.272 -0.893 . . . . 0.0 109.213 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 10.7 m-20 -51.55 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.942 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 10.1 t-20 -81.97 146.56 55.85 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 120.947 -1.096 . . . . 0.0 109.731 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.9 -51.78 2.71 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.813 2.342 . . . . 0.0 111.674 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.9 t -60.14 -31.57 70.21 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 8.5 mtt -60.97 -17.53 52.24 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.778 HD13 ' CD1' ' A' ' 33' ' ' TYR . 63.5 tp -67.85 -54.45 18.86 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 8.1 t -58.19 -27.72 64.13 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -62.28 -58.93 5.89 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -59.62 -21.01 59.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.0 m-20 -80.09 -30.74 39.27 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.612 HD13 ' OH ' ' A' ' 8' ' ' TYR . 35.6 tp -61.14 -40.61 94.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.512 -0.742 . . . . 0.0 109.054 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.0 mt -80.43 -47.49 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.81 . . . . 0.0 109.322 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.59 ' HG2' HG23 ' A' ' 48' ' ' THR . 46.7 ttm-85 -67.66 -43.67 79.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.5 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 84.8 mt-30 65.88 47.18 2.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.387 -0.821 . . . . 0.0 109.58 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.59 HG23 ' HG2' ' A' ' 46' ' ' ARG . 21.3 p -120.83 8.07 10.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.1 t30 52.73 60.65 3.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.409 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 28.9 m -77.87 141.12 39.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.327 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -115.12 168.58 9.81 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.204 -0.935 . . . . 0.0 109.094 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.414 HG23 ' HB ' ' A' ' 25' ' ' VAL . 21.7 mt -79.71 123.55 36.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.146 -0.972 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.518 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 65.2 ttt-85 -81.06 -45.98 15.69 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.571 -0.706 . . . . 0.0 109.266 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -152.99 153.85 33.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 109.138 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 p -74.0 144.89 44.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.0 164.6 40.4 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 75.1 mttt -64.9 138.44 58.37 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.46 -1.024 . . . . 0.0 109.345 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 152.6 44.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 109.418 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.496 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 7.9 m -80.39 -20.15 44.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.393 -0.817 . . . . 0.0 109.285 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 49' ' ' ASN . 86.1 mttt -50.19 -27.13 5.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 108.822 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -108.84 26.53 10.47 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 1.9 t80 -80.97 147.71 30.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.985 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -141.17 114.61 8.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.606 HG21 ' N ' ' A' ' 16' ' ' TYR . 5.4 p -128.71 154.71 39.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.348 -0.845 . . . . 0.0 109.431 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.606 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -110.12 168.42 7.67 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.948 . . . . 0.0 109.327 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.606 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.7 Cg_endo -67.2 -24.82 43.77 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.614 2.209 . . . . 0.0 111.543 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -92.92 -25.02 18.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.218 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.3 mt -85.69 -40.37 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 109.378 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.589 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 70.96 145.9 0.36 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.606 ' N ' HG21 ' A' ' 10' ' ' VAL . 1.9 t80 -51.44 150.89 3.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -1.163 . . . . 0.0 109.331 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -116.92 136.12 53.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.425 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.6 m -142.95 157.27 61.38 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.208 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -69.87 165.42 31.16 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.661 2.241 . . . . 0.0 111.755 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -87.93 -13.34 42.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -72.56 114.34 10.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.181 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 22' ' ' LEU . 38.0 tp -80.04 120.74 24.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 109.629 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.506 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -136.83 107.47 9.0 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.091 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.3 121.66 9.16 Favored 'Trans proline' 0 C--O 1.212 -0.784 0 C-N-CA 123.016 2.478 . . . . 0.0 112.249 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.494 ' HB ' HG23 ' A' ' 52' ' ' ILE . 16.3 m -118.89 155.57 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 109.877 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 32.2 t -97.36 139.03 33.91 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.68 140.31 15.04 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -70.98 -4.77 26.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -1.134 . . . . 0.0 109.618 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -93.57 4.61 53.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.01 20.26 33.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.7 mt-30 -124.63 163.58 21.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -1.139 . . . . 0.0 109.54 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.0 m -125.13 135.58 52.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.128 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.857 ' CD1' HD13 ' A' ' 39' ' ' LEU . 55.3 m-85 -115.36 130.16 56.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.228 -0.92 . . . . 0.0 109.349 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 8.3 m-20 -54.52 -78.15 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.731 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.9 t-20 -81.88 147.86 59.47 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.722 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.4 Cg_endo -62.92 -52.92 1.87 Allowed 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.751 2.3 . . . . 0.0 111.704 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.5 t -60.91 -29.81 69.81 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.984 -1.072 . . . . 0.0 108.111 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 44.9 mmm -63.65 -15.24 57.77 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.857 HD13 ' CD1' ' A' ' 33' ' ' TYR . 39.4 tp -68.76 -49.29 59.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.494 -0.754 . . . . 0.0 109.286 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 3.2 m -69.32 -21.35 63.85 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.551 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 40.5 t60 -70.27 -55.33 9.5 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 78.1 mt-10 -63.28 -19.49 64.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.1 m-20 -75.26 -33.42 61.27 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 40' ' ' CYS . 20.9 mt -59.3 -37.0 76.62 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 45' ' ' ILE . 6.6 mm -72.69 -49.6 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.469 ' HG2' HG23 ' A' ' 48' ' ' THR . 36.4 ttt180 -68.48 -25.86 65.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.1 mt-30 64.03 43.91 4.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.778 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.469 HG23 ' HG2' ' A' ' 46' ' ' ARG . 70.1 p -132.36 166.89 20.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.303 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.48 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 95.9 m-20 -95.71 61.13 2.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.396 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.3 m -72.32 139.3 47.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.619 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.48 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 72.1 m80 -119.15 173.57 6.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.845 . . . . 0.0 109.053 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.494 HG23 ' HB ' ' A' ' 25' ' ' VAL . 35.1 mt -80.07 124.93 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.097 -1.002 . . . . 0.0 109.269 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.486 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.7 ttt180 -79.93 -45.94 17.63 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.679 0.752 . . . . 0.0 109.235 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 p -156.49 146.47 21.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 p -65.37 147.4 53.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.157 -0.965 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.22 165.15 40.47 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.532 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 47.4 mttp -65.69 146.2 55.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -1.087 . . . . 0.0 109.346 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 152.86 35.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.504 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.405 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.7 mtp . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.497 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 34.4 m -80.56 -6.08 57.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.378 -0.826 . . . . 0.0 109.214 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -81.38 12.61 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 110.038 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -132.98 7.83 4.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.991 -1.068 . . . . 0.0 110.399 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 5.8 p90 -105.48 -176.56 3.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.912 -1.118 . . . . 0.0 109.604 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.621 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 10.4 ttt180 -151.48 142.81 23.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.339 -0.851 . . . . 0.0 109.142 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 15' ' ' GLY . 15.0 t -143.61 149.39 18.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.346 -0.846 . . . . 0.0 109.321 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -124.46 175.33 3.0 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.4 Cg_endo -66.71 -21.56 51.45 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.63 2.22 . . . . 0.0 111.739 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 66.1 ttt180 -99.6 -16.89 18.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.84 . . . . 0.0 109.641 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' ' 14' ' ' ILE . 40.0 mm -94.82 -49.82 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.033 -1.042 . . . . 0.0 109.611 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.574 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 86.47 -178.29 48.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.488 ' HE2' ' HH ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -90.63 146.91 23.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 109.736 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.3 tp -114.18 107.59 15.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 74.1 m -117.28 156.62 48.6 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.343 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.1 Cg_endo -72.21 167.94 25.47 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.642 2.228 . . . . 0.0 111.531 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -91.79 -12.81 32.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -66.74 129.45 39.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 109.277 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.901 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -89.56 120.68 31.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.518 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.619 ' N ' HD13 ' A' ' 22' ' ' LEU . 27.3 mttm -143.65 108.13 5.13 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.541 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 47.1 Cg_endo -66.77 122.39 9.76 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 123.056 2.504 . . . . 0.0 112.126 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -116.21 154.66 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 53' ' ' ARG . 49.6 t -97.04 138.56 34.38 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.57 139.82 14.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.9 t0 -69.2 -8.44 45.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -1.099 . . . . 0.0 109.459 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -87.54 3.61 46.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.978 . . . . 0.0 109.438 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.56 17.29 45.98 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 65.8 mt-30 -121.33 175.22 6.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -1.108 . . . . 0.0 109.625 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.643 HG21 ' HG3' ' A' ' 57' ' ' LYS . 10.8 m -134.29 136.78 43.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 0.0 109.54 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.814 ' CD1' HD13 ' A' ' 39' ' ' LEU . 30.6 m-85 -114.42 127.67 55.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.901 ' OD1' HD21 ' A' ' 22' ' ' LEU . 59.6 t-20 -50.6 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.433 -0.792 . . . . 0.0 110.079 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.8 t-20 -80.85 149.5 67.36 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.004 -1.06 . . . . 0.0 109.555 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.35 -54.92 0.85 Allowed 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.793 2.329 . . . . 0.0 111.917 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.2 t -62.09 -28.33 69.54 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.965 -1.084 . . . . 0.0 108.265 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.4 mmm -64.41 -12.58 44.55 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.814 HD13 ' CD1' ' A' ' 33' ' ' TYR . 28.4 tp -73.56 -57.67 3.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.465 -0.772 . . . . 0.0 109.067 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.449 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.8 m -62.85 -18.47 62.93 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -71.85 -58.27 3.6 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -61.92 -17.08 55.52 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -77.15 -31.91 55.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.524 -0.735 . . . . 0.0 109.076 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.511 HD11 ' HH ' ' A' ' 8' ' ' TYR . 19.5 mt -58.55 -35.99 73.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.935 . . . . 0.0 108.678 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.2 mm -78.64 -50.25 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.056 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.9 mtt-85 -64.46 -34.71 78.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.168 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 58.79 36.47 24.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.379 -0.826 . . . . 0.0 109.447 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 p -113.12 11.82 18.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.37 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 46.28 57.73 5.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.367 -0.833 . . . . 0.0 109.44 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.3 m -75.04 140.57 43.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.492 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -112.5 170.01 8.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.551 HG12 HD22 ' A' ' 39' ' ' LEU . 39.7 mt -79.85 126.52 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 41.3 ttt180 -79.77 -45.82 18.12 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.7 p -158.19 162.51 37.9 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.4 p -79.05 133.08 36.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -0.986 . . . . 0.0 109.755 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 99.95 165.35 29.06 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.643 ' HG3' HG21 ' A' ' 32' ' ' THR . 30.1 tttp -54.39 158.51 2.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -1.083 . . . . 0.0 109.236 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.474 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 91.2 m -69.39 150.42 47.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.6 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.384 179.918 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtp . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.9 m -85.48 -22.93 28.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.375 -0.828 . . . . 0.0 109.247 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -74.75 -14.33 60.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -109.34 4.09 22.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.872 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -119.43 155.11 32.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.038 -1.039 . . . . 0.0 109.238 179.909 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -136.74 130.79 32.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.408 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.593 HG21 ' C ' ' A' ' 15' ' ' GLY . 4.9 p -129.39 142.2 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.469 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.775 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -103.88 173.55 3.33 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.775 ' HD2' HD23 ' A' ' 11' ' ' LEU . 47.6 Cg_endo -68.44 -26.72 34.37 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.595 2.197 . . . . 0.0 111.717 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -89.01 -28.41 20.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.295 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.7 mm -84.39 -40.57 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.244 -0.91 . . . . 0.0 109.304 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.593 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 68.56 155.85 0.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CE2' ' CZ ' ' A' ' 8' ' ' TYR . 1.3 t80 -55.67 148.06 17.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.292 -1.122 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.6 tp -123.1 119.62 30.83 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.859 . . . . 0.0 109.323 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.4 m -117.67 155.82 50.2 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.525 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.3 Cg_endo -71.55 166.02 30.69 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.844 2.363 . . . . 0.0 111.791 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -86.63 -8.01 57.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.867 . . . . 0.0 109.335 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -72.99 128.77 36.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 109.304 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.918 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.1 tm? -92.12 124.69 36.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.717 ' N ' HD13 ' A' ' 22' ' ' LEU . 2.2 mmmm -145.27 103.68 4.36 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.304 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 42.6 Cg_endo -65.36 124.29 12.7 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 123.061 2.507 . . . . 0.0 112.298 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 32' ' ' THR . 17.7 m -120.74 156.26 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 109.939 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.6 t -101.64 115.46 30.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.172 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -71.77 139.29 28.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.0 p30 -69.41 -9.83 55.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -1.14 . . . . 0.0 109.484 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.8 m-20 -82.95 8.13 13.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.75 14.35 63.31 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.0 mt-30 -120.75 159.73 24.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.304 -1.116 . . . . 0.0 109.467 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.506 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 33.1 m -119.1 134.66 55.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.286 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.841 ' CD1' HD13 ' A' ' 39' ' ' LEU . 56.5 m-85 -113.26 123.83 51.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.119 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.918 ' OD1' HD21 ' A' ' 22' ' ' LEU . 64.2 t-20 -49.41 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.256 -0.902 . . . . 0.0 109.806 -179.512 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.5 t-20 -80.93 147.97 63.28 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 120.871 -1.143 . . . . 0.0 109.72 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.6 Cg_endo -62.16 -53.11 2.17 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.845 2.363 . . . . 0.0 111.941 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.0 t -60.92 -28.5 68.98 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 120.911 -1.118 . . . . 0.0 108.023 178.863 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 22.2 mtp -63.99 -20.92 66.25 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.841 HD13 ' CD1' ' A' ' 33' ' ' TYR . 32.7 tp -67.38 -54.57 19.31 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.529 ' O ' HD12 ' A' ' 44' ' ' LEU . 38.1 t -58.34 -30.96 67.14 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -66.52 -59.04 4.0 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 73.9 mt-10 -59.2 -18.41 36.43 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.472 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 94.4 m-20 -77.28 -37.88 51.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.589 -0.695 . . . . 0.0 109.162 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.529 HD12 ' O ' ' A' ' 40' ' ' CYS . 5.4 mp -56.38 -34.24 66.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 108.79 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 mt -79.01 -48.49 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.396 -0.815 . . . . 0.0 109.278 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.707 ' HG3' HG23 ' A' ' 48' ' ' THR . 19.9 tpt85 -65.64 -39.22 91.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 88.7 mt-30 62.67 41.84 8.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.56 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.707 HG23 ' HG3' ' A' ' 46' ' ' ARG . 27.3 p -121.92 10.65 10.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.497 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 51.51 60.84 3.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.355 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.472 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 26.7 m -77.52 141.56 39.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.625 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -115.18 172.12 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.011 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.4 mt -82.96 124.75 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.501 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 24.7 tpt180 -82.16 -53.52 6.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.422 -0.799 . . . . 0.0 109.31 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.9 p -148.02 154.58 40.46 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -73.05 147.58 44.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.116 -0.99 . . . . 0.0 109.312 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.95 165.15 40.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.549 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 35.0 mttm -66.86 145.6 55.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -1.041 . . . . 0.0 109.301 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 153.06 29.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.453 -179.964 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 34.8 m -81.13 -17.12 50.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.785 . . . . 0.0 109.475 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 63.1 mttt -80.51 8.38 7.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.733 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 95.9 m-20 -137.83 10.76 2.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.011 -1.056 . . . . 0.0 110.241 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.616 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -121.36 151.18 40.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 109.565 179.803 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -132.02 134.86 46.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.236 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.837 HG13 ' O ' ' A' ' 15' ' ' GLY . 61.8 t -124.47 148.92 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.82 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.564 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -129.6 175.23 3.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.437 -0.789 . . . . 0.0 109.276 179.849 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 43.8 Cg_endo -66.9 -21.73 49.83 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.651 2.234 . . . . 0.0 111.784 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -103.65 -28.26 11.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.52 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' A' ' 11' ' ' LEU . 90.2 mt -81.76 -46.99 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.547 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.837 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 78.97 -166.43 51.83 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.2 t80 -97.16 150.8 20.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.174 . . . . 0.0 109.502 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.6 tp -120.07 116.29 25.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 109.681 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.6 m -127.37 157.37 72.94 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.201 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.8 Cg_endo -71.05 166.49 28.99 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.501 2.134 . . . . 0.0 111.682 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -88.12 -14.41 38.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.521 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -71.87 119.31 15.87 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.207 -0.933 . . . . 0.0 109.242 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 34' ' ' ASN . 43.0 tp -83.61 116.39 22.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.75 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.6 mmtt -129.7 105.45 17.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.885 . . . . 0.0 109.087 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.567 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 43.4 Cg_endo -65.27 119.82 6.91 Favored 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 122.952 2.434 . . . . 0.0 112.283 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 32' ' ' THR . 24.3 m -117.63 154.8 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 25.8 t -95.72 127.61 41.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.329 -0.857 . . . . 0.0 108.753 179.21 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -83.07 137.51 16.61 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.4 p30 -67.8 -8.52 36.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -85.6 7.34 23.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 109.384 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.54 16.07 57.45 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.5 mt-30 -123.2 173.46 7.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.493 HG21 ' HA ' ' A' ' 57' ' ' LYS . 25.9 m -133.0 135.42 45.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.387 -0.82 . . . . 0.0 109.263 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.745 ' CD1' HD13 ' A' ' 39' ' ' LEU . 37.0 m-85 -112.54 130.09 56.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.202 -0.936 . . . . 0.0 109.371 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.525 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 8.4 m-20 -53.77 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 109.72 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.0 t-20 -81.84 147.8 59.45 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.29 -53.87 1.3 Allowed 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.789 2.326 . . . . 0.0 111.813 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -61.32 -27.49 68.52 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 42.8 mmm -64.81 -17.88 64.62 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.234 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.745 HD13 ' CD1' ' A' ' 33' ' ' TYR . 24.2 tp -68.54 -58.16 4.72 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.453 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 10.5 t -56.36 -26.12 51.72 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -68.59 -61.56 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.159 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.403 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 69.1 mt-10 -56.02 -19.86 14.38 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.239 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.2 m-20 -78.56 -40.27 35.31 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.7 tp -55.83 -33.84 64.85 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.417 -0.802 . . . . 0.0 108.845 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mt -78.82 -50.53 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.836 . . . . 0.0 108.995 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 13.2 mtt-85 -65.48 -22.02 66.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 109.348 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 89.0 mt-30 63.83 43.67 5.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.333 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.4 t -131.57 168.99 16.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.579 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 90.7 m-20 -103.56 63.29 0.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.1 m -74.42 140.01 44.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.703 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 31.4 m80 -116.66 178.93 4.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.044 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.411 HG23 ' HB ' ' A' ' 25' ' ' VAL . 30.0 mt -87.99 124.9 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.058 -1.026 . . . . 0.0 109.4 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 69.9 ttt-85 -80.19 -47.5 14.58 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.543 -0.723 . . . . 0.0 109.288 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 p -155.33 152.99 29.83 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -71.69 146.03 48.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.15 -0.969 . . . . 0.0 109.415 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.98 164.23 40.17 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.567 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 26.1 mttp -64.58 143.66 57.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.554 -0.968 . . . . 0.0 109.447 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 151.55 35.47 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.257 -0.902 . . . . 0.0 109.397 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.5 -179.864 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.7 mtp . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.573 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.0 m -85.58 4.14 37.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 109.083 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 mttt -73.05 -20.48 60.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.0 109.383 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 58.6 p30 -148.93 57.55 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 109.838 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.651 ' OH ' HD21 ' A' ' 44' ' ' LEU . 12.0 p90 -120.83 -175.44 3.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 109.242 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -152.64 145.6 24.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.391 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 15' ' ' GLY . 55.5 t -132.04 129.68 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -111.94 175.37 1.9 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.355 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.4 Cg_endo -67.57 -23.66 42.85 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.61 2.207 . . . . 0.0 111.651 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.9 ttp85 -93.28 -39.72 10.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.89 . . . . 0.0 109.207 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.7 mt -79.95 -43.84 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.351 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.843 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 67.27 -155.05 52.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.665 ' CD2' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -112.71 148.13 35.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -1.104 . . . . 0.0 109.25 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.844 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -122.0 128.93 52.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.0 m -136.4 157.27 75.7 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.272 -0.893 . . . . 0.0 109.317 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -70.4 165.73 30.74 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.575 2.184 . . . . 0.0 111.662 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -87.4 -10.5 51.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -78.52 108.88 12.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.443 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.5 tm? -76.0 110.8 10.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 34' ' ' ASN . 2.6 mtpt -124.3 109.66 29.01 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 109.313 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.4 Cg_endo -62.31 121.26 9.19 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 123.035 2.49 . . . . 0.0 112.272 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.582 ' HB ' HG23 ' A' ' 52' ' ' ILE . 11.1 m -115.78 155.78 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -0.804 . . . . 0.0 109.904 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.7 t -97.27 112.92 24.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.365 -0.834 . . . . 0.0 108.932 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -67.18 133.5 31.04 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.4 t0 -69.62 -6.46 31.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 109.783 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 57.4 p30 -85.53 1.99 46.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.084 -1.01 . . . . 0.0 109.342 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.71 18.26 30.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.3 mt-30 -126.84 173.88 9.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.498 -1.001 . . . . 0.0 109.341 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.887 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.5 m -132.63 138.35 47.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.266 -0.896 . . . . 0.0 109.29 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.86 ' CD2' HD12 ' A' ' 39' ' ' LEU . 31.4 m-85 -118.38 139.81 50.81 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.163 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -61.03 -76.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 -179.365 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.0 t-20 -82.31 146.81 55.22 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.988 -1.07 . . . . 0.0 109.64 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.9 Cg_endo -63.65 -52.23 1.98 Allowed 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.599 2.199 . . . . 0.0 111.68 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.537 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -63.42 -27.62 69.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 0.0 108.183 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.496 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 54.3 mtp -67.88 -19.8 65.06 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.315 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.86 HD12 ' CD2' ' A' ' 33' ' ' TYR . 7.3 tt -66.52 -52.92 40.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.331 -0.856 . . . . 0.0 108.873 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 43' ' ' ASN . 9.4 m -51.16 -41.05 59.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 40' ' ' CYS . 16.1 t60 -48.06 -48.1 33.54 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.972 -1.08 . . . . 0.0 108.209 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 49.8 mm-40 -58.37 -22.18 52.75 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 40' ' ' CYS . 2.9 m-80 -75.7 -35.83 60.18 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.997 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.651 HD21 ' OH ' ' A' ' 8' ' ' TYR . 31.7 mt -65.86 -48.69 70.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.301 -0.874 . . . . 0.0 109.389 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 45' ' ' ILE . 5.8 mm -67.2 -52.82 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.118 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.506 ' HG2' HG23 ' A' ' 48' ' ' THR . 72.8 ttt180 -68.56 -22.87 64.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.307 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ASN . 86.7 mt-30 63.06 43.17 6.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.363 -0.835 . . . . 0.0 109.571 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.506 HG23 ' HG2' ' A' ' 46' ' ' ARG . 60.7 p -132.96 167.42 20.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.145 -0.972 . . . . 0.0 109.576 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -94.3 57.83 2.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.601 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.48 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 57.0 m -80.19 127.16 32.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.467 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -115.79 -169.22 1.55 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.444 179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.582 HG23 ' HB ' ' A' ' 25' ' ' VAL . 37.8 mt -88.12 124.98 41.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.473 -0.767 . . . . 0.0 109.836 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.539 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 64.5 ttt180 -82.53 -49.64 9.67 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.746 0.784 . . . . 0.0 109.383 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 p -150.72 138.83 20.14 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -60.95 144.59 52.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.117 -0.99 . . . . 0.0 109.284 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.48 160.72 36.43 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.887 ' HG3' HG21 ' A' ' 32' ' ' THR . 17.7 tttm -61.52 148.87 40.62 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.521 -0.987 . . . . 0.0 109.397 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.1 145.31 32.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.654 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.587 -179.948 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.4 m -80.0 -5.54 55.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.296 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -61.6 -23.2 65.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.674 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -151.31 64.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.928 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.709 ' OH ' HD13 ' A' ' 44' ' ' LEU . 6.7 p90 -123.77 174.33 7.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.109 -0.994 . . . . 0.0 109.198 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -147.35 146.49 29.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.648 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.594 HG21 ' CD2' ' A' ' 16' ' ' TYR . 69.3 t -145.29 132.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.484 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.645 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -117.8 175.08 2.2 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.269 -0.894 . . . . 0.0 109.597 -179.968 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.645 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.9 Cg_endo -67.73 -26.35 39.1 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.687 2.258 . . . . 0.0 111.951 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -107.8 -24.49 11.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.369 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.4 mm -82.59 -43.08 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.577 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.25 -159.14 53.23 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.594 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.7 t80 -98.6 153.73 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -1.177 . . . . 0.0 109.466 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 31.3 tp -107.86 123.25 48.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 109.877 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 68.3 m -140.19 156.48 70.03 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.306 -0.871 . . . . 0.0 109.21 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.4 Cg_endo -71.56 167.6 25.96 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.558 2.172 . . . . 0.0 111.701 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -84.07 -29.47 26.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.613 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.34 125.94 25.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.418 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.584 HD11 ' CB ' ' A' ' 34' ' ' ASN . 59.5 tp -88.26 113.21 23.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.154 -0.966 . . . . 0.0 109.432 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.544 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.5 mttt -121.27 105.61 39.29 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.511 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -64.69 118.67 5.63 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 123.085 2.523 . . . . 0.0 112.215 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.473 ' HB ' HG23 ' A' ' 52' ' ' ILE . 14.1 m -115.72 156.01 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 109.885 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.4 t -98.95 142.87 29.9 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.688 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.404 ' C ' ' HB2' ' A' ' 53' ' ' ARG . . . -95.82 143.7 16.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.488 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.2 t0 -71.87 -14.33 61.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -1.124 . . . . 0.0 109.416 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -83.69 -5.38 59.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.44 22.04 10.87 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 85.5 mt-30 -121.46 170.95 9.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -1.13 . . . . 0.0 109.469 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.541 HG23 ' HA ' ' A' ' 57' ' ' LYS . 86.6 m -133.61 136.66 45.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.493 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.836 ' CD1' HD13 ' A' ' 39' ' ' LEU . 28.3 m-85 -115.02 146.23 41.47 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 108.754 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.584 ' CB ' HD11 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -67.98 -75.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.01 -1.056 . . . . 0.0 108.626 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.9 t-20 -82.77 146.7 53.29 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 109.403 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -63.61 -51.18 2.64 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.693 2.262 . . . . 0.0 111.591 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -62.18 -28.58 69.77 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.878 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.432 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 10.3 mtt -64.4 -16.91 63.21 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.836 HD13 ' CD1' ' A' ' 33' ' ' TYR . 30.9 tp -65.94 -53.69 35.98 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.5 t -60.65 -23.48 64.82 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.726 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 25.2 t60 -67.31 -58.98 3.8 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -58.79 -22.07 57.48 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.986 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 47' ' ' GLN . 78.2 m-20 -80.38 -30.77 37.87 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.709 HD13 ' OH ' ' A' ' 8' ' ' TYR . 49.5 tp -62.38 -35.56 79.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 108.76 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mt -80.49 -50.33 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.4 -0.813 . . . . 0.0 109.249 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 96.1 mtt180 -68.89 -40.27 79.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 92.7 mt-30 65.0 39.56 5.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.543 -0.723 . . . . 0.0 109.547 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 46' ' ' ARG . 40.6 p -108.15 6.97 27.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.393 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.1 t30 52.74 56.79 7.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.524 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.9 m -78.6 140.46 38.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -112.12 169.11 9.08 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.275 -0.891 . . . . 0.0 108.993 179.523 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.507 HG12 HD22 ' A' ' 39' ' ' LEU . 23.3 mt -79.47 127.11 39.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.218 -0.926 . . . . 0.0 109.241 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.488 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 53.7 ttt-85 -79.35 -46.14 18.23 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.389 -0.819 . . . . 0.0 109.134 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 m -160.61 148.08 15.89 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.7 p -61.18 145.3 51.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.6 166.23 40.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HA ' HG23 ' A' ' 32' ' ' THR . 89.2 mttt -67.71 150.16 49.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -1.085 . . . . 0.0 109.499 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 66.7 m -59.79 151.11 26.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.9 . . . . 0.0 109.318 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.488 179.971 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.0 ttm . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.477 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 81.3 m -81.64 -31.18 32.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.244 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -60.49 -23.71 64.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.398 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -76.41 -25.73 54.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.512 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.465 ' OH ' ' CD1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -103.66 155.22 18.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.197 -0.939 . . . . 0.0 109.226 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -128.36 139.71 52.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 0.0 109.317 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.758 HG21 ' C ' ' A' ' 15' ' ' GLY . 13.0 p -123.17 146.0 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -0.924 . . . . 0.0 109.51 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.556 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -108.59 176.08 1.72 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.3 Cg_endo -67.14 -25.4 43.54 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.601 2.201 . . . . 0.0 111.675 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -85.01 -31.3 23.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.253 -0.904 . . . . 0.0 108.917 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.8 mt -87.04 -37.68 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.398 -0.814 . . . . 0.0 109.128 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.758 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 66.52 142.24 0.05 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.678 ' N ' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -42.27 152.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.446 -1.032 . . . . 0.0 109.833 -179.921 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 tp -123.53 118.29 27.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.426 -0.796 . . . . 0.0 109.518 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.7 m -129.24 157.28 76.58 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.188 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.67 165.86 30.63 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.691 2.261 . . . . 0.0 111.755 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -89.12 -8.74 53.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.23 -0.919 . . . . 0.0 109.421 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -76.97 107.18 9.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 0.0 109.07 179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 34' ' ' ASN . 59.4 tp -71.2 121.16 17.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.811 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 31.1 mtmt -139.57 110.53 7.47 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.235 -0.915 . . . . 0.0 109.102 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.8 Cg_endo -65.54 119.48 6.51 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 C-N-CA 123.175 2.584 . . . . 0.0 112.631 -179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 32' ' ' THR . 27.3 m -112.49 156.22 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 0.0 109.65 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 12.3 t -98.59 111.44 23.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 109.315 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.3 138.16 36.17 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 40.1 t0 -71.26 -4.73 27.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -1.199 . . . . 0.0 109.606 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 57.6 m-20 -90.07 7.2 38.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.083 -1.01 . . . . 0.0 109.101 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.77 14.5 59.48 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 27' ' ' GLY . 77.0 mt-30 -125.69 140.23 52.88 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.414 -1.051 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 25' ' ' VAL . 17.1 m -103.59 153.21 20.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -0.902 . . . . 0.0 109.34 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.563 ' CZ ' ' HG3' ' A' ' 42' ' ' GLU . 19.9 m-85 -128.58 143.16 50.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.1 m-20 -58.54 -75.23 0.05 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -0.888 . . . . 0.0 109.962 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.7 t-20 -82.5 147.76 56.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.069 -1.019 . . . . 0.0 109.993 -179.543 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.5 Cg_endo -64.3 -53.44 1.12 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.746 2.298 . . . . 0.0 111.485 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.5 t -60.77 -27.69 68.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 36.5 mmm -63.78 -17.46 63.09 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.369 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.816 HD13 HG12 ' A' ' 52' ' ' ILE . 8.2 tt -68.26 -52.82 29.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.352 -0.843 . . . . 0.0 108.985 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.5 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . 45.0 m -47.9 -47.41 32.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.095 -1.003 . . . . 0.0 108.392 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.439 ' HA ' HD13 ' A' ' 44' ' ' LEU . 14.7 t60 -47.97 -49.35 30.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.128 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.563 ' HG3' ' CZ ' ' A' ' 33' ' ' TYR . 71.8 mm-40 -49.41 -24.05 1.79 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 4.6 m-80 -80.02 -37.64 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.416 -0.803 . . . . 0.0 108.873 179.352 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.3 mp -67.5 -36.71 81.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.221 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 45' ' ' ILE . 5.3 mt -77.12 -52.53 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.077 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 48' ' ' THR . 47.0 mtt-85 -71.85 -20.99 61.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.373 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 43' ' ' ASN . 88.2 mt-30 62.44 35.45 14.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -0.851 . . . . 0.0 109.312 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 46' ' ' ARG . 30.8 p -125.48 175.11 7.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.444 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.449 ' O ' ' CD2' ' A' ' 51' ' ' HIS . 79.8 m-20 -94.75 58.87 2.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 109.451 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.472 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 30.9 m -79.22 126.11 30.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.449 ' CD2' ' O ' ' A' ' 49' ' ' ASN . 48.2 m-70 -115.7 -172.57 2.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.172 179.672 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.816 HG12 HD13 ' A' ' 39' ' ' LEU . 13.0 mt -87.78 124.27 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 109.576 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 61.3 ttt180 -80.07 -53.49 6.66 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.647 0.737 . . . . 0.0 109.319 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 p -150.88 143.89 24.66 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.629 -0.67 . . . . 0.0 109.203 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.3 p -64.83 144.86 56.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.196 -0.94 . . . . 0.0 109.405 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.03 161.66 36.92 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 32' ' ' THR . 23.2 tttt -62.22 144.96 54.82 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.449 -1.03 . . . . 0.0 109.278 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.37 157.22 26.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.616 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.545 -179.986 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.4 mmm . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.595 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 33.5 m -80.31 -17.74 51.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.524 -0.735 . . . . 0.0 109.021 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -80.77 8.35 8.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.516 179.596 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -133.24 2.8 3.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.132 -0.98 . . . . 0.0 109.996 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.677 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -118.76 148.52 42.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.014 -1.054 . . . . 0.0 109.539 -179.977 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.7 mtm-85 -129.14 132.21 47.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.112 179.553 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.606 ' C ' HD22 ' A' ' 11' ' ' LEU . 42.2 t -126.51 140.48 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 -179.654 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 10' ' ' VAL . 3.8 mm? -117.95 170.26 6.53 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 41.7 Cg_endo -65.44 -21.43 60.56 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.192 1.928 . . . . 0.0 111.575 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -94.88 -25.29 16.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.418 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.2 mt -88.92 -50.44 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.298 -0.876 . . . . 0.0 109.944 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.567 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.24 -174.31 53.46 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.677 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -91.81 148.28 22.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -1.172 . . . . 0.0 109.552 -179.938 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.3 tp -120.96 100.67 7.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 109.728 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.6 m -111.04 157.73 37.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.235 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 53.6 Cg_endo -73.22 167.87 26.23 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.67 2.247 . . . . 0.0 111.681 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -87.62 -26.5 23.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 109.346 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.452 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 46.4 m-20 -57.89 124.54 19.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.163 -0.961 . . . . 0.0 109.171 179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 34' ' ' ASN . 36.2 tp -88.73 116.3 26.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.613 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASN . 3.8 mttt -127.43 103.2 22.65 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 108.983 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.527 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.7 Cg_endo -65.63 115.85 3.61 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.937 2.425 . . . . 0.0 111.842 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 32' ' ' THR . 21.7 m -113.89 154.43 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 0.0 109.732 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.1 t -94.22 131.49 39.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.343 -0.848 . . . . 0.0 108.738 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -86.85 137.24 14.64 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.4 p30 -66.23 -12.11 54.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -1.159 . . . . 0.0 109.616 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 52.6 p30 -83.75 8.92 13.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.01 20.83 54.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.451 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 68.8 mt-30 -125.51 175.98 7.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.47 -1.017 . . . . 0.0 109.326 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.602 HG21 ' HA ' ' A' ' 57' ' ' LYS . 14.1 m -135.1 136.38 41.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 109.432 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.65 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.5 m-85 -113.87 120.43 40.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.882 . . . . 0.0 109.267 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 10.4 m-20 -45.55 -78.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.985 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.3 t-20 -81.66 148.92 63.08 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.02 -1.05 . . . . 0.0 109.881 -179.583 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.2 Cg_endo -63.79 -54.35 0.98 Allowed 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.732 2.288 . . . . 0.0 111.927 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -63.01 -25.59 68.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.026 -1.046 . . . . 0.0 108.373 179.137 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.2 mmm -66.43 -11.56 52.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.559 -0.713 . . . . 0.0 109.095 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.65 HD13 ' CD1' ' A' ' 33' ' ' TYR . 20.9 tp -71.38 -60.12 2.4 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.29 -0.881 . . . . 0.0 108.707 179.594 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 10.3 t -54.65 -28.35 46.53 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.966 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -67.8 -60.64 2.36 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.143 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 78.4 mt-10 -57.78 -18.74 23.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 47' ' ' GLN . 96.7 m-20 -77.54 -32.6 54.06 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.92 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.4 tm? -58.36 -38.99 78.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.514 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mm -75.56 -49.73 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -0.867 . . . . 0.0 108.767 179.382 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 47.0 mtt-85 -63.71 -28.55 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.187 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 89.5 mt-30 63.15 44.03 6.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.6 p -133.51 167.05 21.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.576 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 48.7 p-10 -95.91 61.35 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.309 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.9 m -72.46 135.37 45.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.856 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 42.5 m80 -115.28 -178.1 3.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 108.939 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.2 mt -90.25 123.04 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 109.004 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 50.1 ttt85 -79.65 -44.52 20.77 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.393 -0.817 . . . . 0.0 109.432 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 p -158.56 158.09 33.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.549 -0.719 . . . . 0.0 109.121 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 p -75.5 136.97 40.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.897 . . . . 0.0 109.698 -179.626 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.47 162.73 34.11 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.602 ' HA ' HG21 ' A' ' 32' ' ' THR . 48.0 tttm -49.59 159.4 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.486 -1.008 . . . . 0.0 109.216 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.492 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 73.1 m -68.39 145.35 54.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.38 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.549 179.965 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.447 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 45.1 ttm . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 71.2 m -80.48 -9.15 59.77 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.451 -0.781 . . . . 0.0 109.138 179.657 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -81.12 11.03 4.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.092 -1.005 . . . . 0.0 109.617 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 4' ' ' MET . 49.2 p30 -127.31 8.29 6.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.994 -1.066 . . . . 0.0 110.653 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.778 ' OH ' HD11 ' A' ' 44' ' ' LEU . 6.9 p90 -107.59 -177.41 3.34 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.723 -1.235 . . . . 0.0 109.686 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.579 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 46.8 mtt180 -151.91 128.46 10.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.226 179.567 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.591 HG23 ' CE1' ' A' ' 8' ' ' TYR . 24.5 t -127.14 145.36 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.7 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.559 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -118.53 176.33 1.72 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.365 -0.834 . . . . 0.0 109.169 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.0 Cg_endo -66.96 -21.97 49.04 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.557 2.171 . . . . 0.0 111.773 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.8 mtt-85 -96.81 -27.75 14.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 mm -84.1 -47.47 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.707 -179.763 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.468 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 78.32 177.6 48.48 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -83.0 147.68 28.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -1.16 . . . . 0.0 109.435 -179.917 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.0 tp -118.9 105.74 11.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.755 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.9 m -116.22 155.87 47.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 108.964 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.25 165.63 32.08 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.561 2.174 . . . . 0.0 111.543 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -84.04 -31.79 25.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 109.267 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -54.18 132.8 43.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.384 -0.823 . . . . 0.0 109.052 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 34' ' ' ASN . 61.3 tp -96.93 119.45 35.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.175 -0.953 . . . . 0.0 109.628 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' ASN . 3.9 mttm -130.99 106.56 15.1 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 0.0 108.899 179.647 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.64 123.41 11.66 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 123.009 2.472 . . . . 0.0 112.354 -179.183 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.438 ' HB ' HG23 ' A' ' 52' ' ' ILE . 17.6 m -118.18 155.15 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.728 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.7 t -96.49 138.09 34.59 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.44 135.64 12.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -66.83 -11.03 53.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 109.465 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.7 p30 -89.03 10.68 20.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.437 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.45 19.25 57.24 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 90.1 mt-30 -120.5 178.42 4.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -1.147 . . . . 0.0 109.549 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.775 HG21 ' HG3' ' A' ' 57' ' ' LYS . 35.3 m -139.58 136.76 34.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.887 . . . . 0.0 109.29 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.903 ' CD1' HD13 ' A' ' 39' ' ' LEU . 26.4 m-85 -117.81 128.79 55.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.161 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 11.7 m-20 -52.66 -78.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.794 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.5 t-20 -81.69 147.25 58.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.99 -1.069 . . . . 0.0 109.719 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.5 Cg_endo -63.51 -52.12 2.12 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.782 2.321 . . . . 0.0 111.739 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.4 t -62.95 -26.47 68.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.16 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.441 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 54.0 mmm -68.71 -15.15 63.43 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.149 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.903 HD13 ' CD1' ' A' ' 33' ' ' TYR . 21.2 tp -72.21 -50.85 24.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.415 -0.803 . . . . 0.0 109.339 179.784 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.494 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.5 m -66.14 -22.38 66.38 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.017 -1.052 . . . . 0.0 108.224 179.265 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -66.81 -56.17 11.62 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.87 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.485 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 95.5 mt-10 -63.43 -17.04 62.26 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' GLN . 86.2 m-20 -79.95 -26.37 40.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.602 -0.686 . . . . 0.0 109.186 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.778 HD11 ' OH ' ' A' ' 8' ' ' TYR . 19.2 mt -69.02 -33.29 73.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.165 -0.959 . . . . 0.0 108.649 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.4 mt -78.73 -50.36 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 108.978 179.516 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.584 ' HB3' HG23 ' A' ' 48' ' ' THR . 47.0 mtm180 -74.35 -34.25 63.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.305 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 59.62 39.24 21.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.553 179.805 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.584 HG23 ' HB3' ' A' ' 46' ' ' ARG . 38.1 p -103.97 16.68 25.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 48' ' ' THR . 53.2 m-20 44.22 52.13 7.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.408 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.443 ' OG1' ' NH2' ' A' ' 46' ' ' ARG . 76.6 m -74.9 146.26 42.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.614 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -123.72 168.76 12.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.282 179.693 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.502 HG12 HD22 ' A' ' 39' ' ' LEU . 16.9 mt -79.73 124.35 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.447 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 78.3 ttt180 -79.76 -44.14 21.24 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 p -160.19 148.82 17.04 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.624 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 p -64.86 145.12 56.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.166 -0.959 . . . . 0.0 109.536 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.94 164.23 39.79 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.775 ' HG3' HG21 ' A' ' 32' ' ' THR . 17.4 tttt -60.44 151.45 28.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.461 -1.023 . . . . 0.0 109.361 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.402 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 72.2 m -58.47 152.39 18.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.469 179.89 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.556 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 5.7 m -79.77 -12.35 59.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.447 -0.783 . . . . 0.0 109.05 179.496 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -55.21 -26.78 41.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.933 -179.8 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -151.56 65.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.692 -179.757 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.932 ' OH ' HD11 ' A' ' 44' ' ' LEU . 4.1 p90 -128.79 170.7 13.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.508 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -144.85 154.99 43.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.293 -0.88 . . . . 0.0 109.386 179.579 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.846 HG13 ' C ' ' A' ' 15' ' ' GLY . 95.3 t -146.66 127.27 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.523 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -117.19 173.42 3.15 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.21 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HD2' HD23 ' A' ' 11' ' ' LEU . 43.1 Cg_endo -65.94 -22.92 55.11 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.498 2.132 . . . . 0.0 111.568 179.736 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -105.92 -33.66 7.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.852 . . . . 0.0 109.066 179.565 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.403 HD12 HD13 ' A' ' 11' ' ' LEU . 89.6 mt -81.64 -40.95 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.118 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.846 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 65.09 -145.13 48.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.9 t80 -105.34 158.0 16.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.31 -1.112 . . . . 0.0 109.495 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.32 114.01 21.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 62.6 m -128.1 156.19 76.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.331 179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.13 170.28 18.55 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.616 2.211 . . . . 0.0 111.625 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -91.3 -12.48 34.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.122 -0.986 . . . . 0.0 109.644 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -73.3 115.84 13.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.283 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 tp -73.17 126.36 29.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.625 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -139.75 100.39 7.41 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.849 . . . . 0.0 109.007 179.818 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -64.09 117.71 4.71 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.971 2.447 . . . . 0.0 112.345 -179.272 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 32' ' ' THR . 11.0 m -116.1 155.15 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.402 -0.811 . . . . 0.0 109.841 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.7 t -96.81 137.31 36.09 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.27 139.56 14.6 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 46.2 p30 -65.76 -9.12 25.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -1.068 . . . . 0.0 109.612 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -89.12 14.03 11.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.12 26.33 58.06 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.459 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 79.7 mt-30 -130.5 174.86 9.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -1.166 . . . . 0.0 109.288 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 32.9 m -131.81 152.93 50.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.882 ' CD2' HD12 ' A' ' 39' ' ' LEU . 40.6 m-85 -132.68 119.88 20.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.246 -0.909 . . . . 0.0 109.197 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 3.7 m-20 -43.6 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 109.689 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.2 t-20 -81.69 146.26 56.21 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.299 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.94 -50.95 2.57 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.593 2.195 . . . . 0.0 111.483 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.8 t -61.96 -25.35 67.56 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.828 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.438 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 13.9 mtp -68.14 -17.95 64.49 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.368 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.882 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.3 tt -67.74 -50.61 56.35 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.426 -0.796 . . . . 0.0 108.858 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 4.7 t -52.54 -45.69 66.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 0.0 108.521 179.194 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.403 ' HA ' HD23 ' A' ' 44' ' ' LEU . 15.9 t60 -48.99 -48.94 43.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.16 -0.962 . . . . 0.0 108.481 179.041 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 23.0 mm-40 -57.18 -20.22 25.28 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.528 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.8 m-80 -79.69 -33.13 41.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 108.612 179.2 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.932 HD11 ' OH ' ' A' ' 8' ' ' TYR . 3.9 mm? -67.11 -46.71 73.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 109.388 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.495 ' N ' HD13 ' A' ' 45' ' ' ILE . 5.0 mm -66.47 -52.21 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 48' ' ' THR . 66.4 mtp85 -71.02 -19.24 62.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.204 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 60.81 34.45 19.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 46' ' ' ARG . 8.7 p -123.06 -177.55 3.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.519 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 36.5 t-20 -107.59 64.78 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.923 . . . . 0.0 109.527 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 25.0 m -78.91 127.71 32.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 109.66 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.519 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 3.8 m80 -113.84 -172.13 2.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.25 -0.906 . . . . 0.0 109.143 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.474 HG12 HD13 ' A' ' 39' ' ' LEU . 22.9 mt -89.15 124.16 41.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.21 -0.932 . . . . 0.0 109.572 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.3 ttt-85 -80.8 -42.59 21.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.407 -0.808 . . . . 0.0 109.307 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -160.95 140.77 10.83 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.563 -0.71 . . . . 0.0 109.139 -179.568 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 p -57.9 140.6 51.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -0.957 . . . . 0.0 109.623 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 96.38 165.91 33.68 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 27.5 mttp -67.6 143.36 56.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.532 -0.981 . . . . 0.0 109.258 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 62.3 m -53.43 148.92 8.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.446 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.504 -179.955 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.4 mmm . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.571 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.6 m -80.06 -5.0 55.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.369 -0.832 . . . . 0.0 109.301 179.608 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 23.7 mttm -61.26 -28.73 69.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 -179.546 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 80.5 m-20 -145.1 61.66 1.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.067 -1.021 . . . . 0.0 110.339 -179.635 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.637 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 6.5 p90 -127.03 171.34 11.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.064 -1.023 . . . . 0.0 109.309 179.429 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -146.14 148.9 33.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 109.567 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 15' ' ' GLY . 85.8 t -138.51 132.26 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.419 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -123.66 175.65 2.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.349 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.5 Cg_endo -67.21 -25.84 42.71 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.53 2.153 . . . . 0.0 111.514 179.813 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -107.37 -27.33 10.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.388 -0.82 . . . . 0.0 108.991 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.9 mm -82.06 -39.77 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 109.437 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.771 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 68.98 -145.62 43.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.637 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 3.3 t80 -111.17 155.17 23.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -1.164 . . . . 0.0 109.27 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 39.7 mt -111.64 123.79 50.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.942 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.1 m -142.0 155.36 65.58 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.457 -0.777 . . . . 0.0 108.954 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.36 164.57 34.66 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.51 2.14 . . . . 0.0 111.554 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -83.46 -26.48 30.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.875 . . . . 0.0 109.544 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.51 129.31 40.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 109.299 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 34' ' ' ASN . 52.7 tp -88.8 123.17 32.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 0.0 109.472 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.2 mmtm -133.91 102.74 12.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.432 -0.793 . . . . 0.0 109.179 179.815 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' CB ' ' HG3' ' A' ' 57' ' ' LYS . 42.1 Cg_endo -64.05 122.04 9.91 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 123.032 2.488 . . . . 0.0 112.331 -179.222 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 32' ' ' THR . 16.8 m -122.22 155.41 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.753 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 34.7 t -99.15 137.51 37.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.403 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.16 138.74 14.13 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.212 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 56.6 p30 -63.59 -11.14 22.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -1.064 . . . . 0.0 109.671 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 86.4 m-20 -85.76 12.93 7.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.345 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.39 20.22 69.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.0 mt-30 -124.52 159.52 30.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -1.121 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 57.3 m -119.97 142.66 48.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -0.963 . . . . 0.0 109.569 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.648 ' CD2' HD12 ' A' ' 39' ' ' LEU . 57.7 m-85 -121.36 130.88 53.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.386 -0.821 . . . . 0.0 109.16 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.1 m-20 -53.8 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.16 -0.962 . . . . 0.0 109.54 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 11.4 t-20 -82.26 147.07 56.0 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 120.99 -1.069 . . . . 0.0 109.699 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.0 Cg_endo -63.1 -51.24 2.94 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.569 2.179 . . . . 0.0 111.409 179.371 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.502 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -60.25 -29.75 68.98 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.804 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 38.3 mmm -64.4 -23.52 67.32 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.35 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.648 HD12 ' CD2' ' A' ' 33' ' ' TYR . 7.2 tt -63.4 -48.01 79.6 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.362 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 12.0 t -52.63 -34.01 49.32 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -54.43 -50.04 68.59 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 108.763 179.206 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 26.2 tp10 -56.78 -19.9 19.52 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.363 -0.836 . . . . 0.0 108.774 179.338 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 4.7 m-80 -80.06 -31.65 39.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.858 . . . . 0.0 109.125 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.862 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.4 tm? -68.89 -42.39 77.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.084 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 45' ' ' ILE . 4.0 mt -71.17 -55.22 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 109.175 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.443 ' NH1' ' HG2' ' A' ' 46' ' ' ARG . 35.6 mtt-85 -70.33 -21.73 62.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.394 -0.816 . . . . 0.0 109.258 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 62.3 32.33 17.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.343 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.9 p -119.52 176.78 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 109.353 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.562 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 84.6 m-20 -100.13 61.37 1.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.481 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 56.0 m -71.79 131.7 43.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.882 . . . . 0.0 109.522 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 5.8 m80 -116.58 -175.88 2.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.277 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.502 HG12 HD13 ' A' ' 39' ' ' LEU . 20.6 mt -86.19 124.26 40.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.199 -0.938 . . . . 0.0 109.542 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 70.1 ttt180 -80.53 -39.71 27.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.421 -0.799 . . . . 0.0 109.051 179.694 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -158.57 153.56 25.18 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.2 p -73.39 145.57 45.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.179 -0.951 . . . . 0.0 109.495 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.92 164.71 40.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HG3' ' CB ' ' A' ' 24' ' ' PRO . 37.5 mttp -63.09 144.88 56.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.478 -1.013 . . . . 0.0 109.406 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.411 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 0.1 OUTLIER -78.53 156.08 29.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 179.992 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.57 179.998 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.1 mmm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 38.2 m -81.19 -19.58 43.03 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.387 -0.821 . . . . 0.0 109.331 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -80.68 9.26 6.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -133.17 2.69 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.973 . . . . 0.0 109.958 -179.709 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.594 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -119.45 144.89 46.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.02 -1.05 . . . . 0.0 109.74 -179.916 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.0 mtt85 -127.5 129.83 48.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 108.894 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.796 ' O ' HD22 ' A' ' 11' ' ' LEU . 42.9 t -116.76 141.49 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.035 -1.041 . . . . 0.0 110.201 -179.289 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 10' ' ' VAL . 4.0 mm? -124.43 171.09 7.69 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.582 ' HD2' HD12 ' A' ' 11' ' ' LEU . 42.7 Cg_endo -66.28 -22.25 53.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.305 2.003 . . . . 0.0 111.666 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -97.0 -29.51 13.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 109.206 179.635 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 11' ' ' LEU . 80.6 mt -83.06 -48.57 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.402 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.744 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 86.7 -175.0 46.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.459 ' OH ' ' HB3' ' A' ' 40' ' ' CYS . 1.5 t80 -81.15 153.05 27.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -1.143 . . . . 0.0 109.544 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 17' ' ' LEU . 38.6 mt -127.86 134.08 49.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 72.4 m -146.92 158.4 45.35 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.347 -0.845 . . . . 0.0 109.141 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.9 Cg_endo -69.52 167.5 23.94 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.636 2.224 . . . . 0.0 111.459 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -85.62 -21.72 28.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.188 -0.945 . . . . 0.0 109.693 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -68.01 115.98 8.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.307 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 35' ' ' ASN . 32.9 tp -86.95 121.38 29.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.174 -0.954 . . . . 0.0 109.536 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASN . 13.0 mmtm -135.83 113.26 10.75 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.403 -0.81 . . . . 0.0 108.908 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.531 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -64.78 116.06 3.59 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.953 2.436 . . . . 0.0 112.13 -179.351 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 32' ' ' THR . 34.2 m -113.53 156.13 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.956 -179.822 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.5 t -100.49 124.02 45.47 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -80.85 137.54 18.13 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.621 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.584 ' OD1' HG23 ' A' ' 50' ' ' THR . 46.8 p30 -63.9 -10.58 21.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -1.127 . . . . 0.0 109.727 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.412 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 28.5 m-20 -87.29 16.76 4.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.52 19.59 75.95 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.8 mt-30 -120.83 169.0 10.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -1.1 . . . . 0.0 109.392 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 88.6 m -129.86 142.71 50.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.403 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.756 ' HD2' HD12 ' A' ' 39' ' ' LEU . 41.8 m-85 -122.43 118.0 27.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.329 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.1 m-20 -43.09 -75.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.855 . . . . 0.0 109.536 -179.656 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.1 t-20 -81.79 150.28 65.54 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.81 -54.5 1.17 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.684 2.256 . . . . 0.0 111.906 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 4.0 t -58.42 -30.5 66.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.947 -1.095 . . . . 0.0 108.149 179.051 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 7.5 mtt -59.71 -21.09 60.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.882 HD13 HG12 ' A' ' 52' ' ' ILE . 7.3 tt -66.89 -53.63 30.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 16.9 t -49.48 -28.56 5.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.437 ' CD2' HD11 ' A' ' 45' ' ' ILE . 21.5 t60 -57.89 -53.58 56.64 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.282 -0.886 . . . . 0.0 108.617 179.078 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.59 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 16.3 tp10 -54.03 -20.48 6.43 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.8 m-80 -80.46 -33.44 36.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 108.773 179.541 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.26 -39.35 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.83 . . . . 0.0 109.346 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.437 HD11 ' CD2' ' A' ' 41' ' ' HIS . 1.0 OUTLIER -80.31 -46.56 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.66 -179.888 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 27.0 mmt180 -80.3 -33.83 37.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.542 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 89.5 mt-30 58.97 32.05 21.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.504 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 81.2 p -104.63 6.23 34.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.151 -0.968 . . . . 0.0 109.637 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.567 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 73.3 m-20 63.11 52.86 2.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.637 179.92 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.584 HG23 ' OD1' ' A' ' 28' ' ' ASP . 91.6 m -78.7 142.35 37.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 109.357 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 35.7 m80 -120.33 -171.7 2.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.535 179.983 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.882 HG12 HD13 ' A' ' 39' ' ' LEU . 11.2 mt -92.05 123.35 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 179.848 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.4 ttt180 -79.31 -50.73 10.44 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.327 -0.858 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -158.93 139.31 12.35 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 109.348 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.435 ' H ' HG23 ' A' ' 55' ' ' THR . 7.4 p -53.54 145.86 14.11 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.35 162.91 35.5 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 53.8 mttp -66.93 150.04 49.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.458 -1.025 . . . . 0.0 109.528 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 72.7 m -59.27 147.17 36.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.91 . . . . 0.0 109.395 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.534 -179.932 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.6 ttt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.591 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 30.7 m -82.76 -15.46 51.71 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.3 -0.875 . . . . 0.0 109.451 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 23.5 mttm -80.65 7.51 9.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.729 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 98.3 m-20 -138.23 16.02 2.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.028 -1.045 . . . . 0.0 110.29 -179.401 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.1 p90 -126.58 153.0 45.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.925 -1.11 . . . . 0.0 109.697 179.857 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -131.53 143.84 50.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.309 -0.869 . . . . 0.0 108.834 179.171 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.865 HG13 ' O ' ' A' ' 15' ' ' GLY . 55.7 t -132.65 134.96 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 -179.766 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.74 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -115.11 174.65 2.25 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.226 179.89 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.4 Cg_endo -67.15 -22.63 46.81 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.59 2.194 . . . . 0.0 111.68 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -101.7 -22.0 14.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 179.959 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 11' ' ' LEU . 94.8 mt -88.96 -45.42 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.671 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.865 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 77.27 -165.65 53.26 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.7 t80 -96.02 150.01 20.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -1.2 . . . . 0.0 109.499 179.935 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.5 tp -116.97 118.33 32.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.3 m -130.34 157.03 78.53 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.9 Cg_endo -70.91 166.31 29.44 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.612 2.208 . . . . 0.0 111.655 -179.721 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -86.42 -20.9 27.51 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.308 -0.87 . . . . 0.0 109.352 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -65.4 125.95 26.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.95 . . . . 0.0 109.11 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.1 tp -90.77 119.22 30.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.683 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -132.82 106.84 12.73 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.031 179.689 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -65.09 120.55 7.8 Favored 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 122.88 2.387 . . . . 0.0 112.108 -179.556 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.49 ' HB ' HG23 ' A' ' 52' ' ' ILE . 30.3 m -118.14 154.45 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.644 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 31.1 t -97.11 136.14 38.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.251 -0.906 . . . . 0.0 108.769 179.235 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.29 139.98 16.47 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.472 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.7 t0 -70.95 -5.33 30.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.141 -1.211 . . . . 0.0 109.563 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -92.84 5.82 49.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.344 179.676 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.19 14.93 53.39 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.873 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -116.07 175.83 5.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -1.116 . . . . 0.0 109.561 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.929 HG21 ' HG3' ' A' ' 57' ' ' LYS . 30.5 m -138.94 135.43 34.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.122 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.774 ' CD1' HD13 ' A' ' 39' ' ' LEU . 22.0 m-85 -115.6 131.08 57.04 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.307 -179.887 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.5 m-20 -55.41 -76.95 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 -179.515 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.9 t-20 -81.94 148.54 61.04 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.014 -1.053 . . . . 0.0 109.81 -179.73 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.4 Cg_endo -62.73 -53.8 1.54 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.897 2.398 . . . . 0.0 111.916 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.9 t -62.37 -26.91 68.72 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.073 -1.017 . . . . 0.0 108.381 179.189 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.47 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 18.8 mtt -64.67 -18.1 64.67 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.343 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.774 HD13 ' CD1' ' A' ' 33' ' ' TYR . 26.8 tp -66.82 -54.96 17.24 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.451 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.467 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 14.2 t -61.21 -23.9 65.95 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.57 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -70.12 -60.94 1.98 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.19 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.432 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 84.2 tt0 -56.7 -20.98 24.59 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.434 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 47' ' ' GLN . 86.5 m-20 -78.64 -35.99 44.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.133 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 44' ' ' LEU . 42.9 tp -58.65 -33.82 70.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.55 -50.18 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.433 -0.792 . . . . 0.0 108.922 179.452 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 34.5 mtt-85 -69.06 -24.15 64.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.263 179.685 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 43' ' ' ASN . 88.8 mt-30 64.13 41.75 6.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.849 . . . . 0.0 109.478 -179.858 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.4 p -124.74 165.36 18.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 109.267 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -98.36 63.49 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.4 m -78.29 136.24 37.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 109.84 -179.866 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -114.26 171.44 7.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.181 179.63 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.557 HG12 HD22 ' A' ' 39' ' ' LEU . 40.7 mt -80.04 126.92 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.5 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 73.4 ttt180 -79.91 -49.81 11.36 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.652 0.739 . . . . 0.0 109.314 179.806 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.7 m -156.57 145.84 20.5 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.858 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.4 p -61.99 151.3 35.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.537 -179.939 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 81.36 163.49 31.03 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.699 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.929 ' HG3' HG21 ' A' ' 32' ' ' THR . 14.6 tttt -63.81 150.58 44.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -1.068 . . . . 0.0 109.259 179.838 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.24 148.3 34.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.241 -0.912 . . . . 0.0 109.533 -179.909 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.475 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 5' ' ' CYS . 4.2 m -45.82 -25.32 0.5 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.419 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.45 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.4 mt-10 -49.75 -25.27 2.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 0.0 108.689 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.7 mtp -79.87 -27.44 40.06 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.498 ' N ' ' O ' ' A' ' 2' ' ' SER . 4.4 m -80.25 -6.76 58.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.499 -0.751 . . . . 0.0 109.112 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 17.3 mttm -57.69 -25.65 60.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.844 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -149.82 66.87 0.99 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 110.051 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.661 ' OH ' HD13 ' A' ' 44' ' ' LEU . 6.2 p90 -127.27 171.03 11.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 109.153 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -145.39 155.64 43.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.739 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.792 HG13 ' C ' ' A' ' 15' ' ' GLY . 92.7 t -148.57 122.75 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 109.291 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.557 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 mp -114.6 175.67 1.79 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.334 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.9 Cg_endo -67.64 -28.13 37.88 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.579 2.186 . . . . 0.0 111.578 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -101.48 -26.33 13.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.21 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 11' ' ' LEU . 91.6 mt -88.49 -41.19 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.365 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.792 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 66.02 -144.67 46.82 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.52 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 2.0 t80 -104.7 157.66 17.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -1.19 . . . . 0.0 109.476 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.2 tp -119.36 119.55 34.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.897 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 85.9 m -135.52 157.04 77.23 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.153 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.9 Cg_endo -70.93 167.38 26.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.468 2.112 . . . . 0.0 111.585 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.64 -13.89 36.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.431 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.32 121.27 19.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.122 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.6 tp -84.03 114.92 22.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 0.0 109.781 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mmtm -128.45 107.37 19.15 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 108.94 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.6 Cg_endo -65.96 121.06 8.31 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 123.141 2.561 . . . . 0.0 112.41 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.515 ' HB ' HG23 ' A' ' 52' ' ' ILE . 34.8 m -118.2 156.11 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.786 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.5 t -97.1 142.15 29.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 108.855 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.48 138.38 13.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.507 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.5 p30 -66.48 -15.06 63.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -1.105 . . . . 0.0 109.569 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 85.9 m-20 -84.64 8.83 15.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.68 25.81 37.38 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.446 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 82.2 mt-30 -125.65 177.21 6.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -1.094 . . . . 0.0 109.328 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.536 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 16.4 m -137.97 138.4 38.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 109.298 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.823 ' CD1' HD13 ' A' ' 39' ' ' LEU . 41.8 m-85 -118.17 121.08 39.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.316 -0.865 . . . . 0.0 109.265 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.7 m-20 -46.71 -78.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.836 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.7 t-20 -81.54 146.9 58.17 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 120.88 -1.137 . . . . 0.0 109.669 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.26 -53.08 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.839 2.359 . . . . 0.0 111.705 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -62.92 -27.58 69.48 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.988 -1.07 . . . . 0.0 108.13 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.425 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 24.6 mtp -64.52 -17.5 63.96 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.823 HD13 ' CD1' ' A' ' 33' ' ' TYR . 24.5 tp -66.43 -54.75 20.59 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 7.7 t -60.07 -27.35 66.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.52 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 36.8 t60 -63.1 -57.4 10.71 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -61.35 -21.26 63.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 47' ' ' GLN . 89.6 m-20 -79.91 -26.9 40.02 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.661 HD13 ' OH ' ' A' ' 8' ' ' TYR . 38.3 tp -65.71 -36.81 84.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.393 -0.817 . . . . 0.0 108.982 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.6 mt -80.08 -48.57 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.03 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 75.7 mtt-85 -70.77 -39.41 73.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 109.535 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.9 mt-30 64.01 40.66 7.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.83 . . . . 0.0 109.416 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 46' ' ' ARG . 44.8 p -108.93 5.41 24.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.595 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 52.73 59.25 4.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.602 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 m -79.41 141.75 36.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.895 . . . . 0.0 109.467 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.445 ' CD2' ' N ' ' A' ' 51' ' ' HIS . 33.5 m-70 -114.09 167.68 10.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.85 . . . . 0.0 108.967 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.515 HG23 ' HB ' ' A' ' 25' ' ' VAL . 35.1 mt -80.22 127.26 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.026 . . . . 0.0 109.433 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.507 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.7 ttt180 -80.03 -42.24 24.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.373 -0.829 . . . . 0.0 109.146 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 t -160.35 156.22 25.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.6 p -70.91 144.3 50.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 109.475 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.27 166.85 40.68 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 54.1 mttp -67.02 149.68 50.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -1.075 . . . . 0.0 109.404 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 56.7 m -59.46 152.69 21.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.526 -179.883 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.481 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 4.3 m -48.21 -29.07 3.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.331 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -53.41 -25.69 16.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 108.886 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.7 mtp -79.01 -25.52 43.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.463 -0.773 . . . . 0.0 108.934 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 8' ' ' TYR . 31.6 m -81.18 -19.67 42.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -0.847 . . . . 0.0 109.136 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 5' ' ' CYS . 23.5 mttm -45.21 -28.81 0.84 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 109.024 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 55.4 p30 -111.13 31.21 6.23 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 5' ' ' CYS . 2.1 t80 -80.0 144.07 33.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.57 -0.706 . . . . 0.0 109.675 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -142.78 115.24 8.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.352 -0.842 . . . . 0.0 109.299 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.793 HG21 ' N ' ' A' ' 16' ' ' TYR . 9.3 p -129.82 145.78 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.601 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.551 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -103.63 174.47 2.76 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.6 Cg_endo -67.89 -25.1 39.24 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.622 2.215 . . . . 0.0 111.803 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -91.88 -29.72 16.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 0.0 109.255 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.6 mt -81.47 -39.57 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.575 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.694 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 64.41 140.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.793 ' N ' HG21 ' A' ' 10' ' ' VAL . 1.2 t80 -43.85 153.58 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -1.195 . . . . 0.0 109.456 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 32.5 tp -119.26 126.19 50.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.844 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 66.3 m -139.37 156.63 71.64 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.989 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.68 166.34 30.18 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.562 2.175 . . . . 0.0 111.66 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -86.79 -19.89 28.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -66.08 122.58 17.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.274 -0.891 . . . . 0.0 109.502 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.5 tp -82.51 126.5 32.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.55 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -139.86 100.44 7.32 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.32 118.6 5.55 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.904 2.403 . . . . 0.0 112.27 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.411 ' HB ' HG23 ' A' ' 52' ' ' ILE . 13.7 m -116.51 155.53 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.664 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 47.2 t -95.57 133.86 39.1 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 108.804 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.88 136.47 13.65 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.5 p30 -66.99 -8.31 28.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -1.152 . . . . 0.0 109.643 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -88.02 10.47 18.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.352 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.01 21.87 54.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 72.8 mt-30 -126.33 175.52 7.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -1.081 . . . . 0.0 109.578 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.621 HG21 ' HG3' ' A' ' 57' ' ' LYS . 21.1 m -135.2 138.9 44.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.393 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.907 ' CD1' HD13 ' A' ' 39' ' ' LEU . 61.1 m-85 -118.06 125.42 50.28 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.279 -0.888 . . . . 0.0 109.299 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.0 m-20 -49.79 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.646 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.1 t-20 -82.06 146.06 54.41 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.015 -1.053 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.89 -51.64 2.82 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.774 2.316 . . . . 0.0 111.538 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.5 t -60.9 -29.96 69.89 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.442 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 16.4 mtp -65.2 -13.45 58.26 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.907 HD13 ' CD1' ' A' ' 33' ' ' TYR . 43.5 tp -68.87 -52.09 33.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 109.095 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.463 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.8 m -66.68 -22.2 66.08 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -67.27 -55.55 13.48 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.1 mm-40 -61.99 -20.01 63.42 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' GLN . 8.6 m120 -80.43 -36.82 33.14 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.0 tp -54.79 -34.64 62.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.1 mm -80.13 -50.95 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.457 -0.777 . . . . 0.0 108.966 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 7.2 mtp85 -64.36 -24.89 67.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.251 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.4 mt-30 62.96 41.62 8.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.836 . . . . 0.0 109.477 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 p -128.32 167.93 16.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.435 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 48.1 p-10 -98.28 62.27 1.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.536 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.6 m -76.5 129.19 36.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.431 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 59.3 m80 -111.22 172.52 6.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.37 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.514 HG12 HD22 ' A' ' 39' ' ' LEU . 27.5 mt -79.72 124.55 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.234 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 58.7 ttt85 -79.99 -44.38 20.33 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.397 -0.814 . . . . 0.0 109.362 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 p -157.08 158.62 36.77 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.465 -0.772 . . . . 0.0 109.114 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -76.88 133.0 39.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.533 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 100.47 163.48 28.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.621 ' HG3' HG21 ' A' ' 32' ' ' THR . 14.2 tttp -53.34 154.41 3.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.496 -1.002 . . . . 0.0 109.457 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 89.5 m -64.88 147.39 53.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.385 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -60.14 -26.18 66.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 109.491 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -52.18 -26.17 10.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.065 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.429 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 67.8 mtm -76.35 -28.09 56.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.566 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 2.8 m -80.64 -9.47 59.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.497 -0.752 . . . . 0.0 109.173 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -80.53 8.77 7.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 109.662 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 4' ' ' MET . 43.7 p30 -120.1 -0.31 10.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.08 -1.013 . . . . 0.0 110.065 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.78 ' HE1' HG23 ' A' ' 10' ' ' VAL . 4.2 p90 -103.37 -179.61 4.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.974 -1.078 . . . . 0.0 109.632 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.606 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 56.2 mtt180 -162.39 140.93 8.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.522 -0.736 . . . . 0.0 109.201 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.78 HG23 ' HE1' ' A' ' 8' ' ' TYR . 61.4 t -117.69 140.17 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 109.747 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.766 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -128.09 175.65 3.29 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.401 -0.812 . . . . 0.0 109.143 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.766 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.9 Cg_endo -67.31 -22.4 46.18 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.557 2.172 . . . . 0.0 111.674 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -121.47 -12.15 8.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.425 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 11' ' ' LEU . 31.4 mm -86.91 -50.68 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.563 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 83.89 -169.43 46.48 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.567 ' HA ' HG22 ' A' ' 10' ' ' VAL . 1.5 t80 -83.16 148.89 27.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.171 -1.193 . . . . 0.0 109.544 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.443 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 20.8 tp -119.57 130.05 54.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.742 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 73.2 m -145.19 157.53 53.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.0 109.023 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.5 Cg_endo -70.38 166.42 28.43 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.541 2.161 . . . . 0.0 111.554 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -84.2 -31.75 24.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.215 -0.928 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -54.87 134.42 48.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.346 -0.846 . . . . 0.0 109.054 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.935 HD11 ' OD1' ' A' ' 34' ' ' ASN . 61.2 tp -101.74 123.45 45.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.932 . . . . 0.0 109.504 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 10.9 mttt -140.32 111.58 7.13 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -65.59 120.25 7.41 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 122.989 2.459 . . . . 0.0 112.024 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 32' ' ' THR . 35.0 m -117.65 153.86 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.233 -0.917 . . . . 0.0 109.772 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 35.6 t -95.48 132.59 40.41 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.23 137.89 13.94 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 43.0 p30 -67.19 -8.28 30.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -1.062 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.45 16.17 5.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.34 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.25 20.61 72.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 27' ' ' GLY . 76.2 mt-30 -131.13 153.66 49.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -1.209 . . . . 0.0 109.586 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.544 HG21 ' HA ' ' A' ' 57' ' ' LYS . 11.1 m -115.74 141.01 48.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.769 ' HD2' HD12 ' A' ' 39' ' ' LEU . 50.0 m-85 -115.26 130.85 57.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.296 -0.877 . . . . 0.0 109.327 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.935 ' OD1' HD11 ' A' ' 22' ' ' LEU . 50.8 t-20 -53.07 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.315 -0.865 . . . . 0.0 109.563 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -81.39 150.02 66.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.998 -1.064 . . . . 0.0 109.416 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -62.47 -54.08 1.51 Allowed 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.7 2.267 . . . . 0.0 112.051 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.545 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -59.84 -30.61 69.07 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.97 -1.081 . . . . 0.0 108.159 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 16.4 mtp -59.29 -25.41 64.09 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.844 HD13 HG12 ' A' ' 52' ' ' ILE . 7.6 tt -63.93 -46.37 85.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 35.0 m -55.86 -27.99 54.34 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -59.33 -49.73 76.7 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 18.0 tp10 -57.71 -19.22 25.73 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 50' ' ' THR . 4.0 m-80 -80.36 -35.13 35.89 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.38 -37.99 74.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.456 -0.777 . . . . 0.0 109.308 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.94 -51.17 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.259 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.539 ' CD ' ' HG3' ' A' ' 42' ' ' GLU . 67.9 mtp85 -73.13 -33.12 65.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 109.636 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.2 mt-30 58.15 27.45 15.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 82.4 p -105.04 5.17 32.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.18 -0.95 . . . . 0.0 109.544 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.519 ' O ' ' NE2' ' A' ' 51' ' ' HIS . 33.4 m120 64.53 52.37 1.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.873 . . . . 0.0 109.675 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 67.8 m -72.3 135.94 46.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.519 ' NE2' ' O ' ' A' ' 49' ' ' ASN . 5.3 m-70 -115.34 -177.23 3.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.295 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.844 HG12 HD13 ' A' ' 39' ' ' LEU . 23.6 mt -87.09 124.25 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.904 . . . . 0.0 109.473 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 44.7 ttt-85 -80.44 -40.59 26.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.41 -0.806 . . . . 0.0 109.341 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -159.04 151.23 21.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.481 -0.762 . . . . 0.0 109.204 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.6 p -71.21 146.56 48.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.132 -0.98 . . . . 0.0 109.382 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.19 166.69 42.61 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.544 ' HA ' HG21 ' A' ' 32' ' ' THR . 62.4 tttt -65.25 146.32 55.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -1.101 . . . . 0.0 109.252 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.1 150.71 30.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.699 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.45 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.316 0.579 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.6 ' OG ' HD22 ' A' ' 39' ' ' LEU . 3.9 m -51.34 -26.42 7.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.627 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.467 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 4.0 mt-10 -53.69 -20.9 6.0 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.291 -0.881 . . . . 0.0 109.051 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.6 mtt -78.46 -28.6 46.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.312 -0.867 . . . . 0.0 109.028 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 m -79.64 -17.03 54.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 109.133 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 60.9 mttt -47.74 -23.73 0.78 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.254 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -116.66 41.85 2.59 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 17' ' ' LEU . 4.8 t80 -92.63 160.93 14.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.604 0.716 . . . . 0.0 110.748 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.432 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 10.1 ttp180 -146.39 135.47 22.6 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.968 HG13 ' C ' ' A' ' 15' ' ' GLY . 55.2 t -126.87 117.6 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.968 . . . . 0.0 109.669 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.557 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -100.24 175.71 2.26 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 109.506 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.4 Cg_endo -67.45 -24.01 43.16 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.741 2.294 . . . . 0.0 112.118 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -108.66 -21.63 12.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.383 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.1 -45.53 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.868 . . . . 0.0 109.603 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.968 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 65.98 -148.3 50.86 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.519 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 1.2 t80 -99.48 154.55 18.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -1.213 . . . . 0.0 109.372 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.481 ' HB3' ' OH ' ' A' ' 8' ' ' TYR . 18.3 tp -125.76 125.8 43.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.943 . . . . 0.0 109.717 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 86.0 m -138.44 156.88 73.19 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.324 -0.86 . . . . 0.0 109.244 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -69.96 166.01 29.29 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.629 2.219 . . . . 0.0 111.666 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -85.0 -20.43 30.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.306 -0.872 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -65.08 123.07 18.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.335 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.755 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -87.74 121.78 30.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.526 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.548 ' N ' HD13 ' A' ' 22' ' ' LEU . 22.1 mtpt -141.08 114.88 7.04 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 0.0 109.616 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 45.7 Cg_endo -67.31 120.68 7.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.839 2.36 . . . . 0.0 111.627 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.47 ' HB ' HG23 ' A' ' 52' ' ' ILE . 34.1 m -119.44 153.81 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.303 -0.873 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.0 t -97.91 144.83 27.06 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.61 139.92 14.69 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -67.48 -7.37 25.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -1.158 . . . . 0.0 109.578 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 27.5 m-20 -91.04 8.58 34.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.51 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.07 29.43 28.34 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -133.12 165.81 23.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -1.155 . . . . 0.0 109.45 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.488 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 32.4 m -125.25 147.57 49.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.427 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.847 ' CD2' HD12 ' A' ' 39' ' ' LEU . 76.5 m-85 -127.28 119.49 26.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.221 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.555 ' CG ' HD21 ' A' ' 22' ' ' LEU . 50.4 t30 -41.74 -77.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.782 . . . . 0.0 109.673 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -81.28 148.73 64.04 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.985 -1.072 . . . . 0.0 108.863 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 39.3 Cg_endo -62.62 -51.91 2.83 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.506 2.137 . . . . 0.0 112.101 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.0 t -63.52 -25.7 68.37 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.949 -1.094 . . . . 0.0 108.47 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 15.8 mtt -64.72 -18.4 64.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.292 -0.88 . . . . 0.0 108.848 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.847 HD12 ' CD2' ' A' ' 33' ' ' TYR . 4.7 tt -70.13 -53.9 15.31 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.375 -0.828 . . . . 0.0 108.87 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.615 ' N ' HD23 ' A' ' 39' ' ' LEU . 63.8 m -50.9 -24.31 3.5 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -60.04 -49.84 76.06 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.322 -0.861 . . . . 0.0 108.685 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.594 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 12.2 tp10 -55.93 -19.74 13.35 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 50' ' ' THR . 4.0 m-80 -80.07 -32.52 39.32 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.583 HD22 HG21 ' A' ' 10' ' ' VAL . 34.3 tp -66.45 -42.19 87.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.833 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.97 -45.24 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.306 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.447 ' HB3' HG23 ' A' ' 48' ' ' THR . 46.9 mtp85 -77.33 -17.3 58.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.178 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 57.68 28.8 16.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.667 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 46' ' ' ARG . 8.4 p -110.2 -173.11 2.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.235 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -112.03 51.81 0.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.525 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 51.6 m -71.68 122.28 20.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.547 ' HA ' ' CB ' ' A' ' 2' ' ' SER . 26.8 m-70 -109.3 -175.69 2.83 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.324 -0.86 . . . . 0.0 108.999 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.518 HG12 HD13 ' A' ' 39' ' ' LEU . 21.2 mt -80.08 125.82 39.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 109.398 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 26.9 ttt85 -79.87 -45.68 18.21 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.331 -0.856 . . . . 0.0 109.584 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 p -160.42 131.69 5.74 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.57 -0.706 . . . . 0.0 109.465 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.479 ' H ' HG23 ' A' ' 55' ' ' THR . 7.3 p -48.25 142.83 5.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.439 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 93.65 166.71 37.71 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.488 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 68.2 mttt -67.36 148.69 51.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.451 -1.029 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.5 m -57.03 146.39 27.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.449 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.491 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.362 0.601 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.567 ' OG ' HD23 ' A' ' 39' ' ' LEU . 24.2 m -70.98 -3.67 20.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.701 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.8 mt-10 -46.23 -25.5 0.62 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.127 -0.983 . . . . 0.0 108.51 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.404 ' N ' ' C ' ' A' ' 2' ' ' SER . 67.3 mtm -77.02 -35.27 57.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 2' ' ' SER . 2.3 m -79.83 -0.52 34.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.772 . . . . 0.0 109.046 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 12.8 mttm -60.61 -28.86 68.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 109.377 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -149.14 67.09 1.03 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.877 . . . . 0.0 109.681 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 11.4 p90 -118.27 -170.71 1.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 109.414 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -153.91 145.58 23.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.893 . . . . 0.0 109.628 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 15' ' ' GLY . 42.5 t -139.73 135.53 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.409 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.753 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -115.03 174.79 2.16 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.668 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.753 ' HD2' HD23 ' A' ' 11' ' ' LEU . 46.7 Cg_endo -68.1 -22.76 40.7 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.787 2.325 . . . . 0.0 111.678 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -97.35 -29.45 13.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.239 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.11 -44.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.652 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.538 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 65.86 -164.2 39.64 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -100.59 151.37 21.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -1.217 . . . . 0.0 109.569 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.5 tp -116.38 110.47 18.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.337 -0.852 . . . . 0.0 109.828 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 63.4 m -126.62 156.35 73.43 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.245 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 51.5 Cg_endo -72.13 171.39 16.88 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.645 2.23 . . . . 0.0 111.619 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 tttm -88.6 -29.86 19.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.473 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -57.14 133.57 55.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.385 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' A' ' 34' ' ' ASN . 47.7 tp -92.88 115.42 28.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -125.07 104.4 29.57 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.475 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.4 118.65 5.65 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 C-N-CA 122.911 2.407 . . . . 0.0 111.997 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 32' ' ' THR . 14.8 m -117.03 155.68 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 109.737 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.5 t -97.02 123.33 40.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.827 . . . . 0.0 109.006 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -77.57 136.08 17.69 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.603 ' OD1' HG23 ' A' ' 50' ' ' THR . 54.4 p30 -67.39 -8.6 34.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -1.12 . . . . 0.0 109.562 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.4 p30 -87.05 11.96 12.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 17.76 62.3 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.0 mt-30 -123.51 176.92 5.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -1.098 . . . . 0.0 109.53 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.582 HG21 ' HG3' ' A' ' 57' ' ' LYS . 41.1 m -135.91 141.82 44.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.063 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.795 ' CD1' HD13 ' A' ' 39' ' ' LEU . 42.0 m-85 -121.13 128.2 52.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -0.922 . . . . 0.0 109.505 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.7 m-20 -48.66 -79.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.813 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.8 t-20 -81.67 147.13 58.29 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.006 -1.059 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.51 -52.49 1.89 Allowed 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.877 2.385 . . . . 0.0 111.936 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.8 t -64.16 -25.08 67.92 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.941 -1.099 . . . . 0.0 108.208 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 44.3 mmm -68.93 -14.72 63.21 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.795 HD13 ' CD1' ' A' ' 33' ' ' TYR . 20.6 tp -65.69 -51.0 62.86 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.486 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.0 m -68.72 -18.16 64.19 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.444 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 25.7 t60 -69.88 -55.29 10.12 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.517 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 88.7 tt0 -64.26 -18.64 64.75 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 47' ' ' GLN . 9.4 m120 -79.74 -36.11 37.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.9 -32.94 66.43 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mt -80.35 -46.14 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.6 ' HG2' HG23 ' A' ' 48' ' ' THR . 69.7 ttt180 -70.53 -21.6 62.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.118 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . 81.4 mt-30 63.54 43.36 5.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.506 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.6 HG23 ' HG2' ' A' ' 46' ' ' ARG . 75.4 p -126.72 167.68 15.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -103.16 56.52 0.75 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.487 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.603 HG23 ' OD1' ' A' ' 28' ' ' ASP . 85.6 m -77.63 138.77 39.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 109.321 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -118.91 176.46 5.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.26 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.471 HG12 HD22 ' A' ' 39' ' ' LEU . 34.4 mt -80.12 124.72 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 29.2 tpt180 -81.28 -53.27 6.49 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.599 -0.688 . . . . 0.0 109.427 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 p -146.05 146.1 30.82 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.595 -0.69 . . . . 0.0 109.447 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.8 p -66.4 147.85 52.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.396 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.71 162.61 37.53 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HG3' HG21 ' A' ' 32' ' ' THR . 41.0 tttt -63.92 148.85 48.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.474 -1.015 . . . . 0.0 109.341 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.3 148.68 30.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.451 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.33 0.585 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.583 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 3.5 m -56.25 -30.44 62.42 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.312 -0.867 . . . . 0.0 109.444 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -56.32 -24.43 43.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.869 . . . . 0.0 109.23 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 65.1 mmm -74.7 -24.22 58.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -0.793 . . . . 0.0 109.062 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.496 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 13.4 m -84.21 -27.97 27.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.3 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -75.63 -2.48 29.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.632 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 4' ' ' MET . 15.7 p30 -122.94 1.1 9.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.849 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.576 ' OH ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -119.13 154.56 33.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.091 -1.006 . . . . 0.0 109.321 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -133.43 127.46 33.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.259 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.554 HG21 ' C ' ' A' ' 15' ' ' GLY . 4.6 p -124.08 142.73 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 109.588 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.518 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.8 mp -105.62 174.06 2.87 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.158 -0.964 . . . . 0.0 109.211 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.4 Cg_endo -67.79 -28.86 36.19 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.606 2.204 . . . . 0.0 111.88 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -87.4 -28.33 22.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.365 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.2 mt -84.0 -39.39 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 109.401 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.554 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 67.41 155.77 0.55 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CE2' ' OH ' ' A' ' 8' ' ' TYR . 1.3 t80 -52.63 148.39 7.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.281 -1.129 . . . . 0.0 109.604 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.3 tp -115.82 112.49 22.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.457 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 60.5 m -123.7 155.82 65.81 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.303 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.75 165.18 33.33 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.648 2.232 . . . . 0.0 111.794 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -87.31 -10.41 52.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.478 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.66 133.73 44.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.348 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.731 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.1 tm? -89.73 118.94 29.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.644 ' N ' HD13 ' A' ' 22' ' ' LEU . 5.9 mttp -134.38 100.67 12.53 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.319 -0.863 . . . . 0.0 109.103 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.0 Cg_endo -63.33 123.11 11.57 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 123.121 2.547 . . . . 0.0 112.411 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 33' ' ' TYR . 32.4 m -120.62 154.79 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.446 -0.784 . . . . 0.0 109.641 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -98.35 137.5 36.98 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.02 138.16 13.91 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.1 p30 -64.96 -11.31 37.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.366 -1.079 . . . . 0.0 109.535 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.5 p30 -87.43 11.5 14.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.28 21.19 61.03 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.422 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 89.4 mt-30 -122.16 170.37 9.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.509 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.454 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 86.9 m -129.31 135.49 48.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.305 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.766 ' CD1' HD13 ' A' ' 39' ' ' LEU . 64.2 m-85 -115.12 121.22 42.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.286 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.563 ' HB2' HD21 ' A' ' 22' ' ' LEU . 0.6 OUTLIER -44.61 -82.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.835 . . . . 0.0 109.802 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.9 t-20 -80.07 147.13 64.76 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.157 -0.964 . . . . 0.0 109.565 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.6 Cg_endo -62.7 -52.1 2.63 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.659 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.557 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 10.7 t -62.69 -26.71 68.8 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 40.2 mmm -65.32 -16.51 63.65 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.766 HD13 ' CD1' ' A' ' 33' ' ' TYR . 25.6 tp -67.11 -55.57 13.69 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 16' ' ' TYR . 16.1 t -57.72 -23.16 50.39 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -72.92 -59.84 2.51 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.476 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 81.7 mt-10 -58.42 -18.5 28.81 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.5 m-20 -76.72 -39.09 53.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.496 -0.752 . . . . 0.0 108.98 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.936 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.3 tm? -55.67 -37.09 67.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.281 -0.887 . . . . 0.0 108.844 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.4 mt -75.36 -46.17 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 0.0 108.939 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.492 ' HG2' HG23 ' A' ' 48' ' ' THR . 43.9 ttt85 -68.26 -27.84 66.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.0 109.191 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 90.2 mt-30 63.25 42.27 7.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 109.668 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.492 HG23 ' HG2' ' A' ' 46' ' ' ARG . 72.5 p -131.25 175.76 8.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.227 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.575 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 78.9 m-20 -101.57 64.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.215 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.8 m -76.66 132.21 39.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 109.953 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.583 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 42.9 m80 -116.03 171.28 7.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -0.869 . . . . 0.0 108.681 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.431 HG12 HD22 ' A' ' 39' ' ' LEU . 11.4 mt -79.71 123.91 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.073 -1.017 . . . . 0.0 109.186 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 54.7 ttt85 -79.71 -42.09 25.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.292 -0.88 . . . . 0.0 109.317 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 t -160.3 155.07 24.18 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.6 p -70.84 143.89 50.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.094 -1.004 . . . . 0.0 109.171 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.69 168.29 40.94 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.486 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 31.6 mttm -66.47 151.69 46.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -1.1 . . . . 0.0 109.428 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.414 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 71.8 m -60.89 152.58 27.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.346 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.499 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.479 ' OD1' HD12 ' A' ' 52' ' ' ILE . 91.3 m-20 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 m -59.33 -23.76 62.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.871 . . . . 0.0 109.395 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.4 tt0 -52.65 -24.38 8.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.087 -1.008 . . . . 0.0 109.028 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 mtt -79.94 -25.74 40.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.413 -0.804 . . . . 0.0 109.109 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.5 m -86.98 -8.66 56.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.391 -0.818 . . . . 0.0 109.517 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 43.6 mttm -60.02 -23.43 63.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 109.783 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -150.69 63.51 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.062 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.918 ' OH ' HD23 ' A' ' 44' ' ' LEU . 4.2 p90 -129.16 167.12 18.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 109.203 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -143.97 145.07 31.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 109.616 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.862 HG13 ' C ' ' A' ' 15' ' ' GLY . 92.0 t -137.61 131.87 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 109.659 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.544 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -122.49 175.1 2.81 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.36 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.0 Cg_endo -67.67 -26.28 39.49 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.648 2.232 . . . . 0.0 111.772 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -100.3 -27.52 13.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.293 -0.879 . . . . 0.0 109.203 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.8 mm -91.02 -43.2 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.42 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.862 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 68.33 -146.41 45.8 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.489 ' CD2' HG21 ' A' ' 10' ' ' VAL . 2.2 t80 -104.58 157.43 17.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -1.134 . . . . 0.0 109.482 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.1 tp -115.58 115.02 25.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 109.865 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 57.7 m -135.86 155.77 77.69 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 109.231 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.55 167.62 25.91 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.549 2.166 . . . . 0.0 111.587 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -84.68 -18.71 34.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -70.4 123.34 21.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.29 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.685 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -86.46 109.76 19.29 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.492 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -116.05 103.61 53.14 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.399 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.2 Cg_endo -63.68 117.2 4.19 Favored 'Trans proline' 0 C--O 1.213 -0.764 0 C-N-CA 123.082 2.521 . . . . 0.0 112.414 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.459 ' HB ' HG23 ' A' ' 52' ' ' ILE . 11.0 m -115.29 157.18 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.403 -0.811 . . . . 0.0 109.83 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.405 ' O ' ' N ' ' A' ' 53' ' ' ARG . 46.0 t -98.65 141.57 31.31 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.72 141.32 15.48 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.5 t0 -69.84 -9.4 54.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -1.147 . . . . 0.0 109.414 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -90.31 0.59 57.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.404 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.79 21.76 22.77 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.2 mt-30 -121.5 172.66 7.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -1.138 . . . . 0.0 109.48 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' ' 57' ' ' LYS . 99.4 m -133.48 140.09 47.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.884 ' CD1' HD13 ' A' ' 39' ' ' LEU . 40.8 m-85 -121.78 129.01 52.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.012 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.58 ' CB ' HD21 ' A' ' 22' ' ' LEU . 1.8 m-20 -52.77 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.026 -1.046 . . . . 0.0 109.67 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 15.3 t-20 -81.85 145.73 54.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.019 -1.05 . . . . 0.0 109.587 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.29 -51.15 2.87 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.643 2.228 . . . . 0.0 111.346 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.503 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.5 t -61.64 -27.99 69.06 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.444 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 36.3 mmm -67.05 -13.93 62.41 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.884 HD13 ' CD1' ' A' ' 33' ' ' TYR . 29.8 tp -68.44 -53.69 21.92 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.466 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 14.0 t -58.98 -23.29 61.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -69.21 -57.93 4.71 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -61.97 -19.35 62.7 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.491 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 99.2 m-20 -77.15 -32.09 56.03 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.933 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -61.49 -38.09 86.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 108.875 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mt -75.89 -48.51 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.299 -0.876 . . . . 0.0 109.222 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -68.7 -36.86 79.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.885 . . . . 0.0 109.354 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 59.81 38.04 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.425 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' ASN . 43.9 p -112.87 16.66 19.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.391 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.413 ' C ' ' O ' ' A' ' 48' ' ' THR . 57.7 m-20 44.94 58.88 3.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.331 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.491 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 36.0 m -77.21 144.83 38.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.683 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.455 ' CD2' ' N ' ' A' ' 51' ' ' HIS . 28.0 m-70 -118.93 169.45 9.87 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.479 HD12 ' OD1' ' A' ' 1' ' ' ASP . 41.7 mt -79.14 126.55 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.109 -0.995 . . . . 0.0 109.357 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 42.1 ttt85 -79.71 -46.85 16.32 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.412 -0.805 . . . . 0.0 109.251 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 m -160.29 151.92 19.8 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 p -65.29 142.75 58.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.099 -1.001 . . . . 0.0 109.591 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.31 165.02 36.27 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 65.0 mttt -67.94 148.84 50.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -1.056 . . . . 0.0 109.408 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 58.4 m -60.04 153.44 21.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.477 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 21.3 p-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.312 0.577 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 5' ' ' CYS . 3.1 m -46.75 -30.63 2.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.382 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 13.2 mt-10 -52.0 -27.48 13.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 108.697 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 86.9 mtp -76.74 -28.61 55.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 4.0 m -79.75 -6.88 58.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.507 -0.745 . . . . 0.0 109.069 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 15.6 mttm -56.39 -32.29 64.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 77.2 m-20 -146.36 67.18 1.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 109.866 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 1.061 ' OH ' HD21 ' A' ' 44' ' ' LEU . 4.4 p90 -126.41 169.78 12.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 109.068 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -140.95 149.4 41.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.124 -0.985 . . . . 0.0 109.846 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 15' ' ' GLY . 77.8 t -145.06 131.39 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.832 . . . . 0.0 109.359 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mp -122.34 175.09 2.79 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.955 . . . . 0.0 109.551 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.2 Cg_endo -67.9 -22.89 41.76 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.69 2.26 . . . . 0.0 111.77 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -107.07 -31.32 8.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.147 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 14' ' ' ILE . 48.9 mm -83.3 -39.95 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.518 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.749 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 69.83 -145.52 41.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.6 t80 -107.26 156.1 19.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 109.458 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 tp -117.29 121.15 40.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 81.9 m -132.25 157.06 79.26 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.36 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.3 Cg_endo -71.17 165.7 31.59 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.681 2.254 . . . . 0.0 111.578 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -88.68 -13.52 39.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.327 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -68.67 130.66 43.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.103 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.764 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -89.2 122.5 32.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.607 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.673 ' N ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -141.69 105.59 5.86 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.337 -0.852 . . . . 0.0 109.279 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 42.6 Cg_endo -66.05 121.38 8.7 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 C-N-CA 122.951 2.434 . . . . 0.0 111.902 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.481 ' O ' HG23 ' A' ' 32' ' ' THR . 18.7 m -117.14 154.96 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 109.949 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 16.7 t -97.61 130.45 44.63 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.77 139.53 15.42 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.2 p30 -66.33 -9.84 37.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -1.118 . . . . 0.0 109.606 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 57.2 p30 -85.39 12.9 7.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.333 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.35 21.53 64.54 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.446 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 87.2 mt-30 -127.25 168.97 14.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -1.151 . . . . 0.0 109.374 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 25' ' ' VAL . 24.6 m -127.37 139.81 52.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.895 . . . . 0.0 109.513 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.872 ' CD2' HD12 ' A' ' 39' ' ' LEU . 42.9 m-85 -116.8 128.4 55.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.205 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.764 ' OD1' HD21 ' A' ' 22' ' ' LEU . 47.7 t-20 -50.96 -78.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -80.9 148.46 64.73 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 120.825 -1.172 . . . . 0.0 109.48 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HG3' ' HD2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.36 -53.7 1.34 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.645 2.23 . . . . 0.0 111.76 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -61.3 -28.45 69.21 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.987 -1.07 . . . . 0.0 108.144 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 17.0 mtp -63.14 -19.23 64.27 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.872 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.4 tt -67.11 -50.76 60.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.308 -0.87 . . . . 0.0 108.791 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 6.0 t -52.61 -47.33 67.04 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 9.5 t60 -48.51 -49.07 37.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.966 -1.084 . . . . 0.0 108.201 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.572 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 23.6 mm-40 -57.36 -19.41 22.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.1 m-80 -78.87 -32.96 46.15 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.061 HD21 ' OH ' ' A' ' 8' ' ' TYR . 82.9 mt -70.71 -37.19 73.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 109.549 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mt -77.22 -49.6 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.239 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.518 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 14.9 mtt-85 -76.96 -30.99 56.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 109.374 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 57.87 32.91 22.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.439 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.0 p -108.28 7.64 27.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.531 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 38.8 t-20 57.14 55.02 6.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.616 HG21 ' OH ' ' A' ' 33' ' ' TYR . 87.2 m -78.52 136.46 37.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.545 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.531 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 3.8 m80 -114.93 -175.92 2.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.215 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.713 HG12 HD13 ' A' ' 39' ' ' LEU . 29.9 mt -89.59 123.42 41.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.238 -0.914 . . . . 0.0 109.62 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 38.4 ttt-85 -81.39 -46.94 13.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.52 -0.738 . . . . 0.0 109.326 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -153.2 151.27 29.91 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.657 -0.652 . . . . 0.0 109.474 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -70.91 144.38 50.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.964 . . . . 0.0 109.218 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.539 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.59 165.24 40.76 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.575 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 30.3 mttm -65.86 144.03 57.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.443 -1.033 . . . . 0.0 109.464 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -77.22 153.2 34.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.245 -0.909 . . . . 0.0 109.326 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' CYS . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.391 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 16.6 p-10 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 6' ' ' LYS . 1.2 m -44.75 -30.28 0.93 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.179 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.467 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 5.2 mm-40 -52.54 -25.86 11.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.414 -0.804 . . . . 0.0 108.951 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.407 ' HE2' ' HB2' ' A' ' 4' ' ' MET . 60.9 mtm -70.6 -37.65 73.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 109.202 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.485 ' CA ' ' HB2' ' A' ' 8' ' ' TYR . 18.5 p -104.44 -3.28 24.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.236 -0.915 . . . . 0.0 109.537 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 2' ' ' SER . 5.2 mttm -49.23 -24.33 1.72 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.205 -0.934 . . . . 0.0 108.749 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -119.13 28.46 8.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.547 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 3.6 t80 -80.29 157.98 26.27 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.608 0.718 . . . . 0.0 110.617 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.432 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 6.2 ttt85 -142.7 133.45 25.37 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.906 HG21 ' CD2' ' A' ' 16' ' ' TYR . 81.9 t -133.37 136.77 54.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.367 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 10' ' ' VAL . 2.9 mp -119.66 173.16 3.78 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.538 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.8 Cg_endo -68.51 -25.73 34.84 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 122.653 2.235 . . . . 0.0 111.763 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 15.2 ttt180 -104.12 -20.71 13.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.375 -0.828 . . . . 0.0 109.285 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.1 mt -93.13 -46.39 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.891 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.64 -170.72 52.46 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.906 ' CD2' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -87.27 151.44 23.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.174 . . . . 0.0 109.463 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.866 ' N ' HD12 ' A' ' 17' ' ' LEU . 1.8 mp -122.47 132.9 54.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.7 m -139.18 157.32 71.3 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.139 -0.976 . . . . 0.0 109.317 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.2 Cg_endo -70.18 168.78 21.12 Favored 'Trans proline' 0 C--O 1.216 -0.581 0 C-N-CA 122.572 2.181 . . . . 0.0 111.668 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -90.0 -12.67 37.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.482 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -73.94 119.8 18.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.159 -0.963 . . . . 0.0 109.214 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 34' ' ' ASN . 37.2 tp -81.75 112.19 18.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.774 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' CD ' ' HG3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -122.08 105.77 36.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.905 . . . . 0.0 108.741 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 45.2 Cg_endo -66.64 118.32 5.45 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.954 2.436 . . . . 0.0 112.088 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 52' ' ' ILE . 18.8 m -115.59 154.94 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.042 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.4 t -97.3 140.27 32.02 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.53 138.13 13.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.5 p30 -65.49 -12.93 57.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -1.119 . . . . 0.0 109.436 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 84.2 m-20 -86.98 12.37 11.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.216 -0.927 . . . . 0.0 109.374 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.06 32.14 36.77 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 79.6 mt-30 -131.16 173.82 10.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.391 -1.064 . . . . 0.0 109.293 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.5 m -135.12 133.55 39.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.149 -0.969 . . . . 0.0 109.488 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.94 ' CD2' HD13 ' A' ' 39' ' ' LEU . 65.6 m-85 -112.61 122.93 49.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 108.956 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.7 m-20 -48.18 -79.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 110.093 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.7 t-20 -81.98 148.04 59.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.018 -1.051 . . . . 0.0 109.895 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.539 ' HG3' ' CD ' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.6 -53.33 1.41 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.718 2.279 . . . . 0.0 111.768 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.7 t -61.42 -25.78 67.43 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 29.7 mtp -70.49 -5.87 31.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.177 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.94 HD13 ' CD2' ' A' ' 33' ' ' TYR . 24.4 tp -74.11 -61.36 1.88 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.18 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -54.52 -28.38 44.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 108.567 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 29.4 t60 -60.35 -56.88 16.09 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -64.06 -19.43 65.22 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.486 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 89.6 m-20 -79.44 -31.01 42.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.506 -0.746 . . . . 0.0 109.037 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.933 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.2 tm? -63.46 -37.81 88.73 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.385 -0.822 . . . . 0.0 108.844 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mm -77.09 -48.64 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.114 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 26.4 mtt-85 -68.14 -38.46 82.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.436 -0.79 . . . . 0.0 109.192 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 86.3 mt-30 62.2 38.74 13.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.478 -0.764 . . . . 0.0 109.449 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.4 p -113.37 15.38 19.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 0.0 109.384 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 46.29 60.41 3.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.472 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.486 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 76.8 m -79.96 143.01 34.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -118.97 170.61 8.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 108.855 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.451 HG12 HD22 ' A' ' 39' ' ' LEU . 30.9 mt -79.99 126.86 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.07 -1.019 . . . . 0.0 109.271 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 18.0 ttt-85 -81.82 -41.5 21.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.398 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -160.53 151.78 19.2 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -67.61 142.56 56.41 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.074 -1.016 . . . . 0.0 109.443 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.55 166.17 38.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.513 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 41.2 mttm -65.45 149.04 50.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -1.018 . . . . 0.0 109.467 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 59.0 m -59.3 153.84 17.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.444 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.304 0.573 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.415 ' HA ' ' SG ' ' A' ' 40' ' ' CYS . 1.0 OUTLIER -52.98 -32.99 49.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.943 . . . . 0.0 109.386 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -54.21 -23.27 13.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 108.963 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.41 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 76.8 mtp -74.29 -16.55 60.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.837 . . . . 0.0 108.818 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.2 m -91.91 -18.4 23.81 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.419 -0.8 . . . . 0.0 109.165 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -78.41 -0.02 27.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.91 . . . . 0.0 109.478 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.412 ' C ' ' OD1' ' A' ' 7' ' ' ASP . 34.6 p30 -106.78 -9.44 16.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.786 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.547 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 1.1 p90 -107.61 170.49 7.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.166 -0.959 . . . . 0.0 109.47 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -133.37 161.02 35.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.202 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.721 HG21 ' C ' ' A' ' 15' ' ' GLY . 13.4 p -140.43 166.01 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.94 . . . . 0.0 109.81 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.75 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -121.75 174.49 3.16 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.846 . . . . 0.0 109.312 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.75 ' HD2' HD23 ' A' ' 11' ' ' LEU . 48.2 Cg_endo -68.19 -23.62 39.08 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.726 2.284 . . . . 0.0 111.806 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.8 tpt85 -89.0 -19.41 25.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.222 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -99.02 -34.6 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.292 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.721 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 73.66 -68.65 1.53 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.547 ' CE1' ' OH ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -155.38 159.11 39.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -1.153 . . . . 0.0 109.489 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 tp -127.74 114.42 17.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.742 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.5 m -131.56 157.63 77.63 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 108.977 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.1 Cg_endo -70.45 167.01 26.56 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.591 2.194 . . . . 0.0 111.586 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -88.38 -16.68 32.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.417 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -71.54 129.2 38.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.269 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 ' N ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -91.26 114.75 27.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 34' ' ' ASN . 2.5 mtmt -126.79 107.2 22.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.19 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.53 116.67 4.05 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 C-N-CA 122.807 2.338 . . . . 0.0 111.796 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 32' ' ' THR . 20.2 m -114.84 155.41 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.741 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 40.5 t -97.74 123.4 41.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.369 -0.832 . . . . 0.0 109.046 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -77.15 137.93 21.21 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.6 p-10 -67.88 -7.52 28.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -1.098 . . . . 0.0 109.425 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -88.71 7.69 32.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.485 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.45 12.91 62.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' GLY . 78.0 mt-30 -118.32 166.44 12.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -1.163 . . . . 0.0 109.323 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.607 HG21 ' HG3' ' A' ' 57' ' ' LYS . 36.9 m -127.3 137.27 52.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.302 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.776 ' CD1' HD13 ' A' ' 39' ' ' LEU . 34.1 m-85 -114.29 130.47 56.65 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.234 -0.916 . . . . 0.0 109.361 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.4 m-20 -53.57 -76.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.33 -0.857 . . . . 0.0 109.65 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -81.84 148.66 61.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.074 -1.016 . . . . 0.0 109.466 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.458 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.0 Cg_endo -63.65 -53.25 1.42 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.726 2.284 . . . . 0.0 111.9 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.7 t -63.58 -28.69 70.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.047 -1.033 . . . . 0.0 108.394 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.0 mmm -59.87 -23.57 63.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.776 HD13 ' CD1' ' A' ' 33' ' ' TYR . 27.9 tp -61.9 -43.83 98.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.607 -0.683 . . . . 0.0 109.288 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.511 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.2 m -71.32 -20.07 62.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.216 -0.928 . . . . 0.0 108.554 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -72.98 -53.42 11.23 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.426 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 70.0 mt-10 -64.53 -19.0 65.34 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.5 m-20 -74.69 -37.58 62.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.958 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.8 tm? -56.39 -36.16 68.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.343 -0.848 . . . . 0.0 108.735 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mt -74.43 -50.01 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.461 -0.774 . . . . 0.0 109.033 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 31.2 mtm-85 -68.59 -23.97 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.139 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' ASN . 85.6 mt-30 61.81 40.83 12.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.431 -0.793 . . . . 0.0 109.564 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.1 p -128.67 169.71 14.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.293 -0.879 . . . . 0.0 109.199 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -97.5 62.24 1.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.373 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.1 m -70.98 130.2 40.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -0.85 . . . . 0.0 109.599 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -113.82 169.43 8.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 108.979 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.456 HG23 ' HB ' ' A' ' 25' ' ' VAL . 43.4 mt -79.81 127.06 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.009 . . . . 0.0 109.339 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 47.7 ttt85 -84.71 -49.51 8.43 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.373 -0.829 . . . . 0.0 109.533 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.1 p -149.23 141.3 23.89 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.432 -0.792 . . . . 0.0 109.254 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.4 p -61.86 143.97 55.57 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.258 -0.901 . . . . 0.0 109.182 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.53 163.29 39.18 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.607 ' HG3' HG21 ' A' ' 32' ' ' THR . 53.4 tttt -50.88 152.54 2.09 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.541 -0.976 . . . . 0.0 109.601 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 31.5 m -55.65 142.12 35.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.634 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.397 179.862 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.308 0.575 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.598 ' OG ' HD23 ' A' ' 39' ' ' LEU . 4.0 m -45.58 -29.17 1.12 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.34 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -51.55 -28.08 12.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.199 -0.938 . . . . 0.0 108.75 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.4 mmm -79.04 -30.37 44.07 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.4 m -83.93 0.59 47.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.503 -0.748 . . . . 0.0 109.191 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 10.7 mttm -61.38 -30.32 70.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.344 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 76.2 m-20 -147.84 68.02 1.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.67 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.566 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 12.6 p90 -119.78 -171.59 2.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.268 -0.895 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -153.76 139.65 18.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 109.746 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 15' ' ' GLY . 53.4 t -132.73 137.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 109.612 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.579 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -112.63 174.38 2.35 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.832 . . . . 0.0 109.275 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.579 ' HD2' HD23 ' A' ' 11' ' ' LEU . 46.9 Cg_endo -67.85 -24.44 40.19 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.655 2.237 . . . . 0.0 111.816 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -96.77 -26.94 14.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.468 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.1 mm -85.91 -48.17 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.546 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.674 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.84 -163.2 54.42 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.817 ' CE2' HD11 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -102.37 150.27 23.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -1.157 . . . . 0.0 109.315 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.3 tp -116.74 106.83 13.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.8 m -120.67 155.89 56.55 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.128 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.04 166.61 29.11 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.545 2.163 . . . . 0.0 111.625 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -89.81 -13.94 35.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.9 . . . . 0.0 109.662 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -72.31 123.88 23.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 0.0 109.278 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 34' ' ' ASN . 48.1 tp -80.29 121.17 25.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.619 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 3.2 mttp -133.71 101.45 12.95 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.324 -0.86 . . . . 0.0 109.242 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 41.0 Cg_endo -64.15 120.66 8.07 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.848 2.365 . . . . 0.0 112.122 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 32' ' ' THR . 7.9 m -119.81 157.36 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.8 t -99.49 114.76 27.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -0.824 . . . . 0.0 109.028 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -69.94 137.76 28.83 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 58.4 p30 -68.4 -8.02 36.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.344 -1.092 . . . . 0.0 109.661 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -84.86 6.81 23.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 109.341 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.91 17.86 55.45 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -126.76 160.62 30.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -1.09 . . . . 0.0 109.429 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.506 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 38.5 m -116.79 144.86 43.98 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.931 . . . . 0.0 109.207 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.777 ' CD1' HD13 ' A' ' 39' ' ' LEU . 87.4 m-85 -124.51 129.37 50.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.292 -0.88 . . . . 0.0 109.331 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.2 m-20 -50.44 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.2 t-20 -82.16 146.41 54.84 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 0.0 109.788 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.0 Cg_endo -63.53 -52.36 1.95 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.772 2.315 . . . . 0.0 111.555 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.1 t -60.97 -30.87 70.51 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.477 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 23.0 mtt -61.6 -20.68 63.61 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.777 HD13 ' CD1' ' A' ' 33' ' ' TYR . 58.6 tp -62.06 -46.81 87.49 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.973 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.3 m -70.94 -26.48 63.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.461 ' HA ' ' CD1' ' A' ' 44' ' ' LEU . 33.3 t60 -64.42 -55.04 23.64 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 73.8 mm-40 -65.1 -17.5 64.51 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.237 -0.914 . . . . 0.0 108.671 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 47' ' ' GLN . 92.1 m-20 -76.53 -30.91 57.32 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.469 -0.77 . . . . 0.0 109.278 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.973 HD12 ' O ' ' A' ' 40' ' ' CYS . 1.8 mp -59.76 -36.63 77.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.12 -0.987 . . . . 0.0 108.624 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 45' ' ' ILE . 7.0 mm -75.72 -48.67 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 15.7 mtp85 -67.28 -25.52 66.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.429 -0.794 . . . . 0.0 109.153 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.9 mt-30 63.71 41.26 7.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.54 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 p -130.63 164.07 25.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.214 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.562 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 65.6 m-20 -95.68 59.99 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 109.504 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 m -75.0 132.05 41.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 109.417 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 6.6 m80 -112.87 -172.32 2.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.138 -0.976 . . . . 0.0 109.333 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.7 mt -89.79 126.62 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.337 -0.852 . . . . 0.0 109.776 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 16.2 tpt180 -85.4 -53.98 4.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.557 -0.714 . . . . 0.0 109.365 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 p -144.76 152.61 40.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -72.96 144.45 47.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.095 -1.003 . . . . 0.0 109.385 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.92 166.19 39.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.573 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 55.1 mttp -68.07 141.5 56.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.36 -1.083 . . . . 0.0 109.306 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.23 149.8 37.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.482 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.541 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.757 ' OG ' HD23 ' A' ' 39' ' ' LEU . 13.6 m -52.26 -26.72 12.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 16.2 mt-10 -51.56 -26.39 8.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.02 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.6 mtm -68.13 -28.79 67.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.765 . . . . 0.0 109.307 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 9.7 m -79.81 -17.94 52.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.928 . . . . 0.0 109.23 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 44.5 mttm -51.13 -22.93 2.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 108.994 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -118.13 36.87 4.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 5.2 t80 -85.09 159.48 20.17 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.559 0.695 . . . . 0.0 110.663 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.443 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 7.7 ttm180 -140.71 136.6 32.76 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 1.036 HG13 ' O ' ' A' ' 15' ' ' GLY . 52.1 t -134.83 128.03 49.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.768 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.55 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -106.23 175.51 2.05 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.437 -0.79 . . . . 0.0 109.057 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.8 Cg_endo -67.21 -23.15 45.66 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.541 2.161 . . . . 0.0 111.632 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -110.83 -24.33 10.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.342 -0.849 . . . . 0.0 109.326 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 11' ' ' LEU . 81.5 mt -83.25 -38.46 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.622 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 1.036 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 61.28 -143.8 48.66 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.828 ' CE1' HD11 ' A' ' 44' ' ' LEU . 1.6 t80 -107.3 150.65 26.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.239 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.7 tp -114.7 121.59 43.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.813 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.0 m -135.52 157.04 77.23 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.029 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.2 Cg_endo -70.01 163.82 37.06 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.588 2.192 . . . . 0.0 111.683 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -87.77 -8.77 55.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.43 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -77.76 111.45 13.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.855 . . . . 0.0 109.182 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.4 tp -79.62 123.17 27.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.935 . . . . 0.0 109.66 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 34' ' ' ASN . 7.4 mtmt -140.63 109.22 6.64 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.812 . . . . 0.0 109.054 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.543 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.9 Cg_endo -63.56 123.85 12.74 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.86 2.373 . . . . 0.0 112.214 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.654 ' HB ' HG23 ' A' ' 52' ' ' ILE . 29.2 m -120.39 156.55 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.9 t -98.23 119.71 37.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 109.291 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -73.19 134.7 20.14 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 56.6 p30 -68.05 -7.55 30.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -1.148 . . . . 0.0 109.722 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -86.21 7.57 24.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.75 16.97 53.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 93.6 mt-30 -126.05 171.96 10.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 25' ' ' VAL . 89.3 m -129.37 142.75 50.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.182 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.662 ' CD2' HD12 ' A' ' 39' ' ' LEU . 20.3 m-85 -123.68 128.82 50.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.2 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.1 m-20 -51.14 -79.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.203 -0.936 . . . . 0.0 109.822 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.527 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 7.3 t-20 -81.82 147.45 58.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.917 -1.114 . . . . 0.0 109.758 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.2 Cg_endo -63.3 -52.19 2.18 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.728 2.285 . . . . 0.0 111.872 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -64.04 -27.8 69.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.033 -1.042 . . . . 0.0 108.297 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.527 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.5 mmm -62.51 -16.2 54.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.471 -0.768 . . . . 0.0 109.191 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.757 HD23 ' OG ' ' A' ' 2' ' ' SER . 8.1 tp -68.55 -51.79 39.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.347 -0.845 . . . . 0.0 109.125 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.482 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.9 m -63.78 -18.49 64.14 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -69.16 -57.64 5.12 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -64.74 -18.61 65.19 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.2 m-20 -72.79 -31.47 64.89 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.828 HD11 ' CE1' ' A' ' 16' ' ' TYR . 36.8 mt -58.85 -38.9 79.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 108.745 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mt -74.31 -51.96 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.46 -0.775 . . . . 0.0 109.091 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.516 ' NH2' ' OH ' ' A' ' 33' ' ' TYR . 45.2 mtm180 -66.49 -25.27 66.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 0.0 109.415 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.3 mt-30 63.73 44.47 5.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.527 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 p -130.21 167.88 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.524 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.456 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 72.9 m-20 -103.37 65.21 0.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.258 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.439 ' OG1' ' NH2' ' A' ' 46' ' ' ARG . 51.9 m -73.43 136.5 44.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.76 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.456 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 70.4 m80 -117.13 169.7 9.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.322 -0.861 . . . . 0.0 108.88 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 25' ' ' VAL . 22.2 mm -80.17 127.01 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.005 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 72.0 ttt180 -85.79 -47.93 9.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.368 -0.833 . . . . 0.0 109.446 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -148.29 142.6 26.22 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.535 -0.728 . . . . 0.0 109.367 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.2 p -62.24 151.3 36.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.911 . . . . 0.0 109.368 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.12 166.42 40.71 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.52 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 39.5 mttt -59.98 147.15 39.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.419 -1.047 . . . . 0.0 109.445 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.433 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 53.2 m -47.62 142.1 4.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 109.379 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.476 -179.934 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 2' ' ' SER . 76.3 m-20 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.552 ' OG ' HD22 ' A' ' 39' ' ' LEU . 2.8 m -45.12 -34.24 2.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.309 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.496 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 49.9 mt-10 -47.26 -31.93 4.18 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.0 mmm -77.1 -32.26 56.47 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.566 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.6 m -82.12 4.06 24.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.362 -0.836 . . . . 0.0 109.214 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.496 ' HE3' ' HG2' ' A' ' 3' ' ' GLU . 11.6 mttm -62.95 -28.64 70.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.706 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.459 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 14.3 t70 -147.31 68.34 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 110.13 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.66 ' CZ ' HD21 ' A' ' 44' ' ' LEU . 19.7 p90 -127.12 -177.77 4.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 109.382 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptt-85 -156.07 146.06 21.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.323 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 15' ' ' GLY . 74.4 t -130.56 135.96 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.714 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -109.57 175.5 1.91 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.276 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.7 Cg_endo -67.95 -24.72 39.28 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.594 2.196 . . . . 0.0 111.83 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -95.78 -31.18 13.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 109.421 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.3 mt -80.87 -49.41 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.474 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.605 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.4 -173.52 43.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.541 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -98.96 146.53 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.2 tp -114.44 110.0 19.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.817 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 55.7 m -125.73 154.7 73.2 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 109.077 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.32 165.68 31.68 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.454 2.103 . . . . 0.0 111.655 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -85.22 -23.07 28.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -62.72 128.91 38.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 34' ' ' ASN . 22.0 tp -83.83 126.2 32.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 109.421 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -137.71 97.69 10.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.0 109.436 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.4 Cg_endo -62.69 121.01 8.77 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.961 2.441 . . . . 0.0 111.938 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.506 ' HB ' HG23 ' A' ' 52' ' ' ILE . 9.8 m -121.65 155.75 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.981 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.6 t -98.3 141.22 31.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -96.65 136.73 12.95 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.593 ' OD1' HG23 ' A' ' 50' ' ' THR . 58.4 p30 -62.26 -12.4 20.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -1.113 . . . . 0.0 109.58 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 48.8 m-20 -88.33 10.01 21.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 0.0 109.595 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.18 15.68 68.86 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.5 mt-30 -117.85 156.24 28.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.382 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.963 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.7 m -118.32 148.56 42.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.453 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.826 ' HD2' HD12 ' A' ' 39' ' ' LEU . 78.0 m-85 -130.26 127.83 40.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.317 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 m-20 -49.36 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.8 t-20 -82.06 146.19 54.71 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.978 -1.076 . . . . 0.0 109.468 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.522 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.64 -50.15 3.58 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.463 2.108 . . . . 0.0 111.459 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 8.0 t -62.2 -27.68 69.15 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.464 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 23.8 mtt -69.78 -23.58 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.826 HD12 ' HD2' ' A' ' 33' ' ' TYR . 4.8 tt -63.59 -47.34 81.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.344 -0.847 . . . . 0.0 108.782 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.547 ' N ' HD23 ' A' ' 39' ' ' LEU . 9.5 m -56.75 -27.97 60.33 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -56.83 -47.78 79.52 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 29.1 tp10 -57.87 -22.01 45.99 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 3.3 m-80 -76.57 -31.85 57.78 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.903 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.66 HD21 ' CZ ' ' A' ' 8' ' ' TYR . 67.0 mt -64.43 -41.19 96.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.384 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 mt -73.29 -54.23 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.392 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.679 HH22 HG21 ' A' ' 50' ' ' THR . 81.0 mtm180 -70.22 -22.02 62.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.383 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 63.01 36.0 12.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -120.0 177.35 5.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -103.98 56.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.55 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.679 HG21 HH22 ' A' ' 46' ' ' ARG . 82.9 m -75.88 129.38 36.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 109.579 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.446 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 15.0 m-70 -115.34 -170.96 1.87 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.177 -0.952 . . . . 0.0 109.33 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.534 HG12 HD13 ' A' ' 39' ' ' LEU . 41.3 mt -85.9 126.56 40.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.727 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 12.7 tpt180 -81.06 -43.14 19.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.408 -0.808 . . . . 0.0 109.24 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.8 p -154.51 137.89 15.83 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 p -58.48 149.34 25.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 109.405 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 83.43 165.89 38.96 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.963 ' HG3' HG21 ' A' ' 32' ' ' THR . 39.5 tttm -65.3 149.04 50.64 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.352 -1.087 . . . . 0.0 109.356 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.8 138.7 39.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.481 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.471 ' HB2' ' ND1' ' A' ' 51' ' ' HIS . 0.6 OUTLIER -55.59 -33.03 63.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.32 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.424 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.0 OUTLIER -55.56 -23.26 25.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.323 -0.861 . . . . 0.0 109.042 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.444 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 81.5 mtp -72.23 -26.54 62.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 108.834 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.581 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 24.6 m -85.23 -13.03 51.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.446 -0.784 . . . . 0.0 109.28 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 17.0 mttm -80.95 10.87 4.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.923 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 4' ' ' MET . 41.7 p30 -145.02 19.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.032 -1.042 . . . . 0.0 109.671 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.632 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -128.24 154.09 46.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.129 -0.982 . . . . 0.0 109.494 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 9' ' ' ARG . 39.2 tpt85 -135.66 146.81 48.2 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.305 -0.872 . . . . 0.0 108.984 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 15' ' ' GLY . 75.5 t -137.58 137.53 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.15 -0.969 . . . . 0.0 109.647 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.556 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -116.0 175.66 1.84 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 109.233 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.4 Cg_endo -66.53 -21.77 52.42 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.598 2.198 . . . . 0.0 111.763 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -101.96 -28.66 12.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -0.847 . . . . 0.0 109.563 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 11' ' ' LEU . 83.2 mt -80.87 -51.56 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.856 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 81.29 -165.38 46.73 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.8 OUTLIER -100.78 147.45 26.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -1.112 . . . . 0.0 109.672 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.83 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -119.87 127.64 52.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.853 . . . . 0.0 109.481 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 70.4 m -133.48 156.72 79.38 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.296 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.7 Cg_endo -70.06 166.66 27.21 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.621 2.214 . . . . 0.0 111.815 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -87.53 -14.42 40.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 109.534 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -73.01 106.1 4.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.311 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.422 HD11 ' HB3' ' A' ' 34' ' ' ASN . 48.8 tp -72.93 113.66 10.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.455 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.8 mttm -124.02 102.92 33.91 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 109.323 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 42.9 Cg_endo -65.09 116.98 4.15 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.875 2.383 . . . . 0.0 112.138 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 32' ' ' THR . 7.6 m -116.41 156.93 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 16.5 t -98.3 111.94 24.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.566 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.08 139.16 37.8 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.516 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.1 p30 -69.8 -9.74 55.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -1.109 . . . . 0.0 109.667 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -81.42 1.99 30.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.446 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.48 15.19 44.68 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -125.03 168.66 13.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.336 -1.097 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.566 HG21 ' HA ' ' A' ' 57' ' ' LYS . 39.1 m -123.45 134.18 53.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.661 ' CD1' HD13 ' A' ' 39' ' ' LEU . 72.8 m-85 -110.99 121.09 44.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 109.215 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 8.7 m-20 -46.89 -82.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.4 -0.812 . . . . 0.0 109.722 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.3 t-20 -81.84 146.38 55.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 109.593 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -62.95 -51.96 2.54 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.77 2.313 . . . . 0.0 111.599 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.8 t -61.92 -26.78 68.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.959 -1.088 . . . . 0.0 108.091 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 31.5 mmm -67.43 -16.66 64.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.661 HD13 ' CD1' ' A' ' 33' ' ' TYR . 17.3 tp -68.03 -57.35 6.29 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 9.4 t -55.45 -25.41 36.21 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -69.51 -61.7 1.68 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.571 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 88.5 mt-10 -57.57 -19.53 26.13 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.421 ' ND2' ' HG ' ' A' ' 39' ' ' LEU . 92.9 m-20 -75.39 -33.55 61.02 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.95 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.2 tm? -57.76 -38.23 75.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.412 -0.805 . . . . 0.0 108.882 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mt -77.3 -46.81 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.846 . . . . 0.0 108.972 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.438 ' O ' HG23 ' A' ' 48' ' ' THR . 62.2 mtt-85 -64.76 -26.22 68.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 109.01 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 91.5 mt-30 61.27 37.99 16.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.37 -0.831 . . . . 0.0 109.639 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 46' ' ' ARG . 10.1 p -128.39 169.77 13.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.322 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.512 ' O ' ' NE2' ' A' ' 51' ' ' HIS . 79.9 m-20 -98.91 63.13 1.35 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.266 -0.896 . . . . 0.0 109.311 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.6 m -71.47 137.65 48.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.827 . . . . 0.0 109.666 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.512 ' NE2' ' O ' ' A' ' 49' ' ' ASN . 11.8 m-70 -117.95 178.54 4.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 109.022 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.413 HG23 ' HB ' ' A' ' 25' ' ' VAL . 20.4 mt -86.08 124.8 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.142 -0.974 . . . . 0.0 109.611 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 66.4 ttt180 -80.99 -56.73 3.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.142 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -147.13 156.56 43.09 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.535 -0.728 . . . . 0.0 109.037 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -75.05 142.72 43.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.0 109.632 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.04 162.46 35.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.566 ' HA ' HG21 ' A' ' 32' ' ' THR . 32.5 mttt -64.77 136.75 57.25 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.588 -0.948 . . . . 0.0 109.484 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -71.11 149.15 46.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.388 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 58' ' ' CYS . 84.4 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.502 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.479 ' OG ' ' HA ' ' A' ' 51' ' ' HIS . 0.6 OUTLIER -54.43 -34.5 61.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.45 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.79 -21.54 7.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.189 -0.944 . . . . 0.0 108.78 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.3 mtp -71.54 -30.66 66.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.036 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 8' ' ' TYR . 3.9 m -82.8 -26.84 31.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.441 -0.787 . . . . 0.0 109.376 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' CYS . 69.3 mttt -44.76 -27.24 0.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.348 -0.845 . . . . 0.0 108.757 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 5' ' ' CYS . 94.5 m-20 -116.08 35.05 4.66 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 5' ' ' CYS . 2.7 t80 -80.34 163.2 24.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -150.64 114.61 5.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -0.829 . . . . 0.0 109.093 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.873 HG13 ' C ' ' A' ' 15' ' ' GLY . 59.7 t -116.97 156.74 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 109.639 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.55 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -136.27 174.91 3.97 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.371 -0.83 . . . . 0.0 109.386 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.9 Cg_endo -67.44 -21.75 46.32 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.672 2.248 . . . . 0.0 111.947 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -112.1 -21.56 11.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.673 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 11' ' ' LEU . 97.0 mt -88.21 -49.32 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 0.0 109.627 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.873 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 75.2 -165.43 54.62 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.83 ' CD1' HG21 ' A' ' 10' ' ' VAL . 1.2 t80 -94.06 153.84 17.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -1.212 . . . . 0.0 109.514 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.8 tp -117.08 109.92 17.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.965 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.9 m -126.13 155.35 73.71 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 109.115 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.09 168.52 23.82 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.527 2.151 . . . . 0.0 111.611 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -88.19 -23.34 23.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -0.964 . . . . 0.0 109.741 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.53 126.53 28.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.329 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 34' ' ' ASN . 31.3 tp -85.0 113.13 21.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.528 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -121.45 104.35 40.26 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 0.0 109.363 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.499 ' HB2' ' HG3' ' A' ' 57' ' ' LYS . 43.2 Cg_endo -65.62 117.28 4.49 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.875 2.383 . . . . 0.0 112.059 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.489 ' HB ' HG23 ' A' ' 52' ' ' ILE . 34.0 m -120.44 154.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.871 . . . . 0.0 109.835 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.0 t -97.3 140.79 31.24 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -90.99 142.39 16.11 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 43.9 t0 -68.58 -11.5 60.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -1.203 . . . . 0.0 109.306 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -86.4 -5.0 59.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.303 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.77 21.38 14.35 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 27' ' ' GLY . 66.8 mt-30 -127.58 145.84 50.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -1.194 . . . . 0.0 109.585 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.48 HG23 ' HA ' ' A' ' 57' ' ' LYS . 92.8 m -99.4 154.72 17.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.868 . . . . 0.0 109.602 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.655 ' CD2' HD12 ' A' ' 39' ' ' LEU . 48.8 m-85 -135.59 117.63 15.36 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.372 -0.83 . . . . 0.0 108.901 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.552 ' HB3' HD11 ' A' ' 22' ' ' LEU . 10.8 m-20 -41.97 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.0 109.828 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.8 t-20 -82.27 146.61 54.89 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.031 . . . . 0.0 109.205 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.18 -51.16 2.93 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.618 2.212 . . . . 0.0 111.695 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.5 t -63.34 -28.27 69.89 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.094 -1.004 . . . . 0.0 108.423 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 14.0 mtp -60.89 -14.93 25.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.019 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.712 HD22 ' CD1' ' A' ' 52' ' ' ILE . 6.2 tp -74.65 -54.9 6.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.494 -0.754 . . . . 0.0 109.746 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.472 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.4 m -61.72 -19.92 62.93 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.197 -0.94 . . . . 0.0 108.665 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.57 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 34.9 t60 -67.79 -54.39 19.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -66.2 -18.75 65.55 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.0 m-20 -75.79 -27.47 58.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.45 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.974 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.8 tm? -67.52 -35.98 80.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -0.976 . . . . 0.0 108.966 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.25 -46.27 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.208 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.502 ' NH2' ' OE1' ' A' ' 31' ' ' GLN . 74.2 mtm180 -75.79 -35.01 60.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 109.109 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.2 mt-30 62.51 40.36 10.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.71 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.444 HG23 ' HB3' ' A' ' 46' ' ' ARG . 32.9 p -109.8 7.31 24.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 47.82 60.66 3.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.853 . . . . 0.0 109.761 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.3 m -79.77 133.49 36.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.451 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.479 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 8.1 m-70 -105.46 -173.97 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.478 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.712 ' CD1' HD22 ' A' ' 39' ' ' LEU . 33.6 mm -91.33 127.15 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.616 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 73.8 ttt180 -79.44 -49.01 12.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.231 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.6 p -159.3 155.18 26.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 p -67.82 141.56 56.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.074 -1.016 . . . . 0.0 109.769 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.29 165.77 35.17 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.499 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 83.0 mttt -66.94 146.28 54.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -1.087 . . . . 0.0 109.364 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 70.1 m -55.28 150.54 11.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.59 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.458 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.294 0.569 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.478 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 3.5 m -52.93 -40.4 63.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.383 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -54.25 -26.41 28.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.441 -0.787 . . . . 0.0 109.069 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 48.2 ttm -67.68 -25.88 65.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.108 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.457 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 38.9 m -80.82 -28.06 36.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.335 -0.853 . . . . 0.0 109.167 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -68.08 -12.6 61.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 109.368 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -91.0 -16.59 27.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.689 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.495 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -109.76 157.22 19.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.183 179.852 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -128.95 140.79 51.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.564 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.766 HG21 ' C ' ' A' ' 15' ' ' GLY . 14.7 p -125.71 146.77 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.561 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mp -108.77 175.6 1.9 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.3 Cg_endo -67.32 -23.3 44.81 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.641 2.227 . . . . 0.0 111.669 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -88.93 -30.6 18.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.247 -0.908 . . . . 0.0 109.146 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.429 ' HA ' HD13 ' A' ' 14' ' ' ILE . 28.6 mm -85.9 -39.79 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 0.0 109.307 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.766 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 69.18 144.71 0.16 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.912 ' CE1' HD11 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -41.88 152.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -1.065 . . . . 0.0 109.789 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.1 tp -128.35 111.72 13.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.882 . . . . 0.0 109.511 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 81.0 m -116.85 158.08 44.72 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.327 -0.858 . . . . 0.0 109.2 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -71.79 165.62 31.99 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.575 2.183 . . . . 0.0 111.792 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -86.81 -11.61 50.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -74.11 113.42 11.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.246 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.975 HD11 ' OD1' ' A' ' 34' ' ' ASN . 55.9 tp -80.02 123.22 27.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.554 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 11.9 mmtm -141.03 109.63 6.44 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.394 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -66.02 120.28 7.42 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 123.04 2.493 . . . . 0.0 112.055 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 32' ' ' THR . 11.1 m -116.86 156.64 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 109.82 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 46.8 t -98.59 119.8 37.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.0 109.368 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -72.62 137.31 24.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -68.33 -7.61 32.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -1.08 . . . . 0.0 109.532 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 91.5 m-20 -89.07 11.77 17.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.504 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.6 71.59 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 27' ' ' GLY . 78.4 mt-30 -116.01 173.95 6.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -1.164 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.652 HG21 ' HG3' ' A' ' 57' ' ' LYS . 50.6 m -133.9 140.33 46.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.328 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.766 ' CD1' HD13 ' A' ' 39' ' ' LEU . 24.6 m-85 -118.62 123.32 44.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.467 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.975 ' OD1' HD11 ' A' ' 22' ' ' LEU . 54.6 t-20 -45.99 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 109.737 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.8 t-20 -80.82 147.52 62.53 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.866 -1.146 . . . . 0.0 109.343 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.8 Cg_endo -62.45 -53.15 2.0 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.699 2.266 . . . . 0.0 111.804 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.6 t -62.76 -28.15 69.78 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.485 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 50.3 mmm -63.13 -16.77 61.12 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.766 HD13 ' CD1' ' A' ' 33' ' ' TYR . 27.9 tp -66.77 -50.67 61.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.454 -0.779 . . . . 0.0 108.899 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.6 m -67.92 -19.36 64.98 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -73.54 -54.82 7.3 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 88.6 mt-10 -63.35 -17.05 62.17 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 47' ' ' GLN . 94.0 m-20 -77.35 -35.74 54.36 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.493 -0.754 . . . . 0.0 108.967 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.912 HD11 ' CE1' ' A' ' 16' ' ' TYR . 31.2 mt -54.14 -36.09 62.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.116 -0.99 . . . . 0.0 108.567 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mt -78.45 -50.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.075 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 91.5 mtt-85 -65.31 -26.89 68.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.23 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.97 41.95 7.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 109.587 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 p -128.86 158.61 38.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.446 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.475 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 63.0 m-20 -87.71 58.4 4.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.332 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.435 ' OG1' ' OD2' ' A' ' 29' ' ' ASP . 57.6 m -75.15 133.6 41.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.858 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 67.9 m80 -119.88 174.86 6.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.858 . . . . 0.0 108.873 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.519 HG23 ' HB ' ' A' ' 25' ' ' VAL . 37.9 mt -79.71 138.43 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.322 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HA ' ' OD2' ' A' ' 28' ' ' ASP . 23.3 ttt180 -101.9 -47.52 4.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.387 -0.821 . . . . 0.0 109.578 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.5 m -146.86 137.61 23.84 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.49 -0.756 . . . . 0.0 109.33 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.7 p -60.69 145.17 50.3 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.24 164.09 39.9 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.652 ' HG3' HG21 ' A' ' 32' ' ' THR . 22.4 tttp -53.88 150.22 7.91 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.348 -1.09 . . . . 0.0 109.525 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 36.3 m -52.73 144.85 13.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.444 179.888 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 51' ' ' HIS . 3.7 m -54.24 -23.8 16.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.438 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.2 tt0 -48.57 -27.05 2.52 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.21 -0.931 . . . . 0.0 108.561 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.6 mtm -79.99 -36.29 36.23 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.511 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.2 m -85.5 8.96 17.2 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.691 ' HE2' ' CE1' ' A' ' 51' ' ' HIS . 31.1 mttt -70.13 -27.42 64.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 82.6 m-20 -144.44 64.25 1.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.882 ' OH ' HD21 ' A' ' 44' ' ' LEU . 11.7 p90 -125.33 -176.44 3.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.442 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -146.7 152.87 39.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 109.557 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 15' ' ' GLY . 42.5 t -144.57 127.93 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -106.8 175.32 2.09 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.865 . . . . 0.0 109.501 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -67.94 -23.23 41.05 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.693 2.262 . . . . 0.0 111.844 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -96.73 -26.64 15.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.254 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.2 mt -89.3 -42.07 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.655 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.586 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 64.32 -165.46 31.49 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.484 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -93.42 149.83 20.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -1.197 . . . . 0.0 109.407 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.2 tp -116.24 107.19 14.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.639 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 60.3 m -125.47 156.26 70.67 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 109.557 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 51.5 Cg_endo -72.12 167.84 25.69 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.733 2.288 . . . . 0.0 111.669 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -84.32 -26.0 28.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -62.34 117.01 5.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -84.67 104.32 14.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 34' ' ' ASN . 16.1 mtpt -116.12 111.37 42.71 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.223 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.6 Cg_endo -63.38 121.14 8.84 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 C-N-CA 122.999 2.466 . . . . 0.0 112.21 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' A' ' 52' ' ' ILE . 5.8 m -115.1 157.73 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.418 -0.801 . . . . 0.0 109.584 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 53' ' ' ARG . 47.6 t -97.21 140.58 31.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.8 135.38 12.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.7 p30 -62.0 -12.23 17.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -1.065 . . . . 0.0 109.71 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 49.8 m-20 -87.47 10.84 16.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.484 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.72 64.31 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 62.0 mt-30 -117.35 178.79 4.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.519 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.611 HG21 ' HG3' ' A' ' 57' ' ' LYS . 20.7 m -139.49 142.65 37.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.31 -0.869 . . . . 0.0 109.234 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.832 ' CD2' HD12 ' A' ' 39' ' ' LEU . 23.9 m-85 -122.42 134.84 54.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.58 ' CB ' HD21 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -54.68 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 109.491 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.4 t-20 -82.16 146.39 54.81 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.003 -1.061 . . . . 0.0 109.504 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.64 -52.3 1.94 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.703 2.269 . . . . 0.0 111.645 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.536 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -63.5 -24.28 67.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.509 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 62.2 mtp -73.66 -16.51 61.21 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.832 HD12 ' CD2' ' A' ' 33' ' ' TYR . 7.5 tt -64.55 -51.8 60.95 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' ASN . 8.7 m -54.09 -38.54 65.45 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.425 ' C ' ' O ' ' A' ' 40' ' ' CYS . 7.2 t60 -47.48 -50.21 23.78 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HG3' ' CD1' ' A' ' 33' ' ' TYR . 37.3 mm-40 -56.48 -25.98 52.78 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.2 m-80 -74.32 -33.72 63.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 0.0 108.85 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.882 HD21 ' OH ' ' A' ' 8' ' ' TYR . 37.2 mt -63.96 -44.26 93.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.1 mm -74.86 -52.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.125 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 37.7 mtt-85 -66.83 -22.25 66.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.198 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 61.51 35.26 17.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.359 -0.838 . . . . 0.0 109.584 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 p -123.13 170.38 10.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.419 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -96.77 57.37 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.857 . . . . 0.0 109.609 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.622 HG21 ' OH ' ' A' ' 33' ' ' TYR . 43.9 m -80.03 126.12 30.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.554 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.691 ' CE1' ' HE2' ' A' ' 6' ' ' LYS . 34.2 m-70 -113.18 -173.32 2.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.804 HG12 HD13 ' A' ' 39' ' ' LEU . 31.8 mt -87.09 124.69 40.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.176 -0.952 . . . . 0.0 109.366 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 79.3 ttt180 -80.44 -39.99 27.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.366 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.06 148.64 17.15 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.493 -0.754 . . . . 0.0 109.288 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -65.91 144.43 56.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.723 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.11 162.01 38.06 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.611 ' HG3' HG21 ' A' ' 32' ' ' THR . 13.5 tttm -54.8 154.27 5.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.51 -0.994 . . . . 0.0 109.372 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 84.5 m -62.55 141.13 58.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.499 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.488 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.517 ' OD1' HD12 ' A' ' 52' ' ' ILE . 61.9 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.47 -0.566 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.511 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 6.1 m -44.01 -27.56 0.38 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.252 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.487 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 20.8 mt-10 -49.39 -29.3 6.1 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.8 mtp -75.26 -27.43 59.42 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 2' ' ' SER . 4.1 m -79.73 -5.68 55.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.455 -0.778 . . . . 0.0 108.968 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.487 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 18.5 mttm -54.24 -31.47 53.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.795 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -146.43 67.74 1.18 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -0.948 . . . . 0.0 110.073 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.612 ' OH ' HD13 ' A' ' 44' ' ' LEU . 5.8 p90 -125.2 173.76 8.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.158 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -143.9 147.52 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.063 -1.023 . . . . 0.0 109.755 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 15' ' ' GLY . 66.6 t -144.57 132.83 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.126 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 1.5 mp -125.42 170.94 8.34 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 109.497 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.71 -24.59 40.93 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.556 2.171 . . . . 0.0 111.449 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -102.89 -27.16 12.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.039 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.4 mt -88.88 -43.09 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.294 -0.879 . . . . 0.0 109.24 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.785 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 76.04 -141.72 27.52 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.62 ' CD2' HG21 ' A' ' 10' ' ' VAL . 2.9 t80 -114.17 155.3 26.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 32.5 tp -112.44 124.5 52.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.991 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -138.54 156.66 73.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.388 -0.82 . . . . 0.0 109.057 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.2 Cg_endo -72.59 168.21 25.02 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.633 2.222 . . . . 0.0 111.552 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -84.82 -27.83 26.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.379 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.82 130.88 48.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.471 HD11 ' HB3' ' A' ' 34' ' ' ASN . 63.7 tp -95.06 117.71 30.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 109.5 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.531 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 7.5 mttt -128.22 104.88 19.94 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.3 Cg_endo -64.62 120.41 7.69 Favored 'Trans proline' 0 C--O 1.213 -0.755 0 C-N-CA 122.962 2.442 . . . . 0.0 112.081 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 32' ' ' THR . 11.9 m -119.62 156.46 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.851 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.3 t -99.87 121.48 41.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.432 -0.793 . . . . 0.0 108.873 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -79.41 137.05 18.45 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 45.5 p30 -68.5 -8.82 44.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -1.152 . . . . 0.0 109.548 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 29' ' ' ASP . 58.0 p30 -82.89 8.21 13.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -0.955 . . . . 0.0 109.313 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.44 23.01 45.2 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.4 mt-30 -133.79 158.25 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -1.154 . . . . 0.0 109.499 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 42.2 m -116.19 143.63 45.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 109.225 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.778 ' CD1' HD13 ' A' ' 39' ' ' LEU . 81.0 m-85 -122.51 127.82 50.02 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.272 -0.893 . . . . 0.0 109.213 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 10.7 m-20 -51.55 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.942 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 10.1 t-20 -81.97 146.56 55.85 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 120.947 -1.096 . . . . 0.0 109.731 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.9 -51.78 2.71 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.813 2.342 . . . . 0.0 111.674 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.9 t -60.14 -31.57 70.21 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 8.5 mtt -60.97 -17.53 52.24 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.778 HD13 ' CD1' ' A' ' 33' ' ' TYR . 63.5 tp -67.85 -54.45 18.86 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 8.1 t -58.19 -27.72 64.13 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -62.28 -58.93 5.89 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -59.62 -21.01 59.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.0 m-20 -80.09 -30.74 39.27 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.612 HD13 ' OH ' ' A' ' 8' ' ' TYR . 35.6 tp -61.14 -40.61 94.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.512 -0.742 . . . . 0.0 109.054 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.0 mt -80.43 -47.49 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.81 . . . . 0.0 109.322 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.59 ' HG2' HG23 ' A' ' 48' ' ' THR . 46.7 ttm-85 -67.66 -43.67 79.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.5 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 84.8 mt-30 65.88 47.18 2.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.387 -0.821 . . . . 0.0 109.58 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.59 HG23 ' HG2' ' A' ' 46' ' ' ARG . 21.3 p -120.83 8.07 10.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.449 ' OD1' ' CB ' ' A' ' 2' ' ' SER . 41.1 t30 52.73 60.65 3.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.535 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.409 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 28.9 m -77.87 141.12 39.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.327 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.511 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 59.6 m80 -115.12 168.58 9.81 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.204 -0.935 . . . . 0.0 109.094 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.517 HD12 ' OD1' ' A' ' 1' ' ' ASP . 21.7 mt -79.71 123.55 36.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.146 -0.972 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.518 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 65.2 ttt-85 -81.06 -45.98 15.69 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.571 -0.706 . . . . 0.0 109.266 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -152.99 153.85 33.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 109.138 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 p -74.0 144.89 44.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.0 164.6 40.4 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 75.1 mttt -64.9 138.44 58.37 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.46 -1.024 . . . . 0.0 109.345 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 152.6 44.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 109.418 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.496 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.252 0.549 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.491 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 7.6 m -53.64 -26.7 23.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.375 -0.828 . . . . 0.0 109.389 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.469 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 6.3 mt-10 -53.17 -24.41 10.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.279 -0.888 . . . . 0.0 109.055 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.9 mtm -70.62 -30.06 66.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.104 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 7.9 m -80.39 -20.15 44.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.393 -0.817 . . . . 0.0 109.285 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 86.1 mttt -50.19 -27.13 5.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 108.822 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -108.84 26.53 10.47 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 1.9 t80 -80.97 147.71 30.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.985 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -141.17 114.61 8.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.606 HG21 ' N ' ' A' ' 16' ' ' TYR . 5.4 p -128.71 154.71 39.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.348 -0.845 . . . . 0.0 109.431 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.606 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -110.12 168.42 7.67 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.948 . . . . 0.0 109.327 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.606 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.7 Cg_endo -67.2 -24.82 43.77 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.614 2.209 . . . . 0.0 111.543 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -92.92 -25.02 18.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.218 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.3 mt -85.69 -40.37 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 109.378 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.589 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 70.96 145.9 0.36 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.606 ' N ' HG21 ' A' ' 10' ' ' VAL . 1.9 t80 -51.44 150.89 3.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -1.163 . . . . 0.0 109.331 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -116.92 136.12 53.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.425 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.6 m -142.95 157.27 61.38 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.208 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -69.87 165.42 31.16 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.661 2.241 . . . . 0.0 111.755 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -87.93 -13.34 42.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -72.56 114.34 10.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.181 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 22' ' ' LEU . 38.0 tp -80.04 120.74 24.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 109.629 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.506 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -136.83 107.47 9.0 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.091 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.3 121.66 9.16 Favored 'Trans proline' 0 C--O 1.212 -0.784 0 C-N-CA 123.016 2.478 . . . . 0.0 112.249 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.494 ' HB ' HG23 ' A' ' 52' ' ' ILE . 16.3 m -118.89 155.57 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 109.877 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 32.2 t -97.36 139.03 33.91 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.68 140.31 15.04 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -70.98 -4.77 26.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -1.134 . . . . 0.0 109.618 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -93.57 4.61 53.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.01 20.26 33.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.7 mt-30 -124.63 163.58 21.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -1.139 . . . . 0.0 109.54 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.0 m -125.13 135.58 52.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.128 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.857 ' CD1' HD13 ' A' ' 39' ' ' LEU . 55.3 m-85 -115.36 130.16 56.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.228 -0.92 . . . . 0.0 109.349 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 8.3 m-20 -54.52 -78.15 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.731 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.9 t-20 -81.88 147.86 59.47 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.722 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.4 Cg_endo -62.92 -52.92 1.87 Allowed 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.751 2.3 . . . . 0.0 111.704 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.5 t -60.91 -29.81 69.81 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.984 -1.072 . . . . 0.0 108.111 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 44.9 mmm -63.65 -15.24 57.77 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.857 HD13 ' CD1' ' A' ' 33' ' ' TYR . 39.4 tp -68.76 -49.29 59.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.494 -0.754 . . . . 0.0 109.286 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 3.2 m -69.32 -21.35 63.85 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.551 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 40.5 t60 -70.27 -55.33 9.5 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 78.1 mt-10 -63.28 -19.49 64.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.1 m-20 -75.26 -33.42 61.27 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 40' ' ' CYS . 20.9 mt -59.3 -37.0 76.62 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 45' ' ' ILE . 6.6 mm -72.69 -49.6 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.469 ' HG2' HG23 ' A' ' 48' ' ' THR . 36.4 ttt180 -68.48 -25.86 65.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.1 mt-30 64.03 43.91 4.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.778 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.469 HG23 ' HG2' ' A' ' 46' ' ' ARG . 70.1 p -132.36 166.89 20.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.303 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.48 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 95.9 m-20 -95.71 61.13 2.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.396 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.3 m -72.32 139.3 47.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.619 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 72.1 m80 -119.15 173.57 6.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.845 . . . . 0.0 109.053 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.494 HG23 ' HB ' ' A' ' 25' ' ' VAL . 35.1 mt -80.07 124.93 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.097 -1.002 . . . . 0.0 109.269 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.486 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.7 ttt180 -79.93 -45.94 17.63 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.679 0.752 . . . . 0.0 109.235 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 p -156.49 146.47 21.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 p -65.37 147.4 53.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.157 -0.965 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.22 165.15 40.47 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.532 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 47.4 mttp -65.69 146.2 55.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -1.087 . . . . 0.0 109.346 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 152.86 35.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.504 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.405 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.474 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 1.8 m -58.26 -29.63 65.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.378 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.3 tt0 -53.17 -24.25 10.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.313 -0.867 . . . . 0.0 108.895 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.7 mtp -70.17 -32.1 69.89 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.497 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 34.4 m -80.56 -6.08 57.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.378 -0.826 . . . . 0.0 109.214 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 65.6 mttt -81.38 12.61 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 110.038 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -132.98 7.83 4.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.991 -1.068 . . . . 0.0 110.399 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 5.8 p90 -105.48 -176.56 3.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.912 -1.118 . . . . 0.0 109.604 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.621 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 10.4 ttt180 -151.48 142.81 23.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.339 -0.851 . . . . 0.0 109.142 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 15' ' ' GLY . 15.0 t -143.61 149.39 18.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.346 -0.846 . . . . 0.0 109.321 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -124.46 175.33 3.0 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.4 Cg_endo -66.71 -21.56 51.45 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.63 2.22 . . . . 0.0 111.739 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 66.1 ttt180 -99.6 -16.89 18.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.84 . . . . 0.0 109.641 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' ' 14' ' ' ILE . 40.0 mm -94.82 -49.82 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.033 -1.042 . . . . 0.0 109.611 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.574 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 86.47 -178.29 48.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.488 ' HE2' ' HH ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -90.63 146.91 23.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 109.736 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.3 tp -114.18 107.59 15.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 74.1 m -117.28 156.62 48.6 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.343 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.1 Cg_endo -72.21 167.94 25.47 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.642 2.228 . . . . 0.0 111.531 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -91.79 -12.81 32.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -66.74 129.45 39.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 109.277 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.901 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -89.56 120.68 31.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.518 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.619 ' N ' HD13 ' A' ' 22' ' ' LEU . 27.3 mttm -143.65 108.13 5.13 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.541 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 47.1 Cg_endo -66.77 122.39 9.76 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 123.056 2.504 . . . . 0.0 112.126 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -116.21 154.66 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 53' ' ' ARG . 49.6 t -97.04 138.56 34.38 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.57 139.82 14.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.9 t0 -69.2 -8.44 45.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -1.099 . . . . 0.0 109.459 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -87.54 3.61 46.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.978 . . . . 0.0 109.438 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.56 17.29 45.98 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 65.8 mt-30 -121.33 175.22 6.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -1.108 . . . . 0.0 109.625 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.643 HG21 ' HG3' ' A' ' 57' ' ' LYS . 10.8 m -134.29 136.78 43.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 0.0 109.54 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.814 ' CD1' HD13 ' A' ' 39' ' ' LEU . 30.6 m-85 -114.42 127.67 55.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.901 ' OD1' HD21 ' A' ' 22' ' ' LEU . 59.6 t-20 -50.6 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.433 -0.792 . . . . 0.0 110.079 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.8 t-20 -80.85 149.5 67.36 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.004 -1.06 . . . . 0.0 109.555 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.35 -54.92 0.85 Allowed 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.793 2.329 . . . . 0.0 111.917 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.2 t -62.09 -28.33 69.54 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.965 -1.084 . . . . 0.0 108.265 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.4 mmm -64.41 -12.58 44.55 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.814 HD13 ' CD1' ' A' ' 33' ' ' TYR . 28.4 tp -73.56 -57.67 3.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.465 -0.772 . . . . 0.0 109.067 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.449 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.8 m -62.85 -18.47 62.93 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -71.85 -58.27 3.6 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -61.92 -17.08 55.52 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -77.15 -31.91 55.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.524 -0.735 . . . . 0.0 109.076 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.511 HD11 ' HH ' ' A' ' 8' ' ' TYR . 19.5 mt -58.55 -35.99 73.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.935 . . . . 0.0 108.678 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.2 mm -78.64 -50.25 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.056 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.9 mtt-85 -64.46 -34.71 78.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.168 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 58.79 36.47 24.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.379 -0.826 . . . . 0.0 109.447 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 p -113.12 11.82 18.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.37 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 46.28 57.73 5.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.367 -0.833 . . . . 0.0 109.44 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.3 m -75.04 140.57 43.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.492 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 48.7 m-70 -112.5 170.01 8.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.551 HG12 HD22 ' A' ' 39' ' ' LEU . 39.7 mt -79.85 126.52 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 41.3 ttt180 -79.77 -45.82 18.12 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.7 p -158.19 162.51 37.9 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.4 p -79.05 133.08 36.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -0.986 . . . . 0.0 109.755 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 99.95 165.35 29.06 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.643 ' HG3' HG21 ' A' ' 32' ' ' THR . 30.1 tttp -54.39 158.51 2.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -1.083 . . . . 0.0 109.236 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.474 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 91.2 m -69.39 150.42 47.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.6 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.384 179.918 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.46 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 3.1 m -53.97 -34.95 61.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.361 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -54.15 -27.52 34.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.3 -0.875 . . . . 0.0 109.039 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtp -71.71 -19.84 62.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.392 -0.818 . . . . 0.0 109.044 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.9 m -85.48 -22.93 28.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.375 -0.828 . . . . 0.0 109.247 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -74.75 -14.33 60.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -109.34 4.09 22.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.872 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -119.43 155.11 32.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.038 -1.039 . . . . 0.0 109.238 179.909 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -136.74 130.79 32.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.408 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.593 HG21 ' C ' ' A' ' 15' ' ' GLY . 4.9 p -129.39 142.2 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.469 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.775 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -103.88 173.55 3.33 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.775 ' HD2' HD23 ' A' ' 11' ' ' LEU . 47.6 Cg_endo -68.44 -26.72 34.37 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.595 2.197 . . . . 0.0 111.717 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -89.01 -28.41 20.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.295 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.7 mm -84.39 -40.57 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.244 -0.91 . . . . 0.0 109.304 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.593 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 68.56 155.85 0.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CE2' ' CZ ' ' A' ' 8' ' ' TYR . 1.3 t80 -55.67 148.06 17.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.292 -1.122 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.6 tp -123.1 119.62 30.83 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.859 . . . . 0.0 109.323 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.4 m -117.67 155.82 50.2 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.525 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.3 Cg_endo -71.55 166.02 30.69 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.844 2.363 . . . . 0.0 111.791 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -86.63 -8.01 57.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.867 . . . . 0.0 109.335 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -72.99 128.77 36.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 109.304 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.918 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.1 tm? -92.12 124.69 36.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.717 ' N ' HD13 ' A' ' 22' ' ' LEU . 2.2 mmmm -145.27 103.68 4.36 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.304 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 42.6 Cg_endo -65.36 124.29 12.7 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 123.061 2.507 . . . . 0.0 112.298 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 32' ' ' THR . 17.7 m -120.74 156.26 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 109.939 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.6 t -101.64 115.46 30.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.172 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -71.77 139.29 28.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.0 p30 -69.41 -9.83 55.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -1.14 . . . . 0.0 109.484 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.8 m-20 -82.95 8.13 13.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.75 14.35 63.31 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.0 mt-30 -120.75 159.73 24.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.304 -1.116 . . . . 0.0 109.467 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.506 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 33.1 m -119.1 134.66 55.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.286 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.841 ' CD1' HD13 ' A' ' 39' ' ' LEU . 56.5 m-85 -113.26 123.83 51.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.119 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.918 ' OD1' HD21 ' A' ' 22' ' ' LEU . 64.2 t-20 -49.41 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.256 -0.902 . . . . 0.0 109.806 -179.512 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.5 t-20 -80.93 147.97 63.28 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 120.871 -1.143 . . . . 0.0 109.72 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.6 Cg_endo -62.16 -53.11 2.17 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.845 2.363 . . . . 0.0 111.941 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.0 t -60.92 -28.5 68.98 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 120.911 -1.118 . . . . 0.0 108.023 178.863 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 22.2 mtp -63.99 -20.92 66.25 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.841 HD13 ' CD1' ' A' ' 33' ' ' TYR . 32.7 tp -67.38 -54.57 19.31 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.529 ' O ' HD12 ' A' ' 44' ' ' LEU . 38.1 t -58.34 -30.96 67.14 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -66.52 -59.04 4.0 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 73.9 mt-10 -59.2 -18.41 36.43 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.472 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 94.4 m-20 -77.28 -37.88 51.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.589 -0.695 . . . . 0.0 109.162 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.529 HD12 ' O ' ' A' ' 40' ' ' CYS . 5.4 mp -56.38 -34.24 66.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 108.79 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 mt -79.01 -48.49 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.396 -0.815 . . . . 0.0 109.278 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.707 ' HG3' HG23 ' A' ' 48' ' ' THR . 19.9 tpt85 -65.64 -39.22 91.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 88.7 mt-30 62.67 41.84 8.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.56 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.707 HG23 ' HG3' ' A' ' 46' ' ' ARG . 27.3 p -121.92 10.65 10.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.497 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 51.51 60.84 3.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.355 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.472 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 26.7 m -77.52 141.56 39.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.625 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.46 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 22.7 m-70 -115.18 172.12 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.011 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.4 mt -82.96 124.75 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.501 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 24.7 tpt180 -82.16 -53.52 6.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.422 -0.799 . . . . 0.0 109.31 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.9 p -148.02 154.58 40.46 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -73.05 147.58 44.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.116 -0.99 . . . . 0.0 109.312 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.95 165.15 40.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.549 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 35.0 mttm -66.86 145.6 55.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -1.041 . . . . 0.0 109.301 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 153.06 29.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.453 -179.964 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 14.9 p30 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.34 0.59 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m -56.17 -28.34 57.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.336 -0.852 . . . . 0.0 109.235 179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -53.12 -26.1 15.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.282 -0.886 . . . . 0.0 108.863 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.1 mtm -69.32 -26.62 64.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 108.777 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 34.8 m -81.13 -17.12 50.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.785 . . . . 0.0 109.475 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 63.1 mttt -80.51 8.38 7.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.733 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 95.9 m-20 -137.83 10.76 2.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.011 -1.056 . . . . 0.0 110.241 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.616 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -121.36 151.18 40.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 109.565 179.803 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -132.02 134.86 46.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.236 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.837 HG13 ' O ' ' A' ' 15' ' ' GLY . 61.8 t -124.47 148.92 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.82 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.564 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -129.6 175.23 3.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.437 -0.789 . . . . 0.0 109.276 179.849 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 43.8 Cg_endo -66.9 -21.73 49.83 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.651 2.234 . . . . 0.0 111.784 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -103.65 -28.26 11.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.52 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' A' ' 11' ' ' LEU . 90.2 mt -81.76 -46.99 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.547 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.837 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 78.97 -166.43 51.83 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.2 t80 -97.16 150.8 20.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.174 . . . . 0.0 109.502 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.6 tp -120.07 116.29 25.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 109.681 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.6 m -127.37 157.37 72.94 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.201 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.8 Cg_endo -71.05 166.49 28.99 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.501 2.134 . . . . 0.0 111.682 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -88.12 -14.41 38.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.521 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -71.87 119.31 15.87 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.207 -0.933 . . . . 0.0 109.242 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 34' ' ' ASN . 43.0 tp -83.61 116.39 22.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.75 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.6 mmtt -129.7 105.45 17.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.885 . . . . 0.0 109.087 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.567 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 43.4 Cg_endo -65.27 119.82 6.91 Favored 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 122.952 2.434 . . . . 0.0 112.283 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 32' ' ' THR . 24.3 m -117.63 154.8 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 25.8 t -95.72 127.61 41.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.329 -0.857 . . . . 0.0 108.753 179.21 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -83.07 137.51 16.61 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.4 p30 -67.8 -8.52 36.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -85.6 7.34 23.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 109.384 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.54 16.07 57.45 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.5 mt-30 -123.2 173.46 7.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.493 HG21 ' HA ' ' A' ' 57' ' ' LYS . 25.9 m -133.0 135.42 45.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.387 -0.82 . . . . 0.0 109.263 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.745 ' CD1' HD13 ' A' ' 39' ' ' LEU . 37.0 m-85 -112.54 130.09 56.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.202 -0.936 . . . . 0.0 109.371 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.525 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 8.4 m-20 -53.77 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 109.72 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.0 t-20 -81.84 147.8 59.45 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.29 -53.87 1.3 Allowed 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.789 2.326 . . . . 0.0 111.813 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -61.32 -27.49 68.52 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 42.8 mmm -64.81 -17.88 64.62 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.234 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.745 HD13 ' CD1' ' A' ' 33' ' ' TYR . 24.2 tp -68.54 -58.16 4.72 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.453 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 10.5 t -56.36 -26.12 51.72 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -68.59 -61.56 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.159 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.403 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 69.1 mt-10 -56.02 -19.86 14.38 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.239 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.2 m-20 -78.56 -40.27 35.31 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.7 tp -55.83 -33.84 64.85 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.417 -0.802 . . . . 0.0 108.845 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mt -78.82 -50.53 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.836 . . . . 0.0 108.995 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 13.2 mtt-85 -65.48 -22.02 66.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 109.348 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 89.0 mt-30 63.83 43.67 5.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.333 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.4 t -131.57 168.99 16.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -103.56 63.29 0.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.1 m -74.42 140.01 44.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.703 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -116.66 178.93 4.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.044 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.411 HG23 ' HB ' ' A' ' 25' ' ' VAL . 30.0 mt -87.99 124.9 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.058 -1.026 . . . . 0.0 109.4 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 69.9 ttt-85 -80.19 -47.5 14.58 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.543 -0.723 . . . . 0.0 109.288 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 p -155.33 152.99 29.83 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -71.69 146.03 48.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.15 -0.969 . . . . 0.0 109.415 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.98 164.23 40.17 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.567 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 26.1 mttp -64.58 143.66 57.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.554 -0.968 . . . . 0.0 109.447 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 151.55 35.47 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.257 -0.902 . . . . 0.0 109.397 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.5 -179.864 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.31 0.576 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.462 ' HB2' ' HB3' ' A' ' 51' ' ' HIS . 5.0 m -55.08 -26.55 38.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.3 tt0 -53.22 -25.88 15.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.062 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.7 mtp -73.89 -36.02 64.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.351 -0.843 . . . . 0.0 108.915 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.573 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.0 m -85.58 4.14 37.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 109.083 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 24.7 mttt -73.05 -20.48 60.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 58.6 p30 -148.93 57.55 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 109.838 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.651 ' OH ' HD21 ' A' ' 44' ' ' LEU . 12.0 p90 -120.83 -175.44 3.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 109.242 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -152.64 145.6 24.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.391 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 15' ' ' GLY . 55.5 t -132.04 129.68 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -111.94 175.37 1.9 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.355 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.4 Cg_endo -67.57 -23.66 42.85 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.61 2.207 . . . . 0.0 111.651 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.9 ttp85 -93.28 -39.72 10.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.89 . . . . 0.0 109.207 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.7 mt -79.95 -43.84 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.351 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.843 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 67.27 -155.05 52.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.665 ' CD2' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -112.71 148.13 35.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -1.104 . . . . 0.0 109.25 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.844 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -122.0 128.93 52.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.0 m -136.4 157.27 75.7 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.272 -0.893 . . . . 0.0 109.317 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -70.4 165.73 30.74 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.575 2.184 . . . . 0.0 111.662 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -87.4 -10.5 51.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -78.52 108.88 12.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.443 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.5 tm? -76.0 110.8 10.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 34' ' ' ASN . 2.6 mtpt -124.3 109.66 29.01 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 109.313 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.4 Cg_endo -62.31 121.26 9.19 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 123.035 2.49 . . . . 0.0 112.272 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.582 ' HB ' HG23 ' A' ' 52' ' ' ILE . 11.1 m -115.78 155.78 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -0.804 . . . . 0.0 109.904 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.7 t -97.27 112.92 24.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.365 -0.834 . . . . 0.0 108.932 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -67.18 133.5 31.04 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.4 t0 -69.62 -6.46 31.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 109.783 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 57.4 p30 -85.53 1.99 46.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.084 -1.01 . . . . 0.0 109.342 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.71 18.26 30.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.3 mt-30 -126.84 173.88 9.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.498 -1.001 . . . . 0.0 109.341 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.887 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.5 m -132.63 138.35 47.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.266 -0.896 . . . . 0.0 109.29 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.86 ' CD2' HD12 ' A' ' 39' ' ' LEU . 31.4 m-85 -118.38 139.81 50.81 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.163 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -61.03 -76.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 -179.365 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.0 t-20 -82.31 146.81 55.22 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.988 -1.07 . . . . 0.0 109.64 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.9 Cg_endo -63.65 -52.23 1.98 Allowed 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.599 2.199 . . . . 0.0 111.68 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -63.42 -27.62 69.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 0.0 108.183 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.496 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 54.3 mtp -67.88 -19.8 65.06 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.315 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.86 HD12 ' CD2' ' A' ' 33' ' ' TYR . 7.3 tt -66.52 -52.92 40.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.331 -0.856 . . . . 0.0 108.873 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 43' ' ' ASN . 9.4 m -51.16 -41.05 59.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 40' ' ' CYS . 16.1 t60 -48.06 -48.1 33.54 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.972 -1.08 . . . . 0.0 108.209 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 49.8 mm-40 -58.37 -22.18 52.75 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 40' ' ' CYS . 2.9 m-80 -75.7 -35.83 60.18 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.997 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.651 HD21 ' OH ' ' A' ' 8' ' ' TYR . 31.7 mt -65.86 -48.69 70.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.301 -0.874 . . . . 0.0 109.389 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 45' ' ' ILE . 5.8 mm -67.2 -52.82 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.118 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.506 ' HG2' HG23 ' A' ' 48' ' ' THR . 72.8 ttt180 -68.56 -22.87 64.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.307 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ASN . 86.7 mt-30 63.06 43.17 6.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.363 -0.835 . . . . 0.0 109.571 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.506 HG23 ' HG2' ' A' ' 46' ' ' ARG . 60.7 p -132.96 167.42 20.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.145 -0.972 . . . . 0.0 109.576 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -94.3 57.83 2.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.601 -179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.48 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 57.0 m -80.19 127.16 32.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.467 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 2' ' ' SER . 23.7 m-70 -115.79 -169.22 1.55 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.444 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.582 HG23 ' HB ' ' A' ' 25' ' ' VAL . 37.8 mt -88.12 124.98 41.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.473 -0.767 . . . . 0.0 109.836 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.539 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 64.5 ttt180 -82.53 -49.64 9.67 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.746 0.784 . . . . 0.0 109.383 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 p -150.72 138.83 20.14 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.629 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -60.95 144.59 52.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.117 -0.99 . . . . 0.0 109.284 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.48 160.72 36.43 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.887 ' HG3' HG21 ' A' ' 32' ' ' THR . 17.7 tttm -61.52 148.87 40.62 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.521 -0.987 . . . . 0.0 109.397 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.1 145.31 32.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.654 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.587 -179.948 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.468 ' OD1' ' CG1' ' A' ' 52' ' ' ILE . 72.3 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.2 m -51.55 -26.12 8.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.87 . . . . 0.0 109.352 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 4.4 mt-10 -52.13 -25.93 10.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.22 -0.925 . . . . 0.0 108.867 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.5 mtt -80.36 -31.79 37.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.375 -0.828 . . . . 0.0 109.034 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.4 m -80.0 -5.54 55.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.296 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 32.2 mttm -61.6 -23.2 65.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.674 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -151.31 64.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.928 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.709 ' OH ' HD13 ' A' ' 44' ' ' LEU . 6.7 p90 -123.77 174.33 7.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.109 -0.994 . . . . 0.0 109.198 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -147.35 146.49 29.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.648 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.594 HG21 ' CD2' ' A' ' 16' ' ' TYR . 69.3 t -145.29 132.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.484 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.645 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -117.8 175.08 2.2 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.269 -0.894 . . . . 0.0 109.597 -179.968 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.645 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.9 Cg_endo -67.73 -26.35 39.1 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.687 2.258 . . . . 0.0 111.951 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -107.8 -24.49 11.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.369 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.4 mm -82.59 -43.08 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.577 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.25 -159.14 53.23 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.594 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.7 t80 -98.6 153.73 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -1.177 . . . . 0.0 109.466 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 31.3 tp -107.86 123.25 48.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 109.877 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 68.3 m -140.19 156.48 70.03 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.306 -0.871 . . . . 0.0 109.21 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.4 Cg_endo -71.56 167.6 25.96 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.558 2.172 . . . . 0.0 111.701 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -84.07 -29.47 26.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.613 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.34 125.94 25.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.418 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.584 HD11 ' CB ' ' A' ' 34' ' ' ASN . 59.5 tp -88.26 113.21 23.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.154 -0.966 . . . . 0.0 109.432 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.544 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.5 mttt -121.27 105.61 39.29 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.511 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -64.69 118.67 5.63 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 123.085 2.523 . . . . 0.0 112.215 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.473 ' HB ' HG23 ' A' ' 52' ' ' ILE . 14.1 m -115.72 156.01 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 109.885 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.4 t -98.95 142.87 29.9 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.404 ' C ' ' HB2' ' A' ' 53' ' ' ARG . . . -95.82 143.7 16.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.488 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.2 t0 -71.87 -14.33 61.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -1.124 . . . . 0.0 109.416 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -83.69 -5.38 59.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.44 22.04 10.87 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 85.5 mt-30 -121.46 170.95 9.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -1.13 . . . . 0.0 109.469 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.541 HG23 ' HA ' ' A' ' 57' ' ' LYS . 86.6 m -133.61 136.66 45.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.493 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.836 ' CD1' HD13 ' A' ' 39' ' ' LEU . 28.3 m-85 -115.02 146.23 41.47 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 108.754 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.584 ' CB ' HD11 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -67.98 -75.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.01 -1.056 . . . . 0.0 108.626 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.9 t-20 -82.77 146.7 53.29 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 109.403 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -63.61 -51.18 2.64 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.693 2.262 . . . . 0.0 111.591 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -62.18 -28.58 69.77 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.432 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 10.3 mtt -64.4 -16.91 63.21 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.836 HD13 ' CD1' ' A' ' 33' ' ' TYR . 30.9 tp -65.94 -53.69 35.98 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.5 t -60.65 -23.48 64.82 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.726 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 25.2 t60 -67.31 -58.98 3.8 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -58.79 -22.07 57.48 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 47' ' ' GLN . 78.2 m-20 -80.38 -30.77 37.87 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.709 HD13 ' OH ' ' A' ' 8' ' ' TYR . 49.5 tp -62.38 -35.56 79.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 108.76 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mt -80.49 -50.33 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.4 -0.813 . . . . 0.0 109.249 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 96.1 mtt180 -68.89 -40.27 79.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 92.7 mt-30 65.0 39.56 5.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.543 -0.723 . . . . 0.0 109.547 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 46' ' ' ARG . 40.6 p -108.15 6.97 27.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.393 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.1 t30 52.74 56.79 7.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.524 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.9 m -78.6 140.46 38.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 -112.12 169.11 9.08 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.275 -0.891 . . . . 0.0 108.993 179.523 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.507 HG12 HD22 ' A' ' 39' ' ' LEU . 23.3 mt -79.47 127.11 39.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.218 -0.926 . . . . 0.0 109.241 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.488 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 53.7 ttt-85 -79.35 -46.14 18.23 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.389 -0.819 . . . . 0.0 109.134 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 m -160.61 148.08 15.89 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.7 p -61.18 145.3 51.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.6 166.23 40.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HA ' HG23 ' A' ' 32' ' ' THR . 89.2 mttt -67.71 150.16 49.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -1.085 . . . . 0.0 109.499 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 66.7 m -59.79 151.11 26.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.9 . . . . 0.0 109.318 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.488 179.971 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.516 ' OG ' ' CD2' ' A' ' 39' ' ' LEU . 1.4 m -49.91 -36.88 29.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.224 -0.923 . . . . 0.0 109.482 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -54.28 -27.19 33.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.301 -0.874 . . . . 0.0 108.93 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.0 ttm -69.17 -28.73 66.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -0.812 . . . . 0.0 109.277 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.477 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 81.3 m -81.64 -31.18 32.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.244 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -60.49 -23.71 64.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.398 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -76.41 -25.73 54.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.512 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.465 ' OH ' ' CD1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -103.66 155.22 18.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.197 -0.939 . . . . 0.0 109.226 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -128.36 139.71 52.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 0.0 109.317 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.758 HG21 ' C ' ' A' ' 15' ' ' GLY . 13.0 p -123.17 146.0 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -0.924 . . . . 0.0 109.51 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.556 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -108.59 176.08 1.72 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.3 Cg_endo -67.14 -25.4 43.54 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.601 2.201 . . . . 0.0 111.675 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -85.01 -31.3 23.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.253 -0.904 . . . . 0.0 108.917 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.8 mt -87.04 -37.68 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.398 -0.814 . . . . 0.0 109.128 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.758 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 66.52 142.24 0.05 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.678 ' N ' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -42.27 152.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.446 -1.032 . . . . 0.0 109.833 -179.921 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 tp -123.53 118.29 27.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.426 -0.796 . . . . 0.0 109.518 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.7 m -129.24 157.28 76.58 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.188 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.67 165.86 30.63 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.691 2.261 . . . . 0.0 111.755 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -89.12 -8.74 53.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.23 -0.919 . . . . 0.0 109.421 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -76.97 107.18 9.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 0.0 109.07 179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 34' ' ' ASN . 59.4 tp -71.2 121.16 17.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.811 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 31.1 mtmt -139.57 110.53 7.47 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.235 -0.915 . . . . 0.0 109.102 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.8 Cg_endo -65.54 119.48 6.51 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 C-N-CA 123.175 2.584 . . . . 0.0 112.631 -179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 32' ' ' THR . 27.3 m -112.49 156.22 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 0.0 109.65 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 12.3 t -98.59 111.44 23.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 109.315 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.3 138.16 36.17 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 40.1 t0 -71.26 -4.73 27.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -1.199 . . . . 0.0 109.606 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 57.6 m-20 -90.07 7.2 38.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.083 -1.01 . . . . 0.0 109.101 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.77 14.5 59.48 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 27' ' ' GLY . 77.0 mt-30 -125.69 140.23 52.88 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.414 -1.051 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 25' ' ' VAL . 17.1 m -103.59 153.21 20.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -0.902 . . . . 0.0 109.34 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.563 ' CZ ' ' HG3' ' A' ' 42' ' ' GLU . 19.9 m-85 -128.58 143.16 50.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.1 m-20 -58.54 -75.23 0.05 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -0.888 . . . . 0.0 109.962 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.7 t-20 -82.5 147.76 56.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.069 -1.019 . . . . 0.0 109.993 -179.543 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.5 Cg_endo -64.3 -53.44 1.12 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.746 2.298 . . . . 0.0 111.485 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.5 t -60.77 -27.69 68.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 36.5 mmm -63.78 -17.46 63.09 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.369 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.816 HD13 HG12 ' A' ' 52' ' ' ILE . 8.2 tt -68.26 -52.82 29.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.352 -0.843 . . . . 0.0 108.985 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.5 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . 45.0 m -47.9 -47.41 32.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.095 -1.003 . . . . 0.0 108.392 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.439 ' HA ' HD13 ' A' ' 44' ' ' LEU . 14.7 t60 -47.97 -49.35 30.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.128 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.563 ' HG3' ' CZ ' ' A' ' 33' ' ' TYR . 71.8 mm-40 -49.41 -24.05 1.79 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 4.6 m-80 -80.02 -37.64 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.416 -0.803 . . . . 0.0 108.873 179.352 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.3 mp -67.5 -36.71 81.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.221 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 45' ' ' ILE . 5.3 mt -77.12 -52.53 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.077 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 48' ' ' THR . 47.0 mtt-85 -71.85 -20.99 61.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.373 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 43' ' ' ASN . 88.2 mt-30 62.44 35.45 14.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -0.851 . . . . 0.0 109.312 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 46' ' ' ARG . 30.8 p -125.48 175.11 7.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.444 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.449 ' O ' ' CD2' ' A' ' 51' ' ' HIS . 79.8 m-20 -94.75 58.87 2.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 109.451 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.472 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 30.9 m -79.22 126.11 30.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.45 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 48.2 m-70 -115.7 -172.57 2.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.172 179.672 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.816 HG12 HD13 ' A' ' 39' ' ' LEU . 13.0 mt -87.78 124.27 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 109.576 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 61.3 ttt180 -80.07 -53.49 6.66 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.647 0.737 . . . . 0.0 109.319 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 p -150.88 143.89 24.66 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.629 -0.67 . . . . 0.0 109.203 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.3 p -64.83 144.86 56.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.196 -0.94 . . . . 0.0 109.405 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.03 161.66 36.92 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 32' ' ' THR . 23.2 tttt -62.22 144.96 54.82 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.449 -1.03 . . . . 0.0 109.278 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.37 157.22 26.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.616 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.545 -179.986 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.579 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 0.5 OUTLIER -52.62 -35.04 53.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.136 -0.977 . . . . 0.0 109.289 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -51.58 -26.47 8.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.298 -0.877 . . . . 0.0 108.74 179.739 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.4 mmm -72.17 -23.78 61.33 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.244 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.595 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 33.5 m -80.31 -17.74 51.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.524 -0.735 . . . . 0.0 109.021 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -80.77 8.35 8.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.516 179.596 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -133.24 2.8 3.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.132 -0.98 . . . . 0.0 109.996 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.677 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -118.76 148.52 42.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.014 -1.054 . . . . 0.0 109.539 -179.977 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.7 mtm-85 -129.14 132.21 47.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.112 179.553 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.606 ' C ' HD22 ' A' ' 11' ' ' LEU . 42.2 t -126.51 140.48 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 -179.654 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 10' ' ' VAL . 3.8 mm? -117.95 170.26 6.53 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 41.7 Cg_endo -65.44 -21.43 60.56 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.192 1.928 . . . . 0.0 111.575 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -94.88 -25.29 16.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.418 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.2 mt -88.92 -50.44 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.298 -0.876 . . . . 0.0 109.944 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.567 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.24 -174.31 53.46 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.801 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.677 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -91.81 148.28 22.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -1.172 . . . . 0.0 109.552 -179.938 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.3 tp -120.96 100.67 7.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 109.728 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.6 m -111.04 157.73 37.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.235 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 53.6 Cg_endo -73.22 167.87 26.23 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.67 2.247 . . . . 0.0 111.681 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -87.62 -26.5 23.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 109.346 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.452 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 46.4 m-20 -57.89 124.54 19.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.163 -0.961 . . . . 0.0 109.171 179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 34' ' ' ASN . 36.2 tp -88.73 116.3 26.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.613 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASN . 3.8 mttt -127.43 103.2 22.65 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 108.983 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.527 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.7 Cg_endo -65.63 115.85 3.61 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.937 2.425 . . . . 0.0 111.842 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 32' ' ' THR . 21.7 m -113.89 154.43 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 0.0 109.732 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.1 t -94.22 131.49 39.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.343 -0.848 . . . . 0.0 108.738 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -86.85 137.24 14.64 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.4 p30 -66.23 -12.11 54.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -1.159 . . . . 0.0 109.616 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 52.6 p30 -83.75 8.92 13.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.01 20.83 54.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.451 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 68.8 mt-30 -125.51 175.98 7.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.47 -1.017 . . . . 0.0 109.326 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.602 HG21 ' HA ' ' A' ' 57' ' ' LYS . 14.1 m -135.1 136.38 41.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 109.432 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.65 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.5 m-85 -113.87 120.43 40.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.882 . . . . 0.0 109.267 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 10.4 m-20 -45.55 -78.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.985 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.3 t-20 -81.66 148.92 63.08 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.02 -1.05 . . . . 0.0 109.881 -179.583 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.2 Cg_endo -63.79 -54.35 0.98 Allowed 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.732 2.288 . . . . 0.0 111.927 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -63.01 -25.59 68.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.026 -1.046 . . . . 0.0 108.373 179.137 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.2 mmm -66.43 -11.56 52.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.559 -0.713 . . . . 0.0 109.095 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.65 HD13 ' CD1' ' A' ' 33' ' ' TYR . 20.9 tp -71.38 -60.12 2.4 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.29 -0.881 . . . . 0.0 108.707 179.594 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 10.3 t -54.65 -28.35 46.53 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.966 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -67.8 -60.64 2.36 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.143 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 78.4 mt-10 -57.78 -18.74 23.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 47' ' ' GLN . 96.7 m-20 -77.54 -32.6 54.06 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.92 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.4 tm? -58.36 -38.99 78.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.514 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mm -75.56 -49.73 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -0.867 . . . . 0.0 108.767 179.382 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 47.0 mtt-85 -63.71 -28.55 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.187 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 89.5 mt-30 63.15 44.03 6.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.6 p -133.51 167.05 21.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.576 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 48.7 p-10 -95.91 61.35 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.309 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.9 m -72.46 135.37 45.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.856 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.579 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 42.5 m80 -115.28 -178.1 3.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 108.939 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.2 mt -90.25 123.04 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 109.004 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 50.1 ttt85 -79.65 -44.52 20.77 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.393 -0.817 . . . . 0.0 109.432 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 p -158.56 158.09 33.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.549 -0.719 . . . . 0.0 109.121 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 p -75.5 136.97 40.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.897 . . . . 0.0 109.698 -179.626 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.47 162.73 34.11 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.602 ' HA ' HG21 ' A' ' 32' ' ' THR . 48.0 tttm -49.59 159.4 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.486 -1.008 . . . . 0.0 109.216 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.492 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 73.1 m -68.39 145.35 54.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.38 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.549 179.965 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.478 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 2.8 m -52.25 -39.49 60.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.281 -0.887 . . . . 0.0 109.531 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 35.4 mt-10 -50.61 -31.18 15.24 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.447 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 45.1 ttm -66.12 -27.23 67.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.11 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 71.2 m -80.48 -9.15 59.77 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.451 -0.781 . . . . 0.0 109.138 179.657 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 22.5 mttm -81.12 11.03 4.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.092 -1.005 . . . . 0.0 109.617 179.508 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 4' ' ' MET . 49.2 p30 -127.31 8.29 6.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.994 -1.066 . . . . 0.0 110.653 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.778 ' OH ' HD11 ' A' ' 44' ' ' LEU . 6.9 p90 -107.59 -177.41 3.34 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.723 -1.235 . . . . 0.0 109.686 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.579 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 46.8 mtt180 -151.91 128.46 10.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.226 179.567 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.591 HG23 ' CE1' ' A' ' 8' ' ' TYR . 24.5 t -127.14 145.36 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.7 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.559 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -118.53 176.33 1.72 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.365 -0.834 . . . . 0.0 109.169 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.0 Cg_endo -66.96 -21.97 49.04 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.557 2.171 . . . . 0.0 111.773 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.8 mtt-85 -96.81 -27.75 14.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 mm -84.1 -47.47 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.707 -179.763 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.468 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 78.32 177.6 48.48 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -83.0 147.68 28.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -1.16 . . . . 0.0 109.435 -179.917 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.0 tp -118.9 105.74 11.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.755 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.9 m -116.22 155.87 47.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 108.964 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.25 165.63 32.08 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.561 2.174 . . . . 0.0 111.543 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -84.04 -31.79 25.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 109.267 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -54.18 132.8 43.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.384 -0.823 . . . . 0.0 109.052 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 34' ' ' ASN . 61.3 tp -96.93 119.45 35.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.175 -0.953 . . . . 0.0 109.628 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' ASN . 3.9 mttm -130.99 106.56 15.1 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 0.0 108.899 179.647 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.64 123.41 11.66 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 123.009 2.472 . . . . 0.0 112.354 -179.183 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.438 ' HB ' HG23 ' A' ' 52' ' ' ILE . 17.6 m -118.18 155.15 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.728 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.7 t -96.49 138.09 34.59 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.44 135.64 12.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -66.83 -11.03 53.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 109.465 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.7 p30 -89.03 10.68 20.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.437 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.45 19.25 57.24 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 90.1 mt-30 -120.5 178.42 4.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -1.147 . . . . 0.0 109.549 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.775 HG21 ' HG3' ' A' ' 57' ' ' LYS . 35.3 m -139.58 136.76 34.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.887 . . . . 0.0 109.29 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.903 ' CD1' HD13 ' A' ' 39' ' ' LEU . 26.4 m-85 -117.81 128.79 55.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.161 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 11.7 m-20 -52.66 -78.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.794 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.5 t-20 -81.69 147.25 58.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.99 -1.069 . . . . 0.0 109.719 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.5 Cg_endo -63.51 -52.12 2.12 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.782 2.321 . . . . 0.0 111.739 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.4 t -62.95 -26.47 68.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.16 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.441 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 54.0 mmm -68.71 -15.15 63.43 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.149 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.903 HD13 ' CD1' ' A' ' 33' ' ' TYR . 21.2 tp -72.21 -50.85 24.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.415 -0.803 . . . . 0.0 109.339 179.784 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.494 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.5 m -66.14 -22.38 66.38 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.017 -1.052 . . . . 0.0 108.224 179.265 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -66.81 -56.17 11.62 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 95.5 mt-10 -63.43 -17.04 62.26 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' GLN . 86.2 m-20 -79.95 -26.37 40.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.602 -0.686 . . . . 0.0 109.186 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.778 HD11 ' OH ' ' A' ' 8' ' ' TYR . 19.2 mt -69.02 -33.29 73.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.165 -0.959 . . . . 0.0 108.649 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.4 mt -78.73 -50.36 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 108.978 179.516 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.584 ' HB3' HG23 ' A' ' 48' ' ' THR . 47.0 mtm180 -74.35 -34.25 63.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.305 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 59.62 39.24 21.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.553 179.805 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.584 HG23 ' HB3' ' A' ' 46' ' ' ARG . 38.1 p -103.97 16.68 25.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 48' ' ' THR . 53.2 m-20 44.22 52.13 7.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.408 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.443 ' OG1' ' NH2' ' A' ' 46' ' ' ARG . 76.6 m -74.9 146.26 42.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.614 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 31.6 m-70 -123.72 168.76 12.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.282 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.502 HG12 HD22 ' A' ' 39' ' ' LEU . 16.9 mt -79.73 124.35 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.447 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 78.3 ttt180 -79.76 -44.14 21.24 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 p -160.19 148.82 17.04 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.624 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 p -64.86 145.12 56.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.166 -0.959 . . . . 0.0 109.536 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.94 164.23 39.79 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.775 ' HG3' HG21 ' A' ' 32' ' ' THR . 17.4 tttt -60.44 151.45 28.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.461 -1.023 . . . . 0.0 109.361 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.402 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 72.2 m -58.47 152.39 18.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.469 179.89 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -47.9 -37.88 15.14 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.185 179.739 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 11.0 mt-10 -49.88 -26.42 4.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 ttm -70.41 -27.58 64.4 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.556 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 5.7 m -79.77 -12.35 59.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.447 -0.783 . . . . 0.0 109.05 179.496 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 28.3 mttm -55.21 -26.78 41.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.933 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -151.56 65.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.692 -179.757 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.932 ' OH ' HD11 ' A' ' 44' ' ' LEU . 4.1 p90 -128.79 170.7 13.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.508 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -144.85 154.99 43.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.293 -0.88 . . . . 0.0 109.386 179.579 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.846 HG13 ' C ' ' A' ' 15' ' ' GLY . 95.3 t -146.66 127.27 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.523 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -117.19 173.42 3.15 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.21 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HD2' HD23 ' A' ' 11' ' ' LEU . 43.1 Cg_endo -65.94 -22.92 55.11 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.498 2.132 . . . . 0.0 111.568 179.736 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -105.92 -33.66 7.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.852 . . . . 0.0 109.066 179.565 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.403 HD12 HD13 ' A' ' 11' ' ' LEU . 89.6 mt -81.64 -40.95 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.118 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.846 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 65.09 -145.13 48.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.9 t80 -105.34 158.0 16.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.31 -1.112 . . . . 0.0 109.495 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.32 114.01 21.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 62.6 m -128.1 156.19 76.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.331 179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.13 170.28 18.55 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.616 2.211 . . . . 0.0 111.625 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -91.3 -12.48 34.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.122 -0.986 . . . . 0.0 109.644 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -73.3 115.84 13.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.283 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 tp -73.17 126.36 29.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.625 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -139.75 100.39 7.41 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.849 . . . . 0.0 109.007 179.818 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -64.09 117.71 4.71 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.971 2.447 . . . . 0.0 112.345 -179.272 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 32' ' ' THR . 11.0 m -116.1 155.15 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.402 -0.811 . . . . 0.0 109.841 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.7 t -96.81 137.31 36.09 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.27 139.56 14.6 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 46.2 p30 -65.76 -9.12 25.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -1.068 . . . . 0.0 109.612 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -89.12 14.03 11.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.12 26.33 58.06 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.459 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 79.7 mt-30 -130.5 174.86 9.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -1.166 . . . . 0.0 109.288 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 32.9 m -131.81 152.93 50.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.882 ' CD2' HD12 ' A' ' 39' ' ' LEU . 40.6 m-85 -132.68 119.88 20.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.246 -0.909 . . . . 0.0 109.197 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 3.7 m-20 -43.6 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 109.689 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.2 t-20 -81.69 146.26 56.21 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.299 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.94 -50.95 2.57 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.593 2.195 . . . . 0.0 111.483 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.8 t -61.96 -25.35 67.56 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.828 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.438 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 13.9 mtp -68.14 -17.95 64.49 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.368 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.882 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.3 tt -67.74 -50.61 56.35 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.426 -0.796 . . . . 0.0 108.858 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 4.7 t -52.54 -45.69 66.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 0.0 108.521 179.194 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.403 ' HA ' HD23 ' A' ' 44' ' ' LEU . 15.9 t60 -48.99 -48.94 43.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.16 -0.962 . . . . 0.0 108.481 179.041 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 23.0 mm-40 -57.18 -20.22 25.28 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.528 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.8 m-80 -79.69 -33.13 41.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 108.612 179.2 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.932 HD11 ' OH ' ' A' ' 8' ' ' TYR . 3.9 mm? -67.11 -46.71 73.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 109.388 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.495 ' N ' HD13 ' A' ' 45' ' ' ILE . 5.0 mm -66.47 -52.21 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 48' ' ' THR . 66.4 mtp85 -71.02 -19.24 62.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.204 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 60.81 34.45 19.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 46' ' ' ARG . 8.7 p -123.06 -177.55 3.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.519 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 36.5 t-20 -107.59 64.78 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.923 . . . . 0.0 109.527 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 25.0 m -78.91 127.71 32.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 109.66 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.519 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 3.8 m80 -113.84 -172.13 2.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.25 -0.906 . . . . 0.0 109.143 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.474 HG12 HD13 ' A' ' 39' ' ' LEU . 22.9 mt -89.15 124.16 41.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.21 -0.932 . . . . 0.0 109.572 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.3 ttt-85 -80.8 -42.59 21.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.407 -0.808 . . . . 0.0 109.307 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -160.95 140.77 10.83 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.563 -0.71 . . . . 0.0 109.139 -179.568 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 p -57.9 140.6 51.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -0.957 . . . . 0.0 109.623 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 96.38 165.91 33.68 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 27.5 mttp -67.6 143.36 56.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.532 -0.981 . . . . 0.0 109.258 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 62.3 m -53.43 148.92 8.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.446 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.504 -179.955 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 21.0 p-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.26 0.553 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 5' ' ' CYS . 3.6 m -48.78 -33.11 9.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -0.833 . . . . 0.0 109.385 179.858 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.48 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 31.4 mt-10 -49.74 -30.5 9.54 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.692 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.4 mmm -76.23 -29.1 57.42 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.571 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.6 m -80.06 -5.0 55.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.369 -0.832 . . . . 0.0 109.301 179.608 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HE3' ' HG2' ' A' ' 3' ' ' GLU . 23.7 mttm -61.26 -28.73 69.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 -179.546 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 80.5 m-20 -145.1 61.66 1.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.067 -1.021 . . . . 0.0 110.339 -179.635 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.637 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 6.5 p90 -127.03 171.34 11.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.064 -1.023 . . . . 0.0 109.309 179.429 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -146.14 148.9 33.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 109.567 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 15' ' ' GLY . 85.8 t -138.51 132.26 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.419 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -123.66 175.65 2.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.349 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.5 Cg_endo -67.21 -25.84 42.71 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.53 2.153 . . . . 0.0 111.514 179.813 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -107.37 -27.33 10.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.388 -0.82 . . . . 0.0 108.991 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.9 mm -82.06 -39.77 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 109.437 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.771 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 68.98 -145.62 43.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.637 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 3.3 t80 -111.17 155.17 23.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -1.164 . . . . 0.0 109.27 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 39.7 mt -111.64 123.79 50.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.942 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.1 m -142.0 155.36 65.58 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.457 -0.777 . . . . 0.0 108.954 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.36 164.57 34.66 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.51 2.14 . . . . 0.0 111.554 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -83.46 -26.48 30.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.875 . . . . 0.0 109.544 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.51 129.31 40.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 109.299 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 34' ' ' ASN . 52.7 tp -88.8 123.17 32.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 0.0 109.472 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.2 mmtm -133.91 102.74 12.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.432 -0.793 . . . . 0.0 109.179 179.815 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' CB ' ' HG3' ' A' ' 57' ' ' LYS . 42.1 Cg_endo -64.05 122.04 9.91 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 123.032 2.488 . . . . 0.0 112.331 -179.222 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 32' ' ' THR . 16.8 m -122.22 155.41 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.753 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 34.7 t -99.15 137.51 37.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.403 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.16 138.74 14.13 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.212 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 56.6 p30 -63.59 -11.14 22.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -1.064 . . . . 0.0 109.671 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 86.4 m-20 -85.76 12.93 7.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.345 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.39 20.22 69.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.0 mt-30 -124.52 159.52 30.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -1.121 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 57.3 m -119.97 142.66 48.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -0.963 . . . . 0.0 109.569 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.648 ' CD2' HD12 ' A' ' 39' ' ' LEU . 57.7 m-85 -121.36 130.88 53.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.386 -0.821 . . . . 0.0 109.16 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.1 m-20 -53.8 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.16 -0.962 . . . . 0.0 109.54 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 11.4 t-20 -82.26 147.07 56.0 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 120.99 -1.069 . . . . 0.0 109.699 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.0 Cg_endo -63.1 -51.24 2.94 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.569 2.179 . . . . 0.0 111.409 179.371 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.502 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -60.25 -29.75 68.98 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.804 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 38.3 mmm -64.4 -23.52 67.32 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.35 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.648 HD12 ' CD2' ' A' ' 33' ' ' TYR . 7.2 tt -63.4 -48.01 79.6 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.362 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 12.0 t -52.63 -34.01 49.32 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -54.43 -50.04 68.59 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 108.763 179.206 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 26.2 tp10 -56.78 -19.9 19.52 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.363 -0.836 . . . . 0.0 108.774 179.338 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 4.7 m-80 -80.06 -31.65 39.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.858 . . . . 0.0 109.125 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.862 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.4 tm? -68.89 -42.39 77.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.084 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 45' ' ' ILE . 4.0 mt -71.17 -55.22 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 109.175 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.443 ' NH1' ' HG2' ' A' ' 46' ' ' ARG . 35.6 mtt-85 -70.33 -21.73 62.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.394 -0.816 . . . . 0.0 109.258 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 62.3 32.33 17.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.343 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.9 p -119.52 176.78 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 109.353 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.532 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 84.6 m-20 -100.13 61.37 1.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.481 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 56.0 m -71.79 131.7 43.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.882 . . . . 0.0 109.522 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 14.7 m-70 -116.58 -175.88 2.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.277 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.502 HG12 HD13 ' A' ' 39' ' ' LEU . 20.6 mt -86.19 124.26 40.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.199 -0.938 . . . . 0.0 109.542 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 70.1 ttt180 -80.53 -39.71 27.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.421 -0.799 . . . . 0.0 109.051 179.694 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -158.57 153.56 25.18 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.2 p -73.39 145.57 45.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.179 -0.951 . . . . 0.0 109.495 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.92 164.71 40.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HG3' ' CB ' ' A' ' 24' ' ' PRO . 37.5 mttp -63.09 144.88 56.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.478 -1.013 . . . . 0.0 109.406 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.411 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 0.1 OUTLIER -78.53 156.08 29.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 179.992 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.57 179.998 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' A' ' 3' ' ' GLU . 24.4 p30 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -47.8 -29.92 3.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.617 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.467 ' HB2' ' OD1' ' A' ' 1' ' ' ASP . 1.2 mt-10 -54.73 -21.81 12.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 109.008 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 1' ' ' ASP . 51.1 mmm -77.56 -26.85 51.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.37 -0.831 . . . . 0.0 108.957 179.535 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 38.2 m -81.19 -19.58 43.03 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.387 -0.821 . . . . 0.0 109.331 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -80.68 9.26 6.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -133.17 2.69 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.973 . . . . 0.0 109.958 -179.709 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.594 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -119.45 144.89 46.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.02 -1.05 . . . . 0.0 109.74 -179.916 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.0 mtt85 -127.5 129.83 48.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 108.894 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.796 ' O ' HD22 ' A' ' 11' ' ' LEU . 42.9 t -116.76 141.49 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.035 -1.041 . . . . 0.0 110.201 -179.289 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 10' ' ' VAL . 4.0 mm? -124.43 171.09 7.69 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.582 ' HD2' HD12 ' A' ' 11' ' ' LEU . 42.7 Cg_endo -66.28 -22.25 53.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.305 2.003 . . . . 0.0 111.666 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -97.0 -29.51 13.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 109.206 179.635 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 11' ' ' LEU . 80.6 mt -83.06 -48.57 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.402 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.744 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 86.7 -175.0 46.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.459 ' OH ' ' HB3' ' A' ' 40' ' ' CYS . 1.5 t80 -81.15 153.05 27.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -1.143 . . . . 0.0 109.544 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 17' ' ' LEU . 38.6 mt -127.86 134.08 49.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 72.4 m -146.92 158.4 45.35 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.347 -0.845 . . . . 0.0 109.141 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.9 Cg_endo -69.52 167.5 23.94 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.636 2.224 . . . . 0.0 111.459 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -85.62 -21.72 28.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.188 -0.945 . . . . 0.0 109.693 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -68.01 115.98 8.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.307 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 35' ' ' ASN . 32.9 tp -86.95 121.38 29.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.174 -0.954 . . . . 0.0 109.536 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASN . 13.0 mmtm -135.83 113.26 10.75 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.403 -0.81 . . . . 0.0 108.908 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.531 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -64.78 116.06 3.59 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.953 2.436 . . . . 0.0 112.13 -179.351 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 32' ' ' THR . 34.2 m -113.53 156.13 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.956 -179.822 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.5 t -100.49 124.02 45.47 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -80.85 137.54 18.13 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.621 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.584 ' OD1' HG23 ' A' ' 50' ' ' THR . 46.8 p30 -63.9 -10.58 21.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -1.127 . . . . 0.0 109.727 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.412 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 28.5 m-20 -87.29 16.76 4.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.52 19.59 75.95 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.8 mt-30 -120.83 169.0 10.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -1.1 . . . . 0.0 109.392 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 88.6 m -129.86 142.71 50.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.403 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.756 ' HD2' HD12 ' A' ' 39' ' ' LEU . 41.8 m-85 -122.43 118.0 27.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.329 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.1 m-20 -43.09 -75.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.855 . . . . 0.0 109.536 -179.656 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.1 t-20 -81.79 150.28 65.54 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.81 -54.5 1.17 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.684 2.256 . . . . 0.0 111.906 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 4.0 t -58.42 -30.5 66.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.947 -1.095 . . . . 0.0 108.149 179.051 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 7.5 mtt -59.71 -21.09 60.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.882 HD13 HG12 ' A' ' 52' ' ' ILE . 7.3 tt -66.89 -53.63 30.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 16.9 t -49.48 -28.56 5.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.437 ' CD2' HD11 ' A' ' 45' ' ' ILE . 21.5 t60 -57.89 -53.58 56.64 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.282 -0.886 . . . . 0.0 108.617 179.078 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.59 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 16.3 tp10 -54.03 -20.48 6.43 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.8 m-80 -80.46 -33.44 36.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 108.773 179.541 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.26 -39.35 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.83 . . . . 0.0 109.346 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.437 HD11 ' CD2' ' A' ' 41' ' ' HIS . 1.0 OUTLIER -80.31 -46.56 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.66 -179.888 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 27.0 mmt180 -80.3 -33.83 37.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.542 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 89.5 mt-30 58.97 32.05 21.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.504 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 81.2 p -104.63 6.23 34.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.151 -0.968 . . . . 0.0 109.637 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 48' ' ' THR . 73.3 m-20 63.11 52.86 2.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.637 179.92 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.584 HG23 ' OD1' ' A' ' 28' ' ' ASP . 91.6 m -78.7 142.35 37.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 109.357 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -120.33 -171.7 2.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.535 179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.882 HG12 HD13 ' A' ' 39' ' ' LEU . 11.2 mt -92.05 123.35 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 179.848 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.4 ttt180 -79.31 -50.73 10.44 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.327 -0.858 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -158.93 139.31 12.35 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 109.348 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.435 ' H ' HG23 ' A' ' 55' ' ' THR . 7.4 p -53.54 145.86 14.11 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.35 162.91 35.5 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 53.8 mttp -66.93 150.04 49.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.458 -1.025 . . . . 0.0 109.528 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 72.7 m -59.27 147.17 36.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.91 . . . . 0.0 109.395 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.534 -179.932 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.287 0.565 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.502 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 3.6 m -60.11 -33.4 72.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 0.0 109.431 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -54.75 -25.93 30.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 109.119 179.872 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.6 ttt -73.57 -26.14 60.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.421 -0.799 . . . . 0.0 109.034 179.547 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.591 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 30.7 m -82.76 -15.46 51.71 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.3 -0.875 . . . . 0.0 109.451 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 23.5 mttm -80.65 7.51 9.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.729 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 98.3 m-20 -138.23 16.02 2.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.028 -1.045 . . . . 0.0 110.29 -179.401 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.1 p90 -126.58 153.0 45.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.925 -1.11 . . . . 0.0 109.697 179.857 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -131.53 143.84 50.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.309 -0.869 . . . . 0.0 108.834 179.171 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.865 HG13 ' O ' ' A' ' 15' ' ' GLY . 55.7 t -132.65 134.96 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 -179.766 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.74 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -115.11 174.65 2.25 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.226 179.89 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.4 Cg_endo -67.15 -22.63 46.81 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.59 2.194 . . . . 0.0 111.68 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -101.7 -22.0 14.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 179.959 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 11' ' ' LEU . 94.8 mt -88.96 -45.42 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.671 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.865 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 77.27 -165.65 53.26 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.7 t80 -96.02 150.01 20.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -1.2 . . . . 0.0 109.499 179.935 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.5 tp -116.97 118.33 32.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.3 m -130.34 157.03 78.53 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.9 Cg_endo -70.91 166.31 29.44 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.612 2.208 . . . . 0.0 111.655 -179.721 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -86.42 -20.9 27.51 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.308 -0.87 . . . . 0.0 109.352 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -65.4 125.95 26.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.95 . . . . 0.0 109.11 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.1 tp -90.77 119.22 30.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.683 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -132.82 106.84 12.73 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.031 179.689 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -65.09 120.55 7.8 Favored 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 122.88 2.387 . . . . 0.0 112.108 -179.556 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.49 ' HB ' HG23 ' A' ' 52' ' ' ILE . 30.3 m -118.14 154.45 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.644 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 31.1 t -97.11 136.14 38.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.251 -0.906 . . . . 0.0 108.769 179.235 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.29 139.98 16.47 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.472 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.7 t0 -70.95 -5.33 30.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.141 -1.211 . . . . 0.0 109.563 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -92.84 5.82 49.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.344 179.676 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.19 14.93 53.39 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.873 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -116.07 175.83 5.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -1.116 . . . . 0.0 109.561 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.929 HG21 ' HG3' ' A' ' 57' ' ' LYS . 30.5 m -138.94 135.43 34.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.122 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.774 ' CD1' HD13 ' A' ' 39' ' ' LEU . 22.0 m-85 -115.6 131.08 57.04 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.307 -179.887 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.5 m-20 -55.41 -76.95 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 -179.515 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.9 t-20 -81.94 148.54 61.04 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.014 -1.053 . . . . 0.0 109.81 -179.73 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.4 Cg_endo -62.73 -53.8 1.54 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.897 2.398 . . . . 0.0 111.916 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.9 t -62.37 -26.91 68.72 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.073 -1.017 . . . . 0.0 108.381 179.189 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.47 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 18.8 mtt -64.67 -18.1 64.67 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.343 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.774 HD13 ' CD1' ' A' ' 33' ' ' TYR . 26.8 tp -66.82 -54.96 17.24 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.451 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.467 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 14.2 t -61.21 -23.9 65.95 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.57 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -70.12 -60.94 1.98 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.19 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 84.2 tt0 -56.7 -20.98 24.59 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.434 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 47' ' ' GLN . 86.5 m-20 -78.64 -35.99 44.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.133 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 44' ' ' LEU . 42.9 tp -58.65 -33.82 70.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.55 -50.18 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.433 -0.792 . . . . 0.0 108.922 179.452 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 34.5 mtt-85 -69.06 -24.15 64.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.263 179.685 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 43' ' ' ASN . 88.8 mt-30 64.13 41.75 6.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.849 . . . . 0.0 109.478 -179.858 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.4 p -124.74 165.36 18.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 109.267 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -98.36 63.49 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.4 m -78.29 136.24 37.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 109.84 -179.866 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.502 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 51.3 m-70 -114.26 171.44 7.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.181 179.63 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.557 HG12 HD22 ' A' ' 39' ' ' LEU . 40.7 mt -80.04 126.92 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.5 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 73.4 ttt180 -79.91 -49.81 11.36 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.652 0.739 . . . . 0.0 109.314 179.806 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.7 m -156.57 145.84 20.5 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.858 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.4 p -61.99 151.3 35.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.537 -179.939 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 81.36 163.49 31.03 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.699 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.929 ' HG3' HG21 ' A' ' 32' ' ' THR . 14.6 tttt -63.81 150.58 44.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -1.068 . . . . 0.0 109.259 179.838 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.24 148.3 34.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.241 -0.912 . . . . 0.0 109.533 -179.909 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.475 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.4 m -80.25 -6.76 58.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.499 -0.751 . . . . 0.0 109.112 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.3 mttm -57.69 -25.65 60.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.844 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -149.82 66.87 0.99 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 110.051 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.661 ' OH ' HD13 ' A' ' 44' ' ' LEU . 6.2 p90 -127.27 171.03 11.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 109.153 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -145.39 155.64 43.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.739 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.792 HG13 ' C ' ' A' ' 15' ' ' GLY . 92.7 t -148.57 122.75 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 109.291 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.557 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 mp -114.6 175.67 1.79 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.334 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.9 Cg_endo -67.64 -28.13 37.88 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.579 2.186 . . . . 0.0 111.578 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -101.48 -26.33 13.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.21 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 11' ' ' LEU . 91.6 mt -88.49 -41.19 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.365 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.792 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 66.02 -144.67 46.82 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.52 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 2.0 t80 -104.7 157.66 17.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -1.19 . . . . 0.0 109.476 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.2 tp -119.36 119.55 34.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.897 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 85.9 m -135.52 157.04 77.23 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.153 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.9 Cg_endo -70.93 167.38 26.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.468 2.112 . . . . 0.0 111.585 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.64 -13.89 36.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.431 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.32 121.27 19.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.122 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.6 tp -84.03 114.92 22.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 0.0 109.781 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mmtm -128.45 107.37 19.15 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 108.94 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.6 Cg_endo -65.96 121.06 8.31 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 123.141 2.561 . . . . 0.0 112.41 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.515 ' HB ' HG23 ' A' ' 52' ' ' ILE . 34.8 m -118.2 156.11 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.786 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.5 t -97.1 142.15 29.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 108.855 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.48 138.38 13.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.507 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.5 p30 -66.48 -15.06 63.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -1.105 . . . . 0.0 109.569 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 85.9 m-20 -84.64 8.83 15.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.68 25.81 37.38 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.446 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 82.2 mt-30 -125.65 177.21 6.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -1.094 . . . . 0.0 109.328 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.536 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 16.4 m -137.97 138.4 38.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 109.298 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.823 ' CD1' HD13 ' A' ' 39' ' ' LEU . 41.8 m-85 -118.17 121.08 39.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.316 -0.865 . . . . 0.0 109.265 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.7 m-20 -46.71 -78.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.836 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.7 t-20 -81.54 146.9 58.17 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 120.88 -1.137 . . . . 0.0 109.669 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.26 -53.08 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.839 2.359 . . . . 0.0 111.705 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -62.92 -27.58 69.48 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.988 -1.07 . . . . 0.0 108.13 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.425 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 24.6 mtp -64.52 -17.5 63.96 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.823 HD13 ' CD1' ' A' ' 33' ' ' TYR . 24.5 tp -66.43 -54.75 20.59 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 7.7 t -60.07 -27.35 66.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.52 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 36.8 t60 -63.1 -57.4 10.71 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -61.35 -21.26 63.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 47' ' ' GLN . 89.6 m-20 -79.91 -26.9 40.02 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.661 HD13 ' OH ' ' A' ' 8' ' ' TYR . 38.3 tp -65.71 -36.81 84.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.393 -0.817 . . . . 0.0 108.982 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.6 mt -80.08 -48.57 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.03 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 75.7 mtt-85 -70.77 -39.41 73.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 109.535 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.9 mt-30 64.01 40.66 7.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.83 . . . . 0.0 109.416 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 46' ' ' ARG . 44.8 p -108.93 5.41 24.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.595 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.458 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 39.8 t-20 52.73 59.25 4.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.602 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 m -79.41 141.75 36.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.895 . . . . 0.0 109.467 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.458 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 33.5 m80 -114.09 167.68 10.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.85 . . . . 0.0 108.967 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.515 HG23 ' HB ' ' A' ' 25' ' ' VAL . 35.1 mt -80.22 127.26 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.026 . . . . 0.0 109.433 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.507 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.7 ttt180 -80.03 -42.24 24.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.373 -0.829 . . . . 0.0 109.146 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 t -160.35 156.22 25.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.6 p -70.91 144.3 50.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 109.475 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.27 166.85 40.68 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 54.1 mttp -67.02 149.68 50.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -1.075 . . . . 0.0 109.404 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 56.7 m -59.46 152.69 21.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.526 -179.883 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.7 mtp . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 8' ' ' TYR . 31.6 m -81.18 -19.67 42.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -0.847 . . . . 0.0 109.136 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 5' ' ' CYS . 23.5 mttm -45.21 -28.81 0.84 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 109.024 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 55.4 p30 -111.13 31.21 6.23 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 5' ' ' CYS . 2.1 t80 -80.0 144.07 33.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.57 -0.706 . . . . 0.0 109.675 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -142.78 115.24 8.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.352 -0.842 . . . . 0.0 109.299 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.793 HG21 ' N ' ' A' ' 16' ' ' TYR . 9.3 p -129.82 145.78 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.601 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.551 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -103.63 174.47 2.76 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.6 Cg_endo -67.89 -25.1 39.24 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.622 2.215 . . . . 0.0 111.803 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -91.88 -29.72 16.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 0.0 109.255 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.6 mt -81.47 -39.57 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.575 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.694 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 64.41 140.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.793 ' N ' HG21 ' A' ' 10' ' ' VAL . 1.2 t80 -43.85 153.58 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -1.195 . . . . 0.0 109.456 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 32.5 tp -119.26 126.19 50.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.844 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 66.3 m -139.37 156.63 71.64 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.989 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.68 166.34 30.18 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.562 2.175 . . . . 0.0 111.66 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -86.79 -19.89 28.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -66.08 122.58 17.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.274 -0.891 . . . . 0.0 109.502 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.5 tp -82.51 126.5 32.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.55 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -139.86 100.44 7.32 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.32 118.6 5.55 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.904 2.403 . . . . 0.0 112.27 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.411 ' HB ' HG23 ' A' ' 52' ' ' ILE . 13.7 m -116.51 155.53 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.664 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 47.2 t -95.57 133.86 39.1 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 108.804 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.88 136.47 13.65 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.5 p30 -66.99 -8.31 28.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -1.152 . . . . 0.0 109.643 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -88.02 10.47 18.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.352 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.01 21.87 54.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 72.8 mt-30 -126.33 175.52 7.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -1.081 . . . . 0.0 109.578 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.621 HG21 ' HG3' ' A' ' 57' ' ' LYS . 21.1 m -135.2 138.9 44.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.393 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.907 ' CD1' HD13 ' A' ' 39' ' ' LEU . 61.1 m-85 -118.06 125.42 50.28 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.279 -0.888 . . . . 0.0 109.299 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.0 m-20 -49.79 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.646 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.1 t-20 -82.06 146.06 54.41 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.015 -1.053 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.89 -51.64 2.82 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.774 2.316 . . . . 0.0 111.538 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.5 t -60.9 -29.96 69.89 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.442 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 16.4 mtp -65.2 -13.45 58.26 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.907 HD13 ' CD1' ' A' ' 33' ' ' TYR . 43.5 tp -68.87 -52.09 33.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 109.095 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.463 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.8 m -66.68 -22.2 66.08 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -67.27 -55.55 13.48 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.1 mm-40 -61.99 -20.01 63.42 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' GLN . 61.2 m-20 -80.43 -36.82 33.14 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.0 tp -54.79 -34.64 62.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.1 mm -80.13 -50.95 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.457 -0.777 . . . . 0.0 108.966 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 7.2 mtp85 -64.36 -24.89 67.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.251 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.4 mt-30 62.96 41.62 8.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.836 . . . . 0.0 109.477 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 p -128.32 167.93 16.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.435 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 48.1 p-10 -98.28 62.27 1.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.536 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.6 m -76.5 129.19 36.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.431 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.435 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 59.3 m80 -111.22 172.52 6.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.37 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.514 HG12 HD22 ' A' ' 39' ' ' LEU . 27.5 mt -79.72 124.55 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.234 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 58.7 ttt85 -79.99 -44.38 20.33 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.397 -0.814 . . . . 0.0 109.362 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 p -157.08 158.62 36.77 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.465 -0.772 . . . . 0.0 109.114 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -76.88 133.0 39.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.533 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 100.47 163.48 28.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.621 ' HG3' HG21 ' A' ' 32' ' ' THR . 14.2 tttp -53.34 154.41 3.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.496 -1.002 . . . . 0.0 109.457 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 89.5 m -64.88 147.39 53.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.385 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.429 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 67.8 mtm . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.566 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 2.8 m -80.64 -9.47 59.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.497 -0.752 . . . . 0.0 109.173 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -80.53 8.77 7.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 109.662 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 4' ' ' MET . 43.7 p30 -120.1 -0.31 10.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.08 -1.013 . . . . 0.0 110.065 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.78 ' HE1' HG23 ' A' ' 10' ' ' VAL . 4.2 p90 -103.37 -179.61 4.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.974 -1.078 . . . . 0.0 109.632 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.606 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 56.2 mtt180 -162.39 140.93 8.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.522 -0.736 . . . . 0.0 109.201 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.78 HG23 ' HE1' ' A' ' 8' ' ' TYR . 61.4 t -117.69 140.17 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 109.747 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.766 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -128.09 175.65 3.29 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.401 -0.812 . . . . 0.0 109.143 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.766 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.9 Cg_endo -67.31 -22.4 46.18 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.557 2.172 . . . . 0.0 111.674 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -121.47 -12.15 8.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.425 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 11' ' ' LEU . 31.4 mm -86.91 -50.68 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.563 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 83.89 -169.43 46.48 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.567 ' HA ' HG22 ' A' ' 10' ' ' VAL . 1.5 t80 -83.16 148.89 27.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.171 -1.193 . . . . 0.0 109.544 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.443 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 20.8 tp -119.57 130.05 54.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.742 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 73.2 m -145.19 157.53 53.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.0 109.023 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.5 Cg_endo -70.38 166.42 28.43 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.541 2.161 . . . . 0.0 111.554 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -84.2 -31.75 24.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.215 -0.928 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -54.87 134.42 48.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.346 -0.846 . . . . 0.0 109.054 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.935 HD11 ' OD1' ' A' ' 34' ' ' ASN . 61.2 tp -101.74 123.45 45.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.932 . . . . 0.0 109.504 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 10.9 mttt -140.32 111.58 7.13 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -65.59 120.25 7.41 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 122.989 2.459 . . . . 0.0 112.024 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 32' ' ' THR . 35.0 m -117.65 153.86 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.233 -0.917 . . . . 0.0 109.772 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 35.6 t -95.48 132.59 40.41 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.23 137.89 13.94 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 43.0 p30 -67.19 -8.28 30.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -1.062 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.45 16.17 5.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.34 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.25 20.61 72.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 27' ' ' GLY . 76.2 mt-30 -131.13 153.66 49.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -1.209 . . . . 0.0 109.586 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.544 HG21 ' HA ' ' A' ' 57' ' ' LYS . 11.1 m -115.74 141.01 48.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.769 ' HD2' HD12 ' A' ' 39' ' ' LEU . 50.0 m-85 -115.26 130.85 57.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.296 -0.877 . . . . 0.0 109.327 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.935 ' OD1' HD11 ' A' ' 22' ' ' LEU . 50.8 t-20 -53.07 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.315 -0.865 . . . . 0.0 109.563 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -81.39 150.02 66.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.998 -1.064 . . . . 0.0 109.416 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -62.47 -54.08 1.51 Allowed 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.7 2.267 . . . . 0.0 112.051 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.545 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -59.84 -30.61 69.07 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.97 -1.081 . . . . 0.0 108.159 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 16.4 mtp -59.29 -25.41 64.09 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.844 HD13 HG12 ' A' ' 52' ' ' ILE . 7.6 tt -63.93 -46.37 85.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 35.0 m -55.86 -27.99 54.34 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -59.33 -49.73 76.7 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 18.0 tp10 -57.71 -19.22 25.73 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 50' ' ' THR . 4.0 m-80 -80.36 -35.13 35.89 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.38 -37.99 74.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.456 -0.777 . . . . 0.0 109.308 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.94 -51.17 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.259 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.539 ' CD ' ' HG3' ' A' ' 42' ' ' GLU . 67.9 mtp85 -73.13 -33.12 65.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 109.636 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.2 mt-30 58.15 27.45 15.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 82.4 p -105.04 5.17 32.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.18 -0.95 . . . . 0.0 109.544 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.519 ' O ' ' NE2' ' A' ' 51' ' ' HIS . 33.4 m120 64.53 52.37 1.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.873 . . . . 0.0 109.675 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 67.8 m -72.3 135.94 46.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.519 ' NE2' ' O ' ' A' ' 49' ' ' ASN . 5.3 m-70 -115.34 -177.23 3.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.295 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.844 HG12 HD13 ' A' ' 39' ' ' LEU . 23.6 mt -87.09 124.25 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.904 . . . . 0.0 109.473 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 44.7 ttt-85 -80.44 -40.59 26.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.41 -0.806 . . . . 0.0 109.341 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -159.04 151.23 21.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.481 -0.762 . . . . 0.0 109.204 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.6 p -71.21 146.56 48.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.132 -0.98 . . . . 0.0 109.382 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.19 166.69 42.61 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.544 ' HA ' HG21 ' A' ' 32' ' ' THR . 62.4 tttt -65.25 146.32 55.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -1.101 . . . . 0.0 109.252 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.1 150.71 30.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.699 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.45 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 m -79.64 -17.03 54.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 109.133 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -47.74 -23.73 0.78 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.254 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -116.66 41.85 2.59 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 17' ' ' LEU . 4.8 t80 -92.63 160.93 14.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.604 0.716 . . . . 0.0 110.748 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.432 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 10.1 ttp180 -146.39 135.47 22.6 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.968 HG13 ' C ' ' A' ' 15' ' ' GLY . 55.2 t -126.87 117.6 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.968 . . . . 0.0 109.669 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.557 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -100.24 175.71 2.26 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 109.506 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.4 Cg_endo -67.45 -24.01 43.16 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.741 2.294 . . . . 0.0 112.118 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -108.66 -21.63 12.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.383 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.1 -45.53 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.868 . . . . 0.0 109.603 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.968 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 65.98 -148.3 50.86 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.519 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 1.2 t80 -99.48 154.55 18.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -1.213 . . . . 0.0 109.372 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.481 ' HB3' ' OH ' ' A' ' 8' ' ' TYR . 18.3 tp -125.76 125.8 43.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.943 . . . . 0.0 109.717 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 86.0 m -138.44 156.88 73.19 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.324 -0.86 . . . . 0.0 109.244 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -69.96 166.01 29.29 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.629 2.219 . . . . 0.0 111.666 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -85.0 -20.43 30.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.306 -0.872 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -65.08 123.07 18.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.335 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.755 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -87.74 121.78 30.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.526 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.548 ' N ' HD13 ' A' ' 22' ' ' LEU . 22.1 mtpt -141.08 114.88 7.04 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 0.0 109.616 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 45.7 Cg_endo -67.31 120.68 7.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.839 2.36 . . . . 0.0 111.627 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.47 ' HB ' HG23 ' A' ' 52' ' ' ILE . 34.1 m -119.44 153.81 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.303 -0.873 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.0 t -97.91 144.83 27.06 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.61 139.92 14.69 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -67.48 -7.37 25.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -1.158 . . . . 0.0 109.578 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 27.5 m-20 -91.04 8.58 34.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.51 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.07 29.43 28.34 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -133.12 165.81 23.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -1.155 . . . . 0.0 109.45 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.488 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 32.4 m -125.25 147.57 49.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.427 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.847 ' CD2' HD12 ' A' ' 39' ' ' LEU . 76.5 m-85 -127.28 119.49 26.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.221 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.555 ' CG ' HD21 ' A' ' 22' ' ' LEU . 50.4 t30 -41.74 -77.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.782 . . . . 0.0 109.673 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -81.28 148.73 64.04 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.985 -1.072 . . . . 0.0 108.863 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 39.3 Cg_endo -62.62 -51.91 2.83 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.506 2.137 . . . . 0.0 112.101 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.0 t -63.52 -25.7 68.37 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.949 -1.094 . . . . 0.0 108.47 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 15.8 mtt -64.72 -18.4 64.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.292 -0.88 . . . . 0.0 108.848 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.847 HD12 ' CD2' ' A' ' 33' ' ' TYR . 4.7 tt -70.13 -53.9 15.31 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.375 -0.828 . . . . 0.0 108.87 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.615 ' N ' HD23 ' A' ' 39' ' ' LEU . 63.8 m -50.9 -24.31 3.5 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -60.04 -49.84 76.06 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.322 -0.861 . . . . 0.0 108.685 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.594 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 12.2 tp10 -55.93 -19.74 13.35 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 50' ' ' THR . 4.0 m-80 -80.07 -32.52 39.32 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.583 HD22 HG21 ' A' ' 10' ' ' VAL . 34.3 tp -66.45 -42.19 87.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.833 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.97 -45.24 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.306 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.447 ' HB3' HG23 ' A' ' 48' ' ' THR . 46.9 mtp85 -77.33 -17.3 58.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.178 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 57.68 28.8 16.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.667 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 46' ' ' ARG . 8.4 p -110.2 -173.11 2.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.235 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -112.03 51.81 0.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.525 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 51.6 m -71.68 122.28 20.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 26.8 m-70 -109.3 -175.69 2.83 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.324 -0.86 . . . . 0.0 108.999 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.518 HG12 HD13 ' A' ' 39' ' ' LEU . 21.2 mt -80.08 125.82 39.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 109.398 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 26.9 ttt85 -79.87 -45.68 18.21 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.331 -0.856 . . . . 0.0 109.584 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 p -160.42 131.69 5.74 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.57 -0.706 . . . . 0.0 109.465 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.479 ' H ' HG23 ' A' ' 55' ' ' THR . 7.3 p -48.25 142.83 5.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.439 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 93.65 166.71 37.71 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.488 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 68.2 mttt -67.36 148.69 51.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.451 -1.029 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.5 m -57.03 146.39 27.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.449 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.491 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 67.3 mtm . . . . . 0 N--CA 1.489 1.481 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.3 m -79.83 -0.52 34.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.772 . . . . 0.0 109.046 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -60.61 -28.86 68.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 109.377 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -149.14 67.09 1.03 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.877 . . . . 0.0 109.681 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 11.4 p90 -118.27 -170.71 1.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 109.414 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -153.91 145.58 23.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.893 . . . . 0.0 109.628 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 15' ' ' GLY . 42.5 t -139.73 135.53 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.409 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.753 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -115.03 174.79 2.16 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.668 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.753 ' HD2' HD23 ' A' ' 11' ' ' LEU . 46.7 Cg_endo -68.1 -22.76 40.7 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.787 2.325 . . . . 0.0 111.678 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -97.35 -29.45 13.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.239 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.11 -44.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.652 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.538 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 65.86 -164.2 39.64 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -100.59 151.37 21.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -1.217 . . . . 0.0 109.569 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.5 tp -116.38 110.47 18.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.337 -0.852 . . . . 0.0 109.828 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 63.4 m -126.62 156.35 73.43 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.245 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 51.5 Cg_endo -72.13 171.39 16.88 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.645 2.23 . . . . 0.0 111.619 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 tttm -88.6 -29.86 19.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.473 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -57.14 133.57 55.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.385 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' A' ' 34' ' ' ASN . 47.7 tp -92.88 115.42 28.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -125.07 104.4 29.57 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.475 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.4 118.65 5.65 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 C-N-CA 122.911 2.407 . . . . 0.0 111.997 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 32' ' ' THR . 14.8 m -117.03 155.68 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 109.737 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.5 t -97.02 123.33 40.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.827 . . . . 0.0 109.006 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -77.57 136.08 17.69 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.603 ' OD1' HG23 ' A' ' 50' ' ' THR . 54.4 p30 -67.39 -8.6 34.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -1.12 . . . . 0.0 109.562 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.4 p30 -87.05 11.96 12.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 17.76 62.3 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.0 mt-30 -123.51 176.92 5.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -1.098 . . . . 0.0 109.53 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.582 HG21 ' HG3' ' A' ' 57' ' ' LYS . 41.1 m -135.91 141.82 44.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.063 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.795 ' CD1' HD13 ' A' ' 39' ' ' LEU . 42.0 m-85 -121.13 128.2 52.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -0.922 . . . . 0.0 109.505 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.7 m-20 -48.66 -79.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.813 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.8 t-20 -81.67 147.13 58.29 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.006 -1.059 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.51 -52.49 1.89 Allowed 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.877 2.385 . . . . 0.0 111.936 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.8 t -64.16 -25.08 67.92 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.941 -1.099 . . . . 0.0 108.208 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 44.3 mmm -68.93 -14.72 63.21 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.795 HD13 ' CD1' ' A' ' 33' ' ' TYR . 20.6 tp -65.69 -51.0 62.86 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.486 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.0 m -68.72 -18.16 64.19 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.444 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 25.7 t60 -69.88 -55.29 10.12 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.517 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 88.7 tt0 -64.26 -18.64 64.75 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 47' ' ' GLN . 73.8 m-20 -79.74 -36.11 37.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.9 -32.94 66.43 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mt -80.35 -46.14 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.6 ' HG2' HG23 ' A' ' 48' ' ' THR . 69.7 ttt180 -70.53 -21.6 62.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.118 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . 81.4 mt-30 63.54 43.36 5.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.506 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.6 HG23 ' HG2' ' A' ' 46' ' ' ARG . 75.4 p -126.72 167.68 15.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -103.16 56.52 0.75 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.487 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.603 HG23 ' OD1' ' A' ' 28' ' ' ASP . 85.6 m -77.63 138.77 39.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 109.321 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -118.91 176.46 5.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.26 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.471 HG12 HD22 ' A' ' 39' ' ' LEU . 34.4 mt -80.12 124.72 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 29.2 tpt180 -81.28 -53.27 6.49 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.599 -0.688 . . . . 0.0 109.427 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 p -146.05 146.1 30.82 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.595 -0.69 . . . . 0.0 109.447 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.8 p -66.4 147.85 52.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.396 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.71 162.61 37.53 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HG3' HG21 ' A' ' 32' ' ' THR . 41.0 tttt -63.92 148.85 48.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.474 -1.015 . . . . 0.0 109.341 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.3 148.68 30.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.451 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 65.1 mmm . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.496 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 13.4 m -84.21 -27.97 27.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.3 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -75.63 -2.48 29.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.632 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 4' ' ' MET . 15.7 p30 -122.94 1.1 9.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.849 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.576 ' OH ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -119.13 154.56 33.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.091 -1.006 . . . . 0.0 109.321 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -133.43 127.46 33.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.259 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.554 HG21 ' C ' ' A' ' 15' ' ' GLY . 4.6 p -124.08 142.73 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 109.588 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.518 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.8 mp -105.62 174.06 2.87 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.158 -0.964 . . . . 0.0 109.211 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.4 Cg_endo -67.79 -28.86 36.19 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.606 2.204 . . . . 0.0 111.88 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -87.4 -28.33 22.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.365 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.2 mt -84.0 -39.39 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 109.401 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.554 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 67.41 155.77 0.55 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CE2' ' OH ' ' A' ' 8' ' ' TYR . 1.3 t80 -52.63 148.39 7.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.281 -1.129 . . . . 0.0 109.604 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.3 tp -115.82 112.49 22.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.457 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 60.5 m -123.7 155.82 65.81 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.303 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.75 165.18 33.33 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.648 2.232 . . . . 0.0 111.794 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -87.31 -10.41 52.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.478 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.66 133.73 44.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.348 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.731 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.1 tm? -89.73 118.94 29.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.644 ' N ' HD13 ' A' ' 22' ' ' LEU . 5.9 mttp -134.38 100.67 12.53 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.319 -0.863 . . . . 0.0 109.103 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.0 Cg_endo -63.33 123.11 11.57 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 123.121 2.547 . . . . 0.0 112.411 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 33' ' ' TYR . 32.4 m -120.62 154.79 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.446 -0.784 . . . . 0.0 109.641 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -98.35 137.5 36.98 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.02 138.16 13.91 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.1 p30 -64.96 -11.31 37.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.366 -1.079 . . . . 0.0 109.535 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.5 p30 -87.43 11.5 14.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.28 21.19 61.03 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.422 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 89.4 mt-30 -122.16 170.37 9.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.509 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.454 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 86.9 m -129.31 135.49 48.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.305 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.766 ' CD1' HD13 ' A' ' 39' ' ' LEU . 64.2 m-85 -115.12 121.22 42.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.286 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.563 ' HB2' HD21 ' A' ' 22' ' ' LEU . 0.6 OUTLIER -44.61 -82.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.835 . . . . 0.0 109.802 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.9 t-20 -80.07 147.13 64.76 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.157 -0.964 . . . . 0.0 109.565 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.6 Cg_endo -62.7 -52.1 2.63 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.659 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.557 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 10.7 t -62.69 -26.71 68.8 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 40.2 mmm -65.32 -16.51 63.65 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.766 HD13 ' CD1' ' A' ' 33' ' ' TYR . 25.6 tp -67.11 -55.57 13.69 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 16' ' ' TYR . 16.1 t -57.72 -23.16 50.39 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -72.92 -59.84 2.51 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.476 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 81.7 mt-10 -58.42 -18.5 28.81 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.5 m-20 -76.72 -39.09 53.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.496 -0.752 . . . . 0.0 108.98 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.936 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.3 tm? -55.67 -37.09 67.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.281 -0.887 . . . . 0.0 108.844 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.4 mt -75.36 -46.17 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 0.0 108.939 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.492 ' HG2' HG23 ' A' ' 48' ' ' THR . 43.9 ttt85 -68.26 -27.84 66.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.0 109.191 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 90.2 mt-30 63.25 42.27 7.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 109.668 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.492 HG23 ' HG2' ' A' ' 46' ' ' ARG . 72.5 p -131.25 175.76 8.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.227 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.575 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 78.9 m-20 -101.57 64.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.215 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.8 m -76.66 132.21 39.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 109.953 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 42.9 m80 -116.03 171.28 7.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -0.869 . . . . 0.0 108.681 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.431 HG12 HD22 ' A' ' 39' ' ' LEU . 11.4 mt -79.71 123.91 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.073 -1.017 . . . . 0.0 109.186 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 54.7 ttt85 -79.71 -42.09 25.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.292 -0.88 . . . . 0.0 109.317 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 t -160.3 155.07 24.18 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.6 p -70.84 143.89 50.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.094 -1.004 . . . . 0.0 109.171 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.69 168.29 40.94 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.486 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 31.6 mttm -66.47 151.69 46.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -1.1 . . . . 0.0 109.428 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.414 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 71.8 m -60.89 152.58 27.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.346 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.499 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 mtt . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.5 m -86.98 -8.66 56.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.391 -0.818 . . . . 0.0 109.517 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -60.02 -23.43 63.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 109.783 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -150.69 63.51 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.062 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.918 ' OH ' HD23 ' A' ' 44' ' ' LEU . 4.2 p90 -129.16 167.12 18.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 109.203 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -143.97 145.07 31.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 109.616 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.862 HG13 ' C ' ' A' ' 15' ' ' GLY . 92.0 t -137.61 131.87 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 109.659 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.544 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -122.49 175.1 2.81 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.36 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.0 Cg_endo -67.67 -26.28 39.49 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.648 2.232 . . . . 0.0 111.772 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -100.3 -27.52 13.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.293 -0.879 . . . . 0.0 109.203 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.8 mm -91.02 -43.2 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.42 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.862 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 68.33 -146.41 45.8 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.489 ' CD2' HG21 ' A' ' 10' ' ' VAL . 2.2 t80 -104.58 157.43 17.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -1.134 . . . . 0.0 109.482 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.1 tp -115.58 115.02 25.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 109.865 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 57.7 m -135.86 155.77 77.69 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 109.231 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.55 167.62 25.91 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.549 2.166 . . . . 0.0 111.587 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -84.68 -18.71 34.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -70.4 123.34 21.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.29 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.685 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -86.46 109.76 19.29 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.492 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -116.05 103.61 53.14 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.399 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.2 Cg_endo -63.68 117.2 4.19 Favored 'Trans proline' 0 C--O 1.213 -0.764 0 C-N-CA 123.082 2.521 . . . . 0.0 112.414 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.459 ' HB ' HG23 ' A' ' 52' ' ' ILE . 11.0 m -115.29 157.18 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.403 -0.811 . . . . 0.0 109.83 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.405 ' O ' ' N ' ' A' ' 53' ' ' ARG . 46.0 t -98.65 141.57 31.31 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.72 141.32 15.48 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.5 t0 -69.84 -9.4 54.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -1.147 . . . . 0.0 109.414 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -90.31 0.59 57.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.404 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.79 21.76 22.77 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.2 mt-30 -121.5 172.66 7.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -1.138 . . . . 0.0 109.48 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' ' 57' ' ' LYS . 99.4 m -133.48 140.09 47.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.884 ' CD1' HD13 ' A' ' 39' ' ' LEU . 40.8 m-85 -121.78 129.01 52.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.012 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.58 ' CB ' HD21 ' A' ' 22' ' ' LEU . 1.8 m-20 -52.77 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.026 -1.046 . . . . 0.0 109.67 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 15.3 t-20 -81.85 145.73 54.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.019 -1.05 . . . . 0.0 109.587 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.29 -51.15 2.87 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.643 2.228 . . . . 0.0 111.346 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.503 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.5 t -61.64 -27.99 69.06 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.444 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 36.3 mmm -67.05 -13.93 62.41 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.884 HD13 ' CD1' ' A' ' 33' ' ' TYR . 29.8 tp -68.44 -53.69 21.92 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.466 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 14.0 t -58.98 -23.29 61.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -69.21 -57.93 4.71 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -61.97 -19.35 62.7 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.491 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 99.2 m-20 -77.15 -32.09 56.03 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.933 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -61.49 -38.09 86.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 108.875 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mt -75.89 -48.51 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.299 -0.876 . . . . 0.0 109.222 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -68.7 -36.86 79.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.885 . . . . 0.0 109.354 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 59.81 38.04 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.425 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' ASN . 43.9 p -112.87 16.66 19.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.391 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.572 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 57.7 m-20 44.94 58.88 3.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.331 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.491 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 36.0 m -77.21 144.83 38.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.683 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 27.6 m80 -118.93 169.45 9.87 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.459 HG23 ' HB ' ' A' ' 25' ' ' VAL . 41.7 mt -79.14 126.55 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.109 -0.995 . . . . 0.0 109.357 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 42.1 ttt85 -79.71 -46.85 16.32 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.412 -0.805 . . . . 0.0 109.251 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 m -160.29 151.92 19.8 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 p -65.29 142.75 58.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.099 -1.001 . . . . 0.0 109.591 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.31 165.02 36.27 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 65.0 mttt -67.94 148.84 50.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -1.056 . . . . 0.0 109.408 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 58.4 m -60.04 153.44 21.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.477 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 86.9 mtp . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 4.0 m -79.75 -6.88 58.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.507 -0.745 . . . . 0.0 109.069 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.419 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 15.6 mttm -56.39 -32.29 64.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 77.2 m-20 -146.36 67.18 1.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 109.866 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 1.061 ' OH ' HD21 ' A' ' 44' ' ' LEU . 4.4 p90 -126.41 169.78 12.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 109.068 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -140.95 149.4 41.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.124 -0.985 . . . . 0.0 109.846 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 15' ' ' GLY . 77.8 t -145.06 131.39 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.832 . . . . 0.0 109.359 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mp -122.34 175.09 2.79 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.955 . . . . 0.0 109.551 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.2 Cg_endo -67.9 -22.89 41.76 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.69 2.26 . . . . 0.0 111.77 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -107.07 -31.32 8.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.147 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 14' ' ' ILE . 48.9 mm -83.3 -39.95 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.518 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.749 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 69.83 -145.52 41.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.6 t80 -107.26 156.1 19.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 109.458 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 tp -117.29 121.15 40.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 81.9 m -132.25 157.06 79.26 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.36 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.3 Cg_endo -71.17 165.7 31.59 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.681 2.254 . . . . 0.0 111.578 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -88.68 -13.52 39.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.327 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -68.67 130.66 43.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.103 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.764 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -89.2 122.5 32.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.607 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.673 ' N ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -141.69 105.59 5.86 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.337 -0.852 . . . . 0.0 109.279 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 42.6 Cg_endo -66.05 121.38 8.7 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 C-N-CA 122.951 2.434 . . . . 0.0 111.902 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.481 ' O ' HG23 ' A' ' 32' ' ' THR . 18.7 m -117.14 154.96 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 109.949 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 16.7 t -97.61 130.45 44.63 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.77 139.53 15.42 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.2 p30 -66.33 -9.84 37.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -1.118 . . . . 0.0 109.606 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 57.2 p30 -85.39 12.9 7.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.333 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.35 21.53 64.54 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.446 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 87.2 mt-30 -127.25 168.97 14.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -1.151 . . . . 0.0 109.374 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 25' ' ' VAL . 24.6 m -127.37 139.81 52.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.895 . . . . 0.0 109.513 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.872 ' CD2' HD12 ' A' ' 39' ' ' LEU . 42.9 m-85 -116.8 128.4 55.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.205 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.764 ' OD1' HD21 ' A' ' 22' ' ' LEU . 47.7 t-20 -50.96 -78.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -80.9 148.46 64.73 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 120.825 -1.172 . . . . 0.0 109.48 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HG3' ' HD2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.36 -53.7 1.34 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.645 2.23 . . . . 0.0 111.76 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -61.3 -28.45 69.21 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.987 -1.07 . . . . 0.0 108.144 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 17.0 mtp -63.14 -19.23 64.27 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.872 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.4 tt -67.11 -50.76 60.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.308 -0.87 . . . . 0.0 108.791 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 6.0 t -52.61 -47.33 67.04 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 9.5 t60 -48.51 -49.07 37.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.966 -1.084 . . . . 0.0 108.201 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.572 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 23.6 mm-40 -57.36 -19.41 22.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.1 m-80 -78.87 -32.96 46.15 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.061 HD21 ' OH ' ' A' ' 8' ' ' TYR . 82.9 mt -70.71 -37.19 73.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 109.549 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mt -77.22 -49.6 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.239 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.518 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 14.9 mtt-85 -76.96 -30.99 56.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 109.374 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 57.87 32.91 22.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.439 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.0 p -108.28 7.64 27.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.531 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 38.8 t-20 57.14 55.02 6.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.616 HG21 ' OH ' ' A' ' 33' ' ' TYR . 87.2 m -78.52 136.46 37.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.545 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.531 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 3.8 m80 -114.93 -175.92 2.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.215 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.713 HG12 HD13 ' A' ' 39' ' ' LEU . 29.9 mt -89.59 123.42 41.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.238 -0.914 . . . . 0.0 109.62 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 38.4 ttt-85 -81.39 -46.94 13.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.52 -0.738 . . . . 0.0 109.326 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -153.2 151.27 29.91 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.657 -0.652 . . . . 0.0 109.474 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -70.91 144.38 50.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.964 . . . . 0.0 109.218 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.539 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.59 165.24 40.76 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.575 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 30.3 mttm -65.86 144.03 57.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.443 -1.033 . . . . 0.0 109.464 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -77.22 153.2 34.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.245 -0.909 . . . . 0.0 109.326 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' CYS . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.391 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 60.9 mtm . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.485 ' CA ' ' HB2' ' A' ' 8' ' ' TYR . 18.5 p -104.44 -3.28 24.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.236 -0.915 . . . . 0.0 109.537 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -49.23 -24.33 1.72 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.205 -0.934 . . . . 0.0 108.749 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -119.13 28.46 8.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.547 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 3.6 t80 -80.29 157.98 26.27 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.608 0.718 . . . . 0.0 110.617 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.432 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 6.2 ttt85 -142.7 133.45 25.37 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.906 HG21 ' CD2' ' A' ' 16' ' ' TYR . 81.9 t -133.37 136.77 54.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.367 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 10' ' ' VAL . 2.9 mp -119.66 173.16 3.78 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.538 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.8 Cg_endo -68.51 -25.73 34.84 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 122.653 2.235 . . . . 0.0 111.763 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 15.2 ttt180 -104.12 -20.71 13.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.375 -0.828 . . . . 0.0 109.285 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.1 mt -93.13 -46.39 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.891 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.64 -170.72 52.46 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.906 ' CD2' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -87.27 151.44 23.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.174 . . . . 0.0 109.463 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.866 ' N ' HD12 ' A' ' 17' ' ' LEU . 1.8 mp -122.47 132.9 54.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.7 m -139.18 157.32 71.3 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.139 -0.976 . . . . 0.0 109.317 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.2 Cg_endo -70.18 168.78 21.12 Favored 'Trans proline' 0 C--O 1.216 -0.581 0 C-N-CA 122.572 2.181 . . . . 0.0 111.668 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -90.0 -12.67 37.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.482 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -73.94 119.8 18.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.159 -0.963 . . . . 0.0 109.214 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 34' ' ' ASN . 37.2 tp -81.75 112.19 18.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.774 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.539 ' CD ' ' HG3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -122.08 105.77 36.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.905 . . . . 0.0 108.741 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 45.2 Cg_endo -66.64 118.32 5.45 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.954 2.436 . . . . 0.0 112.088 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 52' ' ' ILE . 18.8 m -115.59 154.94 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.042 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.4 t -97.3 140.27 32.02 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.53 138.13 13.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.5 p30 -65.49 -12.93 57.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -1.119 . . . . 0.0 109.436 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 84.2 m-20 -86.98 12.37 11.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.216 -0.927 . . . . 0.0 109.374 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.06 32.14 36.77 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 79.6 mt-30 -131.16 173.82 10.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.391 -1.064 . . . . 0.0 109.293 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.5 m -135.12 133.55 39.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.149 -0.969 . . . . 0.0 109.488 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.94 ' CD2' HD13 ' A' ' 39' ' ' LEU . 65.6 m-85 -112.61 122.93 49.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 108.956 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.7 m-20 -48.18 -79.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 110.093 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.7 t-20 -81.98 148.04 59.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.018 -1.051 . . . . 0.0 109.895 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.539 ' HG3' ' CD ' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.6 -53.33 1.41 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.718 2.279 . . . . 0.0 111.768 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.7 t -61.42 -25.78 67.43 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 29.7 mtp -70.49 -5.87 31.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.177 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.94 HD13 ' CD2' ' A' ' 33' ' ' TYR . 24.4 tp -74.11 -61.36 1.88 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.18 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -54.52 -28.38 44.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 108.567 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 29.4 t60 -60.35 -56.88 16.09 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -64.06 -19.43 65.22 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.486 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 89.6 m-20 -79.44 -31.01 42.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.506 -0.746 . . . . 0.0 109.037 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.933 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.2 tm? -63.46 -37.81 88.73 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.385 -0.822 . . . . 0.0 108.844 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mm -77.09 -48.64 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.114 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 26.4 mtt-85 -68.14 -38.46 82.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.436 -0.79 . . . . 0.0 109.192 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 86.3 mt-30 62.2 38.74 13.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.478 -0.764 . . . . 0.0 109.449 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.4 p -113.37 15.38 19.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 0.0 109.384 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 46.29 60.41 3.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.472 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.486 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 76.8 m -79.96 143.01 34.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -118.97 170.61 8.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 108.855 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.451 HG12 HD22 ' A' ' 39' ' ' LEU . 30.9 mt -79.99 126.86 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.07 -1.019 . . . . 0.0 109.271 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 18.0 ttt-85 -81.82 -41.5 21.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.398 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -160.53 151.78 19.2 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -67.61 142.56 56.41 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.074 -1.016 . . . . 0.0 109.443 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.55 166.17 38.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.513 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 41.2 mttm -65.45 149.04 50.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -1.018 . . . . 0.0 109.467 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 59.0 m -59.3 153.84 17.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.444 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.41 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 76.8 mtp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.2 m -91.91 -18.4 23.81 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.419 -0.8 . . . . 0.0 109.165 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -78.41 -0.02 27.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.91 . . . . 0.0 109.478 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.412 ' C ' ' OD1' ' A' ' 7' ' ' ASP . 34.6 p30 -106.78 -9.44 16.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.786 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.547 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 1.1 p90 -107.61 170.49 7.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.166 -0.959 . . . . 0.0 109.47 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -133.37 161.02 35.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.202 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.721 HG21 ' C ' ' A' ' 15' ' ' GLY . 13.4 p -140.43 166.01 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.94 . . . . 0.0 109.81 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.75 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -121.75 174.49 3.16 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.846 . . . . 0.0 109.312 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.75 ' HD2' HD23 ' A' ' 11' ' ' LEU . 48.2 Cg_endo -68.19 -23.62 39.08 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.726 2.284 . . . . 0.0 111.806 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.8 tpt85 -89.0 -19.41 25.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.222 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -99.02 -34.6 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.292 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.721 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 73.66 -68.65 1.53 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.547 ' CE1' ' OH ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -155.38 159.11 39.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -1.153 . . . . 0.0 109.489 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 tp -127.74 114.42 17.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.742 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.5 m -131.56 157.63 77.63 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 108.977 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.1 Cg_endo -70.45 167.01 26.56 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.591 2.194 . . . . 0.0 111.586 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -88.38 -16.68 32.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.417 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -71.54 129.2 38.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.269 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 ' N ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -91.26 114.75 27.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 34' ' ' ASN . 2.5 mtmt -126.79 107.2 22.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.19 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.53 116.67 4.05 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 C-N-CA 122.807 2.338 . . . . 0.0 111.796 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 32' ' ' THR . 20.2 m -114.84 155.41 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.741 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 40.5 t -97.74 123.4 41.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.369 -0.832 . . . . 0.0 109.046 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -77.15 137.93 21.21 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.6 p-10 -67.88 -7.52 28.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -1.098 . . . . 0.0 109.425 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -88.71 7.69 32.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.485 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.45 12.91 62.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' GLY . 78.0 mt-30 -118.32 166.44 12.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -1.163 . . . . 0.0 109.323 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.607 HG21 ' HG3' ' A' ' 57' ' ' LYS . 36.9 m -127.3 137.27 52.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.302 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.776 ' CD1' HD13 ' A' ' 39' ' ' LEU . 34.1 m-85 -114.29 130.47 56.65 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.234 -0.916 . . . . 0.0 109.361 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.4 m-20 -53.57 -76.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.33 -0.857 . . . . 0.0 109.65 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -81.84 148.66 61.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.074 -1.016 . . . . 0.0 109.466 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.458 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.0 Cg_endo -63.65 -53.25 1.42 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.726 2.284 . . . . 0.0 111.9 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.7 t -63.58 -28.69 70.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.047 -1.033 . . . . 0.0 108.394 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.0 mmm -59.87 -23.57 63.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.776 HD13 ' CD1' ' A' ' 33' ' ' TYR . 27.9 tp -61.9 -43.83 98.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.607 -0.683 . . . . 0.0 109.288 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.511 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.2 m -71.32 -20.07 62.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.216 -0.928 . . . . 0.0 108.554 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -72.98 -53.42 11.23 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.426 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 70.0 mt-10 -64.53 -19.0 65.34 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.5 m-20 -74.69 -37.58 62.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.958 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.8 tm? -56.39 -36.16 68.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.343 -0.848 . . . . 0.0 108.735 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mt -74.43 -50.01 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.461 -0.774 . . . . 0.0 109.033 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 31.2 mtm-85 -68.59 -23.97 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.139 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' ASN . 85.6 mt-30 61.81 40.83 12.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.431 -0.793 . . . . 0.0 109.564 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.1 p -128.67 169.71 14.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.293 -0.879 . . . . 0.0 109.199 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -97.5 62.24 1.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.373 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.1 m -70.98 130.2 40.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -0.85 . . . . 0.0 109.599 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -113.82 169.43 8.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 108.979 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.456 HG23 ' HB ' ' A' ' 25' ' ' VAL . 43.4 mt -79.81 127.06 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.009 . . . . 0.0 109.339 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 47.7 ttt85 -84.71 -49.51 8.43 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.373 -0.829 . . . . 0.0 109.533 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.1 p -149.23 141.3 23.89 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.432 -0.792 . . . . 0.0 109.254 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.4 p -61.86 143.97 55.57 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.258 -0.901 . . . . 0.0 109.182 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.53 163.29 39.18 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.607 ' HG3' HG21 ' A' ' 32' ' ' THR . 53.4 tttt -50.88 152.54 2.09 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.541 -0.976 . . . . 0.0 109.601 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 31.5 m -55.65 142.12 35.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.634 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.397 179.862 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.4 mmm . . . . . 0 N--CA 1.487 1.422 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.4 m -83.93 0.59 47.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.503 -0.748 . . . . 0.0 109.191 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 10.7 mttm -61.38 -30.32 70.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.344 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 76.2 m-20 -147.84 68.02 1.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.67 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.566 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 12.6 p90 -119.78 -171.59 2.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.268 -0.895 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -153.76 139.65 18.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 109.746 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 15' ' ' GLY . 53.4 t -132.73 137.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 109.612 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.579 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -112.63 174.38 2.35 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.832 . . . . 0.0 109.275 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.579 ' HD2' HD23 ' A' ' 11' ' ' LEU . 46.9 Cg_endo -67.85 -24.44 40.19 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.655 2.237 . . . . 0.0 111.816 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -96.77 -26.94 14.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.468 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.1 mm -85.91 -48.17 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.546 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.674 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.84 -163.2 54.42 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.817 ' CE2' HD11 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -102.37 150.27 23.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -1.157 . . . . 0.0 109.315 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.3 tp -116.74 106.83 13.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.8 m -120.67 155.89 56.55 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.128 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.04 166.61 29.11 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.545 2.163 . . . . 0.0 111.625 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -89.81 -13.94 35.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.9 . . . . 0.0 109.662 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -72.31 123.88 23.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 0.0 109.278 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 34' ' ' ASN . 48.1 tp -80.29 121.17 25.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.619 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 3.2 mttp -133.71 101.45 12.95 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.324 -0.86 . . . . 0.0 109.242 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 41.0 Cg_endo -64.15 120.66 8.07 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.848 2.365 . . . . 0.0 112.122 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 32' ' ' THR . 7.9 m -119.81 157.36 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.8 t -99.49 114.76 27.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -0.824 . . . . 0.0 109.028 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -69.94 137.76 28.83 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 58.4 p30 -68.4 -8.02 36.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.344 -1.092 . . . . 0.0 109.661 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -84.86 6.81 23.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 109.341 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.91 17.86 55.45 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -126.76 160.62 30.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -1.09 . . . . 0.0 109.429 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.506 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 38.5 m -116.79 144.86 43.98 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.931 . . . . 0.0 109.207 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.777 ' CD1' HD13 ' A' ' 39' ' ' LEU . 87.4 m-85 -124.51 129.37 50.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.292 -0.88 . . . . 0.0 109.331 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.2 m-20 -50.44 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.2 t-20 -82.16 146.41 54.84 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 0.0 109.788 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.0 Cg_endo -63.53 -52.36 1.95 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.772 2.315 . . . . 0.0 111.555 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.1 t -60.97 -30.87 70.51 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.477 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 23.0 mtt -61.6 -20.68 63.61 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.777 HD13 ' CD1' ' A' ' 33' ' ' TYR . 58.6 tp -62.06 -46.81 87.49 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.973 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.3 m -70.94 -26.48 63.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.461 ' HA ' ' CD1' ' A' ' 44' ' ' LEU . 33.3 t60 -64.42 -55.04 23.64 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 73.8 mm-40 -65.1 -17.5 64.51 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.237 -0.914 . . . . 0.0 108.671 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 47' ' ' GLN . 92.1 m-20 -76.53 -30.91 57.32 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.469 -0.77 . . . . 0.0 109.278 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.973 HD12 ' O ' ' A' ' 40' ' ' CYS . 1.8 mp -59.76 -36.63 77.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.12 -0.987 . . . . 0.0 108.624 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 45' ' ' ILE . 7.0 mm -75.72 -48.67 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 15.7 mtp85 -67.28 -25.52 66.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.429 -0.794 . . . . 0.0 109.153 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.9 mt-30 63.71 41.26 7.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.54 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 p -130.63 164.07 25.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.214 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.562 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 65.6 m-20 -95.68 59.99 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 109.504 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 m -75.0 132.05 41.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 109.417 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 6.6 m80 -112.87 -172.32 2.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.138 -0.976 . . . . 0.0 109.333 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.7 mt -89.79 126.62 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.337 -0.852 . . . . 0.0 109.776 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 16.2 tpt180 -85.4 -53.98 4.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.557 -0.714 . . . . 0.0 109.365 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 p -144.76 152.61 40.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -72.96 144.45 47.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.095 -1.003 . . . . 0.0 109.385 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.92 166.19 39.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.573 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 55.1 mttp -68.07 141.5 56.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.36 -1.083 . . . . 0.0 109.306 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.23 149.8 37.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.482 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.541 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 9.7 m -79.81 -17.94 52.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.928 . . . . 0.0 109.23 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -51.13 -22.93 2.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 108.994 179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -118.13 36.87 4.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 5.2 t80 -85.09 159.48 20.17 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.559 0.695 . . . . 0.0 110.663 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.443 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 7.7 ttm180 -140.71 136.6 32.76 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 1.036 HG13 ' O ' ' A' ' 15' ' ' GLY . 52.1 t -134.83 128.03 49.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.768 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.55 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -106.23 175.51 2.05 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.437 -0.79 . . . . 0.0 109.057 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.8 Cg_endo -67.21 -23.15 45.66 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.541 2.161 . . . . 0.0 111.632 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -110.83 -24.33 10.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.342 -0.849 . . . . 0.0 109.326 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 11' ' ' LEU . 81.5 mt -83.25 -38.46 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.622 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 1.036 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 61.28 -143.8 48.66 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.828 ' CE1' HD11 ' A' ' 44' ' ' LEU . 1.6 t80 -107.3 150.65 26.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.239 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.7 tp -114.7 121.59 43.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.813 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.0 m -135.52 157.04 77.23 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.029 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.2 Cg_endo -70.01 163.82 37.06 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.588 2.192 . . . . 0.0 111.683 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -87.77 -8.77 55.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.43 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -77.76 111.45 13.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.855 . . . . 0.0 109.182 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.4 tp -79.62 123.17 27.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.935 . . . . 0.0 109.66 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 34' ' ' ASN . 7.4 mtmt -140.63 109.22 6.64 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.812 . . . . 0.0 109.054 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.543 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.9 Cg_endo -63.56 123.85 12.74 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.86 2.373 . . . . 0.0 112.214 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.654 ' HB ' HG23 ' A' ' 52' ' ' ILE . 29.2 m -120.39 156.55 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.9 t -98.23 119.71 37.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 109.291 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -73.19 134.7 20.14 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 56.6 p30 -68.05 -7.55 30.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -1.148 . . . . 0.0 109.722 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -86.21 7.57 24.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.75 16.97 53.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 93.6 mt-30 -126.05 171.96 10.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 25' ' ' VAL . 89.3 m -129.37 142.75 50.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.182 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.662 ' CD2' HD12 ' A' ' 39' ' ' LEU . 20.3 m-85 -123.68 128.82 50.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.2 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.1 m-20 -51.14 -79.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.203 -0.936 . . . . 0.0 109.822 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.527 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 7.3 t-20 -81.82 147.45 58.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.917 -1.114 . . . . 0.0 109.758 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.2 Cg_endo -63.3 -52.19 2.18 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.728 2.285 . . . . 0.0 111.872 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -64.04 -27.8 69.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.033 -1.042 . . . . 0.0 108.297 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.527 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.5 mmm -62.51 -16.2 54.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.471 -0.768 . . . . 0.0 109.191 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.662 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.1 tp -68.55 -51.79 39.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.347 -0.845 . . . . 0.0 109.125 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.482 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.9 m -63.78 -18.49 64.14 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -69.16 -57.64 5.12 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -64.74 -18.61 65.19 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.2 m-20 -72.79 -31.47 64.89 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.828 HD11 ' CE1' ' A' ' 16' ' ' TYR . 36.8 mt -58.85 -38.9 79.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 108.745 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mt -74.31 -51.96 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.46 -0.775 . . . . 0.0 109.091 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.516 ' NH2' ' OH ' ' A' ' 33' ' ' TYR . 45.2 mtm180 -66.49 -25.27 66.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 0.0 109.415 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.3 mt-30 63.73 44.47 5.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.527 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 p -130.21 167.88 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.524 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.456 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 72.9 m-20 -103.37 65.21 0.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.258 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.439 ' OG1' ' NH2' ' A' ' 46' ' ' ARG . 51.9 m -73.43 136.5 44.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.76 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.456 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 70.4 m80 -117.13 169.7 9.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.322 -0.861 . . . . 0.0 108.88 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 25' ' ' VAL . 22.2 mm -80.17 127.01 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.005 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 72.0 ttt180 -85.79 -47.93 9.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.368 -0.833 . . . . 0.0 109.446 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -148.29 142.6 26.22 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.535 -0.728 . . . . 0.0 109.367 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.2 p -62.24 151.3 36.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.911 . . . . 0.0 109.368 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.12 166.42 40.71 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.52 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 39.5 mttt -59.98 147.15 39.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.419 -1.047 . . . . 0.0 109.445 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.433 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 53.2 m -47.62 142.1 4.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 109.379 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.476 -179.934 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.0 mmm . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.566 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.6 m -82.12 4.06 24.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.362 -0.836 . . . . 0.0 109.214 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.6 mttm -62.95 -28.64 70.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.706 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.459 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 14.3 t70 -147.31 68.34 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 110.13 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.66 ' CZ ' HD21 ' A' ' 44' ' ' LEU . 19.7 p90 -127.12 -177.77 4.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 109.382 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptt-85 -156.07 146.06 21.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.323 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 15' ' ' GLY . 74.4 t -130.56 135.96 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.714 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -109.57 175.5 1.91 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.276 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.7 Cg_endo -67.95 -24.72 39.28 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.594 2.196 . . . . 0.0 111.83 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -95.78 -31.18 13.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 109.421 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.3 mt -80.87 -49.41 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.474 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.605 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.4 -173.52 43.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.541 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -98.96 146.53 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.2 tp -114.44 110.0 19.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.817 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 55.7 m -125.73 154.7 73.2 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 109.077 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.32 165.68 31.68 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.454 2.103 . . . . 0.0 111.655 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -85.22 -23.07 28.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -62.72 128.91 38.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 34' ' ' ASN . 22.0 tp -83.83 126.2 32.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 109.421 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.522 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -137.71 97.69 10.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.0 109.436 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.4 Cg_endo -62.69 121.01 8.77 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.961 2.441 . . . . 0.0 111.938 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.506 ' HB ' HG23 ' A' ' 52' ' ' ILE . 9.8 m -121.65 155.75 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.981 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.6 t -98.3 141.22 31.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -96.65 136.73 12.95 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.593 ' OD1' HG23 ' A' ' 50' ' ' THR . 58.4 p30 -62.26 -12.4 20.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -1.113 . . . . 0.0 109.58 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 48.8 m-20 -88.33 10.01 21.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 0.0 109.595 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.18 15.68 68.86 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.5 mt-30 -117.85 156.24 28.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.382 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.963 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.7 m -118.32 148.56 42.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.453 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.826 ' HD2' HD12 ' A' ' 39' ' ' LEU . 78.0 m-85 -130.26 127.83 40.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.317 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 m-20 -49.36 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.8 t-20 -82.06 146.19 54.71 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.978 -1.076 . . . . 0.0 109.468 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.522 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.64 -50.15 3.58 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.463 2.108 . . . . 0.0 111.459 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 8.0 t -62.2 -27.68 69.15 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.464 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 23.8 mtt -69.78 -23.58 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.826 HD12 ' HD2' ' A' ' 33' ' ' TYR . 4.8 tt -63.59 -47.34 81.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.344 -0.847 . . . . 0.0 108.782 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.547 ' N ' HD23 ' A' ' 39' ' ' LEU . 9.5 m -56.75 -27.97 60.33 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -56.83 -47.78 79.52 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 29.1 tp10 -57.87 -22.01 45.99 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 3.3 m-80 -76.57 -31.85 57.78 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.903 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.66 HD21 ' CZ ' ' A' ' 8' ' ' TYR . 67.0 mt -64.43 -41.19 96.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.384 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 mt -73.29 -54.23 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.392 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.679 HH22 HG21 ' A' ' 50' ' ' THR . 81.0 mtm180 -70.22 -22.02 62.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.383 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 63.01 36.0 12.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -120.0 177.35 5.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.565 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 90.7 m-20 -103.98 56.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.55 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.679 HG21 HH22 ' A' ' 46' ' ' ARG . 82.9 m -75.88 129.38 36.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 109.579 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 8.0 m80 -115.34 -170.96 1.87 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.177 -0.952 . . . . 0.0 109.33 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.534 HG12 HD13 ' A' ' 39' ' ' LEU . 41.3 mt -85.9 126.56 40.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.727 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 12.7 tpt180 -81.06 -43.14 19.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.408 -0.808 . . . . 0.0 109.24 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.8 p -154.51 137.89 15.83 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 p -58.48 149.34 25.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 109.405 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 83.43 165.89 38.96 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.963 ' HG3' HG21 ' A' ' 32' ' ' THR . 39.5 tttm -65.3 149.04 50.64 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.352 -1.087 . . . . 0.0 109.356 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.8 138.7 39.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.481 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.444 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 81.5 mtp . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.581 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 24.6 m -85.23 -13.03 51.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.446 -0.784 . . . . 0.0 109.28 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -80.95 10.87 4.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.923 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 4' ' ' MET . 41.7 p30 -145.02 19.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.032 -1.042 . . . . 0.0 109.671 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.632 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -128.24 154.09 46.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.129 -0.982 . . . . 0.0 109.494 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 9' ' ' ARG . 39.2 tpt85 -135.66 146.81 48.2 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.305 -0.872 . . . . 0.0 108.984 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 15' ' ' GLY . 75.5 t -137.58 137.53 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.15 -0.969 . . . . 0.0 109.647 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.556 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -116.0 175.66 1.84 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 109.233 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.4 Cg_endo -66.53 -21.77 52.42 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.598 2.198 . . . . 0.0 111.763 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -101.96 -28.66 12.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -0.847 . . . . 0.0 109.563 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 11' ' ' LEU . 83.2 mt -80.87 -51.56 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.856 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 81.29 -165.38 46.73 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.8 OUTLIER -100.78 147.45 26.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -1.112 . . . . 0.0 109.672 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.83 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -119.87 127.64 52.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.853 . . . . 0.0 109.481 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 70.4 m -133.48 156.72 79.38 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.296 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.7 Cg_endo -70.06 166.66 27.21 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.621 2.214 . . . . 0.0 111.815 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -87.53 -14.42 40.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 109.534 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -73.01 106.1 4.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.311 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.422 HD11 ' HB3' ' A' ' 34' ' ' ASN . 48.8 tp -72.93 113.66 10.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.455 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.8 mttm -124.02 102.92 33.91 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 109.323 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 42.9 Cg_endo -65.09 116.98 4.15 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.875 2.383 . . . . 0.0 112.138 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 32' ' ' THR . 7.6 m -116.41 156.93 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 16.5 t -98.3 111.94 24.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.566 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.08 139.16 37.8 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.516 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.1 p30 -69.8 -9.74 55.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -1.109 . . . . 0.0 109.667 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -81.42 1.99 30.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.446 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.48 15.19 44.68 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -125.03 168.66 13.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.336 -1.097 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.566 HG21 ' HA ' ' A' ' 57' ' ' LYS . 39.1 m -123.45 134.18 53.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.661 ' CD1' HD13 ' A' ' 39' ' ' LEU . 72.8 m-85 -110.99 121.09 44.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 109.215 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 8.7 m-20 -46.89 -82.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.4 -0.812 . . . . 0.0 109.722 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.3 t-20 -81.84 146.38 55.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 109.593 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -62.95 -51.96 2.54 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.77 2.313 . . . . 0.0 111.599 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.8 t -61.92 -26.78 68.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.959 -1.088 . . . . 0.0 108.091 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 31.5 mmm -67.43 -16.66 64.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.661 HD13 ' CD1' ' A' ' 33' ' ' TYR . 17.3 tp -68.03 -57.35 6.29 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 9.4 t -55.45 -25.41 36.21 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -69.51 -61.7 1.68 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.571 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 88.5 mt-10 -57.57 -19.53 26.13 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.421 ' ND2' ' HG ' ' A' ' 39' ' ' LEU . 92.9 m-20 -75.39 -33.55 61.02 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.95 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.2 tm? -57.76 -38.23 75.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.412 -0.805 . . . . 0.0 108.882 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mt -77.3 -46.81 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.846 . . . . 0.0 108.972 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.438 ' O ' HG23 ' A' ' 48' ' ' THR . 62.2 mtt-85 -64.76 -26.22 68.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 109.01 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 91.5 mt-30 61.27 37.99 16.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.37 -0.831 . . . . 0.0 109.639 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 46' ' ' ARG . 10.1 p -128.39 169.77 13.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.322 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.512 ' O ' ' NE2' ' A' ' 51' ' ' HIS . 79.9 m-20 -98.91 63.13 1.35 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.266 -0.896 . . . . 0.0 109.311 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.6 m -71.47 137.65 48.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.827 . . . . 0.0 109.666 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.512 ' NE2' ' O ' ' A' ' 49' ' ' ASN . 11.8 m-70 -117.95 178.54 4.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 109.022 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.413 HG23 ' HB ' ' A' ' 25' ' ' VAL . 20.4 mt -86.08 124.8 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.142 -0.974 . . . . 0.0 109.611 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 66.4 ttt180 -80.99 -56.73 3.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.142 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -147.13 156.56 43.09 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.535 -0.728 . . . . 0.0 109.037 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -75.05 142.72 43.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.0 109.632 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.04 162.46 35.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.566 ' HA ' HG21 ' A' ' 32' ' ' THR . 32.5 mttt -64.77 136.75 57.25 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.588 -0.948 . . . . 0.0 109.484 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -71.11 149.15 46.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.388 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 58' ' ' CYS . 84.4 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.502 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.3 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 8' ' ' TYR . 3.9 m -82.8 -26.84 31.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.441 -0.787 . . . . 0.0 109.376 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' CYS . 69.3 mttt -44.76 -27.24 0.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.348 -0.845 . . . . 0.0 108.757 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 5' ' ' CYS . 94.5 m-20 -116.08 35.05 4.66 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 5' ' ' CYS . 2.7 t80 -80.34 163.2 24.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -150.64 114.61 5.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -0.829 . . . . 0.0 109.093 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.873 HG13 ' C ' ' A' ' 15' ' ' GLY . 59.7 t -116.97 156.74 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 109.639 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.55 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -136.27 174.91 3.97 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.371 -0.83 . . . . 0.0 109.386 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.9 Cg_endo -67.44 -21.75 46.32 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.672 2.248 . . . . 0.0 111.947 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -112.1 -21.56 11.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.673 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 11' ' ' LEU . 97.0 mt -88.21 -49.32 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 0.0 109.627 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.873 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 75.2 -165.43 54.62 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.83 ' CD1' HG21 ' A' ' 10' ' ' VAL . 1.2 t80 -94.06 153.84 17.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -1.212 . . . . 0.0 109.514 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.8 tp -117.08 109.92 17.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.965 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.9 m -126.13 155.35 73.71 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 109.115 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.09 168.52 23.82 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.527 2.151 . . . . 0.0 111.611 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -88.19 -23.34 23.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -0.964 . . . . 0.0 109.741 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.53 126.53 28.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.329 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 34' ' ' ASN . 31.3 tp -85.0 113.13 21.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.528 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -121.45 104.35 40.26 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 0.0 109.363 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.499 ' HB2' ' HG3' ' A' ' 57' ' ' LYS . 43.2 Cg_endo -65.62 117.28 4.49 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.875 2.383 . . . . 0.0 112.059 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.489 ' HB ' HG23 ' A' ' 52' ' ' ILE . 34.0 m -120.44 154.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.871 . . . . 0.0 109.835 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.0 t -97.3 140.79 31.24 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -90.99 142.39 16.11 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 43.9 t0 -68.58 -11.5 60.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -1.203 . . . . 0.0 109.306 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -86.4 -5.0 59.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.303 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.77 21.38 14.35 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 27' ' ' GLY . 66.8 mt-30 -127.58 145.84 50.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -1.194 . . . . 0.0 109.585 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.48 HG23 ' HA ' ' A' ' 57' ' ' LYS . 92.8 m -99.4 154.72 17.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.868 . . . . 0.0 109.602 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.655 ' CD2' HD12 ' A' ' 39' ' ' LEU . 48.8 m-85 -135.59 117.63 15.36 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.372 -0.83 . . . . 0.0 108.901 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.552 ' HB3' HD11 ' A' ' 22' ' ' LEU . 10.8 m-20 -41.97 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.0 109.828 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.8 t-20 -82.27 146.61 54.89 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.031 . . . . 0.0 109.205 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.18 -51.16 2.93 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.618 2.212 . . . . 0.0 111.695 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.5 t -63.34 -28.27 69.89 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.094 -1.004 . . . . 0.0 108.423 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 14.0 mtp -60.89 -14.93 25.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.019 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.712 HD22 ' CD1' ' A' ' 52' ' ' ILE . 6.2 tp -74.65 -54.9 6.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.494 -0.754 . . . . 0.0 109.746 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.472 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.4 m -61.72 -19.92 62.93 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.197 -0.94 . . . . 0.0 108.665 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.57 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 34.9 t60 -67.79 -54.39 19.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -66.2 -18.75 65.55 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.0 m-20 -75.79 -27.47 58.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.45 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.974 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.8 tm? -67.52 -35.98 80.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -0.976 . . . . 0.0 108.966 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.25 -46.27 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.208 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.502 ' NH2' ' OE1' ' A' ' 31' ' ' GLN . 74.2 mtm180 -75.79 -35.01 60.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 109.109 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.2 mt-30 62.51 40.36 10.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.71 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.444 HG23 ' HB3' ' A' ' 46' ' ' ARG . 32.9 p -109.8 7.31 24.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 47.82 60.66 3.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.853 . . . . 0.0 109.761 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.3 m -79.77 133.49 36.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.451 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -105.46 -173.97 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.478 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.712 ' CD1' HD22 ' A' ' 39' ' ' LEU . 33.6 mm -91.33 127.15 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.616 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 73.8 ttt180 -79.44 -49.01 12.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.231 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.6 p -159.3 155.18 26.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 p -67.82 141.56 56.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.074 -1.016 . . . . 0.0 109.769 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.29 165.77 35.17 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.499 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 83.0 mttt -66.94 146.28 54.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -1.087 . . . . 0.0 109.364 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 70.1 m -55.28 150.54 11.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.59 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.458 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 48.2 ttm . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.457 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 38.9 m -80.82 -28.06 36.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.335 -0.853 . . . . 0.0 109.167 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -68.08 -12.6 61.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 109.368 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -91.0 -16.59 27.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.689 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.495 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -109.76 157.22 19.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.183 179.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -128.95 140.79 51.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.564 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.766 HG21 ' C ' ' A' ' 15' ' ' GLY . 14.7 p -125.71 146.77 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.561 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mp -108.77 175.6 1.9 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.3 Cg_endo -67.32 -23.3 44.81 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.641 2.227 . . . . 0.0 111.669 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -88.93 -30.6 18.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.247 -0.908 . . . . 0.0 109.146 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.429 ' HA ' HD13 ' A' ' 14' ' ' ILE . 28.6 mm -85.9 -39.79 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 0.0 109.307 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.766 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 69.18 144.71 0.16 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.912 ' CE1' HD11 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -41.88 152.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -1.065 . . . . 0.0 109.789 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.1 tp -128.35 111.72 13.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.882 . . . . 0.0 109.511 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 81.0 m -116.85 158.08 44.72 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.327 -0.858 . . . . 0.0 109.2 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -71.79 165.62 31.99 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.575 2.183 . . . . 0.0 111.792 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -86.81 -11.61 50.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -74.11 113.42 11.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.246 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.975 HD11 ' OD1' ' A' ' 34' ' ' ASN . 55.9 tp -80.02 123.22 27.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.554 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 11.9 mmtm -141.03 109.63 6.44 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.394 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -66.02 120.28 7.42 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 123.04 2.493 . . . . 0.0 112.055 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 32' ' ' THR . 11.1 m -116.86 156.64 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 109.82 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 46.8 t -98.59 119.8 37.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.0 109.368 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -72.62 137.31 24.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -68.33 -7.61 32.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -1.08 . . . . 0.0 109.532 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 91.5 m-20 -89.07 11.77 17.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.504 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.6 71.59 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 27' ' ' GLY . 78.4 mt-30 -116.01 173.95 6.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -1.164 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.652 HG21 ' HG3' ' A' ' 57' ' ' LYS . 50.6 m -133.9 140.33 46.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.328 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.766 ' CD1' HD13 ' A' ' 39' ' ' LEU . 24.6 m-85 -118.62 123.32 44.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.467 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.975 ' OD1' HD11 ' A' ' 22' ' ' LEU . 54.6 t-20 -45.99 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 109.737 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.8 t-20 -80.82 147.52 62.53 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.866 -1.146 . . . . 0.0 109.343 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.8 Cg_endo -62.45 -53.15 2.0 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.699 2.266 . . . . 0.0 111.804 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.6 t -62.76 -28.15 69.78 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.485 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 50.3 mmm -63.13 -16.77 61.12 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.766 HD13 ' CD1' ' A' ' 33' ' ' TYR . 27.9 tp -66.77 -50.67 61.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.454 -0.779 . . . . 0.0 108.899 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.6 m -67.92 -19.36 64.98 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -73.54 -54.82 7.3 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 88.6 mt-10 -63.35 -17.05 62.17 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 47' ' ' GLN . 94.0 m-20 -77.35 -35.74 54.36 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.493 -0.754 . . . . 0.0 108.967 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.912 HD11 ' CE1' ' A' ' 16' ' ' TYR . 31.2 mt -54.14 -36.09 62.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.116 -0.99 . . . . 0.0 108.567 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mt -78.45 -50.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.075 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 91.5 mtt-85 -65.31 -26.89 68.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.23 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.97 41.95 7.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 109.587 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 p -128.86 158.61 38.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.446 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.475 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 63.0 m-20 -87.71 58.4 4.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.332 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.435 ' OG1' ' OD2' ' A' ' 29' ' ' ASP . 57.6 m -75.15 133.6 41.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.858 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.475 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 67.9 m80 -119.88 174.86 6.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.858 . . . . 0.0 108.873 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.519 HG23 ' HB ' ' A' ' 25' ' ' VAL . 37.9 mt -79.71 138.43 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.322 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HA ' ' OD2' ' A' ' 28' ' ' ASP . 23.3 ttt180 -101.9 -47.52 4.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.387 -0.821 . . . . 0.0 109.578 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.5 m -146.86 137.61 23.84 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.49 -0.756 . . . . 0.0 109.33 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.7 p -60.69 145.17 50.3 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.24 164.09 39.9 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.652 ' HG3' HG21 ' A' ' 32' ' ' THR . 22.4 tttp -53.88 150.22 7.91 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.348 -1.09 . . . . 0.0 109.525 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 36.3 m -52.73 144.85 13.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.444 179.888 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.6 mtm . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.511 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.2 m -85.5 8.96 17.2 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.491 ' HE2' ' NE2' ' A' ' 51' ' ' HIS . 31.1 mttt -70.13 -27.42 64.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 82.6 m-20 -144.44 64.25 1.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.882 ' OH ' HD21 ' A' ' 44' ' ' LEU . 11.7 p90 -125.33 -176.44 3.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.442 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -146.7 152.87 39.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 109.557 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 15' ' ' GLY . 42.5 t -144.57 127.93 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -106.8 175.32 2.09 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.865 . . . . 0.0 109.501 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -67.94 -23.23 41.05 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.693 2.262 . . . . 0.0 111.844 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -96.73 -26.64 15.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.254 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.2 mt -89.3 -42.07 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.655 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.586 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 64.32 -165.46 31.49 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.484 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -93.42 149.83 20.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -1.197 . . . . 0.0 109.407 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.2 tp -116.24 107.19 14.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.639 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 60.3 m -125.47 156.26 70.67 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 109.557 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 51.5 Cg_endo -72.12 167.84 25.69 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.733 2.288 . . . . 0.0 111.669 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -84.32 -26.0 28.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -62.34 117.01 5.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -84.67 104.32 14.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 34' ' ' ASN . 16.1 mtpt -116.12 111.37 42.71 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.223 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.6 Cg_endo -63.38 121.14 8.84 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 C-N-CA 122.999 2.466 . . . . 0.0 112.21 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' A' ' 52' ' ' ILE . 5.8 m -115.1 157.73 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.418 -0.801 . . . . 0.0 109.584 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 53' ' ' ARG . 47.6 t -97.21 140.58 31.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.8 135.38 12.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.7 p30 -62.0 -12.23 17.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -1.065 . . . . 0.0 109.71 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 49.8 m-20 -87.47 10.84 16.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.484 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.72 64.31 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 62.0 mt-30 -117.35 178.79 4.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.519 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.611 HG21 ' HG3' ' A' ' 57' ' ' LYS . 20.7 m -139.49 142.65 37.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.31 -0.869 . . . . 0.0 109.234 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.832 ' CD2' HD12 ' A' ' 39' ' ' LEU . 23.9 m-85 -122.42 134.84 54.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.58 ' CB ' HD21 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -54.68 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 109.491 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.4 t-20 -82.16 146.39 54.81 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.003 -1.061 . . . . 0.0 109.504 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.64 -52.3 1.94 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.703 2.269 . . . . 0.0 111.645 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.536 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -63.5 -24.28 67.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.509 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 62.2 mtp -73.66 -16.51 61.21 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.832 HD12 ' CD2' ' A' ' 33' ' ' TYR . 7.5 tt -64.55 -51.8 60.95 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' ASN . 8.7 m -54.09 -38.54 65.45 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.425 ' C ' ' O ' ' A' ' 40' ' ' CYS . 7.2 t60 -47.48 -50.21 23.78 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HG3' ' CD1' ' A' ' 33' ' ' TYR . 37.3 mm-40 -56.48 -25.98 52.78 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.2 m-80 -74.32 -33.72 63.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 0.0 108.85 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.882 HD21 ' OH ' ' A' ' 8' ' ' TYR . 37.2 mt -63.96 -44.26 93.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.1 mm -74.86 -52.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.125 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 37.7 mtt-85 -66.83 -22.25 66.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.198 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 61.51 35.26 17.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.359 -0.838 . . . . 0.0 109.584 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 p -123.13 170.38 10.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.419 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.57 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 77.7 m-20 -96.77 57.37 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.857 . . . . 0.0 109.609 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.622 HG21 ' OH ' ' A' ' 33' ' ' TYR . 43.9 m -80.03 126.12 30.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.554 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.57 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 22.3 m80 -113.18 -173.32 2.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.804 HG12 HD13 ' A' ' 39' ' ' LEU . 31.8 mt -87.09 124.69 40.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.176 -0.952 . . . . 0.0 109.366 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 79.3 ttt180 -80.44 -39.99 27.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.366 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.06 148.64 17.15 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.493 -0.754 . . . . 0.0 109.288 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -65.91 144.43 56.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.723 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.11 162.01 38.06 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.611 ' HG3' HG21 ' A' ' 32' ' ' THR . 13.5 tttm -54.8 154.27 5.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.51 -0.994 . . . . 0.0 109.372 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 84.5 m -62.55 141.13 58.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.499 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.488 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.1 m -79.73 -5.68 55.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.455 -0.778 . . . . 0.0 108.968 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 mttm -54.24 -31.47 53.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.795 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -146.43 67.74 1.18 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -0.948 . . . . 0.0 110.073 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.612 ' OH ' HD13 ' A' ' 44' ' ' LEU . 5.8 p90 -125.2 173.76 8.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.158 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -143.9 147.52 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.063 -1.023 . . . . 0.0 109.755 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 15' ' ' GLY . 66.6 t -144.57 132.83 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.126 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 1.5 mp -125.42 170.94 8.34 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 109.497 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.71 -24.59 40.93 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.556 2.171 . . . . 0.0 111.449 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -102.89 -27.16 12.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.039 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.4 mt -88.88 -43.09 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.294 -0.879 . . . . 0.0 109.24 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.785 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 76.04 -141.72 27.52 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.62 ' CD2' HG21 ' A' ' 10' ' ' VAL . 2.9 t80 -114.17 155.3 26.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 32.5 tp -112.44 124.5 52.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.991 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -138.54 156.66 73.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.388 -0.82 . . . . 0.0 109.057 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.2 Cg_endo -72.59 168.21 25.02 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.633 2.222 . . . . 0.0 111.552 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -84.82 -27.83 26.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.379 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.82 130.88 48.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.471 HD11 ' HB3' ' A' ' 34' ' ' ASN . 63.7 tp -95.06 117.71 30.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 109.5 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.531 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 7.5 mttt -128.22 104.88 19.94 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.3 Cg_endo -64.62 120.41 7.69 Favored 'Trans proline' 0 C--O 1.213 -0.755 0 C-N-CA 122.962 2.442 . . . . 0.0 112.081 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 32' ' ' THR . 11.9 m -119.62 156.46 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.851 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.3 t -99.87 121.48 41.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.432 -0.793 . . . . 0.0 108.873 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -79.41 137.05 18.45 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 45.5 p30 -68.5 -8.82 44.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -1.152 . . . . 0.0 109.548 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 29' ' ' ASP . 58.0 p30 -82.89 8.21 13.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -0.955 . . . . 0.0 109.313 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.44 23.01 45.2 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.4 mt-30 -133.79 158.25 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -1.154 . . . . 0.0 109.499 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 42.2 m -116.19 143.63 45.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 109.225 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.778 ' CD1' HD13 ' A' ' 39' ' ' LEU . 81.0 m-85 -122.51 127.82 50.02 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.272 -0.893 . . . . 0.0 109.213 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 10.7 m-20 -51.55 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.942 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 10.1 t-20 -81.97 146.56 55.85 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 120.947 -1.096 . . . . 0.0 109.731 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.9 -51.78 2.71 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.813 2.342 . . . . 0.0 111.674 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.9 t -60.14 -31.57 70.21 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 8.5 mtt -60.97 -17.53 52.24 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.778 HD13 ' CD1' ' A' ' 33' ' ' TYR . 63.5 tp -67.85 -54.45 18.86 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 8.1 t -58.19 -27.72 64.13 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -62.28 -58.93 5.89 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -59.62 -21.01 59.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.0 m-20 -80.09 -30.74 39.27 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.612 HD13 ' OH ' ' A' ' 8' ' ' TYR . 35.6 tp -61.14 -40.61 94.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.512 -0.742 . . . . 0.0 109.054 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.0 mt -80.43 -47.49 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.81 . . . . 0.0 109.322 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.59 ' HG2' HG23 ' A' ' 48' ' ' THR . 46.7 ttm-85 -67.66 -43.67 79.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.5 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 84.8 mt-30 65.88 47.18 2.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.387 -0.821 . . . . 0.0 109.58 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.59 HG23 ' HG2' ' A' ' 46' ' ' ARG . 21.3 p -120.83 8.07 10.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.1 t30 52.73 60.65 3.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.535 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.409 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 28.9 m -77.87 141.12 39.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.327 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 59.6 m80 -115.12 168.58 9.81 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.204 -0.935 . . . . 0.0 109.094 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.414 HG23 ' HB ' ' A' ' 25' ' ' VAL . 21.7 mt -79.71 123.55 36.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.146 -0.972 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.518 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 65.2 ttt-85 -81.06 -45.98 15.69 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.571 -0.706 . . . . 0.0 109.266 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -152.99 153.85 33.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 109.138 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 p -74.0 144.89 44.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.0 164.6 40.4 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 75.1 mttt -64.9 138.44 58.37 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.46 -1.024 . . . . 0.0 109.345 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 152.6 44.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 109.418 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.496 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.9 mtm . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 7.9 m -80.39 -20.15 44.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.393 -0.817 . . . . 0.0 109.285 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 49' ' ' ASN . 86.1 mttt -50.19 -27.13 5.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 108.822 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -108.84 26.53 10.47 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 1.9 t80 -80.97 147.71 30.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.985 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -141.17 114.61 8.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.606 HG21 ' N ' ' A' ' 16' ' ' TYR . 5.4 p -128.71 154.71 39.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.348 -0.845 . . . . 0.0 109.431 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.606 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -110.12 168.42 7.67 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.948 . . . . 0.0 109.327 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.606 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.7 Cg_endo -67.2 -24.82 43.77 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.614 2.209 . . . . 0.0 111.543 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -92.92 -25.02 18.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.218 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.3 mt -85.69 -40.37 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 109.378 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.589 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 70.96 145.9 0.36 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.606 ' N ' HG21 ' A' ' 10' ' ' VAL . 1.9 t80 -51.44 150.89 3.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -1.163 . . . . 0.0 109.331 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -116.92 136.12 53.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.425 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.6 m -142.95 157.27 61.38 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.208 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -69.87 165.42 31.16 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.661 2.241 . . . . 0.0 111.755 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -87.93 -13.34 42.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -72.56 114.34 10.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.181 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 22' ' ' LEU . 38.0 tp -80.04 120.74 24.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 109.629 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.506 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -136.83 107.47 9.0 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.091 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.3 121.66 9.16 Favored 'Trans proline' 0 C--O 1.212 -0.784 0 C-N-CA 123.016 2.478 . . . . 0.0 112.249 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.494 ' HB ' HG23 ' A' ' 52' ' ' ILE . 16.3 m -118.89 155.57 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 109.877 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 32.2 t -97.36 139.03 33.91 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.68 140.31 15.04 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -70.98 -4.77 26.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -1.134 . . . . 0.0 109.618 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -93.57 4.61 53.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.01 20.26 33.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.7 mt-30 -124.63 163.58 21.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -1.139 . . . . 0.0 109.54 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.0 m -125.13 135.58 52.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.128 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.857 ' CD1' HD13 ' A' ' 39' ' ' LEU . 55.3 m-85 -115.36 130.16 56.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.228 -0.92 . . . . 0.0 109.349 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 8.3 m-20 -54.52 -78.15 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.731 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.9 t-20 -81.88 147.86 59.47 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.722 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.4 Cg_endo -62.92 -52.92 1.87 Allowed 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.751 2.3 . . . . 0.0 111.704 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.5 t -60.91 -29.81 69.81 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.984 -1.072 . . . . 0.0 108.111 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 44.9 mmm -63.65 -15.24 57.77 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.857 HD13 ' CD1' ' A' ' 33' ' ' TYR . 39.4 tp -68.76 -49.29 59.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.494 -0.754 . . . . 0.0 109.286 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 3.2 m -69.32 -21.35 63.85 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.551 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 40.5 t60 -70.27 -55.33 9.5 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 78.1 mt-10 -63.28 -19.49 64.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.1 m-20 -75.26 -33.42 61.27 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 40' ' ' CYS . 20.9 mt -59.3 -37.0 76.62 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 45' ' ' ILE . 6.6 mm -72.69 -49.6 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.469 ' HG2' HG23 ' A' ' 48' ' ' THR . 36.4 ttt180 -68.48 -25.86 65.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.1 mt-30 64.03 43.91 4.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.778 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.469 HG23 ' HG2' ' A' ' 46' ' ' ARG . 70.1 p -132.36 166.89 20.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.303 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.48 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 95.9 m-20 -95.71 61.13 2.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.396 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.3 m -72.32 139.3 47.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.619 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.48 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 72.1 m80 -119.15 173.57 6.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.845 . . . . 0.0 109.053 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.494 HG23 ' HB ' ' A' ' 25' ' ' VAL . 35.1 mt -80.07 124.93 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.097 -1.002 . . . . 0.0 109.269 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.486 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.7 ttt180 -79.93 -45.94 17.63 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.679 0.752 . . . . 0.0 109.235 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 p -156.49 146.47 21.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 p -65.37 147.4 53.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.157 -0.965 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.22 165.15 40.47 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.532 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 47.4 mttp -65.69 146.2 55.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -1.087 . . . . 0.0 109.346 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 152.86 35.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.504 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.405 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.7 mtp . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.497 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 34.4 m -80.56 -6.08 57.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.378 -0.826 . . . . 0.0 109.214 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -81.38 12.61 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 110.038 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -132.98 7.83 4.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.991 -1.068 . . . . 0.0 110.399 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 5.8 p90 -105.48 -176.56 3.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.912 -1.118 . . . . 0.0 109.604 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.621 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 10.4 ttt180 -151.48 142.81 23.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.339 -0.851 . . . . 0.0 109.142 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 15' ' ' GLY . 15.0 t -143.61 149.39 18.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.346 -0.846 . . . . 0.0 109.321 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -124.46 175.33 3.0 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.4 Cg_endo -66.71 -21.56 51.45 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.63 2.22 . . . . 0.0 111.739 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 66.1 ttt180 -99.6 -16.89 18.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.84 . . . . 0.0 109.641 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' ' 14' ' ' ILE . 40.0 mm -94.82 -49.82 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.033 -1.042 . . . . 0.0 109.611 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.574 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 86.47 -178.29 48.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.488 ' HE2' ' HH ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -90.63 146.91 23.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 109.736 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.3 tp -114.18 107.59 15.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 74.1 m -117.28 156.62 48.6 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.343 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.1 Cg_endo -72.21 167.94 25.47 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.642 2.228 . . . . 0.0 111.531 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -91.79 -12.81 32.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -66.74 129.45 39.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 109.277 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.901 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -89.56 120.68 31.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.518 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.619 ' N ' HD13 ' A' ' 22' ' ' LEU . 27.3 mttm -143.65 108.13 5.13 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.541 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 47.1 Cg_endo -66.77 122.39 9.76 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 123.056 2.504 . . . . 0.0 112.126 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -116.21 154.66 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 53' ' ' ARG . 49.6 t -97.04 138.56 34.38 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.57 139.82 14.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.9 t0 -69.2 -8.44 45.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -1.099 . . . . 0.0 109.459 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -87.54 3.61 46.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.978 . . . . 0.0 109.438 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.56 17.29 45.98 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 65.8 mt-30 -121.33 175.22 6.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -1.108 . . . . 0.0 109.625 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.643 HG21 ' HG3' ' A' ' 57' ' ' LYS . 10.8 m -134.29 136.78 43.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 0.0 109.54 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.814 ' CD1' HD13 ' A' ' 39' ' ' LEU . 30.6 m-85 -114.42 127.67 55.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.901 ' OD1' HD21 ' A' ' 22' ' ' LEU . 59.6 t-20 -50.6 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.433 -0.792 . . . . 0.0 110.079 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.8 t-20 -80.85 149.5 67.36 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.004 -1.06 . . . . 0.0 109.555 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.35 -54.92 0.85 Allowed 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.793 2.329 . . . . 0.0 111.917 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.2 t -62.09 -28.33 69.54 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.965 -1.084 . . . . 0.0 108.265 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.4 mmm -64.41 -12.58 44.55 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.814 HD13 ' CD1' ' A' ' 33' ' ' TYR . 28.4 tp -73.56 -57.67 3.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.465 -0.772 . . . . 0.0 109.067 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.449 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.8 m -62.85 -18.47 62.93 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -71.85 -58.27 3.6 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -61.92 -17.08 55.52 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -77.15 -31.91 55.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.524 -0.735 . . . . 0.0 109.076 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.511 HD11 ' HH ' ' A' ' 8' ' ' TYR . 19.5 mt -58.55 -35.99 73.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.935 . . . . 0.0 108.678 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.2 mm -78.64 -50.25 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.056 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.9 mtt-85 -64.46 -34.71 78.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.168 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 58.79 36.47 24.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.379 -0.826 . . . . 0.0 109.447 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 p -113.12 11.82 18.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.37 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 46.28 57.73 5.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.367 -0.833 . . . . 0.0 109.44 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.3 m -75.04 140.57 43.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.492 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -112.5 170.01 8.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.551 HG12 HD22 ' A' ' 39' ' ' LEU . 39.7 mt -79.85 126.52 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 41.3 ttt180 -79.77 -45.82 18.12 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.7 p -158.19 162.51 37.9 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.4 p -79.05 133.08 36.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -0.986 . . . . 0.0 109.755 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 99.95 165.35 29.06 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.643 ' HG3' HG21 ' A' ' 32' ' ' THR . 30.1 tttp -54.39 158.51 2.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -1.083 . . . . 0.0 109.236 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.474 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 91.2 m -69.39 150.42 47.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.6 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.384 179.918 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtp . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.9 m -85.48 -22.93 28.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.375 -0.828 . . . . 0.0 109.247 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -74.75 -14.33 60.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -109.34 4.09 22.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.872 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -119.43 155.11 32.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.038 -1.039 . . . . 0.0 109.238 179.909 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -136.74 130.79 32.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.408 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.593 HG21 ' C ' ' A' ' 15' ' ' GLY . 4.9 p -129.39 142.2 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.469 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.775 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -103.88 173.55 3.33 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.775 ' HD2' HD23 ' A' ' 11' ' ' LEU . 47.6 Cg_endo -68.44 -26.72 34.37 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.595 2.197 . . . . 0.0 111.717 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -89.01 -28.41 20.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.295 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.7 mm -84.39 -40.57 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.244 -0.91 . . . . 0.0 109.304 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.593 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 68.56 155.85 0.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CE2' ' CZ ' ' A' ' 8' ' ' TYR . 1.3 t80 -55.67 148.06 17.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.292 -1.122 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.6 tp -123.1 119.62 30.83 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.859 . . . . 0.0 109.323 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.4 m -117.67 155.82 50.2 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.525 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.3 Cg_endo -71.55 166.02 30.69 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.844 2.363 . . . . 0.0 111.791 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -86.63 -8.01 57.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.867 . . . . 0.0 109.335 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -72.99 128.77 36.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 109.304 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.918 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.1 tm? -92.12 124.69 36.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.717 ' N ' HD13 ' A' ' 22' ' ' LEU . 2.2 mmmm -145.27 103.68 4.36 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.304 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 42.6 Cg_endo -65.36 124.29 12.7 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 123.061 2.507 . . . . 0.0 112.298 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 32' ' ' THR . 17.7 m -120.74 156.26 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 109.939 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.6 t -101.64 115.46 30.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.172 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -71.77 139.29 28.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.0 p30 -69.41 -9.83 55.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -1.14 . . . . 0.0 109.484 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.8 m-20 -82.95 8.13 13.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.75 14.35 63.31 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.0 mt-30 -120.75 159.73 24.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.304 -1.116 . . . . 0.0 109.467 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.506 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 33.1 m -119.1 134.66 55.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.286 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.841 ' CD1' HD13 ' A' ' 39' ' ' LEU . 56.5 m-85 -113.26 123.83 51.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.119 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.918 ' OD1' HD21 ' A' ' 22' ' ' LEU . 64.2 t-20 -49.41 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.256 -0.902 . . . . 0.0 109.806 -179.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.5 t-20 -80.93 147.97 63.28 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 120.871 -1.143 . . . . 0.0 109.72 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.6 Cg_endo -62.16 -53.11 2.17 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.845 2.363 . . . . 0.0 111.941 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.0 t -60.92 -28.5 68.98 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 120.911 -1.118 . . . . 0.0 108.023 178.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 22.2 mtp -63.99 -20.92 66.25 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.841 HD13 ' CD1' ' A' ' 33' ' ' TYR . 32.7 tp -67.38 -54.57 19.31 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.529 ' O ' HD12 ' A' ' 44' ' ' LEU . 38.1 t -58.34 -30.96 67.14 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -66.52 -59.04 4.0 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 73.9 mt-10 -59.2 -18.41 36.43 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.472 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 94.4 m-20 -77.28 -37.88 51.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.589 -0.695 . . . . 0.0 109.162 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.529 HD12 ' O ' ' A' ' 40' ' ' CYS . 5.4 mp -56.38 -34.24 66.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 108.79 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 mt -79.01 -48.49 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.396 -0.815 . . . . 0.0 109.278 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.707 ' HG3' HG23 ' A' ' 48' ' ' THR . 19.9 tpt85 -65.64 -39.22 91.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 88.7 mt-30 62.67 41.84 8.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.56 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.707 HG23 ' HG3' ' A' ' 46' ' ' ARG . 27.3 p -121.92 10.65 10.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.497 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 51.51 60.84 3.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.355 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.472 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 26.7 m -77.52 141.56 39.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.625 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 22.7 m-70 -115.18 172.12 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.011 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.4 mt -82.96 124.75 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.501 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 24.7 tpt180 -82.16 -53.52 6.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.422 -0.799 . . . . 0.0 109.31 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.9 p -148.02 154.58 40.46 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -73.05 147.58 44.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.116 -0.99 . . . . 0.0 109.312 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.95 165.15 40.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.549 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 35.0 mttm -66.86 145.6 55.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -1.041 . . . . 0.0 109.301 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 153.06 29.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.453 -179.964 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.1 mtm . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 34.8 m -81.13 -17.12 50.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.785 . . . . 0.0 109.475 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 63.1 mttt -80.51 8.38 7.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.733 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 95.9 m-20 -137.83 10.76 2.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.011 -1.056 . . . . 0.0 110.241 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.616 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -121.36 151.18 40.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 109.565 179.803 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -132.02 134.86 46.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.236 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.837 HG13 ' O ' ' A' ' 15' ' ' GLY . 61.8 t -124.47 148.92 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.82 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.564 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -129.6 175.23 3.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.437 -0.789 . . . . 0.0 109.276 179.849 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 43.8 Cg_endo -66.9 -21.73 49.83 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.651 2.234 . . . . 0.0 111.784 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -103.65 -28.26 11.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.52 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' A' ' 11' ' ' LEU . 90.2 mt -81.76 -46.99 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.547 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.837 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 78.97 -166.43 51.83 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.2 t80 -97.16 150.8 20.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.174 . . . . 0.0 109.502 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.6 tp -120.07 116.29 25.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 109.681 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.6 m -127.37 157.37 72.94 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.201 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.8 Cg_endo -71.05 166.49 28.99 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.501 2.134 . . . . 0.0 111.682 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -88.12 -14.41 38.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.521 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -71.87 119.31 15.87 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.207 -0.933 . . . . 0.0 109.242 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 34' ' ' ASN . 43.0 tp -83.61 116.39 22.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.75 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.6 mmtt -129.7 105.45 17.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.885 . . . . 0.0 109.087 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.567 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 43.4 Cg_endo -65.27 119.82 6.91 Favored 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 122.952 2.434 . . . . 0.0 112.283 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 32' ' ' THR . 24.3 m -117.63 154.8 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 25.8 t -95.72 127.61 41.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.329 -0.857 . . . . 0.0 108.753 179.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -83.07 137.51 16.61 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.4 p30 -67.8 -8.52 36.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -85.6 7.34 23.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 109.384 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.54 16.07 57.45 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.5 mt-30 -123.2 173.46 7.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.493 HG21 ' HA ' ' A' ' 57' ' ' LYS . 25.9 m -133.0 135.42 45.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.387 -0.82 . . . . 0.0 109.263 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.745 ' CD1' HD13 ' A' ' 39' ' ' LEU . 37.0 m-85 -112.54 130.09 56.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.202 -0.936 . . . . 0.0 109.371 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.525 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 8.4 m-20 -53.77 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 109.72 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.0 t-20 -81.84 147.8 59.45 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.29 -53.87 1.3 Allowed 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.789 2.326 . . . . 0.0 111.813 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -61.32 -27.49 68.52 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 42.8 mmm -64.81 -17.88 64.62 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.234 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.745 HD13 ' CD1' ' A' ' 33' ' ' TYR . 24.2 tp -68.54 -58.16 4.72 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.453 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 10.5 t -56.36 -26.12 51.72 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -68.59 -61.56 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.403 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 69.1 mt-10 -56.02 -19.86 14.38 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.239 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.2 m-20 -78.56 -40.27 35.31 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.7 tp -55.83 -33.84 64.85 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.417 -0.802 . . . . 0.0 108.845 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mt -78.82 -50.53 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.836 . . . . 0.0 108.995 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 13.2 mtt-85 -65.48 -22.02 66.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 109.348 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 89.0 mt-30 63.83 43.67 5.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.333 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.4 t -131.57 168.99 16.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.579 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 90.7 m-20 -103.56 63.29 0.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.1 m -74.42 140.01 44.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.703 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 31.4 m80 -116.66 178.93 4.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.044 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.411 HG23 ' HB ' ' A' ' 25' ' ' VAL . 30.0 mt -87.99 124.9 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.058 -1.026 . . . . 0.0 109.4 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 69.9 ttt-85 -80.19 -47.5 14.58 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.543 -0.723 . . . . 0.0 109.288 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 p -155.33 152.99 29.83 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -71.69 146.03 48.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.15 -0.969 . . . . 0.0 109.415 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.98 164.23 40.17 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.567 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 26.1 mttp -64.58 143.66 57.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.554 -0.968 . . . . 0.0 109.447 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 151.55 35.47 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.257 -0.902 . . . . 0.0 109.397 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.5 -179.864 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.7 mtp . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.573 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.0 m -85.58 4.14 37.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 109.083 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.567 ' HE2' ' CD2' ' A' ' 51' ' ' HIS . 24.7 mttt -73.05 -20.48 60.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 58.6 p30 -148.93 57.55 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 109.838 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.651 ' OH ' HD21 ' A' ' 44' ' ' LEU . 12.0 p90 -120.83 -175.44 3.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 109.242 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -152.64 145.6 24.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.391 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 15' ' ' GLY . 55.5 t -132.04 129.68 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -111.94 175.37 1.9 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.355 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.4 Cg_endo -67.57 -23.66 42.85 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.61 2.207 . . . . 0.0 111.651 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.9 ttp85 -93.28 -39.72 10.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.89 . . . . 0.0 109.207 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.7 mt -79.95 -43.84 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.351 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.843 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 67.27 -155.05 52.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.665 ' CD2' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -112.71 148.13 35.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -1.104 . . . . 0.0 109.25 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.844 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -122.0 128.93 52.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.0 m -136.4 157.27 75.7 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.272 -0.893 . . . . 0.0 109.317 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -70.4 165.73 30.74 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.575 2.184 . . . . 0.0 111.662 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -87.4 -10.5 51.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -78.52 108.88 12.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.443 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.5 tm? -76.0 110.8 10.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 34' ' ' ASN . 2.6 mtpt -124.3 109.66 29.01 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 109.313 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.4 Cg_endo -62.31 121.26 9.19 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 123.035 2.49 . . . . 0.0 112.272 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.582 ' HB ' HG23 ' A' ' 52' ' ' ILE . 11.1 m -115.78 155.78 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -0.804 . . . . 0.0 109.904 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.7 t -97.27 112.92 24.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.365 -0.834 . . . . 0.0 108.932 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -67.18 133.5 31.04 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.4 t0 -69.62 -6.46 31.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 109.783 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 57.4 p30 -85.53 1.99 46.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.084 -1.01 . . . . 0.0 109.342 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.71 18.26 30.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.3 mt-30 -126.84 173.88 9.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.498 -1.001 . . . . 0.0 109.341 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.887 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.5 m -132.63 138.35 47.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.266 -0.896 . . . . 0.0 109.29 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.86 ' CD2' HD12 ' A' ' 39' ' ' LEU . 31.4 m-85 -118.38 139.81 50.81 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.163 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -61.03 -76.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 -179.365 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.0 t-20 -82.31 146.81 55.22 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.988 -1.07 . . . . 0.0 109.64 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.9 Cg_endo -63.65 -52.23 1.98 Allowed 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.599 2.199 . . . . 0.0 111.68 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.537 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -63.42 -27.62 69.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 0.0 108.183 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.496 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 54.3 mtp -67.88 -19.8 65.06 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.86 HD12 ' CD2' ' A' ' 33' ' ' TYR . 7.3 tt -66.52 -52.92 40.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.331 -0.856 . . . . 0.0 108.873 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 43' ' ' ASN . 9.4 m -51.16 -41.05 59.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 40' ' ' CYS . 16.1 t60 -48.06 -48.1 33.54 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.972 -1.08 . . . . 0.0 108.209 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 49.8 mm-40 -58.37 -22.18 52.75 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 40' ' ' CYS . 2.9 m-80 -75.7 -35.83 60.18 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.997 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.651 HD21 ' OH ' ' A' ' 8' ' ' TYR . 31.7 mt -65.86 -48.69 70.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.301 -0.874 . . . . 0.0 109.389 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 45' ' ' ILE . 5.8 mm -67.2 -52.82 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.118 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.506 ' HG2' HG23 ' A' ' 48' ' ' THR . 72.8 ttt180 -68.56 -22.87 64.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.307 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ASN . 86.7 mt-30 63.06 43.17 6.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.363 -0.835 . . . . 0.0 109.571 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.506 HG23 ' HG2' ' A' ' 46' ' ' ARG . 60.7 p -132.96 167.42 20.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.145 -0.972 . . . . 0.0 109.576 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.577 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 89.8 m-20 -94.3 57.83 2.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.48 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 57.0 m -80.19 127.16 32.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.467 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 14.6 m80 -115.79 -169.22 1.55 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.444 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.582 HG23 ' HB ' ' A' ' 25' ' ' VAL . 37.8 mt -88.12 124.98 41.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.473 -0.767 . . . . 0.0 109.836 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.539 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 64.5 ttt180 -82.53 -49.64 9.67 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.746 0.784 . . . . 0.0 109.383 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 p -150.72 138.83 20.14 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -60.95 144.59 52.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.117 -0.99 . . . . 0.0 109.284 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.48 160.72 36.43 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.887 ' HG3' HG21 ' A' ' 32' ' ' THR . 17.7 tttm -61.52 148.87 40.62 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.521 -0.987 . . . . 0.0 109.397 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.1 145.31 32.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.654 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.587 -179.948 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.5 mtt . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.4 m -80.0 -5.54 55.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.296 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.2 mttm -61.6 -23.2 65.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.674 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -151.31 64.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.928 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.709 ' OH ' HD13 ' A' ' 44' ' ' LEU . 6.7 p90 -123.77 174.33 7.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.109 -0.994 . . . . 0.0 109.198 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -147.35 146.49 29.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.648 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.594 HG21 ' CD2' ' A' ' 16' ' ' TYR . 69.3 t -145.29 132.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.484 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.645 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -117.8 175.08 2.2 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.269 -0.894 . . . . 0.0 109.597 -179.968 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.645 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.9 Cg_endo -67.73 -26.35 39.1 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.687 2.258 . . . . 0.0 111.951 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -107.8 -24.49 11.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.369 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.4 mm -82.59 -43.08 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.577 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.25 -159.14 53.23 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.594 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.7 t80 -98.6 153.73 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -1.177 . . . . 0.0 109.466 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 31.3 tp -107.86 123.25 48.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 109.877 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 68.3 m -140.19 156.48 70.03 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.306 -0.871 . . . . 0.0 109.21 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.4 Cg_endo -71.56 167.6 25.96 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.558 2.172 . . . . 0.0 111.701 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -84.07 -29.47 26.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.613 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.34 125.94 25.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.418 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.584 HD11 ' CB ' ' A' ' 34' ' ' ASN . 59.5 tp -88.26 113.21 23.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.154 -0.966 . . . . 0.0 109.432 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.544 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.5 mttt -121.27 105.61 39.29 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.511 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -64.69 118.67 5.63 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 123.085 2.523 . . . . 0.0 112.215 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.473 ' HB ' HG23 ' A' ' 52' ' ' ILE . 14.1 m -115.72 156.01 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 109.885 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.4 t -98.95 142.87 29.9 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.404 ' C ' ' HB2' ' A' ' 53' ' ' ARG . . . -95.82 143.7 16.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.488 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.2 t0 -71.87 -14.33 61.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -1.124 . . . . 0.0 109.416 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -83.69 -5.38 59.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.44 22.04 10.87 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 85.5 mt-30 -121.46 170.95 9.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -1.13 . . . . 0.0 109.469 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.541 HG23 ' HA ' ' A' ' 57' ' ' LYS . 86.6 m -133.61 136.66 45.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.493 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.836 ' CD1' HD13 ' A' ' 39' ' ' LEU . 28.3 m-85 -115.02 146.23 41.47 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 108.754 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.584 ' CB ' HD11 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -67.98 -75.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.01 -1.056 . . . . 0.0 108.626 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.9 t-20 -82.77 146.7 53.29 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 109.403 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -63.61 -51.18 2.64 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.693 2.262 . . . . 0.0 111.591 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -62.18 -28.58 69.77 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.432 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 10.3 mtt -64.4 -16.91 63.21 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.836 HD13 ' CD1' ' A' ' 33' ' ' TYR . 30.9 tp -65.94 -53.69 35.98 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.5 t -60.65 -23.48 64.82 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 25.2 t60 -67.31 -58.98 3.8 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -58.79 -22.07 57.48 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 47' ' ' GLN . 78.2 m-20 -80.38 -30.77 37.87 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.709 HD13 ' OH ' ' A' ' 8' ' ' TYR . 49.5 tp -62.38 -35.56 79.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 108.76 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mt -80.49 -50.33 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.4 -0.813 . . . . 0.0 109.249 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 96.1 mtt180 -68.89 -40.27 79.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 92.7 mt-30 65.0 39.56 5.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.543 -0.723 . . . . 0.0 109.547 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 46' ' ' ARG . 40.6 p -108.15 6.97 27.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.393 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.1 t30 52.74 56.79 7.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.524 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.9 m -78.6 140.46 38.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -112.12 169.11 9.08 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.275 -0.891 . . . . 0.0 108.993 179.523 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.507 HG12 HD22 ' A' ' 39' ' ' LEU . 23.3 mt -79.47 127.11 39.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.218 -0.926 . . . . 0.0 109.241 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.488 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 53.7 ttt-85 -79.35 -46.14 18.23 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.389 -0.819 . . . . 0.0 109.134 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 m -160.61 148.08 15.89 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.7 p -61.18 145.3 51.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.6 166.23 40.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HA ' HG23 ' A' ' 32' ' ' THR . 89.2 mttt -67.71 150.16 49.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -1.085 . . . . 0.0 109.499 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 66.7 m -59.79 151.11 26.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.9 . . . . 0.0 109.318 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.488 179.971 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.0 ttm . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.477 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 81.3 m -81.64 -31.18 32.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.244 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -60.49 -23.71 64.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.398 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -76.41 -25.73 54.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.512 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.465 ' OH ' ' CD1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -103.66 155.22 18.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.197 -0.939 . . . . 0.0 109.226 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -128.36 139.71 52.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 0.0 109.317 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.758 HG21 ' C ' ' A' ' 15' ' ' GLY . 13.0 p -123.17 146.0 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -0.924 . . . . 0.0 109.51 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.556 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -108.59 176.08 1.72 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.3 Cg_endo -67.14 -25.4 43.54 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.601 2.201 . . . . 0.0 111.675 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -85.01 -31.3 23.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.253 -0.904 . . . . 0.0 108.917 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.8 mt -87.04 -37.68 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.398 -0.814 . . . . 0.0 109.128 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.758 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 66.52 142.24 0.05 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.678 ' N ' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -42.27 152.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.446 -1.032 . . . . 0.0 109.833 -179.921 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 tp -123.53 118.29 27.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.426 -0.796 . . . . 0.0 109.518 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.7 m -129.24 157.28 76.58 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.188 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.67 165.86 30.63 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.691 2.261 . . . . 0.0 111.755 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -89.12 -8.74 53.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.23 -0.919 . . . . 0.0 109.421 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -76.97 107.18 9.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 0.0 109.07 179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 34' ' ' ASN . 59.4 tp -71.2 121.16 17.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.811 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 31.1 mtmt -139.57 110.53 7.47 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.235 -0.915 . . . . 0.0 109.102 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.8 Cg_endo -65.54 119.48 6.51 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 C-N-CA 123.175 2.584 . . . . 0.0 112.631 -179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 32' ' ' THR . 27.3 m -112.49 156.22 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 0.0 109.65 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 12.3 t -98.59 111.44 23.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 109.315 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.3 138.16 36.17 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 40.1 t0 -71.26 -4.73 27.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -1.199 . . . . 0.0 109.606 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 57.6 m-20 -90.07 7.2 38.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.083 -1.01 . . . . 0.0 109.101 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.77 14.5 59.48 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 27' ' ' GLY . 77.0 mt-30 -125.69 140.23 52.88 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.414 -1.051 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 25' ' ' VAL . 17.1 m -103.59 153.21 20.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -0.902 . . . . 0.0 109.34 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.563 ' CZ ' ' HG3' ' A' ' 42' ' ' GLU . 19.9 m-85 -128.58 143.16 50.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.1 m-20 -58.54 -75.23 0.05 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -0.888 . . . . 0.0 109.962 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.7 t-20 -82.5 147.76 56.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.069 -1.019 . . . . 0.0 109.993 -179.543 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.5 Cg_endo -64.3 -53.44 1.12 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.746 2.298 . . . . 0.0 111.485 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.5 t -60.77 -27.69 68.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 36.5 mmm -63.78 -17.46 63.09 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.816 HD13 HG12 ' A' ' 52' ' ' ILE . 8.2 tt -68.26 -52.82 29.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.352 -0.843 . . . . 0.0 108.985 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.5 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . 45.0 m -47.9 -47.41 32.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.095 -1.003 . . . . 0.0 108.392 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.439 ' HA ' HD13 ' A' ' 44' ' ' LEU . 14.7 t60 -47.97 -49.35 30.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.128 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.563 ' HG3' ' CZ ' ' A' ' 33' ' ' TYR . 71.8 mm-40 -49.41 -24.05 1.79 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 4.6 m-80 -80.02 -37.64 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.416 -0.803 . . . . 0.0 108.873 179.352 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.3 mp -67.5 -36.71 81.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.221 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 45' ' ' ILE . 5.3 mt -77.12 -52.53 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.077 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 48' ' ' THR . 47.0 mtt-85 -71.85 -20.99 61.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.373 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 43' ' ' ASN . 88.2 mt-30 62.44 35.45 14.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -0.851 . . . . 0.0 109.312 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 46' ' ' ARG . 30.8 p -125.48 175.11 7.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.444 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.575 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 79.8 m-20 -94.75 58.87 2.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 109.451 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.472 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 30.9 m -79.22 126.11 30.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 32.3 m80 -115.7 -172.57 2.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.172 179.672 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.816 HG12 HD13 ' A' ' 39' ' ' LEU . 13.0 mt -87.78 124.27 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 109.576 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 61.3 ttt180 -80.07 -53.49 6.66 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.647 0.737 . . . . 0.0 109.319 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 p -150.88 143.89 24.66 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.629 -0.67 . . . . 0.0 109.203 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.3 p -64.83 144.86 56.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.196 -0.94 . . . . 0.0 109.405 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.03 161.66 36.92 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 32' ' ' THR . 23.2 tttt -62.22 144.96 54.82 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.449 -1.03 . . . . 0.0 109.278 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.37 157.22 26.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.616 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.545 -179.986 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.4 mmm . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.595 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 33.5 m -80.31 -17.74 51.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.524 -0.735 . . . . 0.0 109.021 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -80.77 8.35 8.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.516 179.596 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -133.24 2.8 3.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.132 -0.98 . . . . 0.0 109.996 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.677 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -118.76 148.52 42.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.014 -1.054 . . . . 0.0 109.539 -179.977 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.7 mtm-85 -129.14 132.21 47.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.112 179.553 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.606 ' C ' HD22 ' A' ' 11' ' ' LEU . 42.2 t -126.51 140.48 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 -179.654 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 10' ' ' VAL . 3.8 mm? -117.95 170.26 6.53 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 41.7 Cg_endo -65.44 -21.43 60.56 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.192 1.928 . . . . 0.0 111.575 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -94.88 -25.29 16.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.418 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.2 mt -88.92 -50.44 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.298 -0.876 . . . . 0.0 109.944 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.567 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.24 -174.31 53.46 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.677 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -91.81 148.28 22.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -1.172 . . . . 0.0 109.552 -179.938 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.3 tp -120.96 100.67 7.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 109.728 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.6 m -111.04 157.73 37.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.235 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 53.6 Cg_endo -73.22 167.87 26.23 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.67 2.247 . . . . 0.0 111.681 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -87.62 -26.5 23.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 109.346 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.452 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 46.4 m-20 -57.89 124.54 19.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.163 -0.961 . . . . 0.0 109.171 179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 34' ' ' ASN . 36.2 tp -88.73 116.3 26.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.613 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASN . 3.8 mttt -127.43 103.2 22.65 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 108.983 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.527 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.7 Cg_endo -65.63 115.85 3.61 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.937 2.425 . . . . 0.0 111.842 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 32' ' ' THR . 21.7 m -113.89 154.43 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 0.0 109.732 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.1 t -94.22 131.49 39.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.343 -0.848 . . . . 0.0 108.738 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -86.85 137.24 14.64 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.4 p30 -66.23 -12.11 54.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -1.159 . . . . 0.0 109.616 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 52.6 p30 -83.75 8.92 13.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.01 20.83 54.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.451 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 68.8 mt-30 -125.51 175.98 7.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.47 -1.017 . . . . 0.0 109.326 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.602 HG21 ' HA ' ' A' ' 57' ' ' LYS . 14.1 m -135.1 136.38 41.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 109.432 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.65 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.5 m-85 -113.87 120.43 40.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.882 . . . . 0.0 109.267 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 10.4 m-20 -45.55 -78.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.985 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.3 t-20 -81.66 148.92 63.08 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.02 -1.05 . . . . 0.0 109.881 -179.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.2 Cg_endo -63.79 -54.35 0.98 Allowed 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.732 2.288 . . . . 0.0 111.927 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -63.01 -25.59 68.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.026 -1.046 . . . . 0.0 108.373 179.137 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.2 mmm -66.43 -11.56 52.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.559 -0.713 . . . . 0.0 109.095 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.65 HD13 ' CD1' ' A' ' 33' ' ' TYR . 20.9 tp -71.38 -60.12 2.4 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.29 -0.881 . . . . 0.0 108.707 179.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 10.3 t -54.65 -28.35 46.53 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -67.8 -60.64 2.36 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.143 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 78.4 mt-10 -57.78 -18.74 23.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 47' ' ' GLN . 96.7 m-20 -77.54 -32.6 54.06 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.92 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.4 tm? -58.36 -38.99 78.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.514 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mm -75.56 -49.73 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -0.867 . . . . 0.0 108.767 179.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 47.0 mtt-85 -63.71 -28.55 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.187 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 89.5 mt-30 63.15 44.03 6.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.6 p -133.51 167.05 21.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.576 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 48.7 p-10 -95.91 61.35 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.309 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.9 m -72.46 135.37 45.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.856 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 42.5 m80 -115.28 -178.1 3.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 108.939 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.2 mt -90.25 123.04 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 109.004 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 50.1 ttt85 -79.65 -44.52 20.77 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.393 -0.817 . . . . 0.0 109.432 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 p -158.56 158.09 33.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.549 -0.719 . . . . 0.0 109.121 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 p -75.5 136.97 40.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.897 . . . . 0.0 109.698 -179.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.47 162.73 34.11 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.602 ' HA ' HG21 ' A' ' 32' ' ' THR . 48.0 tttm -49.59 159.4 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.486 -1.008 . . . . 0.0 109.216 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.492 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 73.1 m -68.39 145.35 54.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.38 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.549 179.965 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.447 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 45.1 ttm . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 71.2 m -80.48 -9.15 59.77 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.451 -0.781 . . . . 0.0 109.138 179.657 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -81.12 11.03 4.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.092 -1.005 . . . . 0.0 109.617 179.508 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 4' ' ' MET . 49.2 p30 -127.31 8.29 6.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.994 -1.066 . . . . 0.0 110.653 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.778 ' OH ' HD11 ' A' ' 44' ' ' LEU . 6.9 p90 -107.59 -177.41 3.34 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.723 -1.235 . . . . 0.0 109.686 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.579 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 46.8 mtt180 -151.91 128.46 10.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.226 179.567 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.591 HG23 ' CE1' ' A' ' 8' ' ' TYR . 24.5 t -127.14 145.36 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.7 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.559 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -118.53 176.33 1.72 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.365 -0.834 . . . . 0.0 109.169 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.0 Cg_endo -66.96 -21.97 49.04 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.557 2.171 . . . . 0.0 111.773 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.8 mtt-85 -96.81 -27.75 14.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 mm -84.1 -47.47 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.707 -179.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.468 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 78.32 177.6 48.48 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -83.0 147.68 28.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -1.16 . . . . 0.0 109.435 -179.917 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.0 tp -118.9 105.74 11.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.755 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.9 m -116.22 155.87 47.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 108.964 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.25 165.63 32.08 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.561 2.174 . . . . 0.0 111.543 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -84.04 -31.79 25.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 109.267 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -54.18 132.8 43.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.384 -0.823 . . . . 0.0 109.052 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 34' ' ' ASN . 61.3 tp -96.93 119.45 35.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.175 -0.953 . . . . 0.0 109.628 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' ASN . 3.9 mttm -130.99 106.56 15.1 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 0.0 108.899 179.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.64 123.41 11.66 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 123.009 2.472 . . . . 0.0 112.354 -179.183 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.438 ' HB ' HG23 ' A' ' 52' ' ' ILE . 17.6 m -118.18 155.15 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.728 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.7 t -96.49 138.09 34.59 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.44 135.64 12.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -66.83 -11.03 53.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 109.465 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.7 p30 -89.03 10.68 20.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.437 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.45 19.25 57.24 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 90.1 mt-30 -120.5 178.42 4.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -1.147 . . . . 0.0 109.549 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.775 HG21 ' HG3' ' A' ' 57' ' ' LYS . 35.3 m -139.58 136.76 34.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.887 . . . . 0.0 109.29 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.903 ' CD1' HD13 ' A' ' 39' ' ' LEU . 26.4 m-85 -117.81 128.79 55.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.161 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 11.7 m-20 -52.66 -78.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.794 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.5 t-20 -81.69 147.25 58.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.99 -1.069 . . . . 0.0 109.719 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.5 Cg_endo -63.51 -52.12 2.12 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.782 2.321 . . . . 0.0 111.739 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.4 t -62.95 -26.47 68.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.16 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.441 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 54.0 mmm -68.71 -15.15 63.43 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.149 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.903 HD13 ' CD1' ' A' ' 33' ' ' TYR . 21.2 tp -72.21 -50.85 24.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.415 -0.803 . . . . 0.0 109.339 179.784 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.494 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.5 m -66.14 -22.38 66.38 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.017 -1.052 . . . . 0.0 108.224 179.265 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -66.81 -56.17 11.62 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.485 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 95.5 mt-10 -63.43 -17.04 62.26 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' GLN . 86.2 m-20 -79.95 -26.37 40.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.602 -0.686 . . . . 0.0 109.186 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.778 HD11 ' OH ' ' A' ' 8' ' ' TYR . 19.2 mt -69.02 -33.29 73.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.165 -0.959 . . . . 0.0 108.649 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.4 mt -78.73 -50.36 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 108.978 179.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.584 ' HB3' HG23 ' A' ' 48' ' ' THR . 47.0 mtm180 -74.35 -34.25 63.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.305 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 59.62 39.24 21.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.553 179.805 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.584 HG23 ' HB3' ' A' ' 46' ' ' ARG . 38.1 p -103.97 16.68 25.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 48' ' ' THR . 53.2 m-20 44.22 52.13 7.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.408 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.443 ' OG1' ' NH2' ' A' ' 46' ' ' ARG . 76.6 m -74.9 146.26 42.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.614 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 31.6 m-70 -123.72 168.76 12.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.282 179.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.502 HG12 HD22 ' A' ' 39' ' ' LEU . 16.9 mt -79.73 124.35 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.447 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 78.3 ttt180 -79.76 -44.14 21.24 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 p -160.19 148.82 17.04 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 p -64.86 145.12 56.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.166 -0.959 . . . . 0.0 109.536 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.94 164.23 39.79 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.775 ' HG3' HG21 ' A' ' 32' ' ' THR . 17.4 tttt -60.44 151.45 28.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.461 -1.023 . . . . 0.0 109.361 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.402 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 72.2 m -58.47 152.39 18.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.469 179.89 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 ttm . . . . . 0 N--CA 1.488 1.457 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.556 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 5.7 m -79.77 -12.35 59.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.447 -0.783 . . . . 0.0 109.05 179.496 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 mttm -55.21 -26.78 41.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.933 -179.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -151.56 65.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.692 -179.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.932 ' OH ' HD11 ' A' ' 44' ' ' LEU . 4.1 p90 -128.79 170.7 13.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.508 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -144.85 154.99 43.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.293 -0.88 . . . . 0.0 109.386 179.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.846 HG13 ' C ' ' A' ' 15' ' ' GLY . 95.3 t -146.66 127.27 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.523 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -117.19 173.42 3.15 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.21 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HD2' HD23 ' A' ' 11' ' ' LEU . 43.1 Cg_endo -65.94 -22.92 55.11 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.498 2.132 . . . . 0.0 111.568 179.736 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -105.92 -33.66 7.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.852 . . . . 0.0 109.066 179.565 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.403 HD12 HD13 ' A' ' 11' ' ' LEU . 89.6 mt -81.64 -40.95 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.118 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.846 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 65.09 -145.13 48.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.557 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.9 t80 -105.34 158.0 16.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.31 -1.112 . . . . 0.0 109.495 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.32 114.01 21.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 62.6 m -128.1 156.19 76.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.331 179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.13 170.28 18.55 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.616 2.211 . . . . 0.0 111.625 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -91.3 -12.48 34.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.122 -0.986 . . . . 0.0 109.644 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -73.3 115.84 13.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.283 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 tp -73.17 126.36 29.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.625 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -139.75 100.39 7.41 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.849 . . . . 0.0 109.007 179.818 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -64.09 117.71 4.71 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.971 2.447 . . . . 0.0 112.345 -179.272 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 32' ' ' THR . 11.0 m -116.1 155.15 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.402 -0.811 . . . . 0.0 109.841 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.7 t -96.81 137.31 36.09 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.27 139.56 14.6 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 46.2 p30 -65.76 -9.12 25.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -1.068 . . . . 0.0 109.612 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -89.12 14.03 11.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.12 26.33 58.06 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.459 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 79.7 mt-30 -130.5 174.86 9.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -1.166 . . . . 0.0 109.288 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 32.9 m -131.81 152.93 50.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.882 ' CD2' HD12 ' A' ' 39' ' ' LEU . 40.6 m-85 -132.68 119.88 20.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.246 -0.909 . . . . 0.0 109.197 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 3.7 m-20 -43.6 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 109.689 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.2 t-20 -81.69 146.26 56.21 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.299 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.94 -50.95 2.57 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.593 2.195 . . . . 0.0 111.483 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.8 t -61.96 -25.35 67.56 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.438 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 13.9 mtp -68.14 -17.95 64.49 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.368 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.882 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.3 tt -67.74 -50.61 56.35 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.426 -0.796 . . . . 0.0 108.858 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 4.7 t -52.54 -45.69 66.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 0.0 108.521 179.194 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.403 ' HA ' HD23 ' A' ' 44' ' ' LEU . 15.9 t60 -48.99 -48.94 43.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.16 -0.962 . . . . 0.0 108.481 179.041 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 23.0 mm-40 -57.18 -20.22 25.28 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.528 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.8 m-80 -79.69 -33.13 41.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 108.612 179.2 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.932 HD11 ' OH ' ' A' ' 8' ' ' TYR . 3.9 mm? -67.11 -46.71 73.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 109.388 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.495 ' N ' HD13 ' A' ' 45' ' ' ILE . 5.0 mm -66.47 -52.21 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 48' ' ' THR . 66.4 mtp85 -71.02 -19.24 62.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.204 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 60.81 34.45 19.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 46' ' ' ARG . 8.7 p -123.06 -177.55 3.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.519 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 36.5 t-20 -107.59 64.78 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.923 . . . . 0.0 109.527 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 25.0 m -78.91 127.71 32.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 109.66 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.519 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 3.8 m80 -113.84 -172.13 2.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.25 -0.906 . . . . 0.0 109.143 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.474 HG12 HD13 ' A' ' 39' ' ' LEU . 22.9 mt -89.15 124.16 41.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.21 -0.932 . . . . 0.0 109.572 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.3 ttt-85 -80.8 -42.59 21.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.407 -0.808 . . . . 0.0 109.307 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -160.95 140.77 10.83 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.563 -0.71 . . . . 0.0 109.139 -179.568 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 p -57.9 140.6 51.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -0.957 . . . . 0.0 109.623 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 96.38 165.91 33.68 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 27.5 mttp -67.6 143.36 56.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.532 -0.981 . . . . 0.0 109.258 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 62.3 m -53.43 148.92 8.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.446 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.504 -179.955 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.4 mmm . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.571 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.6 m -80.06 -5.0 55.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.369 -0.832 . . . . 0.0 109.301 179.608 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 23.7 mttm -61.26 -28.73 69.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 -179.546 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 80.5 m-20 -145.1 61.66 1.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.067 -1.021 . . . . 0.0 110.339 -179.635 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.637 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 6.5 p90 -127.03 171.34 11.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.064 -1.023 . . . . 0.0 109.309 179.429 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -146.14 148.9 33.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 109.567 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 15' ' ' GLY . 85.8 t -138.51 132.26 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.419 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -123.66 175.65 2.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.349 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.5 Cg_endo -67.21 -25.84 42.71 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.53 2.153 . . . . 0.0 111.514 179.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -107.37 -27.33 10.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.388 -0.82 . . . . 0.0 108.991 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.9 mm -82.06 -39.77 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 109.437 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.771 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 68.98 -145.62 43.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.637 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 3.3 t80 -111.17 155.17 23.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -1.164 . . . . 0.0 109.27 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 39.7 mt -111.64 123.79 50.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.942 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.1 m -142.0 155.36 65.58 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.457 -0.777 . . . . 0.0 108.954 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.36 164.57 34.66 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.51 2.14 . . . . 0.0 111.554 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -83.46 -26.48 30.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.875 . . . . 0.0 109.544 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.51 129.31 40.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 109.299 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 34' ' ' ASN . 52.7 tp -88.8 123.17 32.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 0.0 109.472 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.2 mmtm -133.91 102.74 12.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.432 -0.793 . . . . 0.0 109.179 179.815 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' CB ' ' HG3' ' A' ' 57' ' ' LYS . 42.1 Cg_endo -64.05 122.04 9.91 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 123.032 2.488 . . . . 0.0 112.331 -179.222 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 32' ' ' THR . 16.8 m -122.22 155.41 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.753 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 34.7 t -99.15 137.51 37.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.403 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.16 138.74 14.13 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.212 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 56.6 p30 -63.59 -11.14 22.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -1.064 . . . . 0.0 109.671 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 86.4 m-20 -85.76 12.93 7.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.345 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.39 20.22 69.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.0 mt-30 -124.52 159.52 30.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -1.121 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 57.3 m -119.97 142.66 48.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -0.963 . . . . 0.0 109.569 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.648 ' CD2' HD12 ' A' ' 39' ' ' LEU . 57.7 m-85 -121.36 130.88 53.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.386 -0.821 . . . . 0.0 109.16 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.1 m-20 -53.8 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.16 -0.962 . . . . 0.0 109.54 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 11.4 t-20 -82.26 147.07 56.0 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 120.99 -1.069 . . . . 0.0 109.699 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.0 Cg_endo -63.1 -51.24 2.94 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.569 2.179 . . . . 0.0 111.409 179.371 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.502 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -60.25 -29.75 68.98 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 38.3 mmm -64.4 -23.52 67.32 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.35 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.648 HD12 ' CD2' ' A' ' 33' ' ' TYR . 7.2 tt -63.4 -48.01 79.6 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.362 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 12.0 t -52.63 -34.01 49.32 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -54.43 -50.04 68.59 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 108.763 179.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 26.2 tp10 -56.78 -19.9 19.52 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.363 -0.836 . . . . 0.0 108.774 179.338 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 4.7 m-80 -80.06 -31.65 39.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.858 . . . . 0.0 109.125 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.862 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.4 tm? -68.89 -42.39 77.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.084 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 45' ' ' ILE . 4.0 mt -71.17 -55.22 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 109.175 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.443 ' NH1' ' HG2' ' A' ' 46' ' ' ARG . 35.6 mtt-85 -70.33 -21.73 62.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.394 -0.816 . . . . 0.0 109.258 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 62.3 32.33 17.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.343 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.9 p -119.52 176.78 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 109.353 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.532 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 84.6 m-20 -100.13 61.37 1.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.481 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 56.0 m -71.79 131.7 43.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.882 . . . . 0.0 109.522 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 14.7 m-70 -116.58 -175.88 2.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.277 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.502 HG12 HD13 ' A' ' 39' ' ' LEU . 20.6 mt -86.19 124.26 40.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.199 -0.938 . . . . 0.0 109.542 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 70.1 ttt180 -80.53 -39.71 27.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.421 -0.799 . . . . 0.0 109.051 179.694 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -158.57 153.56 25.18 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.2 p -73.39 145.57 45.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.179 -0.951 . . . . 0.0 109.495 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.92 164.71 40.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HG3' ' CB ' ' A' ' 24' ' ' PRO . 37.5 mttp -63.09 144.88 56.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.478 -1.013 . . . . 0.0 109.406 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.411 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 0.1 OUTLIER -78.53 156.08 29.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 179.992 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.57 179.998 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.1 mmm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 38.2 m -81.19 -19.58 43.03 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.387 -0.821 . . . . 0.0 109.331 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -80.68 9.26 6.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -133.17 2.69 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.973 . . . . 0.0 109.958 -179.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.594 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -119.45 144.89 46.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.02 -1.05 . . . . 0.0 109.74 -179.916 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.0 mtt85 -127.5 129.83 48.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 108.894 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.796 ' O ' HD22 ' A' ' 11' ' ' LEU . 42.9 t -116.76 141.49 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.035 -1.041 . . . . 0.0 110.201 -179.289 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 10' ' ' VAL . 4.0 mm? -124.43 171.09 7.69 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.582 ' HD2' HD12 ' A' ' 11' ' ' LEU . 42.7 Cg_endo -66.28 -22.25 53.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.305 2.003 . . . . 0.0 111.666 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -97.0 -29.51 13.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 109.206 179.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 11' ' ' LEU . 80.6 mt -83.06 -48.57 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.402 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.744 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 86.7 -175.0 46.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.459 ' OH ' ' HB3' ' A' ' 40' ' ' CYS . 1.5 t80 -81.15 153.05 27.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -1.143 . . . . 0.0 109.544 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 17' ' ' LEU . 38.6 mt -127.86 134.08 49.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 72.4 m -146.92 158.4 45.35 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.347 -0.845 . . . . 0.0 109.141 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.9 Cg_endo -69.52 167.5 23.94 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.636 2.224 . . . . 0.0 111.459 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -85.62 -21.72 28.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.188 -0.945 . . . . 0.0 109.693 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -68.01 115.98 8.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.307 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 35' ' ' ASN . 32.9 tp -86.95 121.38 29.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.174 -0.954 . . . . 0.0 109.536 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASN . 13.0 mmtm -135.83 113.26 10.75 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.403 -0.81 . . . . 0.0 108.908 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.531 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -64.78 116.06 3.59 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.953 2.436 . . . . 0.0 112.13 -179.351 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 32' ' ' THR . 34.2 m -113.53 156.13 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.956 -179.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.5 t -100.49 124.02 45.47 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -80.85 137.54 18.13 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.621 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.584 ' OD1' HG23 ' A' ' 50' ' ' THR . 46.8 p30 -63.9 -10.58 21.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -1.127 . . . . 0.0 109.727 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.412 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 28.5 m-20 -87.29 16.76 4.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.52 19.59 75.95 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.8 mt-30 -120.83 169.0 10.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -1.1 . . . . 0.0 109.392 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 88.6 m -129.86 142.71 50.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.403 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.756 ' HD2' HD12 ' A' ' 39' ' ' LEU . 41.8 m-85 -122.43 118.0 27.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.329 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.1 m-20 -43.09 -75.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.855 . . . . 0.0 109.536 -179.656 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.1 t-20 -81.79 150.28 65.54 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.81 -54.5 1.17 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.684 2.256 . . . . 0.0 111.906 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 4.0 t -58.42 -30.5 66.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.947 -1.095 . . . . 0.0 108.149 179.051 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 7.5 mtt -59.71 -21.09 60.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.882 HD13 HG12 ' A' ' 52' ' ' ILE . 7.3 tt -66.89 -53.63 30.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 16.9 t -49.48 -28.56 5.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.437 ' CD2' HD11 ' A' ' 45' ' ' ILE . 21.5 t60 -57.89 -53.58 56.64 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.282 -0.886 . . . . 0.0 108.617 179.078 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.59 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 16.3 tp10 -54.03 -20.48 6.43 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.8 m-80 -80.46 -33.44 36.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 108.773 179.541 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.26 -39.35 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.83 . . . . 0.0 109.346 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.437 HD11 ' CD2' ' A' ' 41' ' ' HIS . 1.0 OUTLIER -80.31 -46.56 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.66 -179.888 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 27.0 mmt180 -80.3 -33.83 37.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.542 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 89.5 mt-30 58.97 32.05 21.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.504 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 81.2 p -104.63 6.23 34.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.151 -0.968 . . . . 0.0 109.637 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.567 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 73.3 m-20 63.11 52.86 2.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.637 179.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.584 HG23 ' OD1' ' A' ' 28' ' ' ASP . 91.6 m -78.7 142.35 37.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 109.357 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 35.7 m80 -120.33 -171.7 2.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.535 179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.882 HG12 HD13 ' A' ' 39' ' ' LEU . 11.2 mt -92.05 123.35 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 179.848 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.4 ttt180 -79.31 -50.73 10.44 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.327 -0.858 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -158.93 139.31 12.35 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 109.348 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.435 ' H ' HG23 ' A' ' 55' ' ' THR . 7.4 p -53.54 145.86 14.11 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.35 162.91 35.5 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 53.8 mttp -66.93 150.04 49.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.458 -1.025 . . . . 0.0 109.528 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 72.7 m -59.27 147.17 36.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.91 . . . . 0.0 109.395 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.534 -179.932 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.6 ttt . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.591 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 30.7 m -82.76 -15.46 51.71 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.3 -0.875 . . . . 0.0 109.451 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 23.5 mttm -80.65 7.51 9.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.729 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 98.3 m-20 -138.23 16.02 2.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.028 -1.045 . . . . 0.0 110.29 -179.401 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.1 p90 -126.58 153.0 45.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.925 -1.11 . . . . 0.0 109.697 179.857 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -131.53 143.84 50.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.309 -0.869 . . . . 0.0 108.834 179.171 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.865 HG13 ' O ' ' A' ' 15' ' ' GLY . 55.7 t -132.65 134.96 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 -179.766 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.74 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -115.11 174.65 2.25 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.226 179.89 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.4 Cg_endo -67.15 -22.63 46.81 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.59 2.194 . . . . 0.0 111.68 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -101.7 -22.0 14.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 179.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 11' ' ' LEU . 94.8 mt -88.96 -45.42 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.671 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.865 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 77.27 -165.65 53.26 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.7 t80 -96.02 150.01 20.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -1.2 . . . . 0.0 109.499 179.935 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.5 tp -116.97 118.33 32.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.3 m -130.34 157.03 78.53 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.9 Cg_endo -70.91 166.31 29.44 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.612 2.208 . . . . 0.0 111.655 -179.721 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -86.42 -20.9 27.51 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.308 -0.87 . . . . 0.0 109.352 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -65.4 125.95 26.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.95 . . . . 0.0 109.11 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.1 tp -90.77 119.22 30.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.683 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -132.82 106.84 12.73 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.031 179.689 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -65.09 120.55 7.8 Favored 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 122.88 2.387 . . . . 0.0 112.108 -179.556 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.49 ' HB ' HG23 ' A' ' 52' ' ' ILE . 30.3 m -118.14 154.45 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.644 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 31.1 t -97.11 136.14 38.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.251 -0.906 . . . . 0.0 108.769 179.235 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.29 139.98 16.47 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.472 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.7 t0 -70.95 -5.33 30.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.141 -1.211 . . . . 0.0 109.563 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -92.84 5.82 49.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.344 179.676 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.19 14.93 53.39 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.873 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -116.07 175.83 5.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -1.116 . . . . 0.0 109.561 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.929 HG21 ' HG3' ' A' ' 57' ' ' LYS . 30.5 m -138.94 135.43 34.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.122 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.774 ' CD1' HD13 ' A' ' 39' ' ' LEU . 22.0 m-85 -115.6 131.08 57.04 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.307 -179.887 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.5 m-20 -55.41 -76.95 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 -179.515 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.9 t-20 -81.94 148.54 61.04 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.014 -1.053 . . . . 0.0 109.81 -179.73 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.4 Cg_endo -62.73 -53.8 1.54 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.897 2.398 . . . . 0.0 111.916 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.9 t -62.37 -26.91 68.72 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.073 -1.017 . . . . 0.0 108.381 179.189 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.47 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 18.8 mtt -64.67 -18.1 64.67 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.343 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.774 HD13 ' CD1' ' A' ' 33' ' ' TYR . 26.8 tp -66.82 -54.96 17.24 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.451 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.467 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 14.2 t -61.21 -23.9 65.95 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.57 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -70.12 -60.94 1.98 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.19 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.432 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 84.2 tt0 -56.7 -20.98 24.59 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.434 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 47' ' ' GLN . 86.5 m-20 -78.64 -35.99 44.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.133 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 44' ' ' LEU . 42.9 tp -58.65 -33.82 70.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.55 -50.18 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.433 -0.792 . . . . 0.0 108.922 179.452 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 34.5 mtt-85 -69.06 -24.15 64.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.263 179.685 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 43' ' ' ASN . 88.8 mt-30 64.13 41.75 6.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.849 . . . . 0.0 109.478 -179.858 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.4 p -124.74 165.36 18.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 109.267 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -98.36 63.49 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.4 m -78.29 136.24 37.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 109.84 -179.866 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 51.3 m-70 -114.26 171.44 7.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.181 179.63 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.557 HG12 HD22 ' A' ' 39' ' ' LEU . 40.7 mt -80.04 126.92 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.5 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 73.4 ttt180 -79.91 -49.81 11.36 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.652 0.739 . . . . 0.0 109.314 179.806 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.7 m -156.57 145.84 20.5 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.858 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.4 p -61.99 151.3 35.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.537 -179.939 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 81.36 163.49 31.03 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.699 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.929 ' HG3' HG21 ' A' ' 32' ' ' THR . 14.6 tttt -63.81 150.58 44.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -1.068 . . . . 0.0 109.259 179.838 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.24 148.3 34.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.241 -0.912 . . . . 0.0 109.533 -179.909 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.475 179.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.533 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 4.2 m -45.82 -25.32 0.5 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.419 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.45 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.4 mt-10 -49.75 -25.27 2.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 0.0 108.689 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.7 mtp -79.87 -27.44 40.06 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.498 ' N ' ' O ' ' A' ' 2' ' ' SER . 4.4 m -80.25 -6.76 58.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.499 -0.751 . . . . 0.0 109.112 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 17.3 mttm -57.69 -25.65 60.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.309 -0.869 . . . . 0.0 109.844 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -149.82 66.87 0.99 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.0 110.051 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.661 ' OH ' HD13 ' A' ' 44' ' ' LEU . 6.2 p90 -127.27 171.03 11.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.097 -1.002 . . . . 0.0 109.153 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -145.39 155.64 43.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.106 -0.996 . . . . 0.0 109.739 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.792 HG13 ' C ' ' A' ' 15' ' ' GLY . 92.7 t -148.57 122.75 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 109.291 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.557 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 mp -114.6 175.67 1.79 Allowed Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.916 . . . . 0.0 109.334 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.9 Cg_endo -67.64 -28.13 37.88 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.579 2.186 . . . . 0.0 111.578 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 64.2 mtt180 -101.48 -26.33 13.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.337 -0.852 . . . . 0.0 109.21 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 11' ' ' LEU . 91.6 mt -88.49 -41.19 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 0.0 109.365 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.792 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 66.02 -144.67 46.82 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.52 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 2.0 t80 -104.7 157.66 17.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -1.19 . . . . 0.0 109.476 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.2 tp -119.36 119.55 34.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.264 -0.897 . . . . 0.0 109.528 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 85.9 m -135.52 157.04 77.23 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.284 -0.885 . . . . 0.0 109.153 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.9 Cg_endo -70.93 167.38 26.13 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.468 2.112 . . . . 0.0 111.585 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.64 -13.89 36.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.431 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.32 121.27 19.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.122 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.6 tp -84.03 114.92 22.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.143 -0.973 . . . . 0.0 109.781 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mmtm -128.45 107.37 19.15 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 108.94 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.6 Cg_endo -65.96 121.06 8.31 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 123.141 2.561 . . . . 0.0 112.41 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.515 ' HB ' HG23 ' A' ' 52' ' ' ILE . 34.8 m -118.2 156.11 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.0 109.786 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 44.5 t -97.1 142.15 29.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.293 -0.88 . . . . 0.0 108.855 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.48 138.38 13.89 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.507 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.5 p30 -66.48 -15.06 63.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -1.105 . . . . 0.0 109.569 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 85.9 m-20 -84.64 8.83 15.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.68 25.81 37.38 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.446 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 82.2 mt-30 -125.65 177.21 6.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.34 -1.094 . . . . 0.0 109.328 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.536 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 16.4 m -137.97 138.4 38.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 109.298 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.823 ' CD1' HD13 ' A' ' 39' ' ' LEU . 41.8 m-85 -118.17 121.08 39.62 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.316 -0.865 . . . . 0.0 109.265 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.7 m-20 -46.71 -78.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.323 -0.861 . . . . 0.0 109.836 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.7 t-20 -81.54 146.9 58.17 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 120.88 -1.137 . . . . 0.0 109.669 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.26 -53.08 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.839 2.359 . . . . 0.0 111.705 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -62.92 -27.58 69.48 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.988 -1.07 . . . . 0.0 108.13 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.425 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 24.6 mtp -64.52 -17.5 63.96 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.823 HD13 ' CD1' ' A' ' 33' ' ' TYR . 24.5 tp -66.43 -54.75 20.59 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 7.7 t -60.07 -27.35 66.9 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.52 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 36.8 t60 -63.1 -57.4 10.71 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 -61.35 -21.26 63.86 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.47 ' O ' ' N ' ' A' ' 47' ' ' GLN . 89.6 m-20 -79.91 -26.9 40.02 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.661 HD13 ' OH ' ' A' ' 8' ' ' TYR . 38.3 tp -65.71 -36.81 84.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.393 -0.817 . . . . 0.0 108.982 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.6 mt -80.08 -48.57 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.03 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 75.7 mtt-85 -70.77 -39.41 73.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.394 -0.816 . . . . 0.0 109.535 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.47 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.9 mt-30 64.01 40.66 7.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.83 . . . . 0.0 109.416 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 46' ' ' ARG . 44.8 p -108.93 5.41 24.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.595 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.458 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 39.8 t-20 52.73 59.25 4.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.194 -0.941 . . . . 0.0 109.602 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 37.9 m -79.41 141.75 36.57 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.267 -0.895 . . . . 0.0 109.467 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 33.5 m80 -114.09 167.68 10.47 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.339 -0.85 . . . . 0.0 108.967 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.515 HG23 ' HB ' ' A' ' 25' ' ' VAL . 35.1 mt -80.22 127.26 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.059 -1.026 . . . . 0.0 109.433 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.507 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.7 ttt180 -80.03 -42.24 24.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.373 -0.829 . . . . 0.0 109.146 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.5 t -160.35 156.22 25.89 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.6 p -70.91 144.3 50.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 109.475 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.27 166.85 40.68 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.536 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 54.1 mttp -67.02 149.68 50.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.373 -1.075 . . . . 0.0 109.404 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 56.7 m -59.46 152.69 21.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.526 -179.883 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.481 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 4.3 m -48.21 -29.07 3.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.272 -0.892 . . . . 0.0 109.331 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -53.41 -25.69 16.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 108.886 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 87.7 mtp -79.01 -25.52 43.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.463 -0.773 . . . . 0.0 108.934 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 8' ' ' TYR . 31.6 m -81.18 -19.67 42.83 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.345 -0.847 . . . . 0.0 109.136 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 5' ' ' CYS . 23.5 mttm -45.21 -28.81 0.84 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 109.024 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 55.4 p30 -111.13 31.21 6.23 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.475 ' N ' ' O ' ' A' ' 5' ' ' CYS . 2.1 t80 -80.0 144.07 33.56 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.57 -0.706 . . . . 0.0 109.675 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -142.78 115.24 8.51 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.352 -0.842 . . . . 0.0 109.299 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.793 HG21 ' N ' ' A' ' 16' ' ' TYR . 9.3 p -129.82 145.78 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.601 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.551 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -103.63 174.47 2.76 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.355 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.6 Cg_endo -67.89 -25.1 39.24 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.622 2.215 . . . . 0.0 111.803 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 66.6 mtt180 -91.88 -29.72 16.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.907 . . . . 0.0 109.255 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.6 mt -81.47 -39.57 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.305 -0.872 . . . . 0.0 109.575 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.694 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 64.41 140.61 0.02 OUTLIER Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.793 ' N ' HG21 ' A' ' 10' ' ' VAL . 1.2 t80 -43.85 153.58 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.169 -1.195 . . . . 0.0 109.456 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 32.5 tp -119.26 126.19 50.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 109.844 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 66.3 m -139.37 156.63 71.64 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.989 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.68 166.34 30.18 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.562 2.175 . . . . 0.0 111.66 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -86.79 -19.89 28.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.394 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -66.08 122.58 17.74 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.274 -0.891 . . . . 0.0 109.502 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.5 tp -82.51 126.5 32.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.533 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.55 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -139.86 100.44 7.32 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.32 118.6 5.55 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 C-N-CA 122.904 2.403 . . . . 0.0 112.27 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.411 ' HB ' HG23 ' A' ' 52' ' ' ILE . 13.7 m -116.51 155.53 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.664 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 47.2 t -95.57 133.86 39.1 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.349 -0.844 . . . . 0.0 108.804 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.88 136.47 13.65 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.486 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.5 p30 -66.99 -8.31 28.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -1.152 . . . . 0.0 109.643 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -88.02 10.47 18.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.352 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.01 21.87 54.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 72.8 mt-30 -126.33 175.52 7.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.362 -1.081 . . . . 0.0 109.578 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.621 HG21 ' HG3' ' A' ' 57' ' ' LYS . 21.1 m -135.2 138.9 44.07 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.319 -0.863 . . . . 0.0 109.393 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.907 ' CD1' HD13 ' A' ' 39' ' ' LEU . 61.1 m-85 -118.06 125.42 50.28 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.279 -0.888 . . . . 0.0 109.299 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.0 m-20 -49.79 -77.84 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.646 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.1 t-20 -82.06 146.06 54.41 Favored Pre-proline 0 C--N 1.3 -1.55 0 O-C-N 121.015 -1.053 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.89 -51.64 2.82 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.774 2.316 . . . . 0.0 111.538 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.5 t -60.9 -29.96 69.89 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.442 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 16.4 mtp -65.2 -13.45 58.26 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.907 HD13 ' CD1' ' A' ' 33' ' ' TYR . 43.5 tp -68.87 -52.09 33.42 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.392 -0.818 . . . . 0.0 109.095 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.463 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.8 m -66.68 -22.2 66.08 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -67.27 -55.55 13.48 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.1 mm-40 -61.99 -20.01 63.42 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.464 ' O ' ' N ' ' A' ' 47' ' ' GLN . 61.2 m-20 -80.43 -36.82 33.14 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.0 tp -54.79 -34.64 62.95 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.1 mm -80.13 -50.95 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.457 -0.777 . . . . 0.0 108.966 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 7.2 mtp85 -64.36 -24.89 67.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.251 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.4 mt-30 62.96 41.62 8.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.363 -0.836 . . . . 0.0 109.477 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.6 p -128.32 167.93 16.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.5 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.435 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 48.1 p-10 -98.28 62.27 1.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.205 -0.934 . . . . 0.0 109.536 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.6 m -76.5 129.19 36.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.431 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.481 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 59.3 m80 -111.22 172.52 6.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.37 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.514 HG12 HD22 ' A' ' 39' ' ' LEU . 27.5 mt -79.72 124.55 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.289 -0.882 . . . . 0.0 109.234 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.486 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 58.7 ttt85 -79.99 -44.38 20.33 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.397 -0.814 . . . . 0.0 109.362 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.6 p -157.08 158.62 36.77 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.465 -0.772 . . . . 0.0 109.114 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -76.88 133.0 39.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.533 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 100.47 163.48 28.3 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.621 ' HG3' HG21 ' A' ' 32' ' ' THR . 14.2 tttp -53.34 154.41 3.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.496 -1.002 . . . . 0.0 109.457 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 89.5 m -64.88 147.39 53.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.446 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.385 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -60.14 -26.18 66.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 0.0 109.491 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -52.18 -26.17 10.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.268 -0.895 . . . . 0.0 109.065 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.429 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 67.8 mtm -76.35 -28.09 56.72 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.566 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 2.8 m -80.64 -9.47 59.79 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.497 -0.752 . . . . 0.0 109.173 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -80.53 8.77 7.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 0.0 109.662 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 4' ' ' MET . 43.7 p30 -120.1 -0.31 10.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.08 -1.013 . . . . 0.0 110.065 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.78 ' HE1' HG23 ' A' ' 10' ' ' VAL . 4.2 p90 -103.37 -179.61 4.0 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.974 -1.078 . . . . 0.0 109.632 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.606 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 56.2 mtt180 -162.39 140.93 8.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.522 -0.736 . . . . 0.0 109.201 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.78 HG23 ' HE1' ' A' ' 8' ' ' TYR . 61.4 t -117.69 140.17 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 0.0 109.747 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.766 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -128.09 175.65 3.29 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.401 -0.812 . . . . 0.0 109.143 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.766 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.9 Cg_endo -67.31 -22.4 46.18 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.557 2.172 . . . . 0.0 111.674 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -121.47 -12.15 8.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.425 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.447 ' HB ' ' HB2' ' A' ' 11' ' ' LEU . 31.4 mm -86.91 -50.68 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.4 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.563 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 83.89 -169.43 46.48 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.567 ' HA ' HG22 ' A' ' 10' ' ' VAL . 1.5 t80 -83.16 148.89 27.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.171 -1.193 . . . . 0.0 109.544 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.443 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 20.8 tp -119.57 130.05 54.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.2 -0.937 . . . . 0.0 109.742 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 73.2 m -145.19 157.53 53.27 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 0.0 109.023 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.5 Cg_endo -70.38 166.42 28.43 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.541 2.161 . . . . 0.0 111.554 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -84.2 -31.75 24.91 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.215 -0.928 . . . . 0.0 109.352 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -54.87 134.42 48.24 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.346 -0.846 . . . . 0.0 109.054 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.935 HD11 ' OD1' ' A' ' 34' ' ' ASN . 61.2 tp -101.74 123.45 45.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.21 -0.932 . . . . 0.0 109.504 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 10.9 mttt -140.32 111.58 7.13 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -65.59 120.25 7.41 Favored 'Trans proline' 0 C--O 1.213 -0.757 0 C-N-CA 122.989 2.459 . . . . 0.0 112.024 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.535 ' O ' HG23 ' A' ' 32' ' ' THR . 35.0 m -117.65 153.86 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.233 -0.917 . . . . 0.0 109.772 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 35.6 t -95.48 132.59 40.41 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.23 137.89 13.94 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 43.0 p30 -67.19 -8.28 30.11 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.395 -1.062 . . . . 0.0 109.566 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -87.45 16.17 5.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.254 -0.904 . . . . 0.0 109.34 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.25 20.61 72.08 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.499 ' O ' ' N ' ' A' ' 27' ' ' GLY . 76.2 mt-30 -131.13 153.66 49.15 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -1.209 . . . . 0.0 109.586 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.544 HG21 ' HA ' ' A' ' 57' ' ' LYS . 11.1 m -115.74 141.01 48.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -0.921 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.769 ' HD2' HD12 ' A' ' 39' ' ' LEU . 50.0 m-85 -115.26 130.85 57.03 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.296 -0.877 . . . . 0.0 109.327 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.935 ' OD1' HD11 ' A' ' 22' ' ' LEU . 50.8 t-20 -53.07 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.315 -0.865 . . . . 0.0 109.563 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -81.39 150.02 66.46 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 120.998 -1.064 . . . . 0.0 109.416 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -62.47 -54.08 1.51 Allowed 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.7 2.267 . . . . 0.0 112.051 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.545 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 7.1 t -59.84 -30.61 69.07 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.97 -1.081 . . . . 0.0 108.159 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 16.4 mtp -59.29 -25.41 64.09 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.844 HD13 HG12 ' A' ' 52' ' ' ILE . 7.6 tt -63.93 -46.37 85.04 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 35.0 m -55.86 -27.99 54.34 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -59.33 -49.73 76.7 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.579 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 18.0 tp10 -57.71 -19.22 25.73 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 50' ' ' THR . 4.0 m-80 -80.36 -35.13 35.89 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.7 tp -70.38 -37.99 74.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.456 -0.777 . . . . 0.0 109.308 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 mm -79.94 -51.17 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.259 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.539 ' CD ' ' HG3' ' A' ' 42' ' ' GLU . 67.9 mtp85 -73.13 -33.12 65.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.31 -0.869 . . . . 0.0 109.636 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.425 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.2 mt-30 58.15 27.45 15.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.276 -0.89 . . . . 0.0 109.472 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.454 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 82.4 p -105.04 5.17 32.32 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.18 -0.95 . . . . 0.0 109.544 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.519 ' O ' ' NE2' ' A' ' 51' ' ' HIS . 33.4 m120 64.53 52.37 1.8 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.873 . . . . 0.0 109.675 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 67.8 m -72.3 135.94 46.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.519 ' NE2' ' O ' ' A' ' 49' ' ' ASN . 5.3 m-70 -115.34 -177.23 3.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.295 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.844 HG12 HD13 ' A' ' 39' ' ' LEU . 23.6 mt -87.09 124.25 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.904 . . . . 0.0 109.473 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 44.7 ttt-85 -80.44 -40.59 26.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.41 -0.806 . . . . 0.0 109.341 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -159.04 151.23 21.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.481 -0.762 . . . . 0.0 109.204 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.6 p -71.21 146.56 48.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.132 -0.98 . . . . 0.0 109.382 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.19 166.69 42.61 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.544 ' HA ' HG21 ' A' ' 32' ' ' THR . 62.4 tttt -65.25 146.32 55.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -1.101 . . . . 0.0 109.252 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.1 150.71 30.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.34 -0.85 . . . . 0.0 109.699 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.45 -179.952 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.316 0.579 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.6 ' OG ' HD22 ' A' ' 39' ' ' LEU . 3.9 m -51.34 -26.42 7.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 0.0 109.627 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.467 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 4.0 mt-10 -53.69 -20.9 6.0 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.291 -0.881 . . . . 0.0 109.051 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.6 mtt -78.46 -28.6 46.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.312 -0.867 . . . . 0.0 109.028 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 m -79.64 -17.03 54.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.204 -0.935 . . . . 0.0 109.133 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 60.9 mttt -47.74 -23.73 0.78 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.305 -0.872 . . . . 0.0 109.254 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -116.66 41.85 2.59 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.481 ' OH ' ' HB3' ' A' ' 17' ' ' LEU . 4.8 t80 -92.63 160.93 14.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 121.604 0.716 . . . . 0.0 110.748 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.432 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 10.1 ttp180 -146.39 135.47 22.6 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.968 HG13 ' C ' ' A' ' 15' ' ' GLY . 55.2 t -126.87 117.6 48.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.968 . . . . 0.0 109.669 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.557 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -100.24 175.71 2.26 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 109.506 -179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.4 Cg_endo -67.45 -24.01 43.16 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.741 2.294 . . . . 0.0 112.118 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -108.66 -21.63 12.61 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 0.0 109.383 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.0 mt -89.1 -45.53 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.868 . . . . 0.0 109.603 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.968 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 65.98 -148.3 50.86 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.519 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 1.2 t80 -99.48 154.55 18.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -1.213 . . . . 0.0 109.372 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.481 ' HB3' ' OH ' ' A' ' 8' ' ' TYR . 18.3 tp -125.76 125.8 43.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -0.943 . . . . 0.0 109.717 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 86.0 m -138.44 156.88 73.19 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.324 -0.86 . . . . 0.0 109.244 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -69.96 166.01 29.29 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.629 2.219 . . . . 0.0 111.666 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -85.0 -20.43 30.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.306 -0.872 . . . . 0.0 109.436 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -65.08 123.07 18.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.335 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.755 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -87.74 121.78 30.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.526 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.548 ' N ' HD13 ' A' ' 22' ' ' LEU . 22.1 mtpt -141.08 114.88 7.04 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 0.0 109.616 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 45.7 Cg_endo -67.31 120.68 7.74 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.839 2.36 . . . . 0.0 111.627 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.47 ' HB ' HG23 ' A' ' 52' ' ' ILE . 34.1 m -119.44 153.81 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.303 -0.873 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.0 t -97.91 144.83 27.06 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.61 139.92 14.69 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -67.48 -7.37 25.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -1.158 . . . . 0.0 109.578 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 27.5 m-20 -91.04 8.58 34.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.16 -0.963 . . . . 0.0 109.51 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.07 29.43 28.34 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -133.12 165.81 23.9 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.237 -1.155 . . . . 0.0 109.45 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.488 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 32.4 m -125.25 147.57 49.03 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.427 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.847 ' CD2' HD12 ' A' ' 39' ' ' LEU . 76.5 m-85 -127.28 119.49 26.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.221 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.555 ' CG ' HD21 ' A' ' 22' ' ' LEU . 50.4 t30 -41.74 -77.35 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.448 -0.782 . . . . 0.0 109.673 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -81.28 148.73 64.04 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 120.985 -1.072 . . . . 0.0 108.863 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.467 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 39.3 Cg_endo -62.62 -51.91 2.83 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.506 2.137 . . . . 0.0 112.101 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.52 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.0 t -63.52 -25.7 68.37 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.949 -1.094 . . . . 0.0 108.47 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 15.8 mtt -64.72 -18.4 64.98 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.292 -0.88 . . . . 0.0 108.848 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.847 HD12 ' CD2' ' A' ' 33' ' ' TYR . 4.7 tt -70.13 -53.9 15.31 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.375 -0.828 . . . . 0.0 108.87 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.615 ' N ' HD23 ' A' ' 39' ' ' LEU . 63.8 m -50.9 -24.31 3.5 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -60.04 -49.84 76.06 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.322 -0.861 . . . . 0.0 108.685 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.594 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 12.2 tp10 -55.93 -19.74 13.35 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 50' ' ' THR . 4.0 m-80 -80.07 -32.52 39.32 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.583 HD22 HG21 ' A' ' 10' ' ' VAL . 34.3 tp -66.45 -42.19 87.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.368 -0.833 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.97 -45.24 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.306 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.447 ' HB3' HG23 ' A' ' 48' ' ' THR . 46.9 mtp85 -77.33 -17.3 58.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.178 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.516 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 57.68 28.8 16.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.338 -0.851 . . . . 0.0 109.667 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 46' ' ' ARG . 8.4 p -110.2 -173.11 2.17 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.308 -0.87 . . . . 0.0 109.235 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -112.03 51.81 0.79 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.25 -0.906 . . . . 0.0 109.63 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.525 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 51.6 m -71.68 122.28 20.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.547 ' HA ' ' CB ' ' A' ' 2' ' ' SER . 26.8 m-70 -109.3 -175.69 2.83 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.324 -0.86 . . . . 0.0 108.999 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.518 HG12 HD13 ' A' ' 39' ' ' LEU . 21.2 mt -80.08 125.82 39.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.295 -0.878 . . . . 0.0 109.398 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 26.9 ttt85 -79.87 -45.68 18.21 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.331 -0.856 . . . . 0.0 109.584 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.7 p -160.42 131.69 5.74 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.57 -0.706 . . . . 0.0 109.465 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.479 ' H ' HG23 ' A' ' 55' ' ' THR . 7.3 p -48.25 142.83 5.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.208 -0.932 . . . . 0.0 109.439 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 93.65 166.71 37.71 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.488 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 68.2 mttt -67.36 148.69 51.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.451 -1.029 . . . . 0.0 109.437 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.5 m -57.03 146.39 27.41 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.897 . . . . 0.0 109.449 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.491 -179.987 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.362 0.601 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.567 ' OG ' HD23 ' A' ' 39' ' ' LEU . 24.2 m -70.98 -3.67 20.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.412 -0.805 . . . . 0.0 109.701 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 7.8 mt-10 -46.23 -25.5 0.62 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.127 -0.983 . . . . 0.0 108.51 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.404 ' N ' ' C ' ' A' ' 2' ' ' SER . 67.3 mtm -77.02 -35.27 57.12 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.517 ' N ' ' O ' ' A' ' 2' ' ' SER . 2.3 m -79.83 -0.52 34.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.466 -0.772 . . . . 0.0 109.046 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 12.8 mttm -60.61 -28.86 68.84 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 109.377 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -149.14 67.09 1.03 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.298 -0.877 . . . . 0.0 109.681 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 11.4 p90 -118.27 -170.71 1.94 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -0.909 . . . . 0.0 109.414 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 19.8 mtm180 -153.91 145.58 23.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -0.893 . . . . 0.0 109.628 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.538 HG13 ' O ' ' A' ' 15' ' ' GLY . 42.5 t -139.73 135.53 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.213 -0.929 . . . . 0.0 109.409 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.753 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -115.03 174.79 2.16 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.668 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.753 ' HD2' HD23 ' A' ' 11' ' ' LEU . 46.7 Cg_endo -68.1 -22.76 40.7 Favored 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.787 2.325 . . . . 0.0 111.678 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -97.35 -29.45 13.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.239 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 mm -88.11 -44.53 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.652 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.538 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 65.86 -164.2 39.64 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.61 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.7 OUTLIER -100.59 151.37 21.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.131 -1.217 . . . . 0.0 109.569 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.5 tp -116.38 110.47 18.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.337 -0.852 . . . . 0.0 109.828 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 63.4 m -126.62 156.35 73.43 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.322 -0.861 . . . . 0.0 109.245 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 51.5 Cg_endo -72.13 171.39 16.88 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.645 2.23 . . . . 0.0 111.619 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.2 tttm -88.6 -29.86 19.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.473 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -57.14 133.57 55.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.301 -0.874 . . . . 0.0 109.385 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.487 HD11 ' HB3' ' A' ' 34' ' ' ASN . 47.7 tp -92.88 115.42 28.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -125.07 104.4 29.57 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 109.475 -179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.4 118.65 5.65 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 C-N-CA 122.911 2.407 . . . . 0.0 111.997 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 32' ' ' THR . 14.8 m -117.03 155.68 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 0.0 109.737 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.5 t -97.02 123.33 40.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.376 -0.827 . . . . 0.0 109.006 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -77.57 136.08 17.69 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.603 ' OD1' HG23 ' A' ' 50' ' ' THR . 54.4 p30 -67.39 -8.6 34.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -1.12 . . . . 0.0 109.562 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.4 p30 -87.05 11.96 12.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.18 -0.95 . . . . 0.0 109.365 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.09 17.76 62.3 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.495 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.0 mt-30 -123.51 176.92 5.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -1.098 . . . . 0.0 109.53 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.582 HG21 ' HG3' ' A' ' 57' ' ' LYS . 41.1 m -135.91 141.82 44.58 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.063 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.795 ' CD1' HD13 ' A' ' 39' ' ' LEU . 42.0 m-85 -121.13 128.2 52.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -0.922 . . . . 0.0 109.505 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.7 m-20 -48.66 -79.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.813 -179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.8 t-20 -81.67 147.13 58.29 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.006 -1.059 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.51 -52.49 1.89 Allowed 'Trans proline' 0 C--O 1.216 -0.6 0 C-N-CA 122.877 2.385 . . . . 0.0 111.936 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.8 t -64.16 -25.08 67.92 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.941 -1.099 . . . . 0.0 108.208 179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.455 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 44.3 mmm -68.93 -14.72 63.21 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.795 HD13 ' CD1' ' A' ' 33' ' ' TYR . 20.6 tp -65.69 -51.0 62.86 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.486 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.0 m -68.72 -18.16 64.19 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.444 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 25.7 t60 -69.88 -55.29 10.12 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.517 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 88.7 tt0 -64.26 -18.64 64.75 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 47' ' ' GLN . 73.8 m-20 -79.74 -36.11 37.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.8 tp -56.9 -32.94 66.43 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mt -80.35 -46.14 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.6 ' HG2' HG23 ' A' ' 48' ' ' THR . 69.7 ttt180 -70.53 -21.6 62.71 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.118 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . 81.4 mt-30 63.54 43.36 5.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.506 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.6 HG23 ' HG2' ' A' ' 46' ' ' ARG . 75.4 p -126.72 167.68 15.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.366 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -103.16 56.52 0.75 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 0.0 109.487 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.603 HG23 ' OD1' ' A' ' 28' ' ' ASP . 85.6 m -77.63 138.77 39.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.928 . . . . 0.0 109.321 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -118.91 176.46 5.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.26 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.471 HG12 HD22 ' A' ' 39' ' ' LEU . 34.4 mt -80.12 124.72 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 29.2 tpt180 -81.28 -53.27 6.49 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.599 -0.688 . . . . 0.0 109.427 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 p -146.05 146.1 30.82 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.595 -0.69 . . . . 0.0 109.447 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.8 p -66.4 147.85 52.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.216 -0.927 . . . . 0.0 109.396 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.71 162.61 37.53 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.582 ' HG3' HG21 ' A' ' 32' ' ' THR . 41.0 tttt -63.92 148.85 48.52 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.474 -1.015 . . . . 0.0 109.341 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.3 148.68 30.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.277 -0.889 . . . . 0.0 109.491 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.451 -179.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.33 0.585 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.583 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 3.5 m -56.25 -30.44 62.42 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.312 -0.867 . . . . 0.0 109.444 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -56.32 -24.43 43.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.31 -0.869 . . . . 0.0 109.23 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 65.1 mmm -74.7 -24.22 58.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -0.793 . . . . 0.0 109.062 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.496 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 13.4 m -84.21 -27.97 27.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.442 -0.786 . . . . 0.0 109.3 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.3 mttt -75.63 -2.48 29.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.327 -0.858 . . . . 0.0 109.632 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 4' ' ' MET . 15.7 p30 -122.94 1.1 9.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.849 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.576 ' OH ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -119.13 154.56 33.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.091 -1.006 . . . . 0.0 109.321 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -133.43 127.46 33.41 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.259 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.554 HG21 ' C ' ' A' ' 15' ' ' GLY . 4.6 p -124.08 142.73 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.314 -0.866 . . . . 0.0 109.588 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.518 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.8 mp -105.62 174.06 2.87 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.158 -0.964 . . . . 0.0 109.211 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.4 Cg_endo -67.79 -28.86 36.19 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.606 2.204 . . . . 0.0 111.88 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -87.4 -28.33 22.22 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.874 . . . . 0.0 109.365 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.2 mt -84.0 -39.39 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.289 -0.882 . . . . 0.0 109.401 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.554 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 67.41 155.77 0.55 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CE2' ' OH ' ' A' ' 8' ' ' TYR . 1.3 t80 -52.63 148.39 7.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.281 -1.129 . . . . 0.0 109.604 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.3 tp -115.82 112.49 22.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.457 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 60.5 m -123.7 155.82 65.81 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.302 -0.874 . . . . 0.0 109.303 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.75 165.18 33.33 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.648 2.232 . . . . 0.0 111.794 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -87.31 -10.41 52.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.297 -0.877 . . . . 0.0 109.478 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.66 133.73 44.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 0.0 109.348 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.731 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.1 tm? -89.73 118.94 29.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.435 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.644 ' N ' HD13 ' A' ' 22' ' ' LEU . 5.9 mttp -134.38 100.67 12.53 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.319 -0.863 . . . . 0.0 109.103 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.0 Cg_endo -63.33 123.11 11.57 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 123.121 2.547 . . . . 0.0 112.411 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 33' ' ' TYR . 32.4 m -120.62 154.79 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.446 -0.784 . . . . 0.0 109.641 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.5 t -98.35 137.5 36.98 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.02 138.16 13.91 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.1 p30 -64.96 -11.31 37.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.366 -1.079 . . . . 0.0 109.535 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.5 p30 -87.43 11.5 14.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.205 -0.934 . . . . 0.0 109.443 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.28 21.19 61.03 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.422 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 89.4 mt-30 -122.16 170.37 9.95 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.262 -1.14 . . . . 0.0 109.509 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.454 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 86.9 m -129.31 135.49 48.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.21 -0.931 . . . . 0.0 109.305 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.766 ' CD1' HD13 ' A' ' 39' ' ' LEU . 64.2 m-85 -115.12 121.22 42.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.286 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.563 ' HB2' HD21 ' A' ' 22' ' ' LEU . 0.6 OUTLIER -44.61 -82.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.365 -0.835 . . . . 0.0 109.802 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.9 t-20 -80.07 147.13 64.76 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.157 -0.964 . . . . 0.0 109.565 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.6 Cg_endo -62.7 -52.1 2.63 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.659 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.557 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 10.7 t -62.69 -26.71 68.8 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.485 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 40.2 mmm -65.32 -16.51 63.65 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.766 HD13 ' CD1' ' A' ' 33' ' ' TYR . 25.6 tp -67.11 -55.57 13.69 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.547 ' HB3' ' CZ ' ' A' ' 16' ' ' TYR . 16.1 t -57.72 -23.16 50.39 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -72.92 -59.84 2.51 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.476 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 81.7 mt-10 -58.42 -18.5 28.81 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.448 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.5 m-20 -76.72 -39.09 53.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.496 -0.752 . . . . 0.0 108.98 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.936 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.3 tm? -55.67 -37.09 67.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.281 -0.887 . . . . 0.0 108.844 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.4 mt -75.36 -46.17 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 0.0 108.939 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.492 ' HG2' HG23 ' A' ' 48' ' ' THR . 43.9 ttt85 -68.26 -27.84 66.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.378 -0.826 . . . . 0.0 109.191 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 90.2 mt-30 63.25 42.27 7.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 109.668 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.492 HG23 ' HG2' ' A' ' 46' ' ' ARG . 72.5 p -131.25 175.76 8.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.227 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.575 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 78.9 m-20 -101.57 64.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.215 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 65.8 m -76.66 132.21 39.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 109.953 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.583 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 42.9 m80 -116.03 171.28 7.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.31 -0.869 . . . . 0.0 108.681 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.431 HG12 HD22 ' A' ' 39' ' ' LEU . 11.4 mt -79.71 123.91 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.073 -1.017 . . . . 0.0 109.186 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 54.7 ttt85 -79.71 -42.09 25.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.292 -0.88 . . . . 0.0 109.317 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.0 t -160.3 155.07 24.18 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.6 p -70.84 143.89 50.93 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.094 -1.004 . . . . 0.0 109.171 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.69 168.29 40.94 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.486 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 31.6 mttm -66.47 151.69 46.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.33 -1.1 . . . . 0.0 109.428 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.414 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 71.8 m -60.89 152.58 27.08 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.346 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.499 -179.947 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.479 ' OD1' HD12 ' A' ' 52' ' ' ILE . 91.3 m-20 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.6 m -59.33 -23.76 62.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.306 -0.871 . . . . 0.0 109.395 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.4 tt0 -52.65 -24.38 8.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.087 -1.008 . . . . 0.0 109.028 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 mtt -79.94 -25.74 40.36 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.413 -0.804 . . . . 0.0 109.109 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.5 m -86.98 -8.66 56.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.391 -0.818 . . . . 0.0 109.517 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 43.6 mttm -60.02 -23.43 63.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 109.783 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -150.69 63.51 0.93 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 0.0 110.062 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.918 ' OH ' HD23 ' A' ' 44' ' ' LEU . 4.2 p90 -129.16 167.12 18.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.107 -0.996 . . . . 0.0 109.203 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -143.97 145.07 31.99 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.17 -0.956 . . . . 0.0 109.616 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.862 HG13 ' C ' ' A' ' 15' ' ' GLY . 92.0 t -137.61 131.87 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.175 -0.953 . . . . 0.0 109.659 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.544 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -122.49 175.1 2.81 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.26 -0.9 . . . . 0.0 109.36 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.0 Cg_endo -67.67 -26.28 39.49 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.648 2.232 . . . . 0.0 111.772 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -100.3 -27.52 13.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.293 -0.879 . . . . 0.0 109.203 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 27.8 mm -91.02 -43.2 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.315 -0.866 . . . . 0.0 109.42 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.862 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 68.33 -146.41 45.8 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.489 ' CD2' HG21 ' A' ' 10' ' ' VAL . 2.2 t80 -104.58 157.43 17.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -1.134 . . . . 0.0 109.482 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.1 tp -115.58 115.02 25.73 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.28 -0.888 . . . . 0.0 109.865 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 57.7 m -135.86 155.77 77.69 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.296 -0.878 . . . . 0.0 109.231 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.55 167.62 25.91 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.549 2.166 . . . . 0.0 111.587 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 34.7 mttm -84.68 -18.71 34.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -0.909 . . . . 0.0 109.522 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -70.4 123.34 21.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.29 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.685 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -86.46 109.76 19.29 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.166 -0.959 . . . . 0.0 109.492 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -116.05 103.61 53.14 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.235 -0.915 . . . . 0.0 109.399 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.2 Cg_endo -63.68 117.2 4.19 Favored 'Trans proline' 0 C--O 1.213 -0.764 0 C-N-CA 123.082 2.521 . . . . 0.0 112.414 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.459 ' HB ' HG23 ' A' ' 52' ' ' ILE . 11.0 m -115.29 157.18 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.403 -0.811 . . . . 0.0 109.83 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.405 ' O ' ' N ' ' A' ' 53' ' ' ARG . 46.0 t -98.65 141.57 31.31 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.72 141.32 15.48 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.5 t0 -69.84 -9.4 54.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.249 -1.147 . . . . 0.0 109.414 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -90.31 0.59 57.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.233 -0.917 . . . . 0.0 109.404 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.79 21.76 22.77 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.452 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.2 mt-30 -121.5 172.66 7.92 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.266 -1.138 . . . . 0.0 109.48 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' ' 57' ' ' LYS . 99.4 m -133.48 140.09 47.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.884 ' CD1' HD13 ' A' ' 39' ' ' LEU . 40.8 m-85 -121.78 129.01 52.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.916 . . . . 0.0 109.012 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.58 ' CB ' HD21 ' A' ' 22' ' ' LEU . 1.8 m-20 -52.77 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.026 -1.046 . . . . 0.0 109.67 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 15.3 t-20 -81.85 145.73 54.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.019 -1.05 . . . . 0.0 109.587 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.523 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.29 -51.15 2.87 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.643 2.228 . . . . 0.0 111.346 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.503 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.5 t -61.64 -27.99 69.06 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.444 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 36.3 mmm -67.05 -13.93 62.41 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.884 HD13 ' CD1' ' A' ' 33' ' ' TYR . 29.8 tp -68.44 -53.69 21.92 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.466 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 14.0 t -58.98 -23.29 61.65 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -69.21 -57.93 4.71 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -61.97 -19.35 62.7 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.491 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 99.2 m-20 -77.15 -32.09 56.03 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.933 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -61.49 -38.09 86.04 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 108.875 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.6 mt -75.89 -48.51 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.299 -0.876 . . . . 0.0 109.222 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 13.9 mtt-85 -68.7 -36.86 79.02 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.283 -0.885 . . . . 0.0 109.354 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 59.81 38.04 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.307 -0.871 . . . . 0.0 109.425 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 49' ' ' ASN . 43.9 p -112.87 16.66 19.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.276 -0.89 . . . . 0.0 109.391 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.572 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 57.7 m-20 44.94 58.88 3.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.331 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.491 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 36.0 m -77.21 144.83 38.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -0.901 . . . . 0.0 109.683 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 27.6 m80 -118.93 169.45 9.87 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.311 -0.868 . . . . 0.0 108.717 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.479 HD12 ' OD1' ' A' ' 1' ' ' ASP . 41.7 mt -79.14 126.55 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.109 -0.995 . . . . 0.0 109.357 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 42.1 ttt85 -79.71 -46.85 16.32 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.412 -0.805 . . . . 0.0 109.251 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.7 m -160.29 151.92 19.8 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.3 p -65.29 142.75 58.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.099 -1.001 . . . . 0.0 109.591 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.31 165.02 36.27 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.515 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 65.0 mttt -67.94 148.84 50.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.404 -1.056 . . . . 0.0 109.408 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.452 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 58.4 m -60.04 153.44 21.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 0.0 109.431 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.477 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 21.3 p-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.312 0.577 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 5' ' ' CYS . 3.1 m -46.75 -30.63 2.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.355 -0.84 . . . . 0.0 109.382 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 13.2 mt-10 -52.0 -27.48 13.61 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 108.697 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 86.9 mtp -76.74 -28.61 55.84 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 4.0 m -79.75 -6.88 58.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.507 -0.745 . . . . 0.0 109.069 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 15.6 mttm -56.39 -32.29 64.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 77.2 m-20 -146.36 67.18 1.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.168 -0.958 . . . . 0.0 109.866 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 1.061 ' OH ' HD21 ' A' ' 44' ' ' LEU . 4.4 p90 -126.41 169.78 12.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.949 . . . . 0.0 109.068 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.9 mtm180 -140.95 149.4 41.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.124 -0.985 . . . . 0.0 109.846 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.749 HG13 ' O ' ' A' ' 15' ' ' GLY . 77.8 t -145.06 131.39 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.368 -0.832 . . . . 0.0 109.359 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mp -122.34 175.09 2.79 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.171 -0.955 . . . . 0.0 109.551 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.2 Cg_endo -67.9 -22.89 41.76 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.69 2.26 . . . . 0.0 111.77 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -107.07 -31.32 8.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.308 -0.87 . . . . 0.0 109.147 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 14' ' ' ILE . 48.9 mm -83.3 -39.95 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.518 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.749 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 69.83 -145.52 41.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.6 t80 -107.26 156.1 19.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.287 -1.125 . . . . 0.0 109.458 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 tp -117.29 121.15 40.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.856 . . . . 0.0 109.476 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 81.9 m -132.25 157.06 79.26 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.278 -0.889 . . . . 0.0 109.36 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.3 Cg_endo -71.17 165.7 31.59 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.681 2.254 . . . . 0.0 111.578 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.4 mttt -88.68 -13.52 39.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.884 . . . . 0.0 109.327 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -68.67 130.66 43.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.228 -0.92 . . . . 0.0 109.103 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.764 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -89.2 122.5 32.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.305 -0.872 . . . . 0.0 109.607 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.673 ' N ' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -141.69 105.59 5.86 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.337 -0.852 . . . . 0.0 109.279 179.66 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 42.6 Cg_endo -66.05 121.38 8.7 Favored 'Trans proline' 0 C--O 1.213 -0.762 0 C-N-CA 122.951 2.434 . . . . 0.0 111.902 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.481 ' O ' HG23 ' A' ' 32' ' ' THR . 18.7 m -117.14 154.96 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 109.949 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 16.7 t -97.61 130.45 44.63 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.77 139.53 15.42 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.2 p30 -66.33 -9.84 37.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.299 -1.118 . . . . 0.0 109.606 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 57.2 p30 -85.39 12.9 7.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.333 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.35 21.53 64.54 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.446 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 87.2 mt-30 -127.25 168.97 14.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -1.151 . . . . 0.0 109.374 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 25' ' ' VAL . 24.6 m -127.37 139.81 52.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.269 -0.895 . . . . 0.0 109.513 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.872 ' CD2' HD12 ' A' ' 39' ' ' LEU . 42.9 m-85 -116.8 128.4 55.25 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.34 -0.85 . . . . 0.0 109.205 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.764 ' OD1' HD21 ' A' ' 22' ' ' LEU . 47.7 t-20 -50.96 -78.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.295 -0.878 . . . . 0.0 110.108 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -80.9 148.46 64.73 Favored Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 120.825 -1.172 . . . . 0.0 109.48 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HG3' ' HD2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.36 -53.7 1.34 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.645 2.23 . . . . 0.0 111.76 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -61.3 -28.45 69.21 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.987 -1.07 . . . . 0.0 108.144 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 17.0 mtp -63.14 -19.23 64.27 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.872 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.4 tt -67.11 -50.76 60.39 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.308 -0.87 . . . . 0.0 108.791 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 6.0 t -52.61 -47.33 67.04 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.531 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 9.5 t60 -48.51 -49.07 37.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.966 -1.084 . . . . 0.0 108.201 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.572 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 23.6 mm-40 -57.36 -19.41 22.67 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.1 m-80 -78.87 -32.96 46.15 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.061 HD21 ' OH ' ' A' ' 8' ' ' TYR . 82.9 mt -70.71 -37.19 73.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.414 -0.804 . . . . 0.0 109.549 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mt -77.22 -49.6 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.239 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.518 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 14.9 mtt-85 -76.96 -30.99 56.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.322 -0.861 . . . . 0.0 109.374 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 57.87 32.91 22.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.439 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.0 p -108.28 7.64 27.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.531 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 38.8 t-20 57.14 55.02 6.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 109.411 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.616 HG21 ' OH ' ' A' ' 33' ' ' TYR . 87.2 m -78.52 136.46 37.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.89 . . . . 0.0 109.545 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.531 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 3.8 m80 -114.93 -175.92 2.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.25 -0.906 . . . . 0.0 109.215 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.713 HG12 HD13 ' A' ' 39' ' ' LEU . 29.9 mt -89.59 123.42 41.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.238 -0.914 . . . . 0.0 109.62 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 38.4 ttt-85 -81.39 -46.94 13.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.52 -0.738 . . . . 0.0 109.326 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.0 p -153.2 151.27 29.91 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.657 -0.652 . . . . 0.0 109.474 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -70.91 144.38 50.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.158 -0.964 . . . . 0.0 109.218 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.539 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.59 165.24 40.76 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.575 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 30.3 mttm -65.86 144.03 57.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.443 -1.033 . . . . 0.0 109.464 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' GLU . 0.0 OUTLIER -77.22 153.2 34.28 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.245 -0.909 . . . . 0.0 109.326 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' CYS . 95.8 mt-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.016 -0.993 . . . . 0.0 109.391 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 16.6 p-10 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 6' ' ' LYS . 1.2 m -44.75 -30.28 0.93 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.179 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.467 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 5.2 mm-40 -52.54 -25.86 11.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.414 -0.804 . . . . 0.0 108.951 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.407 ' HE2' ' HB2' ' A' ' 4' ' ' MET . 60.9 mtm -70.6 -37.65 73.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.543 -0.723 . . . . 0.0 109.202 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.485 ' CA ' ' HB2' ' A' ' 8' ' ' TYR . 18.5 p -104.44 -3.28 24.22 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.236 -0.915 . . . . 0.0 109.537 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' N ' ' O ' ' A' ' 2' ' ' SER . 5.2 mttm -49.23 -24.33 1.72 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.205 -0.934 . . . . 0.0 108.749 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -119.13 28.46 8.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.547 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 3.6 t80 -80.29 157.98 26.27 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.608 0.718 . . . . 0.0 110.617 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.432 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 6.2 ttt85 -142.7 133.45 25.37 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.906 HG21 ' CD2' ' A' ' 16' ' ' TYR . 81.9 t -133.37 136.77 54.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.367 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.514 HD12 ' O ' ' A' ' 10' ' ' VAL . 2.9 mp -119.66 173.16 3.78 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.538 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.8 Cg_endo -68.51 -25.73 34.84 Favored 'Trans proline' 0 C--O 1.213 -0.74 0 C-N-CA 122.653 2.235 . . . . 0.0 111.763 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.47 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 15.2 ttt180 -104.12 -20.71 13.73 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.375 -0.828 . . . . 0.0 109.285 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 77.1 mt -93.13 -46.39 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.22 -0.925 . . . . 0.0 109.574 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.891 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.64 -170.72 52.46 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.906 ' CD2' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -87.27 151.44 23.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.174 . . . . 0.0 109.463 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.866 ' N ' HD12 ' A' ' 17' ' ' LEU . 1.8 mp -122.47 132.9 54.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.7 m -139.18 157.32 71.3 Favored Pre-proline 0 C--N 1.301 -1.536 0 O-C-N 121.139 -0.976 . . . . 0.0 109.317 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.2 Cg_endo -70.18 168.78 21.12 Favored 'Trans proline' 0 C--O 1.216 -0.581 0 C-N-CA 122.572 2.181 . . . . 0.0 111.668 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -90.0 -12.67 37.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.482 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -73.94 119.8 18.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.159 -0.963 . . . . 0.0 109.214 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.414 HD11 ' HB3' ' A' ' 34' ' ' ASN . 37.2 tp -81.75 112.19 18.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.774 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' CD ' ' HG3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -122.08 105.77 36.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.253 -0.905 . . . . 0.0 108.741 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 45.2 Cg_endo -66.64 118.32 5.45 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.954 2.436 . . . . 0.0 112.088 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.451 ' HB ' HG23 ' A' ' 52' ' ' ILE . 18.8 m -115.59 154.94 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.27 -0.894 . . . . 0.0 110.042 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.4 t -97.3 140.27 32.02 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.53 138.13 13.75 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.934 -1.267 . . . . 0.0 109.934 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.5 p30 -65.49 -12.93 57.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -1.119 . . . . 0.0 109.436 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 84.2 m-20 -86.98 12.37 11.4 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.216 -0.927 . . . . 0.0 109.374 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.06 32.14 36.77 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 79.6 mt-30 -131.16 173.82 10.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.391 -1.064 . . . . 0.0 109.293 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 87.5 m -135.12 133.55 39.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.149 -0.969 . . . . 0.0 109.488 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.94 ' CD2' HD13 ' A' ' 39' ' ' LEU . 65.6 m-85 -112.61 122.93 49.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 108.956 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.7 m-20 -48.18 -79.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 110.093 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.7 t-20 -81.98 148.04 59.58 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.018 -1.051 . . . . 0.0 109.895 -179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.539 ' HG3' ' CD ' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.6 -53.33 1.41 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.718 2.279 . . . . 0.0 111.768 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.7 t -61.42 -25.78 67.43 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 29.7 mtp -70.49 -5.87 31.94 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.486 -0.759 . . . . 0.0 109.177 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.94 HD13 ' CD2' ' A' ' 33' ' ' TYR . 24.4 tp -74.11 -61.36 1.88 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.18 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -54.52 -28.38 44.8 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 108.567 179.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 29.4 t60 -60.35 -56.88 16.09 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.6 tp10 -64.06 -19.43 65.22 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.486 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 89.6 m-20 -79.44 -31.01 42.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.506 -0.746 . . . . 0.0 109.037 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.933 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.2 tm? -63.46 -37.81 88.73 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.385 -0.822 . . . . 0.0 108.844 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mm -77.09 -48.64 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.114 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 26.4 mtt-85 -68.14 -38.46 82.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.436 -0.79 . . . . 0.0 109.192 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 86.3 mt-30 62.2 38.74 13.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.478 -0.764 . . . . 0.0 109.449 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.4 p -113.37 15.38 19.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.325 -0.859 . . . . 0.0 109.384 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 46.29 60.41 3.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.472 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.486 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 76.8 m -79.96 143.01 34.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.45 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -118.97 170.61 8.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 0.0 108.855 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.451 HG12 HD22 ' A' ' 39' ' ' LEU . 30.9 mt -79.99 126.86 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.07 -1.019 . . . . 0.0 109.271 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 18.0 ttt-85 -81.82 -41.5 21.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.309 -0.87 . . . . 0.0 109.398 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 t -160.53 151.78 19.2 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 p -67.61 142.56 56.41 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.074 -1.016 . . . . 0.0 109.443 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.55 166.17 38.9 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.513 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 41.2 mttm -65.45 149.04 50.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.47 -1.018 . . . . 0.0 109.467 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 59.0 m -59.3 153.84 17.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 109.436 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.444 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.304 0.573 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.415 ' HA ' ' SG ' ' A' ' 40' ' ' CYS . 1.0 OUTLIER -52.98 -32.99 49.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.192 -0.943 . . . . 0.0 109.386 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -54.21 -23.27 13.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 108.963 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.41 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 76.8 mtp -74.29 -16.55 60.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.837 . . . . 0.0 108.818 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 82.2 m -91.91 -18.4 23.81 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.419 -0.8 . . . . 0.0 109.165 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.2 mttm -78.41 -0.02 27.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.91 . . . . 0.0 109.478 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.412 ' C ' ' OD1' ' A' ' 7' ' ' ASP . 34.6 p30 -106.78 -9.44 16.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.786 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.547 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 1.1 p90 -107.61 170.49 7.95 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.166 -0.959 . . . . 0.0 109.47 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -133.37 161.02 35.66 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.202 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.721 HG21 ' C ' ' A' ' 15' ' ' GLY . 13.4 p -140.43 166.01 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.94 . . . . 0.0 109.81 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.75 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -121.75 174.49 3.16 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.347 -0.846 . . . . 0.0 109.312 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.75 ' HD2' HD23 ' A' ' 11' ' ' LEU . 48.2 Cg_endo -68.19 -23.62 39.08 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.726 2.284 . . . . 0.0 111.806 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.8 tpt85 -89.0 -19.41 25.71 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -0.898 . . . . 0.0 109.222 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 59.2 mt -99.02 -34.6 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.379 -0.826 . . . . 0.0 109.292 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.721 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 73.66 -68.65 1.53 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.547 ' CE1' ' OH ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -155.38 159.11 39.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -1.153 . . . . 0.0 109.489 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.9 tp -127.74 114.42 17.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.281 -0.887 . . . . 0.0 109.742 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.5 m -131.56 157.63 77.63 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.338 -0.851 . . . . 0.0 108.977 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.1 Cg_endo -70.45 167.01 26.56 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.591 2.194 . . . . 0.0 111.586 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -88.38 -16.68 32.29 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.417 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -71.54 129.2 38.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.303 -0.873 . . . . 0.0 109.269 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 ' N ' ' A' ' 23' ' ' LYS . 0.4 OUTLIER -91.26 114.75 27.36 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 34' ' ' ASN . 2.5 mtmt -126.79 107.2 22.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 109.19 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.53 116.67 4.05 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 C-N-CA 122.807 2.338 . . . . 0.0 111.796 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 32' ' ' THR . 20.2 m -114.84 155.41 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.235 -0.916 . . . . 0.0 109.741 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 40.5 t -97.74 123.4 41.66 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.369 -0.832 . . . . 0.0 109.046 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -77.15 137.93 21.21 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.498 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.6 p-10 -67.88 -7.52 28.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -1.098 . . . . 0.0 109.425 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -88.71 7.69 32.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.916 . . . . 0.0 109.485 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.45 12.91 62.27 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.521 ' O ' ' N ' ' A' ' 27' ' ' GLY . 78.0 mt-30 -118.32 166.44 12.63 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.224 -1.163 . . . . 0.0 109.323 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.607 HG21 ' HG3' ' A' ' 57' ' ' LYS . 36.9 m -127.3 137.27 52.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.302 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.776 ' CD1' HD13 ' A' ' 39' ' ' LEU . 34.1 m-85 -114.29 130.47 56.65 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.234 -0.916 . . . . 0.0 109.361 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.4 m-20 -53.57 -76.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.33 -0.857 . . . . 0.0 109.65 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.0 t-20 -81.84 148.66 61.74 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.074 -1.016 . . . . 0.0 109.466 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.458 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.0 Cg_endo -63.65 -53.25 1.42 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.726 2.284 . . . . 0.0 111.9 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.7 t -63.58 -28.69 70.1 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.047 -1.033 . . . . 0.0 108.394 179.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 26.0 mmm -59.87 -23.57 63.53 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.776 HD13 ' CD1' ' A' ' 33' ' ' TYR . 27.9 tp -61.9 -43.83 98.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.607 -0.683 . . . . 0.0 109.288 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.511 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.2 m -71.32 -20.07 62.24 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.216 -0.928 . . . . 0.0 108.554 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.7 t60 -72.98 -53.42 11.23 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.426 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 70.0 mt-10 -64.53 -19.0 65.34 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.5 m-20 -74.69 -37.58 62.61 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.958 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.8 tm? -56.39 -36.16 68.57 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.343 -0.848 . . . . 0.0 108.735 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mt -74.43 -50.01 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.461 -0.774 . . . . 0.0 109.033 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.442 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 31.2 mtm-85 -68.59 -23.97 64.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.332 -0.855 . . . . 0.0 109.139 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' ASN . 85.6 mt-30 61.81 40.83 12.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.431 -0.793 . . . . 0.0 109.564 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.1 p -128.67 169.71 14.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.293 -0.879 . . . . 0.0 109.199 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -97.5 62.24 1.69 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.373 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.1 m -70.98 130.2 40.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.339 -0.85 . . . . 0.0 109.599 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -113.82 169.43 8.99 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 108.979 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.456 HG23 ' HB ' ' A' ' 25' ' ' VAL . 43.4 mt -79.81 127.06 39.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.085 -1.009 . . . . 0.0 109.339 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.498 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 47.7 ttt85 -84.71 -49.51 8.43 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.373 -0.829 . . . . 0.0 109.533 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.1 p -149.23 141.3 23.89 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.432 -0.792 . . . . 0.0 109.254 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.4 p -61.86 143.97 55.57 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.258 -0.901 . . . . 0.0 109.182 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.53 163.29 39.18 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.339 -1.505 . . . . 0.0 109.339 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.607 ' HG3' HG21 ' A' ' 32' ' ' THR . 53.4 tttt -50.88 152.54 2.09 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.541 -0.976 . . . . 0.0 109.601 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.426 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 31.5 m -55.65 142.12 35.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.297 -0.877 . . . . 0.0 109.634 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.026 -0.987 . . . . 0.0 109.397 179.862 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.308 0.575 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.598 ' OG ' HD23 ' A' ' 39' ' ' LEU . 4.0 m -45.58 -29.17 1.12 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.34 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -51.55 -28.08 12.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.199 -0.938 . . . . 0.0 108.75 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.4 mmm -79.04 -30.37 44.07 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.4 m -83.93 0.59 47.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.503 -0.748 . . . . 0.0 109.191 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.432 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 10.7 mttm -61.38 -30.32 70.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.118 -0.989 . . . . 0.0 109.344 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 76.2 m-20 -147.84 68.02 1.11 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.884 . . . . 0.0 109.67 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.566 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 12.6 p90 -119.78 -171.59 2.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.268 -0.895 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -153.76 139.65 18.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.104 -0.997 . . . . 0.0 109.746 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 15' ' ' GLY . 53.4 t -132.73 137.99 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.162 -0.961 . . . . 0.0 109.612 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.579 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -112.63 174.38 2.35 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.368 -0.832 . . . . 0.0 109.275 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.579 ' HD2' HD23 ' A' ' 11' ' ' LEU . 46.9 Cg_endo -67.85 -24.44 40.19 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.655 2.237 . . . . 0.0 111.816 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 68.5 mtt85 -96.77 -26.94 14.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.328 -0.858 . . . . 0.0 109.468 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 21.1 mm -85.91 -48.17 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.546 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.674 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.84 -163.2 54.42 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.817 ' CE2' HD11 ' A' ' 44' ' ' LEU . 1.0 OUTLIER -102.37 150.27 23.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.233 -1.157 . . . . 0.0 109.315 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.3 tp -116.74 106.83 13.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 109.805 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.8 m -120.67 155.89 56.55 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.275 -0.891 . . . . 0.0 109.128 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -72.04 166.61 29.11 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.545 2.163 . . . . 0.0 111.625 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -89.81 -13.94 35.52 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.259 -0.9 . . . . 0.0 109.662 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -72.31 123.88 23.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 0.0 109.278 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 34' ' ' ASN . 48.1 tp -80.29 121.17 25.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.619 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 3.2 mttp -133.71 101.45 12.95 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.324 -0.86 . . . . 0.0 109.242 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.573 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 41.0 Cg_endo -64.15 120.66 8.07 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.848 2.365 . . . . 0.0 112.122 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 32' ' ' THR . 7.9 m -119.81 157.36 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.35 -0.844 . . . . 0.0 109.941 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.8 t -99.49 114.76 27.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -0.824 . . . . 0.0 109.028 179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -69.94 137.76 28.83 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 58.4 p30 -68.4 -8.02 36.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.344 -1.092 . . . . 0.0 109.661 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 55.5 p30 -84.86 6.81 23.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 0.0 109.341 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.91 17.86 55.45 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.525 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -126.76 160.62 30.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.347 -1.09 . . . . 0.0 109.429 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.506 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 38.5 m -116.79 144.86 43.98 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.21 -0.931 . . . . 0.0 109.207 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.777 ' CD1' HD13 ' A' ' 39' ' ' LEU . 87.4 m-85 -124.51 129.37 50.5 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.292 -0.88 . . . . 0.0 109.331 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.2 m-20 -50.44 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.284 -0.885 . . . . 0.0 109.723 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.2 t-20 -82.16 146.41 54.84 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 0.0 109.788 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.0 Cg_endo -63.53 -52.36 1.95 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.772 2.315 . . . . 0.0 111.555 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.1 t -60.97 -30.87 70.51 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.477 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 23.0 mtt -61.6 -20.68 63.61 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.777 HD13 ' CD1' ' A' ' 33' ' ' TYR . 58.6 tp -62.06 -46.81 87.49 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.973 ' O ' HD12 ' A' ' 44' ' ' LEU . 3.3 m -70.94 -26.48 63.2 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.461 ' HA ' ' CD1' ' A' ' 44' ' ' LEU . 33.3 t60 -64.42 -55.04 23.64 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 73.8 mm-40 -65.1 -17.5 64.51 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.237 -0.914 . . . . 0.0 108.671 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 47' ' ' GLN . 92.1 m-20 -76.53 -30.91 57.32 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.469 -0.77 . . . . 0.0 109.278 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.973 HD12 ' O ' ' A' ' 40' ' ' CYS . 1.8 mp -59.76 -36.63 77.05 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.12 -0.987 . . . . 0.0 108.624 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 45' ' ' ILE . 7.0 mm -75.72 -48.67 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 15.7 mtp85 -67.28 -25.52 66.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.429 -0.794 . . . . 0.0 109.153 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.9 mt-30 63.71 41.26 7.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.54 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.5 p -130.63 164.07 25.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.256 -0.903 . . . . 0.0 109.214 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.562 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 65.6 m-20 -95.68 59.99 2.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.192 -0.942 . . . . 0.0 109.504 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.2 m -75.0 132.05 41.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.178 -0.951 . . . . 0.0 109.417 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.562 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 6.6 m80 -112.87 -172.32 2.03 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.138 -0.976 . . . . 0.0 109.333 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 54.7 mt -89.79 126.62 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.337 -0.852 . . . . 0.0 109.776 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 16.2 tpt180 -85.4 -53.98 4.87 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.557 -0.714 . . . . 0.0 109.365 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.4 p -144.76 152.61 40.62 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 p -72.96 144.45 47.26 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.095 -1.003 . . . . 0.0 109.385 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 91.92 166.19 39.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.573 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 55.1 mttp -68.07 141.5 56.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.36 -1.083 . . . . 0.0 109.306 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.23 149.8 37.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.16 -0.962 . . . . 0.0 109.482 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.541 -179.92 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.757 ' OG ' HD23 ' A' ' 39' ' ' LEU . 13.6 m -52.26 -26.72 12.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.349 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.463 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 16.2 mt-10 -51.56 -26.39 8.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.364 -0.835 . . . . 0.0 109.02 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.6 mtm -68.13 -28.79 67.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.477 -0.765 . . . . 0.0 109.307 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 9.7 m -79.81 -17.94 52.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.216 -0.928 . . . . 0.0 109.23 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.463 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 44.5 mttm -51.13 -22.93 2.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.21 -0.931 . . . . 0.0 108.994 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -118.13 36.87 4.18 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 5.2 t80 -85.09 159.48 20.17 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.559 0.695 . . . . 0.0 110.663 -178.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.443 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 7.7 ttm180 -140.71 136.6 32.76 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 1.036 HG13 ' O ' ' A' ' 15' ' ' GLY . 52.1 t -134.83 128.03 49.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.337 -0.852 . . . . 0.0 109.768 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.55 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -106.23 175.51 2.05 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.437 -0.79 . . . . 0.0 109.057 179.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.8 Cg_endo -67.21 -23.15 45.66 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.541 2.161 . . . . 0.0 111.632 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -110.83 -24.33 10.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.342 -0.849 . . . . 0.0 109.326 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 11' ' ' LEU . 81.5 mt -83.25 -38.46 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 0.0 109.622 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 1.036 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 61.28 -143.8 48.66 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.828 ' CE1' HD11 ' A' ' 44' ' ' LEU . 1.6 t80 -107.3 150.65 26.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.094 -1.239 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.7 tp -114.7 121.59 43.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.284 -0.885 . . . . 0.0 109.813 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.0 m -135.52 157.04 77.23 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.324 -0.86 . . . . 0.0 109.029 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.2 Cg_endo -70.01 163.82 37.06 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.588 2.192 . . . . 0.0 111.683 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -87.77 -8.77 55.55 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.0 109.43 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -77.76 111.45 13.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.331 -0.855 . . . . 0.0 109.182 179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.4 tp -79.62 123.17 27.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.935 . . . . 0.0 109.66 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 34' ' ' ASN . 7.4 mtmt -140.63 109.22 6.64 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.812 . . . . 0.0 109.054 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.543 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.9 Cg_endo -63.56 123.85 12.74 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 122.86 2.373 . . . . 0.0 112.214 -179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.654 ' HB ' HG23 ' A' ' 52' ' ' ILE . 29.2 m -120.39 156.55 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.377 -0.827 . . . . 0.0 109.738 -179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 53.9 t -98.23 119.71 37.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.311 -0.868 . . . . 0.0 109.291 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -73.19 134.7 20.14 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 56.6 p30 -68.05 -7.55 30.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -1.148 . . . . 0.0 109.722 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -86.21 7.57 24.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.75 16.97 53.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 93.6 mt-30 -126.05 171.96 10.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -1.123 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.541 HG23 ' O ' ' A' ' 25' ' ' VAL . 89.3 m -129.37 142.75 50.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 109.182 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.662 ' CD2' HD12 ' A' ' 39' ' ' LEU . 20.3 m-85 -123.68 128.82 50.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.395 -0.816 . . . . 0.0 109.2 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.1 m-20 -51.14 -79.27 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.203 -0.936 . . . . 0.0 109.822 -179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.527 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 7.3 t-20 -81.82 147.45 58.61 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.917 -1.114 . . . . 0.0 109.758 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.2 Cg_endo -63.3 -52.19 2.18 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.728 2.285 . . . . 0.0 111.872 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -64.04 -27.8 69.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.033 -1.042 . . . . 0.0 108.297 179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.527 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.5 mmm -62.51 -16.2 54.43 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.471 -0.768 . . . . 0.0 109.191 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.757 HD23 ' OG ' ' A' ' 2' ' ' SER . 8.1 tp -68.55 -51.79 39.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.347 -0.845 . . . . 0.0 109.125 179.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.482 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.9 m -63.78 -18.49 64.14 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.8 t60 -69.16 -57.64 5.12 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -64.74 -18.61 65.19 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.2 m-20 -72.79 -31.47 64.89 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.828 HD11 ' CE1' ' A' ' 16' ' ' TYR . 36.8 mt -58.85 -38.9 79.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 108.745 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.9 mt -74.31 -51.96 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.46 -0.775 . . . . 0.0 109.091 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.516 ' NH2' ' OH ' ' A' ' 33' ' ' TYR . 45.2 mtm180 -66.49 -25.27 66.62 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.378 -0.826 . . . . 0.0 109.415 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.3 mt-30 63.73 44.47 5.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.527 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.9 p -130.21 167.88 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.524 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.456 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 72.9 m-20 -103.37 65.21 0.84 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.258 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.439 ' OG1' ' NH2' ' A' ' 46' ' ' ARG . 51.9 m -73.43 136.5 44.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.228 -0.92 . . . . 0.0 109.76 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.456 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 70.4 m80 -117.13 169.7 9.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.322 -0.861 . . . . 0.0 108.88 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.654 HG23 ' HB ' ' A' ' 25' ' ' VAL . 22.2 mm -80.17 127.01 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.093 -1.005 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 72.0 ttt180 -85.79 -47.93 9.27 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.368 -0.833 . . . . 0.0 109.446 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.6 m -148.29 142.6 26.22 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.535 -0.728 . . . . 0.0 109.367 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.2 p -62.24 151.3 36.62 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.911 . . . . 0.0 109.368 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.12 166.42 40.71 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.52 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 39.5 mttt -59.98 147.15 39.94 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.419 -1.047 . . . . 0.0 109.445 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.433 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 53.2 m -47.62 142.1 4.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.28 -0.888 . . . . 0.0 109.379 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.008 -0.996 . . . . 0.0 109.476 -179.934 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 2' ' ' SER . 76.3 m-20 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.552 ' OG ' HD22 ' A' ' 39' ' ' LEU . 2.8 m -45.12 -34.24 2.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.309 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.496 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 49.9 mt-10 -47.26 -31.93 4.18 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.0 mmm -77.1 -32.26 56.47 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.566 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.6 m -82.12 4.06 24.63 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.362 -0.836 . . . . 0.0 109.214 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.496 ' HE3' ' HG2' ' A' ' 3' ' ' GLU . 11.6 mttm -62.95 -28.64 70.22 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.706 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.459 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 14.3 t70 -147.31 68.34 1.14 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 110.13 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.66 ' CZ ' HD21 ' A' ' 44' ' ' LEU . 19.7 p90 -127.12 -177.77 4.18 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 109.382 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.4 ptt-85 -156.07 146.06 21.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.323 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 15' ' ' GLY . 74.4 t -130.56 135.96 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.208 -0.933 . . . . 0.0 109.714 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -109.57 175.5 1.91 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.276 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.7 Cg_endo -67.95 -24.72 39.28 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.594 2.196 . . . . 0.0 111.83 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -95.78 -31.18 13.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.255 -0.903 . . . . 0.0 109.421 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.3 mt -80.87 -49.41 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.357 -0.839 . . . . 0.0 109.474 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.605 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.4 -173.52 43.24 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.541 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -98.96 146.53 25.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.245 -1.15 . . . . 0.0 109.609 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.2 tp -114.44 110.0 19.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.899 . . . . 0.0 109.817 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 55.7 m -125.73 154.7 73.2 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.369 -0.832 . . . . 0.0 109.077 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.32 165.68 31.68 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.454 2.103 . . . . 0.0 111.655 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -85.22 -23.07 28.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -62.72 128.91 38.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.231 -0.918 . . . . 0.0 109.456 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 34' ' ' ASN . 22.0 tp -83.83 126.2 32.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.156 -0.965 . . . . 0.0 109.421 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -137.71 97.69 10.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.942 . . . . 0.0 109.436 -179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.4 Cg_endo -62.69 121.01 8.77 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 C-N-CA 122.961 2.441 . . . . 0.0 111.938 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.506 ' HB ' HG23 ' A' ' 52' ' ' ILE . 9.8 m -121.65 155.75 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.3 -0.875 . . . . 0.0 109.981 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.6 t -98.3 141.22 31.47 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -96.65 136.73 12.95 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.593 ' OD1' HG23 ' A' ' 50' ' ' THR . 58.4 p30 -62.26 -12.4 20.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -1.113 . . . . 0.0 109.58 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 48.8 m-20 -88.33 10.01 21.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.15 -0.969 . . . . 0.0 109.595 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.18 15.68 68.86 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.5 mt-30 -117.85 156.24 28.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.382 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.963 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.7 m -118.32 148.56 42.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.095 -1.003 . . . . 0.0 109.453 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.826 ' HD2' HD12 ' A' ' 39' ' ' LEU . 78.0 m-85 -130.26 127.83 40.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.272 -0.892 . . . . 0.0 109.317 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.8 m-20 -49.36 -77.63 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.8 t-20 -82.06 146.19 54.71 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.978 -1.076 . . . . 0.0 109.468 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.522 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.64 -50.15 3.58 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.463 2.108 . . . . 0.0 111.459 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 8.0 t -62.2 -27.68 69.15 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.464 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 23.8 mtt -69.78 -23.58 63.38 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.826 HD12 ' HD2' ' A' ' 33' ' ' TYR . 4.8 tt -63.59 -47.34 81.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.344 -0.847 . . . . 0.0 108.782 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.547 ' N ' HD23 ' A' ' 39' ' ' LEU . 9.5 m -56.75 -27.97 60.33 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.5 t60 -56.83 -47.78 79.52 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.599 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 29.1 tp10 -57.87 -22.01 45.99 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.525 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 3.3 m-80 -76.57 -31.85 57.78 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.903 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.66 HD21 ' CZ ' ' A' ' 8' ' ' TYR . 67.0 mt -64.43 -41.19 96.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.265 -0.897 . . . . 0.0 109.384 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 mt -73.29 -54.23 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.392 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.679 HH22 HG21 ' A' ' 50' ' ' THR . 81.0 mtm180 -70.22 -22.02 62.95 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.884 . . . . 0.0 109.383 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 63.01 36.0 12.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.3 p -120.0 177.35 5.02 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.292 -0.88 . . . . 0.0 109.392 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.565 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 90.7 m-20 -103.98 56.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.189 -0.944 . . . . 0.0 109.55 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.679 HG21 HH22 ' A' ' 46' ' ' ARG . 82.9 m -75.88 129.38 36.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.0 109.579 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 8.0 m80 -115.34 -170.96 1.87 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.177 -0.952 . . . . 0.0 109.33 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.534 HG12 HD13 ' A' ' 39' ' ' LEU . 41.3 mt -85.9 126.56 40.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 109.727 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 12.7 tpt180 -81.06 -43.14 19.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.408 -0.808 . . . . 0.0 109.24 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.8 p -154.51 137.89 15.83 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 p -58.48 149.34 25.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.099 -1.001 . . . . 0.0 109.405 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 83.43 165.89 38.96 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.963 ' HG3' HG21 ' A' ' 32' ' ' THR . 39.5 tttm -65.3 149.04 50.64 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.352 -1.087 . . . . 0.0 109.356 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.8 138.7 39.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 109.393 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.481 -179.987 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.471 ' HB2' ' ND1' ' A' ' 51' ' ' HIS . 0.6 OUTLIER -55.59 -33.03 63.57 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.945 . . . . 0.0 109.32 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.424 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.0 OUTLIER -55.56 -23.26 25.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.323 -0.861 . . . . 0.0 109.042 179.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.444 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 81.5 mtp -72.23 -26.54 62.06 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.293 -0.879 . . . . 0.0 108.834 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.581 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 24.6 m -85.23 -13.03 51.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.446 -0.784 . . . . 0.0 109.28 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.424 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 17.0 mttm -80.95 10.87 4.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.211 -0.931 . . . . 0.0 109.923 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.444 ' OD1' ' O ' ' A' ' 4' ' ' MET . 41.7 p30 -145.02 19.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.032 -1.042 . . . . 0.0 109.671 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.632 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -128.24 154.09 46.23 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.129 -0.982 . . . . 0.0 109.494 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 9' ' ' ARG . 39.2 tpt85 -135.66 146.81 48.2 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.305 -0.872 . . . . 0.0 108.984 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 15' ' ' GLY . 75.5 t -137.58 137.53 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.15 -0.969 . . . . 0.0 109.647 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.556 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -116.0 175.66 1.84 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.444 -0.785 . . . . 0.0 109.233 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.4 Cg_endo -66.53 -21.77 52.42 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.598 2.198 . . . . 0.0 111.763 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -101.96 -28.66 12.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -0.847 . . . . 0.0 109.563 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.556 HD12 ' HB2' ' A' ' 11' ' ' LEU . 83.2 mt -80.87 -51.56 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.616 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.856 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 81.29 -165.38 46.73 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.632 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 0.8 OUTLIER -100.78 147.45 26.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -1.112 . . . . 0.0 109.672 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.83 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -119.87 127.64 52.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.336 -0.853 . . . . 0.0 109.481 179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 70.4 m -133.48 156.72 79.38 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.296 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.7 Cg_endo -70.06 166.66 27.21 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.621 2.214 . . . . 0.0 111.815 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 53.6 tttt -87.53 -14.42 40.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 0.0 109.534 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -73.01 106.1 4.75 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.311 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.422 HD11 ' HB3' ' A' ' 34' ' ' ASN . 48.8 tp -72.93 113.66 10.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.224 -0.922 . . . . 0.0 109.455 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.8 mttm -124.02 102.92 33.91 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.966 . . . . 0.0 109.323 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.559 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 42.9 Cg_endo -65.09 116.98 4.15 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.875 2.383 . . . . 0.0 112.138 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 32' ' ' THR . 7.6 m -116.41 156.93 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.878 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.452 ' O ' ' HB3' ' A' ' 53' ' ' ARG . 16.5 t -98.3 111.94 24.11 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.884 . . . . 0.0 109.566 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.08 139.16 37.8 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.516 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.1 p30 -69.8 -9.74 55.79 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -1.109 . . . . 0.0 109.667 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -81.42 1.99 30.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.17 -0.956 . . . . 0.0 109.446 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.48 15.19 44.68 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.51 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -125.03 168.66 13.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.336 -1.097 . . . . 0.0 109.514 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.566 HG21 ' HA ' ' A' ' 57' ' ' LYS . 39.1 m -123.45 134.18 53.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.661 ' CD1' HD13 ' A' ' 39' ' ' LEU . 72.8 m-85 -110.99 121.09 44.48 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.198 -0.939 . . . . 0.0 109.215 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 8.7 m-20 -46.89 -82.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.4 -0.812 . . . . 0.0 109.722 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.3 t-20 -81.84 146.38 55.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.924 -1.11 . . . . 0.0 109.593 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -62.95 -51.96 2.54 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.77 2.313 . . . . 0.0 111.599 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.522 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.8 t -61.92 -26.78 68.38 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.959 -1.088 . . . . 0.0 108.091 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 31.5 mmm -67.43 -16.66 64.35 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.661 HD13 ' CD1' ' A' ' 33' ' ' TYR . 17.3 tp -68.03 -57.35 6.29 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 9.4 t -55.45 -25.41 36.21 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.5 t60 -69.51 -61.7 1.68 Allowed 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.571 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 88.5 mt-10 -57.57 -19.53 26.13 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.421 ' ND2' ' HG ' ' A' ' 39' ' ' LEU . 92.9 m-20 -75.39 -33.55 61.02 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.95 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.2 tm? -57.76 -38.23 75.04 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.412 -0.805 . . . . 0.0 108.882 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mt -77.3 -46.81 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.846 . . . . 0.0 108.972 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.438 ' O ' HG23 ' A' ' 48' ' ' THR . 62.2 mtt-85 -64.76 -26.22 68.26 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.292 -0.88 . . . . 0.0 109.01 179.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 91.5 mt-30 61.27 37.99 16.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.37 -0.831 . . . . 0.0 109.639 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 46' ' ' ARG . 10.1 p -128.39 169.77 13.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.939 . . . . 0.0 109.322 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.512 ' O ' ' NE2' ' A' ' 51' ' ' HIS . 79.9 m-20 -98.91 63.13 1.35 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.266 -0.896 . . . . 0.0 109.311 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 32.6 m -71.47 137.65 48.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.827 . . . . 0.0 109.666 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.512 ' NE2' ' O ' ' A' ' 49' ' ' ASN . 11.8 m-70 -117.95 178.54 4.38 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.326 -0.859 . . . . 0.0 109.022 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.413 HG23 ' HB ' ' A' ' 25' ' ' VAL . 20.4 mt -86.08 124.8 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.142 -0.974 . . . . 0.0 109.611 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.516 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 66.4 ttt180 -80.99 -56.73 3.91 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.142 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -147.13 156.56 43.09 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.535 -0.728 . . . . 0.0 109.037 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -75.05 142.72 43.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.159 -0.963 . . . . 0.0 109.632 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.04 162.46 35.64 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.566 ' HA ' HG21 ' A' ' 32' ' ' THR . 32.5 mttt -64.77 136.75 57.25 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.588 -0.948 . . . . 0.0 109.484 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 59' ' ' GLU . 0.1 OUTLIER -71.11 149.15 46.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.388 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 58' ' ' CYS . 84.4 tt0 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.502 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.479 ' OG ' ' HA ' ' A' ' 51' ' ' HIS . 0.6 OUTLIER -54.43 -34.5 61.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.45 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.79 -21.54 7.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.189 -0.944 . . . . 0.0 108.78 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 71.3 mtp -71.54 -30.66 66.15 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.474 -0.766 . . . . 0.0 109.036 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 8' ' ' TYR . 3.9 m -82.8 -26.84 31.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.441 -0.787 . . . . 0.0 109.376 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 5' ' ' CYS . 69.3 mttt -44.76 -27.24 0.48 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.348 -0.845 . . . . 0.0 108.757 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 5' ' ' CYS . 94.5 m-20 -116.08 35.05 4.66 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.474 ' N ' ' O ' ' A' ' 5' ' ' CYS . 2.7 t80 -80.34 163.2 24.09 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.415 -0.803 . . . . 0.0 109.837 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.4 mtt180 -150.64 114.61 5.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.374 -0.829 . . . . 0.0 109.093 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.873 HG13 ' C ' ' A' ' 15' ' ' GLY . 59.7 t -116.97 156.74 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.438 -0.789 . . . . 0.0 109.639 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.55 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -136.27 174.91 3.97 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.371 -0.83 . . . . 0.0 109.386 -179.942 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.9 Cg_endo -67.44 -21.75 46.32 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.672 2.248 . . . . 0.0 111.947 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -112.1 -21.56 11.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.173 -0.954 . . . . 0.0 109.673 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 11' ' ' LEU . 97.0 mt -88.21 -49.32 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.925 . . . . 0.0 109.627 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.873 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 75.2 -165.43 54.62 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.83 ' CD1' HG21 ' A' ' 10' ' ' VAL . 1.2 t80 -94.06 153.84 17.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.14 -1.212 . . . . 0.0 109.514 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.8 tp -117.08 109.92 17.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.209 -0.932 . . . . 0.0 109.965 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.9 m -126.13 155.35 73.71 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.249 -0.907 . . . . 0.0 109.115 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.09 168.52 23.82 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.527 2.151 . . . . 0.0 111.611 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -88.19 -23.34 23.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.158 -0.964 . . . . 0.0 109.741 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.53 126.53 28.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.132 -0.98 . . . . 0.0 109.329 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 34' ' ' ASN . 31.3 tp -85.0 113.13 21.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.257 -0.902 . . . . 0.0 109.475 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.528 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -121.45 104.35 40.26 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 0.0 109.363 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.499 ' HB2' ' HG3' ' A' ' 57' ' ' LYS . 43.2 Cg_endo -65.62 117.28 4.49 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.875 2.383 . . . . 0.0 112.059 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.489 ' HB ' HG23 ' A' ' 52' ' ' ILE . 34.0 m -120.44 154.8 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.307 -0.871 . . . . 0.0 109.835 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.0 t -97.3 140.79 31.24 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -90.99 142.39 16.11 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 43.9 t0 -68.58 -11.5 60.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.155 -1.203 . . . . 0.0 109.306 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -86.4 -5.0 59.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.303 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.77 21.38 14.35 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 27' ' ' GLY . 66.8 mt-30 -127.58 145.84 50.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -1.194 . . . . 0.0 109.585 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.48 HG23 ' HA ' ' A' ' 57' ' ' LYS . 92.8 m -99.4 154.72 17.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.312 -0.868 . . . . 0.0 109.602 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.655 ' CD2' HD12 ' A' ' 39' ' ' LEU . 48.8 m-85 -135.59 117.63 15.36 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.372 -0.83 . . . . 0.0 108.901 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.552 ' HB3' HD11 ' A' ' 22' ' ' LEU . 10.8 m-20 -41.97 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.504 -0.748 . . . . 0.0 109.828 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.8 t-20 -82.27 146.61 54.89 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.051 -1.031 . . . . 0.0 109.205 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.18 -51.16 2.93 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.618 2.212 . . . . 0.0 111.695 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.5 t -63.34 -28.27 69.89 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.094 -1.004 . . . . 0.0 108.423 179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.474 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 14.0 mtp -60.89 -14.93 25.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.521 -0.737 . . . . 0.0 109.019 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.712 HD22 ' CD1' ' A' ' 52' ' ' ILE . 6.2 tp -74.65 -54.9 6.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.494 -0.754 . . . . 0.0 109.746 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.472 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.4 m -61.72 -19.92 62.93 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.197 -0.94 . . . . 0.0 108.665 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.57 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 34.9 t60 -67.79 -54.39 19.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -66.2 -18.75 65.55 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.0 m-20 -75.79 -27.47 58.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.45 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.974 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.8 tm? -67.52 -35.98 80.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.139 -0.976 . . . . 0.0 108.966 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -78.25 -46.27 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.208 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.502 ' NH2' ' OE1' ' A' ' 31' ' ' GLN . 74.2 mtm180 -75.79 -35.01 60.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.284 -0.885 . . . . 0.0 109.109 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.2 mt-30 62.51 40.36 10.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.71 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.444 HG23 ' HB3' ' A' ' 46' ' ' ARG . 32.9 p -109.8 7.31 24.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.258 -0.901 . . . . 0.0 109.445 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 47.82 60.66 3.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.334 -0.853 . . . . 0.0 109.761 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 95.3 m -79.77 133.49 36.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.451 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.479 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 8.1 m-70 -105.46 -173.97 2.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.478 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.712 ' CD1' HD22 ' A' ' 39' ' ' LEU . 33.6 mm -91.33 127.15 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.352 -0.842 . . . . 0.0 109.616 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 73.8 ttt180 -79.44 -49.01 12.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.428 -0.795 . . . . 0.0 109.231 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.6 p -159.3 155.18 26.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.1 p -67.82 141.56 56.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.074 -1.016 . . . . 0.0 109.769 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.29 165.77 35.17 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.499 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 83.0 mttt -66.94 146.28 54.55 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.351 -1.087 . . . . 0.0 109.364 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 70.1 m -55.28 150.54 11.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.59 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.458 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.294 0.569 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.478 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 3.5 m -52.93 -40.4 63.6 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.257 -0.902 . . . . 0.0 109.383 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -54.25 -26.41 28.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.441 -0.787 . . . . 0.0 109.069 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 48.2 ttm -67.68 -25.88 65.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.108 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.457 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 38.9 m -80.82 -28.06 36.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.335 -0.853 . . . . 0.0 109.167 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.7 mttp -68.08 -12.6 61.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.304 -0.873 . . . . 0.0 109.368 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -91.0 -16.59 27.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.325 -0.86 . . . . 0.0 109.689 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.495 ' OH ' ' CE1' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -109.76 157.22 19.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 109.183 179.852 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -128.95 140.79 51.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.201 -0.937 . . . . 0.0 109.564 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.766 HG21 ' C ' ' A' ' 15' ' ' GLY . 14.7 p -125.71 146.77 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.276 -0.89 . . . . 0.0 109.508 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.561 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mp -108.77 175.6 1.9 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.3 Cg_endo -67.32 -23.3 44.81 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.641 2.227 . . . . 0.0 111.669 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -88.93 -30.6 18.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.247 -0.908 . . . . 0.0 109.146 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.429 ' HA ' HD13 ' A' ' 14' ' ' ILE . 28.6 mm -85.9 -39.79 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 0.0 109.307 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.766 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 69.18 144.71 0.16 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.912 ' CE1' HD11 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -41.88 152.0 0.08 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.389 -1.065 . . . . 0.0 109.789 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 20.1 tp -128.35 111.72 13.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.288 -0.882 . . . . 0.0 109.511 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 81.0 m -116.85 158.08 44.72 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.327 -0.858 . . . . 0.0 109.2 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -71.79 165.62 31.99 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.575 2.183 . . . . 0.0 111.792 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -86.81 -11.61 50.42 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.237 -0.914 . . . . 0.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -74.11 113.42 11.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.246 179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.975 HD11 ' OD1' ' A' ' 34' ' ' ASN . 55.9 tp -80.02 123.22 27.64 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.554 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 11.9 mmtm -141.03 109.63 6.44 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.394 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -66.02 120.28 7.42 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 123.04 2.493 . . . . 0.0 112.055 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.607 ' O ' HG23 ' A' ' 32' ' ' THR . 11.1 m -116.86 156.64 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.23 -0.919 . . . . 0.0 109.82 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 46.8 t -98.59 119.8 37.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.0 109.368 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -72.62 137.31 24.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -68.33 -7.61 32.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.364 -1.08 . . . . 0.0 109.532 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.435 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 91.5 m-20 -89.07 11.77 17.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.253 -0.905 . . . . 0.0 109.504 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.0 10.6 71.59 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.509 ' O ' ' N ' ' A' ' 27' ' ' GLY . 78.4 mt-30 -116.01 173.95 6.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -1.164 . . . . 0.0 109.507 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.652 HG21 ' HG3' ' A' ' 57' ' ' LYS . 50.6 m -133.9 140.33 46.75 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.328 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.766 ' CD1' HD13 ' A' ' 39' ' ' LEU . 24.6 m-85 -118.62 123.32 44.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 109.467 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.975 ' OD1' HD11 ' A' ' 22' ' ' LEU . 54.6 t-20 -45.99 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.309 -0.869 . . . . 0.0 109.737 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.8 t-20 -80.82 147.52 62.53 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 120.866 -1.146 . . . . 0.0 109.343 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.8 Cg_endo -62.45 -53.15 2.0 Allowed 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.699 2.266 . . . . 0.0 111.804 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.518 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.6 t -62.76 -28.15 69.78 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.485 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 50.3 mmm -63.13 -16.77 61.12 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.766 HD13 ' CD1' ' A' ' 33' ' ' TYR . 27.9 tp -66.77 -50.67 61.95 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.454 -0.779 . . . . 0.0 108.899 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.6 m -67.92 -19.36 64.98 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -73.54 -54.82 7.3 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 88.6 mt-10 -63.35 -17.05 62.17 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 47' ' ' GLN . 94.0 m-20 -77.35 -35.74 54.36 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.493 -0.754 . . . . 0.0 108.967 179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.912 HD11 ' CE1' ' A' ' 16' ' ' TYR . 31.2 mt -54.14 -36.09 62.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.116 -0.99 . . . . 0.0 108.567 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mt -78.45 -50.19 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.075 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 91.5 mtt-85 -65.31 -26.89 68.26 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.302 -0.874 . . . . 0.0 109.23 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.97 41.95 7.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -0.802 . . . . 0.0 109.587 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 p -128.86 158.61 38.25 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.888 . . . . 0.0 109.446 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.475 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 63.0 m-20 -87.71 58.4 4.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.204 -0.935 . . . . 0.0 109.332 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.435 ' OG1' ' OD2' ' A' ' 29' ' ' ASP . 57.6 m -75.15 133.6 41.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.252 -0.905 . . . . 0.0 109.858 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 67.9 m80 -119.88 174.86 6.19 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.858 . . . . 0.0 108.873 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.519 HG23 ' HB ' ' A' ' 25' ' ' VAL . 37.9 mt -79.71 138.43 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.111 -0.993 . . . . 0.0 109.322 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HA ' ' OD2' ' A' ' 28' ' ' ASP . 23.3 ttt180 -101.9 -47.52 4.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.387 -0.821 . . . . 0.0 109.578 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.5 m -146.86 137.61 23.84 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.49 -0.756 . . . . 0.0 109.33 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.7 p -60.69 145.17 50.3 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.233 -0.917 . . . . 0.0 109.338 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.24 164.09 39.9 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.652 ' HG3' HG21 ' A' ' 32' ' ' THR . 22.4 tttp -53.88 150.22 7.91 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.348 -1.09 . . . . 0.0 109.525 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 36.3 m -52.73 144.85 13.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.446 -0.784 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.444 179.888 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.483 ' OG ' ' HA ' ' A' ' 51' ' ' HIS . 3.7 m -54.24 -23.8 16.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.127 -0.983 . . . . 0.0 109.612 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.438 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.2 tt0 -48.57 -27.05 2.52 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.21 -0.931 . . . . 0.0 108.561 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.6 mtm -79.99 -36.29 36.23 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.511 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 3.2 m -85.5 8.96 17.2 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.491 ' HE2' ' NE2' ' A' ' 51' ' ' HIS . 31.1 mttt -70.13 -27.42 64.55 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.257 -0.902 . . . . 0.0 109.408 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 82.6 m-20 -144.44 64.25 1.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.792 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.882 ' OH ' HD21 ' A' ' 44' ' ' LEU . 11.7 p90 -125.33 -176.44 3.58 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.175 -0.953 . . . . 0.0 109.442 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -146.7 152.87 39.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 109.557 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 15' ' ' GLY . 42.5 t -144.57 127.93 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.49 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -106.8 175.32 2.09 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.315 -0.865 . . . . 0.0 109.501 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -67.94 -23.23 41.05 Favored 'Trans proline' 0 C--O 1.214 -0.708 0 C-N-CA 122.693 2.262 . . . . 0.0 111.844 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -96.73 -26.64 15.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.227 -0.921 . . . . 0.0 109.254 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 78.2 mt -89.3 -42.07 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.215 -0.928 . . . . 0.0 109.655 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.586 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 64.32 -165.46 31.49 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.484 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -93.42 149.83 20.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -1.197 . . . . 0.0 109.407 179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.2 tp -116.24 107.19 14.55 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.164 -0.96 . . . . 0.0 109.639 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 60.3 m -125.47 156.26 70.67 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 109.557 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 51.5 Cg_endo -72.12 167.84 25.69 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.733 2.288 . . . . 0.0 111.669 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -84.32 -26.0 28.82 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.188 -0.945 . . . . 0.0 109.546 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -62.34 117.01 5.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.526 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -84.67 104.32 14.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 34' ' ' ASN . 16.1 mtpt -116.12 111.37 42.71 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.223 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.6 Cg_endo -63.38 121.14 8.84 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 C-N-CA 122.999 2.466 . . . . 0.0 112.21 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.463 ' HB ' HG23 ' A' ' 52' ' ' ILE . 5.8 m -115.1 157.73 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.418 -0.801 . . . . 0.0 109.584 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 53' ' ' ARG . 47.6 t -97.21 140.58 31.48 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -96.8 135.38 12.21 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.7 p30 -62.0 -12.23 17.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -1.065 . . . . 0.0 109.71 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 49.8 m-20 -87.47 10.84 16.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 109.484 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.15 17.72 64.31 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 62.0 mt-30 -117.35 178.79 4.25 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.519 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.611 HG21 ' HG3' ' A' ' 57' ' ' LYS . 20.7 m -139.49 142.65 37.3 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.31 -0.869 . . . . 0.0 109.234 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.832 ' CD2' HD12 ' A' ' 39' ' ' LEU . 23.9 m-85 -122.42 134.84 54.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 0.0 109.431 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.58 ' CB ' HD21 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -54.68 -78.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 0.0 109.491 -179.473 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.4 t-20 -82.16 146.39 54.81 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.003 -1.061 . . . . 0.0 109.504 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.64 -52.3 1.94 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.703 2.269 . . . . 0.0 111.645 -179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.536 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -63.5 -24.28 67.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.509 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 62.2 mtp -73.66 -16.51 61.21 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.832 HD12 ' CD2' ' A' ' 33' ' ' TYR . 7.5 tt -64.55 -51.8 60.95 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.51 ' O ' ' N ' ' A' ' 43' ' ' ASN . 8.7 m -54.09 -38.54 65.45 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.425 ' C ' ' O ' ' A' ' 40' ' ' CYS . 7.2 t60 -47.48 -50.21 23.78 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HG3' ' CD1' ' A' ' 33' ' ' TYR . 37.3 mm-40 -56.48 -25.98 52.78 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.2 m-80 -74.32 -33.72 63.26 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.295 -0.878 . . . . 0.0 108.85 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.882 HD21 ' OH ' ' A' ' 8' ' ' TYR . 37.2 mt -63.96 -44.26 93.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.396 -0.815 . . . . 0.0 109.407 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.1 mm -74.86 -52.22 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.125 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 37.7 mtt-85 -66.83 -22.25 66.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 109.198 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.487 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 61.51 35.26 17.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.359 -0.838 . . . . 0.0 109.584 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.2 p -123.13 170.38 10.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.419 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.57 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 77.7 m-20 -96.77 57.37 1.55 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.857 . . . . 0.0 109.609 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.622 HG21 ' OH ' ' A' ' 33' ' ' TYR . 43.9 m -80.03 126.12 30.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.0 109.554 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.57 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 22.3 m80 -113.18 -173.32 2.23 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.804 HG12 HD13 ' A' ' 39' ' ' LEU . 31.8 mt -87.09 124.69 40.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.176 -0.952 . . . . 0.0 109.366 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.484 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 79.3 ttt180 -80.44 -39.99 27.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.321 -0.862 . . . . 0.0 109.366 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.06 148.64 17.15 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.493 -0.754 . . . . 0.0 109.288 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 p -65.91 144.43 56.8 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -0.925 . . . . 0.0 109.723 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.11 162.01 38.06 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.611 ' HG3' HG21 ' A' ' 32' ' ' THR . 13.5 tttm -54.8 154.27 5.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.51 -0.994 . . . . 0.0 109.372 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.467 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 84.5 m -62.55 141.13 58.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.309 -0.869 . . . . 0.0 109.499 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.488 179.972 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.517 ' OD1' HD12 ' A' ' 52' ' ' ILE . 61.9 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.47 -0.566 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.511 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 6.1 m -44.01 -27.56 0.38 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.252 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.487 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 20.8 mt-10 -49.39 -29.3 6.1 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.8 mtp -75.26 -27.43 59.42 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.493 ' N ' ' O ' ' A' ' 2' ' ' SER . 4.1 m -79.73 -5.68 55.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.455 -0.778 . . . . 0.0 108.968 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.487 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 18.5 mttm -54.24 -31.47 53.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.217 -0.927 . . . . 0.0 109.795 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -146.43 67.74 1.18 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.184 -0.948 . . . . 0.0 110.073 -179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.612 ' OH ' HD13 ' A' ' 44' ' ' LEU . 5.8 p90 -125.2 173.76 8.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.185 -0.947 . . . . 0.0 109.158 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -143.9 147.52 34.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.063 -1.023 . . . . 0.0 109.755 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.785 HG13 ' O ' ' A' ' 15' ' ' GLY . 66.6 t -144.57 132.83 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.307 -0.871 . . . . 0.0 109.126 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.466 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 1.5 mp -125.42 170.94 8.34 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.113 -0.992 . . . . 0.0 109.497 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.71 -24.59 40.93 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.556 2.171 . . . . 0.0 111.449 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -102.89 -27.16 12.82 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.039 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 90.4 mt -88.88 -43.09 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.294 -0.879 . . . . 0.0 109.24 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.785 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 76.04 -141.72 27.52 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.62 ' CD2' HG21 ' A' ' 10' ' ' VAL . 2.9 t80 -114.17 155.3 26.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 109.467 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 32.5 tp -112.44 124.5 52.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -0.872 . . . . 0.0 109.991 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -138.54 156.66 73.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.388 -0.82 . . . . 0.0 109.057 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.2 Cg_endo -72.59 168.21 25.02 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.633 2.222 . . . . 0.0 111.552 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -84.82 -27.83 26.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -0.952 . . . . 0.0 109.379 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -59.82 130.88 48.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.471 HD11 ' HB3' ' A' ' 34' ' ' ASN . 63.7 tp -95.06 117.71 30.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.0 109.5 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.531 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 7.5 mttt -128.22 104.88 19.94 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 109.263 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.3 Cg_endo -64.62 120.41 7.69 Favored 'Trans proline' 0 C--O 1.213 -0.755 0 C-N-CA 122.962 2.442 . . . . 0.0 112.081 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 32' ' ' THR . 11.9 m -119.62 156.46 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.265 -0.897 . . . . 0.0 109.851 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.3 t -99.87 121.48 41.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.432 -0.793 . . . . 0.0 108.873 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -79.41 137.05 18.45 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.518 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 45.5 p30 -68.5 -8.82 44.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.241 -1.152 . . . . 0.0 109.548 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' ' 29' ' ' ASP . 58.0 p30 -82.89 8.21 13.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.172 -0.955 . . . . 0.0 109.313 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.44 23.01 45.2 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.494 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.4 mt-30 -133.79 158.25 43.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -1.154 . . . . 0.0 109.499 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 42.2 m -116.19 143.63 45.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.284 -0.885 . . . . 0.0 109.225 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.778 ' CD1' HD13 ' A' ' 39' ' ' LEU . 81.0 m-85 -122.51 127.82 50.02 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.272 -0.893 . . . . 0.0 109.213 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 10.7 m-20 -51.55 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.341 -0.849 . . . . 0.0 109.942 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 10.1 t-20 -81.97 146.56 55.85 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 120.947 -1.096 . . . . 0.0 109.731 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.9 -51.78 2.71 Favored 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 122.813 2.342 . . . . 0.0 111.674 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.523 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.9 t -60.14 -31.57 70.21 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 8.5 mtt -60.97 -17.53 52.24 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.778 HD13 ' CD1' ' A' ' 33' ' ' TYR . 63.5 tp -67.85 -54.45 18.86 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 8.1 t -58.19 -27.72 64.13 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.5 t60 -62.28 -58.93 5.89 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -59.62 -21.01 59.83 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.0 m-20 -80.09 -30.74 39.27 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.612 HD13 ' OH ' ' A' ' 8' ' ' TYR . 35.6 tp -61.14 -40.61 94.46 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.512 -0.742 . . . . 0.0 109.054 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.0 mt -80.43 -47.49 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.81 . . . . 0.0 109.322 179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.59 ' HG2' HG23 ' A' ' 48' ' ' THR . 46.7 ttm-85 -67.66 -43.67 79.7 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.318 -0.864 . . . . 0.0 109.5 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 84.8 mt-30 65.88 47.18 2.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.387 -0.821 . . . . 0.0 109.58 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.59 HG23 ' HG2' ' A' ' 46' ' ' ARG . 21.3 p -120.83 8.07 10.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.449 ' OD1' ' CB ' ' A' ' 2' ' ' SER . 41.1 t30 52.73 60.65 3.65 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.199 -0.938 . . . . 0.0 109.535 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.409 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 28.9 m -77.87 141.12 39.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 109.327 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.511 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 59.6 m80 -115.12 168.58 9.81 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.204 -0.935 . . . . 0.0 109.094 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.517 HD12 ' OD1' ' A' ' 1' ' ' ASP . 21.7 mt -79.71 123.55 36.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.146 -0.972 . . . . 0.0 109.547 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.518 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 65.2 ttt-85 -81.06 -45.98 15.69 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.571 -0.706 . . . . 0.0 109.266 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -152.99 153.85 33.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.402 -0.811 . . . . 0.0 109.138 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 p -74.0 144.89 44.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.0 164.6 40.4 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 75.1 mttt -64.9 138.44 58.37 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.46 -1.024 . . . . 0.0 109.345 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.81 152.6 44.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 109.418 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.496 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.252 0.549 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.491 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 7.6 m -53.64 -26.7 23.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.375 -0.828 . . . . 0.0 109.389 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.469 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 6.3 mt-10 -53.17 -24.41 10.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.279 -0.888 . . . . 0.0 109.055 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.9 mtm -70.62 -30.06 66.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.104 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 7.9 m -80.39 -20.15 44.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.393 -0.817 . . . . 0.0 109.285 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 86.1 mttt -50.19 -27.13 5.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 108.822 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -108.84 26.53 10.47 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.494 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 1.9 t80 -80.97 147.71 30.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.609 -0.682 . . . . 0.0 109.985 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -141.17 114.61 8.8 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.305 -0.872 . . . . 0.0 109.255 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.606 HG21 ' N ' ' A' ' 16' ' ' TYR . 5.4 p -128.71 154.71 39.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.348 -0.845 . . . . 0.0 109.431 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.606 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -110.12 168.42 7.67 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.184 -0.948 . . . . 0.0 109.327 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.606 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.7 Cg_endo -67.2 -24.82 43.77 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.614 2.209 . . . . 0.0 111.543 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -92.92 -25.02 18.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.218 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 72.3 mt -85.69 -40.37 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.372 -0.83 . . . . 0.0 109.378 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.589 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 70.96 145.9 0.36 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.606 ' N ' HG21 ' A' ' 10' ' ' VAL . 1.9 t80 -51.44 150.89 3.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -1.163 . . . . 0.0 109.331 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.807 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -116.92 136.12 53.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.253 -0.905 . . . . 0.0 109.425 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.6 m -142.95 157.27 61.38 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.0 109.208 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -69.87 165.42 31.16 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.661 2.241 . . . . 0.0 111.755 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -87.93 -13.34 42.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.448 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -72.56 114.34 10.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.236 -0.915 . . . . 0.0 109.181 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 22' ' ' LEU . 38.0 tp -80.04 120.74 24.61 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.908 . . . . 0.0 109.629 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.506 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.4 OUTLIER -136.83 107.47 9.0 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.372 -0.83 . . . . 0.0 109.091 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.3 121.66 9.16 Favored 'Trans proline' 0 C--O 1.212 -0.784 0 C-N-CA 123.016 2.478 . . . . 0.0 112.249 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.494 ' HB ' HG23 ' A' ' 52' ' ' ILE . 16.3 m -118.89 155.57 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 109.877 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 32.2 t -97.36 139.03 33.91 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.68 140.31 15.04 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -70.98 -4.77 26.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.273 -1.134 . . . . 0.0 109.618 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -93.57 4.61 53.69 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.44 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.01 20.26 33.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.7 mt-30 -124.63 163.58 21.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.263 -1.139 . . . . 0.0 109.54 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.0 m -125.13 135.58 52.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -0.914 . . . . 0.0 109.128 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.857 ' CD1' HD13 ' A' ' 39' ' ' LEU . 55.3 m-85 -115.36 130.16 56.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.228 -0.92 . . . . 0.0 109.349 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 8.3 m-20 -54.52 -78.15 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.731 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.9 t-20 -81.88 147.86 59.47 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.722 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.4 Cg_endo -62.92 -52.92 1.87 Allowed 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.751 2.3 . . . . 0.0 111.704 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.5 t -60.91 -29.81 69.81 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.984 -1.072 . . . . 0.0 108.111 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 44.9 mmm -63.65 -15.24 57.77 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.857 HD13 ' CD1' ' A' ' 33' ' ' TYR . 39.4 tp -68.76 -49.29 59.9 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.494 -0.754 . . . . 0.0 109.286 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 3.2 m -69.32 -21.35 63.85 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.551 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 40.5 t60 -70.27 -55.33 9.5 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 78.1 mt-10 -63.28 -19.49 64.62 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.1 m-20 -75.26 -33.42 61.27 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 40' ' ' CYS . 20.9 mt -59.3 -37.0 76.62 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 45' ' ' ILE . 6.6 mm -72.69 -49.6 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.469 ' HG2' HG23 ' A' ' 48' ' ' THR . 36.4 ttt180 -68.48 -25.86 65.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.323 -0.861 . . . . 0.0 109.087 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.1 mt-30 64.03 43.91 4.92 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.778 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.469 HG23 ' HG2' ' A' ' 46' ' ' ARG . 70.1 p -132.36 166.89 20.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.303 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.48 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 95.9 m-20 -95.71 61.13 2.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.396 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.3 m -72.32 139.3 47.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.619 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.491 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 72.1 m80 -119.15 173.57 6.84 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.845 . . . . 0.0 109.053 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.494 HG23 ' HB ' ' A' ' 25' ' ' VAL . 35.1 mt -80.07 124.93 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.097 -1.002 . . . . 0.0 109.269 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.486 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.7 ttt180 -79.93 -45.94 17.63 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.679 0.752 . . . . 0.0 109.235 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 p -156.49 146.47 21.13 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.3 p -65.37 147.4 53.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.157 -0.965 . . . . 0.0 109.41 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.22 165.15 40.47 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.532 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 47.4 mttp -65.69 146.2 55.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.352 -1.087 . . . . 0.0 109.346 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -76.5 152.86 35.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.504 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.405 -179.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.474 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 1.8 m -58.26 -29.63 65.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.265 -0.897 . . . . 0.0 109.378 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.3 tt0 -53.17 -24.25 10.31 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.313 -0.867 . . . . 0.0 108.895 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.7 mtp -70.17 -32.1 69.89 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.497 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 34.4 m -80.56 -6.08 57.72 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.378 -0.826 . . . . 0.0 109.214 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 65.6 mttt -81.38 12.61 3.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.007 -1.058 . . . . 0.0 110.038 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -132.98 7.83 4.03 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.991 -1.068 . . . . 0.0 110.399 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 5.8 p90 -105.48 -176.56 3.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.912 -1.118 . . . . 0.0 109.604 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.621 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 10.4 ttt180 -151.48 142.81 23.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.339 -0.851 . . . . 0.0 109.142 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.574 HG13 ' O ' ' A' ' 15' ' ' GLY . 15.0 t -143.61 149.39 18.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.346 -0.846 . . . . 0.0 109.321 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -124.46 175.33 3.0 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.34 -0.85 . . . . 0.0 109.462 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.4 Cg_endo -66.71 -21.56 51.45 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.63 2.22 . . . . 0.0 111.739 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 66.1 ttt180 -99.6 -16.89 18.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.355 -0.84 . . . . 0.0 109.641 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.407 ' HA ' HD13 ' A' ' 14' ' ' ILE . 40.0 mm -94.82 -49.82 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.033 -1.042 . . . . 0.0 109.611 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.574 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 86.47 -178.29 48.93 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.488 ' HE2' ' HH ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -90.63 146.91 23.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 109.736 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.3 tp -114.18 107.59 15.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 74.1 m -117.28 156.62 48.6 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.343 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.1 Cg_endo -72.21 167.94 25.47 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.642 2.228 . . . . 0.0 111.531 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -91.79 -12.81 32.75 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -66.74 129.45 39.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.293 -0.879 . . . . 0.0 109.277 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.901 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -89.56 120.68 31.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 109.518 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.619 ' N ' HD13 ' A' ' 22' ' ' LEU . 27.3 mttm -143.65 108.13 5.13 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.209 -0.932 . . . . 0.0 109.541 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 47.1 Cg_endo -66.77 122.39 9.76 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 123.056 2.504 . . . . 0.0 112.126 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 m -116.21 154.66 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 53' ' ' ARG . 49.6 t -97.04 138.56 34.38 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.57 139.82 14.82 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.9 t0 -69.2 -8.44 45.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -1.099 . . . . 0.0 109.459 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -87.54 3.61 46.8 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.136 -0.978 . . . . 0.0 109.438 179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.56 17.29 45.98 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 65.8 mt-30 -121.33 175.22 6.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.316 -1.108 . . . . 0.0 109.625 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.643 HG21 ' HG3' ' A' ' 57' ' ' LYS . 10.8 m -134.29 136.78 43.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.245 -0.909 . . . . 0.0 109.54 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.814 ' CD1' HD13 ' A' ' 39' ' ' LEU . 30.6 m-85 -114.42 127.67 55.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 109.236 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.901 ' OD1' HD21 ' A' ' 22' ' ' LEU . 59.6 t-20 -50.6 -80.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.433 -0.792 . . . . 0.0 110.079 -179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.8 t-20 -80.85 149.5 67.36 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.004 -1.06 . . . . 0.0 109.555 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.35 -54.92 0.85 Allowed 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.793 2.329 . . . . 0.0 111.917 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.2 t -62.09 -28.33 69.54 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.965 -1.084 . . . . 0.0 108.265 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.4 mmm -64.41 -12.58 44.55 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.814 HD13 ' CD1' ' A' ' 33' ' ' TYR . 28.4 tp -73.56 -57.67 3.83 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.465 -0.772 . . . . 0.0 109.067 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.449 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.8 m -62.85 -18.47 62.93 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -71.85 -58.27 3.6 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -61.92 -17.08 55.52 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -77.15 -31.91 55.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.524 -0.735 . . . . 0.0 109.076 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.511 HD11 ' HH ' ' A' ' 8' ' ' TYR . 19.5 mt -58.55 -35.99 73.21 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.205 -0.935 . . . . 0.0 108.678 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.2 mm -78.64 -50.25 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.445 -0.784 . . . . 0.0 109.056 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 42.9 mtt-85 -64.46 -34.71 78.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.168 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 58.79 36.47 24.79 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.379 -0.826 . . . . 0.0 109.447 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.2 p -113.12 11.82 18.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.37 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 46.28 57.73 5.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.367 -0.833 . . . . 0.0 109.44 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 56.3 m -75.04 140.57 43.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.492 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 48.7 m-70 -112.5 170.01 8.48 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.551 HG12 HD22 ' A' ' 39' ' ' LEU . 39.7 mt -79.85 126.52 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.458 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 41.3 ttt180 -79.77 -45.82 18.12 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.403 -0.811 . . . . 0.0 109.285 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.7 p -158.19 162.51 37.9 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.4 p -79.05 133.08 36.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.122 -0.986 . . . . 0.0 109.755 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.535 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 99.95 165.35 29.06 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.643 ' HG3' HG21 ' A' ' 32' ' ' THR . 30.1 tttp -54.39 158.51 2.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.358 -1.083 . . . . 0.0 109.236 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.474 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 91.2 m -69.39 150.42 47.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.6 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.384 179.918 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.46 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 3.1 m -53.97 -34.95 61.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.361 179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -54.15 -27.52 34.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.3 -0.875 . . . . 0.0 109.039 179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtp -71.71 -19.84 62.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.392 -0.818 . . . . 0.0 109.044 179.612 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.9 m -85.48 -22.93 28.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.375 -0.828 . . . . 0.0 109.247 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -74.75 -14.33 60.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.289 -0.882 . . . . 0.0 109.488 179.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -109.34 4.09 22.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.872 -179.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.611 ' CZ ' ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -119.43 155.11 32.62 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.038 -1.039 . . . . 0.0 109.238 179.909 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.2 mtt180 -136.74 130.79 32.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.408 179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.593 HG21 ' C ' ' A' ' 15' ' ' GLY . 4.9 p -129.39 142.2 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -0.938 . . . . 0.0 109.469 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.775 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -103.88 173.55 3.33 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.36 179.956 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.775 ' HD2' HD23 ' A' ' 11' ' ' LEU . 47.6 Cg_endo -68.44 -26.72 34.37 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.595 2.197 . . . . 0.0 111.717 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 mtt180 -89.01 -28.41 20.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.289 -0.882 . . . . 0.0 109.295 179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.7 mm -84.39 -40.57 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.244 -0.91 . . . . 0.0 109.304 179.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.593 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 68.56 155.85 0.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.611 ' CE2' ' CZ ' ' A' ' 8' ' ' TYR . 1.3 t80 -55.67 148.06 17.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.292 -1.122 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.6 tp -123.1 119.62 30.83 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.325 -0.859 . . . . 0.0 109.323 179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.4 m -117.67 155.82 50.2 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 0.0 109.525 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.3 Cg_endo -71.55 166.02 30.69 Favored 'Trans proline' 0 C--O 1.216 -0.603 0 C-N-CA 122.844 2.363 . . . . 0.0 111.791 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -86.63 -8.01 57.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.867 . . . . 0.0 109.335 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -72.99 128.77 36.44 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.863 . . . . 0.0 109.304 179.708 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.918 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.1 tm? -92.12 124.69 36.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 109.49 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.717 ' N ' HD13 ' A' ' 22' ' ' LEU . 2.2 mmmm -145.27 103.68 4.36 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.0 109.304 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 42.6 Cg_endo -65.36 124.29 12.7 Favored 'Trans proline' 0 C--O 1.213 -0.727 0 C-N-CA 123.061 2.507 . . . . 0.0 112.298 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' HG23 ' A' ' 32' ' ' THR . 17.7 m -120.74 156.26 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.338 -0.851 . . . . 0.0 109.939 179.804 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.6 t -101.64 115.46 30.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 109.172 179.563 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -71.77 139.29 28.45 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.0 p30 -69.41 -9.83 55.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -1.14 . . . . 0.0 109.484 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.421 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.8 m-20 -82.95 8.13 13.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 0.0 109.31 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.75 14.35 63.31 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.0 mt-30 -120.75 159.73 24.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.304 -1.116 . . . . 0.0 109.467 -179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.506 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 33.1 m -119.1 134.66 55.06 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.834 . . . . 0.0 109.286 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.841 ' CD1' HD13 ' A' ' 39' ' ' LEU . 56.5 m-85 -113.26 123.83 51.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.119 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.918 ' OD1' HD21 ' A' ' 22' ' ' LEU . 64.2 t-20 -49.41 -81.46 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.256 -0.902 . . . . 0.0 109.806 -179.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.545 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.5 t-20 -80.93 147.97 63.28 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 120.871 -1.143 . . . . 0.0 109.72 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.6 Cg_endo -62.16 -53.11 2.17 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.845 2.363 . . . . 0.0 111.941 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.545 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.0 t -60.92 -28.5 68.98 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 120.911 -1.118 . . . . 0.0 108.023 178.863 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 22.2 mtp -63.99 -20.92 66.25 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.173 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.841 HD13 ' CD1' ' A' ' 33' ' ' TYR . 32.7 tp -67.38 -54.57 19.31 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.529 ' O ' HD12 ' A' ' 44' ' ' LEU . 38.1 t -58.34 -30.96 67.14 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -66.52 -59.04 4.0 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.335 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 73.9 mt-10 -59.2 -18.41 36.43 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.269 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.472 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 94.4 m-20 -77.28 -37.88 51.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.589 -0.695 . . . . 0.0 109.162 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.529 HD12 ' O ' ' A' ' 40' ' ' CYS . 5.4 mp -56.38 -34.24 66.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.173 -0.954 . . . . 0.0 108.79 179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.0 mt -79.01 -48.49 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.396 -0.815 . . . . 0.0 109.278 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.707 ' HG3' HG23 ' A' ' 48' ' ' THR . 19.9 tpt85 -65.64 -39.22 91.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.381 -0.824 . . . . 0.0 109.394 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 88.7 mt-30 62.67 41.84 8.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.414 -0.804 . . . . 0.0 109.56 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.707 HG23 ' HG3' ' A' ' 46' ' ' ARG . 27.3 p -121.92 10.65 10.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.281 -0.887 . . . . 0.0 109.497 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 51.51 60.84 3.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.212 -0.93 . . . . 0.0 109.355 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.472 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 26.7 m -77.52 141.56 39.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.268 -0.895 . . . . 0.0 109.625 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.46 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 22.7 m-70 -115.18 172.12 7.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 109.011 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.4 mt -82.96 124.75 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.147 -0.971 . . . . 0.0 109.499 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.501 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 24.7 tpt180 -82.16 -53.52 6.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.422 -0.799 . . . . 0.0 109.31 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.9 p -148.02 154.58 40.46 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.776 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.3 p -73.05 147.58 44.9 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.116 -0.99 . . . . 0.0 109.312 179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.95 165.15 40.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.549 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 35.0 mttm -66.86 145.6 55.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.43 -1.041 . . . . 0.0 109.301 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.75 153.06 29.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.267 -0.896 . . . . 0.0 109.534 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.453 -179.964 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 14.9 p30 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.34 0.59 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.558 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 4.0 m -56.17 -28.34 57.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.336 -0.852 . . . . 0.0 109.235 179.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -53.12 -26.1 15.45 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.282 -0.886 . . . . 0.0 108.863 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.1 mtm -69.32 -26.62 64.8 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.328 -0.857 . . . . 0.0 108.777 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 34.8 m -81.13 -17.12 50.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -0.785 . . . . 0.0 109.475 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 63.1 mttt -80.51 8.38 7.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.733 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.445 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 95.9 m-20 -137.83 10.76 2.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.011 -1.056 . . . . 0.0 110.241 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.616 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -121.36 151.18 40.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.907 -1.121 . . . . 0.0 109.565 179.803 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.8 mtt180 -132.02 134.86 46.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.415 -0.803 . . . . 0.0 109.236 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.837 HG13 ' O ' ' A' ' 15' ' ' GLY . 61.8 t -124.47 148.92 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.82 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.564 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.9 OUTLIER -129.6 175.23 3.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.437 -0.789 . . . . 0.0 109.276 179.849 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 43.8 Cg_endo -66.9 -21.73 49.83 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.651 2.234 . . . . 0.0 111.784 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.8 mtp85 -103.65 -28.26 11.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.375 -0.828 . . . . 0.0 109.52 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' A' ' 11' ' ' LEU . 90.2 mt -81.76 -46.99 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.298 -0.876 . . . . 0.0 109.547 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.837 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 78.97 -166.43 51.83 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.2 t80 -97.16 150.8 20.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.205 -1.174 . . . . 0.0 109.502 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.6 tp -120.07 116.29 25.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 109.681 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.6 m -127.37 157.37 72.94 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.266 -0.896 . . . . 0.0 109.201 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.8 Cg_endo -71.05 166.49 28.99 Favored 'Trans proline' 0 C--O 1.215 -0.671 0 C-N-CA 122.501 2.134 . . . . 0.0 111.682 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -88.12 -14.41 38.84 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.521 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -71.87 119.31 15.87 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.207 -0.933 . . . . 0.0 109.242 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.409 HD11 ' HB3' ' A' ' 34' ' ' ASN . 43.0 tp -83.61 116.39 22.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.75 -179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.6 mmtt -129.7 105.45 17.11 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.285 -0.885 . . . . 0.0 109.087 179.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.567 ' HB2' ' CG ' ' A' ' 57' ' ' LYS . 43.4 Cg_endo -65.27 119.82 6.91 Favored 'Trans proline' 0 C--O 1.213 -0.766 0 C-N-CA 122.952 2.434 . . . . 0.0 112.283 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 32' ' ' THR . 24.3 m -117.63 154.8 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.873 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 25.8 t -95.72 127.61 41.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.329 -0.857 . . . . 0.0 108.753 179.21 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -83.07 137.51 16.61 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.4 p30 -67.8 -8.52 36.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -1.153 . . . . 0.0 109.536 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -85.6 7.34 23.54 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 109.384 179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.54 16.07 57.45 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -179.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.452 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.5 mt-30 -123.2 173.46 7.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.265 -1.138 . . . . 0.0 109.567 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.493 HG21 ' HA ' ' A' ' 57' ' ' LYS . 25.9 m -133.0 135.42 45.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.387 -0.82 . . . . 0.0 109.263 179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.745 ' CD1' HD13 ' A' ' 39' ' ' LEU . 37.0 m-85 -112.54 130.09 56.13 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.202 -0.936 . . . . 0.0 109.371 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.525 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 8.4 m-20 -53.77 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 109.72 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.0 t-20 -81.84 147.8 59.45 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.075 -1.016 . . . . 0.0 109.642 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.29 -53.87 1.3 Allowed 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.789 2.326 . . . . 0.0 111.813 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -61.32 -27.49 68.52 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 42.8 mmm -64.81 -17.88 64.62 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.234 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.745 HD13 ' CD1' ' A' ' 33' ' ' TYR . 24.2 tp -68.54 -58.16 4.72 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.453 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 10.5 t -56.36 -26.12 51.72 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.687 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -68.59 -61.56 1.77 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.403 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 69.1 mt-10 -56.02 -19.86 14.38 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.239 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.2 m-20 -78.56 -40.27 35.31 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.7 tp -55.83 -33.84 64.85 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.417 -0.802 . . . . 0.0 108.845 179.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 mt -78.82 -50.53 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.363 -0.836 . . . . 0.0 108.995 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 13.2 mtt-85 -65.48 -22.02 66.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.279 -0.888 . . . . 0.0 109.348 179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 89.0 mt-30 63.83 43.67 5.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.365 -0.834 . . . . 0.0 109.333 -179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.4 t -131.57 168.99 16.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.32 -0.863 . . . . 0.0 109.409 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.579 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 90.7 m-20 -103.56 63.29 0.78 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.43 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 35.1 m -74.42 140.01 44.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -0.867 . . . . 0.0 109.703 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.579 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 31.4 m80 -116.66 178.93 4.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.044 179.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.411 HG23 ' HB ' ' A' ' 25' ' ' VAL . 30.0 mt -87.99 124.9 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.058 -1.026 . . . . 0.0 109.4 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 69.9 ttt-85 -80.19 -47.5 14.58 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.543 -0.723 . . . . 0.0 109.288 179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.3 p -155.33 152.99 29.83 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -71.69 146.03 48.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.15 -0.969 . . . . 0.0 109.415 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.98 164.23 40.17 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 -179.767 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.567 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 26.1 mttp -64.58 143.66 57.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.554 -0.968 . . . . 0.0 109.447 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.05 151.55 35.47 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.257 -0.902 . . . . 0.0 109.397 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.5 -179.864 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.31 0.576 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.462 ' HB2' ' HB3' ' A' ' 51' ' ' HIS . 5.0 m -55.08 -26.55 38.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.3 tt0 -53.22 -25.88 15.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.062 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.7 mtp -73.89 -36.02 64.73 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.351 -0.843 . . . . 0.0 108.915 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.573 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.0 m -85.58 4.14 37.49 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.342 -0.849 . . . . 0.0 109.083 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.567 ' HE2' ' CD2' ' A' ' 51' ' ' HIS . 24.7 mttt -73.05 -20.48 60.97 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.219 -0.926 . . . . 0.0 109.383 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 58.6 p30 -148.93 57.55 1.03 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.363 -0.836 . . . . 0.0 109.838 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.651 ' OH ' HD21 ' A' ' 44' ' ' LEU . 12.0 p90 -120.83 -175.44 3.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.239 -0.913 . . . . 0.0 109.242 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -152.64 145.6 24.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.916 . . . . 0.0 109.391 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 15' ' ' GLY . 55.5 t -132.04 129.68 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.243 -0.911 . . . . 0.0 109.579 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -111.94 175.37 1.9 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.906 . . . . 0.0 109.355 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.4 Cg_endo -67.57 -23.66 42.85 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.61 2.207 . . . . 0.0 111.651 179.874 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.9 ttp85 -93.28 -39.72 10.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.89 . . . . 0.0 109.207 179.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 84.7 mt -79.95 -43.84 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.359 -0.838 . . . . 0.0 109.351 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.843 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 67.27 -155.05 52.86 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.665 ' CD2' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -112.71 148.13 35.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.323 -1.104 . . . . 0.0 109.25 179.974 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.844 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.5 OUTLIER -122.0 128.93 52.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.211 -0.931 . . . . 0.0 109.474 179.998 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.0 m -136.4 157.27 75.7 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.272 -0.893 . . . . 0.0 109.317 179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -70.4 165.73 30.74 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.575 2.184 . . . . 0.0 111.662 179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -87.4 -10.5 51.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -78.52 108.88 12.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.299 -0.876 . . . . 0.0 109.443 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.709 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.5 tm? -76.0 110.8 10.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 -179.87 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 34' ' ' ASN . 2.6 mtpt -124.3 109.66 29.01 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.269 -0.894 . . . . 0.0 109.313 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 40.4 Cg_endo -62.31 121.26 9.19 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 123.035 2.49 . . . . 0.0 112.272 -179.692 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.582 ' HB ' HG23 ' A' ' 52' ' ' ILE . 11.1 m -115.78 155.78 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.414 -0.804 . . . . 0.0 109.904 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.7 t -97.27 112.92 24.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.365 -0.834 . . . . 0.0 108.932 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -67.18 133.5 31.04 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.788 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.539 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.4 t0 -69.62 -6.46 31.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -1.188 . . . . 0.0 109.783 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 57.4 p30 -85.53 1.99 46.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.084 -1.01 . . . . 0.0 109.342 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.71 18.26 30.62 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -179.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.3 mt-30 -126.84 173.88 9.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.498 -1.001 . . . . 0.0 109.341 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.887 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.5 m -132.63 138.35 47.34 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.266 -0.896 . . . . 0.0 109.29 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.86 ' CD2' HD12 ' A' ' 39' ' ' LEU . 31.4 m-85 -118.38 139.81 50.81 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.163 -179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 0.7 OUTLIER -61.03 -76.02 0.06 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 -179.365 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.537 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.0 t-20 -82.31 146.81 55.22 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 120.988 -1.07 . . . . 0.0 109.64 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.9 Cg_endo -63.65 -52.23 1.98 Allowed 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.599 2.199 . . . . 0.0 111.68 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.6 t -63.42 -27.62 69.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 0.0 108.183 178.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.496 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 54.3 mtp -67.88 -19.8 65.06 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.86 HD12 ' CD2' ' A' ' 33' ' ' TYR . 7.3 tt -66.52 -52.92 40.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.331 -0.856 . . . . 0.0 108.873 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 43' ' ' ASN . 9.4 m -51.16 -41.05 59.89 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.41 ' C ' ' O ' ' A' ' 40' ' ' CYS . 16.1 t60 -48.06 -48.1 33.54 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.972 -1.08 . . . . 0.0 108.209 178.85 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 49.8 mm-40 -58.37 -22.18 52.75 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.348 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.509 ' N ' ' O ' ' A' ' 40' ' ' CYS . 2.9 m-80 -75.7 -35.83 60.18 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.473 -0.891 . . . . 0.0 108.997 179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.651 HD21 ' OH ' ' A' ' 8' ' ' TYR . 31.7 mt -65.86 -48.69 70.76 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.301 -0.874 . . . . 0.0 109.389 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 45' ' ' ILE . 5.8 mm -67.2 -52.82 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 109.118 179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.506 ' HG2' HG23 ' A' ' 48' ' ' THR . 72.8 ttt180 -68.56 -22.87 64.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.307 179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' ASN . 86.7 mt-30 63.06 43.17 6.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.363 -0.835 . . . . 0.0 109.571 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.506 HG23 ' HG2' ' A' ' 46' ' ' ARG . 60.7 p -132.96 167.42 20.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.145 -0.972 . . . . 0.0 109.576 179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.577 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 89.8 m-20 -94.3 57.83 2.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.233 -0.917 . . . . 0.0 109.601 -179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.48 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 57.0 m -80.19 127.16 32.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.467 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 14.6 m80 -115.79 -169.22 1.55 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.444 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.582 HG23 ' HB ' ' A' ' 25' ' ' VAL . 37.8 mt -88.12 124.98 41.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.473 -0.767 . . . . 0.0 109.836 -179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.539 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 64.5 ttt180 -82.53 -49.64 9.67 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.746 0.784 . . . . 0.0 109.383 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 p -150.72 138.83 20.14 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.629 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.1 p -60.95 144.59 52.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.117 -0.99 . . . . 0.0 109.284 -179.907 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.48 160.72 36.43 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.887 ' HG3' HG21 ' A' ' 32' ' ' THR . 17.7 tttm -61.52 148.87 40.62 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.521 -0.987 . . . . 0.0 109.397 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.1 145.31 32.46 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.654 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.587 -179.948 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.468 ' OD1' ' CG1' ' A' ' 52' ' ' ILE . 72.3 m-20 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.525 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 5.2 m -51.55 -26.12 8.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.87 . . . . 0.0 109.352 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 4.4 mt-10 -52.13 -25.93 10.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.22 -0.925 . . . . 0.0 108.867 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.5 mtt -80.36 -31.79 37.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.375 -0.828 . . . . 0.0 109.034 179.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.4 m -80.0 -5.54 55.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.296 179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 32.2 mttm -61.6 -23.2 65.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.674 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -151.31 64.51 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 109.928 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.709 ' OH ' HD13 ' A' ' 44' ' ' LEU . 6.7 p90 -123.77 174.33 7.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.109 -0.994 . . . . 0.0 109.198 179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -147.35 146.49 29.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.648 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.594 HG21 ' CD2' ' A' ' 16' ' ' TYR . 69.3 t -145.29 132.14 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.286 -0.884 . . . . 0.0 109.484 -179.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.645 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -117.8 175.08 2.2 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.269 -0.894 . . . . 0.0 109.597 -179.968 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.645 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.9 Cg_endo -67.73 -26.35 39.1 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.687 2.258 . . . . 0.0 111.951 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 25.9 mtt85 -107.8 -24.49 11.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.369 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.4 mm -82.59 -43.08 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.3 -0.875 . . . . 0.0 109.557 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.577 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.25 -159.14 53.23 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.594 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.7 t80 -98.6 153.73 18.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -1.177 . . . . 0.0 109.466 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 31.3 tp -107.86 123.25 48.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 109.877 -179.562 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 68.3 m -140.19 156.48 70.03 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.306 -0.871 . . . . 0.0 109.21 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.4 Cg_endo -71.56 167.6 25.96 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.558 2.172 . . . . 0.0 111.701 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.3 tttm -84.07 -29.47 26.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.613 -179.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.34 125.94 25.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.241 -0.912 . . . . 0.0 109.418 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.584 HD11 ' CB ' ' A' ' 34' ' ' ASN . 59.5 tp -88.26 113.21 23.64 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.154 -0.966 . . . . 0.0 109.432 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.544 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.5 mttt -121.27 105.61 39.29 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 0.0 109.511 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -64.69 118.67 5.63 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 123.085 2.523 . . . . 0.0 112.215 -179.56 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.473 ' HB ' HG23 ' A' ' 52' ' ' ILE . 14.1 m -115.72 156.01 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.316 -0.865 . . . . 0.0 109.885 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.4 t -98.95 142.87 29.9 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.404 ' C ' ' HB2' ' A' ' 53' ' ' ARG . . . -95.82 143.7 16.82 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.488 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.2 t0 -71.87 -14.33 61.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -1.124 . . . . 0.0 109.416 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -83.69 -5.38 59.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.0 109.35 179.666 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.44 22.04 10.87 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 85.5 mt-30 -121.46 170.95 9.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -1.13 . . . . 0.0 109.469 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.541 HG23 ' HA ' ' A' ' 57' ' ' LYS . 86.6 m -133.61 136.66 45.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.493 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.836 ' CD1' HD13 ' A' ' 39' ' ' LEU . 28.3 m-85 -115.02 146.23 41.47 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.329 -0.857 . . . . 0.0 108.754 179.419 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.584 ' CB ' HD11 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -67.98 -75.53 0.1 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.01 -1.056 . . . . 0.0 108.626 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.9 t-20 -82.77 146.7 53.29 Favored Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.44 -0.788 . . . . 0.0 109.403 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -63.61 -51.18 2.64 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.693 2.262 . . . . 0.0 111.591 179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -62.18 -28.58 69.77 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.432 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 10.3 mtt -64.4 -16.91 63.21 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.364 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.836 HD13 ' CD1' ' A' ' 33' ' ' TYR . 30.9 tp -65.94 -53.69 35.98 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 12.5 t -60.65 -23.48 64.82 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 25.2 t60 -67.31 -58.98 3.8 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -58.79 -22.07 57.48 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 178.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.461 ' O ' ' N ' ' A' ' 47' ' ' GLN . 78.2 m-20 -80.38 -30.77 37.87 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.531 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.709 HD13 ' OH ' ' A' ' 8' ' ' TYR . 49.5 tp -62.38 -35.56 79.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.228 -0.92 . . . . 0.0 108.76 179.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mt -80.49 -50.33 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.4 -0.813 . . . . 0.0 109.249 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 96.1 mtt180 -68.89 -40.27 79.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -0.903 . . . . 0.0 109.516 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 92.7 mt-30 65.0 39.56 5.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.543 -0.723 . . . . 0.0 109.547 -179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 46' ' ' ARG . 40.6 p -108.15 6.97 27.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 0.0 109.393 179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.1 t30 52.74 56.79 7.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.524 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 72.9 m -78.6 140.46 38.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.542 179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.525 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 51.2 m80 -112.12 169.11 9.08 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.275 -0.891 . . . . 0.0 108.993 179.523 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.507 HG12 HD22 ' A' ' 39' ' ' LEU . 23.3 mt -79.47 127.11 39.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.218 -0.926 . . . . 0.0 109.241 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.488 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 53.7 ttt-85 -79.35 -46.14 18.23 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.389 -0.819 . . . . 0.0 109.134 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.8 m -160.61 148.08 15.89 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.7 p -61.18 145.3 51.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.165 -0.959 . . . . 0.0 109.42 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.6 166.23 40.9 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.798 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HA ' HG23 ' A' ' 32' ' ' THR . 89.2 mttt -67.71 150.16 49.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.355 -1.085 . . . . 0.0 109.499 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 66.7 m -59.79 151.11 26.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.261 -0.9 . . . . 0.0 109.318 179.769 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.488 179.971 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.516 ' OG ' ' CD2' ' A' ' 39' ' ' LEU . 1.4 m -49.91 -36.88 29.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.224 -0.923 . . . . 0.0 109.482 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -54.28 -27.19 33.63 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.301 -0.874 . . . . 0.0 108.93 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.0 ttm -69.17 -28.73 66.67 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.4 -0.812 . . . . 0.0 109.277 179.523 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.477 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 81.3 m -81.64 -31.18 32.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.244 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -60.49 -23.71 64.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.398 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -76.41 -25.73 54.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.359 -0.838 . . . . 0.0 109.512 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.465 ' OH ' ' CD1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -103.66 155.22 18.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.197 -0.939 . . . . 0.0 109.226 -179.889 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 82.3 mtm-85 -128.36 139.71 52.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.322 -0.861 . . . . 0.0 109.317 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.758 HG21 ' C ' ' A' ' 15' ' ' GLY . 13.0 p -123.17 146.0 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.221 -0.924 . . . . 0.0 109.51 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.556 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -108.59 176.08 1.72 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.556 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.3 Cg_endo -67.14 -25.4 43.54 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.601 2.201 . . . . 0.0 111.675 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -85.01 -31.3 23.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.253 -0.904 . . . . 0.0 108.917 179.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 88.8 mt -87.04 -37.68 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.398 -0.814 . . . . 0.0 109.128 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.758 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 66.52 142.24 0.05 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.678 ' N ' HG21 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -42.27 152.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.446 -1.032 . . . . 0.0 109.833 -179.921 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 tp -123.53 118.29 27.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.426 -0.796 . . . . 0.0 109.518 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.7 m -129.24 157.28 76.58 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.374 -0.829 . . . . 0.0 109.188 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.67 165.86 30.63 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.691 2.261 . . . . 0.0 111.755 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -89.12 -8.74 53.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.23 -0.919 . . . . 0.0 109.421 -179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -76.97 107.18 9.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 0.0 109.07 179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 34' ' ' ASN . 59.4 tp -71.2 121.16 17.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.811 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 31.1 mtmt -139.57 110.53 7.47 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.235 -0.915 . . . . 0.0 109.102 179.607 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.8 Cg_endo -65.54 119.48 6.51 Favored 'Trans proline' 0 C--O 1.213 -0.738 0 C-N-CA 123.175 2.584 . . . . 0.0 112.631 -179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 32' ' ' THR . 27.3 m -112.49 156.22 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 0.0 109.65 179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 12.3 t -98.59 111.44 23.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 109.315 179.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.3 138.16 36.17 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 40.1 t0 -71.26 -4.73 27.38 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -1.199 . . . . 0.0 109.606 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 57.6 m-20 -90.07 7.2 38.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.083 -1.01 . . . . 0.0 109.101 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.77 14.5 59.48 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.441 ' O ' ' N ' ' A' ' 27' ' ' GLY . 77.0 mt-30 -125.69 140.23 52.88 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.414 -1.051 . . . . 0.0 109.46 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 25' ' ' VAL . 17.1 m -103.59 153.21 20.85 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -0.902 . . . . 0.0 109.34 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.563 ' CZ ' ' HG3' ' A' ' 42' ' ' GLU . 19.9 m-85 -128.58 143.16 50.91 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.353 -0.842 . . . . 0.0 109.336 -179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.1 m-20 -58.54 -75.23 0.05 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.279 -0.888 . . . . 0.0 109.962 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 6.7 t-20 -82.5 147.76 56.93 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.069 -1.019 . . . . 0.0 109.993 -179.543 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.5 Cg_endo -64.3 -53.44 1.12 Allowed 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.746 2.298 . . . . 0.0 111.485 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.529 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.5 t -60.77 -27.69 68.18 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 36.5 mmm -63.78 -17.46 63.09 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 179.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.816 HD13 HG12 ' A' ' 52' ' ' ILE . 8.2 tt -68.26 -52.82 29.63 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.352 -0.843 . . . . 0.0 108.985 179.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.5 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . 45.0 m -47.9 -47.41 32.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.095 -1.003 . . . . 0.0 108.392 179.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.439 ' HA ' HD13 ' A' ' 44' ' ' LEU . 14.7 t60 -47.97 -49.35 30.89 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.128 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.563 ' HG3' ' CZ ' ' A' ' 33' ' ' TYR . 71.8 mm-40 -49.41 -24.05 1.79 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 4.6 m-80 -80.02 -37.64 33.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.416 -0.803 . . . . 0.0 108.873 179.352 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.3 mp -67.5 -36.71 81.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.221 179.575 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.414 HG21 HD13 ' A' ' 45' ' ' ILE . 5.3 mt -77.12 -52.53 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.077 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 48' ' ' THR . 47.0 mtt-85 -71.85 -20.99 61.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.327 -0.858 . . . . 0.0 109.373 179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 43' ' ' ASN . 88.2 mt-30 62.44 35.45 14.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.338 -0.851 . . . . 0.0 109.312 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.442 HG23 ' O ' ' A' ' 46' ' ' ARG . 30.8 p -125.48 175.11 7.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.344 -0.847 . . . . 0.0 109.444 -179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.575 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 79.8 m-20 -94.75 58.87 2.34 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.211 -0.931 . . . . 0.0 109.451 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.472 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 30.9 m -79.22 126.11 30.33 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 32.3 m80 -115.7 -172.57 2.18 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.172 179.672 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.816 HG12 HD13 ' A' ' 39' ' ' LEU . 13.0 mt -87.78 124.27 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.156 -0.965 . . . . 0.0 109.576 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 61.3 ttt180 -80.07 -53.49 6.66 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.647 0.737 . . . . 0.0 109.319 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 p -150.88 143.89 24.66 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.629 -0.67 . . . . 0.0 109.203 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.3 p -64.83 144.86 56.97 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.196 -0.94 . . . . 0.0 109.405 -179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.03 161.66 36.92 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 32' ' ' THR . 23.2 tttt -62.22 144.96 54.82 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.449 -1.03 . . . . 0.0 109.278 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.37 157.22 26.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 109.616 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.545 -179.986 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.579 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 0.5 OUTLIER -52.62 -35.04 53.76 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.136 -0.977 . . . . 0.0 109.289 179.972 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -51.58 -26.47 8.79 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.298 -0.877 . . . . 0.0 108.74 179.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.4 mmm -72.17 -23.78 61.33 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.244 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.595 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 33.5 m -80.31 -17.74 51.19 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.524 -0.735 . . . . 0.0 109.021 179.657 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -80.77 8.35 8.33 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.516 179.596 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -133.24 2.8 3.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.132 -0.98 . . . . 0.0 109.996 -179.667 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.677 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 0.4 OUTLIER -118.76 148.52 42.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.014 -1.054 . . . . 0.0 109.539 -179.977 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.7 mtm-85 -129.14 132.21 47.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.86 . . . . 0.0 109.112 179.553 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.606 ' C ' HD22 ' A' ' 11' ' ' LEU . 42.2 t -126.51 140.48 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.149 -0.969 . . . . 0.0 109.892 -179.654 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 10' ' ' VAL . 3.8 mm? -117.95 170.26 6.53 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 41.7 Cg_endo -65.44 -21.43 60.56 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.192 1.928 . . . . 0.0 111.575 179.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -94.88 -25.29 16.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.366 -0.834 . . . . 0.0 109.418 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 83.2 mt -88.92 -50.44 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.298 -0.876 . . . . 0.0 109.944 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.567 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.24 -174.31 53.46 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.801 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.677 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -91.81 148.28 22.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -1.172 . . . . 0.0 109.552 -179.938 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.3 tp -120.96 100.67 7.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.898 . . . . 0.0 109.728 -179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.6 m -111.04 157.73 37.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 109.235 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 53.6 Cg_endo -73.22 167.87 26.23 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.67 2.247 . . . . 0.0 111.681 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -87.62 -26.5 23.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -0.917 . . . . 0.0 109.346 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.452 ' HB2' ' HE2' ' A' ' 23' ' ' LYS . 46.4 m-20 -57.89 124.54 19.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.163 -0.961 . . . . 0.0 109.171 179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.406 HD11 ' HB3' ' A' ' 34' ' ' ASN . 36.2 tp -88.73 116.3 26.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.944 . . . . 0.0 109.613 -179.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASN . 3.8 mttt -127.43 103.2 22.65 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 108.983 179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.527 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.7 Cg_endo -65.63 115.85 3.61 Favored 'Trans proline' 0 C--O 1.214 -0.72 0 C-N-CA 122.937 2.425 . . . . 0.0 111.842 -179.431 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.421 ' O ' HG23 ' A' ' 32' ' ' THR . 21.7 m -113.89 154.43 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.891 . . . . 0.0 109.732 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.1 t -94.22 131.49 39.75 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.343 -0.848 . . . . 0.0 108.738 179.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -86.85 137.24 14.64 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.4 p30 -66.23 -12.11 54.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -1.159 . . . . 0.0 109.616 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 52.6 p30 -83.75 8.92 13.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.184 -0.947 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.01 20.83 54.64 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.451 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 68.8 mt-30 -125.51 175.98 7.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.47 -1.017 . . . . 0.0 109.326 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.602 HG21 ' HA ' ' A' ' 57' ' ' LYS . 14.1 m -135.1 136.38 41.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.213 -0.929 . . . . 0.0 109.432 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.65 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.5 m-85 -113.87 120.43 40.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.29 -0.882 . . . . 0.0 109.267 179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 10.4 m-20 -45.55 -78.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.985 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.3 t-20 -81.66 148.92 63.08 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.02 -1.05 . . . . 0.0 109.881 -179.583 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 41.2 Cg_endo -63.79 -54.35 0.98 Allowed 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.732 2.288 . . . . 0.0 111.927 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -63.01 -25.59 68.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.026 -1.046 . . . . 0.0 108.373 179.137 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 35.2 mmm -66.43 -11.56 52.45 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.559 -0.713 . . . . 0.0 109.095 179.39 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.65 HD13 ' CD1' ' A' ' 33' ' ' TYR . 20.9 tp -71.38 -60.12 2.4 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.29 -0.881 . . . . 0.0 108.707 179.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 10.3 t -54.65 -28.35 46.53 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.966 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -67.8 -60.64 2.36 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.143 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 78.4 mt-10 -57.78 -18.74 23.45 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.217 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.436 ' O ' ' N ' ' A' ' 47' ' ' GLN . 96.7 m-20 -77.54 -32.6 54.06 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.92 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.4 tm? -58.36 -38.99 78.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.514 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 mm -75.56 -49.73 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -0.867 . . . . 0.0 108.767 179.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 47.0 mtt-85 -63.71 -28.55 69.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.334 -0.854 . . . . 0.0 109.187 179.667 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 89.5 mt-30 63.15 44.03 6.01 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.45 -0.781 . . . . 0.0 109.505 179.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.6 p -133.51 167.05 21.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.369 -0.832 . . . . 0.0 109.346 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.576 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 48.7 p-10 -95.91 61.35 2.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.309 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 93.9 m -72.46 135.37 45.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.856 -179.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.579 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 42.5 m80 -115.28 -178.1 3.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 108.939 179.471 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.2 mt -90.25 123.04 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.169 -0.957 . . . . 0.0 109.004 179.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 50.1 ttt85 -79.65 -44.52 20.77 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.393 -0.817 . . . . 0.0 109.432 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 p -158.56 158.09 33.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.549 -0.719 . . . . 0.0 109.121 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.9 p -75.5 136.97 40.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.264 -0.897 . . . . 0.0 109.698 -179.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.47 162.73 34.11 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.991 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.602 ' HA ' HG21 ' A' ' 32' ' ' THR . 48.0 tttm -49.59 159.4 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.486 -1.008 . . . . 0.0 109.216 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.492 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 73.1 m -68.39 145.35 54.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.38 -179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.045 -0.978 . . . . 0.0 109.549 179.965 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.478 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 2.8 m -52.25 -39.49 60.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.281 -0.887 . . . . 0.0 109.531 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 35.4 mt-10 -50.61 -31.18 15.24 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.447 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 45.1 ttm -66.12 -27.23 67.88 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.11 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.543 ' O ' ' CD2' ' A' ' 8' ' ' TYR . 71.2 m -80.48 -9.15 59.77 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.451 -0.781 . . . . 0.0 109.138 179.657 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 22.5 mttm -81.12 11.03 4.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.092 -1.005 . . . . 0.0 109.617 179.508 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' ' 4' ' ' MET . 49.2 p30 -127.31 8.29 6.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.994 -1.066 . . . . 0.0 110.653 -179.295 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.778 ' OH ' HD11 ' A' ' 44' ' ' LEU . 6.9 p90 -107.59 -177.41 3.34 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.723 -1.235 . . . . 0.0 109.686 179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.579 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 46.8 mtt180 -151.91 128.46 10.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.391 -0.818 . . . . 0.0 109.226 179.567 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.591 HG23 ' CE1' ' A' ' 8' ' ' TYR . 24.5 t -127.14 145.36 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.7 -179.678 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.559 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -118.53 176.33 1.72 Allowed Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.365 -0.834 . . . . 0.0 109.169 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.0 Cg_endo -66.96 -21.97 49.04 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.557 2.171 . . . . 0.0 111.773 179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 76.8 mtt-85 -96.81 -27.75 14.57 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.2 mm -84.1 -47.47 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.707 -179.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.468 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 78.32 177.6 48.48 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.494 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -83.0 147.68 28.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -1.16 . . . . 0.0 109.435 -179.917 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.0 tp -118.9 105.74 11.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.755 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.9 m -116.22 155.87 47.73 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.903 . . . . 0.0 108.964 179.501 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.25 165.63 32.08 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.561 2.174 . . . . 0.0 111.543 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -84.04 -31.79 25.21 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 109.267 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -54.18 132.8 43.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.384 -0.823 . . . . 0.0 109.052 179.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 34' ' ' ASN . 61.3 tp -96.93 119.45 35.42 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.175 -0.953 . . . . 0.0 109.628 -179.761 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' ASN . 3.9 mttm -130.99 106.56 15.1 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 0.0 108.899 179.647 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.64 123.41 11.66 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 123.009 2.472 . . . . 0.0 112.354 -179.183 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.438 ' HB ' HG23 ' A' ' 52' ' ' ILE . 17.6 m -118.18 155.15 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.412 -0.805 . . . . 0.0 109.728 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 48.7 t -96.49 138.09 34.59 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.44 135.64 12.9 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -66.83 -11.03 53.96 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.248 -1.148 . . . . 0.0 109.465 179.815 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.462 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.7 p30 -89.03 10.68 20.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.437 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.45 19.25 57.24 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 90.1 mt-30 -120.5 178.42 4.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -1.147 . . . . 0.0 109.549 179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.775 HG21 ' HG3' ' A' ' 57' ' ' LYS . 35.3 m -139.58 136.76 34.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.28 -0.887 . . . . 0.0 109.29 179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.903 ' CD1' HD13 ' A' ' 39' ' ' LEU . 26.4 m-85 -117.81 128.79 55.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.161 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 11.7 m-20 -52.66 -78.97 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.274 -0.891 . . . . 0.0 109.794 -179.476 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.5 t-20 -81.69 147.25 58.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 120.99 -1.069 . . . . 0.0 109.719 -179.68 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.5 Cg_endo -63.51 -52.12 2.12 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.782 2.321 . . . . 0.0 111.739 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.525 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.4 t -62.95 -26.47 68.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.16 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.441 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 54.0 mmm -68.71 -15.15 63.43 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.149 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.903 HD13 ' CD1' ' A' ' 33' ' ' TYR . 21.2 tp -72.21 -50.85 24.29 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.415 -0.803 . . . . 0.0 109.339 179.784 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.494 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.5 m -66.14 -22.38 66.38 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.017 -1.052 . . . . 0.0 108.224 179.265 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -66.81 -56.17 11.62 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 178.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 95.5 mt-10 -63.43 -17.04 62.26 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' GLN . 86.2 m-20 -79.95 -26.37 40.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.602 -0.686 . . . . 0.0 109.186 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.778 HD11 ' OH ' ' A' ' 8' ' ' TYR . 19.2 mt -69.02 -33.29 73.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.165 -0.959 . . . . 0.0 108.649 179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.4 mt -78.73 -50.36 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.431 -0.793 . . . . 0.0 108.978 179.516 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.584 ' HB3' HG23 ' A' ' 48' ' ' THR . 47.0 mtm180 -74.35 -34.25 63.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.904 . . . . 0.0 109.305 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 59.62 39.24 21.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.367 -0.833 . . . . 0.0 109.553 179.805 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.584 HG23 ' HB3' ' A' ' 46' ' ' ARG . 38.1 p -103.97 16.68 25.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.51 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 48' ' ' THR . 53.2 m-20 44.22 52.13 7.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.408 179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.443 ' OG1' ' NH2' ' A' ' 46' ' ' ARG . 76.6 m -74.9 146.26 42.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.614 -179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 31.6 m-70 -123.72 168.76 12.26 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.28 -0.887 . . . . 0.0 109.282 179.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.502 HG12 HD22 ' A' ' 39' ' ' LEU . 16.9 mt -79.73 124.35 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.236 -0.915 . . . . 0.0 109.447 -179.954 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 78.3 ttt180 -79.76 -44.14 21.24 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.358 -0.839 . . . . 0.0 109.235 179.939 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 p -160.19 148.82 17.04 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.8 p -64.86 145.12 56.72 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.166 -0.959 . . . . 0.0 109.536 -179.835 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.94 164.23 39.79 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.775 ' HG3' HG21 ' A' ' 32' ' ' THR . 17.4 tttt -60.44 151.45 28.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.461 -1.023 . . . . 0.0 109.361 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.402 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 72.2 m -58.47 152.39 18.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.498 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.469 179.89 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -47.9 -37.88 15.14 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.273 -0.892 . . . . 0.0 109.185 179.739 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 11.0 mt-10 -49.88 -26.42 4.07 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.765 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 ttm -70.41 -27.58 64.4 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.556 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 5.7 m -79.77 -12.35 59.79 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.447 -0.783 . . . . 0.0 109.05 179.496 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 28.3 mttm -55.21 -26.78 41.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.213 -0.929 . . . . 0.0 109.933 -179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -151.56 65.77 0.88 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.692 -179.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.932 ' OH ' HD11 ' A' ' 44' ' ' LEU . 4.1 p90 -128.79 170.7 13.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.17 -0.956 . . . . 0.0 109.508 179.756 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 ttt180 -144.85 154.99 43.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.293 -0.88 . . . . 0.0 109.386 179.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.846 HG13 ' C ' ' A' ' 15' ' ' GLY . 95.3 t -146.66 127.27 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.523 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -117.19 173.42 3.15 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.338 -0.851 . . . . 0.0 109.21 -179.881 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HD2' HD23 ' A' ' 11' ' ' LEU . 43.1 Cg_endo -65.94 -22.92 55.11 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.498 2.132 . . . . 0.0 111.568 179.736 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -105.92 -33.66 7.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.336 -0.852 . . . . 0.0 109.066 179.565 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.403 HD12 HD13 ' A' ' 11' ' ' LEU . 89.6 mt -81.64 -40.95 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.359 -0.838 . . . . 0.0 109.118 179.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.846 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 65.09 -145.13 48.91 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.795 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.557 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.9 t80 -105.34 158.0 16.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.31 -1.112 . . . . 0.0 109.495 -179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.32 114.01 21.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.251 -0.906 . . . . 0.0 109.489 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 62.6 m -128.1 156.19 76.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 109.331 179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.13 170.28 18.55 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.616 2.211 . . . . 0.0 111.625 -179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -91.3 -12.48 34.94 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.122 -0.986 . . . . 0.0 109.644 -179.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -73.3 115.84 13.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.25 -0.906 . . . . 0.0 109.283 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.4 tp -73.17 126.36 29.85 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.625 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -139.75 100.39 7.41 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.341 -0.849 . . . . 0.0 109.007 179.818 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -64.09 117.71 4.71 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.971 2.447 . . . . 0.0 112.345 -179.272 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 32' ' ' THR . 11.0 m -116.1 155.15 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.402 -0.811 . . . . 0.0 109.841 -179.952 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 49.7 t -96.81 137.31 36.09 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.307 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.27 139.56 14.6 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 46.2 p30 -65.76 -9.12 25.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.384 -1.068 . . . . 0.0 109.612 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -89.12 14.03 11.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.478 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.12 26.33 58.06 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.459 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 79.7 mt-30 -130.5 174.86 9.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.218 -1.166 . . . . 0.0 109.288 -179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 32.9 m -131.81 152.93 50.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.276 -0.89 . . . . 0.0 109.376 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.882 ' CD2' HD12 ' A' ' 39' ' ' LEU . 40.6 m-85 -132.68 119.88 20.98 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.246 -0.909 . . . . 0.0 109.197 -179.849 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 3.7 m-20 -43.6 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 109.689 -179.289 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.2 t-20 -81.69 146.26 56.21 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.094 -1.004 . . . . 0.0 109.299 179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.94 -50.95 2.57 Favored 'Trans proline' 0 C--O 1.215 -0.633 0 C-N-CA 122.593 2.195 . . . . 0.0 111.483 179.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.8 t -61.96 -25.35 67.56 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.828 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.438 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 13.9 mtp -68.14 -17.95 64.49 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.368 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.882 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.3 tt -67.74 -50.61 56.35 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.426 -0.796 . . . . 0.0 108.858 179.654 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 4.7 t -52.54 -45.69 66.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 0.0 108.521 179.194 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.403 ' HA ' HD23 ' A' ' 44' ' ' LEU . 15.9 t60 -48.99 -48.94 43.02 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.16 -0.962 . . . . 0.0 108.481 179.041 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 23.0 mm-40 -57.18 -20.22 25.28 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.528 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.8 m-80 -79.69 -33.13 41.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 108.612 179.2 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.932 HD11 ' OH ' ' A' ' 8' ' ' TYR . 3.9 mm? -67.11 -46.71 73.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 109.388 179.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.495 ' N ' HD13 ' A' ' 45' ' ' ILE . 5.0 mm -66.47 -52.21 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 48' ' ' THR . 66.4 mtp85 -71.02 -19.24 62.53 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.307 -0.871 . . . . 0.0 109.204 179.719 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.459 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 60.81 34.45 19.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 0.0 109.629 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 46' ' ' ARG . 8.7 p -123.06 -177.55 3.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.519 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 36.5 t-20 -107.59 64.78 0.63 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.224 -0.923 . . . . 0.0 109.527 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 25.0 m -78.91 127.71 32.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 109.66 179.841 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.519 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 3.8 m80 -113.84 -172.13 2.03 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.25 -0.906 . . . . 0.0 109.143 179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.474 HG12 HD13 ' A' ' 39' ' ' LEU . 22.9 mt -89.15 124.16 41.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.21 -0.932 . . . . 0.0 109.572 179.883 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.3 ttt-85 -80.8 -42.59 21.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.407 -0.808 . . . . 0.0 109.307 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p -160.95 140.77 10.83 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.563 -0.71 . . . . 0.0 109.139 -179.568 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 p -57.9 140.6 51.65 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -0.957 . . . . 0.0 109.623 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 96.38 165.91 33.68 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 27.5 mttp -67.6 143.36 56.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.532 -0.981 . . . . 0.0 109.258 179.768 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 62.3 m -53.43 148.92 8.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -0.914 . . . . 0.0 109.446 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.504 -179.955 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 21.0 p-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.26 0.553 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 5' ' ' CYS . 3.6 m -48.78 -33.11 9.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -0.833 . . . . 0.0 109.385 179.858 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.48 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 31.4 mt-10 -49.74 -30.5 9.54 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.692 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.4 mmm -76.23 -29.1 57.42 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.613 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.571 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.6 m -80.06 -5.0 55.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.369 -0.832 . . . . 0.0 109.301 179.608 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.48 ' HE3' ' HG2' ' A' ' 3' ' ' GLU . 23.7 mttm -61.26 -28.73 69.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.0 110.087 -179.546 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 80.5 m-20 -145.1 61.66 1.3 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.067 -1.021 . . . . 0.0 110.339 -179.635 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.637 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 6.5 p90 -127.03 171.34 11.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.064 -1.023 . . . . 0.0 109.309 179.429 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -146.14 148.9 33.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.277 -0.89 . . . . 0.0 109.567 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 15' ' ' GLY . 85.8 t -138.51 132.26 40.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.298 -0.876 . . . . 0.0 109.419 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -123.66 175.65 2.68 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.349 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.5 Cg_endo -67.21 -25.84 42.71 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.53 2.153 . . . . 0.0 111.514 179.813 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -107.37 -27.33 10.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.388 -0.82 . . . . 0.0 108.991 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 28.9 mm -82.06 -39.77 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.421 -0.799 . . . . 0.0 109.437 -179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.771 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 68.98 -145.62 43.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.637 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 3.3 t80 -111.17 155.17 23.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -1.164 . . . . 0.0 109.27 179.723 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 39.7 mt -111.64 123.79 50.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.267 -0.895 . . . . 0.0 109.942 -179.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.1 m -142.0 155.36 65.58 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.457 -0.777 . . . . 0.0 108.954 179.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.36 164.57 34.66 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.51 2.14 . . . . 0.0 111.554 179.912 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -83.46 -26.48 30.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.875 . . . . 0.0 109.544 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -60.51 129.31 40.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.253 -0.905 . . . . 0.0 109.299 179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 34' ' ' ASN . 52.7 tp -88.8 123.17 32.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.933 . . . . 0.0 109.472 -179.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.537 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.2 mmtm -133.91 102.74 12.15 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.432 -0.793 . . . . 0.0 109.179 179.815 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' CB ' ' HG3' ' A' ' 57' ' ' LYS . 42.1 Cg_endo -64.05 122.04 9.91 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 123.032 2.488 . . . . 0.0 112.331 -179.222 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.432 ' O ' HG23 ' A' ' 32' ' ' THR . 16.8 m -122.22 155.41 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.272 -0.892 . . . . 0.0 109.753 179.856 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 34.7 t -99.15 137.51 37.56 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.403 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.16 138.74 14.13 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -179.212 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 56.6 p30 -63.59 -11.14 22.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.392 -1.064 . . . . 0.0 109.671 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.469 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 86.4 m-20 -85.76 12.93 7.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.0 109.345 179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.39 20.22 69.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.909 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.46 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.0 mt-30 -124.52 159.52 30.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.294 -1.121 . . . . 0.0 109.511 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 57.3 m -119.97 142.66 48.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.16 -0.963 . . . . 0.0 109.569 179.811 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.648 ' CD2' HD12 ' A' ' 39' ' ' LEU . 57.7 m-85 -121.36 130.88 53.86 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.386 -0.821 . . . . 0.0 109.16 179.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.1 m-20 -53.8 -76.07 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.16 -0.962 . . . . 0.0 109.54 -179.616 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 11.4 t-20 -82.26 147.07 56.0 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 120.99 -1.069 . . . . 0.0 109.699 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.0 Cg_endo -63.1 -51.24 2.94 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.569 2.179 . . . . 0.0 111.409 179.371 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.502 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.4 t -60.25 -29.75 68.98 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.804 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.479 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 38.3 mmm -64.4 -23.52 67.32 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.35 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.648 HD12 ' CD2' ' A' ' 33' ' ' TYR . 7.2 tt -63.4 -48.01 79.6 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.362 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 12.0 t -52.63 -34.01 49.32 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -54.43 -50.04 68.59 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.364 -0.835 . . . . 0.0 108.763 179.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.51 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 26.2 tp10 -56.78 -19.9 19.52 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.363 -0.836 . . . . 0.0 108.774 179.338 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 4.7 m-80 -80.06 -31.65 39.43 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.328 -0.858 . . . . 0.0 109.125 179.785 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.862 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.4 tm? -68.89 -42.39 77.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.084 179.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 45' ' ' ILE . 4.0 mt -71.17 -55.22 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 109.175 179.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.443 ' NH1' ' HG2' ' A' ' 46' ' ' ARG . 35.6 mtt-85 -70.33 -21.73 62.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.394 -0.816 . . . . 0.0 109.258 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.461 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 62.3 32.33 17.08 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.343 -179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.9 p -119.52 176.78 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.301 -0.875 . . . . 0.0 109.353 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.532 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 84.6 m-20 -100.13 61.37 1.08 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.914 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.481 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 56.0 m -71.79 131.7 43.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.29 -0.882 . . . . 0.0 109.522 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.532 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 14.7 m-70 -116.58 -175.88 2.85 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.254 -0.904 . . . . 0.0 109.277 179.73 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.502 HG12 HD13 ' A' ' 39' ' ' LEU . 20.6 mt -86.19 124.26 40.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.199 -0.938 . . . . 0.0 109.542 179.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 70.1 ttt180 -80.53 -39.71 27.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.421 -0.799 . . . . 0.0 109.051 179.694 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 t -158.57 153.56 25.18 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.2 p -73.39 145.57 45.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.179 -0.951 . . . . 0.0 109.495 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.92 164.71 40.51 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.364 -1.494 . . . . 0.0 109.364 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HG3' ' CB ' ' A' ' 24' ' ' PRO . 37.5 mttp -63.09 144.88 56.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.478 -1.013 . . . . 0.0 109.406 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.411 ' HB2' ' OG1' ' A' ' 32' ' ' THR . 0.1 OUTLIER -78.53 156.08 29.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 0.0 109.404 179.992 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.57 179.998 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' A' ' 3' ' ' GLU . 24.4 p30 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -47.8 -29.92 3.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.236 -0.915 . . . . 0.0 109.617 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.467 ' HB2' ' OD1' ' A' ' 1' ' ' ASP . 1.2 mt-10 -54.73 -21.81 12.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.271 -0.893 . . . . 0.0 109.008 179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 1' ' ' ASP . 51.1 mmm -77.56 -26.85 51.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.37 -0.831 . . . . 0.0 108.957 179.535 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 38.2 m -81.19 -19.58 43.03 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.387 -0.821 . . . . 0.0 109.331 179.825 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -80.68 9.26 6.42 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 109.833 179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -133.17 2.69 3.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.144 -0.973 . . . . 0.0 109.958 -179.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.594 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -119.45 144.89 46.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.02 -1.05 . . . . 0.0 109.74 -179.916 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.0 mtt85 -127.5 129.83 48.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 0.0 108.894 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.796 ' O ' HD22 ' A' ' 11' ' ' LEU . 42.9 t -116.76 141.49 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.035 -1.041 . . . . 0.0 110.201 -179.289 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.796 HD22 ' O ' ' A' ' 10' ' ' VAL . 4.0 mm? -124.43 171.09 7.69 Favored Pre-proline 0 N--CA 1.49 1.565 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.582 ' HD2' HD12 ' A' ' 11' ' ' LEU . 42.7 Cg_endo -66.28 -22.25 53.54 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.305 2.003 . . . . 0.0 111.666 179.855 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -97.0 -29.51 13.61 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 109.206 179.635 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.466 HD12 ' HB2' ' A' ' 11' ' ' LEU . 80.6 mt -83.06 -48.57 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.377 -0.827 . . . . 0.0 109.402 179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.744 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 86.7 -175.0 46.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.459 ' OH ' ' HB3' ' A' ' 40' ' ' CYS . 1.5 t80 -81.15 153.05 27.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -1.143 . . . . 0.0 109.544 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' A' ' 17' ' ' LEU . 38.6 mt -127.86 134.08 49.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.283 -0.886 . . . . 0.0 109.588 179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 72.4 m -146.92 158.4 45.35 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.347 -0.845 . . . . 0.0 109.141 179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.9 Cg_endo -69.52 167.5 23.94 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.636 2.224 . . . . 0.0 111.459 179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -85.62 -21.72 28.31 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.188 -0.945 . . . . 0.0 109.693 -179.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -68.01 115.98 8.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -0.929 . . . . 0.0 109.307 179.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 35' ' ' ASN . 32.9 tp -86.95 121.38 29.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.174 -0.954 . . . . 0.0 109.536 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' O ' ' O ' ' A' ' 34' ' ' ASN . 13.0 mmtm -135.83 113.26 10.75 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.403 -0.81 . . . . 0.0 108.908 179.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.531 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -64.78 116.06 3.59 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.953 2.436 . . . . 0.0 112.13 -179.351 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 32' ' ' THR . 34.2 m -113.53 156.13 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.4 -0.813 . . . . 0.0 109.956 -179.822 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.5 t -100.49 124.02 45.47 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.076 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -80.85 137.54 18.13 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.621 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.584 ' OD1' HG23 ' A' ' 50' ' ' THR . 46.8 p30 -63.9 -10.58 21.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -1.127 . . . . 0.0 109.727 -179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.412 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 28.5 m-20 -87.29 16.76 4.93 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.17 -0.956 . . . . 0.0 109.444 179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.52 19.59 75.95 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.8 mt-30 -120.83 169.0 10.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.33 -1.1 . . . . 0.0 109.392 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 88.6 m -129.86 142.71 50.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.403 179.755 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.756 ' HD2' HD12 ' A' ' 39' ' ' LEU . 41.8 m-85 -122.43 118.0 27.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.329 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.1 m-20 -43.09 -75.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.333 -0.855 . . . . 0.0 109.536 -179.656 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.1 t-20 -81.79 150.28 65.54 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.348 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.471 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.5 Cg_endo -62.81 -54.5 1.17 Allowed 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.684 2.256 . . . . 0.0 111.906 -179.867 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 4.0 t -58.42 -30.5 66.92 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.947 -1.095 . . . . 0.0 108.149 179.051 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 7.5 mtt -59.71 -21.09 60.16 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.53 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.882 HD13 HG12 ' A' ' 52' ' ' ILE . 7.3 tt -66.89 -53.63 30.29 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 16.9 t -49.48 -28.56 5.48 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.437 ' CD2' HD11 ' A' ' 45' ' ' ILE . 21.5 t60 -57.89 -53.58 56.64 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.282 -0.886 . . . . 0.0 108.617 179.078 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.59 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 16.3 tp10 -54.03 -20.48 6.43 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.199 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.8 m-80 -80.46 -33.44 36.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.376 -0.828 . . . . 0.0 108.773 179.541 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.3 tp -73.26 -39.35 65.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.83 . . . . 0.0 109.346 179.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.437 HD11 ' CD2' ' A' ' 41' ' ' HIS . 1.0 OUTLIER -80.31 -46.56 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.66 -179.888 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' HG3' ' HG3' ' A' ' 42' ' ' GLU . 27.0 mmt180 -80.3 -33.83 37.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -0.939 . . . . 0.0 109.542 -179.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 89.5 mt-30 58.97 32.05 21.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.504 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 81.2 p -104.63 6.23 34.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.151 -0.968 . . . . 0.0 109.637 -179.956 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.567 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 73.3 m-20 63.11 52.86 2.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 109.637 179.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.584 HG23 ' OD1' ' A' ' 28' ' ' ASP . 91.6 m -78.7 142.35 37.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 109.357 179.772 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 35.7 m80 -120.33 -171.7 2.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.21 -0.931 . . . . 0.0 109.535 179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.882 HG12 HD13 ' A' ' 39' ' ' LEU . 11.2 mt -92.05 123.35 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 179.848 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.4 ttt180 -79.31 -50.73 10.44 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.327 -0.858 . . . . 0.0 109.433 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -158.93 139.31 12.35 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 109.348 -179.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.435 ' H ' HG23 ' A' ' 55' ' ' THR . 7.4 p -53.54 145.86 14.11 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.193 -0.942 . . . . 0.0 109.418 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.35 162.91 35.5 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.784 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 53.8 mttp -66.93 150.04 49.77 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.458 -1.025 . . . . 0.0 109.528 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 72.7 m -59.27 147.17 36.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.91 . . . . 0.0 109.395 -179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.534 -179.932 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.287 0.565 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.502 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 3.6 m -60.11 -33.4 72.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 0.0 109.431 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -54.75 -25.93 30.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.0 109.119 179.872 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.6 ttt -73.57 -26.14 60.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.421 -0.799 . . . . 0.0 109.034 179.547 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.591 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 30.7 m -82.76 -15.46 51.71 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.3 -0.875 . . . . 0.0 109.451 179.79 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 23.5 mttm -80.65 7.51 9.97 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.234 -0.916 . . . . 0.0 109.729 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 98.3 m-20 -138.23 16.02 2.8 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.028 -1.045 . . . . 0.0 110.29 -179.401 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.1 p90 -126.58 153.0 45.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.925 -1.11 . . . . 0.0 109.697 179.857 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -131.53 143.84 50.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.309 -0.869 . . . . 0.0 108.834 179.171 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.865 HG13 ' O ' ' A' ' 15' ' ' GLY . 55.7 t -132.65 134.96 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.292 -0.88 . . . . 0.0 109.567 -179.766 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.74 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -115.11 174.65 2.25 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.226 179.89 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.74 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.4 Cg_endo -67.15 -22.63 46.81 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.59 2.194 . . . . 0.0 111.68 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -101.7 -22.0 14.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.559 179.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 11' ' ' LEU . 94.8 mt -88.96 -45.42 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.226 -0.921 . . . . 0.0 109.671 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.865 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 77.27 -165.65 53.26 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 -179.746 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.7 t80 -96.02 150.01 20.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.16 -1.2 . . . . 0.0 109.499 179.935 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.5 tp -116.97 118.33 32.12 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.244 -0.91 . . . . 0.0 109.606 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.3 m -130.34 157.03 78.53 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.092 179.707 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.9 Cg_endo -70.91 166.31 29.44 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.612 2.208 . . . . 0.0 111.655 -179.721 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -86.42 -20.9 27.51 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.308 -0.87 . . . . 0.0 109.352 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -65.4 125.95 26.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.95 . . . . 0.0 109.11 179.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.1 tp -90.77 119.22 30.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.202 -0.936 . . . . 0.0 109.683 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -132.82 106.84 12.73 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.031 179.689 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -65.09 120.55 7.8 Favored 'Trans proline' 0 C--O 1.212 -0.805 0 C-N-CA 122.88 2.387 . . . . 0.0 112.108 -179.556 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.49 ' HB ' HG23 ' A' ' 52' ' ' ILE . 30.3 m -118.14 154.45 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.315 -0.866 . . . . 0.0 109.644 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 31.1 t -97.11 136.14 38.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.251 -0.906 . . . . 0.0 108.769 179.235 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.29 139.98 16.47 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.472 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.7 t0 -70.95 -5.33 30.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.141 -1.211 . . . . 0.0 109.563 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 57.0 p30 -92.84 5.82 49.88 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 109.344 179.676 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.19 14.93 53.39 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.873 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -116.07 175.83 5.37 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -1.116 . . . . 0.0 109.561 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.929 HG21 ' HG3' ' A' ' 57' ' ' LYS . 30.5 m -138.94 135.43 34.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.377 -0.827 . . . . 0.0 109.122 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.774 ' CD1' HD13 ' A' ' 39' ' ' LEU . 22.0 m-85 -115.6 131.08 57.04 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.324 -0.86 . . . . 0.0 109.307 -179.887 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.5 m-20 -55.41 -76.95 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.255 -0.903 . . . . 0.0 109.625 -179.515 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.9 t-20 -81.94 148.54 61.04 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.014 -1.053 . . . . 0.0 109.81 -179.73 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.464 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.4 Cg_endo -62.73 -53.8 1.54 Allowed 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.897 2.398 . . . . 0.0 111.916 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.9 t -62.37 -26.91 68.72 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.073 -1.017 . . . . 0.0 108.381 179.189 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.47 ' SD ' ' HB3' ' A' ' 35' ' ' ASN . 18.8 mtt -64.67 -18.1 64.67 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.343 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.774 HD13 ' CD1' ' A' ' 33' ' ' TYR . 26.8 tp -66.82 -54.96 17.24 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.451 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.467 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 14.2 t -61.21 -23.9 65.95 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.57 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.6 t60 -70.12 -60.94 1.98 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 179.19 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 84.2 tt0 -56.7 -20.98 24.59 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.434 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 47' ' ' GLN . 86.5 m-20 -78.64 -35.99 44.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.133 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.444 HD12 ' HA ' ' A' ' 44' ' ' LEU . 42.9 tp -58.65 -33.82 70.51 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.317 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mt -77.55 -50.18 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.433 -0.792 . . . . 0.0 108.922 179.452 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 34.5 mtt-85 -69.06 -24.15 64.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.364 -0.835 . . . . 0.0 109.263 179.685 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 43' ' ' ASN . 88.8 mt-30 64.13 41.75 6.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.342 -0.849 . . . . 0.0 109.478 -179.858 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.4 p -124.74 165.36 18.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -0.877 . . . . 0.0 109.267 179.86 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -98.36 63.49 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.213 -0.929 . . . . 0.0 109.403 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.4 m -78.29 136.24 37.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.358 -0.839 . . . . 0.0 109.84 -179.866 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.502 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 51.3 m-70 -114.26 171.44 7.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.367 -0.833 . . . . 0.0 109.181 179.63 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.557 HG12 HD22 ' A' ' 39' ' ' LEU . 40.7 mt -80.04 126.92 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 0.0 109.5 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 73.4 ttt180 -79.91 -49.81 11.36 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.652 0.739 . . . . 0.0 109.314 179.806 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.7 m -156.57 145.84 20.5 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -179.858 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.4 p -61.99 151.3 35.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.158 -0.964 . . . . 0.0 109.537 -179.939 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 81.36 163.49 31.03 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.699 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.929 ' HG3' HG21 ' A' ' 32' ' ' THR . 14.6 tttt -63.81 150.58 44.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.385 -1.068 . . . . 0.0 109.259 179.838 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -78.24 148.3 34.02 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.241 -0.912 . . . . 0.0 109.533 -179.909 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.475 179.916 . . . . . . . . 0 0 . 1 stop_ save_